PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Schiffmann, R; Kopp, JB; Austin, HA; Sabnis, S; Moore, DF; Weibel, T; Balow, JE; Brady, RO				Schiffmann, R; Kopp, JB; Austin, HA; Sabnis, S; Moore, DF; Weibel, T; Balow, JE; Brady, RO			Enzyme replacement therapy in Fabry disease - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANCER PAIN; MANIFESTATIONS; INVOLVEMENT; SEVERITY; STORAGE	Context Fabry disease is a metabolic disorder without a specific treatment, caused by a deficiency of the lysosomal enzyme alpha -galactosidase A (alpha -gal A). Most patients experience debilitating neuropathic pain and premature mortality because of renal failure, cardiovascular disease, or cerebrovascular disease. Objective To evaluate the safety and efficacy of intravenous alpha -gal A for Fabry disease. Design and Setting Double-blind placebo-controlled trial conducted from December 1998 to August 1999 at the Clinical Research Center of the National Institutes of Health. Patients Twenty-six hemizygous male patients, aged 18 years or older, with Fabry disease that was confirmed by alpha -gal A assay, Intervention A dosage of 0.2 mg/kg of alpha -gal A, administered intravenously every other week (12 doses total), Main Outcome Measure Effect of therapy on neuropathic pain while without neuropathic pain medications measured by question 3 of the Brief Pain Inventory (BPI), Results Mean (SE) BPI neuropathic pain severity score declined from 6.2 (0.46) to 4.3 (0.73) in patients treated with alpha -gal A vs no significant change in the placebo group (P =.02). Pain-related quality of life declined from 3.2 (0.55) to 2.1 (0.56) for patients receiving alpha -gal A vs 4.8 (0.59) to 4.2 (0.74) for placebo (P =.05). In the kidney, glomeruli with mesangial widening decreased by a mean of 12.5% for patients receiving alpha -gal vs a 16.5% increase for placebo (P =.01), Mean inulin clearance decreased by 6.2 mL/min for patients receiving alpha -gal A vs 19.5 mL/min for placebo (P =.19). Mean creatinine clearance increased by 2.1 mL/min (0.4 mL/s) for patients receiving a-gal A vs a decrease of 16.1 mL/min (0.3 mL/s) for placebo (P =.02). In patients treated with alpha -gal A, there was an approximately 50% reduction in plasma glycosphingolipid levels, a significant improvement in cardiac conduction, and a significant increase in body weight. Conclusion Intravenous infusions of alpha -gal A are safe and have widespread therapeutic efficacy in Fabry disease.	NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; Armed Forces Inst Pathol, Div Nephropathol, Washington, DC 20306 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); United States Department of Defense	Schiffmann, R (corresponding author), NINDS, Dev & Metab Neurol Branch, NIH, Bldg 10,Room 3D03,9000 Rockville Pike, Bethesda, MD 20892 USA.		Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK043308, ZIADK043308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002984] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 2014, METABOLIC MOL BASES; BECKER AE, 1975, AM J CARDIOL, V36, P829, DOI 10.1016/0002-9149(75)90468-3; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; BRADY RO, 1973, NEW ENGL J MED, V289, P9, DOI 10.1056/NEJM197307052890103; Breitbart W, 1996, PAIN, V68, P315, DOI 10.1016/S0304-3959(96)03215-0; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; Crawley AC, 1996, J CLIN INVEST, V97, P1864, DOI 10.1172/JCI118617; Crutchfield KE, 1998, NEUROLOGY, V50, P1746, DOI 10.1212/WNL.50.6.1746; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; DESNICK RJ, 1979, P NATL ACAD SCI USA, V76, P5326, DOI 10.1073/pnas.76.10.5326; DESNICK RJ, 1976, CIRCULATION, V54, P818, DOI 10.1161/01.CIR.54.5.818; DEVEBER GA, 1992, ANN NEUROL, V31, P409, DOI 10.1002/ana.410310410; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; GUBLER MC, 1978, KIDNEY INT, V13, P223, DOI 10.1038/ki.1978.32; KAHN P, 1973, J NEUROL NEUROSUR PS, V36, P1053, DOI 10.1136/jnnp.36.6.1053; KAKKIS ED, 1994, PROTEIN EXPRES PURIF, V5, P225, DOI 10.1006/prep.1994.1035; KAYE EM, 1988, ANN NEUROL, V23, P505, DOI 10.1002/ana.410230513; LARUE F, 1995, BRIT MED J, V310, P1034, DOI 10.1136/bmj.310.6986.1034; LYDICK E, 1995, QUAL LIFE RES, V4, P41, DOI 10.1007/BF00434382; MEHTA J, 1977, AM HEART J, V93, P699, DOI 10.1016/S0002-8703(77)80064-1; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Mistry PK, 1996, LANCET, V348, P1555, DOI 10.1016/S0140-6736(96)04451-0; PABICO RC, 1973, AM J MED, V55, P415, DOI 10.1016/0002-9343(73)90140-X; SAKURABA H, 1986, CLIN GENET, V29, P276; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; SETH KJ, 1983, AM J KIDNEY DIS, V2, P651; SHACHAM S, 1984, PAIN, V18, P187, DOI 10.1016/0304-3959(84)90886-8; Sirvent AE, 1997, NEPHROL DIAL TRANSPL, V12, P1503, DOI 10.1093/ndt/12.7.1503	30	988	1038	1	35	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2743	2749		10.1001/jama.285.21.2743	http://dx.doi.org/10.1001/jama.285.21.2743			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386930				2022-12-28	WOS:000168985800027
J	Gandy, S; Naslund, J; Nordstedt, C				Gandy, S; Naslund, J; Nordstedt, C			Alzheimer's disease - Molecular consequences of presenilin-1 mutation	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; PEPTIDE VARIANTS; BETA-PROTEIN; INHIBITORS		Univ Western Australia, Sir James McCusker Alzheimer Res Unit, Perth, WA, Australia; NYU, Sch Med, Dept Psychiat, Orangeburg, NY 10962 USA; Karolinska Inst, S-14186 Huddinge, Sweden; AstraZeneca, S-15185 Sodertalje, Sweden	University of Western Australia; New York University; Karolinska Institutet; AstraZeneca	Gandy, S (corresponding author), Univ Western Australia, Sir James McCusker Alzheimer Res Unit, Perth, WA, Australia.	samgandy@earthlink.net						CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Chen FS, 2000, J BIOL CHEM, V275, P36794, DOI 10.1074/jbc.M006986200; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Gouras GK, 1998, J NEUROCHEM, V71, P1920; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735	12	8	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					654	655		10.1038/35079682	http://dx.doi.org/10.1038/35079682			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395757				2022-12-28	WOS:000169112500031
J	Bellwood, DR; Hughes, TP				Bellwood, DR; Hughes, TP			Regional-scale assembly rules and biodiversity of coral reefs	SCIENCE			English	Article							LONG-TERM; DIVERSITY; CONSEQUENCES; RECOVERY; PATTERNS; DISTURBANCE; LEVEL	Tropical reef fishes and corals exhibit highly predictable patterns of taxonomic composition across the Indian and Pacific Oceans. Despite steep Longitudinal and Latitudinal gradients in total species richness, the composition of these key taxa is constrained within a remarkably narrow range of values. Regional-scale variation in reef biodiversity is best explained by Large-scale patterns in the availability of shallow-water habitat. Once habitat area is accounted for, there is surprisingly little residual effect of Latitude or Longitude. Low-diversity regions are most vulnerable to human impacts such as global warming, underscoring the urgent need for integrated management at multinational scales.	James Cook Univ N Queensland, Dept Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia	James Cook University	Bellwood, DR (corresponding author), James Cook Univ N Queensland, Dept Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia.	david.bellwood@jcu.edu.au	Hughes, Terry P/L-4721-2013; Bellwood, David/E-2497-2011	Hughes, Terry P/0000-0002-5257-5063; 				Ayre DJ, 2000, EVOLUTION, V54, P1590; Bellwood D. R., 1997, P 8 INT COR REEF S, V1, P379; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; BROWN BE, 1985, ADV MAR BIOL, V22, P1, DOI 10.1016/S0065-2881(08)60049-8; Bryant D., 1998, REEFS RISK MAP BASED; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; JABLONSKI D, 1987, SCIENCE, V238, P360, DOI 10.1126/science.238.4825.360; JACKSON JBC, 1974, AM NAT, V108, P541, DOI 10.1086/282933; JACKSON JBC, 1993, SCIENCE, V260, P1624, DOI 10.1126/science.260.5114.1624; JACKSON JBC, IN PRESS SCIENCE; Leis J.M., 1991, P183; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Palumbi SR, 1997, CORAL REEFS, V16, pS47, DOI 10.1007/s003380050241; PAULAY G, 1990, PALEOBIOLOGY, V16, P415, DOI 10.1017/S0094837300010162; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 1999, SCIENCE, V284, P276, DOI 10.1126/science.284.5412.276; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; STEHLI FG, 1971, SYST ZOOL, V20, P115, DOI 10.2307/2412052; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; VERON JEN, 1995, CORALS SPACE TIME BI; Wilson Moyra E. J., 1998, P165	33	420	445	1	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1532	1534		10.1126/science.1058635	http://dx.doi.org/10.1126/science.1058635			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375488				2022-12-28	WOS:000168963800041
J	Avraham, N; Khaykovich, B; Myasoedov, Y; Rappaport, M; Shtrikman, H; Feldman, DE; Tamegai, T; Kes, PH; Li, M; Konczykowski, M; van der Beek, K; Zeldov, E				Avraham, N; Khaykovich, B; Myasoedov, Y; Rappaport, M; Shtrikman, H; Feldman, DE; Tamegai, T; Kes, PH; Li, M; Konczykowski, M; van der Beek, K; Zeldov, E			'Inverse' melting of a vortex lattice	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; SINGLE-CRYSTALS; BI2SR2CACU2O8 CRYSTALS; PHASE-DIAGRAM; TRANSITION; YBA2CU3O7-DELTA; GLASS; IRREVERSIBILITY; VORTICES; BARRIERS	Inverse melting is the process in which a crystal reversibly transforms into a liquid or amorphous phase when its temperature is decreased. Such a process is considered to be very rare(1), and the search for it is often hampered by the formation of non-equilibrium states or intermediate phases(2). Here we report the discovery of first-order inverse melting of the lattice formed by magnetic flux lines in a high-temperature superconductor. At low temperatures, disorder in the material pins the vortices, preventing the observation of their equilibrium properties and therefore the determination of whether a phase transition occurs. But by using a technique(3) to 'dither' the vortices, we were able to equilibrate the lattice, which enabled us to obtain direct thermodynamic evidence of inverse melting of the ordered lattice into a disordered vortex phase as the temperature is decreased. The ordered lattice has larger entropy than the low-temperature disordered phase. The mechanism of the first-order phase transition changes gradually from thermally induced melting at high temperatures to a disorder-induced transition at low temperatures.	Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel; LD Landau Theoret Phys Inst, Chernogolovka 142432, Moscow Region, Russia; Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan; Leiden Univ, Kamerlingh Onnes Lab, NL-2300 RA Leiden, Netherlands; Ecole Polytech, Solides Irradies Lab, CNRS, UMR 7642, F-91128 Palaiseau, France; Ecole Polytech, CEA, DSM, DRECAM, F-91128 Palaiseau, France	Weizmann Institute of Science; Russian Academy of Sciences; Landau Institute for Theoretical Physics; University of Tokyo; Japan Science & Technology Agency (JST); Leiden University; Leiden University - Excl LUMC; CEA; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; CNRS - Institute of Physics (INP); CEA; Institut Polytechnique de Paris	Avraham, N (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel.	nurit.avraham@weizmann.ac.il	Khaykovich, Boris/A-7376-2012; Konczykowski, Marcin/AAI-3112-2020; Tamegai, Tsuyoshi/C-6656-2011; van der Beek, C J/E-4359-2018; Zeldov, Eli/K-1546-2012	Khaykovich, Boris/0000-0002-9490-2771; van der Beek, C J/0000-0003-1870-7920; Zeldov, Eli/0000-0002-8200-4974; Konczykowski, Marcin/0000-0003-3376-5635				BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Burlachkov L, 1996, PHYS REV B, V54, P6750, DOI 10.1103/PhysRevB.54.6750; CHIKUMOTO N, 1992, PHYS REV LETT, V69, P1260, DOI 10.1103/PhysRevLett.69.1260; CUBITT R, 1993, NATURE, V365, P407, DOI 10.1038/365407a0; Deligiannis K, 1997, PHYS REV LETT, V79, P2121, DOI 10.1103/PhysRevLett.79.2121; Ertas D, 1996, PHYSICA C, V272, P79, DOI 10.1016/S0921-4534(96)00563-1; Fuchs DT, 1998, PHYS REV LETT, V80, P4971, DOI 10.1103/PhysRevLett.80.4971; Gaifullin MB, 2000, PHYS REV LETT, V84, P2945, DOI 10.1103/PhysRevLett.84.2945; GIAMARCHI T, 1994, PHYS REV LETT, V72, P1530, DOI 10.1103/PhysRevLett.72.1530; Giller D, 2000, PHYS REV LETT, V84, P3698, DOI 10.1103/PhysRevLett.84.3698; Giller D, 1997, PHYS REV LETT, V79, P2542, DOI 10.1103/PhysRevLett.79.2542; Greer AL, 2000, NATURE, V404, P134, DOI 10.1038/35004689; Khaykovich B, 1996, PHYS REV LETT, V76, P2555, DOI 10.1103/PhysRevLett.76.2555; Kierfeld J, 2000, PHYS REV B, V61, P14928, DOI 10.1103/PhysRevB.61.R14928; Koshelev AE, 1999, PHYS REV LETT, V83, P187, DOI 10.1103/PhysRevLett.83.187; KWOK WK, 1992, PHYS REV LETT, V69, P3370, DOI 10.1103/PhysRevLett.69.3370; LI TW, 1994, J CRYST GROWTH, V135, P481, DOI 10.1016/0022-0248(94)90138-4; Nattermann T, 2000, ADV PHYS, V49, P607, DOI 10.1080/000187300412257; NONOMURA Y, 2000, CONDMAT0011349; OLSSON P, 2000, CONDMAT0012184; Ooi S, 1998, PHYSICA C, V302, P339, DOI 10.1016/S0921-4534(98)00215-9; Paltiel Y, 2000, PHYS REV LETT, V85, P3712, DOI 10.1103/PhysRevLett.85.3712; PASTORIZA H, 1994, PHYS REV LETT, V72, P2951, DOI 10.1103/PhysRevLett.72.2951; Rastogi S, 1999, MACROMOLECULES, V32, P8897, DOI 10.1021/ma9912958; Reichhardt C, 2000, PHYS REV LETT, V84, P1994, DOI 10.1103/PhysRevLett.84.1994; SAFAR H, 1992, PHYS REV LETT, V69, P824, DOI 10.1103/PhysRevLett.69.824; van der Beek CJ, 2000, PHYS REV LETT, V84, P4196, DOI 10.1103/PhysRevLett.84.4196; Willemin M, 1998, PHYS REV LETT, V81, P4236, DOI 10.1103/PhysRevLett.81.4236; ZELDOV E, 1995, NATURE, V375, P373, DOI 10.1038/375373a0; ZELDOV E, 1994, PHYS REV LETT, V73, P1428, DOI 10.1103/PhysRevLett.73.1428	30	245	245	0	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					451	454		10.1038/35078021	http://dx.doi.org/10.1038/35078021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373671	Green Submitted			2022-12-28	WOS:000168858700040
J	Ohida, T; Sakurai, H; Mochizuki, Y; Kamal, AMM; Takemura, S; Minowa, M; Kawahara, K				Ohida, T; Sakurai, H; Mochizuki, Y; Kamal, AMM; Takemura, S; Minowa, M; Kawahara, K			Smoking prevalence and attitudes toward smoking among Japanese physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIGARETTE-SMOKING; HOSPITAL STAFF; HABITS; INTERVENTION; NURSES	Context The World Health Organization has advocated that physicians should not smoke cigarettes and surveys on this issue should be conducted among medical professionals. However, no nationally representative surveys of smoking among physicians in Japan have been reported. Objectives To estimate the nationwide prevalence of smoking and determine the attitudes toward smoking among Japanese physicians. Design, Setting, and Participants Descriptive study in which anonymous questionnaires were mailed to 4500 randomly selected physician members of the Japan Medical Association in the year 2000, which represents 63% of all Japanese physicians; 3771 (84%) respondents were included in the analysis. Main Outcome Measures Smoking prevalence among physicians, history of smoking, and attitudes toward smoking. Results The prevalence of cigarette smoking among physicians was 27.1% for men and 6.8% for women, about half the age-adjusted prevalences among the general Japanese population. Smoking prevalence was higher among male physicians in Ja pan than those in the United States (3%-10%) and the United Kingdom (4%-5%), Smoking prevalence differed by age, with the highest prevalence among male past smokers aged 70 years or older (51.8%; 95% confidence interval [CI], 47.4%-56.2%). Among male current smokers, the highest rates were for those aged 40 to 49 years (31%; 95% CI, 27.5%-34.5%); rates for female past smokers were highest among those aged 50 to 59 years (10.7%; 95% CI, 6.6%-14.8%) and for female current smokers were highest among those aged 70 years or older (8.2%; 95% CI, 4.8%-11.6%). Nonsmoking physicians had more unfavorable views toward smoking and were more active in encouraging patients not to smoke than those physicians who smoked. Conclusion Smoking cessation programs should be introduced among Japanese physicians to reduce the number of smoking physicians. Also, a continuing education program should be instituted to motivate physicians about their role in society.	Natl Inst Publ Hlth, Dept Publ Hlth Adm, Minato Ku, Tokyo 1088638, Japan; Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hlth Policy Sci, Tokyo, Japan; Natl Inst Publ Hlth, Dept Epidemiol, Tokyo 108, Japan; Japan Med Assoc, Tokyo, Japan	National Institute of Public Health - Japan; Tokyo Medical & Dental University (TMDU); National Institute of Public Health - Japan	Ohida, T (corresponding author), Natl Inst Publ Hlth, Dept Publ Hlth Adm, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088638, Japan.							BURGESS AM, 1970, NEW ENGL J MED, V282, P908, DOI 10.1056/NEJM197004162821607; Davis RM, 1993, TOBACCO CONTR, V2, P187, DOI DOI 10.1136/tc.2.3.187; DEKKER HM, 1993, SOC SCI MED, V36, P817, DOI 10.1016/0277-9536(93)90042-3; FARGESTROM KO, 1978, ADDICT BEHAV, V3, P235; FOWLER FJ, 1993, SURVEY RES METHODS S; FOWLER G, 1989, LANCET, V1, P1253; Goldberg R J, 1993, J Cancer Educ, V8, P133; HALLETT R, 1983, J ROY COLL GEN PRACT, V33, P565; Hay DR, 1998, NEW ZEAL MED J, V111, P102; HENSRUD DD, 1993, AM J PUBLIC HEALTH, V83, P415, DOI 10.2105/AJPH.83.3.415; HOLLIS JF, 1993, ANN INTERN MED, V118, P521, DOI 10.7326/0003-4819-118-7-199304010-00006; HUGHES PH, 1991, JAMA-J AM MED ASSOC, V265, P2069, DOI 10.1001/jama.265.16.2069; HUSSAIN SF, 1993, THORAX, V48, P174, DOI 10.1136/thx.48.2.174; Igarashi S, 1989, TOYAMAKEN IHOU, V1012, P18; INOUE C, 1994, MED J SENDAI RED CRO, V3, P59; *JAP TOB IND INC, 1998, NAT CIG SMOK SURV 19; Kawahara K, 2000, J Epidemiol, V10, P157; *MIN HLTH WELF, 2000, HLTH JAP, V21, P111; Mori T, 1993, Nihon Koshu Eisei Zasshi, V40, P71; NAKAMURA M, 2001, GEKKAN HODANREN, V688, P13; NAKAMURA M, 1991, JPN J PRIM CARE, V14, P29; *NAT TAX ADM AG, 1998, ANN STAT REP 1998; NELSON DE, 1994, JAMA-J AM MED ASSOC, V271, P1273, DOI 10.1001/jama.271.16.1273; NOMURA Y, 1991, J KANAGAWA MED ASS, V18, P19; OCKENE JK, 1988, AM J PREV MED, V4, P14, DOI 10.1016/S0749-3797(18)31214-5; OSHIMA A, 2001, GEKKAN HODANREN, V688, P6; *STAT INF DEP, 1999, SURV PHYS DENT PHARM, P121; TESSIER JF, 1993, TOB CONTROL, V2, P226; TSUKUE I, 1997, J JPN MED ASS, V117, P197; UEDA K, 1999, NIPPON KOSHU EISEI S, V46, P193; *WHO, 1999, LEAV PACK, P33; *WORK GROUP TOB HL, 1987, GUID COND TOB SMOK S, P3; YOKOTA B, 1988, JPN MED J, V3337, P95; Zanetti F, 1998, PUBLIC HEALTH, V112, P57, DOI 10.1016/S0033-3506(98)00208-X	34	65	74	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2643	2648		10.1001/jama.285.20.2643	http://dx.doi.org/10.1001/jama.285.20.2643			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433LY	11368741				2022-12-28	WOS:000168761900034
J	Silagy, C; Formica, N				Silagy, C; Formica, N			Place of bupropion in smoking-cessation therapy	LANCET			English	Editorial Material									Monash Med Ctr, Monash Inst Hlth Serv Res, Melbourne, Vic 3168, Australia	Monash University	Silagy, C (corresponding author), Monash Med Ctr, Monash Inst Hlth Serv Res, Melbourne, Vic 3168, Australia.							FIORE MC, 2000, TREATING TOBACCO USE; HUGHES JR, 2000, COCHRANE DATABASE SY, V2; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Lancaster T, 2000, BRIT MED J, V321, P355, DOI 10.1136/bmj.321.7257.355; Peto R., 2000, CRITICAL ISSUES GLOB, P154; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987	6	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1550	1550		10.1016/S0140-6736(00)04781-4	http://dx.doi.org/10.1016/S0140-6736(00)04781-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377641				2022-12-28	WOS:000168830100007
J	Schuyler, SC; Pellman, D				Schuyler, SC; Pellman, D			Microtubule "plus-end-tracking proteins": The end is just the beginning	CELL			English	Review							YEAST; CLIP-170; DYNAMICS		Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Schuyler, SC (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.							Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Chen CR, 2000, MOL BIOL CELL, V11, P4067, DOI 10.1091/mbc.11.12.4067; Chen XYP, 1998, J CELL BIOL, V141, P1169, DOI 10.1083/jcb.141.5.1169; Choi JH, 2000, CURR BIOL, V10, P861, DOI 10.1016/S0960-9822(00)00599-6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Richards KL, 2000, MOL BIOL CELL, V11, P1887, DOI 10.1091/mbc.11.5.1887; Schroer TA, 2001, CURR OPIN CELL BIOL, V13, P92, DOI 10.1016/S0955-0674(00)00179-4; Schuyler SC, 2001, J CELL SCI, V114, P247; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Segal M, 2001, TRENDS CELL BIOL, V11, P160, DOI 10.1016/S0962-8924(01)01954-7; TIMAUER JS, 2000, J CELL BIOL, V149, P761	20	306	316	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					421	424		10.1016/S0092-8674(01)00364-6	http://dx.doi.org/10.1016/S0092-8674(01)00364-6			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371339	Bronze			2022-12-28	WOS:000168840700002
J	Baker, DA; Mille-Baker, B; Wainwright, SM; Ish-Horowicz, D; Dibb, NJ				Baker, DA; Mille-Baker, B; Wainwright, SM; Ish-Horowicz, D; Dibb, NJ			Mae mediates MAP kinase phosphorylation of Ets transcription factors in Drosophila	NATURE			English	Article							EMBRYONIC VENTRAL ECTODERM; EGF RECEPTOR PATHWAY; SIGNALING PATHWAY; DOMAIN PROTEIN; FEEDBACK LOOP; DNA-BINDING; YAN GENE; MIDLINE; MOTIF; DIFFERENTIATION	The evolutionarily conserved Ras/mitogen-activated protein kinase (MAPK) cascade is an integral part of the processes of cell division, differentiation, movement and death. Signals received at the cell surface are relayed into the nucleus, where MAPK phosphorylates and thereby modulates the activities of a subset of transcription factors(1,2). Here we report the cloning and characterization of a new component of this signal transduction pathway called Mae (for modulator of the activity of Ets). Mae is a signalling intermediate that directly links the MAPK signalling pathway to its downstream transcription factor targets. Phosphorylation by MAPK of the critical serine residue (Ser 127) of the Drosophila transcription factor Yan depends on Mae, and is mediated by the binding of Yan to Mae through their Pointed domains. This phosphorylation is both necessary and sufficient to abrogate transcriptional repression by Yan. Mae also regulates the activity of the transcriptional activator Pointed-P2 by a similar mechanism. Mae is essential for the normal development and viability of Drosophila, and is required in vivo for normal signalling of the epidermal growth factor receptor. Our study indicates that MAPK signalling specificity may depend on proteins that couple specific substrates to the kinase.	Hammersmith Hosp, Imperial Coll Sch Med, Inst Reprod & Dev Biol, Cell Signalling Unit, London W12 0NN, England; Imperial Canc Res Fund, Dev Genet Lab, London WC2A 3PX, England	Imperial College London; Cancer Research UK	Baker, DA (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Inst Reprod & Dev Biol, Cell Signalling Unit, Du Cane Rd, London W12 0NN, England.			Ish-Horowicz, David/0000-0001-5684-7129				BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Dumstrei K, 1998, DEVELOPMENT, V125, P3417; Gabay L, 1996, DEVELOPMENT, V122, P3355; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Golembo M, 1999, GENE DEV, V13, P158, DOI 10.1101/gad.13.2.158; Golembo M, 1996, DEVELOPMENT, V122, P3363; Golembo M, 1996, DEVELOPMENT, V122, P223; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KLAMBT C, 1993, DEVELOPMENT, V117, P163; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Rebay I, 2000, GENETICS, V154, P695; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Roch F, 1998, MOL GEN GENET, V257, P103, DOI 10.1007/PL00008620; Rogge R, 1995, DEVELOPMENT, V121, P3947; Scholz H, 1997, MECH DEVELOP, V64, P137; SOUDANT N, 1994, NUCLEIC ACIDS RES, V22, P3871, DOI 10.1093/nar/22.19.3871; Spradling AC, 1999, GENETICS, V153, P135; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wieschaus E., 1986, P199; Yagi Y, 1998, DEVELOPMENT, V125, P3625	31	58	59	1	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					330	334		10.1038/35077122	http://dx.doi.org/10.1038/35077122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357138				2022-12-28	WOS:000168710000053
J	Hoeijmakers, JHJ				Hoeijmakers, JHJ			Genome maintenance mechanisms for preventing cancer	NATURE			English	Review							NUCLEOTIDE EXCISION-REPAIR; DOUBLE-STRAND BREAK; TELOMERASE-DEFICIENT MICE; DNA MISMATCH REPAIR; XERODERMA-PIGMENTOSUM; MOUSE MODELS; PROTEIN MUTS; DAMAGE; RECOGNITION; INSTABILITY	The early notion that cancer is caused by mutations in genes critical for the control of cell growth implied that genome stability is important for preventing oncogenesis. During the past decade, knowledge about the mechanisms by which genes erode and the molecular machinery designed to counteract this time-dependent genetic degeneration has increased markedly. At the same time, it has become apparent that inherited or acquired deficiencies in genome maintenance systems contribute significantly to the onset of cancer. This review summarizes the main DNA caretaking systems and their impact on genome stability and carcinogenesis.	Erasmus Univ, Ctr Biomed Genet, MGC Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Ctr Biomed Genet, MGC Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Hoeijmakers, Jan/AAX-6972-2021; Pinheiro, Maísa/E-7424-2012					Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; BOOTSMA D, 2001, METABOLIC MOL BASES, V1, P677; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Buschta-Hedayat N, 1999, P NATL ACAD SCI USA, V96, P6090, DOI 10.1073/pnas.96.11.6090; Cadet J, 1997, Rev Physiol Biochem Pharmacol, V131, P1; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; de Boer J, 1999, BIOCHIMIE, V81, P127, DOI 10.1016/S0300-9084(99)80045-5; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; de Lange T, 1999, CELL, V98, P273, DOI 10.1016/S0092-8674(00)81955-8; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Digweed M, 1999, BIOESSAYS, V21, P649, DOI 10.1002/(SICI)1521-1878(199908)21:8<649::AID-BIES4>3.0.CO;2-O; Divine KK, 2001, MUTAT RES-DNA REPAIR, V461, P273, DOI 10.1016/S0921-8777(00)00059-8; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Goodman MF, 2000, CURR OPIN GENET DEV, V10, P162, DOI 10.1016/S0959-437X(00)00057-5; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; Gurley KE, 2001, CURR BIOL, V11, P191, DOI 10.1016/S0960-9822(01)00048-3; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Heyer J, 1999, ONCOGENE, V18, P5325, DOI 10.1038/sj.onc.1203036; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Jasin M, 2000, CANCER INVEST, V18, P78, DOI 10.3109/07357900009023065; Jiricny J, 2000, CURR OPIN GENET DEV, V10, P157, DOI 10.1016/S0959-437X(00)00066-6; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; LAWRENCE C, 1994, BIOESSAYS, V16, P253, DOI 10.1002/bies.950160408; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOEB LA, 1991, CANCER RES, V51, P3075; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Tang RP, 1998, CANCER RES, V58, P4052; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; YAMAIZUMI M, 1994, ONCOGENE, V9, P2775; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	67	2949	3087	10	486	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					366	374		10.1038/35077232	http://dx.doi.org/10.1038/35077232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357144				2022-12-28	WOS:000168710000059
J	Liotta, LA; Kohn, EC				Liotta, LA; Kohn, EC			The microenvironment of the tumour-host interface	NATURE			English	Article							CARCINOMA IN-SITU; GROWTH-FACTOR RECEPTOR; INHIBITS ANGIOGENESIS; EXTRACELLULAR-MATRIX; CANCER METASTASIS; EXPRESSION; INTEGRINS; PROGRESSION; INVASION; PATHWAYS	Throughout the entire process of cancer aetiology, progression and metastasis, the microenvironment of the local host tissue can be an active participant. Invasion occurs within a tumour-host microecology, where stroma and tumour cells exchange enzymes and cytokines that modify the local extracellular matrix, stimulate migration, and promote proliferation and survival. A new class of cancer therapies that targets this pathological communication interface between tumour cells and host cells is currently under development.	NCI, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Liotta, LA (corresponding author), NCI, Pathol Lab, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA.							Aboseif S, 1999, DIFFERENTIATION, V65, P113, DOI 10.1046/j.1432-0436.1999.6520113.x; Airola K, 2001, J INVEST DERMATOL, V116, P85, DOI 10.1046/j.1523-1747.2001.00223.x; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bonfoco E, 2000, NEUROSCIENCE, V101, P1145, DOI 10.1016/S0306-4522(00)00429-2; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Braga V, 2000, NAT CELL BIOL, V2, pE182, DOI 10.1038/35036433; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Brown LF, 1999, CLIN CANCER RES, V5, P1041; Brown PD, 1995, ANN ONCOL, V6, P967, DOI 10.1093/oxfordjournals.annonc.a059091; Cantley L, 2001, CURR OPIN CELL BIOL, V13, P121, DOI 10.1016/S0955-0674(00)00187-3; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen HC, 1998, J BIOL CHEM, V273, P25777, DOI 10.1074/jbc.273.40.25777; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D; DUSKO I, 1995, NATURE, V377, P539; Fang XJ, 2000, ANN NY ACAD SCI, V905, P188; Fashena Sarah J., 2000, Nature Cell Biology, V2, pE225, DOI 10.1038/35046654; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; FUKAI F, 1995, BIOCHEMISTRY-US, V34, P11453, DOI 10.1021/bi00036a018; Furui T, 1999, CLIN CANCER RES, V5, P4308; Gilead Assaf, 1999, Neoplasia (New York), V1, P226, DOI 10.1038/sj.neo.7900032; Guidi AJ, 1997, CANCER, V80, P1945, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y; Gutheil JC, 2000, CLIN CANCER RES, V6, P3056; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Iyer SN, 1999, J PHARMACOL EXP THER, V291, P367; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Kohl NE, 1999, ANN NY ACAD SCI, V886, P91, DOI 10.1111/j.1749-6632.1999.tb09404.x; KOHN EC, 1995, P NATL ACAD SCI USA, V92, P1307, DOI 10.1073/pnas.92.5.1307; KOHN EC, 1995, CANCER RES, V55, P1856; KOHN EC, IN PRESS CLIN CANC R; Lee AHS, 1999, J PATHOL, V187, P285; Li YW, 2000, DIFFERENTIATION, V66, P126, DOI 10.1046/j.1432-0436.2000.660207.x; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Lode HN, 1999, P NATL ACAD SCI USA, V96, P1591, DOI 10.1073/pnas.96.4.1591; Masiero L, 1999, J CELL SCI, V112, P3205; Mehdi AB, 2000, NAT MED, V6, P100; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Nilsson E, 2001, J SOC GYNECOL INVEST, V8, pS17, DOI 10.1016/S1071-5576(00)00099-X; Olumi AF, 1999, CANCER RES, V59, P5002; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Perrotte P, 1999, CLIN CANCER RES, V5, P257; ROBERTS AB, 1992, KIDNEY INT, V41, P557, DOI 10.1038/ki.1992.81; Rowinsky EK, 2000, J CLIN ONCOL, V18, P178, DOI 10.1200/JCO.2000.18.1.178; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Sills AK, 1998, CANCER RES, V58, P2784; St Croix B, 2000, SCIENCE, V289, P1197; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Stromblad S, 1996, CHEM BIOL, V3, P881, DOI 10.1016/S1074-5521(96)90176-3; Tomakidi P, 1999, DIFFERENTIATION, V64, P263, DOI 10.1046/j.1432-0436.1999.6450263.x; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Vaccariello M, 1999, J INVEST DERMATOL, V113, P384, DOI 10.1046/j.1523-1747.1999.00701.x; Varner JA, 1995, CELL ADHES COMMUN, V3, P367, DOI 10.3109/15419069509081020; Varner JA, 1996, CURR OPIN CELL BIOL, V8, P724, DOI 10.1016/S0955-0674(96)80115-3; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wernert N, 1997, VIRCHOWS ARCH, V430, P433, DOI 10.1007/s004280050053; Weyant MJ, 2000, CLIN CANCER RES, V6, P949; Xue LZ, 2000, J BIOL CHEM, V275, P8817, DOI 10.1074/jbc.275.12.8817; Yuan ZQ, 2000, ONCOGENE, V19, P2324, DOI 10.1038/sj.onc.1203598; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	65	1891	2015	14	489	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					375	379		10.1038/35077241	http://dx.doi.org/10.1038/35077241			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357145				2022-12-28	WOS:000168710000060
J	Georgoulias, V; Papadakis, E; Alexopoulos, A; Tsiafaki, X; Rapti, A; Veslemes, M; Palamidas, P; Vlachonikolis, I				Georgoulias, V; Papadakis, E; Alexopoulos, A; Tsiafaki, X; Rapti, A; Veslemes, M; Palamidas, P; Vlachonikolis, I		Greek Oncology Cooperative Grp Lun	Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial	LANCET			English	Article							PHASE-II TRIAL; CISPLATIN; DOCETAXEL; GEMCITABINE; ETOPOSIDE; VINDESINE		Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece; Sotiria Gen Hosp, Dept Pulm Dis 1, Athens, Greece; Sotiria Gen Hosp, Dept Pulm Dis 3, Athens, Greece; Agios Savas Canc Hosp, Dept Med Oncol 1, Athens, Greece; Sismanoglion Gen Hosp, Dept Pulm Dis 2, Athens, Greece; Sismanoglion Gen Hosp, Dept Pulm Dis 3, Athens, Greece; Univ Athens, Dept Pulm Dis, Sotiria Gen Hosp, GR-10679 Athens, Greece; Univ Crete, Sch Med, Dept Biostat, Iraklion, Greece	University Hospital of Heraklion; National & Kapodistrian University of Athens; University of Crete	Georgoulias, V (corresponding author), Univ Gen Hosp Heraklion, Dept Med Oncol, POB 1352, Iraklion 71110, Crete, Greece.	georgsec@med.uch.gr						ABBRATT RP, 1994, J CLIN ONCOL, V12, P1821; ALBAIN KS, 1991, J CLIN ONCOL, V9, P1618, DOI 10.1200/JCO.1991.9.9.1618; ALBERTI W, 1995, BRIT MED J, V311, P899; Altman G., 1991, PRACTICAL STAT MED R; Anton A, 1998, LUNG CANCER-J IASLC, V22, P139, DOI 10.1016/S0169-5002(98)00069-5; Armitage P., 2001, STAT METHODS MED RES; Collett D, 1994, MODELLING SURVIVAL D; Cox DR., 1970, ANAL BINARY DATA; FEIGAL EG, 1993, SEMIN ONCOL, V20, P185; FOSSELLA FV, 1994, J CLIN ONCOL, V12, P1238, DOI 10.1200/JCO.1994.12.6.1238; Gatzemeier U, 1996, EUR J CANCER, V32A, P243, DOI 10.1016/0959-8049(95)00444-0; GATZEMEIER U, 1991, AM J CLIN ONCOL-CANC, V14, P405, DOI 10.1097/00000421-199110000-00009; Georgoulias V, 1998, ANN ONCOL, V9, P331, DOI 10.1023/A:1008278103446; Georgoulias V, 1999, J CLIN ONCOL, V17, P914, DOI 10.1200/JCO.1999.17.3.914; Gridelli C, 1996, ANN ONCOL, V7, P821; Koo HM, 1999, CANCER RES, V59, P6057; KOSMIDIS PA, 2000, P AN M AM SOC CLIN, V19, P488; Lippe P, 1999, ANN ONCOL, V10, P217, DOI 10.1023/A:1008323604269; LUEDKE DW, 1990, J CLIN ONCOL, V8, P886, DOI 10.1200/JCO.1990.8.5.886; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; MILLER VA, 1995, CANCER-AM CANCER SOC, V75, P968, DOI 10.1002/1097-0142(19950215)75:4<968::AID-CNCR2820750411>3.0.CO;2-Y; Rizvi NA, 1999, SEMIN ONCOL, V26, P27; RODENHUIS S, 1988, CANCER RES, V48, P5738; SKLAR MD, 1988, CANCER RES, V48, P793; SOUQUET PJ, 1993, LANCET, V342, P19; Yamamoto N, 2000, ANN ONCOL, V11, P107; Zalcberg J, 1998, J CLIN ONCOL, V16, P1948, DOI 10.1200/JCO.1998.16.5.1948	27	287	295	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2001	357	9267					1478	1484		10.1016/S0140-6736(00)04644-4	http://dx.doi.org/10.1016/S0140-6736(00)04644-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377599				2022-12-28	WOS:000168614300011
J	Hughes, RAC				Hughes, RAC			Sensory form of Guillain-Barre syndrome	LANCET			English	Editorial Material									Guys Kings & St Thomas Sch Med, Dept Neuroimmunol, London SE1 9RT, England	University of London; King's College London	Hughes, RAC (corresponding author), Guys Kings & St Thomas Sch Med, Dept Neuroimmunol, Guys Campus, London SE1 9RT, England.							Chiba A, 1997, BRAIN RES, V745, P32, DOI 10.1016/S0006-8993(96)01123-7; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; Oh SJ, 2001, NEUROLOGY, V56, P82, DOI 10.1212/WNL.56.1.82; Wilmshurst J M, 1999, Eur J Paediatr Neurol, V3, P277, DOI 10.1016/S1090-3798(99)90983-2; WINDEBANK AJ, 1990, NEUROLOGY, V40, P584, DOI 10.1212/WNL.40.4.584	7	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1465	1465		10.1016/S0140-6736(00)04672-9	http://dx.doi.org/10.1016/S0140-6736(00)04672-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377594				2022-12-28	WOS:000168614300006
J	Toole, MJ				Toole, MJ			Refuge for the selected few	LANCET			English	Article									Macfarlane Burnet Ctr Med Res, Int Hlth Unit, Melbourne, Vic 3078, Australia		Toole, MJ (corresponding author), Macfarlane Burnet Ctr Med Res, Int Hlth Unit, Melbourne, Vic 3078, Australia.							*NORW REF COUNC, 1998, INT DISPL PERS GLOB; United Nations High Commissioner for Refugees, 2000, STAT WORLDS REF 2000; *US COMM REF, 2000, WORLD REF SURV 1999	3	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1426	1427						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356461				2022-12-28	WOS:000168478200032
J	Grindlay, JE; Heinke, C; Edmonds, PD; Murray, SS				Grindlay, JE; Heinke, C; Edmonds, PD; Murray, SS			High-resolution X-ray imaging of a globular cluster core: Compact binaries in 47Tuc	SCIENCE			English	Article							HUBBLE-SPACE-TELESCOPE; CATACLYSMIC VARIABLES; MILLISECOND PULSARS; DENSITY PROFILE; 47-TUCANAE; DWARF	We have obtained high-resolution (less than or similar to1") deep x-ray images of the globular cluster 47Tucanae (NGC 104) with the Chandra X-ray Observatory to study the population of compact binaries in the high stellar density core. A 70-kilosecond exposure of the cluster reveals a centrally concentrated population of faint (L-x similar to 10(30-33) ergs per second) x-ray sources, with at Least 108 Located within the central 2' x 2.5' and greater than or similar to half with L-x less than or similar to 10(30.5) ergs per second. All 15 millisecond pulsars (MSPs) recently Located precisely by radio observations are identified, though 2 are unresolved by Chandra. The x-ray spectral and temporal characteristics, as well as initial optical identifications with the Hubble Space Telescope, suggest that greater than or similar to 50 percent are MSPs, about 30 percent are accreting white dwarfs, about 15 percent are main-sequence binaries in flare outbursts, and only two to three are quiescent Low-mass x-ray binaries containing neutron stars, the conventional progenitors of MSPs. An upper Limit of about 470 times the mass of the sun is derived for the mass of an accreting central black hole in the cluster. These observations provide the first x-ray "color-magnitude" diagram for a globular cluster and census of its compact object and binary population.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Grindlay, JE (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.			Heinke, Craig/0000-0003-3944-6109				AURIERE M, 1989, ASTRON ASTROPHYS, V214, P113; Becker W, 1999, ASTRON ASTROPHYS, V341, P803; BHATTACHARYA D, 1991, PHYS REP, V203, P1, DOI 10.1016/0370-1573(91)90064-S; CALZETTI D, 1993, ASTROPHYS J, V402, pL1, DOI 10.1086/186685; Camilo F, 2000, ASTROPHYS J, V535, P975, DOI 10.1086/308859; DeMarchi G, 1996, ASTROPHYS J, V468, pL51, DOI 10.1086/310230; Dempsey RC, 1997, ASTROPHYS J, V478, P358, DOI 10.1086/303786; DISTEFANO R, 1994, ASTROPHYS J, V423, P274, DOI 10.1086/173805; EDMONDS P, UNPUB; Edmonds PD, 1996, ASTROPHYS J, V468, P241, DOI 10.1086/177687; Edmonds PD, 1999, ASTROPHYS J, V516, P250, DOI 10.1086/307106; FREIRE PC, IN PRESS MON NOT R A; Garcia MR, 2001, ASTROPHYS J, V553, pL47, DOI 10.1086/320494; GARMIRE G, UNPUB; Giacconi R, 2001, ASTROPHYS J, V551, P624, DOI 10.1086/320222; Grindlay J., UNPUB; GRINDLAY JE, 1984, ASTROPHYS J, V282, pL13, DOI 10.1086/184294; Grindlay JE, 1999, ASTR SOC P, V157, P377; GRINDLAY JE, 1993, ASTR SOC P, V48, P156; GRINDLAY JE, 1988, NATURE, V336, P48, DOI 10.1038/336048a0; GUHATHAKURTA P, 1993, ASTR SOC P, V50, P303; HEINKE C, UNPUB; Hellier C, 1999, ASTR SOC P, V157, P1; HERTZ P, 1983, ASTROPHYS J, V275, P105, DOI 10.1086/161516; Homer L, 2001, ASTROPHYS J, V550, pL155, DOI 10.1086/319652; Horne K, 1999, ASTR SOC P, V157, P349; Howell JH, 2000, PUBL ASTRON SOC PAC, V112, P1200, DOI 10.1086/316621; HUT P, 1992, PUBL ASTRON SOC PAC, V104, P981, DOI 10.1086/133085; KATZ JI, 1975, NATURE, V253, P698, DOI 10.1038/253698a0; Lewin W.H.G., 1995, XRAY BINARIES, P175; MEYLAN G, 1993, ASTR SOC P, V50, P31; Minniti D, 1997, ASTROPHYS J, V474, pL27, DOI 10.1086/310425; PARESCE F, 1992, NATURE, V360, P46, DOI 10.1038/360046a0; Pfahl E, 2001, ASTROPHYS J, V550, P172, DOI 10.1086/319741; Quataert E, 1999, ASTROPHYS J, V520, P298, DOI 10.1086/307439; Rasio FA, 2000, ASTROPHYS J, V532, pL47, DOI 10.1086/312555; Rutledge RE, 2001, ASTROPHYS J, V551, P921, DOI 10.1086/320247; Shara MM, 1996, ASTROPHYS J, V471, P804, DOI 10.1086/178008; vanTeeseling A, 1996, ASTRON ASTROPHYS, V315, P467; VERBUNT F, 1984, MON NOT R ASTRON SOC, V210, P899, DOI 10.1093/mnras/210.4.899; Verbunt F, 1998, ASTRON ASTROPHYS, V336, P895; Warner B, 2003, CATACLYSMIC VARIABLE; WEISSKOPF M, 1996, P SOC PHOTO-OPT INS, V2805, P142; ZDJIARSKI A, 1999, ASP C SERIES, V161, P16; Zoccali M, 2001, ASTROPHYS J, V553, P733, DOI 10.1086/320980; Zwart SFP, 2000, ASTROPHYS J, V528, pL17, DOI 10.1086/312422	47	207	207	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2290	2295		10.1126/science.1061135	http://dx.doi.org/10.1126/science.1061135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11358997	Green Submitted			2022-12-28	WOS:000169455900046
J	Koizumi, S; Watanabe, K; Hasegawa, M; Kanda, H				Koizumi, S; Watanabe, K; Hasegawa, M; Kanda, H			Ultraviolet emission from a diamond pn junction	SCIENCE			English	Article							CHEMICAL-VAPOR-DEPOSITION; RECOMBINATION RADIATION; DOPED DIAMOND; THIN-FILMS; CATHODOLUMINESCENCE; TRIMETHYLBORON; GROWTH	We report the realization of an ultraviolet Light-emitting diode with the use of a diamond pn junction. The pn junction was formed from a boron-doped p-type diamond Layer and phosphorus-doped n-type diamond Layer grown epitaxially on the {111} surface of single crystalline diamond. The pn junction exhibited good diode characteristics, and at forward bias of about 20 volts strong ultraviolet Light emission at 235 nanometers was observed and was attributed to free exciton recombination.	Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan; Natl Inst Adv Ind Sci & Technol, Res Ctr Adv Carbon Mat, Tsukuba, Ibaraki 3058565, Japan	National Institute for Materials Science; National Institute of Advanced Industrial Science & Technology (AIST)	Koizumi, S (corresponding author), Natl Inst Mat Sci, Adv Mat Lab, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	KOIZUMl.satoshi@nims.go.jp	KOIZUMI, Satoshi/H-2989-2011					COLLINS AT, 1989, J PHYS-CONDENS MAT, V1, P4029, DOI 10.1088/0953-8984/1/25/016; DEAN PJ, 1965, PHYS REV, V140, pA352, DOI 10.1103/PhysRev.140.A352; Horiuchi K, 2000, JPN J APPL PHYS 2, V39, pL604, DOI 10.1143/JJAP.39.L604; KAMO M, 1991, P 2 INT C NEW DIAM S, P637; Koizumi S, 1997, APPL PHYS LETT, V71, P1065, DOI 10.1063/1.119729; Koizumi S, 2000, DIAM RELAT MATER, V9, P935, DOI 10.1016/S0925-9635(00)00217-X; LAWSON SC, 1995, J APPL PHYS, V77, P1729, DOI 10.1063/1.358865; Maeda H, 1998, DIAM RELAT MATER, V7, P88, DOI 10.1016/S0925-9635(98)80001-0; PRINS JF, 1989, J PHYS D APPL PHYS, V22, P1562, DOI 10.1088/0022-3727/22/10/026; Sternschulte H, 1999, PHYS REV B, V59, P12924, DOI 10.1103/PhysRevB.59.12924; Teraji T, 2000, APPL PHYS LETT, V76, P1303, DOI 10.1063/1.126016; Watanabe H, 1998, APPL PHYS LETT, V73, P981, DOI 10.1063/1.122059; Yamanaka S, 1998, JPN J APPL PHYS 2, V37, pL1129, DOI 10.1143/JJAP.37.L1129	13	426	440	13	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1899	1901		10.1126/science.1060258	http://dx.doi.org/10.1126/science.1060258			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397942				2022-12-28	WOS:000169200700045
J	Chadwick, D				Chadwick, D			Vagal-nerve stimulation for epilepsy	LANCET			English	Editorial Material							VAGUS NERVE; SEIZURES; CHILDREN; TRIAL		Univ Liverpool, Walton Ctr Neurol & Neurosurg, Dept Neurol Sci, Liverpool L9 7IJ, Merseyside, England	University of Liverpool; Walton Centre	Chadwick, D (corresponding author), Univ Liverpool, Walton Ctr Neurol & Neurosurg, Dept Neurol Sci, Liverpool L9 7IJ, Merseyside, England.							Annegers JF, 2000, EPILEPSIA, V41, P549, DOI 10.1111/j.1528-1157.2000.tb00208.x; DeGiorgio CM, 2000, EPILEPSIA, V41, P1195, DOI 10.1111/j.1528-1157.2000.tb00325.x; GEORGE R, 1995, NEUROLOGY, V45, P224, DOI 10.1212/wnl.45.2.224; Handforth A, 1998, NEUROLOGY, V51, P48, DOI 10.1212/WNL.51.1.48; Labar D, 2000, DEV MED CHILD NEUROL, V42, P496, DOI 10.1017/S001216220000092X; Marson AG, 2001, J NEUROL NEUROSUR PS, V70, P143, DOI 10.1136/jnnp.70.2.143; MCLACHLAN RS, 1993, EPILEPSIA, V34, P918, DOI 10.1111/j.1528-1157.1993.tb02112.x; Patwardhan RV, 2000, NEUROSURGERY, V47, P1353, DOI 10.1097/00006123-200012000-00016; Salinsky MC, 1996, ARCH NEUROL-CHICAGO, V53, P1176, DOI 10.1001/archneur.1996.00550110128021; Tatum WO, 1999, NEUROLOGY, V52, P1267, DOI 10.1212/WNL.52.6.1267; WOODBURY DM, 1990, EPILEPSIA, V31, pS7, DOI 10.1111/j.1528-1157.1990.tb05852.x; ZABARA J, 1992, EPILEPSIA, V33, P1005, DOI 10.1111/j.1528-1157.1992.tb01751.x	12	20	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1726	1727		10.1016/S0140-6736(00)04933-3	http://dx.doi.org/10.1016/S0140-6736(00)04933-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403805				2022-12-28	WOS:000169156200006
J	Moher, M; Yudkin, P; Wright, L; Turner, R; Fuller, A; Schofield, T; Mant, D				Moher, M; Yudkin, P; Wright, L; Turner, R; Fuller, A; Schofield, T; Mant, D		Assessment Implementation Strategi	Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTITIONERS; INTERVENTION	Objective To assess the effectiveness of three different methods of promoting secondary prevention of coronary heart disease in primary care. Design Pragmatic, unblinded, duster randomised controlled trial. Setting Warwickshire. Subjects 21 general practices received intervention; outcome measured in 1906 patients aged 55-75 years with established coronary heart disease. Interventions Audit of notes with summary feedback to primary health care team (audit group); assistance with setting up a disease register and systematic recall of patients to general practitioner (GP recall group); assistance with setting up a disease register and systematic recall of patients to a nurse led clinic (nurse recall group). Main outcome measures At 18 months' follow up: adequate assessment (defined) of 3 risk factors (blood pressure, cholesterol, and smoking status); prescribing of hypotensive agents, lipid lowering drugs, and antiplatelet drugs; blood pressure, serum cholesterol level, and plasma cotinine levels. Results Adequate assessment of all 3 risk factors was much more common in the nurse and GP recall groups (85%,76%) than the audit group (52%). The advantage in the nurse recall compared with the audit group was 33% (95% confidence interval 19% to 46%); in the GP recall group compared with the audit group 23% (10% to 36%), and in the nurse recall group compared with the GP recall group 9% (-3% to 22%). However, these differences in assessment were not reflected in clinical outcomes. Mean blood pressure (148/80, 147/81, 148/81 mm Hp), total cholesterol (5.4, 5.5, 5.5 mmol/l), and cotinine levels (% probable smokers 17%, 16%, 19%) varied little between the nurse recall, GP recall, and audit groups respectively, as did prescribing of hypotensive and lipid lowering agents. Prescribing of antiplatelet drugs was higher in the nurse recall group (85%) than the GP recall or audit groups (80%, 74%). After adjustment for baseline levels, the advantage in the nurse recall group compared with the audit group was 10% (3% to 17%), in the nurse recall group compared with the GP recall group 8% (1% to 15%) and in the GP recall group compared with the audit group 2'% (- 6% to 10%). Conclusions Setting up a register and recall system improved patient assessment at 18 months' follow up but was not consistently better than audit alone in improving treatment or risk factor levels. Understanding the reasons for this is the key next step in improving the quality of care of patients with coronary heart disease.	Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, Oxford OX3 7LF, England; MRC, Clin Trials Unit, London NW1 2AD, England	University of Oxford; Medical Research Council Clinical Trials Unit	Moher, M (corresponding author), Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, Oxford OX3 7LF, England.	michael.moher@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009					[Anonymous], 1999, EFFECTIVE HLTH CARE, V5; Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; Campbell M, 2000, J Health Serv Res Policy, V5, P12; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1434, DOI 10.1136/bmj.316.7142.1434; CUPPLES ME, 1994, BRIT MED J, V309, P993, DOI 10.1136/bmj.309.6960.993; *DEP HLTH, 2000, NAT SERV FRAM COR HE; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Donner A, 1996, J CLIN EPIDEMIOL, V49, P435, DOI 10.1016/0895-4356(95)00511-0; DONNER A, 1981, AM J EPIDEMIOL, V114, P906, DOI 10.1093/oxfordjournals.aje.a113261; Feder G, 1999, BRIT MED J, V318, P1522, DOI 10.1136/bmj.318.7197.1522; FEDER G, 1995, BRIT MED J, V311, P1473, DOI 10.1136/bmj.311.7018.1473; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; Jolly K, 1999, BMJ-BRIT MED J, V318, P706; McCartney P, 1997, BRIT MED J, V315, P35, DOI 10.1136/bmj.315.7099.35; Moher M, 2000, BRIT J GEN PRACT, V50, P706; Moher M., 1995, EVIDENCE EFFECTIVENE; NELSON E, 1987, J CHRON DIS, V40, pS55, DOI 10.1016/S0021-9681(87)80033-4; Omar RZ, 2000, STAT MED, V19, P2675, DOI 10.1002/1097-0258(20001015)19:19<2675::AID-SIM556>3.3.CO;2-1; PIERCE M, 1989, BMJ-BRIT MED J, V299, P160, DOI 10.1136/bmj.299.6692.160; Rogers S, 2000, BRIT MED J, V320, P1580, DOI 10.1136/bmj.320.7249.1580; SHAPER AG, 1985, J EPIDEMIOL COMMUN H, V39, P197, DOI 10.1136/jech.39.3.197; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson S, 2000, BMJ-BRIT MED J, V321, P24, DOI 10.1136/bmj.321.7252.24	25	101	103	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2001	322	7298					1338	1342A		10.1136/bmj.322.7298.1338	http://dx.doi.org/10.1136/bmj.322.7298.1338			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387182	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000169167900020
J	Agrawal, AF; Brodie, ED; Brown, J				Agrawal, AF; Brodie, ED; Brown, J			Parent-offspring coadaptation and the dual genetic control of maternal care	SCIENCE			English	Article							BURROWER BUG; SOLICITATION; SIGNALS; NEED	In many animal species, the amount of care provided by parents is determined through a complex interaction of offspring signals and responses by parents to those signals. As predicted by honest signaling theory, we show that in the burrower bug, Sehirus cinctus, maternal provisioning responds to experimental manipulations of offspring condition. Despite this predicted environmental influence, we find evidence from two cross-foster experiments that variation in maternal care also stems from two distinct genetic sources: variation among offspring in their ability to elicit care and variation among parents in their response to offspring signals, Furthermore, as predicted by maternal-offspring coadaptation theory, offspring signaling is negatively genetically correlated with maternal provisioning.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Agrawal, AF (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	aagrawal@bio.indiana.edu	Brodie, Edmund D/B-2335-2013; Brown, Jeremy/B-4544-2010	Brown, Jeremy/0000-0002-1447-8633				AGRAWAL AF, UNPUB; Bergstrom CT, 1998, P NATL ACAD SCI USA, V95, P5100, DOI 10.1073/pnas.95.9.5100; CHEVERUD JM, 1984, QUANTITATIVE GENETIC, P67; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Johnstone RA, 1999, P NATL ACAD SCI USA, V96, P12644, DOI 10.1073/pnas.96.22.12644; Kight SL, 1997, ANIM BEHAV, V53, P105, DOI 10.1006/anbe.1996.0282; Kight SL, 1998, PHYSIOL ENTOMOL, V23, P38, DOI 10.1046/j.1365-3032.1998.2310038.x; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kolliker M, 2000, P ROY SOC B-BIOL SCI, V267, P2127, DOI 10.1098/rspb.2000.1259; Lynch M., 1998, GENETICS ANAL QUANTI; Mock D. W., 1997, EVOLUTION SIBLING RI; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Rauter CM, 1999, P ROY SOC B-BIOL SCI, V266, P1691, DOI 10.1098/rspb.1999.0833; SITES RW, 1982, ANN ENTOMOL SOC AM, V75, P210, DOI 10.1093/aesa/75.2.210; TALFAMY DW, 1999, ANIM BEHAV, V57, P727; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wade MJ, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P5; Wolf JB, 2000, EVOLUTION, V54, P1882, DOI 10.1111/j.0014-3820.2000.tb01235.x; Wolf JB, 1998, EVOLUTION, V52, P299, DOI [10.1111/j.1558-5646.1998.tb01632.x, 10.2307/2411068]	21	144	146	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1710	1712		10.1126/science.1059910	http://dx.doi.org/10.1126/science.1059910			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387474				2022-12-28	WOS:000169031800043
J	Platzbecker, U; Platzbecker, H				Platzbecker, U; Platzbecker, H			Infiltration of bone marrow by a signet-ring-cell gastric carcinoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Hosp Carl Gustav Carus, D-01307 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Platzbecker, U (corresponding author), Univ Hosp Carl Gustav Carus, D-01307 Dresden, Germany.								0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2001	344	22					1680	1680		10.1056/NEJM200105313442205	http://dx.doi.org/10.1056/NEJM200105313442205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YG	11386267				2022-12-28	WOS:000168963000005
J	Reisz, RR; Smith, MM				Reisz, RR; Smith, MM			Developmental biology - Lungfish dental pattern conserved for 360 Myr	NATURE			English	Article									Kings Coll London, Inst Dent, London SE1 9RT, England; Univ Toronto, Mississauga, ON L5L 1C6, Canada	University of London; King's College London; University of Toronto; University Toronto Mississauga	Reisz, RR (corresponding author), Univ Toronto, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.	moya.smith@kcl.ac.uk		Meredith Smith, Moya/0000-0002-3397-873X				KEMP A, 1995, J MORPHOL, V225, P345, DOI 10.1002/jmor.1052250306; Krupina Natasha I., 1999, Modern Geology, V24, P99; KRUPINA NI, IN PRESS CAN J EARTH; Smith M.M., 1988, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V53, P179; SMITH MM, IN PRESS J ANAT	5	22	25	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					548	548		10.1038/35079187	http://dx.doi.org/10.1038/35079187			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385561	Bronze			2022-12-28	WOS:000168982500040
J	Strome, M; Stein, J; Esclamado, R; Hicks, D; Lorenz, RR; Braun, W; Yetman, R; Eliachar, I; Mayes, J				Strome, M; Stein, J; Esclamado, R; Hicks, D; Lorenz, RR; Braun, W; Yetman, R; Eliachar, I; Mayes, J			Brief report: Laryngeal transplantation and 40-month follow-up.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RAT MODEL; ALLOGRAFT		Cleveland Clin Fdn, Dept Otolaryngol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Hypertens & Nephrol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Plast & Reconstruct Surg, Cleveland, OH 44195 USA; Lifelink Transplant Inst, Tampa, FL USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Strome, M (corresponding author), Cleveland Clin Fdn, Dept Otolaryngol, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Barthel SW, 2001, ANN OTO RHINOL LARYN, V110, P20, DOI 10.1177/000348940111000104; Birchall M, 1998, LANCET, V351, P539, DOI 10.1016/S0140-6736(05)78550-0; Jacobs JP, 1999, ANN THORAC SURG, V68, P1043, DOI 10.1016/S0003-4975(99)00878-4; KLUYSKENS P, 1970, LARYNGOSCOPE, V80, P1244, DOI 10.1288/00005537-197008000-00006; ROSE KG, 1979, LANCET, V1, P433; STROME M, 1993, LARYNGOSCOPE, V103, P394, DOI 10.1002/lary.5541030406; STROME M, 1994, LARYNGOSCOPE, V104, P666; STROME M, 1996, LARYNX MULTIDISCIPLI, P625; STROME S, 1992, ANN OTO RHINOL LARYN, V101, P156, DOI 10.1177/000348949210100209; STROME S, 1992, ANN OTO RHINOL LARYN, V101, P950, DOI 10.1177/000348949210101112	10	215	235	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2001	344	22					1676	1679		10.1056/NEJM200105313442204	http://dx.doi.org/10.1056/NEJM200105313442204			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YG	11386266				2022-12-28	WOS:000168963000004
J	Crenshaw, DM				Crenshaw, DM			Astrophysics - Mass outflow in active galactic nuclei	SCIENCE			English	Editorial Material							X-RAY-ABSORPTION; LINE; DYNAMICS; NGC-5548		Catholic Univ Amer, Greenbelt, MD 20771 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Catholic University of America; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Crenshaw, DM (corresponding author), Catholic Univ Amer, Code 681, Greenbelt, MD 20771 USA.							Arav N, 1999, ASTROPHYS J, V524, P566, DOI 10.1086/307841; Bottorff MC, 2000, ASTROPHYS J, V537, P134, DOI 10.1086/309006; Crenshaw DM, 2000, ASTRON J, V120, P1731, DOI 10.1086/301574; Kaastra JS, 2000, ASTRON ASTROPHYS, V354, pL83; Kaspi S, 2000, ASTROPHYS J, V535, pL17, DOI 10.1086/312697; Kormendy J, 2000, SCIENCE, V289, P1484, DOI 10.1126/science.289.5484.1484; KRAEMER SB, IN PRESS ASTROPHYS J; Mathur S, 2000, ASTROPHYS J, V533, pL79, DOI 10.1086/312617; Meier DL, 2001, SCIENCE, V291, P84, DOI 10.1126/science.291.5501.84; Nandra K, 1999, ASTROPHYS J, V523, pL17, DOI 10.1086/312252; Proga D, 2000, ASTROPHYS J, V543, P686, DOI 10.1086/317154; Seyfert CK, 1943, ASTROPHYS J, V97, P28, DOI 10.1086/144488; 2001, MASS OUTFLOW AGN NEW	13	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1500	1501		10.1126/science.1061145	http://dx.doi.org/10.1126/science.1061145			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11379632				2022-12-28	WOS:000168963800032
J	Kikkawa, M; Sablin, EP; Okada, Y; Yajima, H; Fletterick, RJ; Hirokawa, N				Kikkawa, M; Sablin, EP; Okada, Y; Yajima, H; Fletterick, RJ; Hirokawa, N			Switch-based mechanism of kinesin motors	NATURE			English	Article							X-RAY STRUCTURE; FACTOR EF-TU; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; MOLECULAR MOTOR; NUCLEOTIDE-BINDING; MICROTUBULE; PROTEIN; DOMAIN; NCD	Kinesin motors are specialized enzymes that use hydrolysis of ATP to generate force and movement along their cellular tracks, the microtubules. Although numerous biochemical and biophysical studies have accumulated much data that link microtubule-assisted ATP hydrolysis to kinesin motion, the structural view of kinesin movement remains unclear. This study of the monomeric kinesin motor KIF1A combines X-ray crystallography and cryo-electron microscopy, and allows analysis of force-generating conformational changes at atomic resolution. The motor is revealed in its two functionally critical states-complexed with ADP and with a non-hydrolysable analogue of ATP. The conformational change observed between the ADP-bound and the ATP-like structures of the KIF1A catalytic core is modular, extends to all kinesins and is similar to the conformational change used by myosin motors and G proteins. Docking of the ADP-bound and ATP-like crystallographic models of KIF1A into the corresponding cryo-electron microscopy maps suggests a rationale for the plus-end directional bias associated with the kinesin catalytic core.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; Univ Calif San Francisco, Dept Biochem Biophys, San Francisco, CA 94143 USA	University of Tokyo; University of California System; University of California San Francisco	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Yajima, Hiroaki/AAS-6021-2020; Okada, Yasushi/N-5067-2015; Kikkawa, Masahide/I-7958-2015	Okada, Yasushi/0000-0003-2601-3689; Kikkawa, Masahide/0000-0001-7656-8194				Alonso MC, 1998, EMBO J, V17, P945, DOI 10.1093/emboj/17.4.945; Arnal I, 1998, STRUCTURE, V6, P33, DOI 10.1016/S0969-2126(98)00005-7; Bohm A, 1997, CURR OPIN BIOTECH, V8, P480, DOI 10.1016/S0958-1669(97)80072-9; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; Henningsen U, 1997, NATURE, V389, P93, DOI 10.1038/38022; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirose K, 2000, EMBO J, V19, P5308, DOI 10.1093/emboj/19.20.5308; HIROSE K, 1995, NATURE, V376, P277, DOI 10.1038/376277a0; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Hoenger A, 1998, J CELL BIOL, V141, P419, DOI 10.1083/jcb.141.2.419; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Song HB, 1998, NATURE, V396, P587, DOI 10.1038/25153; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Vale RD, 2000, PHILOS T ROY SOC B, V355, P449, DOI 10.1098/rstb.2000.0586; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3	50	286	299	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					439	445		10.1038/35078000	http://dx.doi.org/10.1038/35078000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373668				2022-12-28	WOS:000168858700037
J	Olsen, SJ; DeBess, EE; McGivern, TE; Marano, N; Eby, T; Mauvais, S; Balan, VK; Zirnstein, G; Cieslak, PR; Angulo, FJ				Olsen, SJ; DeBess, EE; McGivern, TE; Marano, N; Eby, T; Mauvais, S; Balan, VK; Zirnstein, G; Cieslak, PR; Angulo, FJ			A nosocomial outbreak of fluoroquinolone-resistant salmonella infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES	Background: Infection with fluoroquinolone-resistant strains of salmonella is rare, as is nosocomial salmonella infection. We describe the first recognized outbreak of fluoroquinolone-resistant salmonella infection in the United States, which occurred in two nursing homes and one hospital in Oregon. Methods: We interviewed medical staff and reviewed patients' charts and death certificates. In Nursing Home A we conducted a case-control study. Patients were defined as residents of the nursing home from whom fluoroquinolone-resistant Salmonella enterica serotype Schwarzengrund was isolated between February 1996 and December 1998. Controls were residents with similar medical conditions whose cultures did not yield salmonella. Results: Eleven patients with fluoroquinolone-resistant salmonellosis were identified at two nursing homes. In nine patients a urine culture was positive, in one a stool culture, and in one a wound culture. The index patient had been hospitalized in the Philippines and had probably acquired the infection there. Transmission was probably direct (from patient to patient) or through contact with contaminated surfaces. Treatment with fluoroquinolones during the six months before a culture was obtained was associated with a significant risk of salmonella infection. More fluoroquinolones were used at Nursing Home A than at similar nursing homes in Oregon. The isolates from the outbreak had similar patterns on pulsed-field gel electrophoresis and the same gyrA mutations. The isolates from the outbreak were also similar to the only previous isolate of fluoroquinolone-resistant salmonella in the United States, which came from a patient in New York who had been transferred from a hospital in the Philippines. Conclusions: We describe a prolonged nosocomial outbreak of infection with fluoroquinolone-resistant S. enterica serotype Schwarzengrund. More such outbreaks are likely in institutional settings, particularly those in which there is heavy use of antimicrobial agents. (N Engl J Med 2001;344:1572-9.) Copyright (C) 2001 Massachusetts Medical Society.	CDCP, Foodborne Diarrheal Dis Branch, Div Bacterial Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; Oregon Dept Human Serv, Hlth Div, Portland, OR USA; Oregon Dept Human Serv, Hlth Div, Portland, OR USA; Multnomah Cty Dept Hlth, Portland, OR USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Olsen, SJ (corresponding author), CDCP, Foodborne Diarrheal Dis Branch, Div Bacterial Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,Mailstop A-38, Atlanta, GA 30333 USA.	sco2@cdc.gov						Acar JF, 1997, CLIN INFECT DIS, V24, pS67, DOI 10.1093/clinids/24.Supplement_1.S67; Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; *CDCP, 1998, STAND MOL SUBT FOODB; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; Griggs DJ, 1996, ANTIMICROB AGENTS CH, V40, P1009, DOI 10.1128/AAC.40.4.1009; Herikstad H, 1997, EMERG INFECT DIS, V3, P371, DOI 10.3201/eid0303.970316; Kumar A, 1995, Indian Pediatr, V32, P881; LEE LA, 1994, J INFECT DIS, V170, P128, DOI 10.1093/infdis/170.1.128; LEPAGE P, 1987, LANCET, V1, P1458; Li JH, 1996, AM J EPIDEMIOL, V143, P1042; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller S.I., 2000, PRINCIPLES PRACTICE, V2, P2344; OLSEN S, 2000, INT C EM INF DIS ATL, P144; PAVIA AT, 1990, J INFECT DIS, V161, P255, DOI 10.1093/infdis/161.2.255; Pers C, 1996, SCAND J INFECT DIS, V28, P529, DOI 10.3109/00365549609037954; Piddock L J, 1995, Drugs, V49 Suppl 2, P29; PIDDOCK LJV, 1993, ANTIMICROB AGENTS CH, V37, P662, DOI 10.1128/AAC.37.4.662; RILEY LW, 1984, J INFECT DIS, V150, P236, DOI 10.1093/infdis/150.2.236; TAUXE RV, 1991, J FOOD PROTECT, V54, P563, DOI 10.4315/0362-028X-54.7.563; Turnidge J, 1995, Drugs, V49 Suppl 2, P43; Vasallo FJ, 1998, CLIN INFECT DIS, V26, P535, DOI 10.1086/517087; *WHO, 1998, WHOEMCZDI9812	22	107	116	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1572	1579		10.1056/NEJM200105243442102	http://dx.doi.org/10.1056/NEJM200105243442102			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372008				2022-12-28	WOS:000168829700002
J	Carroli, G; Villar, J; Piaggio, G; Khan-Neelofur, D; Gulmezoglu, M; Mugford, M; Lumbiganon, P; Farnot, U; Bersgjo, P				Carroli, G; Villar, J; Piaggio, G; Khan-Neelofur, D; Gulmezoglu, M; Mugford, M; Lumbiganon, P; Farnot, U; Bersgjo, P		WHO Antenatal Care Trial Res Grp	WHO systematic review of randomised controlled trials of routine antenatal care	LANCET			English	Article							LOW-RISK WOMEN; PRENATAL-CARE; VISITS; FREQUENCY; RANDOMIZATION; METAANALYSES	Background There is a lack of strong evidence on the effectiveness of the content, frequency, and timing of visits in standard antenatal-care programmes. We undertook a systematic review of randomised trials assessing the effectiveness of different models of antenatal care. The main hypothesis was that a model with a lower number of antenatal visits, with or without goal-oriented components, would be as effective as the standard antenatal-care model in terms of clinical outcomes, perceived satisfaction, and costs. Methods The interventions compared were the provision of a lower number of antenatal visits (new model) and a standard antenatal-visits programme. The selected outcomes were preeclampsia, urinary-tract infection, postpartum anaemia, maternal mortality, low birthweight, and perinatal mortality. We also selected measures of women's satisfaction with care and cost-effectiveness. This review drew on the search strategy developed for the Cochrane Pregnancy and Childbirth Group of the Cochrane Collaboration. Findings Seven eligible randomised controlled trials were identified. 57 418 women participated in these studies: 30 799 in the new-model groups (29 870 with outcome data) and 26 619 in the standard-model groups (25 821 with outcome data). There was no clinically differential effect of the reduced number of antenatal visits when the results were pooled for pre-eclampsia (typical odds ratio 0.91 [95% CI 0.66-1.26]), urinary-tract infection (0.93 [0.79-1.10]). postpartum anaemia (1.01), maternal mortality (0.91 [0.55-1.51]), or low birthweight (1.04 [0.93-1.17]). The rates of perinatal mortality were similar, although the rarity of the outcome did not allow formal statistical equivalence to be attained. Some dissatisfaction with care, particularly among women in more developed countries, was observed with the new model. The cost of the new model was equal to or less than that of the standard model. Interpretation A model with a reduced number of antenatal visits, with or without goal-oriented components, could be introduced into clinical practice without risk to mother or baby, but some degree of dissatisfaction by the mother could be expected. Lower costs can be achieved.	Ctr Rosarino Estudios Perinatales, RA-2000 Rosario, Santa Fe, Argentina; WHO, Dept Reprod Hlth & Res, Special Programme Res Dev & Res Training Human Re, CH-1211 Geneva, Switzerland; Univ E Anglia, Sch Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Khon Kaen Univ, Khon Kaen, Thailand; Hosp Ginecoobstet Amer Arias, Havana, Cuba; Univ Bergen, Dept Obstet & Gynaecol, Bergen, Norway	World Health Organization; University of East Anglia; Khon Kaen University; University of Bergen	Carroli, G (corresponding author), Ctr Rosarino Estudios Perinatales, Pueyrredon 985, RA-2000 Rosario, Santa Fe, Argentina.							Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; BERLIN JA, 1989, STAT MED, V8, P141, DOI 10.1002/sim.4780080202; BINSTOCK MA, 1995, J REPROD MED, V40, P507; Clement S, 1999, BRIT J OBSTET GYNAEC, V106, P367, DOI 10.1111/j.1471-0528.1999.tb08276.x; *COCHR COLL, 2000, COCHR LIB DAT DISK C; CORNFIELD J, 1978, AM J EPIDEMIOL, V108, P100, DOI 10.1093/oxfordjournals.aje.a112592; DONNER A, 1993, J CLIN EPIDEMIOL, V46, P123, DOI 10.1016/0895-4356(93)90050-B; Donner A, 1998, PAEDIATR PERINAT EP, V12, P59, DOI 10.1046/j.1365-3016.1998.00007.x; DONNER A, IN PRESS STAT METHOD; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Henderson J, 2000, J Health Serv Res Policy, V5, P69; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; MAJOKO F, 1999, 4 INT SCI ROYAL COLL, P2; McDuffie RS, 1996, JAMA-J AM MED ASSOC, V275, P847, DOI 10.1001/jama.275.11.847; MULROW CD, 2000, COCHR LIB DATABASE D; Munjanja SP, 1996, LANCET, V348, P364, DOI 10.1016/S0140-6736(96)01250-0; PETITTI DB, 2000, METAANALYSIS DECISIO; Piaggio G, 2001, STAT MED, V20, P401, DOI 10.1002/1097-0258(20010215)20:3<401::AID-SIM801>3.0.CO;2-1; Sikorski J, 1996, BRIT MED J, V312, P546, DOI 10.1136/bmj.312.7030.546; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Villar J, 1997, J CLIN EPIDEMIOL, V50, P997, DOI 10.1016/S0895-4356(97)00148-0; Villar J, 1996, PREV MED, V25, P365, DOI 10.1006/pmed.1996.0067; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Walker DS, 1997, J NURSE-MIDWIFERY, V42, P295	26	246	259	0	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1565	1570		10.1016/S0140-6736(00)04723-1	http://dx.doi.org/10.1016/S0140-6736(00)04723-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377643				2022-12-28	WOS:000168830100009
J	Krentz, AJ; Mikhail, S; Cantrell, P; Hill, GM				Krentz, AJ; Mikhail, S; Cantrell, P; Hill, GM			Pseudophaeochromocytoma syndrome associated with clozapine	BRITISH MEDICAL JOURNAL			English	Article							PHEOCHROMOCYTOMA		Southampton Gen Hosp, Southampton SO16 6YG, Hants, England; Chase Farm Hosp, Camlet Lodge Reg Secure Unit, Enfield EN2 8JL, Middx, England; Doncaster Royal Infirm, Doncaster DN2 5LT, England	University of Southampton; University of London; University College London; Royal Free London NHS Foundation Trust	Krentz, AJ (corresponding author), Southampton Gen Hosp, Southampton SO16 6YG, Hants, England.		Krentz, Andrew/AAD-2493-2019					DAVIDSON M, 1993, PSYCHIAT RES, V46, P151, DOI 10.1016/0165-1781(93)90017-B; ERESHEFSKY L, 1989, CLIN PHARMACY, V8, P691; Li JKY, 1997, AUST NZ J PSYCHIAT, V31, P889, DOI 10.3109/00048679709065519; MAYER R D, 1989, Human Psychopharmacology, V4, P149, DOI 10.1002/hup.470040212; Witteles RM, 2000, ARCH INTERN MED, V160, P2521, DOI 10.1001/archinte.160.16.2521	5	26	28	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2001	322	7296					1213	1213		10.1136/bmj.322.7296.1213	http://dx.doi.org/10.1136/bmj.322.7296.1213			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435UV	11358774	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000168900700026
J	Singer, PA				Singer, PA			Commentary: Learning to love mistakes	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada	University of Toronto	Singer, PA (corresponding author), Univ Toronto, Joint Ctr Bioeth, 88 Coll St, Toronto, ON M5G 1L4, Canada.							Benatar SR, 1999, BRIT MED J, V318, P249	1	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2001	322	7296					1238	1238						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11398783				2022-12-28	WOS:000168900700036
J	Boehnhardt, H				Boehnhardt, H			Planetary science - The death of a comet and the birth of our solar system	SCIENCE			English	Editorial Material									European So Observ, VLT Observ Cerro Paranal, Santiago, Vitacura, Chile	European Southern Observatory	Boehnhardt, H (corresponding author), European So Observ, VLT Observ Cerro Paranal, Alonso de Cordova 3107, Santiago, Vitacura, Chile.							Bockelee-Morvan D, 2001, SCIENCE, V292, P1339, DOI 10.1126/science.1058512; CASSEN P, 1998, ENCY SOLAR SYSTEM, P36; DURIG D, 2000, 7267 IAUC; Farnham TL, 2001, SCIENCE, V292, P1348, DOI 10.1126/science.1058886; KIDGER M, 2000, 7467 IAUC; LISSE, 2001, SCIENCE, V292, P1343; Mumma MJ, 2001, SCIENCE, V292, P1334, DOI 10.1126/science.1058929; ORTON G, 1995, SCIENCE, V267, P1277, DOI 10.1126/science.7871423; SCHLEICHER DG, 2000, 7342 IAUC; SCOTI JV, 1996, 6301 IAUC; SEKANINA Z, 1994, ASTRON ASTROPHYS, V289, P607; Sekanina Z, 1997, ASTRON ASTROPHYS, V318, pL5; Teemu J, 2001, SCIENCE, V292, P1326, DOI 10.1126/science.1060858; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606	14	6	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1307	+		10.1126/science.1061654	http://dx.doi.org/10.1126/science.1061654			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360985				2022-12-28	WOS:000168862900026
J	Teemu, J; Makinen, T; Bertaux, JL; Combi, MR; Quemerais, E				Teemu, J; Makinen, T; Bertaux, JL; Combi, MR; Quemerais, E			Water production of comet C/1999 S4 (LINEAR) observed with the SWAN instrument	SCIENCE			English	Article							ATMOSPHERES	The SWAN (Solar Wind ANisotropies) Lyman-alpha all-sky camera on the SOHO spacecraft observed the hydrogen coma of comet C/1999 S4 (LINEAR) from the end of May through mid-August 2000. A systematic set of water-production rates was obtained for this well-documented event of complete fragmentation of a cometary nucleus. The observations indicate that the lower limit for the sunlit surface area of the nucleus was about 1 square kilometer before the fragmentation and that the amount of water released throughout the observing period was 3.3 x 10(9) kilograms. Evidence suggests that the activity of the comet was dominated by successive fragmentation. There were four major outbursts, occurring about every 16 days. The 21 July event led to the complete fragmentation and sublimation of what remained of the nucleus, producing the last 3 x 10(8) kilograms of water. A model where the fragment size distribution follows the power Law N(R) similar to R-2.7, where N and R are the number and radius of fragments, reproduces the observed dissipation. This distribution possibly reflects the internal structure of the nucleus.	Finnish Meteorol Inst, FIN-00101 Helsinki, Finland; CNRS, Serv Aeron, F-91371 Verrieres Buisson, France; Univ Michigan, Space Phys Res Lab, Ann Arbor, MI 48109 USA	Finnish Meteorological Institute; Centre National de la Recherche Scientifique (CNRS); University of Michigan System; University of Michigan	Makinen, T (corresponding author), Finnish Meteorol Inst, POB 503, FIN-00101 Helsinki, Finland.		Combi, Michael/J-1697-2012	Combi, Michael/0000-0002-9805-0078				Bertaux JL, 1999, SPACE SCI REV, V87, P129, DOI 10.1023/A:1005178402842; Bertaux JL, 1995, SOL PHYS, V162, P403, DOI 10.1007/BF00733435; Bockelee-Morvan D, 2001, SCIENCE, V292, P1339, DOI 10.1126/science.1058512; COMBI MR, 1980, ASTROPHYS J, V237, P633, DOI 10.1086/157909; Combi MR, 1997, EARTH MOON PLANETS, V79, P275, DOI 10.1023/A:1006257922294; Farnham TL, 2001, SCIENCE, V292, P1348, DOI 10.1126/science.1058886; FESTOU MC, 1981, ASTRON ASTROPHYS, V95, P69; Haser L., 1957, B ACAD ROY SCI BELGI, V43, P740; KELLER HU, 1990, PHYSICS CHEM COMETS, P18; Makinen JTT, 2000, NATURE, V405, P321, DOI 10.1038/35012526; Makinen JTT, 2001, ASTRON ASTROPHYS, V368, P292, DOI 10.1051/0004-6361:20000545; Oort J. H., 1950, B ASTRON I NETH, V11, P91; PRESS WH, 1986, NUMERICAL RECIPES, P52; Sekanina Z, 1997, ASTRON ASTROPHYS, V318, pL5; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606	15	44	44	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1326	1329		10.1126/science.1060858	http://dx.doi.org/10.1126/science.1060858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359000				2022-12-28	WOS:000168862900033
J	Carding, P; Welch, A; Owen, S; Stafford, F				Carding, P; Welch, A; Owen, S; Stafford, F			Surgical voice restoration	LANCET			English	Editorial Material							QUALITY-OF-LIFE; TOTAL LARYNGECTOMY; NECK-CANCER; HEAD		Freeman Hosp, No Head & Neck Canc Ctr, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Freeman Hospital	Carding, P (corresponding author), Freeman Hosp, No Head & Neck Canc Ctr, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.			Carding, Paul/0000-0002-4206-1827				BLOM ED, 1998, TRACHEOESOPHAGEAL VO; BLOM ED, 1998, TRACHEOESOPHAGEAL VO, pCH10; *BRIT ASS HEAD NEC, 2000, EFF HEAD NECK CANC M; Deleyiannis FWB, 1999, HEAD NECK-J SCI SPEC, V21, P319, DOI 10.1002/(SICI)1097-0347(199907)21:4<319::AID-HED5>3.0.CO;2-H; Hoffman HT, 1997, HEAD NECK-J SCI SPEC, V19, P92, DOI 10.1002/(SICI)1097-0347(199703)19:2<92::AID-HED2>3.0.CO;2-P; JOHNS MME, 1998, TRACHEOESOPHAGEAL VO; Jones AS, 2000, CLIN OTOLARYNGOL, V25, P396, DOI 10.1046/j.1365-2273.2000.00387.x; KAO WW, 1994, ARCH OTOLARYNGOL, V120, P301; LEWIN JS, 1998, TRACHEOESOPHAGEAL VO, pCH9; MORRIS HL, 1992, ANN OTO RHINOL LARYN, V101, P503, DOI 10.1177/000348949210100611; SINGER MI, 1981, ARCH OTOLARYNGOL, V107, P670; STGUILY JL, 1990, ANN OTOLARYNGOL, V107, P205; Weymuller EA, 2000, ARCH OTOLARYNGOL, V126, P329, DOI 10.1001/archotol.126.3.329	13	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1463	1464		10.1016/S0140-6736(00)04671-7	http://dx.doi.org/10.1016/S0140-6736(00)04671-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377593				2022-12-28	WOS:000168614300005
J	Hirsh, J; O'Donnell, MJ				Hirsh, J; O'Donnell, MJ			Venous thromboembolism after long flights: are airlines to blame?	LANCET			English	Editorial Material							DEEP-VEIN THROMBOSIS; AIR-TRAVEL; RISK		McMaster Univ, Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada	McMaster University	Hirsh, J (corresponding author), McMaster Univ, Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada.		O'Donnell, Martin/ABE-7459-2020	O'Donnell, Martin/0000-0002-7347-7761				AMARIGIRI SV, 2000, COCHRANE DATABASE SY, V3; Atri M, 1996, AM J ROENTGENOL, V166, P1361, DOI 10.2214/ajr.166.6.8633448; Clerel M, 1999, B ACAD NAT MED PARIS, V183, P985; CRUICKSHANK JM, 1988, LANCET, V2, P497, DOI 10.1016/S0140-6736(88)90134-1; Dahl OE, 1997, THROMB HAEMOSTASIS, V77, P26; Eklof B, 1996, DERMATOL SURG, V22, P637, DOI 10.1111/j.1524-4725.1996.tb00610.x; Ferrari E, 1999, CHEST, V115, P440, DOI 10.1378/chest.115.2.440; HOMANS J, 1954, NEW ENGL J MED, V250, P148, DOI 10.1056/NEJM195401282500404; JONGBLOETS LMM, 1994, LANCET, V343, P1142, DOI 10.1016/S0140-6736(94)90240-2; Kraaijenhagen RA, 2000, LANCET, V356, P1492, DOI 10.1016/S0140-6736(00)02878-6; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Ridker PM, 1997, ANN INTERN MED, V126, P528, DOI 10.7326/0003-4819-126-7-199704010-00005; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; WELLS PS, 1995, CIRCULATION, V91, P2184, DOI 10.1161/01.CIR.91.8.2184	14	31	32	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1461	1462		10.1016/S0140-6736(00)04669-9	http://dx.doi.org/10.1016/S0140-6736(00)04669-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377591				2022-12-28	WOS:000168614300003
J	Cardinal, RN; Pennicott, DR; Sugathapala, CL; Robbins, TW; Everitt, BJ				Cardinal, RN; Pennicott, DR; Sugathapala, CL; Robbins, TW; Everitt, BJ			Impulsive choice induced in rats by lesions of the nucleus accumbens core	SCIENCE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; REACTION-TIME-TASK; PREFRONTAL CORTEX; D-AMPHETAMINE; REWARD; BEHAVIOR; REINFORCEMENT; CINGULATE; DISSOCIATION	Impulsive choice is exemplified by choosing a small or poor reward that is available immediately, in preference to a Larger but delayed reward. Impulsive choice contributes to drug addiction, attention-deficit/hyperactivity disorder, mania, and personality disorders, but its neuroanatomical basis is unclear. Here, we show that selective Lesions of the nucleus accumbens core induce persistent impulsive choice in rats. In contrast, damage to two of its afferents, the anterior cingulate cortex and medial prefrontal cortex, had no effect on this capacity. Thus, dysfunction of the nucleus accumbens core may be a key element in the neuropathology of impulsivity.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Cardinal, RN (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.		Robbins, Trevor W/A-7551-2008; Cardinal, Rudolf/AAG-2597-2020	Cardinal, Rudolf/0000-0002-8751-5167; Everitt, Barry/0000-0003-4431-6536; Robbins, Trevor/0000-0003-0642-5977	Medical Research Council [G9537855] Funding Source: Medline; MRC [G9537855] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aberman JE, 1999, NEUROSCIENCE, V92, P545, DOI 10.1016/S0306-4522(99)00004-4; AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; ALEXANDER MC, 1985, J COMPUT ASSIST TOMO, V9, P357, DOI 10.1097/00004728-198503000-00024; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], [No title captured]; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Bechara A, 1999, J NEUROSCI, V19, P5473; Bizot JC, 1999, PSYCHOPHARMACOLOGY, V146, P400, DOI 10.1007/PL00005485; Bowman EM, 1998, EXP BRAIN RES, V123, P439, DOI 10.1007/s002210050588; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P908, DOI 10.1037/0735-7044.111.5.908; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; CHRISTAKOU A, UNPUB; COLE BJ, 1989, BEHAV BRAIN RES, V33, P165, DOI 10.1016/S0166-4328(89)80048-8; Dietrich A, 1998, BEHAV NEUROSCI, V112, P1043, DOI 10.1037/0735-7044.112.5.1043; Ernst M, 1998, J NEUROSCI, V18, P5901; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Ho MY, 1999, PSYCHOPHARMACOLOGY, V146, P362, DOI 10.1007/PL00005482; HOK JC, 1995, MODELS INFORMATION P, P249; Muir JL, 1996, CEREB CORTEX, V6, P470, DOI 10.1093/cercor/6.3.470; Parkinson JA, 2000, PROG BRAIN RES, V126, P263; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; RUSSELL V, 1995, BRAIN RES, V676, P343, DOI 10.1016/0006-8993(95)00135-D; Sadile AG, 2000, NEUROSCI BIOBEHAV R, V24, P161, DOI 10.1016/S0149-7634(99)00057-3; Sagvolden T, 1998, BEHAV BRAIN RES, V94, P1; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Wade TR, 2000, PSYCHOPHARMACOLOGY, V150, P90	32	669	683	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2499	2501		10.1126/science.1060818	http://dx.doi.org/10.1126/science.1060818			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11375482				2022-12-28	WOS:000169658200044
J	Milton, SV; Gluskin, E; Arnold, ND; Benson, C; Berg, W; Biedron, SG; Borland, M; Chae, YC; Dejus, RJ; Den Hartog, PK; Deriy, B; Erdmann, M; Eidelmann, YI; Hahne, MW; Huang, Z; Kim, KJ; Lewellen, JW; Li, Y; Lumpkin, AH; Makarov, O; Moog, ER; Nassiri, A; Sajaev, V; Soliday, R; Tieman, BJ; Trakhtenberg, EM; Travish, G; Vasserman, IB; Vinokurov, NA; Wang, XJ; Wiemerslage, G; Yang, BX				Milton, SV; Gluskin, E; Arnold, ND; Benson, C; Berg, W; Biedron, SG; Borland, M; Chae, YC; Dejus, RJ; Den Hartog, PK; Deriy, B; Erdmann, M; Eidelmann, YI; Hahne, MW; Huang, Z; Kim, KJ; Lewellen, JW; Li, Y; Lumpkin, AH; Makarov, O; Moog, ER; Nassiri, A; Sajaev, V; Soliday, R; Tieman, BJ; Trakhtenberg, EM; Travish, G; Vasserman, IB; Vinokurov, NA; Wang, XJ; Wiemerslage, G; Yang, BX			Exponential gain and saturation of a self-amplified spontaneous emission free-electron laser	SCIENCE			English	Article							FEL	Self-amplified spontaneous emission in a free-electron Laser has been proposed for the generation of very high brightness coherent x-rays. This process involves passing a high-energy, high-charge, short-pulse, low-energy-spread, and low-emittance electron beam through the periodic magnetic field of a long series of high-quality undulator magnets. The radiation produced grows exponentially in intensity until if reaches a saturation point. We report on the demonstration of self-amplified spontaneous emission gain, exponential growth, and saturation at visible (530 nanometers) and ultraviolet (385 nanometers) wavelengths. Good agreement between theory and simulation indicates that scaling to much shorter wavelengths may be possible. These results confirm the physics behind the self-amplified spontaneous emission process and forward the development of an operational x-ray free-electron laser.	Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; Lund Univ, MAX Lab, S-22100 Lund, Sweden; Budker Inst Nucl Phys, Novosibirsk 630090, Russia	United States Department of Energy (DOE); Argonne National Laboratory; Lund University; Russian Academy of Sciences; Budker Institute of Nuclear Physics	Milton, SV (corresponding author), Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA.	milton@aps.anl.gov	Vinokurov, Nikolay/AAP-6978-2021; Biedron, Sandra/AAA-2420-2020; Travish, Gil/H-4937-2011	Travish, Gil/0000-0002-4787-0949; Li, Yuelin/0000-0002-6229-7490; Vinokurov, Nikolay/0000-0003-1290-4018				ARNOLD ND, 2000, NUCL INSTRUM METHO A; Babzien M, 1998, PHYS REV E, V57, P6093, DOI 10.1103/PhysRevE.57.6093; Biedron S. G., 1999, Proceedings of the 1999 Particle Accelerator Conference (Cat. No.99CH36366), P2024, DOI 10.1109/PAC.1999.794360; Biedron SG, 1999, PROC SPIE, V3614, P96, DOI 10.1117/12.352655; BONIFACIO R, 1984, OPT COMMUN, V50, P373, DOI 10.1016/0030-4018(84)90105-6; BORLAND M, 2000, P 20 INT LIN C; BRINKMANN R, 1997, DESY97048; CHIN YH, 1992, PHYS REV A, V46, P6662, DOI 10.1103/PhysRevA.46.6662; Cornacchia M., 1998, SLACR521; FAWLEY W, 1995, 104 BP LAWR BERK NAT; Galayda J. N., 1995, Proceedings of the 1995 Particle Accelerator Conference (Cat. No.95CH35843), P4, DOI 10.1109/PAC.1995.504556; Gluskin E, 1999, NUCL INSTRUM METH A, V429, P358, DOI 10.1016/S0168-9002(99)00087-X; Hogan MJ, 1998, PHYS REV LETT, V81, P4867, DOI 10.1103/PhysRevLett.81.4867; KAMITSUBO H, 1997, P PAC97, P6; KIM KJ, 1993, NUCL INSTRUM METH A, V331, P359, DOI 10.1016/0168-9002(93)90072-P; KIRKPATRICK DA, 1989, PHYS FLUIDS B-PLASMA, V1, P1511, DOI 10.1063/1.858927; Kondratenko A. M., 1979, Soviet Physics - Doklady, V24, P986; Laclare J. L., 1993, Proceedings of the 1993 Particle Accelerator Conference (Cat. No.93CH3279-7), P1427, DOI 10.1109/PAC.1993.308580; Milton SV, 2000, PHYS REV LETT, V85, P988, DOI 10.1103/PhysRevLett.85.988; Milton SV, 1998, NUCL INSTRUM METH A, V407, P210, DOI 10.1016/S0168-9002(97)01398-3; NADRUSZKOW J, 2000, PHYS REV LETT, V85, P3825; PELLEGRINI C, 1992, WORKSH 4 GEN LIGH SO; SAKAI F, 1997, BNL65003; TRAVISH G, 2000, P 20 INT LIN C; Vasserman I. B., 1999, Proceedings of the 1999 Particle Accelerator Conference (Cat. No.99CH36366), P2489, DOI 10.1109/PAC.1999.792741; Vasserman IB, 2000, AIP CONF PROC, V521, P368, DOI 10.1063/1.1291817; Xie M, 2000, NUCL INSTRUM METH A, V445, P59, DOI 10.1016/S0168-9002(00)00114-5; XIE M, 1995, P IEEE 1995 PART ACC, P183; YU LH, 1990, PHYS REV LETT, V64, P3011, DOI 10.1103/PhysRevLett.64.3011	29	227	240	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2037	2041		10.1126/science.1059955	http://dx.doi.org/10.1126/science.1059955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11358995	Green Submitted			2022-12-28	WOS:000169284700037
J	Prior, P				Prior, P			A tale of seven surgeons	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1433	1433		10.1136/bmj.322.7299.1433	http://dx.doi.org/10.1136/bmj.322.7299.1433			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397766	Green Published			2022-12-28	WOS:000169284600058
J	Calfee, JE				Calfee, JE			Pharmaceutical price controls and patient welfare	ANNALS OF INTERNAL MEDICINE			English	Article							INHALED INSULIN; SEVERE SEPSIS; DEPRESSION; REALITY	Price controls could have a substantial negative effect on pharmaceutical research and development. Extensive research is required before the development costs of a new drug or its benefits are known; most new drug development projects fail, sometimes after substantial financial and time costs. These conditions pose intractable practical problems for the operation of price controls, which cannot rest on objective, predictable standards such as the benefits or costs of individual drugs. In the absence of objective standards, pressure from health care providers and others would create powerful incentives for price regulators to decrease drug prices toward marginal costs of production and distribution, well below levels sufficient to reward innovative research. This downwardly biased price-setting mechanism would apply with particular force to the few successful projects that yield innovative drugs, whose prices would not be set by regulatory authorities until after research expenditures have been incurred and the new drugs are ready to enter the market. Manufacturers will expect price controls to reduce the potential payoffs from breakthrough drugs. This expectation would substantially reduce the incentives to pursue innovative research, as is evident in advanced economies in which price controls are now in force. Once established, price controls for pharmaceuticals, like those for medical services in the Medicare system, would also tend toward complexity and entrenchment of vested interests and could easily become permanent regardless of the harm they cause to patients.	Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA	American Enterprise Institute for Public Policy Research	Calfee, JE (corresponding author), Amer Enterprise Inst Publ Policy Res, 1150 17th St NW, Washington, DC 20036 USA.	calfeej@aei.org						Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; [Anonymous], 1997, PHARM PRICE REGULATI; Ball BG, 2000, JAMA-J AM MED ASSOC, V284, P2788, DOI 10.1001/jama.284.21.2788; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BERNDT ER, 2000, US DEP HLTH HUM SERV; BOOTH B, 1999, AM MED NEWS     1227; BURTON TM, 2000, WALL STREET J   0630; BUTLER L, 1999, AM MED NEWS     1227; Calfee JE, 2000, PHARMACOECONOMICS, V18, P47, DOI 10.2165/00019053-200018001-00007; CALFEE JE, 2000, PRICES MARKETS PHARM; CALFEE JE, 1997, FEAR PERSUASION NEEW; CALFEE JE, 2001, FRASER FORUM     FEB, P4; CLARKSON KW, 1996, COMPETITIVE STRATEGI, P238; DANZON PM, 1999, REV US CROSS NATL ST; DIMASI JA, 2001, US DEP HLTH HUM SERV; Dubois RW, 2000, HEALTH AFFAIR, V19, P231, DOI 10.1377/hlthaff.19.2.231; *FOOD DRUG ADM, 1999, FED REGISTER, V64, P43197; Gale EAM, 2001, LANCET, V357, P324, DOI 10.1016/S0140-6736(00)03631-X; GLENNERSTER R, 2000, WORLD BANK VACCINE C; Glick ID, 2001, ANN INTERN MED, V134, P47, DOI 10.7326/0003-4819-134-1-200101020-00013; GRABOWSKI HG, 1994, J HEALTH ECON, V13, P383, DOI 10.1016/0167-6296(94)90010-8; Grabowski HG, 2000, PHARMACOECONOMICS, V18, P21, DOI 10.2165/00019053-200018001-00005; GRABOWSKI HG, 1994, HLTH REFORM PHARM IN; GROOPMAN J, 2000, WALL STREE J    0502; *IMS HLTH, 2000, DRUG MON; Kettler H. E., 1998, COMPETITION INNOVATI; KING RT, 1999, WALL STREE J    0219; LANGRETH R, 2001, FORBES MAGAZINE 0222; LANGRETH R, 1999, WALL STREEJ J   0813; LEWERS DT, 2001, AM MED NEWS     0305; Matthay MA, 2001, NEW ENGL J MED, V344, P759, DOI 10.1056/NEJM200103083441009; Mintz M, 2001, WASHINGTON POST 1102, pB1; Monkman D, 2000, BMJ-BRIT MED J, V321, P1299, DOI 10.1136/bmj.321.7272.1299; MOORE SD, 1998, WALL STREET J   1207; Nathan DM, 2001, ANN INTERN MED, V134, P242, DOI 10.7326/0003-4819-134-3-200102060-00016; OLSON E, 1999, NY TIMES        1118; *PAT MED PRIC REV, 2000, ANN REP YEAR END DEC; Pickering TG, 2001, ANN INTERN MED, V134, P72, DOI 10.7326/0003-4819-134-1-200101020-00016; SAGER A, 1999, AFFORDABLE MED AM PR; SEIDEN C, 2001, POTENTIAL BLOCKBUSTE; Spilker B., 1994, MULTINATIONAL PHARM, V2nd; Thomas L. G., 1994, IND CORP CHANGE, V3, P451; Triplett JE, 1999, MEASURING PRICES MED; *US FOOD DRUG ADM, 2001, TEST TUB PAT NEW DRU, P67; WINSLOW R, 2000, WALL STREET J   1214; WINSLOW R, 2000, WALL STREET J   0420, P20; 1999, ECONOMIST       0814; 2000, WORLDS TOP 50 BEST S	48	11	11	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2001	134	11					1060	1064		10.7326/0003-4819-134-11-200106050-00012	http://dx.doi.org/10.7326/0003-4819-134-11-200106050-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	436YL	11388819				2022-12-28	WOS:000168963400006
J	Carr, AJ; Higginson, IJ				Carr, AJ; Higginson, IJ			Measuring quality of life - Are quality of life measures patient centred?	BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE; GENERATED INDEX; HEALTH-STATUS; QUESTIONNAIRE; FAMILY		Univ Nottingham, City Hosp Nottingham, Nottingham NG3 5DE, England; Univ London Kings Coll, New Med Sch, Dept Palliat Care & Policy, London SE5 9PJ, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of London; King's College London	Carr, AJ (corresponding author), Univ Nottingham, City Hosp Nottingham, Nottingham NG3 5DE, England.		Higginson, Irene J/C-7309-2012	Higginson, Irene J/0000-0002-3687-1313				ADDINGTONHALL J, 2001, IN PRESS BMJ; Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; [Anonymous], 1991, LANCET, V338, P350; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bernheim JL, 1999, BIOETHICS, V13, P272, DOI 10.1111/1467-8519.00156; BOWLING A, 1995, SOC SCI MED, V41, P1447, DOI 10.1016/0277-9536(95)00113-L; CALMAN KC, 1984, J MED ETHICS, V10, P124, DOI 10.1136/jme.10.3.124; Carr AJ, 2001, BMJ-BRIT MED J, V322, P1240, DOI 10.1136/bmj.322.7296.1240; Carr AJ, 1996, BRIT J RHEUMATOL, V35, P921; Cella D F, 1990, Oncology (Williston Park), V4, P29; CHAMBERS LW, 1982, MCMASTER HLTH INDEX; COATES AS, 1983, EUR J CANCER CLIN ON, V13, P203; DAZORD A, 1994, DIABETES METAB, V20, P465; DONOVAN J, 1991, ANN RHEUM DIS, V50, P418, DOI 10.1136/ard.50.Suppl_3.418; *EUR GROUP, 1996, EUR EQ 5D US GUID; Hickey AM, 1996, BRIT MED J, V313, P29, DOI 10.1136/bmj.313.7048.29; HIGGINSON I, 1994, SOC SCI MED, V38, P553, DOI 10.1016/0277-9536(94)90251-8; Hunt SM, 1986, MEASURING HLTH STATU; Klassen A, 1999, J EPIDEMIOL COMMUN H, V53, P440, DOI 10.1136/jech.53.7.440; KWOH CK, 1992, J RHEUMATOL, V19, P1031; Macduff C, 1998, QUAL LIFE RES, V7, P761, DOI 10.1023/A:1008831209706; OBOYLE CA, 1992, LANCET, V339, P1088, DOI 10.1016/0140-6736(92)90673-Q; PEARLMAN RA, 1988, J GERONTOL, V43, pM25, DOI 10.1093/geronj/43.2.M25; ROSE M, 1998, QUAL LIFE RES, V7, P655; RUTA DA, 1994, MED CARE, V32, P1109, DOI 10.1097/00005650-199411000-00004; Skevington SM, 1999, J PSYCHOSOM RES, V47, P449, DOI 10.1016/S0022-3999(99)00051-3; Skevington SM, 1998, PAIN, V76, P395, DOI 10.1016/S0304-3959(98)00072-4; SLEVIN ML, 1988, BRIT J CANCER, V57, P109, DOI 10.1038/bjc.1988.20; THUNEDBORG K, 1993, INT J METHOD PSYCH, V3, P45; VACHON MLS, 1995, J PAIN SYMPTOM MANAG, V10, P142, DOI 10.1016/0885-3924(94)00076-W; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHOQoL Group, 1994, QUALITY LIFE ASSESSM, P41	32	358	367	1	28	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2001	322	7298					1357	1360		10.1136/bmj.322.7298.1357	http://dx.doi.org/10.1136/bmj.322.7298.1357			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440GQ	11387189	Green Published			2022-12-28	WOS:000169167900025
J	Olesen, AB; Juul, S; Birkebaek, N; Thestrup-Pedersen, K				Olesen, AB; Juul, S; Birkebaek, N; Thestrup-Pedersen, K			Association between atopic dermatitis and insulin-dependent diabetes mellitus: a case-control study	LANCET			English	Article							PARTY DIAGNOSTIC-CRITERIA; INTERFERON-GAMMA; CLINICAL ASPECTS; NATURAL-HISTORY; TRANSGENIC MICE; EXPRESSION; CHILDREN; ECZEMA; IL-4	Background Up to two-thirds of children with atopic dermatitis have IgE-mediated allergic reactions and a Th2 immune reactivity pattern with low production of interferon gamma and high production of interleukin 4 after allergen stimulation of T lymphocytes. Insulin-dependent diabetes mellitus (IDDM) seems to be associated with a Th1 immune reactivity pattern. We therefore postulated that these diseases may be inversely associated. Methods We designed a case-control study including 920 children with IDDM, registered in the Danish Registry for Childhood Diabetes, and a sample of 9732 non-diabetic children registered in the Danish Medical Birth Registry. The children were aged 3-15 years. Information on atopic dermatitis was obtained by questionnaires. Findings The cumulative incidence of atopic dermatitis up to age 15 years was 13.1% among children with IDDM and 19.8% in non-diabetic children (p<0.0001). Among children who developed IDDM, the incidence of atopic dermatitis was significantly lower than in the controls before onset of IDDM (73 cases in 5314 person-months vs 1375 in 57 432 person-months; odds ratio 0.49 [0.39-0.63]). After onset of IDDM, diabetic and non-diabetic groups did not differ in incidence of atopic dermatitis (1.36 [0.89-2.07]). Interpretation Our findings may be explained by different acquired or inherited reactivity patterns associated with atopic dermatitis (Th2) and IDDM (Th1). The results do not allow us to find out whether early development of atopic dermatitis reduces the risk of IDDM, or a propensity for IDDM reduces the risk of early-onset atopic dermatitis.	Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark; Aarhus Univ Hosp, Dept Parasitol, DK-8000 Aarhus C, Denmark; Univ Aarhus, Dept Epidemiol & Social Med, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Olesen, AB (corresponding author), Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark.	Annebraae@dadlnet.dk		Birkebaek, Niels/0000-0001-6268-6464				Cameron MJ, 1997, J IMMUNOL, V159, P4686; Dahlquist G, 2000, J PEDIATR-US, V137, P470, DOI 10.1067/mpd.2000.109109; de Longueville M, 1997, PEDIATR ALLERGY IMMU, V8, P177; DELPRETE G, 1992, ALLERGY, V47, P450; DELPRETE G, 1988, J IMMUNOL, V140, P4193; DOTTERUD LK, 1995, ACTA DERM-VENEREOL, V75, P50; GREWE M, 1994, LANCET, V343, P25, DOI 10.1016/S0140-6736(94)90879-6; Knudsen LB, 1998, DAN MED BULL, V45, P320; Mandrup-Poulsen T, 1998, BMJ-BRIT MED J, V316, P1221, DOI 10.1136/bmj.316.7139.1221; MEERWALD R, 1998, HORM RES, V50, P125; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; RAJKA G, 1986, CLIN REV ALLERG, V4, P3; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; STROMBERG LGE, 1995, J ALLERGY CLIN IMMUN, V96, P188, DOI 10.1016/S0091-6749(95)70007-2; Thepen T, 1996, J ALLERGY CLIN IMMUN, V97, P828, DOI 10.1016/S0091-6749(96)80161-8; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P397, DOI 10.1111/j.1365-2133.1994.tb08531.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Williams HC, 1998, BRIT J DERMATOL, V139, P834; WILLIAMS HC, 1996, SO I DEFINE ATOPIC E; WOGENSEN L, 1993, J EXP MED, V178, P175, DOI 10.1084/jem.178.1.175; Wuthrich B, 1999, ANN ALLERG ASTHMA IM, V83, P464, DOI 10.1016/S1081-1206(10)62852-9	23	82	84	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2001	357	9270					1749	1752		10.1016/S0140-6736(00)04896-0	http://dx.doi.org/10.1016/S0140-6736(00)04896-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403811				2022-12-28	WOS:000169156200012
J	Lam, JPH; Eunson, GJ; Munro, FD; Orr, JD				Lam, JPH; Eunson, GJ; Munro, FD; Orr, JD			Lessons of the week - Delayed presentation of handlebar injuries in children	BRITISH MEDICAL JOURNAL			English	Review							BLUNT ABDOMINAL-TRAUMA; GASTROINTESTINAL-TRACT PERFORATION; MANAGEMENT		Royal Hosp Sick Children, Dept Paediat Surg, Edinburgh EH9 1LF, Midlothian, Scotland		Munro, FD (corresponding author), Royal Hosp Sick Children, Dept Paediat Surg, Edinburgh EH9 1LF, Midlothian, Scotland.							ACTON CHC, 1994, MED J AUSTRALIA, V160, P344, DOI 10.5694/j.1326-5377.1994.tb138235.x; Albanese CT, 1996, J TRAUMA, V40, P417, DOI 10.1097/00005373-199603000-00016; BASS J, 1988, J PEDIATR SURG, V23, P721, DOI 10.1016/S0022-3468(88)80410-X; BROWN RA, 1992, BRIT J SURG, V79, P522, DOI 10.1002/bjs.1800790615; Ciftci AO, 1998, PEDIATR SURG INT, V13, P259, DOI 10.1007/s003830050311; Clarnette TD, 1997, AUST NZ J SURG, V67, P338, DOI 10.1111/j.1445-2197.1997.tb01986.x; GORENSTEIN A, 1987, J PEDIATR SURG, V22, P1110, DOI 10.1016/S0022-3468(87)80719-4; HILBERS J, 1990, ANN REPORT W AUSTR C; Ruess L, 1997, AM J ROENTGENOL, V169, P1011, DOI 10.2214/ajr.169.4.9308453; SCHENK WG, 1983, J TRAUMA, V23, P54, DOI 10.1097/00005373-198301000-00011; SMITH SD, 1988, J PEDIATR SURG, V23, P610, DOI 10.1016/S0022-3468(88)80628-6; Takishima T, 1996, J PEDIATR SURG, V31, P896, DOI 10.1016/S0022-3468(96)90405-4; Ulman I, 1996, J TRAUMA, V41, P110, DOI 10.1097/00005373-199607000-00017; Winston FK, 1998, PEDIATRICS, V102, P596, DOI 10.1542/peds.102.3.596	14	29	30	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 26	2001	322	7297					1288	1289		10.1136/bmj.322.7297.1288	http://dx.doi.org/10.1136/bmj.322.7297.1288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375234	Green Published			2022-12-28	WOS:000169027800023
J	Gerbi, SA; Garrison, HH; Perkins, JP				Gerbi, SA; Garrison, HH; Perkins, JP			Education - Workforce alternatives to graduate students?	SCIENCE			English	Editorial Material									Brown Univ, Div Biol & Med, JW Wilson Lab, Providence, RI 02912 USA; Federat Amer Soc Expt Biol, Off Publ Affairs, Bethesda, MD 20814 USA; Univ Texas, SW Med Ctr, Grad Sch, Dallas, TX 75235 USA	Brown University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Gerbi, SA (corresponding author), Brown Univ, Div Biol & Med, JW Wilson Lab, Providence, RI 02912 USA.			Garrison, Howard/0000-0001-9455-3527				*AM SOC BIOCH MOL, TRENDS EARL CAR LIF; *COMM POSTD ED ASS, 1998, COMM POSTD ED REP RE; Committee on Dimensions Causes and Implications of Recent Trends in the Careers of Life Scientists & National Research Council, 1998, TRENDS EARL CAR LIF; Committee on National Needs for Biomedical and Behavioral Scientists. Education and Career Studies Unit. Office of Scientific and Engineering Personnel. National Research Council, 2000, ADDR NAT CHANG NEEDS; Committee on Science Engineering and Public Policy, 1995, RESH GRAD ED SCI ENG; Committee on Science Engineering and Public Policy (COSEPUP), 2000, ENH POSTD EXP SCI EN; *FASEB, 1997, REP CONS C GRAD ED; GARRISON H, IN PRESS NATURE IMMU; Garrison HH, 1998, FASEB J, V12, P139, DOI 10.1096/fasebj.12.2.139; HILL ST, 2001, SCI ENG DOCTORATE AW; Marincola E, 1998, SCIENCE, V281, P645, DOI 10.1126/science.281.5377.645; MASSEY WF, 1995, PRODUCTION ULTILIZAT; *NIH, 2001, NIH STAT RESP ADDR N; PERKINS J, 1996, PHARMACOLOGIST, V38, P124	14	7	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1489	1490		10.1126/science.1059268	http://dx.doi.org/10.1126/science.1059268			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11379627				2022-12-28	WOS:000168963800024
J	Gomberg, J; Reasenberg, PA; Bodin, P; Harris, RA				Gomberg, J; Reasenberg, PA; Bodin, P; Harris, RA			Earthquake triggering by seismic waves following the Landers and Hector Mine earthquakes	NATURE			English	Article							STRESS-STRAIN CHANGES; CALIFORNIA; AFTERSHOCKS; TRANSIENT	The proximity and similarity of the 1992, magnitude 7.3 Landers and 1999, magnitude 7.1 Hector Mine earthquakes in California permit testing of earthquake triggering hypotheses not previously possible. The Hector Mine earthquake confirmed inferences that transient, oscillatory 'dynamic' deformations radiated as seismic waves can trigger seismicity rate increases, as proposed for the Landers earthquake(1-6). Here we quantify the spatial and temporal patterns of the seismicity rate changes(7). The seismicity rate increase was to the north for the Landers earthquake and primarily to the south for the Hector Mine earthquake. We suggest that rupture directivity results in elevated dynamic deformations north and south of the Landers and Hector Mine faults, respectively, as evident in the asymmetry of the recorded seismic velocity fields. Both dynamic and static stress changes seem important for triggering in the near field with dynamic stress changes dominating at greater distances. Peak seismic velocities recorded for each earthquake suggest the existence of, and place bounds on, dynamic triggering thresholds. These thresholds vary from a few tenths to a few MPa in most places, depend on local conditions, and exceed inferred static thresholds by more than an order of magnitude. At some sites, the onset of triggering was delayed until after the dynamic deformations subsided. Physical mechanisms consistent with all these observations may be similar to those that give rise to liquefaction or cyclic fatigue.	US Geol Survey, Ctr Earthquake Res & Informat, Memphis, TN 38152 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Univ Memphis, Ctr Earthquake Res & Informat, Memphis, TN 38152 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Memphis	Gomberg, J (corresponding author), US Geol Survey, Ctr Earthquake Res & Informat, 3876 Cent Ave Suite 2, Memphis, TN 38152 USA.	gomberg@usgs.gov	Harris, Ruth A/C-4184-2013	Harris, Ruth A/0000-0002-9247-0768				ANDERSON JG, 1994, B SEISMOL SOC AM, V84, P863; CRAMER CH, 1994, B SEISMOL SOC AM, V84, P589; DAS S, 1981, J GEOPHYS RES, V86, P6039, DOI 10.1029/JB086iB07p06039; DIETERICH J, 1994, J GEOPHYS RES-SOL EA, V99, P2601, DOI 10.1029/93JB02581; Dreger D, 2000, GEOPHYS RES LETT, V27, P1941, DOI 10.1029/1999GL011245; GOMBERG J, 1994, B SEISMOL SOC AM, V84, P844; Gomberg J, 1996, J GEOPHYS RES-SOL EA, V101, P733, DOI 10.1029/95JB03250; Gomberg J, 1996, J GEOPHYS RES-SOL EA, V101, P751, DOI 10.1029/95JB03251; Gomberg J, 1998, J GEOPHYS RES-SOL EA, V103, P24411, DOI 10.1029/98JB01125; Gomberg J, 2000, J GEOPHYS RES-SOL EA, V105, P7857, DOI 10.1029/1999JB900438; Gomberg J, 1996, B SEISMOL SOC AM, V86, P212; GOMBERG J, IN PRESS J GEOPHYS R; Hardebeck JL, 1998, J GEOPHYS RES-SOL EA, V103, P24427, DOI 10.1029/98JB00573; Harris RA, 1998, J GEOPHYS RES-SOL EA, V103, P24347, DOI 10.1029/98JB01576; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; HILL DP, 1995, J GEOPHYS RES-SOL EA, V100, P12985, DOI 10.1029/95JB00860; JI C, IN PRESS B SEISMOL S; Kilb D, 2000, NATURE, V408, P570, DOI 10.1038/35046046; KING GCP, 1994, B SEISMOL SOC AM, V84, P935; LINDE AT, 1994, NATURE, V371, P408, DOI 10.1038/371408a0; MATTHEWS MV, 1988, PURE APPL GEOPHYS, V126, P357, DOI 10.1007/BF00879003; NUR A, 1972, SCIENCE, V175, P885, DOI 10.1126/science.175.4024.885; REASENBERG PA, 1992, SCIENCE, V255, P1687, DOI 10.1126/science.255.5052.1687; SORNETTE D, 1995, J PHYS I, V5, P607, DOI 10.1051/jp1:1995154; SPUDICH P, 1995, J GEOPHYS RES-SOL EA, V100, P675, DOI 10.1029/94JB02477; Sturtevant B, 1996, J GEOPHYS RES-SOL EA, V101, P25269, DOI 10.1029/96JB02654; WALD DJ, 1994, B SEISMOL SOC AM, V84, P668; Ziv A, 2000, J GEOPHYS RES-SOL EA, V105, P13631, DOI 10.1029/2000JB900081	28	253	271	4	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					462	466		10.1038/35078053	http://dx.doi.org/10.1038/35078053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373675				2022-12-28	WOS:000168858700044
J	Ebers, GC				Ebers, GC			Preventing multiple sclerosis?	LANCET			English	Editorial Material							ACUTE OPTIC NEURITIS; HLA FINDINGS; MRI; CSF		Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 CH2, England	Radcliffe Infirmary; University of Oxford	Ebers, GC (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 CH2, England.			Ebers, George/0000-0003-4771-4177				BECK RW, 1993, NEW ENGL J MED, V329, P1764, DOI 10.1056/NEJM199312093292403; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; EBERS GC, 1985, ARCH NEUROL-CHICAGO, V42, P702, DOI 10.1001/archneur.1985.04060070096025; Frederiksen JL, 2000, ACTA OPHTHALMOL SCAN, V78, P490; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Soderstrom M, 1998, NEUROLOGY, V50, P708, DOI 10.1212/WNL.50.3.708	8	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1547	1547		10.1016/S0140-6736(00)04778-4	http://dx.doi.org/10.1016/S0140-6736(00)04778-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377638				2022-12-28	WOS:000168830100004
J	Heaney, D; Wyke, S; Wilson, P; Elton, R; Rutledge, P				Heaney, D; Wyke, S; Wilson, P; Elton, R; Rutledge, P			Assessment of impact of information booklets on use of healthcare services: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							HELP	Objectives To investigate the effect of patient information booklets on overall use of health services, on particular types of use, and on possible interactions between use, and on possible interactions between use, deprivation category of the area in which respondents live, and age. To investigate the possibility of a differential effect on health service use between two information booklets. Design Randomised controlled trial of two patient information booklets (covering the management and treatment of minor illness). Setting 20 general practices in Lothian, Scotland. Participants Random sample of patients from the community health index (n = 4878) and of those contacting out of hours services (n = 4530) in the previous 12 months in each of the study general practices. Intervention Booklets posted to participants in intervention groups (3288 were sent What Should I Do?; 3127 were sent Health Care Manual). Patients randomised to control group (2993) did not receive a booklet. Main outcome measures Use of health services audited from patients' general practice notes in 12 months after receipt of booklet. Results Receipt of either booklet had no significant effect on health service use compared with a control group. However, nine out of ten matched practices allocated to receive Health Care Manual had reduced consultation rates compared with matched practices allocated to What Should I Do? Conclusion Widespread distribution of information booklets about the management of minor illness is unlikely to reduce demand for health services.	Univ Edinburgh, Dept Community Hlth Sci Gen Practice, Edinburgh EH8 9DX, Midlothian, Scotland; Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland; Lothian Hlth, Edinburgh EH8 9RS, Midlothian, Scotland	University of Edinburgh; University of Glasgow	Heaney, D (corresponding author), Univ Edinburgh, Dept Community Hlth Sci Gen Practice, Edinburgh EH8 9DX, Midlothian, Scotland.							CUNNINGHAMBURLE.S, 1990, READINGS MED SOCIOLO; IRVINE S, 1991, BRIT J GEN PRACT, V41, P371; McLoone P., 1994, CARSTAIRS SCORES SCO; Milewa T, 2000, SOC SCI MED, V51, P463, DOI 10.1016/S0277-9536(99)00478-5; *NOP HEALTHC, 1996, APPR WHAT SHOULD I D; PERSAUD J, 1997, MEDECONOMICS     JUN, P47; PESCOSOLIDO BA, 1992, AM J SOCIOL, V97, P1096, DOI 10.1086/229863; ROBERTS H, 1992, SOCIOL REV, V40, P109, DOI 10.1111/j.1467-954X.1992.tb02947.x; RODGERS A, 1999, DEMANDING PATIENTS; Rogers A, 1998, BRIT MED J, V316, P1816, DOI 10.1136/bmj.316.7147.1816; VANDERSLOOT C, 1995, WHAT SHOULD THEY DO	11	21	22	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2001	322	7296					1218	1220		10.1136/bmj.322.7296.1218	http://dx.doi.org/10.1136/bmj.322.7296.1218			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435UV	11358776	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000168900700028
J	Segev, N				Segev, N			Cell biology - A TIP about Rabs	SCIENCE			English	Editorial Material							PROTEINS; RECRUITMENT; GTPASE		Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Segev, N (corresponding author), Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA.	nava@uic.edu						Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Armstrong J, 2000, INT J BIOCHEM CELL B, V32, P303, DOI 10.1016/S1357-2725(99)00112-0; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Gerrard SR, 2000, MOL BIOL CELL, V11, P613, DOI 10.1091/mbc.11.2.613; JEDD G, 1995, J CELL BIOL, V131, P583, DOI 10.1083/jcb.131.3.583; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Scales SJ, 2000, INT REV CYTOL, V195, P67; SEGEV N, IN PRESS SCI STKE	14	9	9	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1313	1314		10.1126/science.1061114	http://dx.doi.org/10.1126/science.1061114			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360988				2022-12-28	WOS:000168862900029
J	Weaver, HA; Sekanina, Z; Toth, I; Delahodde, CE; Hainaut, OR; Lamy, PL; Bauer, JM; A'Hearn, MF; Arpigny, C; Combi, MR; Davies, JK; Feldman, PD; Festou, MC; Hook, R; Jorda, L; Keesey, MSW; Lisse, CM; Marsden, BG; Meech, KJ; Tozzi, GP; West, R				Weaver, HA; Sekanina, Z; Toth, I; Delahodde, CE; Hainaut, OR; Lamy, PL; Bauer, JM; A'Hearn, MF; Arpigny, C; Combi, MR; Davies, JK; Feldman, PD; Festou, MC; Hook, R; Jorda, L; Keesey, MSW; Lisse, CM; Marsden, BG; Meech, KJ; Tozzi, GP; West, R			HST and VLT investigations of the fragments of comet C/1999 S4 (LINEAR)	SCIENCE			English	Article							NUCLEUS; BREAKUP; SPLIT; DUST	At least 16 fragments were detected in images of comet C/1999 S4 (LINEAR) taken on 5 August 2000 with the Hubble Space Telescope (HST) and on 6 August with the Very Large Telescope (VLT). Photometric analysis of the fragments indicates that the largest ones have effective spherical diameters of about 100 meters, which implies that the total mass in the observed fragments was about 2 x 10(9) kilograms. The comet's dust tail, which was the most prominent optical feature in August, was produced during a major fragmentation event, whose activity peaked on UT 22.8 +/- 0.2 July 2000. The mass of small particles (diameters less than about 230 micrometers) in the tail was about 4 x 10(8) kilograms, which is comparable to the mass contained in a large fragment and to the total mass lost from water sublimation after 21 July 2000 (about 3 x 108 kilograms). HST spectroscopic observations during 5 and 6 July 2000 demonstrate that the nucleus contained little carbon monoxide ice (ratio of carbon monoxide to water is less than or equal to 0.4%), which suggests that this volatile species did not play a role in the fragmentation of C/1999 S4 (LINEAR).	Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Konkoly Observ Budapest, H-1525 Budapest, Hungary; European So Observ, Santiago 19, Chile; CNRS, Astron Spatiale Lab, F-13376 Marseille 12, France; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Univ Liege, Inst Astrophys, B-4000 Liege, Belgium; Univ Michigan, Space Phys Res Lab, Ann Arbor, MI 48109 USA; Joint Astron Ctr, Hilo, HI 96720 USA; Observ Midi Pyrenees, F-31400 Toulouse, France; European So Observ, D-85748 Garching, Germany; Space Telescope Sci Inst, Baltimore, MD 21218 USA; Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Osserv Astrofis Arcetri, I-50125 Florence, Italy	Johns Hopkins University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Astronomy & Earth Sciences; European Southern Observatory; Centre National de la Recherche Scientifique (CNRS); University of Hawaii System; University System of Maryland; University of Maryland College Park; University of Liege; University of Michigan System; University of Michigan; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; European Southern Observatory; Space Telescope Science Institute; Smithsonian Institution; Istituto Nazionale Astrofisica (INAF)	Weaver, HA (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, 3400 N Charles St, Baltimore, MD 21218 USA.		Weaver, Harold A/D-9188-2016; Combi, Michael/J-1697-2012; Jorda, Laurent/AAA-1718-2021; Lisse, Carey M/B-7772-2016; Hainaut, Olivier R./AAY-7006-2021; Meech, Karen/CAH-1412-2022	Weaver, Harold A/0000-0003-0951-7762; Combi, Michael/0000-0002-9805-0078; Lisse, Carey M/0000-0002-9548-1526; Meech, Karen/0000-0002-2058-5670; Tozzi, Gian Paolo/0000-0003-4775-5788				Bockelee-Morvan D, 2001, SCIENCE, V292, P1339, DOI 10.1126/science.1058512; CHEN J, 1994, ICARUS, V108, P265, DOI 10.1006/icar.1994.1061; DIVINE N, 1986, SPACE SCI REV, V43, P1, DOI 10.1007/BF00175326; Farnham TL, 2001, SCIENCE, V292, P1348, DOI 10.1126/science.1058886; FERNANDEZ YR, IN PRESS COMETARY N; FINSON ML, 1968, ASTROPHYS J, V154, P353, DOI 10.1086/149762; *INT ASTR UN, 2000, 40988 IAU; Irvine W. M., 2000, Protostars and planets 4, P1159; Keller HU, 1997, ADV SPACE RES-SERIES, V19, P187, DOI 10.1016/S0273-1177(96)00011-7; KIDGER M, 2000, 7467 IAU; Lamy PL, 1998, ASTRON ASTROPHYS, V337, P945; Mumma MJ, 2001, SCIENCE, V292, P1334, DOI 10.1126/science.1058929; Oort J. H., 1950, B ASTRON I NETH, V11, P91; Sekanina Z, 1997, ASTRON ASTROPHYS, V318, pL5; SEKANINA Z, 1984, ICARUS, V58, P81, DOI 10.1016/0019-1035(84)90099-X; Sekanina Z, 1997, EARTH MOON PLANETS, V77, P147, DOI 10.1023/A:1006270428595; SEKANINA Z, 1982, COMETS, P251; Stokes GH, 2000, ICARUS, V148, P21, DOI 10.1006/icar.2000.6493; Teemu J, 2001, SCIENCE, V292, P1326, DOI 10.1126/science.1060858; Toth I, 2001, ASTRON ASTROPHYS, V368, pL25, DOI 10.1051/0004-6361:20010182; WEAVER H, 2000, 7461 IAU; Weissman PR, 1996, ASTR SOC P, V107, P265; YAMAMOTO T, 1991, COMETS POST HALLEY E, V1, P361	23	73	73	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1329	1333		10.1126/science.1058606	http://dx.doi.org/10.1126/science.1058606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359001				2022-12-28	WOS:000168862900034
J	Both, C; Visser, ME				Both, C; Visser, ME			Adjustment to climate change is constrained by arrival date in a long-distance migrant bird	NATURE			English	Article							EGG-LAYING TRENDS; REPRODUCTION; TEMPERATURE; POPULATION; PHENOLOGY; EARLIER; BRITAIN; TITS	Spring temperatures in temperate regions have increased over the past 20 years(1), and many organisms have responded to this increase by advancing the date of their growth and reproduction(2-7). Here we show that adaptation to climate change in a long-distance migrant is constrained by the timing of its migratory journey. For long-distance migrants climate change may advance the phenology of their breeding areas, but the timing of some species' spring migration relies on endogenous rhythms that are not affected by climate change(8). Thus, the spring migration of these species will not advance even though they need to arrive earlier on their breeding grounds to breed at the appropriate time. We show that the migratory pied flycatcher Ficedula hypoleuca has advanced its laying date over the past 20 years. This temporal shift has been insufficient, however, as indicated by increased selection for earlier breeding over the same period. The shift is hampered by its spring arrival date, which has not advanced. Some of the numerous long-distance migrants will suffer from climate change, because either their migration strategy is unaffected by climate change, or the climate in breeding and wintering areas are changing at different speeds, preventing adequate adaptation.	Inst Ecol Res, NL-6666 ZG Heteren, Netherlands; Univ Groningen, Zool Lab, NL-9750 AA Haren, Netherlands	University of Groningen	Visser, ME (corresponding author), Inst Ecol Res, POB 40, NL-6666 ZG Heteren, Netherlands.		Visser, Marcel E/A-9151-2009; Both, Christiaan/E-6459-2011	Visser, Marcel E/0000-0002-1456-1939; Both, Christiaan/0000-0001-7099-9831				ALATALO RV, 1986, NATURE, V323, P152, DOI 10.1038/323152a0; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Berthold P, 1998, NATURWISSENSCHAFTEN, V85, P350, DOI 10.1007/s001140050514; BERTHOLD P, 1990, 20 C INT ORN, P780; BILZECKER J, 1998, 982 VOG ARNH EO; Both C, 2000, J AVIAN BIOL, V31, P412, DOI 10.1034/j.1600-048X.2000.310317.x; Brown JL, 1999, P NATL ACAD SCI USA, V96, P5565, DOI 10.1073/pnas.96.10.5565; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Falconer D. S., 1996, INTRO QUANTATIVE GEN; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Huin N, 1998, BIRD STUDY, V45, P361, DOI 10.1080/00063659809461108; Huin N, 2000, BIRD STUDY, V47, P22, DOI 10.1080/00063650009461157; Lundberg A, 1992, PIED FLYCATCHER; MASON CF, 1995, BIRD STUDY, V42, P182, DOI 10.1080/00063659509477167; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; Myers J.P., 1992, P193; Przybylo R, 2000, J ANIM ECOL, V69, P395, DOI 10.1046/j.1365-2656.2000.00401.x; Pulido F, 1996, P NATL ACAD SCI USA, V93, P14642, DOI 10.1073/pnas.93.25.14642; Stevenson IR, 2000, NATURE, V406, P366, DOI 10.1038/35019151; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363	27	717	758	10	556	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					296	298		10.1038/35077063	http://dx.doi.org/10.1038/35077063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357129	Green Published			2022-12-28	WOS:000168710000044
J	Karlin, S; Bergman, A; Gentles, AJ				Karlin, S; Bergman, A; Gentles, AJ			Genomics - Annotation of the Drosophila genome	NATURE			English	Article							PROTEIN SEQUENCES; DATABASE		Stanford Univ, Dept Math, Stanford, CA 94305 USA	Stanford University	Karlin, S (corresponding author), Stanford Univ, Dept Math, Serra St, Stanford, CA 94305 USA.							Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002; Brocchieri L, 1998, J MOL BIOL, V276, P249, DOI 10.1006/jmbi.1997.1527; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; KARLIN S, 1994, ANNU REV MICROBIOL, V48, P619, DOI 10.1146/annurev.mi.48.100194.003155; KARLIN S, 1995, CURR OPIN STRUC BIOL, V5, P360, DOI 10.1016/0959-440X(95)80098-0	8	21	24	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					259	260		10.1038/35077152	http://dx.doi.org/10.1038/35077152			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357119				2022-12-28	WOS:000168710000034
J	Whitley, RJ; Roizman, B				Whitley, RJ; Roizman, B			Herpes simplex virus infections	LANCET			English	Review							GENITAL HERPES; ORAL ACYCLOVIR; DOUBLE-BLIND; CONTROLLED TRIAL; SUPPRESSION; DIAGNOSIS; THERAPY; MUTANT; GLIOMA; HSV	Herpes simplex virus (HSV) is a member of the herpesviridae family. Recognised since ancient creek times, the virus frequently infects human beings, causing a range of diseases from mild uncomplicated mucocutaneous infection to those that are life threatening. In the past 50 years, substantial advances in our knowledge of the molecular biology of HSV have led to insights into disease pathogenesis and management. This review provides a contemporary interpretation of the biological properties, function, epidemiology, and treatment of HSV diseases.	Univ Alabama Birmingham, Childrens Hosp, Dept Pediat Microbiol & Med, Birmingham, AL 35233 USA; Univ Chicago, Marjorie B Kovler Viral Oncol Labs, Chicago, IL 60637 USA	University of Alabama System; University of Alabama Birmingham; University of Chicago	Whitley, RJ (corresponding author), Univ Alabama Birmingham, Childrens Hosp, Dept Pediat Microbiol & Med, 1600 7th Ave S, Birmingham, AL 35233 USA.	rwhitley@peds.uab.edu	Li, Chia Cheng/D-9906-2015					Balfour HH, 1999, NEW ENGL J MED, V340, P1255, DOI 10.1056/NEJM199904223401608; BROWN ZA, 1995, AM J OBSTET GYNECOL, V172, P1299, DOI 10.1016/0002-9378(95)91496-X; Burke Rae Lynn, 1993, P367; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; COREY L, 1982, JAMA-J AM MED ASSOC, V248, P1041, DOI 10.1001/jama.248.9.1041; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; COREY L, 1999, JAMA-J AM MED ASSOC, V28, P379; DIAZMITOMA F, 1998, JAMA-J AM MED ASSOC, V280, P928; DOUGLAS JM, 1984, NEW ENGL J MED, V310, P1551, DOI 10.1056/NEJM198406143102402; ERLICH KS, 1989, NEW ENGL J MED, V320, P293, DOI 10.1056/NEJM198902023200506; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; Fricker J, 1996, LANCET, V348, P1576, DOI 10.1016/S0140-6736(05)66179-X; Kimberlin DW, 1996, J INFECT DIS, V174, P1162, DOI 10.1093/infdis/174.6.1162; LAKEMAN FD, 1995, J INFECT DIS, V171, P857, DOI 10.1093/infdis/171.4.857; Markert JM, 2000, REV MED VIROL, V10, P17, DOI 10.1002/(SICI)1099-1654(200001/02)10:1<17::AID-RMV258>3.0.CO;2-G; Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205; MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197; NAHMIAS AJ, 1990, SCAND J INFECT DIS, P19; Patel R, 1997, GENITOURIN MED, V73, P105; REICHMAN RC, 1984, JAMA-J AM MED ASSOC, V251, P2103, DOI 10.1001/jama.251.16.2103; ROIZMAN B, IN PRESS FIELDS VIRO; SARAL R, 1981, NEW ENGL J MED, V305, P63, DOI 10.1056/NEJM198107093050202; SPRUANCE S, 2000, 40 INT C ANT AG CHEM; SPRUANCE SL, 1977, NEW ENGL J MED, V297, P69, DOI 10.1056/NEJM197707142970201; STEVENS JG, 1971, SCIENCE, V173, P843, DOI 10.1126/science.173.3999.843; STRAUS SE, 1984, NEW ENGL J MED, V310, P1545, DOI 10.1056/NEJM198406143102401; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; WARD PL, 1994, TRENDS GENET, V10, P267, DOI 10.1016/0168-9525(90)90009-U; WHITLEY R, 1991, NEW ENGL J MED, V324, P450, DOI 10.1056/NEJM199102143240704; Whitley Richard J., 1993, P69; WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303; WHITLEY RJ, FIELDS VIROLOGY	34	744	791	5	116	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2001	357	9267					1513	1518		10.1016/S0140-6736(00)04638-9	http://dx.doi.org/10.1016/S0140-6736(00)04638-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377626				2022-12-28	WOS:000168614300037
J	Butler, D				Butler, D			Bioinformatics to be nurtured online	NATURE			English	News Item																			0	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					513	513		10.1038/35079269	http://dx.doi.org/10.1038/35079269			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385529	Bronze			2022-12-28	WOS:000168982500012
J	Chemla, DS; Shah, J				Chemla, DS; Shah, J			Many-body and correlation effects in semiconductors	NATURE			English	Review							FEMTOSECOND SPECTRAL INTERFEROMETRY; 4-WAVE-MIXING SIGNALS; SECONDARY-EMISSION; QUANTUM KINETICS; BULK GAAS; REGIME; SCATTERING; DYNAMICS; WELLS	Solids consist of 10(22)-10(23) particles per cubic centimetre, interacting through infinite-range Coulomb interactions. The linear response of a solid to a weak external perturbation is well described by the concept of non-interacting 'quasiparticles' first introduced by Landau. But interactions between quasiparticles can be substantial in dense systems. For example, studies over the past decade have shown that Coulomb correlations between quasiparticles dominate the nonlinear optical response of semiconductors, in marked contrast to the behaviour of atomic systems. These Coulomb correlations and other many-body interactions are important not only for semiconductors, but also for all condensed-matter systems.	Bell Labs, Lucent Technol, Holmdel, NJ 07733 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	Alcatel-Lucent; Lucent Technologies; AT&T; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Shah, J (corresponding author), Bell Labs, Lucent Technol, 101 Crawford Corner Rd, Holmdel, NJ 07733 USA.	jags@lucent.com						[Anonymous], 1975, OPTICAL RESONANCE 2; AXT VM, 1994, Z PHYS B CON MAT, V93, P195, DOI 10.1007/BF01316963; BANYAI L, 1995, PHYS REV LETT, V75, P2188, DOI 10.1103/PhysRevLett.75.2188; BarAd S, 1996, PHYS REV LETT, V77, P3177, DOI 10.1103/PhysRevLett.77.3177; BarAd S, 1997, MAT SCI ENG B-SOLID, V48, P83, DOI 10.1016/S0921-5107(97)00085-8; BINDER R, 1995, PROG QUANT ELECTRON, V19, P307, DOI 10.1016/0079-6727(95)00001-S; Birkedal D, 1999, PHYS REV B, V60, P15585, DOI 10.1103/PhysRevB.60.15585; Birkedal D, 1998, PHYS REV LETT, V81, P2372, DOI 10.1103/PhysRevLett.81.2372; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; Bolivar PH, 1997, PHYS REV LETT, V78, P2232, DOI 10.1103/PhysRevLett.78.2232; Bolton SR, 2000, PHYS REV LETT, V85, P2002, DOI 10.1103/PhysRevLett.85.2002; Camescasse FX, 1996, PHYS REV LETT, V77, P5429, DOI 10.1103/PhysRevLett.77.5429; Chemla DS, 1999, SEMICONDUCT SEMIMET, V58, P175; Cohen-Tannoudji C., 1998, ATOM PHOTON INTERACT; Dodge JS, 1999, PHYS REV LETT, V83, P4650, DOI 10.1103/PhysRevLett.83.4650; Fromer NA, 1999, PHYS REV LETT, V83, P4646, DOI 10.1103/PhysRevLett.83.4646; Furst C, 1997, PHYS REV LETT, V78, P3733, DOI 10.1103/PhysRevLett.78.3733; GIRVIN SM, 1986, PHYS REV B, V33, P2481, DOI 10.1103/PhysRevB.33.2481; Haug H., 1996, SPRINGER SERIES SOLI; Haug H., 1993, QUANTUM THEORY OPTIC, V2nd; HENNEBERGER F, 1993, OPTICS SEMICONDUCTOR; Kaindl RA, 2000, SCIENCE, V287, P470, DOI 10.1126/science.287.5452.470; Khitrova G, 1999, REV MOD PHYS, V71, P1591, DOI 10.1103/RevModPhys.71.1591; KIM DS, 1992, PHYS REV LETT, V69, P2725, DOI 10.1103/PhysRevLett.69.2725; Kner P, 1998, PHYS REV LETT, V81, P5386, DOI 10.1103/PhysRevLett.81.5386; Kner P, 1999, PHYS REV B, V60, P4731, DOI 10.1103/PhysRevB.60.4731; Kner P, 1997, PHYS REV LETT, V78, P1319, DOI 10.1103/PhysRevLett.78.1319; LEO K, 1990, PHYS REV LETT, V65, P1340, DOI 10.1103/PhysRevLett.65.1340; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; LINDBERG M, 1988, PHYS REV B, V38, P3342, DOI 10.1103/PhysRevB.38.3342; MAIALLE MZ, 1994, PHYS REV LETT, V73, P3310, DOI 10.1103/PhysRevLett.73.3310; MEIER T, 1994, PHYS REV LETT, V73, P902, DOI 10.1103/PhysRevLett.73.902; Mukamel S., 1995, PRINCIPLES NONLINEAR, V1st; OSTREICH T, 1995, PHYS REV LETT, V74, P4698, DOI 10.1103/PhysRevLett.74.4698; Perakis IE, 1999, INT J MOD PHYS B, V13, P869, DOI 10.1142/S0217979299000734; Perakis IE, 2000, SURF SCI REP, V40, P1, DOI 10.1016/S0167-5729(00)00009-1; PHILLIPS RT, 1994, COHERENT OPTICAL PRO; Pines D., 1966, THEORY QUANTUM LIQUI; ROSSI F, 1992, HOT CARRIERS SEMICON, P153; SCHAFER W, 1993, PHYS REV B, V47, P1217, DOI 10.1103/PhysRevB.47.1217; Schafer W, 2001, PHYS REV LETT, V86, P344, DOI 10.1103/PhysRevLett.86.344; SCHMITTRINK S, 1986, PHYS REV LETT, V57, P2752, DOI 10.1103/PhysRevLett.57.2752; SCHMITTRINK S, 1991, PHYS REV A, V44, P2124, DOI 10.1103/PhysRevA.44.2124; Shah J., 1999, ULTRAFAST SPECTROSCO; STEEL DG, 1984, COHERENT OPTICAL INT, P157; WEGENER M, 1990, PHYS REV A, V42, P5675, DOI 10.1103/PhysRevA.42.5675; Wehner MU, 1998, PHYS REV LETT, V80, P1992, DOI 10.1103/PhysRevLett.80.1992; WEISS S, 1992, PHYS REV LETT, V69, P2685, DOI 10.1103/PhysRevLett.69.2685	48	279	280	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					549	557		10.1038/35079000	http://dx.doi.org/10.1038/35079000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385562	Green Published			2022-12-28	WOS:000168982500041
J	Rempel, AW; Waddington, ED; Wettlaufer, JS; Worster, MG				Rempel, AW; Waddington, ED; Wettlaufer, JS; Worster, MG			Possible displacement of the climate signal in ancient ice by premelting and anomalous diffusion	NATURE			English	Article							POLYCRYSTALLINE ICE; CENTRAL GREENLAND; ANTARCTIC ICE; CORE; RECRYSTALLIZATION; TEMPERATURE; TRANSITION; SYSTEM; ACID	The best high-resolution records of climate over the past few hundred millennia are derived from ice cores retrieved from Greenland and Antarctica(1-3). The interpretation of these records relies on the assumption that the trace constituents used as proxies for past climate have undergone only modest post-depositional migration. Many of the constituents are soluble impurities found principally in unfrozen liquid that separates the grain boundaries in ice sheets. This phase behaviour, termed premelting, is characteristic of polycrystalline material(4,5). Here we show that premelting influences compositional diffusion in a manner that causes the advection of impurity anomalies towards warmer regions while maintaining their spatial integrity. Notwithstanding chemical reactions that might rx certain species against this prevailing transport, we rnd that-under conditions that resemble those encountered in the Eemian interglacial ice of central Greenland (from about 125,000 to 115,000 years ago)-impurity fluctuations may be separated from ice of the same age by as much as 50 cm. This distance is comparable to the ice thickness of the contested sudden cooling events in Eemian ice from the GRIP core.	Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Univ Washington, Dept Phys, Seattle, WA 98105 USA; Univ Cambridge, Dept Appl Math & Theoret Phys, Inst Theoret Geophys, Cambridge CB3 9EW, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Cambridge	Rempel, AW (corresponding author), Univ Washington, Appl Phys Lab, Box 355640, Seattle, WA 98105 USA.		Wettlaufer, John/AAZ-9949-2021	Worster, Michael Grae/0000-0002-9248-2144				Alley RB, 2000, P NATL ACAD SCI USA, V97, P1331, DOI 10.1073/pnas.97.4.1331; ALLEY RB, 1995, NATURE, V373, P393, DOI 10.1038/373393b0; [Anonymous], 1990, THERMODYNAMICS CHEM; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; CUFFEY KM, 1995, SCIENCE, V270, P455, DOI 10.1126/science.270.5235.455; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Dansgaard W., 1969, J GLACIOL, V8, P215, DOI [10.3189/S0022143000031208, DOI 10.3189/S0022143000031208, 10.3189/s0022143000031208]; DASH JG, 1995, REP PROG PHYS, V58, P115, DOI 10.1088/0034-4885/58/1/003; De La Chapelle S, 1998, J GEOPHYS RES-SOL EA, V103, P5091, DOI 10.1029/97JB02621; Fukazawa H, 1998, GEOPHYS RES LETT, V25, P2845, DOI 10.1029/98GL02178; GROSS GW, 1975, J CHEM PHYS, V62, P3085, DOI 10.1063/1.430909; GUNDESTRUP NS, 1993, COLD REG SCI TECHNOL, V21, P399, DOI 10.1016/0165-232X(93)90015-Z; JOHNSEN SJ, 1999, NATO ASI SER, V1, P89; MADER HM, 1992, J GLACIOL, V38, P333, DOI 10.3189/S0022143000002227; MULVANEY R, 1988, NATURE, V331, P247, DOI 10.1038/331247a0; Nye JF, 1998, J GLACIOL, V44, P467, DOI 10.3189/S0022143000001982; NYE JF, 1989, J GLACIOL, V35, P17, DOI 10.3189/002214389793701437; NYE JF, 1992, PHYS CHEM ICE, P200; OHTOMO M, 1983, J PHYS CHEM-US, V87, P4139, DOI 10.1021/j100244a031; Paterson W. S. B., 1994, PHYSICS GLACIERS, P8; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; RAMSEIER RO, 1967, J APPL PHYS, V38, P2553, DOI 10.1063/1.1709948; SMITH CS, 1948, T AM I MIN MET ENG, V175, P15; Steffensen JP, 1997, J GEOPHYS RES-OCEANS, V102, P26747, DOI 10.1029/97JC01491; Thorsteinsson T, 1997, J GEOPHYS RES-OCEANS, V102, P26583, DOI 10.1029/97JC00161; THORSTEINSSON T, 1995, EARTH PLANET SC LETT, V131, P381, DOI 10.1016/0012-821X(95)00031-7; WEAST RC, 1987, CRC HDB CHEM PHYSICS, pD219; Wettlaufer JS, 1999, PHILOS T R SOC A, V357, P3403, DOI 10.1098/rsta.1999.0500; WOLFF EW, 1996, NATO ASI SER 1, V43, P541; Zielinski GA, 2000, QUATERNARY SCI REV, V19, P417, DOI 10.1016/S0277-3791(99)00073-6	30	98	99	1	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					568	571		10.1038/35079043	http://dx.doi.org/10.1038/35079043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385567				2022-12-28	WOS:000168982500046
J	McCord, TB; Hansen, GB; Hibbitts, CA				McCord, TB; Hansen, GB; Hibbitts, CA			Hydrated salt minerals on Ganymede's surface: Evidence of an ocean below	SCIENCE			English	Article							ICY GALILEAN SATELLITES; WATER-ICE; MU-M; EUROPA	Reflectance spectra from Galileo's near-infrared mapping spectrometer (NIMS) suggests that the surface of Ganymede, the Largest satellite of Jupiter, contains hydrated materials. These materials are interpreted to be similar to those found on Europa, that is, mostly frozen magnesium sulfate brines that are derived from a subsurface briny Layer of fluid.	Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Hawaii System	McCord, TB (corresponding author), Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.	tom@higp.hawaii.edu	Hibbitts, Charles/B-7787-2016	Hibbitts, Charles/0000-0001-9089-4391				Anderson JD, 1997, SCIENCE, V276, P1236, DOI 10.1126/science.276.5316.1236; CALVIN WM, 1995, J GEOPHYS RES-PLANET, V100, P19041, DOI 10.1029/94JE03349; Carlson RW, 1999, SCIENCE, V286, P97, DOI 10.1126/science.286.5437.97; CLARK RN, 1980, ICARUS, V41, P323, DOI 10.1016/0019-1035(80)90217-1; Collins G. C, 2000, LUNAR PLANET SCI, P1034; DUFRESNE ER, 1962, GEOCHIM COSMOCHIM AC, V26, P1058; FANALE FP, 1989, ICARUS, V82, P97, DOI 10.1016/0019-1035(89)90026-2; FANALE FP, 1998, LUNAR PLANET SCI, V29, P1248; FANALE FP, 1977, PLANETARY SATELLITES, P379; HANSEN GB, 2000, EOS, V81, pF792; KARGEL JS, 1991, ICARUS, V94, P368, DOI 10.1016/0019-1035(91)90235-L; KIVELSON MG, 2000, EOS, V81, pF789; McCord TB, 1998, J GEOPHYS RES-PLANET, V103, P8603, DOI 10.1029/98JE00788; McCord TB, 1998, SCIENCE, V280, P1242, DOI 10.1126/science.280.5367.1242; McCord TB, 1999, J GEOPHYS RES-PLANET, V104, P11827, DOI 10.1029/1999JE900005; McCord TB, 2001, J GEOPHYS RES-PLANET, V106, P3311, DOI 10.1029/2000JE001282; MCCORD TB, IN PRESS J GEOPHYS R; MCCORD TB, 2000, EOS, V81, P209; Moore JM, 1999, ICARUS, V140, P294, DOI 10.1006/icar.1999.6132; PAPPALARDO RT, 2000, EOS, V81, pF791; PILCHER CB, 1972, SCIENCE, V178, P1087, DOI 10.1126/science.178.4065.1087; SHOEMAKER G, 1982, SATELLITES JUPITER, P435; SPENCER JR, 1987, ICARUS, V69, P297, DOI 10.1016/0019-1035(87)90107-2; VANKEULEN L, 2000, LUNAR PLANET SCI, V31, P1539; ZOLOTOV MY, IN PRESS J GEOPHYS R	25	110	115	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1523	1525		10.1126/science.1059916	http://dx.doi.org/10.1126/science.1059916			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375486				2022-12-28	WOS:000168963800038
J	Cronin, DC; Millis, JM; Siegler, M				Cronin, DC; Millis, JM; Siegler, M			Transplantation of liver grafts from living donors into adults - Too much, too soon.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RIGHT LOBE GRAFT; SURGICAL TECHNIQUES; WAITING TIME; MORTALITY; CHILDREN; SIZE; FAILURE; ETHICS		Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Cronin, DC (corresponding author), Univ Chicago, Chicago, IL 60637 USA.		Millis, Michael/K-5346-2019					Amersi F, 1998, Clin Transpl, P255; Ben-Haim M, 2000, TRANSPLANTATION, V69, pS290; BROELSCH C, 2000, WORKSH LIV DON LIV T; BROELSCH CE, 1991, ANN SURG, V214, P428, DOI 10.1097/00000658-199110000-00007; BROWN R, 2000, WORKSH LIV DON LIV T; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; EMOND JC, 1989, HEPATOLOGY, V10, P867, DOI 10.1002/hep.1840100520; EMOND JC, 1990, ANN SURG, V212, P14, DOI 10.1097/00000658-199007000-00003; Emre S, 1999, LIVER TRANSPLANT SUR, V5, P161, DOI 10.1002/lt.500050315; Everhart JE, 1997, TRANSPLANTATION, V64, P1300, DOI 10.1097/00007890-199711150-00012; Fan ST, 1996, HEPATO-GASTROENTEROL, V43, P893; Fan ST, 2000, ANN SURG, V231, P126, DOI 10.1097/00000658-200001000-00018; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Freeman RB, 2000, LIVER TRANSPLANT, V6, P543, DOI 10.1053/jlts.2000.9744; Goss JA, 1997, TRANSPLANTATION, V64, P871, DOI 10.1097/00007890-199709270-00014; Grewal HP, 1998, ANN SURG, V228, P214, DOI 10.1097/00000658-199808000-00011; Hirano I, 2000, LIVER TRANSPLANT, V6, P250, DOI 10.1016/S1527-6465(00)80023-4; Inomata Y, 2000, TRANSPLANTATION, V69, P258, DOI 10.1097/00007890-200001270-00011; Kim WR, 1998, HEPATOLOGY, V28, P33, DOI 10.1002/hep.510280106; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Lo CM, 1997, TRANSPLANTATION, V63, P1524, DOI 10.1097/00007890-199705270-00027; Lo CM, 1997, ANN SURG, V226, P261, DOI 10.1097/00000658-199709000-00005; MALAGO M, 1994, TRANSPLANT P, V26, P3620; Marcos A, 1999, TRANSPLANTATION, V68, P798, DOI 10.1097/00007890-199909270-00012; MARCOS A, 2000, 1 JOINT ANN M AM SOC; Millis J M, 1995, Clin Transpl, P187; Millis JM, 2000, ANN SURG, V232, P104, DOI 10.1097/00000658-200007000-00015; Miwa S, 1999, HEPATOLOGY, V30, P1521, DOI 10.1002/hep.510300621; MOORE FD, 1988, TRANSPLANT P, V20, P1061; MORI K, 1992, TRANSPLANTATION, V54, P263, DOI 10.1097/00007890-199208000-00014; Piper J B, 1992, Clin Transpl, P179; Pomposelli JJ, 2000, TRANSPLANTATION, V69, pS291; ROGIERS X, 1994, BRIT J SURG, V81, P1251, DOI 10.1002/bjs.1800810903; SINGER PA, 1989, NEW ENGL J MED, V321, P620, DOI 10.1056/NEJM198908313210919; STRONG RW, 1990, NEW ENGL J MED, V322, P1505, DOI 10.1056/NEJM199005243222106; Strong RW, 1999, LIVER TRANSPLANT SUR, V5, P536, DOI 10.1002/lt.500050613; TANAKA K, 1993, ANN SURG, V217, P82, DOI 10.1097/00000658-199301000-00014; Testa G, 1999, LANGENBECK ARCH SURG, V384, P536, DOI 10.1007/s004230050240; *US SCI REG TRANSP, 2000, 2000 ANN REP US SCI; Wachs ME, 1998, TRANSPLANTATION, V66, P1313, DOI 10.1097/00007890-199811270-00008; YAMAOKA Y, 1995, TRANSPLANTATION, V59, P224	42	161	161	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1633	1637		10.1056/NEJM200105243442112	http://dx.doi.org/10.1056/NEJM200105243442112			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372018				2022-12-28	WOS:000168829700012
J	Ku, NO; Gish, R; Wright, TL; Omary, MB				Ku, NO; Gish, R; Wright, TL; Omary, MB			Keratin 8 mutations in patients with cryptogenic liver disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; GENETIC SKIN DISEASES; ENCODING LAMIN A/C; INTERMEDIATE FILAMENTS; TRANSGENIC MICE; PARTIAL LIPODYSTROPHY; HEPATOCYTE INTEGRITY; MISSENSE MUTATIONS; SKELETAL MYOPATHY; RAT HEPATOCYTES	Background: About 10 percent of patients who undergo liver transplantation have cryptogenic liver disease. In animal models, the absence of heteropolymeric keratins 8 and 18 or the presence of mutant keratins in hepatocytes causes or promotes liver disease. We have previously described a mutation in the keratin 18 gene in a patient with cryptogenic cirrhosis, but the importance of mutations in the keratin 8 and keratin 18 genes in such patients is unclear. Methods: We tested for mutations in the keratin 8 and keratin 18 genes in purified genomic DNA isolated from 150 explanted livers and 89 peripheral-blood specimens from three groups of patients: 55 patients with cryptogenic liver disease; 98 patients with noncryptogenic liver disease, with causes that included alcohol use, autoimmunity, drug use, and viral infections; and 86 randomly selected inpatients and outpatients who provided blood to the hematology laboratory. Results: Of the 55 patients with cryptogenic liver disease, 3 had glycine-to-cysteine mutations at position 61 (a highly conserved glycine) of keratin 8, and 2 had tyrosine-to-histidine mutations at position 53 of keratin 8. These mutations were not detected in the patients with other liver diseases or in the randomly selected patients. In transfected cells, the glycine-to-cysteine mutation limited keratin-filament reorganization when the cells were exposed to oxidative stress. In contrast, the tyrosine-to-histidine mutation destabilized keratin filaments when transfected cells were exposed to heat or okadaic acid stress. Conclusions: Mutations in the keratin 8 gene may predispose people to liver disease and may account for cryptogenic liver disease in some patients. (N Engl J Med 2001;344:1580-7.) Copyright (C) 2001 Massachusetts Medical Society.	Vet Affairs Med Ctr, Gastroenterol Sect, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; Calif Pacific Med Ctr, Dept Transplantat, San Francisco, CA USA; Vet Affairs Med Ctr, Gastroenterol Sect, San Francisco, CA 94121 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University; California Pacific Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ku, NO (corresponding author), Vet Affairs Med Ctr, Gastroenterol Sect, Mail Code 154J,3801 Miranda Ave, Palo Alto, CA 94304 USA.		Wilson, Matthew H/K-3193-2013; Gish, Robert/B-3605-2018	Gish, Robert/0000-0001-6306-3189; Omary, Bishr/0000-0002-8624-2347	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052951] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52951] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; CHAN YM, 1993, P NATL ACAD SCI USA, V90, P7414, DOI 10.1073/pnas.90.15.7414; Charlton M R, 1997, Liver Transpl Surg, V3, P359, DOI 10.1002/lt.500030402; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; Covello SP, 1998, BRIT J DERMATOL, V139, P475; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FUCHS E, 1992, CELL, V69, P899, DOI 10.1016/0092-8674(92)90607-E; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Hoet P, 1997, LANCET, V350, P556, DOI 10.1016/S0140-6736(97)03094-8; Irvine AD, 1999, BRIT J DERMATOL, V140, P815, DOI 10.1046/j.1365-2133.1999.02810.x; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Jochimsen EM, 1998, NEW ENGL J MED, V339, P139; Kingham JGC, 2000, GUT, V47, P328, DOI 10.1136/gut.47.3.328; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Ku NO, 1996, J CLIN INVEST, V98, P1034, DOI 10.1172/JCI118864; KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 1997, J CLIN INVEST, V99, P19, DOI 10.1172/JCI119127; KULESH DA, 1989, MOL CELL BIOL, V9, P1553, DOI 10.1128/MCB.9.4.1553; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO J, 1995, EXP CELL RES, V219, P348, DOI 10.1006/excr.1995.1238; Liao J, 1996, ELECTROPHORESIS, V17, P1671, DOI 10.1002/elps.1150171104; Loranger A, 1997, AM J PATHOL, V151, P1673; Magin T M, 1998, Subcell Biochem, V31, P141; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Muller FB, 1998, J INVEST DERMATOL, V111, P900, DOI 10.1046/j.1523-1747.1998.00374.x; Muller T, 1999, J PEDIATR-US, V135, P189, DOI 10.1016/S0022-3476(99)70021-1; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; OHTA T, 1992, CARCINOGENESIS, V13, P2443, DOI 10.1093/carcin/13.12.2443; Omary MB, 1997, HEPATOLOGY, V25, P1043, DOI 10.1002/hep.510250537; Ponsoda X, 1999, BIOCHEM PHARMACOL, V58, P1579, DOI 10.1016/S0006-2952(99)00249-X; Poonawala A, 2000, HEPATOLOGY, V32, P689, DOI 10.1053/jhep.2000.17894; QUINLAN RA, 1984, J MOL BIOL, V178, P365, DOI 10.1016/0022-2836(84)90149-9; RAGHU G, 1986, BRIT J EXP PATHOL, V67, P105; *SAS I, 1995, JMP STAT GRAPH GUID; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; STEINERT PM, 1993, J BIOL CHEM, V268, P2878; STEINERT PM, 1993, TRENDS GENET, V9, P280, DOI 10.1016/0168-9525(93)90014-9; Struben VMD, 2000, AM J MED, V108, P9, DOI 10.1016/S0002-9343(99)00315-0; Toivola DM, 1998, HEPATOLOGY, V28, P116, DOI 10.1002/hep.510280117; Toivola DM, 1997, J CELL SCI, V110, P23; YANG JM, 1994, J INVEST DERMATOL, V102, P17, DOI 10.1111/1523-1747.ep12371725; Yang JM, 1996, J INVEST DERMATOL, V107, P439, DOI 10.1111/1523-1747.ep12365483; Zatloukal K, 2000, AM J PATHOL, V156, P1263, DOI 10.1016/S0002-9440(10)64997-8	53	136	142	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1580	1587		10.1056/NEJM200105243442103	http://dx.doi.org/10.1056/NEJM200105243442103			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372009				2022-12-28	WOS:000168829700003
J	Lemanske, RF; Sorkness, CA; Mauger, EA; Lazarus, SC; Boushey, HA; Fahy, JV; Drazen, JM; Chinchilli, VM; Craig, T; Fish, JE; Ford, JG; Israel, E; Kraft, M; Martin, RJ; Nachman, SA; Peters, SP; Spahn, JD; Szefler, SJ				Lemanske, RF; Sorkness, CA; Mauger, EA; Lazarus, SC; Boushey, HA; Fahy, JV; Drazen, JM; Chinchilli, VM; Craig, T; Fish, JE; Ford, JG; Israel, E; Kraft, M; Martin, RJ; Nachman, SA; Peters, SP; Spahn, JD; Szefler, SJ		Natl Heart Lung Blood Inst Asthma	Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; BRONCHOALVEOLAR LAVAGE; FLUTICASONE PROPIONATE; AIRWAY INFLAMMATION; DOUBLE-BLIND; ALBUTEROL; XINAFOATE; THERAPY; AGONIST	Context Inhaled long-acting beta (2)-agonists improve asthma control when added to inhaled corticosteroid (ICS) therapy. Objective To determine whether ICS therapy can be reduced or eliminated in patients with persistent asthma after adding a long-acting beta (2)-agonist to their treatment regimen. Design and Setting A 24-week randomized, controlled, blinded, double-dummy, parallel-group trial conducted at 6 National Institutes of Health-sponsored, university-based ambulatory care centers from February 1997 through January 1999. Participants One hundred seventy-five patients aged 12 through 65 years with persistent asthma that was suboptimally controlled during a 6-week run-in period of treatment with inhaled triamcinolone acetonide (400 mug twice per day). Intervention Patients continued triamcinolone therapy and were randomly assigned to receive add-on therapy with either placebo (placebo-minus group, n=21) or salmeterol xinafoate, 42 mug twice per day (n = 154) for 2 weeks. The entire placebo-minus group was assigned and half of the salmeterol group (salmeterol-minus group) was randomly assigned to reduce by 50% (for 8 weeks) then eliminate (for 8 weeks) triamcinolone treatment. The other half of the salmeterol group (salmeterol-plus group) was randomly assigned to continue both salmeterol and triamcinolone for the remaining 16 weeks (active control group). Main Outcome Measure Time to asthma treatment failure in patients receiving salmeterol. Results Treatment failure occurred in 8.3% (95% confidence interval [CI], 2%-15%) of the salmeterol-minus group 8 weeks after triamcinolone treatment was reduced compared with 2.8% (95% CI, 0%-7%) of the salmeterol-plus group during the same period. Treatment failure occurred in 46.3% (95% CI, 34%-59%) of the salmeterol-minus group 8 weeks after triamcinolone therapy was eliminated compared with 13.7% (95% CI, 5%-22%) of the salmeterol-plus group. The relative risk (95% CI) of treatment failure at the end of the triamcinolone elimination phase in the salmeterol-minus group was 4.3 (2.0-9.2) compared with the salmeterol-plus group (P<.001). Conclusions Our results indicate that in patients with persistent asthma suboptimally controlled by triamcinolone therapy alone but whose asthma symptoms improve after addition of salmeterol, a substantial reduction (50%) in triamcinolone dose can occur without a significant loss of asthma control. However, total elimination of triamcinolone therapy results in a significant deterioration in asthma control and, therefore, cannot be recommended.	Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI USA; Univ Wisconsin, Sch Pharm, Dept Med, Madison, WI 53706 USA; Milton S Hershey Med Ctr, Dept Hth Evaluat Sci, Hershey, PA USA; Penn State Univ, Milton S Hershey Med Ctr, Dept Med, Hershey, PA 17033 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, New York, NY 10032 USA; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO USA; Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Jefferson University; Columbia University; National Jewish Health; National Jewish Health	Lemanske, RF (corresponding author), Univ Wisconsin, Childrens Hosp, 600 Highland Ave,K4-916-9988, Madison, WI 53792 USA.	rfl@medicine.wisc.edu			NCRR NIH HHS [M01 RR03186, M01 RR-00079] Funding Source: Medline; NHLBI NIH HHS [U10 HL-51843, U10 HL-51810, U10 HL-51823, U10 HL-51834, U10 HL-51831, U10 HL-51845, U10 HL-56443] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186, M01RR000079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL051834, U10HL051843, U10HL056443, U10HL051810, U10HL051845, U10HL051823, U10HL051831] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen DB, 1996, ENDOCRIN METAB CLIN, V25, P699, DOI 10.1016/S0889-8529(05)70348-0; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; CHERVINSKY P, 1994, J ALLERGY CLIN IMMUN, V94, P676, DOI 10.1016/0091-6749(94)90174-0; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; Cox D. R., 1984, ANAL SURVIVAL DATA; DALONZO GE, 1994, JAMA-J AM MED ASSOC, V271, P1412, DOI 10.1001/jama.271.18.1412; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; ERZURUM SC, 1991, ANN INTERN MED, V114, P353, DOI 10.7326/0003-4819-114-5-353; Fish JE, 1997, AM J RESP CRIT CARE, V156, P1165, DOI 10.1164/ajrccm.156.4.9703012; GARDINER PV, 1994, AM J RESP CRIT CARE, V150, P1006, DOI 10.1164/ajrccm.150.4.7921429; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; JUNIPER EF, 1995, AM J RESP CRIT CARE, V151, P66, DOI 10.1164/ajrccm.151.1.7812574; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Kamada AK, 1996, AM J RESP CRIT CARE, V153, P1739, DOI 10.1164/ajrccm.153.6.8665030; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lemanske RF, 1997, AM J RESP CRIT CARE, V156, P685, DOI 10.1164/ajrccm.156.3.ed-13; Li X, 1999, AM J RESP CRIT CARE, V160, P1493, DOI 10.1164/ajrccm.160.5.9811052; McIvor RA, 1998, AM J RESP CRIT CARE, V158, P924; National Asthma Education and Prevention Program, 1991, EXP PAN REP GUID DIA; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; PEARLMAN DS, 1992, NEW ENGL J MED, V327, P1420, DOI 10.1056/NEJM199211123272004; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Roberts JA, 1999, EUR RESPIR J, V14, P275, DOI 10.1034/j.1399-3003.1999.14b07.x; SEARS MR, 1995, CHEST, V108, P590, DOI 10.1378/chest.108.2.590; Sorkness CA, 1998, J ALLERGY CLIN IMMUN, V102, pS52, DOI 10.1016/S0091-6749(98)70005-3; Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X; van Noord JA, 1999, THORAX, V54, P207, DOI 10.1136/thx.54.3.207; Wilding P, 1997, BRIT MED J, V314, P1441, DOI 10.1136/bmj.314.7092.1441; Woolcock A, 1996, AM J RESP CRIT CARE, V153, P1481, DOI 10.1164/ajrccm.153.5.8630590; 1994, MED LETT DRUGS THER, V36, P37	31	209	217	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2594	2603		10.1001/jama.285.20.2594	http://dx.doi.org/10.1001/jama.285.20.2594			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433LY	11368733	Bronze			2022-12-28	WOS:000168761900026
J	Goffin, E; Devogelaer, J; Depresseux, G; Squifflet, JP; Pirson, Y				Goffin, E; Devogelaer, J; Depresseux, G; Squifflet, JP; Pirson, Y			Osteoporosis after organ transplantation	LANCET			English	Letter							RENAL-TRANSPLANTATION; MINERAL DENSITY		Univ Catholique Louvain, Clin St Luc, Dept Nephrol, B-1200 Brussels, Belgium; Univ Catholique Louvain, Clin St Luc, Dept Rheumatol, B-1200 Brussels, Belgium; Univ Catholique Louvain, Clin St Luc, Dept Renal Transplantat, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain	Goffin, E (corresponding author), Univ Catholique Louvain, Clin St Luc, Dept Nephrol, Ave Hippocrate 10, B-1200 Brussels, Belgium.							ALMOND MK, 1994, NEPHRON, V66, P52, DOI 10.1159/000187765; Delmas PD, 2001, LANCET, V357, P325, DOI 10.1016/S0140-6736(00)03632-1; Goffin Eric, 2000, Journal of the American Society of Nephrology, V11, p718A; JULIAN BA, 1991, NEW ENGL J MED, V325, P544, DOI 10.1056/NEJM199108223250804; Leidig-Bruckner G, 2001, LANCET, V357, P342, DOI 10.1016/S0140-6736(00)03641-2	5	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1623	1623		10.1016/S0140-6736(00)04766-8	http://dx.doi.org/10.1016/S0140-6736(00)04766-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11386322				2022-12-28	WOS:000168830100051
J	Villar, J; Ba'aqeel, H; Piaggio, G; Lumbiganon, P; Belizan, JM; Farnot, U; Al-Mazrou, Y; Carroli, G; Pinol, A; Donner, A; Langer, A; Nigenda, G; Mugford, M; Fox-Rushby, J; Hutton, G; Bergsjo, P; Bakketeig, L; Berendes, H				Villar, J; Ba'aqeel, H; Piaggio, G; Lumbiganon, P; Belizan, JM; Farnot, U; Al-Mazrou, Y; Carroli, G; Pinol, A; Donner, A; Langer, A; Nigenda, G; Mugford, M; Fox-Rushby, J; Hutton, G; Bergsjo, P; Bakketeig, L; Berendes, H		WHO Antenatal Care Trial Res Grp	WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care	LANCET			English	Article							LOW-RISK WOMEN; ECONOMIC-EVALUATION; COLORECTAL-CANCER; SCIENTIFIC BASIS; CLINICAL-TRIALS; PRENATAL-CARE; VISITS; DESIGN; POWER; ELIMINATE	Background We undertook a multicentre randomised controlled trial that compared the standard model of antenatal care with a new model that emphasises actions known to be effective in improving maternal or neonatal outcomes and has fewer clinic visits. Methods Clinics in Argentina, Cuba, Saudi Arabia, and Thailand were randomly allocated to provide either the new model (27 clinics) or the standard model currently in use (26 clinics). All women presenting for antenatal care at these clinics over an average of 18 months were enrolled. Women enrolled in clinics offering the new model were classified on the basis of history of obstetric and clinical conditions. Those who did not require further specific assessment or treatment were offered the basic component of the new model, and those deemed at higher risk received the usual care for their conditions; however, all were included in the new-model group for the analyses, which were by intention to treat. The primary outcomes were low birthweight (<2500 g), pre-eclampsia/eclampsia, severe postpartum anaemia (<90 g/L haemoglobin), and treated urinary-tract infection. There was an assessment of quality of care and an economic evaluation. Findings Women attending clinics assigned the new model (n = 12 568) had a median of five visits compared with eight within the standard model (n = 11 958). More women in the new model than in the standard model were referred to higher levels of care (13.4% vs 7.3%), but rates of hospital admission, diagnosis, and length of stay were similar. The groups had similar rates of low birthweight (new model 7.68% vs standard model 7.14%; stratified rate difference 0.96 [95% CI -0.01 to 1.92]), postpartum anaemia (7.59% vs 8.67%; 0.32), and urinary-tract infection (5.95% vs 7.41%; -0.42 [-1.65 to 0.80]). For pre-eclampsia/eclampsia the rate was slightly higher in the new model (1.69% vs 1.38%; 0.21 [-0.25 to 0.67]). Adjustment by several confounding variables did not modify this pattern. There were negligible differences between groups for several secondary outcomes. Women and providers in both groups were, in general, satisfied with the care received, although some women assigned the new model expressed concern about the timing of visits. There was no cost increase, and in some settings the new model decreased cost. Interpretations Provision of routine antenatal care by the new model seems not to affect maternal and perinatal outcomes. It could be implemented without major resistance from women and providers and may reduce cost.	WHO, Dept Reprod Hlth & Res, UNDP,UNFPA, World Bank Special Programme Res Dev & Res Traini, CH-1211 Geneva 27, Switzerland; Natl Guard King Khalid Hosp, Jeddah, Saudi Arabia; Khon Kaen Univ, Khon Kaen, Thailand; Ctr Rosarino Estudios Perinatales, Rosario, Santa Fe, Argentina; Hosp Ginecoobstet Amer Arias, Havana, Cuba; Minist Hlth, Riyadh, Saudi Arabia; Univ Western Ontario, London, ON, Canada; Populat Council, Off Latin Amer & Caribbean, Mexico City, DF, Mexico; Inst Nacl Salud Publ, Ctr Invest Sistemas Salud, Mexico City, DF, Mexico; Univ E Anglia, Sch Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1, England; Univ Bergen, Dept Obstet & Gynaecol, Bergen, Norway; Natl Publ Hlth Inst, Oslo, Norway; NICHHD, NIH, Bethesda, MD 20892 USA	The World Bank; United Nations Population Fund; World Health Organization; King Saud University; King Khalid University Hospital; Khon Kaen University; Ministry of Health - Saudi Arabia; Western University (University of Western Ontario); Instituto Nacional de Salud Publica; University of East Anglia; University of London; London School of Hygiene & Tropical Medicine; University of Bergen; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Villar, J (corresponding author), WHO, Dept Reprod Hlth & Res, UNDP,UNFPA, World Bank Special Programme Res Dev & Res Traini, CH-1211 Geneva 27, Switzerland.		Baaqeel, Hassan/Q-3148-2018	Baaqeel, Hassan/0000-0002-0774-2790; Belizan, Jose/0000-0002-8412-3010; Fox-Rushby, Julia/0000-0003-0748-0871				Al-Mazrou Y, 1990, PRINCIPLES PRACTICE; BAKKETIEG LS, 1992, INT J TECHNOL ASSESS, V1, P33; Baskett TF, 1998, BRIT J OBSTET GYNAEC, V105, P981, DOI 10.1111/j.1471-0528.1998.tb10261.x; Bergsjo P, 1997, ACTA OBSTET GYN SCAN, V76, P15, DOI 10.3109/00016349709047779; BINSTOCK MA, 1995, J REPROD MED, V157, P158; Briggs A, 2000, BRIT MED J, V321, P1362, DOI 10.1136/bmj.321.7273.1362; Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.3.CO;2-F; BROOMBERG J, 1993, S AFR MED J, V83, P272; BULLOUGH CHW, 1989, LANCET, V2, P522; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Clement S, 1999, BRIT J OBSTET GYNAEC, V106, P367, DOI 10.1111/j.1471-0528.1999.tb08276.x; Cochrane A. L, 1972, PUBLIC HEALTH, DOI DOI 10.1016/S0033-3506(73)80082-4; *DEP HLTH, 1999, MAT CHILD HLTH REC; DONNER A, 1992, STAT MED, V11, P743, DOI 10.1002/sim.4780110605; DONNER A, 1993, J CLIN EPIDEMIOL, V46, P123, DOI 10.1016/0895-4356(93)90050-B; Donner A, 1998, PAEDIATR PERINAT EP, V12, P59, DOI 10.1046/j.1365-3016.1998.00007.x; DRUMMOND MF, 1997, METHODS EC EVALUATIO, P278; Henderson J, 2000, J Health Serv Res Policy, V5, P69; HOFMEYER GJ, 2000, COCHRANE LIB; KENDRICK JS, 1995, AM J PUBLIC HEALTH, V85, P217, DOI 10.2105/AJPH.85.2.217; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Langer A, 1998, PAEDIATR PERINAT EP, V12, P98, DOI 10.1046/j.1365-3016.1998.00009.x; Langer A, 1996, SOC SCI MED, V42, P1589, DOI 10.1016/0277-9536(95)00262-6; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LUCE B, 1994, COST EFFECTIFENESS H, P194; McDuffie RS, 1996, JAMA-J AM MED ASSOC, V275, P847, DOI 10.1001/jama.275.11.847; *MIN SAL, 1999, MAN DIAGN TRAT OBST; *MIN SAL ACC SOC N, 1996, PROP NORM PER, V1, P29; Mugford M, 1998, PAEDIATR PERINAT EP, V12, P75, DOI 10.1046/j.1365-3016.1998.00008.x; Munjanja SP, 1996, LANCET, V348, P364, DOI 10.1016/S0140-6736(96)01250-0; Piaggio G, 1998, PAEDIATR PERINAT EP, V12, P116, DOI 10.1046/j.1365-3016.12.s2.1.x; PORTER M, 1984, SOC SCI MED, V19, P1197, DOI 10.1016/0277-9536(84)90370-8; Sanders J, 1999, MIDWIFERY, V15, P257, DOI 10.1054/midw.1999.0183; Sikorski J, 1996, BRIT MED J, V312, P546, DOI 10.1136/bmj.312.7030.546; SIKORSKI J, 1995, MIDWIFERY, V11, P61, DOI 10.1016/0266-6138(95)90068-3; Villar J, 1997, ACTA OBSTET GYN SCAN, V76, P1, DOI 10.3109/00016349709047778; Villar J, 1998, PAEDIATR PERINAT EP, V12, P27, DOI 10.1046/j.1365-3016.1998.00006.x; VILLAR J, 2000, COCHRANE LIB; VILLAR J, 1988, BRIT J OBSTET GYNAEC, V95, P142; WAVER MJ, 1999, LANCET, V353, P525; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203	42	352	378	0	35	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1551	1564		10.1016/S0140-6736(00)04722-X	http://dx.doi.org/10.1016/S0140-6736(00)04722-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434RR	11377642				2022-12-28	WOS:000168830100008
J	Simmons, R				Simmons, R			Sense and sensibility	NATURE			English	Editorial Material									Kings Coll London, Randall Ctr, London SE1 1UL, England	University of London; King's College London	Simmons, R (corresponding author), Kings Coll London, Randall Ctr, New Hunts House,Guys Campus, London SE1 1UL, England.							MEDAWAR PB, 1990, LISTENER, V70; Popper K. R., 1994, KNOWLEDGE BODY MIND; Popper K. R., 1979, OBJECTIVE KNOWLEDGE	3	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					243	243		10.1038/35077175	http://dx.doi.org/10.1038/35077175			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357106				2022-12-28	WOS:000168710000023
J	Lea, DW				Lea, DW			Perspectives: Paleoclimate - Ice Ages, the California Current, and Devils Hole	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; RECORD; OCEAN		Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Lea, DW (corresponding author), Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA.	lea@geol.ucsb.edu						Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; Bender ML, 1999, GEOPH MONOG SERIES, V112, P149; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hendy IL, 2000, PALEOCEANOGRAPHY, V15, P30, DOI 10.1029/1999PA000413; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Kienast M, 2001, SCIENCE, V291, P2132, DOI 10.1126/science.1057131; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pichon JJ, 1992, PALEOCEANOGRAPHY, V7, P289, DOI 10.1029/92PA00709; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Volkman JK, 2000, GEOCHEM GEOPHY GEOSY, V1; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255	13	11	12	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2001	293	5527					59	60		10.1126/science.1061078	http://dx.doi.org/10.1126/science.1061078			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11397911				2022-12-28	WOS:000169780300025
J	Heames, RM; Sado, D; Deakin, CD				Heames, RM; Sado, D; Deakin, CD			Do doctors position defibrillation paddles correctly? Observational study	BRITISH MEDICAL JOURNAL			English	Article									Southampton Gen Hosp NHS Trust, Shackleton Dept Anaesthet, Southampton SO16 6YD, Hants, England		Deakin, CD (corresponding author), Southampton Gen Hosp NHS Trust, Shackleton Dept Anaesthet, Southampton SO16 6YD, Hants, England.							[Anonymous], 2000, RESUSCITATION, V46, P109; [Anonymous], 2000, RESUSCITATION, V46, P73; *EM CARD CAR COMM, 1992, JAMA-J AM MED ASSOC, V268, P2199; LAROSE D, 1993, ANN EMERG MED, V22, P1925, DOI 10.1016/S0196-0644(05)80429-9; Robertson C, 1998, RESUSCITATION, V37, P81, DOI 10.1016/S0300-9572(98)00035-5	5	27	28	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1393	1394		10.1136/bmj.322.7299.1393	http://dx.doi.org/10.1136/bmj.322.7299.1393			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397743	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000169284600016
J	Alroy, J				Alroy, J			A multispecies overkill simulation of the end-Pleistocene megafaunal mass extinction	SCIENCE			English	Article							MAMMALS; HUNTER	A computer simulation of North American end-Pleistocene human and Large herbivore population dynamics correctly predicts the extinction or survival of 32 out of 41 prey species. Slow human population growth rates, random hunting, and Low maximum hunting effort are assumed; additional parameters are based on published values. Predictions are close to observed values for overall extinction rates, human population densities, game consumption rates, and the temporal overlap of humans and extinct species. Results are robust to variation in unconstrained parameters. This fully mechanistic model accounts for megafaunal extinction without invoking climate change and secondary ecological effects.	Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Alroy, J (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	alroy@nceas.ucsb.edu	Alroy, John/B-4585-2009	Alroy, John/0000-0002-9882-2111				ADAMS RHM, 1986, HUM TOXICOL, V5, P5, DOI 10.1177/096032718600500102; ALBERDI MT, 1995, BIOL J LINN SOC, V54, P349, DOI 10.1111/j.1095-8312.1995.tb01042.x; Alroy John, 1999, P105; Beck MW, 1996, PALEOBIOLOGY, V22, P91, DOI 10.1017/S0094837300016043; BELOVSKY GE, 1987, J ANTHROPOL ARCHAEOL, V6, P29, DOI 10.1016/0278-4165(87)90016-X; BELOVSKY GE, 1988, J ANTHROPOL ARCHAEOL, V7, P329, DOI 10.1016/0278-4165(88)90002-5; BROWN JH, 1991, AM NAT, V138, P1478, DOI 10.1086/285297; BUDYKO MI, 1967, SOV GEOGR, V8, P783, DOI 10.1080/00385417.1967.10770945; Choquenot D, 1998, GLOBAL ECOL BIOGEOGR, V7, P167, DOI 10.2307/2997372; Damuth J., 1990, BODY SIZE MAMMALIAN; Diamond J.M., 1984, QUATERNARY EXTINCTIO, P354; Fiedel SJ, 1999, AM ANTIQUITY, V64, P95, DOI 10.2307/2694348; Graham R.W., 1984, P223; Graham RW, 1996, SCIENCE, V272, P1601; Guthrie R.D., 1984, P259; HARVEY PH, 1991, AM NAT, V137, P556, DOI 10.1086/285183; HASSAN FA, 1981, DEMOGRAPHIC ARCHAEOL; Haynes Gary, 1999, P71; HENNEMANN WW, 1983, OECOLOGIA, V56, P104, DOI 10.1007/BF00378224; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Keesing F, 1998, OECOLOGIA, V116, P381, DOI 10.1007/s004420050601; MacPhee Ross D.E., 1997, P169; Martin P.S., 1999, EXTINCTIONS NEAR TIM, P17, DOI DOI 10.1007/978-1-4757-5202-1_2; MARTIN PS, 1973, SCIENCE, V179, P969, DOI 10.1126/science.179.4077.969; Martin PS, 1967, PREHISTORIC EXTINCTI; MOSIMANN JE, 1975, AM SCI, V63, P304; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Silva M, 1997, J ANIM ECOL, V66, P327, DOI 10.2307/5979; Webster D., 1981, P556; WHITLEY DS, 1993, AM ANTIQUITY, V58, P626, DOI 10.2307/282199; Whittington S.L., 1984, P451; Wilkie DS, 1998, CONSERV BIOL, V12, P137, DOI 10.1046/j.1523-1739.1998.96156.x; WINTERHALDER B, 1988, J ANTHROPOL ARCHAEOL, V7, P289, DOI 10.1016/0278-4165(88)90001-3	34	349	367	16	399	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1893	1896		10.1126/science.1059342	http://dx.doi.org/10.1126/science.1059342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397940				2022-12-28	WOS:000169200700043
J	Barbe, F; Mayoralas, LR; Duran, J; Masa, JF; Maimo, A; Montserrat, JM; Monasterio, C; Bosch, M; Ladaria, A; Rubio, M; Rubio, R; Medinas, M; Hernandez, L; Vidal, S; Douglas, NJ; Agusti, AGN				Barbe, F; Mayoralas, LR; Duran, J; Masa, JF; Maimo, A; Montserrat, JM; Monasterio, C; Bosch, M; Ladaria, A; Rubio, M; Rubio, R; Medinas, M; Hernandez, L; Vidal, S; Douglas, NJ; Agusti, AGN			Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE; CPAP; EFFICACY	Background: The sleep apnea-hypopnea syndrome is defined by a pathologic number of respiratory events during sleep (the apnea-hypopnea index, defined as the number of apnea and hypopnea episodes per hour) and daytime symptoms (mostly, excessive sleepiness). In patients with the sleep apnea syndrome, treatment with continuous positive airway pressure (CPAP) normalizes both the apnea-hypopnea index and diurnal symptoms. However, the effect of CPAP in persons with a pathologic apnea-hypopnea index without daytime sleepiness is unclear. Objective: To investigate the short-term effects of CPAP on quality of life, objective sleepiness, cognitive function, and arterial blood pressure in nonsleepy patients with a pathologic apnea-hypopnea index. Design: Multicenter randomized, placebo-controlled, parallel-group study. Setting: Six teaching hospitals in Spain. Patients: 55 patients with an apnea-hypopnea index of 30 or greater who did not have daytime sleepiness (Epworth Sleepiness Scale score less than or equal to 10). Intervention: Patients were randomly assigned to receive optimal (n = 29) or sham (n = 25) CPAP and were observed for 6 weeks. Measurements: Quality of life, objective sleepiness (Multiple Sleep Latency Test score), cognitive function, and arterial blood pressure. Results: The intervention and control groups were similar in terms of mean (+/- SE) age (54 +/- 2 vs. 52 +/- 2 years), apnea-hypopnea index (54 +/- 3 vs. 57 +/- 4), Epworth Sleepiness Scale score (7.0 +/- 0.4 vs. 7.0 +/- 0.4) and adherence to CPAP treatment (5.0 +/- 0.4 vs. 4.0 +/- 0.5 hours/d). Other variables, such as quality of life, cognitive function, and arterial blood pressure, were also similar in both groups before treatment. After 6 weeks of CPAP or sham CPAP, none of these variables changed significantly. Conclusion: In patients with an apnea-hypopnea index of 30 or greater and no subjective daytime sleepiness, CPAP does not modify quality of life, objective sleepiness, vigilance, attention, memory, information processing, visuomotor coordination, or arterial blood pressure. Treatment with CPAP is therefore not indicated in nonsleepy patients with a pathologic apnea-hypopnea index.	Hosp Univ Son Dureta, Serv Pneumol, Palma de Mallorca 07014, Spain; Hosp San Pedro De Alcantara, Caceres, Spain; Hosp Txagorritxu, Vitoria, Spain; Hosp Joan March, Bunyola, Spain; Hosp Clin Barcelona, Barcelona, Spain; Bellvitge Hosp, Lhospitalet De Llobregat, Spain; Royal Infirm, Edinburgh, Midlothian, Scotland	Hospital Universitari Son Espases; Hospital Universitari Son Dureta; University Hospital of Araba; University of Barcelona; Hospital Clinic de Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Royal Infirmary of Edinburgh	Agusti, AGN (corresponding author), Hosp Univ Son Dureta, Serv Pneumol, Andrea Doria 55, Palma de Mallorca 07014, Spain.	aagusti@hsd.es	Barbé, Ferran/A-5988-2010; Douglas, Neil/B-1491-2013; Garcia-Navarro, Alvar Agusti/F-4474-2015; Cantolla, Joaquin Duran/B-6996-2015	Barbé, Ferran/0000-0002-2340-8928; Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; MONTSERRAT, Josep Maria/0000-0003-3098-4605; monasterio ponsa, carmen/0000-0002-6142-0565				Akashiba T, 1999, SLEEP, V22, P849, DOI 10.1093/sleep/22.7.849; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; American Sleep Disorders Association. Diagnostic Classification Steering Committee, 1990, INT CLASS SLEEP DIS, pxii, 396; Ballester E, 1999, AM J RESP CRIT CARE, V159, P495, DOI 10.1164/ajrccm.159.2.9804061; Barbe F, 1995, Arch Bronconeumol, V31, P460; Collard P, 1996, AM J RESP CRIT CARE, V154, P454, DOI 10.1164/ajrccm.154.2.8756822; DAVIES RJO, 1994, CLIN SCI, V86, P417, DOI 10.1042/cs0860417; Davies RJO, 2000, AM J RESP CRIT CARE, V161, P1775, DOI 10.1164/ajrccm.161.6.16166a; Engleman HM, 1999, AM J RESP CRIT CARE, V159, P461, DOI 10.1164/ajrccm.159.2.9803121; Engleman HM, 1998, THORAX, V53, P341, DOI 10.1136/thx.53.5.341; Fagard, 1997, Blood Press Monit, V2, P315; Farre R, 1999, LANCET, V353, P1154, DOI 10.1016/S0140-6736(99)01056-9; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; HEDNER J, 1995, EUR RESPIR J, V8, P222, DOI 10.1183/09031936.95.08020222; Jenkinson C, 1999, LANCET, V353, P2100, DOI 10.1016/S0140-6736(98)10532-9; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lezack MD, 1995, NEUROPSYCHOLOGICAL A, V3rd; Loube DI, 1999, CHEST, V115, P863, DOI 10.1378/chest.115.3.863; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Munoz A, 2000, EUR RESPIR J, V15, P676, DOI 10.1034/j.1399-3003.2000.15d09.x; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Redline S, 1998, AM J RESP CRIT CARE, V157, P858, DOI 10.1164/ajrccm.157.3.9709042; SMITH PL, 1994, AM J RESP CRIT CARE, V150, P1738; Weaver TE, 1997, SLEEP, V20, P835; Wechsler D., 1981, WECHSLER MEMORY SCAL; WECHSLER D, 1998, WECHSLER ADULTS INTE; Wright J, 1997, BRIT MED J, V314, P851; Wright J, 2000, AM J RESP CRIT CARE, V161, P1776, DOI 10.1164/ajrccm.161.6.16166b; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	29	403	412	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2001	134	11					1015	1023		10.7326/0003-4819-134-11-200106050-00007	http://dx.doi.org/10.7326/0003-4819-134-11-200106050-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YL	11388814				2022-12-28	WOS:000168963400001
J	Wickman, S; Sipila, I; Ankarberg-Lindgren, C; Norjavaara, E; Dunkel, L				Wickman, S; Sipila, I; Ankarberg-Lindgren, C; Norjavaara, E; Dunkel, L			A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial	LANCET			English	Article							LUTEINIZING-HORMONE SECRETION; CONSTITUTIONAL DELAY; FINAL HEIGHT; RECEPTOR BLOCKADE; ULNAR GROWTH; TESTOSTERONE; DEFICIENCY; ESTRADIOL; ESTROGEN; OXANDROLONE	Background The role of oestrogens in the closure of growth plates in both sexes is unequivocal. We postulated that inhibition of oestrogen synthesis in boys with delayed puberty would delay maturation of the growth plates and ultimately result in increased adult height. Methods We did a randomised, double-blind, placebo-controlled study in which we treated boys with constitutional delay of puberty with testosterone and placebo, or testosterone and letrozole. Boys who decided to wait for the spontaneous progression of puberty without medical intervention composed the untreated group. Findings Letrozole effectively inhibited oestrogen synthesis and delayed bone maturation. Progression of bone maturation was slower in the letrozole group than in the placebo group. In 18 months, bone age had advanced 1.1 (SD 0.8) years in the untreated group and 1.7 (0.9) years in the group treated with testosterone and placebo, but only 0.9 (0.6) years in the letrozole group (p=0.03 between the treatment groups). Predicted adult height did not change significantly in the untreated group and in the placebo group, whereas in the group treated with letrozole the increase was 5.1 (3.7) cm (p=0.004). Interpretations Our findings suggest that if oestrogen action is inhibited in growing adolescents, adult height will increase. This finding provides a rationale for studies that aim to delay bone maturation in several growth disorders.	Univ Helsinki, Hosp Children & Adolescents, FIN-00029 Helsinki, Finland; Univ Gothenburg, Inst Hlth Women & Children, Goteborg Paediat Growth Res Ctr, Gothenburg, Sweden	University of Helsinki; University of Gothenburg	Dunkel, L (corresponding author), Univ Helsinki, Hosp Children & Adolescents, Ph 281, FIN-00029 Helsinki, Finland.	leo.dunkel@hus.fi		Norjavaara, Ensio/0000-0003-0415-4843				ALBANESE A, 1995, J PEDIATR-US, V126, P545, DOI 10.1016/S0022-3476(95)70347-0; ALBANESE A, 1993, EUR J PEDIATR, V152, P293, DOI 10.1007/BF01956736; APTER D, 1976, CLIN CHEM, V22, P32; BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; Bilezikian JP, 1998, NEW ENGL J MED, V339, P599, DOI 10.1056/NEJM199808273390905; BLETHEN SL, 1984, PEDIATR RES, V18, P467, DOI 10.1203/00006450-198405000-00015; BOYAR RM, 1974, J CLIN INVEST, V54, P609, DOI 10.1172/JCI107798; Carani C, 1997, NEW ENGL J MED, V337, P91, DOI 10.1056/NEJM199707103370204; CARUSONICOLETTI M, 1985, J CLIN ENDOCR METAB, V61, P896, DOI 10.1210/jcem-61-5-896; CASSORLA FG, 1984, J CLIN ENDOCR METAB, V58, P717, DOI 10.1210/jcem-58-4-717; CROWNE EC, 1995, J CLIN ENDOCR METAB, V80, P1869, DOI 10.1210/jc.80.6.1869; CROWNE EC, 1990, ARCH DIS CHILD, V65, P1109, DOI 10.1136/adc.65.10.1109; DUNKEL L, 1990, J CLIN ENDOCR METAB, V70, P107, DOI 10.1210/jcem-70-1-107; FINKELSTEIN JS, 1991, J CLIN ENDOCR METAB, V73, P621, DOI 10.1210/jcem-73-3-621; Greulich WW., 1959, CALIF MED, V91, P53; HANSEN P F, 1952, Acta Med Scand Suppl, V266, P457; JOSS EE, 1989, J CLIN ENDOCR METAB, V69, P1109, DOI 10.1210/jcem-69-6-1109; KERRIGAN JR, 1994, PEDIATR RES, V35, P102, DOI 10.1203/00006450-199401000-00021; Kletter GB, 1997, J CLIN ENDOCR METAB, V82, P4010, DOI 10.1210/jc.82.12.4010; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; LAFRANCHI S, 1991, PEDIATRICS, V87, P82; MARTIN MM, 1986, ACTA ENDOCRINOL-COP, V113, P147; METZGER DL, 1994, J CLIN ENDOCR METAB, V79, P513, DOI 10.1210/jc.79.2.513; MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689; Nachtigall LB, 1996, J CLIN ENDOCR METAB, V81, P3520, DOI 10.1210/jc.81.10.3520; Norjavaara E, 1996, J CLIN ENDOCR METAB, V81, P4095, DOI 10.1210/jc.81.11.4095; OJAJARVI P, 1982, THESIS U HELSINKI HE; PARKER DC, 1975, J CLIN ENDOCR METAB, V40, P1099, DOI 10.1210/jcem-40-6-1099; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; STANHOPE R, 1988, ARCH DIS CHILD, V63, P501, DOI 10.1136/adc.63.5.501; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; TRUNET PF, 1993, J CLIN ENDOCR METAB, V77, P319, DOI 10.1210/jc.77.2.319; VELDHUIS JD, 1984, J CLIN INVEST, V74, P47, DOI 10.1172/JCI111417	33	135	143	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2001	357	9270					1743	1748		10.1016/S0140-6736(00)04895-9	http://dx.doi.org/10.1016/S0140-6736(00)04895-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403810				2022-12-28	WOS:000169156200011
J	Hellberg, ME; Balch, DP; Roy, K				Hellberg, ME; Balch, DP; Roy, K			Climate-driven range expansion and morphological evolution in a marine gastropod	SCIENCE			English	Article							GENE FLOW; DNA-SEQUENCES; ICE AGES; SPECIATION; PLEISTOCENE; POPULATIONS; GRADIENTS; RECORD; SIZE	Little is known about the phenotypic consequences of global climate change, despite the excellent Pleistocene fossil record of many taxa. We used morphological measurements from extant and Pleistocene populations of a marine gastropod (Acanthinucella spirata) in conjunction with mitochondrial DNA sequence variation from Living populations to determine how populations responded phenotypically to Pleistocene climatic changes. Northern populations show Little sequence variation as compared to southern populations, a pattern consistent with a recent northward range expansion. These recently recolonized northern populations also contain shell morphologies that are absent in extant southern populations and throughout the Pleistocene fossil record, Thus, contrary to traditional expectations that morphological evolution should occur Largely within Pleistocene refugia, our data show that geographical range shifts in response to climatic change can Lead to significant morphological evolution.	Univ Calif San Diego, Div Biol, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	University of California System; University of California San Diego; Louisiana State University System; Louisiana State University	Roy, K (corresponding author), Univ Calif San Diego, Div Biol, Sect Ecol Behav & Evolut, 9500 Gilman Dr, La Jolla, CA 92093 USA.							[Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Avise J.C., 2000, PHYLOGEOGRAPHY HIST; Bell M. A., 1997, V82, P323; Bernardi G, 2000, EVOLUTION, V54, P226, DOI 10.1111/j.0014-3820.2000.tb00023.x; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Chiba S, 1998, PALEOBIOLOGY, V24, P99, DOI 10.1017/S0094837300019990; EXCOFFIER L, 1992, GENETICS, V131, P479; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; GIANNINY GL, 1992, VELIGER, V35, P195; Graham RW, 1996, SCIENCE, V272, P1601; Hadly EA, 1998, P NATL ACAD SCI USA, V95, P6893, DOI 10.1073/pnas.95.12.6893; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; HELLBERG ME, 1994, EVOLUTION, V48, P1829, DOI 10.1111/j.1558-5646.1994.tb02218.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Kennedy G.L., 1978, THESIS U CALIFORNIA, pvii; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Lindberg David R., 1996, P161; Losos JB, 1997, NATURE, V387, P70, DOI 10.1038/387070a0; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.1111/j.1558-5646.1998.tb03700.x; Marko PB, 1999, MOL PHYLOGENET EVOL, V13, P275, DOI 10.1006/mpev.1999.0655; Nei M., 1987, MOL EVOLUTIONARY GEN; PEASE CM, 1989, ECOLOGY, V70, P1657, DOI 10.2307/1938100; Price TD, 1997, EVOLUTION, V51, P552, DOI 10.1111/j.1558-5646.1997.tb02442.x; Roy K, 1997, TRENDS ECOL EVOL, V12, P277, DOI 10.1016/S0169-5347(97)81026-9; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Roy K, 1996, TRENDS ECOL EVOL, V11, P458, DOI 10.1016/0169-5347(96)10054-9; ROY K, 1995, GEOLOGY, V23, P1071, DOI 10.1130/0091-7613(1995)023<1071:TAARPI>2.3.CO;2; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; SLATKIN M, 1991, GENETICS, V129, P555; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; SPIGHT T M, 1977, Nautilus, V91, P67; SWOFFORD DL, 1998, PAUP STAR PHYLOGENET; TAJIMA F, 1983, GENETICS, V105, P437; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; VALENTINE JW, 1989, PALEOBIOLOGY, V15, P83, DOI 10.1017/S0094837300009295; Zink RM, 2000, CONSERV BIOL, V14, P1394, DOI 10.1046/j.1523-1739.2000.99082.x	39	136	141	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1707	1710		10.1126/science.1060102	http://dx.doi.org/10.1126/science.1060102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387473				2022-12-28	WOS:000169031800042
J	Mazzarello, P				Mazzarello, P			Sulphur and holy water - Did a devout clergyman inspire the fictional archetype of the diabolical scientist?	NATURE			English	Editorial Material									Univ Pavia, Volta Coll, I-27100 Pavia, Italy; CNR, IGBE, I-27100 Pavia, Italy	University of Pavia; Consiglio Nazionale delle Ricerche (CNR)	Mazzarello, P (corresponding author), Univ Pavia, Volta Coll, Via Abbiat Egrasso 207, I-27100 Pavia, Italy.			MAZZARELLO, PAOLO ANGELO/0000-0003-4130-5727				SPALLANZARI L, 1776, OPUSCOLI FISICA ANIM; SPALLANZARI L, 1989, CARTEGGI, V11	2	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					639	639		10.1038/35079699	http://dx.doi.org/10.1038/35079699			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395744				2022-12-28	WOS:000169112500020
J	Tanner, LH; Hubert, JF; Coffey, BP; McInerney, DP				Tanner, LH; Hubert, JF; Coffey, BP; McInerney, DP			Stability of atmospheric CO2 levels across the Triassic/Jurassic boundary	NATURE			English	Article							TRIASSIC MASS EXTINCTION; CARBON-DIOXIDE; FLOOD BASALTS; RECORD; TIME; SEA	The Triassic/Jurassic boundary, 208 million years ago, is associated with widespread extinctions in both the marine and terrestrial biota. The cause of these extinctions has been widely attributed to the eruption of flood basalts of the Central Atlantic Magmatic Province(1-4). This volcanic event is thought to have released significant amounts of CO2 into the atmosphere, which could have led to catastrophic greenhouse warming(5-7), but the evidence for CO2-induced extinction remains equivocal. Here we present the carbon isotope compositions of pedogenic calcite from palaeosol formations, spanning a 20-Myr period across the Triassic/Jurassic boundary. Using a standard diffusion model(8,9), we interpret these isotopic data to represent a rise in atmospheric CO2 concentrations of about 250 p.p.m. across the boundary, as compared with previous estimates of a 2,000-4,000 p.p.m. increase(4,5). The relative stability of atmospheric CO2 across this boundary suggests that environmental degradation and extinctions during the Early Jurassic were not caused by volcanic outgassing of CO2. Other volcanic effects-such as the release of atmospheric aerosols or tectonically driven sea-level change- may have been responsible for this event.	Bloomsburg Univ Penn, Dept Geog & Geosci, Bloomsburg, PA 17815 USA; Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; Virginia Polytech Inst & State Univ, Dept Geol Sci, Blacksburg, VA 24061 USA; Fleet Natl Bank Connecticut, Environm Risk Management, Hartford, CT 06102 USA	Pennsylvania State System of Higher Education (PASSHE); Bloomsburg University of Pennsylvania; University of Massachusetts System; University of Massachusetts Amherst; Virginia Polytechnic Institute & State University	Tanner, LH (corresponding author), Bloomsburg Univ Penn, Dept Geog & Geosci, Bloomsburg, PA 17815 USA.							BERNER RA, 1994, AM J SCI, V294, P56, DOI 10.2475/ajs.294.1.56; CALDEIRA KG, 1990, GEOL SOC AM SPEC PAP, V247, P117; CERLING TE, 1991, AM J SCI, V291, P377, DOI 10.2475/ajs.291.4.377; CERLINT GE, 1999, SPEC PUBL INT ASS SE, V27, P43; COFFEY BP, 1996, GEOL NAT HIST SUR CO, V1, P6; COFFIN MF, 1993, GEOLOGY, V21, P515, DOI 10.1130/0091-7613(1993)021<0515:STSEDO>2.3.CO;2; Courtillot Vincent, 1994, Israel Journal of Earth Sciences, V43, P255; Curtis Kent, 1999, Paleobios, V19, P19; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; EKART DD, 1996, GEOL SOC AM ABS PROG, V28, P252; FOWELL SJ, 1993, TECTONOPHYSICS, V222, P361, DOI 10.1016/0040-1951(93)90359-R; Hallam A, 1999, EARTH-SCI REV, V48, P217, DOI 10.1016/S0012-8252(99)00055-0; HALLAM A, 2000, GEOL SOC AM ABS PROG, V37, P380; HALLAM A, 1997, MASS EXTINCTIONS THE; HODYCH JP, 1992, GEOLOGY, V20, P51, DOI 10.1130/0091-7613(1992)020<0051:DTMITE>2.3.CO;2; HUBERT JF, 1978, PALAEOGEOGR PALAEOCL, V24, P151, DOI 10.1016/0031-0182(78)90004-4; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; Olsen PE, 1997, ANNU REV EARTH PL SC, V25, P337, DOI 10.1146/annurev.earth.25.1.337; OLSEN PE, 1987, SCIENCE, V237, P1025, DOI 10.1126/science.3616622; Olsen PE, 1999, SCIENCE, V284, P604, DOI 10.1126/science.284.5414.604; PALFY, 2000, GEOLOGY, V28, P39; PARFITT EA, 2000, GEOL SOC AM ABS PROG, V32, P501; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; STOTHERS RB, 1993, GEOPHYS RES LETT, V20, P1399, DOI 10.1029/93GL01381; SUCHECKI RK, 1988, J SEDIMENT PETROL, V58, P801; Tanner LH, 2000, J SEDIMENT RES, V70, P1280, DOI 10.1306/031700701280; TANNER LH, 1996, CONTINENTAL JURASSIC, P656; Wallace P. J., 2000, ENCY VOLCANOES, P149; Yapp CJ, 1996, EARTH PLANET SC LETT, V137, P71, DOI 10.1016/0012-821X(95)00213-V	30	74	78	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					675	677		10.1038/35079548	http://dx.doi.org/10.1038/35079548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395765				2022-12-28	WOS:000169112500039
J	Taylor, T				Taylor, T			Explanatory tyranny	NATURE			English	Article									Univ Bradford, Dept Archaeol Sci, Bradford BD7 1DP, W Yorkshire, England	University of Bradford	Taylor, T (corresponding author), Univ Bradford, Dept Archaeol Sci, Bradford BD7 1DP, W Yorkshire, England.							Dawkins Richard, 1976, SELFISH GENE	1	5	5	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					419	419		10.1038/35078158	http://dx.doi.org/10.1038/35078158			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373652	Bronze			2022-12-28	WOS:000168858700023
J	Hall, MH				Hall, MH			Rationalisation of antenatal care	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL		Aberdeen Matern Hosp, Aberdeen AB25 2ZL, Scotland	University of Aberdeen	Hall, MH (corresponding author), Aberdeen Matern Hosp, Aberdeen AB25 2ZL, Scotland.		Hall, Mei-Hua/GLR-9172-2022	Hall, Mei-Hua/0000-0002-4558-7023				CARROLI G, 2001, PAED PERINATAL EP S1, V15; Jewell D, 2000, BRIT J OBSTET GYNAEC, V107, P1241, DOI 10.1111/j.1471-0528.2000.tb11614.x; LOUDON I, 1992, DEATH CHILDBIRTH INT, P254; LUMBIGANON P, 1998, PAED PERINATAL EPIDE, V12, P1; Munjanja SP, 1996, LANCET, V348, P364, DOI 10.1016/S0140-6736(96)01250-0; ROONEY C, 1992, WHOMSM924 DIV FAM HL	6	8	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1546	1546		10.1016/S0140-6736(00)04777-2	http://dx.doi.org/10.1016/S0140-6736(00)04777-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377637				2022-12-28	WOS:000168830100003
J	Ruggenenti, P; Schieppati, A; Remuzzi, G				Ruggenenti, P; Schieppati, A; Remuzzi, G			Progression, remission, regression of chronic renal diseases	LANCET			English	Review							CONVERTING ENZYME-INHIBITION; DIETARY-PROTEIN RESTRICTION; BLOOD-PRESSURE CONTROL; DIABETIC NEPHROPATHY; ACE-INHIBITION; GLOMERULAR INJURY; RISK FACTOR; FOLLOW-UP; INSUFFICIENCY; HYPERTENSION	The prevalence of chronic renal disease is increasing worldwide. Most chronic nephropathies lack a specific treatment and progress relentlessly to end-stage renal disease. However, research in animals and people has helped our understanding of the mechanisms of this progression and has indicated possible preventive methods. The notion of renoprotection is developing into a combined approach to renal diseases, the main measures being pharmacological control of blood pressure and reduction of proteinuria. Lowering of blood lipids, smoking cessation, and tight glucose control for diabetes also form part of the multimodal protocol for management of renal patients. With available treatments, dialysis can be postponed for many patients with chronic nephropathies, but the real goal has to be less dialysis-in other words remission of disease and regression of structural damage to the kidney. Experimental and clinical data lend support to the notion that less dialysis (and maybe none for some patients) is at least possible.	Osped Riuniti Bergamo, Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24125 Bergamo, Italy; Osped Riuniti Bergamo, Nephrol Unit, I-24125 Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo; Ospedali Riuniti di Bergamo	Remuzzi, G (corresponding author), Osped Riuniti Bergamo, Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24125 Bergamo, Italy.		Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				Abbate M, 1998, J AM SOC NEPHROL, V9, P1213; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; AZIZI M, 1995, CIRCULATION, V92, P825, DOI 10.1161/01.CIR.92.4.825; Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Bakris GL, 1998, KIDNEY INT, V54, P1283, DOI 10.1046/j.1523-1755.1998.00083.x; Benigni A, 1998, DIABETES, V47, P450, DOI 10.2337/diabetes.47.3.450; Benigni A, 1999, LANCET, V353, P133, DOI 10.1016/S0140-6736(98)09423-9; Boner G, 1996, DIABETOLOGIA, V39, P587; BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104; Burnett JC, 2000, CURR OPIN NEPHROL HY, V9, P465, DOI 10.1097/00041552-200009000-00001; CLOSE CF, 1995, BMJ-BRIT MED J, V311, P973; COLLINS A, 2000, J AM SOC NEPHROL, V11, pA133; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Fogo AB, 2001, KIDNEY INT, V59, P804, DOI 10.1046/j.1523-1755.2001.059002804.x; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Gambaro G, 1996, NEPHROL DIAL TRANSPL, V11, P762, DOI 10.1093/oxfordjournals.ndt.a027392; Gambaro G., 2000, Journal of the American Society of Nephrology, V11, p114A; Gerstein HC, 2000, LANCET, V355, P253; GRIFFIN KA, 1995, J CLIN INVEST, V96, P798; HANNEDOUCHE T, 1994, BRIT MED J, V309, P833, DOI 10.1136/bmj.309.6958.833; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hovind P., 2000, Journal of the American Society of Nephrology, V11, p116A; HOY WE, IN PRESS KIDNEY INT; Jafar T. H., 2000, Journal of the American Society of Nephrology, V11, p63A; KASISKE BL, 1993, ANN INTERN MED, V118, P129, DOI 10.7326/0003-4819-118-2-199301150-00009; Kasiske BL, 1998, AM J KIDNEY DIS, V31, P954, DOI 10.1053/ajkd.1998.v31.pm9631839; KEANE WF, 1994, KIDNEY INT, V46, P910, DOI 10.1038/ki.1994.349; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LOCATELLI F, 1991, LANCET, V337, P1299, DOI 10.1016/0140-6736(91)92977-A; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; MOGENSEN CE, 1976, SCAND J CLIN LAB INV, V36, P383, DOI 10.3109/00365517609055274; MOORHEAD JF, 1982, LANCET, V2, P1309; MULEC H, 1993, AM J KIDNEY DIS, V22, P196, DOI 10.1016/S0272-6386(12)70186-5; Nakamura S., 1999, Journal of the American Society of Nephrology, V10, p665A; NAKAMURA T, 1995, J AM SOC NEPHROL, V5, P1492; ORS M, 1998, J AM SOC NEPHROL, V9, P224; Orth SR, 2000, NEPHROL DIAL TRANSPL, V15, P1509, DOI 10.1093/ndt/15.10.1509; Orth SR, 1998, KIDNEY INT, V54, P926, DOI 10.1046/j.1523-1755.1998.00067.x; PARVING HH, 1993, AM J KIDNEY DIS, V22, P188, DOI 10.1016/S0272-6386(12)70185-3; PARVING HH, 1996, KIDNEY, P1864; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; PLATT R, 1952, BMJ-BRIT MED J, V1, P1372, DOI 10.1136/bmj.1.4773.1372; REMUZZI A, 1990, J CLIN INVEST, V85, P541, DOI 10.1172/JCI114470; Remuzzi A, 1999, AM J KIDNEY DIS, V34, P626, DOI 10.1016/S0272-6386(99)70385-9; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Remuzzi G, 1999, AM J KIDNEY DIS, V33, P807, DOI 10.1016/S0272-6386(99)70241-6; ROSSING P, 1993, DIABETES, V42, P715, DOI 10.2337/diabetes.42.5.715; ROULEAU JL, 1999, CIRCULATION S1, V100, P1; ROVIN BH, 1993, KIDNEY INT, V43, P218, DOI 10.1038/ki.1993.35; Ruggenenti P, 2000, KIDNEY INT, V58, P2093, DOI 10.1111/j.1523-1755.2000.00382.x; Ruggenenti P, 1999, J AM SOC NEPHROL, V10, P997; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Ruggenenti P, 2000, J AM SOC NEPHROL, V11, P88, DOI 10.1681/ASN.V11188; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; RUGGENENTI P, IN PRESS NEPHRON; Russo D, 1999, AM J KIDNEY DIS, V33, P851, DOI 10.1016/S0272-6386(99)70416-6; Rutkowski B, 2000, NEPHROL DIAL TRANSPL, V15, P156, DOI 10.1093/ndt/15.2.156; Samuelsson O, 1997, NEPHROL DIAL TRANSPL, V12, P1908, DOI 10.1093/ndt/12.9.1908; Somes GW, 1999, ARCH INTERN MED, V159, P2004, DOI 10.1001/archinte.159.17.2004; Taal Maarten W., 2000, Journal of the American Society of Nephrology, V11, p631A; Tarver-Carr Michelle E., 2000, Journal of the American Society of Nephrology, V11, p168A; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Valderrabano F, 1996, NEPHROL DIAL TRANSPL, V11, P2; Wapstra FH, 1996, EXP NEPHROL, V4, P47; WEBER M, IN PRESS LANCET; WEIDMANN P, 1995, NEPHROL DIAL TRANSPL, V10, P39; Wilmer WA, 1999, AM J KIDNEY DIS, V34, P308, DOI 10.1016/S0272-6386(99)70360-4; Wolf G, 2000, CURR OPIN NEPHROL HY, V9, P233, DOI 10.1097/00041552-200005000-00005; ZATZ R, 1986, J CLIN INVEST, V77, P1925, DOI 10.1172/JCI112521; Zoccali C, 1997, NEPHROL DIAL TRANSPL, V12, P234, DOI 10.1093/oxfordjournals.ndt.a027738; ZOJA C, 1995, J AM SOC NEPHROL, V6, P860; 1998, AM J KIDNEY DIS S, V32, pS20	75	412	438	2	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1601	1608		10.1016/S0140-6736(00)04728-0	http://dx.doi.org/10.1016/S0140-6736(00)04728-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377666				2022-12-28	WOS:000168830100032
J	Shirali, GS; Ni, JY; Chinnock, RE; Johnston, JK; Rosenthal, GL; Bowles, NE; Towbin, JA				Shirali, GS; Ni, JY; Chinnock, RE; Johnston, JK; Rosenthal, GL; Bowles, NE; Towbin, JA			Association of viral genome with graft loss in children after cardiac transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; IDIOPATHIC DILATED CARDIOMYOPATHY; INFANT HEART-TRANSPLANTATION; NUCLEIC-ACID HYBRIDIZATION; CORONARY-ARTERY DISEASE; COXSACKIEVIRUS B3 RNA; ENDOMYOCARDIAL BIOPSY; CYTOMEGALOVIRUS-INFECTION; ENTEROVIRUS RNA; ENDOCARDIAL FIBROELASTOSIS	Background: The survival of recipients of cardiac allografts is limited by rejection and coronary vasculopathy. The purpose of this study in children who had received heart transplants was to evaluate the cardiac allografts for myocardial viral infections and to determine whether the presence of viral genome in the myocardium correlates with rejection, coronary vasculopathy, or graft loss. Methods: We enrolled heart-transplant recipients 1 day to 18 years old who were undergoing evaluation for possible rejection and coronary vasculopathy. Endomyocardial-biopsy specimens were evaluated for evidence of rejection with the use of standard criteria and were analyzed for the presence of virus by the polymerase chain reaction (PCR). Results: PCR analyses were performed on 553 consecutive biopsy samples from 149 transplant recipients. Viral genome was amplified from 48 samples (8.7 percent) from 34 patients (23 percent); adenovirus was found in 30 samples, enterovirus in 9 samples, parvovirus in 5 samples, cytomegalovirus in 2 samples, herpes simplex virus in 1 sample, and Epstein-Barr virus in 1 sample. In 29 of the 34 patients with positive results on PCR (85 percent), an adverse cardiac event occurred within three months after the positive biopsy, and 9 of the 34 patients had graft loss due to coronary vasculopathy, chronic graft failure, or acute rejection. In 39 of the 115 patients with negative results on PCR (34 percent), an adverse cardiac event occurred within three months of the negative PCR finding; graft loss did not occur in any of the patients in this group. The odds of graft loss were 6.5 times as great among those with positive results on PCR (P = 0.006). The detection of adenovirus was associated with considerably reduced graft survival (P = 0.002). Conclusions: Identification of viral genome, particularly adenovirus, in the myocardium of pediatric transplant recipients is predictive of adverse clinical events, including coronary vasculopathy and graft loss. (N Engl J Med 2001;344:1498-503.) Copyright (C) 2001 Massachusetts Medical Society.	Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Cardiovasc Sci, Houston, TX 77030 USA; Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; Loma Linda Univ, Childrens Hosp, Dept Ambulatory Pediat, Loma Linda, CA 92350 USA; Loma Linda Univ, Childrens Hosp, Dept Nursing, Loma Linda, CA 92350 USA; Univ Washington, Dept Pediat Cardiol, Seattle, WA 98195 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Medical University of South Carolina; Children's Hospital Los Angeles; Loma Linda University; Children's Hospital Los Angeles; Loma Linda University; University of Washington; University of Washington Seattle	Towbin, JA (corresponding author), Baylor Coll Med, Dept Pediat Cardiol, Rm 333E,1 Baylor Plaza, Houston, TX 77030 USA.		Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X; Chinnock, Richard/0000-0002-9814-1762				Akhtar N, 1999, CIRCULATION, V99, P2011, DOI 10.1161/01.CIR.99.15.2011; Billingham M E, 1990, J Heart Transplant, V9, P587; BOUCEK MM, 1993, J HEART LUNG TRANSPL, V12, P824; BOUCEK MM, 1994, J HEART LUNG TRANSPL, V13, P66; BOWLES NE, 1989, CIRCULATION, V80, P1128, DOI 10.1161/01.CIR.80.5.1128; BOWLES NE, 1986, LANCET, V1, P1120; Bridges ND, 1998, J THORAC CARDIOV SUR, V116, P617, DOI 10.1016/S0022-5223(98)70168-0; CHAPMAN NM, 1990, J CLIN MICROBIOL, V28, P843, DOI 10.1128/JCM.28.5.843-850.1990; CHOW LH, 1989, J AM COLL CARDIOL, V14, P915, DOI 10.1016/0735-1097(89)90465-8; EISENSTEIN BI, 1990, NEW ENGL J MED, V322, P178; EVERETT JP, 1992, J HEART LUNG TRANS S, V11, P133; FABRICANT CG, 1978, J EXP MED, V148, P335, DOI 10.1084/jem.148.1.335; GRASSO M, 1992, AM J CARDIOL, V69, P658, DOI 10.1016/0002-9149(92)90160-Z; GRATTAN MT, 1989, JAMA-J AM MED ASSOC, V261, P3561, DOI 10.1001/jama.261.24.3561; GRIFFIN LD, 1995, CARDIOVASC PATHOL, V4, P3, DOI 10.1016/1054-8807(94)00025-M; HAUCK AJ, 1989, MAYO CLIN PROC, V64, P1235, DOI 10.1016/S0025-6196(12)61286-5; HILTON DA, 1993, J PATHOL, V170, P45, DOI 10.1002/path.1711700108; JIN O, 1990, CIRCULATION, V82, P8, DOI 10.1161/01.CIR.82.1.8; KANDOLF R, 1987, P NATL ACAD SCI USA, V84, P6272, DOI 10.1073/pnas.84.17.6272; KOSKINEN PK, 1993, J HEART LUNG TRANSPL, V12, P724; LIE JT, 1988, ANN INTERN MED, V109, P525, DOI 10.7326/0003-4819-109-7-525; LOEBE M, 1990, J HEART TRANSPLANT, V9, P707; MARTIN AB, 1994, CIRCULATION, V90, P330, DOI 10.1161/01.CIR.90.1.330; MCDONALD K, 1989, AM J CARDIOL, V64, P359, DOI 10.1016/0002-9149(89)90535-3; MELNICK JL, 1990, JAMA-J AM MED ASSOC, V263, P2204, DOI 10.1001/jama.263.16.2204; MORGANCAPNER P, 1984, VIRAL HEART DISEASE, P99; MUIR P, 1993, J CLIN MICROBIOL, V31, P31, DOI 10.1128/JCM.31.1.31-38.1993; Ni JY, 1997, CIRCULATION, V95, P133, DOI 10.1161/01.CIR.95.1.133; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; PETITJEAN J, 1992, J MED VIROL, V37, P76, DOI 10.1002/jmv.1890370114; PETITJEAN J, 1993, J MED VIROL, V41, P260; REDLINE RW, 1991, AM J CLIN PATHOL, V96, P568; Schowengerdt KO, 1997, CIRCULATION, V96, P3549; Schowengerdt KO, 1996, J HEART LUNG TRANSPL, V15, P111; WEISS LM, 1991, AM J PATHOL, V138, P497; WEISS LM, 1992, J CLIN INVEST, V90, P156, DOI 10.1172/JCI115830; Winters GL, 1998, J HEART LUNG TRANSPL, V17, P754	37	135	146	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1498	1503		10.1056/NEJM200105173442002	http://dx.doi.org/10.1056/NEJM200105173442002			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357152				2022-12-28	WOS:000168677200002
J	Ridker, PM; Stampfer, MJ; Rifai, N				Ridker, PM; Stampfer, MJ; Rifai, N			Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; INFLAMMATION; MORTALITY	Context Several novel risk factors for atherosclerosis have recently been proposed, but few comparative data exist to guide clinical use of these emerging biomarkers. Objective To compare the predictive value of 11 lipid and nonlipid biomarkers as risk factors for development of symptomatic peripheral arterial disease (PAD). Design, Setting, and Participants Nested case-control study using plasma samples collected at baseline from a prospective cohort of 14 916 initially healthy US male physicians aged 40 to 84 years, of whom 140 subsequently developed symptomatic PAD (cases); 140 age- and smoking status-matched men who remained free of vascular disease during an average 9-year follow-up period were randomly selected as controls. Main Outcome Measure Incident PAD, as determined by baseline total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol-HDL-C ratio, triglycerides, homocysteine, C-reactive protein (CRP), lipoprotein(a), fibrinogen, and apolipoproteins (apo) A-I and B-100. Results In univariate analyses, plasma levels of total cholesterol (P<.001), LDL-C (P=.001), triglycerides (P=.001), apo B-100 (P=.001), fibrinogen (P=.02), CRP (P=.006), and the total cholesterol-HDL-C ratio (P<.001) were all significantly higher at baseline among men who subsequently developed PAD compared with those who did not, while levels of HDL-C (P=.009) and apo A-I (P=.05) were lower. Nonsignificant baseline elevations of lipoprotein(a) (P=.40) and homocysteine (P=.90) were observed. In multivariable analyses, the total cholesterol-HDL-C ratio was the strongest lipid predictor of risk (relative risk [RR] for those in the highest vs lowest quartile, 3.9; 95% confidence interval [CI], 1.7-8.6), while CRP was the strongest nonlipid predictor (RR for the highest vs lowest quartile, 2.8; 95% CI, 1.3-5.9). In assessing joint effects, addition of CRP to standard lipid screening significantly improved risk prediction models based on lipid screening alone (P<.001). Conclusions Of 11 atherothrombotic biomarkers assessed at baseline, the total cholesterol-HDL-C ratio and CRP were the strongest independent predictors of development of peripheral arterial disease. C-reactive protein provided additive prognostic information over standard lipid measures.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Div Prevent, Boston, MA 02215 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02215 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Leducq Ctr Mol & Genet Epidemiol Cardiovasc Disor, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Med Ctr, Sch Med,Dept Lab Med, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Med Ctr, Sch Med,Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Ridker, PM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Div Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org			NHLBI NIH HHS [HL 58755] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058755] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; CARMARGO CA, 1997, ANN INTERNM ED, V126, P372; Christen W G, 1994, Ophthalmic Epidemiol, V1, P85; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Klag M J, 1993, Ann Epidemiol, V3, P442; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; Mosca L, 2000, CIRCULATION, V101, pE223, DOI 10.1161/01.CIR.101.1.e3; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 1998, CIRCULATION, V97, P425; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Ridker PM, 1999, ANN INTERN MED, V130, P933, DOI 10.7326/0003-4819-130-11-199906010-00018; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rifai N, 1999, CLIN CHEM, V45, P2136; Smith S C Jr, 2000, Circulation, V101, P111; VOGT MT, 1993, JAMA-J AM MED ASSOC, V270, P465, DOI 10.1001/jama.270.4.465	19	959	997	2	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2481	2485		10.1001/jama.285.19.2481	http://dx.doi.org/10.1001/jama.285.19.2481			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429ZC	11368701	Bronze			2022-12-28	WOS:000168547600030
J	MacQueen, G; Santa-Barbara, J; Neufeld, V; Yusuf, S; Horton, R				MacQueen, G; Santa-Barbara, J; Neufeld, V; Yusuf, S; Horton, R			Health and peace: time for a new discipline	LANCET			English	Editorial Material							WAR; IMPRINTS; CROATIA; BOSNIA		McMaster Univ, Ctr Peace Studies, Hamilton, ON L8S 4K1, Canada; McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8S 4K1, Canada; Lancet, London, England	McMaster University; McMaster University; Population Health Research Institute	MacQueen, G (corresponding author), McMaster Univ, Ctr Peace Studies, Hamilton, ON L8S 4K1, Canada.			Yusuf, Salim/0000-0003-4776-5601				Bush K, 2000, B WORLD HEALTH ORGAN, V78, P281; Horton R, 1999, LANCET, V353, P2139, DOI 10.1016/S0140-6736(99)05242-3; Horton R, 1999, LANCET, V353, P2223, DOI 10.1016/S0140-6736(99)06043-2; MacQueen G, 2000, BRIT MED J, V321, P293, DOI 10.1136/bmj.321.7256.293; MacQueen G., 1997, PEACE CHANGE, V22, P175, DOI [10.1111/0149-0508.451997011, DOI 10.1111/0149-0508.451997011]; MUGAMBI M, 2001, INT C HLTH RES DEV A; MURRAY CJL, 1996, GLOBAL BURDEN DIS, V1; Neufeld V, 2001, CAN MED ASSOC J, V164, P1158; PETERS M, 1996, HLTH PEACE HDB IDEAS; Tangermann RH, 2000, B WORLD HEALTH ORGAN, V78, P330; WEEKES R, 1991, HUMANITARIAN CEASEFI	11	33	33	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1460	1461		10.1016/S0140-6736(00)04668-7	http://dx.doi.org/10.1016/S0140-6736(00)04668-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377590				2022-12-28	WOS:000168614300002
J	Tolfvenstam, T; Papadogiannakis, N; Norbeck, O; Petersson, K; Broliden, K				Tolfvenstam, T; Papadogiannakis, N; Norbeck, O; Petersson, K; Broliden, K			Frequency of human parvovirus B19 infection in intrauterine fetal death	LANCET			English	Article							ANTIGEN	Background Parvovirus B19 is known to cause fetal death in the second trimester, mainly in combination with hydrops fetalis. However, the frequency of parvovirus-B19-associated non-hydropic fetal loss in the late second and third trimester has not been thoroughly investigated. We aimed to investigate the frequency of parvovirus B19 infection in unselected cases of intrauterine fetal death and to assess the sensitivity of different diagnostic procedures. Methods Of 14 147 deliveries in three hospitals in the major Stockholm area of Sweden. all cases of intrauterine fetal death (greater than or equal to 22 gestational weeks) that occurred between January, 1998, and May, 1999 (n=47), referred cases of miscarriage (<22 gestational weeks, n=37), and induced abortions (n=29), were included in the study. Placental and fetal tissues were examined by means of parvovirus-B19-specific PCR, histopathology, and immunohistochemistry. Placental tissues from 53 normal pregnancies at term were also examined. Findings Significantly more cases of intrauterine fetal death were positive for parvovirus B19 DNA (seven [15%]) than were normal pregnancies at term (zero, p=0.049). Furthermore. parvovirus B19 DNA was found in two (5%) of the miscarriages but not in any of the cases of induced abortion. Only three of nine DNA-positive cases had parvovirus-B19-associated inclusions and stained positive for viral proteins. All but one of the DNA-positive cases of intrauterine fetal death were non-hydropic. Interpretation The presence of parvovirus B19 DNA in cases of late second-trimester and third-trimester fetal death is common, and most are non-hydropic. The sensitivity of conventional diagnostic procedures for intrauterine fetal death could be greatly improved by addition of parvovirus B19 PCR.	Huddinge Univ Hosp, Karolinska Inst, Dept Clin Virol, SE-14186 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Pathol, SE-14186 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Obstet & Gynecol, SE-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Tolfvenstam, T (corresponding author), Huddinge Univ Hosp, Karolinska Inst, Dept Clin Virol, SE-14186 Stockholm, Sweden.	Thomas.Tolfvenstam@impi.ki.se		Tolfvenstam, Thomas/0000-0003-3549-8083				ANAND A, 1987, NEW ENGL J MED, V316, P183, DOI 10.1056/NEJM198701223160403; ANDERSON MJ, 1983, LANCET, V1, P1378; ANDERSON MJ, 1987, LANCET, V1, P738; Broliden K, 1998, MED PEDIATR ONCOL, V31, P66; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; BROWN KE, 1989, BRIT J OBSTET GYNAEC, V96, P764, DOI 10.1111/j.1471-0528.1989.tb03313.x; BROWN T, 1984, LANCET, V2, P1033; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P81; Centers for Disease Control (CDC), 1989, MMWR-MORBID MORTAL W, V38, p[81, 93]; CLEWLEY JP, 1987, J MED VIROL, V23, P367, DOI 10.1002/jmv.1890230409; COHEN BJ, 1988, J MED MICROBIOL, V25, P151, DOI 10.1099/00222615-25-2-151; EHRLICH HA, 1989, PCR TECHNOLOGY PRINC, P193; ENDERS G, 1990, Behring Institute Mitteilungen, P74; FRICKHOFEN N, 1990, ANN INTERN MED, V113, P926, DOI 10.7326/0003-4819-113-12-926; HALL SM, 1990, BMJ-BRIT MED J, V300, P1166; Miller E, 1998, BRIT J OBSTET GYNAEC, V105, P174, DOI 10.1111/j.1471-0528.1998.tb10048.x; MOREY AL, 1992, BRIT J OBSTET GYNAEC, V99, P566, DOI 10.1111/j.1471-0528.1992.tb13822.x; PATTISON JR, 1981, LANCET, V1, P664; RODIS JF, 1988, OBSTET GYNECOL, V72, P733; Rogers BB, 1999, PEDIATR DEVEL PATHOL, V2, P296, DOI 10.1007/s100249900128; SERJEANT GR, 1993, LANCET, V341, P1237, DOI 10.1016/0140-6736(93)91145-C; Skjoldebrand-Sparre K, 2000, BRIT J OBSTET GYNAEC, V107, P476, DOI 10.1111/j.1471-0528.2000.tb13265.x; TOROK TJ, 1990, PEDIATR INFECT DIS J, V9, P772; WOOLF AD, 1989, ARCH INTERN MED, V149, P1153, DOI 10.1001/archinte.149.5.1153	24	103	114	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2001	357	9267					1494	1497		10.1016/S0140-6736(00)04647-X	http://dx.doi.org/10.1016/S0140-6736(00)04647-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377602				2022-12-28	WOS:000168614300014
J	Mullen, AC; High, FA; Hutchins, AS; Lee, HW; Villarino, AV; Livingston, DM; Kung, AL; Cereb, N; Yao, TP; Yang, SY; Reiner, SL				Mullen, AC; High, FA; Hutchins, AS; Lee, HW; Villarino, AV; Livingston, DM; Kung, AL; Cereb, N; Yao, TP; Yang, SY; Reiner, SL			Role of T-bet in commitment of T(H)1 cells before IL-12-dependent selection	SCIENCE			English	Article							CYTOKINE GENE-EXPRESSION; TRANSCRIPTION FACTOR; SIGNAL TRANSDUCER; TH2 CELLS; ACTIVATION; RESPONSES; STAT6; IL-4; DIFFERENTIATION; INTERLEUKIN-4	How cytokines control differentiation of helper T (T-H) cells is controversial. We show that T-bet, without apparent assistance from interleukin 12 (IL-12)/ STAT4, specifies T(H)1 effector fate by targeting chromatin remodeling to individual interferon-gamma (IFN-gamma) alleles and by inducing IL-12 receptor beta2 expression. Subsequently, it appears that IL-12/STAT4 serves two essential functions in the development of T(H)1 cells: as growth signal, inducing survival and cell division; and as trans-activator, prolonging IFN-gamma synthesis through a genetic interaction with the coactivator, CREB-binding protein. These results suggest that a cytokine does not simply induce T-H fate choice but instead may act as an essential secondary stimulus that mediates selective survival of a lineage.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Histogenet Inc, Hawthorne, NY 10532 USA; Ctr Genet Polymorphism, Hawthorne, NY 10532 USA; Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Duke University	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; Villarino, Alejandro/0000-0001-8068-2176; Mullen, Alan/0000-0002-4096-3106	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042370] Funding Source: NIH RePORTER; NEI NIH HHS [EY-07131] Funding Source: Medline; NIAID NIH HHS [AI-42370] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Coffman RL, 1999, SCIENCE, V284, P1283, DOI 10.1126/science.284.5418.1283; Farrar JD, 2001, J EXP MED, V193, P643, DOI 10.1084/jem.193.5.643; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Kaplan MH, 1998, J EXP MED, V188, P1191, DOI 10.1084/jem.188.6.1191; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kung AL, 2000, GENE DEV, V14, P272; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MULLEN AC, UNPUB; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Zhang WX, 2000, GENOMICS, V70, P41, DOI 10.1006/geno.2000.6361; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	28	645	692	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1907	1910		10.1126/science.1059835	http://dx.doi.org/10.1126/science.1059835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397944				2022-12-28	WOS:000169200700048
J	Spence, D; Eliasziw, M				Spence, D; Eliasziw, M			Endarterectomy or angioplasty for treatment of carotid stenosis?	LANCET			English	Editorial Material									Robarts Res Inst, Strroke Prevent & Atherosclerosis Res Ctr, London, ON N6G 2V2, Canada	Western University (University of Western Ontario)	Spence, D (corresponding author), Robarts Res Inst, Strroke Prevent & Atherosclerosis Res Ctr, London, ON N6G 2V2, Canada.	dspence@rri.on.ca	Spence, J. David/K-6396-2013	Spence, J. David/0000-0001-7478-1098				Alberts MJ, 2001, STROKE, V32, P325; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Chaturvedi S, 2000, NEUROLOGY, V55, P769, DOI 10.1212/WNL.55.6.769; ELIASZIW M, 1994, STROKE, V25, P2445, DOI 10.1161/01.STR.25.12.2445; *EUR CAR SURG TRIA, 1991, LANCET, V351, P1235; Naylor AR, 1998, J VASC SURG, V28, P326, DOI 10.1016/S0741-5214(98)70182-X; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035	8	22	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2001	357	9270					1722	1723		10.1016/S0140-6736(00)04929-1	http://dx.doi.org/10.1016/S0140-6736(00)04929-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403801				2022-12-28	WOS:000169156200002
J	Agrawal, AF				Agrawal, AF			Sexual selection and the maintenance of sexual reproduction	NATURE			English	Article							DELETERIOUS MUTATIONS; EVOLUTION; LOAD; ADVANTAGE; DOMINANCE; BALANCE	The maintenance of sexual reproduction is a problem in evolutionary theory because, all else being equal, asexual populations have a twofold fitness advantage over their sexual counterparts(1,2) and should rapidly outnumber a sexual population because every individual has the potential to reproduce. The twofold cost of sex exists because of anisogamy or gamete dimorphism(2)-egg-producing females make a larger contribution to the zygote compared with the small contribution made by the sperm of males, but both males and females contribute 50% of the genes. Anisogamy also generates the conditions for sexual selection(3), a powerful evolutionary force that does not exist in asexual populations. The continued prevalence of sexual reproduction indicates that the 'all else being equal' assumption is incorrect. Here I show that sexual selection can mitigate or even eliminate the cost of sex. If sexual selection causes deleterious mutations to be more deleterious in males than females, then deleterious mutations are maintained at lower equilibrium frequency in sexual populations relative to asexual populations. The fitness of sexual females is higher than asexuals because there is no difference in the fecundity of sexual females and asexuals of the same genotype, but the equilibrium frequency of deleterious mutations is lower in sexual populations. The results are not altered by synergistic epistasis in males.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Agrawal, AF (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	aagrawal@bio.indiana.edu						Andersson Malte, 1994; ARNOLD SJ, 1984, EVOLUTION, V38, P720, DOI 10.1111/j.1558-5646.1984.tb00345.x; BELL G, 1982, MASTERPIECE NATURE E; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Chasnov JR, 2000, GENETICS, V156, P1419; CROW J. F., 1970, Biomathematics. Volume 1. Mathematical topics in population genetics., P128; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Garcia-Dorado A, 2000, GENETICS, V155, P1991; HOWARD RS, 1994, NATURE, V367, P554, DOI 10.1038/367554a0; Hurst Laurence D., 1996, Trends in Ecology and Evolution, V11, P46, DOI 10.1016/0169-5347(96)81041-X; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Keightley PD, 1999, GENETICS, V153, P515; KIMURA M, 1966, GENETICS, V54, P1337; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kodric-Brown A, 1987, EVOL ECOL, V1, P95, DOI 10.1007/BF02067393; KOESLAG JH, 1993, J HERED, V84, P396, DOI 10.1093/oxfordjournals.jhered.a111360; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1982, GENET RES, V40, P325, DOI 10.1017/S0016672300019194; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; Lynch M., 1998, GENETICS ANAL QUANTI; MANNING JT, 1984, J THEOR BIOL, V108, P215, DOI 10.1016/S0022-5193(84)80067-3; Maynard Smith J., 1978, EVOLUTION SEX, DOI DOI 10.1093/bioinformatics/btg412; MULCAHY DL, 1979, SCIENCE, V206, P20, DOI 10.1126/science.206.4414.20; Peck JR, 2000, NATURE, V406, P399, DOI 10.1038/35019055; TRIVERS RL, 1972, SEXUAL SELECTION DES, P141; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; Whitlock MC, 2000, EVOLUTION, V54, P1654, DOI 10.1111/j.0014-3820.2000.tb00709.x; Whitlock MC, 2000, EVOLUTION, V54, P1855, DOI 10.1111/j.0014-3820.2000.tb01232.x	30	227	229	0	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					692	695		10.1038/35079590	http://dx.doi.org/10.1038/35079590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395771				2022-12-28	WOS:000169112500045
J	Zhou, M; Morais-Cabral, JH; Mann, S; MacKinnon, R				Zhou, M; Morais-Cabral, JH; Mann, S; MacKinnon, R			Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors	NATURE			English	Article							SHAKER K-CHANNELS; PORE; MECHANISMS; BLOCKADE	Many voltage-dependent K+ channels open when the membrane is depolarized and then rapidly close by a process called inactivation. Neurons use inactivating K+ channels to modulate their firing frequency. In Shaker-type K+ channels, the inactivation gate, which is responsible for the closing of the channel, is formed by the channel's cytoplasmic amino terminus. Here we show that the central cavity and inner pore of the K+ channel form the receptor site for both the inactivation gate and small-molecule inhibitors. We propose that inactivation occurs by a sequential reaction in which the gate binds initially to the cytoplasmic channel surface and then enters the pore as an extended peptide. This mechanism accounts for the functional properties of K+ channel inactivation and indicates that the cavity may be the site of action for certain drugs that alter cation channel function.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu	Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716				Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Antz C, 1998, NEWS PHYSIOL SCI, V13, P177; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GOMEZLAGUNAS F, 1995, BIOPHYS J, V68, P89, DOI 10.1016/S0006-3495(95)80162-1; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LU Z, 1994, J GEN PHYSIOL, V104, P477, DOI 10.1085/jgp.104.3.477; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; OTWINOWSKI Z, 1993, P CCP4 STUD WEEK SER; Rasmusson RL, 1995, J PHYSIOL-LONDON, V489, P709, DOI 10.1113/jphysiol.1995.sp021085; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Schott MK, 1998, EUR BIOPHYS J BIOPHY, V27, P99, DOI 10.1007/s002490050115; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Yarov-Yarovoy V, 2001, J BIOL CHEM, V276, P20, DOI 10.1074/jbc.M006992200; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	31	484	494	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					657	661		10.1038/35079500	http://dx.doi.org/10.1038/35079500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395760				2022-12-28	WOS:000169112500034
J	Hiatt, WR				Hiatt, WR			Drug therapy - Medical treatment of peripheral arterial disease and claudication.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CORONARY-HEART-DISEASE; ANKLE-ARM INDEX; SEVERE INTERMITTENT CLAUDICATION; HORMONE REPLACEMENT THERAPY; PROPIONYL-L-CARNITINE; DOUBLE-BLIND; VASCULAR-DISEASE; OCCLUSIVE DISEASE; INDEPENDENT PREDICTOR; FUNCTIONAL STATUS		Colorado Prevent Ctr, Denver, CO 80203 USA; Univ Colorado, Sch Med, Dept Med, Div Geriatr,Sect Vasc Med, Denver, CO USA; Univ Colorado, Sch Med, Dept Med, Div Cardiol,Sect Vasc Med, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Hiatt, WR (corresponding author), Colorado Prevent Ctr, 789 Sherman St,Suite 200, Denver, CO 80203 USA.	will.hiatt@uchsc.edu						Abbas R, 2000, HUM EXP TOXICOL, V19, P178, DOI 10.1191/096032700678827717; ADHOUTE G, 1990, J CARDIOVASC PHARM, V16, pS75; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Ansell BJ, 1999, JAMA-J AM MED ASSOC, V282, P2051, DOI 10.1001/jama.282.21.2051; Bagger JP, 1997, CIRCULATION, V95, P411; BALSANO F, 1993, CIRCULATION, V87, P1563, DOI 10.1161/01.CIR.87.5.1563; BALSANO F, 1989, J LAB CLIN MED, V114, P84; Beebe HG, 1999, ARCH INTERN MED, V159, P2041, DOI 10.1001/archinte.159.17.2041; Belch JJF, 1997, CIRCULATION, V95, P2298, DOI 10.1161/01.CIR.95.9.2298; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Bennett CL, 1998, ANN INTERN MED, V128, P541, DOI 10.7326/0003-4819-128-7-199804010-00004; BERGQVIST D, 1995, EUR J VASC ENDOVASC, V10, P69, DOI 10.1016/S1078-5884(05)80200-X; Black HR, 1998, ARCH INTERN MED, V158, P573; BLANKENHORN DH, 1991, CIRCULATION, V83, P438, DOI 10.1161/01.CIR.83.2.438; Boger RH, 1998, J AM COLL CARDIOL, V32, P1336, DOI 10.1016/S0735-1097(98)00375-1; Brass EP, 2001, AM J PHYSIOL-HEART C, V280, pH603, DOI 10.1152/ajpheart.2001.280.2.H603; Brass EP, 2000, VASC MED, V5, P55, DOI 10.1177/1358836X0000500109; BREVETTI G, 1995, J AM COLL CARDIOL, V26, P1411, DOI 10.1016/0735-1097(95)00344-4; Brevetti G, 1999, J AM COLL CARDIOL, V34, P1618, DOI 10.1016/S0735-1097(99)00373-3; BREVETTI G, 1992, EUR HEART J, V13, P251, DOI 10.1093/oxfordjournals.eurheartj.a060155; Buchwald H, 1996, SURGERY, V120, P672, DOI 10.1016/S0039-6060(96)80016-X; Clark AL, 1999, QJM-INT J MED, V92, P219, DOI 10.1093/qjmed/92.4.219; COFFMAN JD, 1979, NEW ENGL J MED, V300, P713; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P159, DOI [10.1136/bmj.308.6922.159, DOI 10.1136/BMJ.308.6922.159]; Cone J, 1999, J CARDIOVASC PHARM, V34, P497, DOI 10.1097/00005344-199910000-00004; Creasy T S, 1990, Eur J Vasc Surg, V4, P135, DOI 10.1016/S0950-821X(05)80427-X; CRIQUI MH, 1985, CIRCULATION, V71, P510, DOI 10.1161/01.CIR.71.3.510; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Dawson DL, 2000, AM J MED, V109, P523, DOI 10.1016/S0002-9343(00)00569-6; Dawson DL, 1998, CIRCULATION, V98, P678, DOI 10.1161/01.CIR.98.7.678; De Giorgio L, 2000, NEW ENGL J MED, V342, P1376; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Diehm C, 1997, J VASC SURG, V25, P537, DOI 10.1016/S0741-5214(97)70265-9; Dormandy J, 1999, Semin Vasc Surg, V12, P142; Elam MB, 2000, JAMA-J AM MED ASSOC, V284, P1263, DOI 10.1001/jama.284.10.1263; ERNST E, 1994, ANGIOLOGY, V45, P339, DOI 10.1177/000331979404500502; Ernst E, 1997, CIRCULATION, V96, P1031; Food and Drug Administration, 1998, FED REGISTER, V63, P56802; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; FROHLICH ED, 1969, J AMER MED ASSOC, V208, P2471; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Girolami B, 1999, THROMB HAEMOSTASIS, V81, P715; Girolami B, 1999, ARCH INTERN MED, V159, P337, DOI 10.1001/archinte.159.4.337; GOLDHABER SZ, 1992, LANCET, V340, P143, DOI 10.1016/0140-6736(92)93216-A; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HANKEY G, 2000, COCHRANE DATABASE SY, V2; HEINTZEN MP, 1994, EUR HEART J, V15, P2, DOI 10.1093/eurheartj/15.suppl_C.2; HIATT WR, 1994, CIRCULATION, V90, P1866, DOI 10.1161/01.CIR.90.4.1866; HIATT WR, 1987, J APPL PHYSIOL, V62, P2383, DOI 10.1152/jappl.1987.62.6.2383; HIATT WR, 1990, CIRCULATION, V81, P602, DOI 10.1161/01.CIR.81.2.602; HIATT WR, 1992, J APPL PHYSIOL, V73, P346, DOI 10.1152/jappl.1992.73.1.346; Hiatt WR, 1996, J APPL PHYSIOL, V81, P780, DOI 10.1152/jappl.1996.81.2.780; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; HIATT WR, 1985, CIRCULATION, V72, P1226, DOI 10.1161/01.CIR.72.6.1226; Hood SC, 1996, CAN MED ASSOC J, V155, P1053; Hsia J, 2000, CIRCULATION, V102, P2228; IGAWA T, 1990, THROMB RES, V57, P617, DOI 10.1016/0049-3848(90)90079-R; IMPARATO AM, 1975, SURGERY, V78, P795; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; JANZON L, 1990, J INTERN MED, V227, P301, DOI 10.1111/j.1365-2796.1990.tb00164.x; JANZON L, 1990, J INTERN MED, V228, P659; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Khaira HS, 1996, EUR J VASC ENDOVASC, V11, P65, DOI 10.1016/S1078-5884(96)80136-5; Khan F, 1997, ADV EXP MED BIOL, V428, P49; Kirk G, 1999, VASC MED, V4, P23, DOI 10.1177/1358836X9900400104; KLEIJEN J, 2001, COCHRANE LIB; Kohda N, 1999, THROMB RES, V96, P261, DOI 10.1016/S0049-3848(99)00109-7; KORNITZER M, 1995, ANGIOLOGY, V46, P211, DOI 10.1177/000331979504600304; Kroon AA, 1996, ANN INTERN MED, V125, P945, DOI 10.7326/0003-4819-125-12-199612150-00001; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; LEHERT P, 1994, J CARDIOVASC PHARM, V23, pS48, DOI 10.1097/00005344-199406030-00010; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; LENG GC, 2001, COCHRANE LIB; LEWIS B, 1985, ACTA MED SCAND, P53; Lievre M, 1996, J CARDIOVASC PHARM, V27, P788, DOI 10.1097/00005344-199606000-00004; Lievre M, 2000, CIRCULATION, V102, P426; LINDGARDE F, 1989, CIRCULATION, V80, P1549, DOI 10.1161/01.CIR.80.6.1549; LUNDGREN F, 1989, ANN SURG, V209, P346, DOI 10.1097/00000658-198903000-00016; McDermott MM, 1997, J GEN INTERN MED, V12, P209, DOI 10.1046/j.1525-1497.1997.012004209.x; McDermott MM, 1999, J GEN INTERN MED, V14, P173, DOI 10.1046/j.1525-1497.1999.00309.x; MCKENNA M, 1991, ATHEROSCLEROSIS, V87, P119, DOI 10.1016/0021-9150(91)90014-T; Meijer WT, 1998, ARTERIOSCL THROM VAS, V18, P185, DOI 10.1161/01.ATV.18.2.185; Money SR, 1998, J VASC SURG, V27, P267, DOI 10.1016/S0741-5214(98)70357-X; MOODY AP, 1994, J CARDIOVASC PHARM, V23, pS44; Nehler MR, 1999, ANN VASC SURG, V13, P109, DOI 10.1007/s100169900228; NEWMAN AB, 1991, J CLIN EPIDEMIOL, V44, P15, DOI 10.1016/0895-4356(91)90196-G; Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Norgren L, 1990, Eur J Vasc Surg, V4, P463, DOI 10.1016/S0950-821X(05)80784-4; OHARA J, 1988, BRIT J CLIN PRACT, V42, P377; ORCHARD TJ, 1993, CIRCULATION, V88, P819, DOI 10.1161/01.CIR.88.2.819; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Pedersen TR, 1998, AM J CARDIOL, V81, P333, DOI 10.1016/S0002-9149(97)00904-1; Peters H, 1998, VASA-J VASCULAR DIS, V27, P106; PORTER JM, 1982, AM HEART J, V104, P66, DOI 10.1016/0002-8703(82)90642-1; PRICE JF, 2001, COCHRANE LIB; QUICK CRG, 1982, BRIT J SURG, V69, pS24, DOI 10.1002/bjs.1800691309; RADACK K, 1990, ANN INTERN MED, V113, P135, DOI 10.7326/0003-4819-113-2-135; RADACK K, 1991, ARCH INTERN MED, V151, P1769, DOI 10.1001/archinte.151.9.1769; Regensteiner JG, 1996, J VASC SURG, V23, P104, DOI 10.1016/S0741-5214(05)80040-0; Regensteiner JG, 1997, ANGIOLOGY, V48, P291, DOI 10.1177/000331979704800402; ROSE GA, 1968, WHO MONOGRAPH SERIES, V56; Sachdev GP, 1999, AM J HEALTH-SYST PH, V56, P1505, DOI 10.1093/ajhp/56.15.1505; SAMLASKA CP, 1994, J AM ACAD DERMATOL, V30, P603, DOI 10.1016/S0190-9622(94)70069-9; SCHROLL M, 1981, J CHRON DIS, V34, P261, DOI 10.1016/0021-9681(81)90031-X; SOLOMON SA, 1991, BRIT MED J, V303, P1100, DOI 10.1136/bmj.303.6810.1100; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Timaran CH, 2000, J VASC SURG, V32, P506, DOI 10.1067/mva.2000.108641; TRUBESTEIN G, 1984, ANGIOLOGY, V35, P701, DOI 10.1177/000331978403501103; TRUBESTEIN G, 1984, ANGIOLOGY, V35, P500, DOI 10.1177/000331978403500805; Tsuchikane E, 1999, CIRCULATION, V100, P21, DOI 10.1161/01.CIR.100.1.21; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Severe Limb-Ischaemia Study Group, 1991, EUR J VASCULAR SURG, V5, P511; VERSTRAETE M, 1989, BRIT MED J, V298, P424; Violi F, 2000, THROMB HAEMOSTASIS, V83, P672; VOGT MT, 1994, J AM GERIATR SOC, V42, P923, DOI 10.1111/j.1532-5415.1994.tb06581.x; VOGT MT, 1993, JAMA-J AM MED ASSOC, V270, P465, DOI 10.1001/jama.270.4.465; VOGT MT, 1993, J AM GERIATR SOC, V41, P523, DOI 10.1111/j.1532-5415.1993.tb01889.x; WALLDIUS G, 1994, AM J CARDIOL, V74, P875, DOI 10.1016/0002-9149(94)90579-7; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Westendorp ICD, 2000, ARCH INTERN MED, V160, P2498, DOI 10.1001/archinte.160.16.2498; Yusuf S, 2000, NEW ENGL J MED, V342, P145; ZETTERQUIST S, 1970, SCAND J CLIN LAB INV, V25, P101, DOI 10.3109/00365517009046196; Zheng ZJ, 1997, ATHEROSCLEROSIS, V131, P115, DOI 10.1016/S0021-9150(97)06089-9; 1989, BMJ, V298, P644; 1989, CIRCULATION, V89, P1544	130	770	852	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1608	1621		10.1056/NEJM200105243442108	http://dx.doi.org/10.1056/NEJM200105243442108			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372014				2022-12-28	WOS:000168829700008
J	Hrobjartsson, A; Gotzsche, PC				Hrobjartsson, A; Gotzsche, PC			Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ELECTRICAL NERVE-STIMULATION; RANDOMIZED CONTROLLED TRIAL; COGNITIVE-BEHAVIOR THERAPY; LOW-BACK-PAIN; DOUBLE-BLIND; POSTOPERATIVE PAIN; PARADOXICAL INTENTION; RHEUMATOID-ARTHRITIS; IPRATROPIUM BROMIDE; STRESS MANAGEMENT	Background: Placebo treatments have been reported to help patients with many diseases, but the quality of the evidence supporting this finding has not been rigorously evaluated. Methods: We conducted a systematic review of clinical trials in which patients were randomly assigned to either placebo or no treatment. A placebo could be pharmacologic (e.g., a tablet), physical (e.g., a manipulation), or psychological (e.g., a conversation). Results: We identified 130 trials that met our inclusion criteria. After the exclusion of 16 trials without relevant data on outcomes, there were 32 with binary outcomes (involving 3795 patients, with a median of 51 patients per trial) and 82 with continuous outcomes (involving 4730 patients, with a median of 27 patients per trial). As compared with no treatment, placebo had no significant effect on binary outcomes, regardless of whether these outcomes were subjective or objective. For the trials with continuous outcomes, placebo had a beneficial effect, but the effect decreased with increasing sample size, indicating a possible bias related to the effects of small trials. The pooled standardized mean difference was significant for the trials with subjective outcomes but not for those with objective outcomes. In 27 trials involving the treatment of pain, placebo had a beneficial effect, as indicated by a reduction in the intensity of pain of 6.5 mm on a 100-mm visual-analogue scale. Conclusions: We found little evidence in general that placebos had powerful clinical effects. Although placebos had no significant effects on objective or binary outcomes, they had possible small benefits in studies with continuous subjective outcomes and for the treatment of pain. Outside the setting of clinical trials, there is no justification for the use of placebos. (N Engl J Med 2001;344:1594-602.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Copenhagen, Panum Inst, Dept Med Philosophy & Clin Theory, DK-2200 Copenhagen N, Denmark; Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen	Hrobjartsson, A (corresponding author), Univ Copenhagen, Panum Inst, Dept Med Philosophy & Clin Theory, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.							ADRIAANSE AH, 1995, EUR J OBSTET GYN R B, V61, P135, DOI 10.1016/0301-2115(95)02134-S; Altman D. G., 1991, PRACTICAL STAT MED R, DOI [10.1201/9780429258589, DOI 10.1201/9780429258589]; Altman DG, 1991, PRACTICAL STAT MED R, P179; Andersen AN, 1990, ACTA OBSTET GYN SCAN, V69, P235, DOI 10.3109/00016349009028686; ANTIVALLE M, 1990, J HUM HYPERTENS, V4, P633; ASCHER LM, 1979, BEHAV RES THER, V17, P408, DOI 10.1016/0005-7967(79)90015-9; Aune Audun, 1998, Tidsskrift for den Norske Laegeforening, V118, P1370; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Benedetti F, 1997, ANN THORAC SURG, V63, P773, DOI 10.1016/S0003-4975(96)01249-0; BENEDETTI F, 1995, LANCET, V346, P1231, DOI 10.1016/S0140-6736(95)92938-X; BERG I, 1983, J CHILD PSYCHOL PSYC, V24, P543, DOI 10.1111/j.1469-7610.1983.tb00131.x; BLACKMAN S, 1964, AM J PSYCHIAT, V120, P1194, DOI 10.1176/ajp.120.12.1194; BLOCK J, 1980, PSYCHOTHER-THEOR RES, V17, P277, DOI 10.1037/h0085923; BOSLEY F, 1989, J BEHAV MED, V12, P77, DOI 10.1007/BF00844750; BRAMSTON P, 1985, BEHAV RES THER, V23, P239, DOI 10.1016/0005-7967(85)90001-4; Brown WA, 1998, SCI AM, V278, P90, DOI 10.1038/scientificamerican0198-90; Canino Evelyn, 1994, Acta Cientifica Venezolana, V45, P23; Chenard J, 1991, SCI COMPORTEMENT, V21, P225; CLASSEN W, 1983, NEUROPSYCHOBIOLOGY, V10, P44, DOI 10.1159/000117982; *COCHR CONS COMM G, 1999, COCHR LIB; CONN IG, 1986, ANN ROY COLL SURG, V68, P191; Coyne P J, 1995, J Intraven Nurs, V18, P263; CROSBY L, 1994, HEART LUNG, V23, P493; DAVIDSON AM, 1980, BEHAV RES THER, V18, P1, DOI 10.1016/0005-7967(80)90063-7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESAINTONGE DMC, 1994, LANCET, V344, P995, DOI 10.1016/S0140-6736(94)91647-0; DIAMOND L, 1995, J ALLERGY CLIN IMMUN, V95, P1139, DOI 10.1016/S0091-6749(95)70219-9; DOUBLE DB, 1993, ACTA PSYCHIAT SCAND, V88, P381, DOI 10.1111/j.1600-0447.1993.tb03477.x; DUNDEE JW, 1986, BRIT MED J, V293, P583, DOI 10.1136/bmj.293.6547.583; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELLIOTT CH, 1978, J CONSULT CLIN PSYCH, V46, P1330, DOI 10.1037/0022-006X.46.6.1330; ERNST E, 1995, BMJ-BRIT MED J, V311, P551, DOI 10.1136/bmj.311.7004.551; ESPIE CA, 1989, BEHAV RES THER, V27, P79, DOI 10.1016/0005-7967(89)90123-X; FAAS A, 1993, SPINE, V18, P1388; FORSTER EL, 1994, CHEST, V106, P1343, DOI 10.1378/chest.106.5.1343; FRANK E, 1990, ARCH GEN PSYCHIAT, V47, P1093; FRANKEL BL, 1978, PSYCHOSOM MED, V40, P276, DOI 10.1097/00006842-197806000-00002; Frega A., 1994, Clinical and Experimental Obstetrics and Gynecology, V21, P188; FUCHS CZ, 1977, J CONSULT CLIN PSYCH, V45, P206, DOI 10.1037/0022-006X.45.2.206; GODFREY S, 1973, J PSYCHOSOM RES, V17, P293, DOI 10.1016/0022-3999(73)90106-2; Goodenough B, 1997, PAIN, V72, P383, DOI 10.1016/S0304-3959(97)00062-6; GOTZSCHE PC, 1994, LANCET, V344, P925; GOTZSCHE PC, 1991, J CLIN EPIDEMIOL, V44, P613; GOTZSCHE PC, 1990, J CLIN EPIDEMIOL, V43, P1313; GRACELY RH, 1983, NATURE, V306, P264, DOI 10.1038/306264a0; GRECHO (Groupe de Recherches et d'Essais Cliniques en Homeopathie), 1989, PRESSE MED, V18, P59; GUGLIELMI RS, 1982, BIOFEEDBACK SELF-REG, V7, P99; HALL SM, 1974, J CONSULT CLIN PSYCH, V42, P781, DOI 10.1037/h0037575; HANSON RW, 1976, BEHAV THER, V7, P366, DOI 10.1016/S0005-7894(76)80065-2; HARGREAVES A, 1989, NURS RES, V38, P159; HARRISON RF, 1975, LANCET, V1, P605; HASHISH I, 1988, PAIN, V33, P303, DOI 10.1016/0304-3959(88)90289-8; HASHISH I, 1986, BRIT J RHEUMATOL, V25, P77; HAWKINS PJ, 1995, PSYCHO-ONCOLOGY, V4, P101, DOI 10.1002/pon.2960040203; Hayden FG, 1996, ANN INTERN MED, V125, P89, DOI 10.7326/0003-4819-125-2-199607150-00002; Hedges LV., 1985, STAT METHODS META AN, P76, DOI [10.1016/B978-0-08-057065-5.50010-5, DOI 10.1016/B978-0-08-057065-5.50010-5]; HEINZL S, 1981, GYNECOL OBSTET INVES, V12, P29, DOI 10.1159/000299565; HELMS JM, 1987, OBSTET GYNECOL, V69, P51; Hong C.Z., 1993, J MUSCULOSKELET PAIN, V1, P37, DOI [10.1300/J094v01n02_04, DOI 10.1300/J094V01N02_04]; Hrobjartsson A, 1996, EUR J CLIN PHARMACOL, V50, P345, DOI 10.1007/s002280050120; HROBJARTSSON A, 1999, COCHRANE LIB; HUTTON N, 1991, J PEDIATR-US, V118, P125, DOI 10.1016/S0022-3476(05)81865-7; HYMAN GJ, 1986, ADDICT BEHAV, V11, P355, DOI 10.1016/0306-4603(86)90014-6; Irvin JH, 1996, J PSYCHOSOM OBST GYN, V17, P202, DOI 10.3109/01674829609025684; JACOBS MA, 1971, PSYCHOSOM MED, V33, P545, DOI 10.1097/00006842-197111000-00007; JACOBSON NS, 1978, J CONSULT CLIN PSYCH, V46, P442, DOI 10.1037/0022-006X.46.3.442; Karunakaran S, 1997, METABOLISM, V46, P56, DOI 10.1016/S0026-0495(97)90319-X; KENDALL PC, 1979, J CONSULT CLIN PSYCH, V47, P49, DOI 10.1037/0022-006X.47.1.49; Kienle GS, 1997, J CLIN EPIDEMIOL, V50, P1311, DOI 10.1016/S0895-4356(97)00203-5; KILLEN JD, 1990, J CONSULT CLIN PSYCH, V58, P85, DOI 10.1037/0022-006X.58.1.85; KLERMAN GL, 1974, AM J PSYCHIAT, V131, P186, DOI 10.1176/ajp.131.2.186; LANDER J, 1993, PAIN, V52, P209, DOI 10.1016/0304-3959(93)90133-A; LASAGNA L, 1986, J ALLERGY CLIN IMMUN, V78, P161, DOI 10.1016/0091-6749(86)90008-4; LEVINE JD, 1984, NATURE, V312, P755, DOI 10.1038/312755a0; LICK J, 1975, J CONSULT CLIN PSYCH, V43, P557, DOI 10.1037/h0076894; LICK JR, 1977, J CONSULT CLIN PSYCH, V45, P153, DOI 10.1037/0022-006X.45.2.153; Linde K, 1998, LANCET, V351, P220; Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9; Lindholm LH, 1996, J INTERN MED, V240, P13, DOI 10.1046/j.1365-2796.1996.492831000.x; LONGO DJ, 1988, J CONSULT CLIN PSYCH, V56, P61; LORR M, 1961, ARCH GEN PSYCHIAT, V4, P381; Macaluso AD, 1996, ANESTH ANALG, V82, P158, DOI 10.1097/00000539-199601000-00029; MALCOLM RE, 1980, PSYCHOPHARMACOLOGY, V70, P295, DOI 10.1007/BF00427889; MARKLAND D, 1993, BRIT J CLIN PSYCHOL, V32, P493, DOI 10.1111/j.2044-8260.1993.tb01085.x; MAY O, 1988, EUR RESPIR J, V1, P527; MCLACHLAN DRC, 1991, LANCET, V337, P1618; MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B; MCMILLAN CM, 1994, PHYSIOTHERAPY, V80, P5; Moffett JAK, 1996, PAIN, V67, P121, DOI 10.1016/0304-3959(96)03100-4; MORTON AR, 1993, ANN ALLERGY, V70, P295; MURPHY JK, 1982, BEHAV THER, V13, P681, DOI 10.1016/S0005-7894(82)80024-5; Najnigier B., 1997, ACTA ENDOSCOPICA POL, V7, P125; NANDI DN, 1976, BRIT J PSYCHIAT, V128, P523, DOI 10.1192/bjp.128.6.523; Nawrocki JD, 1997, BRIT J UROL, V79, P389, DOI 10.1046/j.1464-410X.1997.21515.x; NICASSIO P, 1974, J ABNORM PSYCHOL, V83, P253, DOI 10.1037/h0036729; NOCELLA J, 1982, Journal of Pediatric Psychology, V7, P175, DOI 10.1093/jpepsy/7.2.175; OBrien B, 1996, AM J OBSTET GYNECOL, V174, P708, DOI 10.1016/S0002-9378(96)70454-4; OH VMS, 1994, BRIT MED J, V309, P69, DOI 10.1136/bmj.309.6947.69; Parker JC, 1995, ARTHRITIS RHEUM, V38, P1807, DOI 10.1002/art.1780381214; PELHAM WE, 1992, J CONSULT CLIN PSYCH, V60, P282, DOI 10.1037/0022-006X.60.2.282; QUAYHAGEN MP, 1995, NURS RES, V44, P153; RABKIN JG, 1990, AM J PSYCHIAT, V147, P1622; Rawlinson MC, 1985, PLACEBO THEORY RES M, P403; READING AE, 1982, J CLIN PSYCHOL, V38, P504, DOI 10.1002/1097-4679(198207)38:3<504::AID-JCLP2270380307>3.0.CO;2-8; ROSEN GM, 1976, J CONSULT CLIN PSYCH, V44, P208, DOI 10.1037/0022-006X.44.2.208; ROSSI A, 1982, INT J CLIN PHARM TH, V20, P438; ROUGHAN PA, 1981, J SEX MARITAL THER, V7, P223, DOI 10.1080/00926238108405806; Rowbotham MC, 1996, PAIN, V65, P39, DOI 10.1016/0304-3959(95)00146-8; RYBARCZYK BD, 1990, GERONTOLOGIST, V30, P522, DOI 10.1093/geront/30.4.522; SANDERS GE, 1990, J MANIP PHYSIOL THER, V13, P391; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SEER P, 1980, Journal of Behavioral Medicine, V3, P59, DOI 10.1007/BF00844914; SENEDIAK C, 1985, BEHAV PSYCHOTHER, V13, P265, DOI 10.1017/S0141347300012027; SIPICH JF, 1974, J BEHAV THER EXP PSY, V5, P201, DOI 10.1016/0005-7916(74)90115-3; SPANOS NP, 1995, CONT HYPNOSIS, V12, P12; SPROTT H, 1993, AKTUEL RHEUMATOL, V18, P132, DOI 10.1055/s-2008-1047326; STABHOLZ A, 1991, Clinical Preventive Dentistry, V13, P9; STEWART JE, 1991, J CLIN PERIODONTOL, V18, P219, DOI 10.1111/j.1600-051X.1991.tb00418.x; STRANSKY M, 1989, SOUTHERN MED J, V82, P841, DOI 10.1097/00007611-198907000-00011; TAN SY, 1982, BEHAV RES THER, V20, P535, DOI 10.1016/0005-7967(82)90031-6; TAN SY, 1986, EPILEPSIA, V27, P225, DOI 10.1111/j.1528-1157.1986.tb03533.x; Tarrier N, 1998, BRIT MED J, V317, P303, DOI 10.1136/bmj.317.7154.303; THEROUX MC, 1993, PEDIATRICS, V91, P624; THOMAS KB, 1987, BRIT MED J, V294, P1200, DOI 10.1136/bmj.294.6581.1200; TREMEAU M L, 1992, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V21, P375; TUOMILEHTO J, 1980, ACTA MED SCAND, V208, P45; TURNER RM, 1979, J CONSULT CLIN PSYCH, V47, P500, DOI 10.1037/0022-006X.47.3.500; TYLER DB, 1946, AM J PHYSIOL, V146, P458, DOI 10.1152/ajplegacy.1946.146.3.458; Vlaeyen JWS, 1996, J RHEUMATOL, V23, P1237; WALTON RE, 1993, J ENDODONT, V19, P466, DOI 10.1016/S0099-2399(06)80535-2; WATZL H, 1986, Z KLIN PSYCHOL-FORSC, V15, P333; WEINGAER.AH, 1971, J CONSULT CLIN PSYCH, V36, P422, DOI 10.1037/h0031134; WHITTAKER CB, 1963, BRIT J PSYCHIAT, V109, P422, DOI 10.1192/bjp.109.460.422; WILLIAMS JM, 1988, ADDICT BEHAV, V13, P205, DOI 10.1016/0306-4603(88)90014-7; WILSON A, 1980, J STUD ALCOHOL, V41, P429, DOI 10.15288/jsa.1980.41.429; WOJCIECHOWSKI FL, 1984, GEDRAG GEZOND, V12, P16; YATES RG, 1988, J MANIP PHYSIOL THER, V11, P484	137	1025	1058	0	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1594	1602		10.1056/NEJM200105243442106	http://dx.doi.org/10.1056/NEJM200105243442106			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434RM	11372012	Bronze			2022-12-28	WOS:000168829700006
J	Ponticelli, C; Aroldi, A				Ponticelli, C; Aroldi, A			Osteoporosis after organ transplantation	LANCET			English	Letter							RENAL-TRANSPLANTATION; REGIMENS		IRCCS Osped Maggiore Milano, Div Nefrol & Dialisi, I-20122 Milan, Italy		Ponticelli, C (corresponding author), IRCCS Osped Maggiore Milano, Div Nefrol & Dialisi, Via Commenda 15, I-20122 Milan, Italy.							Aroldi A, 1997, TRANSPLANTATION, V63, P380, DOI 10.1097/00007890-199702150-00009; Kahan BD, 1998, TRANSPLANTATION, V66, P1040, DOI 10.1097/00007890-199810270-00013; Leidig-Bruckner G, 2001, LANCET, V357, P342, DOI 10.1016/S0140-6736(00)03641-2; Ponticelli C, 1997, J AM SOC NEPHROL, V8, P638; Shapiro R, 1998, TRANSPLANT P, V30, P1375, DOI 10.1016/S0041-1345(98)00280-2	5	31	35	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1623	1623		10.1016/S0140-6736(00)04765-6	http://dx.doi.org/10.1016/S0140-6736(00)04765-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11386321				2022-12-28	WOS:000168830100050
J	Daily, GC				Daily, GC			Ecological forecasts	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, Stanford, CA 94305 USA	Stanford University	Daily, GC (corresponding author), Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, 371 Serra Mall, Stanford, CA 94305 USA.							[Anonymous], 1997, NATURES SERVICES; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; MYERS N, IN PRESS FUTURE COUR; SALZMAN J, IN PRESS STANFORD EN	4	126	134	0	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					245	245		10.1038/35077178	http://dx.doi.org/10.1038/35077178			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357107				2022-12-28	WOS:000168710000024
J	Retallack, GJ				Retallack, GJ			A 300-million-year record of atmospheric carbon dioxide from fossil plant cuticles	NATURE			English	Article							CO2 CONCENTRATIONS; BOUNDARY; PALEOCLIMATE; AUSTRALIA; GERMANY; CLIMATE	To understand better the link between atmospheric CO2 concentrations and climate over geological time, records of past CO2 are reconstructed from geochemical proxies(1-4). Although these records have provided us with a broad picture of CO2 variation throughout the Phanerozoic eon (the past 544 Myr), inconsistencies and gaps remain that still need to be resolved. Here I present a continuous 300-Myr record of stomatal abundance from fossil leaves of four genera of plants that are closely related to the present-day Ginkgo tree. Using the known relationship between leaf stomatal abundance and growing season CO2 concentrations(5,6), I reconstruct past atmospheric CO2 concentrations. For the past 300 Myr, only two intervals of low CO2 (<1,000 p.p.m.v.) are inferred, both of which coincide with known ice ages in Neogene (1-8 Myr) and early Permian (275- 290 Myr) times. But for most of the Mesozoic era (65-250 Myr), CO2 levels were high (1,000-2,000 p.p.m.v.), with transient excursions to even higher CO2 (>2,000 p.p.m.v.) concentrations. These results are consistent with some reconstructions of past CO2 (refs 1, 2) and palaeotemperature records(7), but suggest that CO2 reconstructions based on carbon isotope proxies(3,4) may be compromised by episodic outbursts of isotopically light methane(8,9). These results support the role of water vapour, methane and CO2 in greenhouse climate warming over the past 300 Myr.	Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA	University of Oregon	Retallack, GJ (corresponding author), Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA.							[Anonymous], PALAEOFLORA SO AFRIC; Arens NC, 2000, PALAIOS, V15, P314, DOI 10.2307/3515539; Beerling DJ, 1998, J EXP BOT, V49, P1603, DOI 10.1093/jexbot/49.326.1603; BERNER RA, 1997, SCIENCE, V276, P543; Cowling SA, 1999, SCIENCE, V285, P1500, DOI 10.1126/science.285.5433.1500; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; FLORIN R., 1931, KUNGLIGA SVENSKA VET, V10, P1; Gomankov A.V., 1986, TATARINOVAYA FLORA S, P401; GRADSTEIN FM, 1995, SEPM SPEC PUBL, V54, P95; Jahren AH, 2001, GEOLOGY, V29, P159, DOI 10.1130/0091-7613(2001)029<0159:TROMHD>2.0.CO;2; Khalil MAK, 2000, ATMOSPHERIC METHANE, P86; Krull ES, 2000, NEW ZEAL J GEOL GEOP, V43, P21, DOI 10.1080/00288306.2000.9514868; Kurschner WM, 1996, MAR MICROPALEONTOL, V27, P299, DOI 10.1016/0377-8398(95)00067-4; Lemarchand D, 2000, NATURE, V408, P951, DOI 10.1038/35050058; McElwain JC, 1996, PALAIOS, V11, P376, DOI 10.2307/3515247; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McGowran B, 1997, MICROPALEONTOLOGY, V43, P129, DOI 10.2307/1485778; Meyen S.V., 1987, FUNDAMENTALS PALAEOB; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Palfy J, 2000, GEOLOGY, V28, P39, DOI 10.1130/0091-7613(2000)28<39:TTEMEF>2.0.CO;2; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Retallack GJ, 1999, GEOL SOC AM BULL, V111, P52, DOI 10.1130/0016-7606(1999)111<0052:PGPRBE>2.3.CO;2; RETALLACK GJ, 2000, GEOL SOC AM SPEC PAP, V344, P1, DOI DOI 10.1130/0-8137-2344-21; RETALLACK GJ, 1997, COLOUR GUIDE PALEOSO, P117; ROYER DL, 2000, GEOL SOC AM ABSTR, V32, pA196; Schwarz T, 1997, PALAEOGEOGR PALAEOCL, V129, P37, DOI 10.1016/S0031-0182(96)00065-X; Thomas Ellen, 2000, P132; Utescher T, 2000, PALAIOS, V15, P430, DOI 10.2307/3515514; VAKRAMEEV VA, 1991, JURASSIC CRETACEOUS, P53; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044	30	302	346	3	130	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					287	290		10.1038/35077041	http://dx.doi.org/10.1038/35077041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357126				2022-12-28	WOS:000168710000041
J	Sukhatme, K; Mukharsky, Y; Chui, T; Pearson, D				Sukhatme, K; Mukharsky, Y; Chui, T; Pearson, D			Observation of the ideal Josephson effect in superfluid He-4	NATURE			English	Article							ANALOG	Superfluids and superconductors are the only states of condensed matter that can be described by a single wavefunction, with a coherent quantum phase Phi. The mass flow in a superfluid can be described by classical hydrodynamics for small flow velocity, but above a critical velocity, quantized vortices are created and the classical picture breaks down. This can be observed for a superfluid flowing through a microscopic aperture when the mass flow is measured as a function of the phase difference across the aperture; the curve resembles a hysteretic sawtooth where each jump corresponds to the creation of a vortex(1-3). When the aperture is made small enough, the system can enter the so-called 'ideal' Josephson regime(1,4), where the superfluid mass flow becomes a continuous function of the phase difference. This regime has been detected(1,5,6) in superfluid He-3, but was hitherto believed to be unobservable, owing to fluctuations(7), in He-4. Here we report the observation of the ideal Josephson effect in He-4. We study the flow of He-4 through an array of micro-apertures and observe a transition to the ideal Josephson regime as the temperature is increased towards the superfluid transition temperature, T-lambda.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Ctr Etud Saclay, Serv Phys Etat Condense, CEA, DRECAM, F-91191 Gif Sur Yvette, France	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Mukharsky, Y (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.		Mukharsky, Yury/F-4920-2013					ANDERSON PW, 1966, REV MOD PHYS, V38, P298, DOI 10.1103/RevModPhys.38.298; AVENEL O, 1994, PHYSICA B, V194, P491, DOI 10.1016/0921-4526(94)90575-4; AVENEL O, 1987, JPN J APPL PHYS 1, V26, P1798, DOI 10.7567/JJAPS.26S3.1798; Backhaus S, 1997, SCIENCE, V278, P1435, DOI 10.1126/science.278.5342.1435; BEECKEN BP, 1987, PHYS REV B, V35, P74, DOI 10.1103/PhysRevB.35.74; BOROVIKROMANOV AS, 1988, JETP LETT+, V47, P478; CLOW RJ, 1967, PHYS REV LETT, V19, P291; Day P, 1997, J LOW TEMP PHYS, V107, P359, DOI 10.1007/BF02397463; FEYNMANN RP, 1975, FEYNMAN LECT PHYSICS, V3, pCH21; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; LIFSHITZ EM, 1980, STATISTICAL PHYSIC 2, P109; LIKHAREV KK, 1979, REV MOD PHYS, V51, P101, DOI 10.1103/RevModPhys.51.101; Schwab K, 1998, J LOW TEMP PHYS, V110, P1043, DOI 10.1023/A:1022364200234; Tinkham M., 1975, INTRO SUPERCONDUCTIV; VAROQUAUX E, 1991, P NATO ADV RES WORKS, P343	15	95	98	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					280	283		10.1038/35077024	http://dx.doi.org/10.1038/35077024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357124				2022-12-28	WOS:000168710000039
J	Woolhouse, M; Chase-Topping, M; Haydon, D; Friar, J; Matthews, L; Hughes, G; Shaw, D; Wilesmith, J; Donaldson, A; Cornell, S; Keeling, M; Grenfell, B				Woolhouse, M; Chase-Topping, M; Haydon, D; Friar, J; Matthews, L; Hughes, G; Shaw, D; Wilesmith, J; Donaldson, A; Cornell, S; Keeling, M; Grenfell, B			Epidemiology - Foot-and-mouth disease under control in the UK	NATURE			English	Article									Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada; Eoscene Corp, Seattle, WA 98104 USA; AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Edinburgh; University of Guelph; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute; Veterinary Laboratories Agency; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge	Woolhouse, M (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland.		Matthews, Louise/E-2913-2013; Cornell, Stephen J/D-3955-2009; Keeling, Matt J/J-9280-2012	Matthews, Louise/0000-0003-4420-8367; Keeling, Matt J/0000-0003-4639-4765; Shaw, Darren/0000-0003-2016-1541; Haydon, Daniel/0000-0002-1240-1886				ANDERSON R M, 1991; FERGUSON N, 2001, SCIENCE         0413; Haydon DT, 1997, IMA J MATH APPL MED, V14, P1; PATIL GP, 1971, STAT ECOLOGY, V2; SELLERS RF, 1981, BRIT VET J, V137, P608, DOI 10.1016/S0007-1935(17)31539-7; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250; 2001, VET REC, V148, P390; 2001, VET REC, V148, P286	8	76	76	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					258	259		10.1038/35077149	http://dx.doi.org/10.1038/35077149			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357118				2022-12-28	WOS:000168710000033
J	Cleeman, JI; Grundy, SM; Becker, D; Clark, LT; Cooper, RS; Denke, MA; Howard, WJ; Hunninghake, DB; Illingworth, DR; Luepker, RV; McBride, P; McKenney, JM; Pasternak, RC; Stone, NJ; Van Horn, L; Brewer, HB; Ernst, ND; Gordon, D; Levy, D; Rifkind, B; Rossouw, JE; Savage, P; Haffner, SM; Orloff, DG; Proschan, MA; Schwartz, JS; Sempos, CT; Shero, ST; Murray, EZ				Cleeman, JI; Grundy, SM; Becker, D; Clark, LT; Cooper, RS; Denke, MA; Howard, WJ; Hunninghake, DB; Illingworth, DR; Luepker, RV; McBride, P; McKenney, JM; Pasternak, RC; Stone, NJ; Van Horn, L; Brewer, HB; Ernst, ND; Gordon, D; Levy, D; Rifkind, B; Rossouw, JE; Savage, P; Haffner, SM; Orloff, DG; Proschan, MA; Schwartz, JS; Sempos, CT; Shero, ST; Murray, EZ		Natl Cholesterol Educ Program Expe	Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									NHLBI, Natl Cholesterol Educ Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Cleeman, JI (corresponding author), NHLBI, Natl Cholesterol Educ Program, 31 Ctr Dr,Room 4A16,MSC 2480, Bethesda, MD 20892 USA.		Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Stone, Neil/ABB-6039-2021	Levy, Daniel/0000-0003-1843-8724; 					0	21014	22068	43	1267	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2486	2497		10.1001/jama.285.19.2486	http://dx.doi.org/10.1001/jama.285.19.2486			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429ZC	11368702				2022-12-28	WOS:000168547600031
J	Pantilat, SZ; Markowitz, AJ				Pantilat, SZ; Markowitz, AJ			Initiating end-of-life discussions with seriously ill patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article														Markowitz, Amy/0000-0001-9314-2814				Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502	1	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2906	2906		10.1001/jama.285.22.2906	http://dx.doi.org/10.1001/jama.285.22.2906			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BP	11401613				2022-12-28	WOS:000169156300031
J	Balter, M				Balter, M			Canser research - Transatlantic war over BRCA1 patent	SCIENCE			English	News Item																			0	6	6	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1818	1818		10.1126/science.292.5523.1818	http://dx.doi.org/10.1126/science.292.5523.1818			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397923				2022-12-28	WOS:000169200700010
J	Platt, FW; Gaspar, DL; Coulehan, JL; Fox, L; Adler, AJ; Weston, WW; Smith, RC; Stewart, M				Platt, FW; Gaspar, DL; Coulehan, JL; Fox, L; Adler, AJ; Weston, WW; Smith, RC; Stewart, M			"Tell me about yourself": The patient-centered interview	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PRIMARY-CARE; PATIENTS EXPECTATIONS; COMMUNICATION-SKILLS; INTERNAL-MEDICINE; GENERAL-PRACTICE; DECISION-MAKING; PHYSICIAN; HEALTH; SATISFACTION; RESIDENTS	The following article initiates a series on "Words That Make a Difference.". Developed under the sponsorship of the American Academy on Physician and Patient, the series will focus on the language physicians use when they talk with patients. Although clinicians understand how important it is to communicate effectively with patients, they often have difficulty knowing exactly what the "best words" are for making the most of each patient interaction. Drawing on careful observation and research results, the authors of this series of articles have identified words and expressions that have proven particularly powerful as tools for understanding patients and helping them manage their illnesses effectively. We are interested in knowing what readers think of the series, and in learning about other uses of language that readers have found important and helpful.	Univ Colorado, Denver, CO 80205 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA; Renal Med Associates Ltd, Albuquerque, NM USA; Brooklyn Vet Affairs Med Ctr, Brooklyn, NY 11209 USA; Univ Western Ontario, London, ON NGK 1C7, Canada; Michigan State Univ, Sch Med, E Lansing, MI 48824 USA; Ctr Studies Family Med, London, ON N6G 4X8, Canada	University of Colorado System; University of Colorado Denver; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Western University (University of Western Ontario); Michigan State University	Platt, FW (corresponding author), Univ Colorado, 1901 E 20th Ave, Denver, CO 80205 USA.			Stewart, Moira/0000-0002-5552-0762				Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; BARSKY AJ, 1981, ANN INTERN MED, V94, P492, DOI 10.7326/0003-4819-94-4-492; Bean WB, 1950, W OSLER APHORISMS, P93; BECKMAN HB, 1984, ANN INTERN MED, V101, P692, DOI 10.7326/0003-4819-101-5-692; BILLINGS JA, 1999, CLIN ENCOUNTER GUIDE; Braddock CH, 1997, J GEN INTERN MED, V12, P339, DOI 10.1046/j.1525-1497.1997.00057.x; BRODY DS, 1980, ANN INTERN MED, V93, P718, DOI 10.7326/0003-4819-93-5-718; BROWN JB, 1989, CAN FAM PHYSICIAN, V35, P153; BROWNE K, 1976, DOCTOR PATIENT RELAT; Broyard, 1992, INTOXICATED MY ILLNE; Brummel-Smith K., 1996, INTERVIEWING PATIENT; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; Cassell EJ, 1991, NATURE SUFFERING GOA; Cohen-Cole SA, 1991, MED INTERVIEW 3 FUNC; COULEHAN JL, 1995, LIT MED, V14, P222, DOI 10.1353/lm.1995.0027; COULEHAN JL, 1997, MED INTERVIEW MASTER, P81; DELBANCO TL, 1992, ANN INTERN MED, V116, P414, DOI 10.7326/0003-4819-116-5-414; DIMATTEO MR, 1997, BEHAV MED PRIMARY CA; EVANS BJ, 1991, MED EDUC, V25, P517, DOI 10.1111/j.1365-2923.1991.tb00105.x; Flores G, 2000, J PEDIATR-US, V136, P14, DOI 10.1016/S0022-3476(00)90043-X; FRANK A, 1991, WILL BODY RELFECTION; Frank AW., 2013, WOUNDED STORYTELLER; FRANKEL RM, 1994, COMMUNICATION PATIEN; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; Greenhalgh T, 1999, BRIT MED J, V318, P48; Gross DA, 1998, J FAM PRACTICE, V47, P133; HALL JA, 1981, J HEALTH SOC BEHAV, V22, P18, DOI 10.2307/2136365; HEYMANN J, 1995, EQUAL PARTNERS PHYSI; Johnson T. M., 1995, MED INTERVIEW CLIN C, P153; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; KLEINMAN A, 1988, ILLNESS NARRATIVES S, V14, P3; KRAVITZ RL, 1994, J GEN INTERN MED, V9, P75, DOI 10.1007/BF02600205; Kravitz RL, 1996, ANN INTERN MED, V125, P730, DOI 10.7326/0003-4819-125-9-199611010-00004; Langewitz WA, 1998, PSYCHOSOM MED, V60, P268, DOI 10.1097/00006842-199805000-00009; LARSEN KM, 1981, J FAM PRACTICE, V12, P481; Launer J, 1999, BRIT MED J, V318, P117, DOI 10.1136/bmj.318.7176.117; LAZARE A, 1975, ARCH GEN PSYCHIAT, V32, P553; Levinson W, 2000, JAMA-J AM MED ASSOC, V284, P1021, DOI 10.1001/jama.284.8.1021; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Like R C, 1996, Fam Med, V28, P291; Lipp M. R., 1986, RESPECTFUL TREATMENT; Loxterkamp D, 1991, J Am Board Fam Pract, V4, P354; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283; MCWHINNEY IR, 1997, TXB FAMILY MED, P83; MISHLER EG, 1984, DISCOURSE MED DIALEC, P137; Molde S, 1985, Image J Nurs Sch, V17, P72; Montgomery Hunter K, 1991, DOCTORS STORIES NARR; PLATT FW, 1979, ANN INTERN MED, V91, P898, DOI 10.7326/0003-4819-91-6-898; PLATT FW, 1999, FIELD GUIDE DIFFICUL; PLATT FW, 1995, CONVERSATION REPAIR, P59; PLATT FW, 1905, CONVERSATION REPAIR, P1; PLATT FW, 1992, CONVERSATION FAILURE; PUTNAM SM, 1995, MED INTERVIEW CLIN C; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; QUILL TE, 1983, ANN INTERN MED, V98, P228, DOI 10.7326/0003-4819-98-2-228; Realini T, 1995, Arch Fam Med, V4, P1028, DOI 10.1001/archfami.4.12.1028; Rogers CR., 1951, CLIENT CENT THER; Roter D.L., 1992, DOCTORS TALKING PATI; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; SACKS O, 1993, LEG STAND ON; SANCHEZMENEGAY C, 1994, J GEN INTERN MED, V9, P404, DOI 10.1007/BF02629524; SILVERMAN J, 1998, SKILLS COMMUNICATING, P71; SIMPSON M, 1991, BMJ-BRIT MED J, V303, P1387; SMITH RC, 1991, ANN INTERN MED, V115, P470, DOI 10.7326/0003-4819-115-6-470; Smith RC, 1998, ANN INTERN MED, V128, P118, DOI 10.7326/0003-4819-128-2-199801150-00008; Smith RC, 1996, PATIENTS STORY INTEG; SMYTH FS, 1962, J MED EDUC, V37, P495; STARFIELD B, 1981, AM J PUBLIC HEALTH, V71, P127, DOI 10.2105/AJPH.71.2.127; Steiner JF, 2000, ANN INTERN MED, V132, P926, DOI 10.7326/0003-4819-132-11-200006060-00026; STEWART M, 1989, CAN FAM PHYSICIAN, V35, P159; Stewart M, 1999, Cancer Prev Control, V3, P25; Stewart M., 1995, PATIENT CTR MED TRAN; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Stoeckle John D., 1995, MED INTERVIEW CLIN C, P147; Suchman AL, 1997, JAMA-J AM MED ASSOC, V277, P678, DOI 10.1001/jama.277.8.678; Tresolini C. P., 1994, HLTH PROFESSIONS ED; WESTON WW, 1989, CAN FAM PHYSICIAN, V35, P147; Williams S, 1998, FAM PRACT, V15, P480, DOI 10.1093/fampra/15.5.480; 1995, CONSUMER REPORTS, V60, P81	79	77	80	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2001	134	11					1079	1085		10.7326/0003-4819-134-11-200106050-00020	http://dx.doi.org/10.7326/0003-4819-134-11-200106050-00020			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YL	11388827				2022-12-28	WOS:000168963400013
J	Costa, E; Soffitta, P; Bellazzini, R; Brez, A; Lumb, N; Spandre, G				Costa, E; Soffitta, P; Bellazzini, R; Brez, A; Lumb, N; Spandre, G			An efficient photoelectric X-ray polarimeter for the study of black holes and neutron stars	NATURE			English	Article							POLARIZATION PROPERTIES; ACCRETION DISKS; RADIATION; EMISSION	The study of astronomical objects using electromagnetic radiation involves four basic observational approaches: imaging, spectroscopy, photometry (accurate counting of the photons received) and polarimetry (measurement of the polarizations of the observed photons). In contrast to observations at other wavelengths, a lack of sensitivity has prevented X-ray astronomy from making use of polarimetry. Yet such a technique could provide a direct picture of the state of matter in extreme magnetic and gravitational fields(1-6), and has the potential to resolve the internal structures of compact sources that would otherwise remain inaccessible, even to X-ray interferometry(7). In binary pulsars, for example, we could directly 'see' the rotation of the magnetic field and determine if the emission is in the form of a 'fan' or a 'pencil' beam(1,8). Also, observation of the characteristic twisting of the polarization angle in other compact sources would reveal the presence of a black hole(9-12). Here we report the development of an instrument that makes X-ray polarimetry possible. The factor of 100 improvement in sensitivity that we have achieved will allow direct exploration of the most dramatic objects of the X-ray sky.	CNR, Ist Astrofis Spaziale, I-00133 Rome, Italy; Ist Nazl Fis Nucl, Sez Pisa, I-56010 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN)	Costa, E (corresponding author), CNR, Ist Astrofis Spaziale, Via Fosso Cavaliere 100, I-00133 Rome, Italy.		Soffitta, Paolo/AAA-7514-2021	Soffitta, Paolo/0000-0002-7781-4104; Costa, Enrico/0000-0003-4925-8523; Spandre, Gloria/0000-0003-0802-3453				ANGELINI F, 1993, NUCL INSTRUM METH A, V335, P69, DOI 10.1016/0168-9002(93)90257-I; AUSTIN RA, 1993, SPIE, V2010, P118; Bao G, 1996, PHYS REV LETT, V77, P12, DOI 10.1103/PhysRevLett.77.12; Bavdaz M, 2000, P SOC PHOTO-OPT INS, V4138, P69, DOI 10.1117/12.407545; BUSCHHORN G, 1994, NUCL INSTRUM METH A, V346, P578, DOI 10.1016/0168-9002(94)90595-9; Campbell M, 1999, IEEE T NUCL SCI, V46, P156, DOI 10.1109/23.775506; Cash W, 2000, NATURE, V407, P160, DOI 10.1038/35025009; CELOTTI A, 1994, MON NOT R ASTRON SOC, V268, P451, DOI 10.1093/mnras/268.2.451; CHRISTENSEN FE, 1997, P SOC PHOTO-OPT INS, V3113, P69; CONNORS PA, 1980, ASTROPHYS J, V235, P224, DOI 10.1086/157627; CONNORS PA, 1977, NATURE, V269, P128, DOI 10.1038/269128a0; GNEDIN YN, 1974, ASTRON ASTROPHYS, V36, P379; Gnedin YN., 1978, SOV ASTRON LETT, V4, P117; KAARET P, 1990, OPT ENG, V29, P773, DOI 10.1117/12.55660; La Monaca A, 1998, NUCL INSTRUM METH A, V416, P267, DOI 10.1016/S0168-9002(98)00486-0; MATT G, 1993, MON NOT R ASTRON SOC, V264, P839, DOI 10.1093/mnras/264.4.839; MESZAROS P, 1979, PHYS REV D, V19, P3565, DOI 10.1103/PhysRevD.19.3565; MESZAROS P, 1988, ASTROPHYS J, V324, P1056, DOI 10.1086/165962; NOVICK R, 1972, ASTROPHYS J, V174, pL1, DOI 10.1086/180938; NOVICK R, 1972, PLANETS STARS NEBULA, P262; Ogura J, 2000, PUBL ASTRON SOC JPN, V52, P841, DOI 10.1093/pasj/52.5.841; POUTANEN J, 1994, ASTROPHYS J SUPPL S, V92, P607, DOI 10.1086/192024; REES MJ, 1975, MON NOT R ASTRON SOC, V171, P457, DOI 10.1093/mnras/171.3.457; RIEGLER GR, 1970, B AM PHYS SOC, V15, P635; Sauli F, 1997, NUCL INSTRUM METH A, V386, P531, DOI 10.1016/S0168-9002(96)01172-2; SCHNOPPE.HW, 1969, ASTRON J, V74, P854, DOI 10.1086/110873; SOFFITTA P, IN PRESS NUCL INSTRU; STARK RF, 1977, NATURE, V266, P429, DOI 10.1038/266429a0; SUNYAEV RA, 1985, ASTRON ASTROPHYS, V143, P374; TANAKA Y, 1995, NATURE, V375, P659, DOI 10.1038/375659a0; TSUNEMI H, 1992, NUCL INSTRUM METH A, V321, P629, DOI 10.1016/0168-9002(92)90075-F; VENTURA J, 1979, PHYS REV D, V19, P1684, DOI 10.1103/PhysRevD.19.1684; WEISSKOPF MC, 1978, ASTROPHYS J, V220, pL117, DOI 10.1086/182648	33	275	275	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					662	665		10.1038/35079508	http://dx.doi.org/10.1038/35079508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395761				2022-12-28	WOS:000169112500035
J	Puertollano, R; Aguilar, RC; Gorshkova, I; Crouch, RJ; Bonifacino, JS				Puertollano, R; Aguilar, RC; Gorshkova, I; Crouch, RJ; Bonifacino, JS			Sorting of mannose 6-phosphate receptors mediated by the GGAs	SCIENCE			English	Article							FACTOR-II RECEPTOR; CYTOPLASMIC DOMAIN; GAMMA-ADAPTIN; TRANS-GOLGI; SIGNALS; PROTEINS; BINDING; FAMILY; RECOGNITION; TRAFFICKING	The delivery of soluble hydrolases to lysosomes is mediated by the cation-independent and cation-dependent mannose 6-phosphate receptors. The cytosolic tails of both receptors contain acidic-cluster-dileucine signals that direct sorting from the trans-Golgi network to the endosomal-lysosomal system. We found that these signals bind to the VHS domain of the Golgi-localized, gamma -ear-containing, ARF-binding proteins (GGAs). The receptors and the GGAs left the trans-Golgi network on the same tubulo-vesicular carriers. A dominant-negative GGA mutant blocked exit of the receptors from the trans-Golgi, network. Thus, the GGAs appear to mediate sorting of the mannose 6-phosphate receptors at the trans-Golgi network.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NICHHD, Genet Mol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bonifacino, JS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.			Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607, ZIAHD000068] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607, Z01HD000068] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; Heilker R, 1999, BIOESSAYS, V21, P558, DOI 10.1002/(SICI)1521-1878(199907)21:7<558::AID-BIES4>3.0.CO;2-R; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; HONING S, 1997, J BIOL CHEM, V272, P1984; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KOMFELD S, 1992, ANNU REV BIOCHEM, V61, P307; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Mauxion F, 1996, J BIOL CHEM, V271, P2171, DOI 10.1074/jbc.271.4.2171; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	17	317	330	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1712	1716		10.1126/science.1060750	http://dx.doi.org/10.1126/science.1060750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387475				2022-12-28	WOS:000169031800044
J	Shlesinger, MF				Shlesinger, MF			Physics in the noise	NATURE			English	Editorial Material									Off Naval Res, Div Phys Sci, Arlington, VA 22217 USA	United States Department of Defense; United States Navy	Shlesinger, MF (corresponding author), Off Naval Res, Div Phys Sci, 800 N Quincy St, Arlington, VA 22217 USA.							Hughes BD, 1995, RANDOM WALKS RANDOM, V1, DOI [10.1079/PNS19950063, DOI 10.1079/PNS19950063]; Klafter J, 1996, PHYS TODAY, V49, P33, DOI 10.1063/1.881487; SHLESINGER MF, 1996, ENCY APPL PHYSICS, V16, P45; Weiss G.H., 1994, ASPECTS APPL RANDOM	4	25	25	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					641	641		10.1038/35079702	http://dx.doi.org/10.1038/35079702			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395745				2022-12-28	WOS:000169112500021
J	Chen, Y; Schier, AF				Chen, Y; Schier, AF			The zebrafish Nodal signal Squint functions as a morphogen	NATURE			English	Article							LONG-RANGE ACTION; ONE-EYED PINHEAD; TGF-BETA FAMILY; ACTIVIN; INDUCTION; MESODERM; GRADIENT; GASTRULATION; ORGANIZER; ENDODERM	Secreted morphogens induce distinct cellular responses in a concentration-dependent manner and act directly at a distance(1-7). The existence of morphogens during mesoderm induction and patterning in vertebrates has been highly controversial, and it remains unknown whether endogenous mesoderm inducers act directly as morphogens(8-10), function locally(9) or act through relay mechanisms(11-12). Here we test the morphogen properties of Cyclops and Squint-two Nodal-related transforming growth factor-beta signals required for mesoderm formation and patterning in zebrafish(13-16). Whereas different levels of both Squint and Cyclops can induce different downstream genes(14,17-19), we rnd that only Squint can function directly at a distance. These results indicate that Squint acts as a secreted morphogen that does not require a relay mechanism.	NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Schier, AF (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA.			Schier, Alexander Franz/0000-0001-7645-5325				Agius E, 2000, DEVELOPMENT, V127, P1173; Erter CE, 1998, DEV BIOL, V204, P361, DOI 10.1006/dbio.1998.9097; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Gritsman K, 2000, DEVELOPMENT, V127, P921; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; Jones CM, 1996, CURR BIOL, V6, P1468, DOI 10.1016/S0960-9822(96)00751-8; JONES CM, 1995, DEVELOPMENT, V121, P3651; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; McDowell N, 1997, CURR BIOL, V7, P671, DOI 10.1016/S0960-9822(06)00294-6; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Reilly KM, 1996, CELL, V86, P743, DOI 10.1016/S0092-8674(00)80149-X; Rodaway A, 1999, DEVELOPMENT, V126, P3067; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1997, DEVELOPMENT, V124, P327; Strahle U, 1997, Genes Funct, V1, P131; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vogel AM, 1999, MECH DEVELOP, V85, P133, DOI 10.1016/S0925-4773(99)00104-5; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	28	238	245	1	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					607	610		10.1038/35079121	http://dx.doi.org/10.1038/35079121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385578				2022-12-28	WOS:000168982500057
J	Ungless, MA; Whistler, JL; Malenka, RC; Bonci, A				Ungless, MA; Whistler, JL; Malenka, RC; Bonci, A			Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons	NATURE			English	Article							VENTRAL TEGMENTAL AREA; EXCITATORY AMINO-ACIDS; BEHAVIORAL SENSITIZATION; AMPA RECEPTORS; SILENT SYNAPSES; GLUTAMATE; AMPHETAMINE; ADDICTION; LTP; RAT	How do drugs of abuse modify neural circuitry and thereby lead to addictive behaviour? As for many forms of experience-dependent plasticity, modifications in glutamatergic synaptic transmission have been suggested to be particularly important(1-4). Evidence of such changes in response to in vivo administration of drugs of abuse is lacking, however. Here we show that a single in vivo exposure to cocaine induces long-term potentiation of AMPA (alpha -amino-3-hydroxy-5-methyl-isoxazole propionic acid)-receptor-mediated currents at excitatory synapses onto dopamine cells in the ventral tegmental area. Potentiation is still observed 5 but not 10 days after cocaine exposure and is blocked when an NMDA (N-methyl-D-aspartate) receptor antagonist is administered with cocaine. Furthermore, long-term potentiation at these synapses is occluded and long-term depression is enhanced by in vivo cocaine exposure. These results show that a prominent form of synaptic plasticity can be elicited by a single in vivo exposure to cocaine and therefore may be involved in the early stages of the development of drug addiction.	Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94134 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Stanford University	Bonci, A (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA.		Ungless, Mark/A-1985-2009; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Ungless, Mark/0000-0002-1730-3353				Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bonci A, 1999, J NEUROSCI, V19, P3723; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Clark D, 1998, ADDICT BIOL, V3, P109, DOI 10.1080/13556219872191; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JACKSON HC, 1993, PHARMACOL BIOCHEM BE, V45, P733, DOI 10.1016/0091-3057(93)90533-Y; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Jones S, 2000, J NEUROSCI, V20, P5575, DOI 10.1523/JNEUROSCI.20-15-05575.2000; KALIVAS PW, 1995, J NEUROSCI, V15, P5379, DOI 10.1523/jneurosci.15-07-05379.1995; KALIVAS PW, 1995, DRUG ALCOHOL DEPEN, V37, P95, DOI 10.1016/0376-8716(94)01063-Q; KALIVAS PW, 1993, J PHARMACOL EXP THER, V267, P486; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Overton PG, 1999, NEUROREPORT, V10, P221, DOI 10.1097/00001756-199902050-00004; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; THOMAS MJ, 2000, SOC NEUR ABSTR; WHITE FJ, 1984, BRAIN RES, V309, P283; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Zhang XF, 1997, J PHARMACOL EXP THER, V281, P699	30	871	897	2	114	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					583	587		10.1038/35079077	http://dx.doi.org/10.1038/35079077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385572				2022-12-28	WOS:000168982500051
J	Price, CP				Price, CP			Regular review - Point of care testing	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GENERAL-PRACTICE; MANAGEMENT; IMPACT		Barts & London NHS Trust, London E1 1BB, England	Barts Health NHS Trust	Price, CP (corresponding author), Barts & London NHS Trust, London E1 1BB, England.	cp.price@mds.qmw.ac.uk						Brogan GX, 1998, CLIN CHEM, V44, P1865; BURNETT D, 1994, HLTH SERVICES MANAGE, V3, P10; Crook MA, 2000, J CLIN PATHOL, V53, P27, DOI 10.1136/jcp.53.1.27; Dahler-Eriksen BS, 1999, CLIN CHEM, V45, P478; DESPOTIS GJ, 1994, TRANSFUSION, V34, P290, DOI 10.1046/j.1537-2995.1994.34494233575.x; Despotis GJ, 1997, CLIN CHEM, V43, P1684; England JM, 1995, CLIN LAB HAEMATOL, V17, P301; Fenwick EAL, 2000, BRIT J GEN PRACT, V50, P635; Gallichan M, 1997, BRIT MED J, V314, P964, DOI 10.1136/bmj.314.7085.964; Grieve R, 1999, HEALTH TECHNOL ASSES, V3, P1, DOI DOI 10.3310/HTA3150; Griffin S, 1998, BMJ-BRIT MED J, V317, P390; Hobbs FD, 1997, HEALTH TECHNOL ASSES, V1, p[i, 1]; Irvin GL, 1999, ANN SURG, V229, P874, DOI 10.1097/00000658-199906000-00015; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Jones R, 1997, ALIMENT PHARM THERAP, V11, P101, DOI 10.1046/j.1365-2036.1997.125296000.x; Kendall J, 1998, BRIT MED J, V316, P1052; LANGER O, 1994, AM J OBSTET GYNECOL, V170, P1036, DOI 10.1016/S0002-9378(94)70097-4; Price CP, 2000, CLIN CHEM, V46, P1041; PRICE CP, 1999, POINT CARE TESTING; RINK E, 1993, BRIT MED J, V307, P775, DOI 10.1136/bmj.307.6907.775; Sawicki PT, 1999, JAMA-J AM MED ASSOC, V281, P145, DOI 10.1001/jama.281.2.145; Scott MG, 2000, CLIN CHEM, V46, P441; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Storm M, 1999, GEOGRAPHY, V84, P187; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WELLS PS, 1995, CIRCULATION, V91, P2184, DOI 10.1161/01.CIR.91.8.2184	26	216	237	3	52	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2001	322	7297					1285	1288		10.1136/bmj.322.7297.1285	http://dx.doi.org/10.1136/bmj.322.7297.1285			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375233	Green Published			2022-12-28	WOS:000169027800022
J	Batista, FD; Iber, D; Neuberger, MS				Batista, FD; Iber, D; Neuberger, MS			B cells acquire antigen from target cells after synapse formation	NATURE			English	Article							FOLLICULAR DENDRITIC CELLS; REACTIVE LYMPHOCYTES-B; PEPTIDE-MHC COMPLEXES; T-CELLS; SURFACE MOLECULES; PRESENTING CELLS; CLASS-II; RECEPTOR; AFFINITY; INTERNALIZATION	Soluble antigen binds to the B-cell antigen receptor and is internalized for subsequent processing and the presentation of antigen-derived peptides to T cells(1). Many antigens are not soluble, however, but are integral components of membrane; furthermore, soluble antigens will usually be encountered in vivo in a membrane-anchored form, tethered by Fc or complement receptors(2-4). Here we show that B-cell interaction with antigens that are immobilized on the surface of a target cell leads to the formation of a synapse and the acquisition, even, of membrane-integral antigens from the target. B-cell antigen receptor accumulates at the synapse, segregated from the CD45 co-receptor which is excluded from the synapse, and there is a corresponding polarization of cytoplasmic effectors in the B cell. B-cell antigen receptor mediates the gathering of antigen into the synapse and its subsequent acquisition, thereby potentiating antigen processing and presentation to T cells with high efficacy. Synapse formation and antigen acquisition will probably enhance the activation of B cells at low antigen concentration, allow context-dependent antigen recognition and enhance the linking of B- and T-cell epitopes.	Med Res Lab Mol Biol, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Batista, FD (corresponding author), Med Res Lab Mol Biol, Hills Rd, Cambridge CB2 2QH, England.		Iber, Dagmar/V-2846-2019	Iber, Dagmar/0000-0001-8051-1035				Aluvihare VR, 1997, EMBO J, V16, P3553, DOI 10.1093/emboj/16.12.3553; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; CASTEN LA, 1985, P NATL ACAD SCI USA, V82, P5890, DOI 10.1073/pnas.82.17.5890; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GREEN SM, 1989, ONCOGENE, V4, P737; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; KLAUS GGB, 1980, IMMUNOL REV, V53, P3, DOI 10.1111/j.1600-065X.1980.tb01038.x; KOSCOVILBOIS MH, 1993, J EXP MED, V178, P2055, DOI 10.1084/jem.178.6.2055; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; SCHREINER GF, 1977, J IMMUNOL, V119, P1549; Serre K, 1998, J IMMUNOL, V161, P6059; Siemasko K, 1998, J IMMUNOL, V160, P5203; TAYLOR RB, 1971, NATURE-NEW BIOL, V233, P225, DOI 10.1038/newbio233225a0; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Weintraub BC, 2000, J EXP MED, V191, P1443, DOI 10.1084/jem.191.8.1443; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	30	468	482	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					489	494		10.1038/35078099	http://dx.doi.org/10.1038/35078099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373683				2022-12-28	WOS:000168858700052
J	Milkereit, P; Gadal, O; Podtelejnikov, A; Trumtel, S; Gas, N; Petfalski, E; Tollervey, D; Mann, M; Hurt, E; Tschochner, H				Milkereit, P; Gadal, O; Podtelejnikov, A; Trumtel, S; Gas, N; Petfalski, E; Tollervey, D; Mann, M; Hurt, E; Tschochner, H			Maturation and intranuclear transport of pre-ribosomes requires Noc proteins	CELL			English	Article							MESSENGER-RNA EXPORT; NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; COMPLEX-FORMATION; BINDING PROTEIN; POLYMERASE I; MEX67P; NUCLEOPORINS; BIOGENESIS; NUCLEOLUS	How pre-ribosomes temporally and spatially mature during intranuclear biogenesis is not known. Here, we report three nucleolar proteins, Noc1p to Noc3p, that are required for ribosome maturation and transport. They can be isolated in two distinct complexes: Noc1p/Noc2p associates with 90S and 66S pre-ribosomes and is enriched in the nucleolus, and Noc2p/Noc3p associates with 66S pre-ribosomes and is mainly nucleoplasmic. Mutation of each Noc protein impairs intranuclear transport of 60S subunits at different stages and inhibits pre-rRNA processing. Overexpression of a conserved domain common to Noc1p and Noc3p is dominant-negative for cell growth, with a defect int nuclear 60S subunit transport, but no inhibition of pre-RNA processing. We propose that the dynamic interaction of Noc proteins is crucial for intranuclear movement of ribosomal precursor particles, and, thereby represent a prerequisite for proper maturation.	Biochem Zentrum Heidelberg, D-69120 Heidelberg, Germany; Odense Univ, Prot Interact Lab, DK-5230 Odense M, Denmark; Lab Biol Mol Eucaryote, F-32062 Toulouse, France; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Ruprecht Karls University Heidelberg; University of Southern Denmark; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Edinburgh	Tschochner, H (corresponding author), Biochem Zentrum Heidelberg, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	cg5@ix.urz.uni-heidelberg.de; IM4@ix.urz.uni-heidelberg.de	Tollervey, David/AAR-6662-2020; Mann, Matthias/A-3454-2013; Podtelejnikov, Alexandre/B-6120-2017; Gadal, Olivier/A-4731-2008; Ed Hurt, Dr./AAE-8874-2019	Tollervey, David/0000-0003-2894-2772; Mann, Matthias/0000-0003-1292-4799; Podtelejnikov, Alexandre/0000-0002-8124-6584; Gadal, Olivier/0000-0001-9421-0831; Ed Hurt, Dr./0000-0002-4535-8255				AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; DOYE V, 1995, TRENDS GENET, V11, P235, DOI 10.1016/S0168-9525(00)89057-5; Edskes HK, 1998, J BIOL CHEM, V273, P28912, DOI 10.1074/jbc.273.44.28912; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; KADOWAKI T, 1992, P NATL ACAD SCI USA, V89, P2312, DOI 10.1073/pnas.89.6.2312; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Leger-Silvestre I, 1999, CHROMOSOMA, V108, P103, DOI 10.1007/s004120050357; LegerSilvestre I, 1997, EUR J CELL BIOL, V72, P13; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maniatis T., 1982, MOL CLONING; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; TRAPMAN J, 1975, EXP CELL RES, V90, P95, DOI 10.1016/0014-4827(75)90361-4; Trumtel S, 2000, MOL BIOL CELL, V11, P2175, DOI 10.1091/mbc.11.6.2175; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Williams M., 1977, QUANTITATIVE METHODS; WOOLFORD JL, 1991, ADV GENET, V29, P63, DOI 10.1016/S0065-2660(08)60107-8	33	156	160	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					499	509		10.1016/S0092-8674(01)00358-0	http://dx.doi.org/10.1016/S0092-8674(01)00358-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371346	Bronze			2022-12-28	WOS:000168840700009
J	Hediger, ML; Overpeck, MD; Kuczmarski, RJ; Ruan, WJ				Hediger, ML; Overpeck, MD; Kuczmarski, RJ; Ruan, WJ			Association between infant breastfeeding and overweight in young children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GESTATIONAL-AGE; PRESCHOOL-CHILDREN; UNITED-STATES; BIRTH-WEIGHT; BORN SMALL; OBESITY; GROWTH; ADIPOSITY; PREVALENCE; CHILDHOOD	Context it has been suggested that breastfeeding is protective against children becoming overweight, and that there is a dose-dependent effect of its duration. Objective To determine whether breastfeeding and its duration are associated with a reduced risk of being overweight among young children in the United States. Design and Setting Data on infant feeding and child overweight status were taken from the third National Health and Nutrition Examination Survey (NHANES iii), a cross-sectional health examination survey conducted from 1988-1994. Subjects Sample of 2685 US-born children between the ages of 3 and 5 years, with birth certificates, height and weight measures, and information on infant feeding. Main Outcome Measures A body mass index (BMI) between the 85th and 94th percentile was considered at risk of overweight and a BMI in the 95th percentile or higher was considered being overweight. Results After adjusting for potential confounders, there was a reduced risk of being at risk of overweight for ever breastfed children (adjusted odds ratio [AOR], 0.63; 95% confidence interval [CI], 0.41-0.96) compared with those never breastfed. There was no reduced risk of being overweight (AOR, 0.84; 95% CI, 0.62-1.13), There was no clear dose-dependent effect of the duration of full breastfeeding on being at risk of overweight or overweight and no threshold effect. The strongest predictor of child overweight status was the mother's concurrent weight. The rate of children being overweight nearly tripled with maternal overweight status (BMI, 25.0-29.9 kg/m(2); AOR, 2.95; 95% CI, 1.35-6.42) and more than quadrupled with maternal obesity status (BMI greater than or equal to 30.0 kg/m(2); AOR, 4.34; 95% CI, 2.50-7.54). Conclusions There are inconsistent associations among breastfeeding, its duration, and the risk of being overweight in young children, Breastfeeding continues to be strongly recommended, but may not be as effective as moderating familial factors, such as dietary habits and physical activity, in preventing children from becoming overweight.	NICHD, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD 20892 USA; US Hlth Resources & Serv Adm, Maternal & Child Hlth Bur, Rockville, MD 20857 USA; Ctr Dis Control & Prevent, Div Hlth Examinat Stat, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); United States Health Resources & Service Administration (HRSA); Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Hediger, ML (corresponding author), NICHD, Div Epidemiol Stat & Prevent Res, NIH, Bldg 6100,Room 7B03,9000 Rockville Pike, Bethesda, MD 20892 USA.	hedigerm@exchange.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002512] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderson JW, 1999, AM J CLIN NUTR, V70, P525; [Anonymous], 2000, ADV DATA VITAL HLTH; BARANOWSKI T, 1990, J DEV BEHAV PEDIATR, V11, P234; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Butte NF, 2000, PEDIATRICS, V106, P1355, DOI 10.1542/peds.106.6.1355; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; Hediger ML, 1998, ARCH PEDIAT ADOL MED, V152, P1225; Hediger ML, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.3.e33; Hediger ML, 2000, AM J CLIN NUTR, V72, P159; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; HUTTLY SRA, 1990, AM J EPIDEMIOL, V132, P572, DOI 10.1093/oxfordjournals.aje.a115693; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Mehta KC, 1998, PEDIATRICS, V102, P569, DOI 10.1542/peds.102.3.569; Mei ZG, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e12; *NAT CTR HLTH STAT, 1997, 1994 NAT DAT SET 21, V4; National Center for Health Statistics, 1996, NHANES 3 REF MAN REP; National Center for Health Statistics, 1994, PLAN OP 3 NAT HLTH N; OCallaghan MJ, 1997, J PAEDIATR CHILD H, V33, P311, DOI 10.1111/j.1440-1754.1997.tb01607.x; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Ogden CL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e1; Overpeck MD, 2000, J PEDIATR-US, V137, P205, DOI 10.1067/mpd.2000.107163; Overpeck MD, 1999, OBSTET GYNECOL, V93, P943, DOI 10.1016/S0029-7844(98)00553-5; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Raisler J, 1999, AM J PUBLIC HEALTH, V89, P25, DOI 10.2105/AJPH.89.1.25; ROLLANDCACHERA MF, 1987, ANN HUM BIOL, V14, P219, DOI 10.1080/03014468700008991; Ryan AS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e12; RYAN AS, 1991, PEDIATRICS, V88, P719; RYAN AS, 1991, AM J PUBLIC HEALTH, V81, P1049, DOI 10.2105/AJPH.81.8.1049; Shah BV, 1997, SUDAAN USERS MANUAL; Tulldahl J, 1999, OBES RES, V7, P431, DOI 10.1002/j.1550-8528.1999.tb00430.x; *US DEPT HHS, 1996, NHANES 3 ANTHR PROC; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; Wadsworth M, 1999, BRIT MED J, V319, P1576, DOI 10.1136/bmj.319.7224.1576; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E; ZIVE MM, 1992, AM J CLIN NUTR, V55, P1104, DOI 10.1093/ajcn/55.6.1104	38	262	277	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2453	2460		10.1001/jama.285.19.2453	http://dx.doi.org/10.1001/jama.285.19.2453			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429ZC	11368697	Bronze			2022-12-28	WOS:000168547600026
J	Outten, CE; O'Halloran, TV				Outten, CE; O'Halloran, TV			Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis	SCIENCE			English	Article							ESCHERICHIA-COLI; REGULATOR ZUR; UPTAKE SYSTEM; HIGH-AFFINITY; METALLOTHIONEIN; IONS; ZNTR; SMTB; FLUORESCENCE; TRANSPORTER	Intracellular zinc is thought to be available in a cytosolic pool of free or Loosely bound Zn(II) ions in the micromolar to picomolar range. To test this, we determined the mechanism of zinc sensors that control metal uptake or export in Escherichia coli and calibrated their response against the thermodynamically defined free line concentration. Whereas the cellular line quota is millimolar, free Zn(II) concentrations that trigger transcription of zinc uptake or efflux machinery are femtomolar, or six orders of magnitude Less than one atom per cell. This is not consistent with a cytosolic pool of free Zn(II) and suggests an extraordinary intracellular zinc-binding capacity. Thus, cells exert tight control over cytosolic metal concentrations, even for relatively Low-toxicity metals such as zinc.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	O'Halloran, TV (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.		O'Halloran, Thomas/ABE-6125-2021; Outten, Caryn E./I-9433-2019	O'Halloran, Thomas/0000-0001-8732-5059; Outten, Caryn E./0000-0003-0335-6531	NIDDK NIH HHS [DK52627] Funding Source: Medline; NIGMS NIH HHS [T32 GM08382, R01 GM038784, R01 GM38784] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038784, T32GM008382] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Ausubel FM, 1995, CURRENT PROTOCOLS MO, V1; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Binet MRB, 2000, FEBS LETT, V473, P67, DOI 10.1016/S0014-5793(00)01509-X; Bremer H., 1996, E COLI SALMONELLA CE, V2, P1553; Brocklehurst KR, 1999, MOL MICROBIOL, V31, P893, DOI 10.1046/j.1365-2958.1999.01229.x; Coleman JE, 1998, CURR OPIN CHEM BIOL, V2, P222, DOI 10.1016/S1367-5931(98)80064-1; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fahrni CJ, 1999, J AM CHEM SOC, V121, P11448, DOI 10.1021/ja992709f; Gaballa A, 1998, J BACTERIOL, V180, P5815, DOI 10.1128/JB.180.22.5815-5821.1998; Granger J, 1999, LIMNOL OCEANOGR, V44, P541, DOI 10.4319/lo.1999.44.3.0541; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; HITOMI Y, UNPUB; HUCKLE JW, 1993, MOL MICROBIOL, V7, P177, DOI 10.1111/j.1365-2958.1993.tb01109.x; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Kar SR, 1997, BIOCHEMISTRY-US, V36, P15343, DOI 10.1021/bi971690v; Martell A.E., 1998, NIST STANDARD REFERE, V46; Nasir MS, 1999, J BIOL INORG CHEM, V4, P775, DOI 10.1007/s007750050350; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; OUTTEN C, UNPUB; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; OUTTEN FW, UNPUB; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; Sensi SL, 1997, J NEUROSCI, V17, P9554; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; VALLEE B L, 1988, Biofactors, V1, P31; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; Williams RJP, 2000, COORDIN CHEM REV, V200, P247, DOI 10.1016/S0010-8545(00)00324-6; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044	36	1113	1136	2	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2488	2492		10.1126/science.1060331	http://dx.doi.org/10.1126/science.1060331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11397910				2022-12-28	WOS:000169658200041
J	Halligan, A; Donaldson, L				Halligan, A; Donaldson, L			Implementing clinical governance: turning vision into reality	BRITISH MEDICAL JOURNAL			English	Article							QUALITY		NHS Clin Goverance Support Team, Leicester LE1 5ZW, Leics, England; Dept Hlth, London SW14 2NS, England		Halligan, A (corresponding author), NHS Clin Goverance Support Team, Millstone Lane, Leicester LE1 5ZW, Leics, England.							*COMM HLTH IMPR, 2000, INV CARM NHS TRUST R; *COMM HLTH IMPR, 2000, INV N LAK NHS TRUST; *DEEP HLTH, 1999, SUPP DOCT PROT PAT; Deming EW., 1986, OUT CRISIS; *DEP HLTH, 1997, CM3807; Department of Health, 1999, NAT SERV FRAM MENT H; Donaldson L., 2005, ORG MEMORY REPORT EX; Dyer G, 1998, BRIT MED J, V317, P767; *GEN MED COUNC, 2000, REV DOCT; Gray JD, 1996, QUAL HEALTH CARE, V5, P201, DOI 10.1136/qshc.5.4.201; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; HALLIGAN A, 1999, J CLIN GOVERNANCE, V7, P155; Juran J. M, 1964, MANAGERIAL BREAKTHRO; KOTTER JP, 1995, HARVARD BUSINESS MAR, P59; MALCOLM AJ, 1995, ENQUIRY BONE TUMOUR; Scally G, 1998, BRIT MED J, V317, P61, DOI 10.1136/bmj.317.7150.61; *SECR STAT HLTH, 2000, CM4818I; Smith R, 1998, BRIT MED J, V317, P1539, DOI 10.1136/bmj.317.7172.1539; THOMSON RG, 1990, J PUBLIC HEALTH MED, V12, P149, DOI 10.1093/oxfordjournals.pubmed.a042539	19	89	90	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1413	1417		10.1136/bmj.322.7299.1413	http://dx.doi.org/10.1136/bmj.322.7299.1413			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397753	Green Published			2022-12-28	WOS:000169284600022
J	Sole, S; Gornitzka, H; Schoeller, WW; Bourissou, D; Bertrand, G				Sole, S; Gornitzka, H; Schoeller, WW; Bourissou, D; Bertrand, G			(Amino)(aryl)carbenes: Stable singlet carbenes featuring a spectator substituent	SCIENCE			English	Article							N-HETEROCYCLIC CARBENES; CATALYSTS; COMPLEXES	Several (amino)(aryl)carbenes have been shown to be stable at room temperature in solution and in the solid state. Electroneutrality of the carbene center is ensured by the amino group, which has both pi -donor and sigma -acceptor electronic character. The aryl group remains a spectator substituent, as shown by single-crystal x-ray analysis and by its chemical behavior. Because only one electron-active substituent is needed, numerous stable carbenes will become accessible, which will open the way for new synthetic developments and applications in various fields.	Univ Toulouse 3, Lab Heterochim Fondamentale & Appl, F-31062 Toulouse 04, France; Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Bielefeld	Bertrand, G (corresponding author), Univ Toulouse 3, Lab Heterochim Fondamentale & Appl, 118 Route Narbonne, F-31062 Toulouse 04, France.	gbertran@ramses.ups-tlse.fr	Schoeller, Wolfgang W/A-5755-2011; Bourissou, Didier/F-7761-2014					Alder RW, 1998, J AM CHEM SOC, V120, P11526, DOI 10.1021/ja9819312; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; Arduengo AJ, 1999, ACCOUNTS CHEM RES, V32, P913, DOI 10.1021/ar980126p; Arduengo AJ, 1999, HELV CHIM ACTA, V82, P2348, DOI 10.1002/(SICI)1522-2675(19991215)82:12<2348::AID-HLCA2348>3.0.CO;2-M; Bielawski CW, 2000, ANGEW CHEM INT EDIT, V39, P2903, DOI 10.1002/1521-3773(20000818)39:16<2903::AID-ANIE2903>3.0.CO;2-Q; Bohm VPW, 2000, ANGEW CHEM INT EDIT, V39, P1602, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1602::AID-ANIE1602>3.0.CO;2-N; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; Brahms DLS, 1996, CHEM REV, V96, P1585, DOI 10.1021/cr941141k; Brinker U. H., 1994, ADV CARBENE CHEM, V1; Brinker U. H., 1998, ADV CARBENE CHEM, V2; Buchner E., 1885, BER DTSCH CHEM GES, V8, P2377; Buron C, 2000, SCIENCE, V288, P834, DOI 10.1126/science.288.5467.834; Dorwald F.Z., 1999, METAL CARBENES ORGAN; Dumas J.B., 1835, ANN CHIM PHYS, V58, P5; HALLEUX A, 1964, ANGEW CHEM INT EDIT, V3, P752, DOI 10.1002/anie.196407521; Herrmann WA, 1997, ANGEW CHEM INT EDIT, V36, P2162, DOI 10.1002/anie.199721621; HIRAI K, 1994, CHEM LETT, P503, DOI 10.1246/cl.1994.503; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Jones M., 1975, CARBENES, VII; Kato T, 2000, J AM CHEM SOC, V122, P998, DOI 10.1021/ja9939542; Louie J, 2001, ANGEW CHEM INT EDIT, V40, P247, DOI 10.1002/1521-3773(20010105)40:1<247::AID-ANIE247>3.0.CO;2-4; McGuinness DS, 2000, ORGANOMETALLICS, V19, P741, DOI 10.1021/om990776c; Moss R. A., 1973, CARBENES, V1; MOSS RA, 1984, TETRAHEDRON LETT, V25, P1023, DOI 10.1016/S0040-4039(01)80090-3; PAULING L, 1980, J CHEM SOC CHEM COMM, P688, DOI 10.1039/c39800000688; REGITZ M, 1989, METHODEN ORG CHEM E, V19; SCHOELLER WW, 1980, J CHEM SOC CHEM COMM, P124, DOI 10.1039/c39800000124; Schurer SC, 2000, ANGEW CHEM INT EDIT, V39, P3898, DOI 10.1002/1521-3773(20001103)39:21<3898::AID-ANIE3898>3.0.CO;2-X; Schwarz J, 2000, CHEM-EUR J, V6, P1773, DOI 10.1002/(SICI)1521-3765(20000515)6:10<1773::AID-CHEM1773>3.3.CO;2-G; Sheldrick G.M., 1997, PROGRAM CRYSTAL STRU; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Staudinger H, 1912, BER DTSCH CHEM GES, V45, P501, DOI 10.1002/cber.19120450174; Takahashi Y, 2000, ANGEW CHEM INT EDIT, V39, P3478, DOI 10.1002/1521-3773(20001002)39:19<3478::AID-ANIE3478>3.0.CO;2-L; Tomioka H, 1997, ACCOUNTS CHEM RES, V30, P315, DOI 10.1021/ar9602157; TOMIOKA H, 1997, J CHEM SOC CHEM COMM, P1745	35	147	147	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1901	1903		10.1126/science.292.5523.1901	http://dx.doi.org/10.1126/science.292.5523.1901			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397943				2022-12-28	WOS:000169200700046
J	Mehler, PS				Mehler, PS			Diagnosis and care of patients with anorexia nervosa in primary care settings	ANNALS OF INTERNAL MEDICINE			English	Review							RESTING ENERGY-EXPENDITURE; BONE-MINERAL DENSITY; EATING-DISORDERS; YOUNG-WOMEN; WEIGHT-LOSS; BULIMIA-NERVOSA; METABOLIC-RATE; LEPTIN LEVELS; BODY-WEIGHT; INDIVIDUAL THERAPY	Anorexia nervosa is a psychiatric disorder characterized by abnormal eating behaviors that results in weight loss and has serious potential medical consequences. Most of these complications are readily treatable if diagnosed and attended to early in the course of the illness. In caring for patients with anorexia nervosa, the primary care physician has several critical roles. Because patients deny the severity of their illness, they delay seeking psychiatric treatment. The primary care physician must be skilled in recognizing this disorder, as well as in diagnosing and effectively treating the medical complications while educating the patient about them. The primary care physician is also involved with arranging and coordinating a comprehensive and multidisciplinary program, including dietary and mental health treatment. The multidisciplinary team is responsible for ensuring safe weight restoration and a judicious refeeding treatment plan. In addition to establishing the diagnosis and treating the multiple medical complications associated with anorexia nervosa, the primary care physician plays a central role in maintaining continuity of care despite the fact that successful care may require a variety of treatment settings. Factors that foster goad prognoses for this increasingly common and often protracted eating disorder include early diagnosis and skilled medical intervention to prevent the inexorable physical decline that marked weight loss can cause.	Denver Hlth Med Ctr, Denver, CO 80204 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA	Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Mehler, PS (corresponding author), Denver Hlth Med Ctr, 660 Bannock St,MC 1914, Denver, CO 80204 USA.							Adachi JD, 1997, NEW ENGL J MED, V337, P382, DOI 10.1056/NEJM199708073370603; [Anonymous], 2000, Am J Psychiatry, V157, P1; Attia E, 1998, AM J PSYCHIAT, V155, P548, DOI 10.1176/ajp.155.4.548; BACHRACH LK, 1990, PEDIATRICS, V86, P440; Baker D, 2000, INT J EAT DISORDER, V27, P29, DOI 10.1002/(SICI)1098-108X(200001)27:1&lt;29::AID-EAT3&gt;3.0.CO;2-P; BARAN SA, 1995, AM J PSYCHIAT, V152, P1070; Batal H, 1998, J WOMENS HEALTH, V7, P211, DOI 10.1089/jwh.1998.7.211; Becker AE, 1999, NEW ENGL J MED, V340, P1092, DOI 10.1056/NEJM199904083401407; BILLER BMK, 1989, J CLIN ENDOCR METAB, V68, P548, DOI 10.1210/jcem-68-3-548; Birketvedt GS, 1999, JAMA-J AM MED ASSOC, V282, P657, DOI 10.1001/jama.282.7.657; Birmingham CL, 1996, INT J EAT DISORDER, V20, P211, DOI 10.1002/(SICI)1098-108X(199609)20:2<211::AID-EAT13>3.0.CO;2-5; Birmingham CL, 1999, INT J EAT DISORDER, V25, P219; Blais MA, 2000, INT J EAT DISORDER, V27, P140, DOI 10.1002/(SICI)1098-108X(200003)27:2<140::AID-EAT2>3.0.CO;2-E; Bosch X, 2000, JAMA-J AM MED ASSOC, V283, P1405, DOI 10.1001/jama.283.11.1405; BOSCH X, 2000, JAMA-J AM MED ASSOC, V283, P1409; Brown JM, 2000, WESTERN J MED, V172, P189, DOI 10.1136/ewjm.172.3.189; Bulik CM, 2000, INT J EAT DISORDER, V28, P139, DOI 10.1002/1098-108X(200009)28:2&lt;139::AID-EAT2&gt;3.0.CO;2-G; Bulik CM, 1999, J CLIN PSYCHIAT, V60, P130, DOI 10.4088/JCP.v60n0212; Bulik CM, 1997, J NERV MENT DIS, V185, P704, DOI 10.1097/00005053-199711000-00009; Carlat DJ, 1997, AM J PSYCHIAT, V154, P1127; Casper RC, 1998, PSYCHOPHARMACOL BULL, V34, P267; Chun AB, 1997, AM J GASTROENTEROL, V92, P1879; COMERCI GD, 1997, ADOLESCENT MED, P683; Conti J, 1998, J PSYCHOSOM RES, V44, P465, DOI 10.1016/S0022-3999(97)00271-7; COOKE RA, 1994, BRIT HEART J, V72, P69; COOKE RA, 1995, BRIT J HOSP MED, V54, P313; COPELAND PM, 1995, PSYCHOSOM MED, V57, P121, DOI 10.1097/00006842-199503000-00004; Crosby RD, 2000, WESTERN J MED, V172, P165, DOI 10.1136/ewjm.172.3.165; Cumming DC, 1996, ARCH INTERN MED, V156, P2193, DOI 10.1001/archinte.156.19.2193; Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P1318, DOI 10.1001/jama.283.10.1318; Daneman D, 1998, HORM RES, V50, P79, DOI 10.1159/000053110; DAVIES KM, 1990, BONE, V11, P143, DOI 10.1016/8756-3282(90)90207-F; DESIMONE GD, 1994, BRIT HEART J, V71, P287; DEVUYST O, 1993, Q J MED, V86, P791; Dresser GK, 2000, CLIN PHARMACOKINET, V38, P41, DOI 10.2165/00003088-200038010-00003; DURAKOVIC Z, 1994, INT J CARDIOL, V45, P115, DOI 10.1016/0167-5273(94)90266-6; EAGLES JM, 1995, AM J PSYCHIAT, V152, P1266; Eisler I, 1997, ARCH GEN PSYCHIAT, V54, P1025; FAHY TA, 1991, PSYCHOL MED, V21, P577, DOI 10.1017/S0033291700022200; Fairley R., 1993, Animal Production, V56, P468; FALK JR, 1982, BIOL PSYCHIAT, V17, P799; FICHTER MM, 1991, INT J EAT DISORDER, V10, P571, DOI 10.1002/1098-108X(199109)10:5&lt;571::AID-EAT2260100510&gt;3.0.CO;2-J; Fichter MM, 1999, INT J EAT DISORDER, V26, P359; Field AE, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e36; FISHER M, 1995, J ADOLESCENT HEALTH, V16, P420, DOI 10.1016/1054-139X(95)00069-5; Fogelholm M, 1999, MED SCI SPORT EXER, V31, P229, DOI 10.1097/00005768-199902000-00005; FRANKO DL, 1993, INT J EAT DISORDER, V13, P41, DOI 10.1002/1098-108X(199301)13:1&lt;41::AID-EAT2260130106&gt;3.0.CO;2-L; FRISCH RE, 1973, HUM BIOL, V45, P469; GARNER DM, 1993, LANCET, V341, P1631, DOI 10.1016/0140-6736(93)90768-C; Garner DM, 1998, CHILD ADOL PSYCH CL, V7, P839, DOI 10.1016/S1056-4993(18)30215-3; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; GARNER DM, 1985, J PSYCHIAT RES, V19, P423, DOI 10.1016/0022-3956(85)90049-4; Gazewood JD, 1998, J FAM PRACTICE, V47, P19; Goebel G, 1999, INT J EAT DISORDER, V25, P143, DOI 10.1002/(SICI)1098-108X(199903)25:2&lt;143::AID-EAT3&gt;3.0.CO;2-3; Golden NH, 1996, J PEDIATR-US, V128, P296, DOI 10.1016/S0022-3476(96)70414-6; Golden NH, 1997, ARCH PEDIAT ADOL MED, V151, P16, DOI 10.1001/archpedi.1997.02170380020003; GOLDEN NH, 1994, INT J EAT DISORDER, V16, P53, DOI 10.1002/1098-108X(199407)16:1<53::AID-EAT2260160105>3.0.CO;2-V; Gowers SG, 2000, BRIT J PSYCHIAT, V176, P138, DOI 10.1192/bjp.176.2.138; GREENFELD D, 1995, AM J PSYCHIAT, V152, P60; Greenspan SL, 1998, J BONE MINER RES, V13, P1431, DOI 10.1359/jbmr.1998.13.9.1431; Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P3861, DOI 10.1210/jc.81.11.3861; Grinspoon S, 1999, J CLIN ENDOCR METAB, V84, P2049, DOI 10.1210/jc.84.6.2049; Grinspoon S, 2000, ANN INTERN MED, V133, P790, DOI 10.7326/0003-4819-133-10-200011210-00011; Gull W., 1874, CLIN SOC T, V7, P22; GUSTAVSSON CG, 1989, J INTERN MED, V225, P63, DOI 10.1111/j.1365-2796.1989.tb00039.x; GWIRTSMAN HE, 1990, J CLIN PSYCHIAT, V51, P378; HALL A, 1987, BRIT J PSYCHIAT, V151, P185, DOI 10.1192/bjp.151.2.185; HALMI KA, 1991, ARCH GEN PSYCHIAT, V48, P712; Halmi KA, 1998, JAMA-J AM MED ASSOC, V279, P1992, DOI 10.1001/jama.279.24.1992; HERGENROEDER AC, 1995, J PEDIATR-US, V126, P683, DOI 10.1016/S0022-3476(95)70393-4; Herzog DB, 1996, PSYCHIAT CLIN N AM, V19, P843, DOI 10.1016/S0193-953X(05)70385-3; HERZOG DB, 1993, J AM ACAD CHILD PSY, V32, P835, DOI 10.1097/00004583-199307000-00020; HIRAKAWA M, 1990, DIGEST DIS SCI, V35, P733, DOI 10.1007/BF01540176; Hotta M, 2000, J CLIN ENDOCR METAB, V85, P200, DOI 10.1210/jc.85.1.200; Howard WT, 1999, AM J PSYCHIAT, V156, P1697; Hsu LKG, 1996, PSYCHIAT CLIN N AM, V19, P681, DOI 10.1016/S0193-953X(05)70375-0; ISNER JM, 1985, ANN INTERN MED, V102, P49, DOI 10.7326/0003-4819-102-1-49; Jeejeebhoy K N, 1998, Semin Gastrointest Dis, V9, P183; JOHNSON GL, 1986, ARCH INTERN MED, V146, P1525, DOI 10.1001/archinte.146.8.1525; Karney P, 2000, J GEN INTERN MED, V15, P600, DOI 10.1046/j.1525-1497.2000.00623.x; KASSETT JA, 1988, AM J PSYCHIAT, V145, P1287; Kaye WH, 1996, PSYCHIAT CLIN N AM, V19, P793, DOI 10.1016/S0193-953X(05)70382-8; KAYE WH, 1991, J CLIN PSYCHIAT, V52, P464; Keel PK, 1999, ARCH GEN PSYCHIAT, V56, P63, DOI 10.1001/archpsyc.56.1.63; Kiningham RB, 1996, AM FAM PHYSICIAN, V53, P1185; Kleifield EI, 1996, PSYCHIAT CLIN N AM, V19, P715, DOI 10.1016/S0193-953X(05)70377-4; KLIBANSKI A, 1995, J CLIN ENDOCR METAB, V80, P898, DOI 10.1210/jc.80.3.898; Kohn MR, 1998, J ADOLESCENT HEALTH, V22, P239, DOI 10.1016/S1054-139X(97)00163-8; KOLLAI M, 1994, EUR HEART J, V15, P1113, DOI 10.1093/oxfordjournals.eurheartj.a060636; KRAHN DD, 1993, J AM DIET ASSOC, V93, P434, DOI 10.1016/0002-8223(93)92291-5; Kreipe R E, 1995, Pediatr Rev, V16, P370, DOI 10.1542/pir.16-10-370; KREIPE RE, 1992, PEDIATR ANN, V21, P760; KREIPE RE, 1989, AM J DIS CHILD, V143, P1322, DOI 10.1001/archpedi.1989.02150230080027; Kulak CAM, 1999, INT J FERTIL WOMEN M, V44, P269; Lambe EK, 1997, ARCH GEN PSYCHIAT, V54, P537; Lennkh C, 1999, J PSYCHIATR RES, V33, P349, DOI 10.1016/S0022-3956(99)00002-3; Lucas AR, 1999, MAYO CLIN PROC, V74, P972; LUCAS AR, 1991, AM J PSYCHIAT, V148, P917; Mangrum JM, 2000, NEW ENGL J MED, V342, P703, DOI 10.1056/NEJM200003093421006; McIver B, 1997, MAYO CLIN PROC, V72, P1161, DOI 10.4065/72.12.1161; MEHLER PS, 1993, INT J EAT DISORDER, V14, P297, DOI 10.1002/1098-108X(199311)14:3&lt;297::AID-EAT2260140308&gt;3.0.CO;2-X; MEHLER PS, 1995, AM J HEMATOL, V49, P171, DOI 10.1002/ajh.2830490219; Mehler PS, 1998, INT J EAT DISORDER, V24, P217, DOI 10.1002/(SICI)1098-108X(199809)24:2&lt;217::AID-EAT11&gt;3.0.CO;2-W; Mehler PS, 1999, INT J EAT DISORDER, V26, P189, DOI 10.1002/(SICI)1098-108X(199909)26:2&lt;189::AID-EAT8&gt;3.0.CO;2-V; MEHLER PS, 1998, J PREV TREAT, V6, P65; MEHLER PS, 2000, WOMENS HLTH SERIES, P140; Melchior J C, 1998, Curr Opin Clin Nutr Metab Care, V1, P481, DOI 10.1097/00075197-199811000-00001; MOORE DC, 1993, J AM COLL NUTR, V12, P505, DOI 10.1080/07315724.1993.10718343; Morgan JF, 2000, WESTERN J MED, V172, P164, DOI 10.1136/ewjm.172.3.164; Neumarker KJ, 1997, INT J EAT DISORDER, V21, P205, DOI 10.1002/(SICI)1098-108X(199704)21:3<205::AID-EAT1>3.0.CO;2-O; NeumarkSztainer D, 1996, ARCH PEDIAT ADOL MED, V150, P304, DOI 10.1001/archpedi.1996.02170280074014; NOZOE SI, 1995, J PSYCHOSOM RES, V39, P271, DOI 10.1016/0022-3999(94)00141-Q; OBARZANEK E, 1994, AM J CLIN NUTR, V60, P666, DOI 10.1093/ajcn/60.5.666; Pauly RP, 2000, INT J EAT DISORDER, V28, P231, DOI 10.1002/1098-108X(200009)28:2&lt;231::AID-EAT14&gt;3.0.CO;2-8; Pawluck DE, 1998, INT J EAT DISORDER, V23, P347, DOI 10.1002/(SICI)1098-108X(199805)23:4&lt;347::AID-EAT1&gt;3.0.CO;2-I; PLATTE P, 1994, INT J EAT DISORDER, V16, P45, DOI 10.1002/1098-108X(199407)16:1&lt;45::AID-EAT2260160104&gt;3.0.CO;2-Z; PRYOR T, 1995, PSYCHIAT ANN, V25, P40, DOI 10.3928/0048-5713-19950101-10; REINDOLLAR RH, 1986, AM J OBSTET GYNECOL, V155, P531, DOI 10.1016/0002-9378(86)90274-7; RICH LM, 1990, ARCH INTERN MED, V150, P894, DOI 10.1001/archinte.150.4.894; Richter JE, 2000, CLEV CLIN J MED, V67, P471; RIGOTTI NA, 1984, NEW ENGL J MED, V311, P1601, DOI 10.1056/NEJM198412203112503; RIGOTTI NA, 1991, JAMA-J AM MED ASSOC, V265, P1133, DOI 10.1001/jama.265.9.1133; Robin AL, 1999, J AM ACAD CHILD PSY, V38, P1482, DOI 10.1097/00004583-199912000-00008; RODIN G, 1991, PSYCHOSOMATICS, V32, P171, DOI 10.1016/S0033-3182(91)72088-4; ROSENVINGE JH, 1990, BRIT J PSYCHIAT, V156, P92, DOI 10.1192/bjp.156.1.92; Rubinstein S, 2000, JAMA-J AM MED ASSOC, V283, P1569, DOI 10.1001/jama.283.12.1569; RUSSELL GFM, 1966, BRIT J PSYCHIAT, V112, P203, DOI 10.1192/bjp.112.483.203; Rydall AC, 1997, NEW ENGL J MED, V336, P1849, DOI 10.1056/NEJM199706263362601; SALISBURY JJ, 1995, INT J EAT DISORDER, V17, P337, DOI 10.1002/1098-108X(199505)17:4&lt;337::AID-EAT2260170405&gt;3.0.CO;2-Q; SAMBROOK P, 1993, NEW ENGL J MED, V328, P1747, DOI 10.1056/NEJM199306173282404; SCHOCKEN DD, 1989, ARCH INTERN MED, V149, P877, DOI 10.1001/archinte.149.4.877; SHISSLAK CM, 1995, INT J EAT DISORDER, V18, P209, DOI 10.1002/1098-108X(199511)18:3&lt;209::AID-EAT2260180303&gt;3.0.CO;2-E; Shoebridge P, 2000, BRIT J PSYCHIAT, V176, P132, DOI 10.1192/bjp.176.2.132; Slay HA, 1998, INT J EAT DISORDER, V23, P267, DOI 10.1002/(SICI)1098-108X(199804)23:3<267::AID-EAT4>3.0.CO;2-H; SOLOMON SM, 1990, JPEN-PARENTER ENTER, V14, P90, DOI 10.1177/014860719001400190; Soyka LA, 1999, J CLIN ENDOCR METAB, V84, P4489, DOI 10.1210/jc.84.12.4489; STACHER G, 1987, GASTROENTEROLOGY, V92, P1000, DOI 10.1016/0016-5085(87)90976-0; STEWART DE, 1990, AM J OBSTET GYNECOL, V163, P1196, DOI 10.1016/0002-9378(90)90688-4; STOFF JS, 1982, AM J MED, V72, P489, DOI 10.1016/0002-9343(82)90520-4; STRACHER G, 1994, INT J EAT DISORDER, V14, P297; Strober M, 2000, AM J PSYCHIAT, V157, P393, DOI 10.1176/appi.ajp.157.3.393; Strober M, 1997, INT J EAT DISORDER, V22, P339, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;339::AID-EAT1&gt;3.0.CO;2-N; Sullivan PF, 1998, AM J PSYCHIAT, V155, P939, DOI 10.1176/ajp.155.7.939; SUNDGOTBORGEN J, 1994, SPORTS MED, V17, P176, DOI 10.2165/00007256-199417030-00004; SZMUKLER GI, 1995, INT J EAT DISORDER, V17, P347, DOI 10.1002/1098-108X(199505)17:4<347::AID-EAT2260170406>3.0.CO;2-K; TAUB DE, 1992, ADOLESCENCE, V27, P833; THEARDEC J, 1997, ACTA PSYCHIAT SCAND, V214, pS1; *US DEP HHS, 1993, NIH PUBL; WALDHOLTZ BD, 1990, GASTROENTEROLOGY, V98, P1415, DOI 10.1016/0016-5085(90)91070-M; Wallace JI, 1997, CLIN GERIATR MED, V13, P717; Walsh BT, 1998, SCIENCE, V280, P1387, DOI 10.1126/science.280.5368.1387; Walsh JME, 2000, J GEN INTERN MED, V15, P577, DOI 10.1046/j.1525-1497.2000.02439.x; Ward A, 1997, INT J EAT DISORDER, V22, P71, DOI 10.1002/(SICI)1098-108X(199707)22:1&lt;71::AID-EAT9&gt;3.0.CO;2-#; WARREN MP, 1992, J CLIN ENDOCR METAB, V75, P1393, DOI 10.1210/jc.75.6.1393; WEINER K, 1999, EATING DISORDERS GUI; WHITEHOUSE AM, 1992, BRIT J GEN PRACT, V42, P57; Wiseman CV, 1998, MED CLIN N AM, V82, P145, DOI 10.1016/S0025-7125(05)70598-8; ZERBE KJ, 1992, B MENNINGER CLIN, V56, P167; Zipfel S, 2000, LANCET, V355, P721, DOI 10.1016/S0140-6736(99)05363-5	159	49	52	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2001	134	11					1048	1059		10.7326/0003-4819-134-11-200106050-00011	http://dx.doi.org/10.7326/0003-4819-134-11-200106050-00011			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	436YL	11388818				2022-12-28	WOS:000168963400005
J	Tappin, DM; Mackenzie, JM; Brown, AJ; Girdwood, RWA; Britten, J; Broadfoot, M				Tappin, DM; Mackenzie, JM; Brown, AJ; Girdwood, RWA; Britten, J; Broadfoot, M			Comparison of breastfeeding rates in Scotland in 1990-1 and 1997-8	BRITISH MEDICAL JOURNAL			English	Article									Royal Hosp Sick Children, Dept Child Hlth, Paediat Epidemiol & Community Hlth Unit, Glasgow G3 8SJ, Lanark, Scotland; Stobhill Gen Hosp, Scottish Inborn Errors Screening Lab, Glasgow G21 3UW, Lanark, Scotland	University of Glasgow	Tappin, DM (corresponding author), Royal Hosp Sick Children, Dept Child Hlth, Paediat Epidemiol & Community Hlth Unit, Glasgow G3 8SJ, Lanark, Scotland.							FERGUSON AE, 1994, BRIT MED J, V308, P824, DOI 10.1136/bmj.308.6932.824; Foster K, 1997, INFANT FEEDING 1995; *MAN EX, 1994, LOC BREASTF TARG, P1; *REG GEN SCOTL, 1998, LIV BIRTHS AG MOTH; *WORK GROUP WEAN D, 1994, WEAN WEAN DIET, P49	5	17	17	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2001	322	7298					1335	1336		10.1136/bmj.322.7298.1335	http://dx.doi.org/10.1136/bmj.322.7298.1335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387179	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000169167900018
J	Dubois, L; Lecourtois, M; Alexandre, C; Hirst, E; Vincent, JP				Dubois, L; Lecourtois, M; Alexandre, C; Hirst, E; Vincent, JP			Regulated endocytic routing modulates wingless signaling in Drosophila embryos	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; EGF RECEPTOR; GRADIENT FORMATION; SPEMANN ORGANIZER; HORSERADISH-PEROXIDASE; MORPHOGEN GRADIENT; VENTRAL ECTODERM; TYROSINE KINASE; CELL-SURFACE; EPIDERMIS	Embryos have evolved various strategies to confine the action of secreted signals. Using an HRP-Wingless fusion protein to track the fate of endocytosed Wingless, we show that degradation by targeting to lysosomes is one such strategy. Wingless protein is specifically degraded at the posterior of each stripe of wingless transcription, even under conditions of over-expression. If lysosomal degradation is compromised genetically or chemically, excess Wingless accumulates and ectopic signaling ensues. In the wild-type, Wingless degradation is slower at the anterior than at the posterior. This follows in part from the segmental activation of signaling by the epidermal growth factor receptor, which accelerates Wingless degradation at the posterior, thus leading to asymmetrical Wingless signaling along the anterior-posterior axis.	Natl Inst Med Res, London NW7 1AA, England	MRC National Institute for Medical Research	Vincent, JP (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.		LECOURTOIS, Magalie/AAL-2531-2020	LECOURTOIS, Magalie/0000-0002-4257-1974				Alexandre C, 1999, DEVELOPMENT, V126, P5689; ARIAS AM, 1993, DEV DROSOPHILA MELAN, P517; ASTROMOFF A, 1995, P NATL ACAD SCI USA, V92, P8110, DOI 10.1073/pnas.92.18.8110; BAZINET C, 1993, GENETICS, V134, P1119; BEJSOVEC A, 1995, GENETICS, V139, P309; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bergeron JJM, 1995, BIOSCIENCE REP, V15, P411, DOI 10.1007/BF01204345; Bohm SK, 1997, BIOCHEM J, V322, P1; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; CLIFFORD R, 1992, DEVELOPMENT, V115, P853; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dickinson WJ, 1997, CELL MOTIL CYTOSKEL, V38, P9; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gabay L, 1996, DEVELOPMENT, V122, P3355; GONZALEZ F, 1991, MECH DEVELOP, V35, P43, DOI 10.1016/0925-4773(91)90040-D; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lawrence PA, 1996, DEVELOPMENT, V122, P4095; LECOURTOIS M, 2001, IN PRESS DEV BIOL; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Moline MM, 1999, DEVELOPMENT, V126, P4375; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Sunio A, 1999, MOL BIOL CELL, V10, P847, DOI 10.1091/mbc.10.4.847; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; VINCENT JP, 1992, CELL, V68, P923, DOI 10.1016/0092-8674(92)90035-B; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang J, 1998, DEVELOPMENT, V125, P3075; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	50	175	175	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					613	624		10.1016/S0092-8674(01)00375-0	http://dx.doi.org/10.1016/S0092-8674(01)00375-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389831	Bronze			2022-12-28	WOS:000169123200008
J	Finlay, BB				Finlay, BB			Microbiology - Cracking Listeria's password	SCIENCE			English	Editorial Material							E-CADHERIN; MONOCYTOGENES; INFECTION; RECEPTOR; CELLS; ENTRY		Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Finlay, BB (corresponding author), Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1Z3, Canada.							Busch DH, 1999, IMMUNOL REV, V172, P163, DOI 10.1111/j.1600-065X.1999.tb01364.x; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Finlay BB, 1999, CELL, V96, P315, DOI 10.1016/S0092-8674(00)80544-9; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Mead PS, 1999, EMERG INFECT DIS, V5, P841, DOI 10.3201/eid0506.990625; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; RACZ P, 1972, LAB INVEST, V26, P694; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E	10	9	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1665	+		10.1126/science.1062045	http://dx.doi.org/10.1126/science.1062045			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387462				2022-12-28	WOS:000169031800028
J	Guenin, LM				Guenin, LM			Essays on science and society - Morals and primordials	SCIENCE			English	Editorial Material									Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Guenin, LM (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.								0	17	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1659	1660		10.1126/science.1062513	http://dx.doi.org/10.1126/science.1062513			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387460				2022-12-28	WOS:000169031800024
J	Ito, G				Ito, G			Reykjanes 'V'-shaped ridges originating from a pulsing and dehydrating mantle plume	NATURE			English	Article							MID-OCEANIC RIDGE; NORTHWEST ICELAND; DYNAMICS; FLOW; MAGNETOSTRATIGRAPHY; EVOLUTION; PIPE	Prominent crustal lineations straddle the Reykjanes ridge, south of Iceland (Fig. 1). These giant V-shaped features are thought to record temporal variations in magma production at the Reykjanes ridge axis, associated with along-axis flow of Icelandic plume material 1. It has been proposed that this flow is channelled preferentially along the ridge axis(2-4), and that temporal variability is induced by fluctuations of the Iceland plume itself(1,4-7) or, alternatively, by relocations of the ridge axis on Iceland(8). Here I present a geodynamic model that predicts the formation of crustal V-shaped ridges from a pulsing and radially flowing mantle plume. In this model, plume pulses produce mantle temperature perturbations that expand away from the plume in all directions beneath the zone of partial melting. The melting zone has a high viscosity owing to mantle dehydration at the onset of partial melting(9). This high-viscosity region allows for reasonable variations in crustal thickness, produces crustal Vs that extend hundreds of kilometres along the axis, and prevents the plume material from being preferentially channelled along the ridge axis. The angle of the crustal V-shaped features relative to the ridge axis reflects the rate of lateral plume flow, which remains several times greater than the ridge half-spreading rate over the length of a crustal V. Consequently, this radially expanding plume produces lineations in crustal thickness and free-air gravity anomalies that appear to be nearly straight.	Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis	Ito, G (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.	gito@geology.ucdavis.edu						Albers M, 2001, EARTH PLANET SC LETT, V187, P207, DOI 10.1016/S0012-821X(01)00276-X; Allen RM, 1999, GEOPHYS J INT, V137, P51, DOI 10.1046/j.1365-246x.1999.00753.x; Canning J, 1999, OPT PHOTONICS NEWS, V10, P4; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; FEIGHNER MA, 1995, EARTH PLANET SC LETT, V129, P171, DOI 10.1016/0012-821X(94)00247-V; GABLE CW, 1989, NUMERICAL MODELS PLA; Hanan BB, 1997, EARTH PLANET SC LETT, V151, P43, DOI 10.1016/S0012-821X(97)00105-2; Hardarson BS, 1997, EARTH PLANET SC LETT, V153, P181, DOI 10.1016/S0012-821X(97)00145-3; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Ito G, 1999, EARTH PLANET SC LETT, V165, P81, DOI 10.1016/S0012-821X(98)00216-7; Ito G, 1996, EARTH PLANET SC LETT, V144, P53, DOI 10.1016/0012-821X(96)00151-3; MCDOUGALL I, 1984, J GEOPHYS RES, V89, P7029, DOI 10.1029/JB089iB08p07029; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; Menke W, 1996, GEOPHYS J INT, V126, P166, DOI 10.1111/j.1365-246X.1996.tb05275.x; OLSON P, 1986, J GEOPHYS RES-SOLID, V91, P6367, DOI 10.1029/JB091iB06p06367; PARKER RL, 1973, GEOPHYS J ROY ASTR S, V31, P447, DOI 10.1111/j.1365-246X.1973.tb06513.x; RIBE NM, 1995, EARTH PLANET SC LETT, V134, P155, DOI 10.1016/0012-821X(95)00116-T; Sandwell DT, 1997, J GEOPHYS RES-SOL EA, V102, P10039, DOI 10.1029/96JB03223; SCHILLING JG, 1982, NATURE, V296, P313, DOI 10.1038/296313a0; SCHILLING JG, 1974, EARTH PLANET SC LETT, V24, P1, DOI 10.1016/0012-821X(74)90002-8; SCHILLING JG, 1985, NATURE, V314, P62, DOI 10.1038/314062a0; SCOTT DR, 1986, NATURE, V319, P759, DOI 10.1038/319759a0; Staples RK, 1997, J GEOPHYS RES-SOL EA, V102, P7849, DOI 10.1029/96JB03911; Vogt P.R., 1983, STRUCTURE DEV GREENL, P191, DOI [10.1007/978-1-4613-3485-9_11, DOI 10.1007/978-1-4613-3485-9_11]; VOGT PR, 1971, EARTH PLANET SC LETT, V13, P153, DOI 10.1016/0012-821X(71)90118-X; VOGT PR, 1979, GEOLOGY, V7, P93, DOI 10.1130/0091-7613(1979)7<93:GMENEA>2.0.CO;2; VOGT PR, 1976, EARTH PLANET SC LETT, V29, P309, DOI 10.1016/0012-821X(76)90135-7; WATKINS ND, 1977, AM J SCI, V277, P513, DOI 10.2475/ajs.277.5.513; Wessel P., 1995, EOS T AM GEOPHYS UN, V79, P329, DOI [10.1029/95EO00198, DOI 10.1029/95EO00198]; WHITE RS, 1995, J GEOL SOC LONDON, V152, P1039, DOI 10.1144/GSL.JGS.1995.152.01.26; Wolfe CJ, 1997, NATURE, V385, P245, DOI 10.1038/385245a0	31	118	120	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					681	684		10.1038/35079561	http://dx.doi.org/10.1038/35079561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395767				2022-12-28	WOS:000169112500041
J	Eichhorn, E; Domanski, M; Krause-Steinrauf, H; Anderson, J; Boardman, K; Bristow, M; Carson, P; Colling, C; Greenberg, B; Lavori, P				Eichhorn, E; Domanski, M; Krause-Steinrauf, H; Anderson, J; Boardman, K; Bristow, M; Carson, P; Colling, C; Greenberg, B; Lavori, P		Beta-Blocker Evaluatin Survival Tr	A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; ADRENERGIC-BLOCKADE; RACIAL-DIFFERENCES; CARDIOMYOPATHY; METOPROLOL; CARVEDILOL	Background: Although beta-adrenergic-receptor antagonists reduce morbidity and mortality in patients with mild-to-moderate chronic heart failure, their effect on survival in patients with more advanced heart failure is unknown. Methods: A total of 2708 patients with heart failure designated as New York Heart Association (NYHA) functional class III (in 92 percent of the patients) or IV (in 8 percent) and a left ventricular ejection fraction of 35 percent or lower were randomly assigned to double-blind treatment with either bucindolol (1354 patients) or placebo (1354 patients) and followed for the primary end point of death from any cause. Results: The data and safety monitoring board recommended stopping the trial after the seventh interim analysis. At that time, there was no significant difference in mortality between the two groups (unadjusted P=0.16). The results presented here are based on complete follow-up at the time of study termination (average, 2.0 years). There were a total of 449 deaths in the placebo group (33 percent) and 411 deaths in the bucindolol group (30 percent, adjusted P=0.13). The risk of the secondary end point of death from cardiovascular causes was lower in the bucindolol group (hazard ratio, 0.86; 95 percent confidence interval, 0.74 to 0.99), as was the risk of heart transplantation or death. In a subgroup analysis, there was a survival benefit in nonblack patients. Conclusions: In a demographically diverse group of patients with NYHA class III and IV heart failure, bucindolol resulted in no significant overall survival benefit. (N Engl J Med 2001;344:1659-67.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Texas, SW Med Ctr, Cardiac Catheterizat Lab IIIA2, Dallas, TX 75216 USA; Univ Texas, Dallas Vet Affairs Med Ctr, Cardiac Catheterizat Lab IIIA2, Dallas, TX 75216 USA; Albany Med Ctr, Albany, NY 12208 USA; Albert Einstein Coll Med, Bronx, NY 10461 USA; Baptist Mem Hosp, Memphis, TN 38146 USA; Baylor Coll Med, Houston, TX 77030 USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Cook Cty Hosp, Chicago, IL 60612 USA; Dartmouth Hitchcock Med Ctr, Hanover, NH 03756 USA; Duke Univ, Med Ctr, Durham, NC 27706 USA; Elmhurst Hosp Ctr, Elmhurst, NY 11373 USA; George Washington Univ, Washington, DC 20052 USA; Georgetown Univ Hosp, Washington, DC 20007 USA; Grady Mem Hosp, Atlanta, GA 30335 USA; Hosp Univ Penn, Philadelphia, PA 19104 USA; Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; Latter Day St Hosp, Salt Lake City, UT 84143 USA; Louisiana State Univ, Baton Rouge, LA 70803 USA; Loyola Univ, Med Ctr, Maywood, IL 60153 USA; Maricopa Med Res Fdn, Phoenix, AZ USA; Mayo Clin, Rochester, MN USA; Mayo Clin Scottsdale, Scottsdale, AZ USA; Med Coll Penn & Hahnemann Univ, Philadelphia, PA 19102 USA; Virginia Commonwealth Univ Med Coll Virginia, Richmond, VA 23298 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Med Univ S Carolina, Charleston, SC 29425 USA; Minneapolis Heart Inst, Minneapolis, MN USA; Montreal Heart Inst, Montreal, PQ, Canada; Morristown Mem Hosp, Morristown, NJ 07962 USA; Natl Naval Med Ctr, Bethesda, MD 20889 USA; Nebraska Heart Inst, Lincoln, NE USA; Tufts Univ New England Med Ctr, Boston, MA 02111 USA; Oklahoma Fdn Cardiol Res, Oklahoma City, OK USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Penn State Univ Hosp, Hershey, PA 17033 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; Univ Florida, Shands Hosp, Gainesville, FL 32611 USA; St Johns Mercy Med Ctr, St Louis, MO 63141 USA; Univ Texas SW, Dallas, TX USA; Washington Univ, Sch Med, St Louis, MO 63130 USA; Univ Alabama, Med Ctr, Tuscaloosa, AL 35487 USA; Univ Calif San Diego, Med Ctr, La Jolla, CA 92093 USA; Univ Cincinnati, Cincinnati, OH 45221 USA; Univ Colorado, Hlth Sci Ctr, Boulder, CO 80309 USA; Univ Connecticut, Ctr Hlth, Storrs, CT 06269 USA; Univ Florida, Hlth Sci Ctr, Gainesville, FL 32611 USA; Univ Iowa Hosp, Iowa City, IA USA; Univ Maryland, College Pk, MD 20742 USA; Univ Arizona, Univ Med Ctr, Tucson, AZ 85721 USA; Univ Minnesota Hosp, Minneapolis, MN 55455 USA; Univ Mississippi, Med Ctr, University, MS 38677 USA; Univ Montreal, Montreal, PQ H3C 3J7, Canada; Univ N Carolina, Chapel Hill, NC 27515 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; Univ Rochester, Med Ctr, Rochester, NY 14627 USA; Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA; Watson Clin, Lakeland, FL USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA; Vet Affairs Med Ctr Baltimore, Baltimore, MD 21201 USA; VAMC Boston, Boston, MA 02130 USA; VAMC Bronx, Bronx, NY 10468 USA; VAMC Charleston, Charleston, SC 29403 USA; VAMC Dallas, Dallas, TX 75216 USA; VAMC Denver, Denver, CO 80220 USA; VAMC Durham, Durham, NC 27705 USA; VAMC Fresno, Fresno, CA 93703 USA; VAMC Hines, Hines, IL USA; VAMC Houston, Houston, TX 77211 USA; VAMC Jackson, Jackson, MS 39216 USA; VAMC Lexington, Lexington, KY 40511 USA; VAMC Little Rock, Little Rock, AR 72205 USA; VAMC Long Beach, Long Beach, CA 90822 USA; VAMC Madison, Madison, WI 53705 USA; VAMC Memphis, Memphis, TN 38104 USA; VAMC Minneapolis, Minneapolis, MN 55417 USA; VAMC Newington, Newington, CT 06111 USA; VAMC Portland, Portland, OR 97207 USA; VAMC Richmond, Richmond, VA 23249 USA; VAMC St Louis, St Louis, MO 63125 USA; VAMC Salem, Salem, VA USA; VAMC San Francisco, San Francisco, CA 94121 USA; VAMC San Diego, San Diego, CA 92161 USA; VAMC Sepulveda, Sepulveda, CA 91343 USA; VAMC San Antonio, San Antonio, TX 78284 USA; VAMC Tampa, Tampa, FL USA; VAMC Tucson, Tucson, AZ 85723 USA; VAMC Washington, Washington, DC USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; Albany Medical College; Yeshiva University; Albert Einstein College of Medicine; Baptist Memorial Hospital Memphis; Baylor College of Medicine; Cedars Sinai Medical Center; Cleveland Clinic Foundation; John H Stroger Junior Hospital Cook County; Dartmouth College; Duke University; George Washington University; Georgetown University; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Medicine; Louisiana State University System; Louisiana State University; Loyola University Chicago; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Drexel University; Virginia Commonwealth University; Medical College of Wisconsin; Medical University of South Carolina; Minneapolis Heart Institute Foundation; Universite de Montreal; Atlantic Health System; Walter Reed National Military Medical Center; Tufts Medical Center; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; State University System of Florida; University of Florida; Saint Johns Mercy Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); University of Alabama System; University of Alabama Tuscaloosa; University of California System; University of California San Diego; University System of Ohio; University of Cincinnati; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of Connecticut; State University System of Florida; University of Florida; University of Iowa; University System of Maryland; University of Maryland College Park; University of Arizona; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota Hospital; University of Mississippi; University of Mississippi Medical Center; Universite de Montreal; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Rochester; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Hunter Holmes McGuire Veterinary Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Salem Veterans Affairs Medical Center	Eichhorn, E (corresponding author), Univ Texas, SW Med Ctr, Cardiac Catheterizat Lab IIIA2, 4500 S Lancaster, Dallas, TX 75216 USA.		bristow, michael r/G-7850-2011					ANDERSON JL, 1995, AM J CARDIOL, V75, P1220; Bloem LJ, 1996, HYPERTENSION, V27, P62, DOI 10.1161/01.HYP.27.1.62; Bristow MR, 1998, CLIN CARDIOL, V21, P3; BRISTOW MR, 1999, CLIN CARDIOL, V22; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Coats AJS, 1999, INT J CARDIOL, V71, P109, DOI 10.1016/S0167-5273(99)00120-5; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; COX DR, 1972, J R STAT SOC B, V34, P187; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Dries DL, 1999, NEW ENGL J MED, V341, P298; EFRON B, 1971, BIOMETRIKA, V58, P403, DOI 10.2307/2334377; Eichhorn EJ, 1997, AM J CARDIOL, V79, P794; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; FRANCIS GS, 1993, CIRCULATION, V87, P140; Freudenberger R, 1997, AM J CARDIOL, V80, P1372, DOI 10.1016/S0002-9149(97)00688-7; GILBERT EM, 1990, AM J MED, V88, P223, DOI 10.1016/0002-9343(90)90146-5; Gilbert EM, 1996, CIRCULATION, V94, P2817, DOI 10.1161/01.CIR.94.11.2817; GILLUM RF, 1993, AM HEART J, V126, P1042, DOI 10.1016/0002-8703(93)90738-U; HALL SA, 1995, J AM COLL CARDIOL, V25, P1154, DOI 10.1016/0735-1097(94)00543-Y; HARRELL FE, 1999, DESIGN HMISC S PLUS; HERSHBERGER RE, 1990, J CARDIOVASC PHARM, V15, P959, DOI 10.1097/00005344-199006000-00014; Hjalmarson A, 1999, LANCET, V353, P2001; *INS, 1998, S PLUS VERS 3 4; JOHNSON JA, 1995, J CARDIOVASC PHARM, V25, P90, DOI 10.1097/00005344-199501000-00015; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAY DM, 1995, J AM COLL CARDIOL, V26, P1257; LAKATOS E, 1986, CONTROL CLIN TRIALS, V7, P189, DOI 10.1016/0197-2456(86)90047-4; LAKATOS E, 1988, BIOMETRICS, V44, P229, DOI 10.2307/2531910; LAKATOS E, 1988, BIOMETRICS, V44, P923; LAN KKG, 1990, BIOMETRICS, V46, P759, DOI 10.2307/2532094; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LAN KKG, 1993, STAT MED, V12, P2219, DOI 10.1002/sim.4780122307; Lechat P, 1999, LANCET, V353, P9; Lowes BD, 2000, CIRCULATION, V102, P628; MATERSON BJ, 1994, NEW ENGL J MED, V330, P1689, DOI 10.1056/NEJM199406093302316; Moore MM, 1999, MUTAGENESIS, V14, P271, DOI 10.1093/mutage/14.3.271; PACKER M, 1987, CIRCULATION, V75, P80; Perry G, 1997, NEW ENGL J MED, V336, P525; Rotimi C, 1996, HYPERTENSION, V27, P558, DOI 10.1161/01.HYP.27.3.558; *SAS I, 1996, SAS PROPR SOFTW; Sederberg J, 2000, J AM COLL CARDIOL, V35, p207A; UCHIDA W, 1984, EUR J PHARMACOL, V103, P51, DOI 10.1016/0014-2999(84)90188-2; Yancy C., 1997, Journal of the American College of Cardiology, V29, p284A; Yoshikawa T, 1996, EUR HEART J, V17, P8, DOI 10.1093/eurheartj/17.suppl_B.8; [No title captured]	45	737	763	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2001	344	22					1659	1667						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YG	11386264				2022-12-28	WOS:000168963000002
J	Hugot, JP; Chamaillard, M; Zouali, H; Lesage, S; Cezard, JP; Belaiche, J; Almer, S; Tysk, C; O'Morain, CA; Gassull, M; Binder, V; Finkel, Y; Cortot, A; Modigliani, R; Laurent-Puig, P; Gower-Rousseau, C; Macry, J; Colombel, JF; Sahbatou, M; Thomas, G				Hugot, JP; Chamaillard, M; Zouali, H; Lesage, S; Cezard, JP; Belaiche, J; Almer, S; Tysk, C; O'Morain, CA; Gassull, M; Binder, V; Finkel, Y; Cortot, A; Modigliani, R; Laurent-Puig, P; Gower-Rousseau, C; Macry, J; Colombel, JF; Sahbatou, M; Thomas, G			Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FACTOR-KAPPA-B; COMPLEX SEGREGATION ANALYSIS; LINKAGE DISEQUILIBRIUM; GENE; ACTIVATION; FAMILIES; C3H/HEJ; SEARCH; MICE	Crohn's disease(1,2) and ulcerative colitis, the two main types of chronic inflammatory bowel disease, are multifactorial conditions of unknown aetiology. A susceptibility locus for Crohn's disease has been mapped(3) to chromosome 16. Here we have used a positional-cloning strategy, based on linkage analysis followed by linkage disequilibrium mapping, to identify three independent associations for Crohn's disease: a frameshift variant and two missense variants of NOD2, encoding a member of the Apaf-1/Ced-4 superfamily of apoptosis regulators that is expressed in monocytes. These NOD2 variants alter the structure of either the leucine-rich repeat domain of the protein or the adjacent region. NOD2 activates nuclear factor NF-kB; this activating function is regulated by the carboxy-terminal leucine-rich repeat domain, which has an inhibitory role and also acts as an intracellular receptor for components of microbial pathogens. These observations suggest that the NOD2 gene product confers susceptibility to Crohn's disease by altering the recognition of these components and/or by over-activating NF-kB in monocytes, thus documenting a molecular model for the pathogenic mechanism of Crohn's disease that can now be further investigated.	Fdn Jean Dausset CEPH, F-75010 Paris, France; Hop Robert Debre, Dept Pediat Gastroenterol, PEWG IBD, F-75019 Paris, France; CHU Liege, GETAID, B-4000 Liege, Belgium; CHU Liege, Dept Gastroenterol, B-4000 Liege, Belgium; Linkoping Univ, IHM, Div Gastroenterol & Hepatol, SE-58185 Linkoping, Sweden; Orebro Med Ctr Hosp, Dept Gastroenterol, SE-70185 Orebro, Sweden; Adelaide & Meath Hosp, Dept Gastroenterol, Dublin 24, Ireland; Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Badalona 08916, Spain; Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark; Astrid Lindgren Childrens Hosp, SE-16176 Stockholm, Sweden; Hop Calmette, Registre EPIMAD, F-59037 Lille, France; Hop St Louis, Dept Gastroenterol, F-75475 Paris, France; Hop Robert Debre, INSERM, U458, F-75019 Paris, France; Hop St Antoine, Dept Surg, F-75012 Paris, France	Foundation Jean Dausset-CEPH; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Liege; University of Liege; Linkoping University; Trinity College Dublin; Hospital Germans Trias i Pujol; University of Copenhagen; Herlev & Gentofte Hospital; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Thomas, G (corresponding author), Fdn Jean Dausset CEPH, 27 Rue J Dodu, F-75010 Paris, France.	thomas@cephb.fr	Hugot, Jean-Pierre/F-6594-2012; Chamaillard, Mathias/L-6542-2013; Gower-Rousseau, Corinne/I-2553-2018; CORTOT, Antoine/I-5796-2015; Laurent-Puig, Pierre/K-3641-2019; laurent-puig, pierre/B-2226-2013; CORTOT, ANTOINE/I-7739-2016	Chamaillard, Mathias/0000-0002-0243-9717; Gower-Rousseau, Corinne/0000-0002-3925-5364; Laurent-Puig, Pierre/0000-0001-8475-5459; laurent-puig, pierre/0000-0001-8475-5459; CORTOT, ANTOINE/0000-0002-1067-8996; Almer, Sven/0000-0001-9334-1821; Hugot, Jean-Pierre/0000-0002-8446-6056				AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Calkins BM, 1995, INFLAMM BOWEL DIS, P31; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Cho JH, 2000, HUM MOL GENET, V9, P1425, DOI 10.1093/hmg/9.9.1425; Colombel JF, 1996, GASTROENTEROLOGY, V111, P604, DOI 10.1053/gast.1996.v111.pm8780563; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; Hugot JP, 1999, INT J COLORECTAL DIS, V14, P2, DOI 10.1007/s003840050175; Hugot JP, 1999, GASTROENTEROLOGY, V116, pA740; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; KUSTER W, 1989, AM J MED GENET, V32, P105, DOI 10.1002/ajmg.1320320122; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McKay DM, 1999, CAN J GASTROENTEROL, V13, P509, DOI 10.1155/1999/680206; MONSEN U, 1990, ACTA CHIR SCAND    S, V559, P7; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Olavesen MG, 2000, IMMUNOGENETICS, V51, P1, DOI 10.1007/s002510050001; ORHOLM M, 1993, BRIT MED J, V306, P20, DOI 10.1136/bmj.306.6869.20; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUNDBERG JP, 1994, GASTROENTEROLOGY, V107, P1726, DOI 10.1016/0016-5085(94)90813-3; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; ZOUALI H, UNPUB EUR J HUM GENE	30	4221	4384	10	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					599	603		10.1038/35079107	http://dx.doi.org/10.1038/35079107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385576				2022-12-28	WOS:000168982500055
J	Elkayam, U; Tummala, PP; Rao, K; Akhter, MW; Karaalp, IS; Wani, OR; Hameed, A; Gviazda, I; Shotan, A				Elkayam, U; Tummala, PP; Rao, K; Akhter, MW; Karaalp, IS; Wani, OR; Hameed, A; Gviazda, I; Shotan, A			Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR FUNCTION	Background: Peripartum cardiomyopathy is a rare but sometimes fatal form of heart failure. Little is known about the outcomes of subsequent pregnancies in women who have had the disorder. Methods: Through a survey of members of the American College of Cardiology, we identified 44 women who had had peripartum cardiomyopathy and had a total of 60 subsequent pregnancies. We then reviewed the medical records of these women and interviewed the women or their physicians. Results: Among the first subsequent pregnancies in the 44 women, 28 occurred in women in whom left ventricular function had returned to normal (group 1) and 16 occurred in women with persistent left ventricular dysfunction (group 2). The pregnancies were associated with a reduction in the mean (+/-SD) left ventricular ejection fraction both in the total cohort (from 49+/-12 percent to 42+/-13 percent, P<0.001) and in each group separately (from 56+/-7 percent to 49+/-10 percent in group 1, P=0.002; and from 36+/-9 percent to 32+/-11 percent in group 2, P=0.08). During these pregnancies, symptoms of heart failure occurred in 21 percent of the women in group 1 and 44 percent of those in group 2. The mortality rate was 0 percent in group 1 and 19 percent in group 2 (P=0.06). In addition, the frequency of premature delivery was higher in group 2 (37 percent vs. 11 percent), as was that of therapeutic abortions (25 percent vs. 4 percent). Conclusions: Subsequent pregnancy in women with a history of peripartum cardiomyopathy is associated with a significant decrease in left ventricular function and can result in clinical deterioration and even death. (N Engl J Med 2001;344:1567-71.) Copyright (C) 2001 Massachusetts Medical Society.	Univ So Calif, Sch Med, LAC USC Med Ctr, Dept Med,Div Cardiol,Sect Heart Failure, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA	Los Angeles County+USC Medical Center; University of Southern California; University of Southern California	Elkayam, U (corresponding author), Univ So Calif, Sch Med, LAC USC Med Ctr, Dept Med,Div Cardiol,Sect Heart Failure, 2025 Zonal Ave,Rm 7621, Los Angeles, CA 90033 USA.		Wan Ahmad, Wan Azman/B-9879-2012					Ceci O, 1998, EUR J OBSTET GYN R B, V76, P29, DOI 10.1016/S0301-2115(97)00148-6; DEMAKIS JG, 1971, CIRCULATION, V44, P1053, DOI 10.1161/01.CIR.44.6.1053; ELKAYAM U, 1992, HEART DIS TXB CARDIO, P1790; FEIGENBAUM H, 1994, ECHOCARDIOGR-J CARD, P658; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Geva T, 1997, AM HEART J, V133, P53, DOI 10.1016/S0002-8703(97)70247-3; Heider A L, 1999, Obstet Gynecol Surv, V54, P526, DOI 10.1097/00006254-199908000-00023; Lampert MB, 1997, AM J OBSTET GYNECOL, V176, P189, DOI 10.1016/S0002-9378(97)80034-8; Lang R., 1998, CARDIAC PROBLEMS PRE, V3e, P87; OSTRZEGA E, 1995, CIRCULATION S1, V92, P333; Pearson GD, 2000, JAMA-J AM MED ASSOC, V283, P1183, DOI 10.1001/jama.283.9.1183; SUTTON MS, 1991, AM HEART J, V121, P1776; Witlin AG, 1997, AM J OBSTET GYNECOL, V176, P182, DOI 10.1016/S0002-9378(97)80033-6	13	272	284	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1567	1571		10.1056/NEJM200105243442101	http://dx.doi.org/10.1056/NEJM200105243442101			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372007				2022-12-28	WOS:000168829700001
J	Hopfner, KP; Karcher, A; Craig, L; Woo, TT; Carney, JP; Tainer, JA				Hopfner, KP; Karcher, A; Craig, L; Woo, TT; Carney, JP; Tainer, JA			Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase	CELL			English	Article							CRYSTAL-STRUCTURE; CHROMOSOMES SMC; PROTEIN COMPLEX; RAD50; RECOMBINATION; MAINTENANCE; YEAST; MISMATCH; MUTANTS; BINDING	To clarify functions of the Mre11/Rad50 (MR) complex in DNA double-strand break repair, we report Pyrococcus furiosus Mre11 crystal structures, revealing a protein phosphatase-like, dimanganese binding domain capped by a unique domain controlling active site access. These structures unify Mre11's multiple nuclease activities in a single endo/exonuclease mechanism and reveal eukaryotic macromolecular interaction sites by mapping human and yeast Mre11 mutations. Furthermore, the structure of the P. furiosus Rad50 ABC-ATPase with its adjacent coiled-coil defines a compact Mre11/Rad50-ATPase complex and suggests that Rad50-ATP-driven conformational switching directly controls the Mre11 exonuclease. Electron microscopy, small angle X-ray scattering, and ultracentrifugation data of human and P. furiosus MR reveal a dual functional complex consisting of a (Mre11)(2)/(Rad50)(2) heterotetrameric DNA processing head and a double coiled-coil linker.	Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Dept Radiat Oncol,Radiat Oncol Res Lab, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Mol & Cell Biol Grad Program, Baltimore, MD 21201 USA	Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Tainer, JA (corresponding author), Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	jat@scripps.edu	Hopfner, Karl-Peter/B-6864-2014; Tainer, John/GWQ-4878-2022	Hopfner, Karl-Peter/0000-0002-4528-8357; Tainer, John/0000-0003-1659-2429; Craig, Lisa/0000-0001-8515-9915				ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bierne H, 1997, EMBO J, V16, P3332, DOI 10.1093/emboj/16.11.3332; Bressan DA, 1998, GENETICS, V150, P591; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chamankhah M, 2000, GENETICS, V155, P569; Connelly JC, 1997, J BIOL CHEM, V272, P19819, DOI 10.1074/jbc.272.32.19819; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Dolganov GM, 1996, MOL CELL BIOL, V16, P4832; Fishel R, 1997, CURR OPIN GENET DEV, V7, P105, DOI 10.1016/S0959-437X(97)80117-7; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; JOHZUKA K, 1995, GENETICS, V139, P1521; KADYK LC, 1992, GENETICS, V132, P387; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lam WC, 1999, BIOCHEMISTRY-US, V38, P2661, DOI 10.1021/bi9820762; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; LEACH DRF, 1996, GENETIC RECOMBINATIO; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; OTWINOWSKI Z, 1993, DATA COLLECTION PROC; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Petrini J H, 1997, Semin Immunol, V9, P181, DOI 10.1006/smim.1997.0067; PHILLIPS JW, 1994, MOL CELL BIOL, V14, P5794, DOI 10.1128/MCB.14.9.5794; RAYMOND WE, 1993, NUCLEIC ACIDS RES, V21, P3851, DOI 10.1093/nar/21.16.3851; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; Roth D., 1988, GENETIC RECOMBINATIO, P621; RUSNACK F, 2000, METAL IONS BIOL SYST; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; TURK D, 1992, THESIS TU MUNCHEN; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Zdzienicka MZ, 1996, CANCER SURV, V28, P281	63	392	406	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					473	485		10.1016/S0092-8674(01)00335-X	http://dx.doi.org/10.1016/S0092-8674(01)00335-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371344	Bronze			2022-12-28	WOS:000168840700007
J	Harries, AD; Hargreaves, NJ; Kemp, J; Jindani, A; Enarson, DA; Maher, D; Salaniponi, FM				Harries, AD; Hargreaves, NJ; Kemp, J; Jindani, A; Enarson, DA; Maher, D; Salaniponi, FM			Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; PULMONARY TUBERCULOSIS; DISEASE PROGRESSION; MORTALITY; MALAWI; DIAGNOSIS; COHORT; CARE; IMPACT; ADULTS		Minist Hlth, Natl TB Control Programme, Lilongwe, Malawi; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Int Union TB & Lung Dis, F-75006 Paris, France; WHO, CH-1211 Geneva, Switzerland	Liverpool School of Tropical Medicine; University of Liverpool; World Health Organization	Harries, AD (corresponding author), British High Commiss, POB 30042, Lilongwe 3, Malawi.			Jindani, Amina/0000-0002-7110-5286; Maher, Dermot/0000-0003-0466-1976				ALZEER AH, 1993, TUBERCLE LUNG DIS, V74, P6, DOI 10.1016/0962-8479(93)90060-B; BAUM MK, 1995, AIDS, V9, P1051, DOI 10.1097/00002030-199509000-00010; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; ELLIOTT AM, 1995, T ROY SOC TROP MED H, V89, P78, DOI 10.1016/0035-9203(95)90668-1; ELLIS ME, 1983, LANCET, V1, P665; Enarson DA, 1996, TUBERCULOSIS GUIDE L; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Hakim JG, 2000, HEART, V84, P183, DOI 10.1136/heart.84.2.183; Harries AD, 1997, T ROY SOC TROP MED H, V91, P416, DOI 10.1016/S0035-9203(97)90262-5; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; Harries AD, 1999, T ROY SOC TROP MED H, V93, P32, DOI 10.1016/S0035-9203(99)90170-0; Lawn SD, 1997, INT J TUBERC LUNG D, V1, P485; Lawn SD, 1998, INT J TUBERC LUNG D, V2, P635; Maher D, 1999, INT J TUBERC LUNG D, V3, P762; *MIN HLTH, 1991, MAN NAT TUB CONTR PR; NUNN P, 1992, AM REV RESPIR DIS, V146, P849, DOI 10.1164/ajrccm/146.4.849; OKWERA A, 1994, LANCET, V344, P1323, DOI 10.1016/S0140-6736(94)90693-9; PELOQUIN CA, 1993, NEW ENGL J MED, V329, P1122, DOI 10.1056/NEJM199310073291513; Pozniak AL, 1999, AIDS, V13, P435, DOI 10.1097/00002030-199903110-00001; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Salaniponi FML, 2000, INT J TUBERC LUNG D, V4, P581; Salaniponi FML, 2000, INT J TUBERC LUNG D, V4, P327; Steen TW, 1998, INT J TUBERC LUNG D, V2, P627; Tang AM, 1997, AIDS, V11, P613, DOI 10.1097/00002030-199705000-00009; *UNAIDS, 2000, PROV WHO UNAIDS REC; Whalen CC, 2000, AIDS, V14, P1219, DOI 10.1097/00002030-200006160-00020; *WHO, 2000, WHOCDSTB2000275; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization, 1997, WHOTB97220	29	140	146	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1519	1523		10.1016/S0140-6736(00)04639-0	http://dx.doi.org/10.1016/S0140-6736(00)04639-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377627				2022-12-28	WOS:000168614300038
J	Narod, SA; Sun, P; Ghadirian, P; Lynch, H; Isaacs, C; Garber, J; Weber, B; Karlan, B; Fishman, D; Rosen, B; Tung, N; Neuhausen, SL				Narod, SA; Sun, P; Ghadirian, P; Lynch, H; Isaacs, C; Garber, J; Weber, B; Karlan, B; Fishman, D; Rosen, B; Tung, N; Neuhausen, SL		Hereditary Ovarian Canc Clinical	Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study	LANCET			English	Article							BREAST-CANCER; WOMEN; HYSTERECTOMY	Background In several case-control and prospective studies, tubal ligation has been associated with a decreased risk of invasive epithelial ovarian cancer. We aimed to assess the potential of tubal ligation in reducing the risk of ovarian cancer in women who carry predisposing mutations in the BRCA1 or BRCA2 genes. Methods We did a matched case-control study among women from Canada, the USA, and the UK who had undergone genetic testing and who carried a pathogenic mutation in BRCA1 or BRCA2. Cases were 232 women with a history of invasive ovarian cancer, and controls were 232 women without ovarian cancer, and who had both ovaries intact. Cases and controls were matched for year of birth, country of residence, and mutation (BRCA1 or BRCA2). The odds ratio for developing ovarian cancer was estimated for tubal ligation, adjusting for oral contraceptive use, parity, history of breast cancer, and ethnic group. Findings In an unadjusted analysis among BRCA1 carriers, significantly fewer cases than controls had ever had tubal ligation (30 of 173 [18%] vs 60 of 173 [35%], odds ratio 0.37 [95% CI 0.21-0.63]; p=0.0003). After adjustment for oral contraceptive use, parity, history of breast cancer and ethnic group, the odds ratio was 0.39 (p=0.002). Combination of tubal ligation and past use of an oral contraceptive was associated with an odds ratio of 0.28 (0.15-0.52). No protective effect of tubal ligation was seen among carriers of the BRCA2 mutation. Interpretation Tubal ligation is a feasible option to reduce the risk of ovarian cancer in women with BRCA1 mutations who have completed childbearing.	Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada; Hotel Dieu, CHUM, Epidemiol Res Unit, Montreal, PQ, Canada; Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA; Georgetown Univ, Med Ctr, Lombardi Canc Ctr, Washington, DC 20007 USA; Dana Farber Canc Ctr, Boston, MA USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Hlth Network, Dept Obstet & Gynecol, Toronto, ON, Canada; Beth Israel Deaconess Hosp, Boston, MA USA; Univ Utah, Dept Med Informat, Salt Lake City, UT 84112 USA	University of Toronto; Laval University; Universite de Montreal; Creighton University; Georgetown University; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine; Cedars Sinai Medical Center; Northwestern University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Beth Israel Deaconess Medical Center; Utah System of Higher Education; University of Utah	Narod, SA (corresponding author), Univ Toronto, Ctr Res Womens Hlth, 790 Bay St,Room 750, Toronto, ON M5G 1N8, Canada.		Narod, Steven A/AAA-6112-2022		NCI NIH HHS [CA74415, CA61231, CA 63678, CA 57601, 1RO1 CA 63682, N01-CN-67000] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063678, R01CA061231, R01CA063682, R01CA057601, R01CA074415] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brinton LA, 2000, BRIT J CANCER, V82, P1600; Brinton LA, 1997, AM J OBSTET GYNECOL, V176, P572, DOI 10.1016/S0002-9378(97)70550-7; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Cramer DW, 1998, FERTIL STERIL, V70, P371, DOI 10.1016/S0015-0282(98)00153-8; Cramer DW, 1998, LANCET, V351, P104, DOI 10.1016/S0140-6736(97)08064-1; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gertig DM, 2000, J NATL CANCER I, V92, P249, DOI 10.1093/jnci/92.3.249; Green A, 1997, AUST NZ J PUBL HEAL, V21, P337, DOI 10.1111/j.1467-842X.1997.tb01710.x; HANKINSON SE, 1993, JAMA-J AM MED ASSOC, V270, P2813, DOI 10.1001/jama.270.23.2813; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Ness RB, 1999, JNCI-J NATL CANCER I, V91, P1459, DOI 10.1093/jnci/91.17.1459; Peterson HB, 2000, NEW ENGL J MED, V343, P1681, DOI 10.1056/NEJM200012073432303; RILMAN T, 1998, CLIN ENDOCRINOL, V49, P695; RISCH HA, 1995, CANCER EPIDEM BIOMAR, V4, P447; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Rosenblatt KA, 1996, CANCER EPIDEM BIOMAR, V5, P933; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1184, DOI 10.1093/oxfordjournals.aje.a116427	21	138	146	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1467	1470		10.1016/S0140-6736(00)04642-0	http://dx.doi.org/10.1016/S0140-6736(00)04642-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377596				2022-12-28	WOS:000168614300008
J	Hoerauf, A; Mand, S; Adjei, O; Fleischer, B; Buttner, DW				Hoerauf, A; Mand, S; Adjei, O; Fleischer, B; Buttner, DW			Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment	LANCET			English	Article							CHEMOTHERAPY	Ivermectin is the drug used for mass chemotherapy of onchocerciasis within the WHO African Programme for Onchocerciasis Control. This approach aims to eliminate the disease as a public health problem but using one dose per year may not completely interrupt transmission since it does not suppress microfilaridermia thoroughly enough. Here we show that additional treatment with doxycycline, previously shown to sterilise adult female worms for a few months by depletion of symbiotic wolbachia endobacteria, significantly enhances ivermectin-induced suppression of microfilaridermia, rendering anti-wolbachia treatment a promising basis for blocking transmission by a drug-based approach.	Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Univ Sci & Technol Kumasi, Kumasi, Ghana	Bernhard Nocht Institut fur Tropenmedizin; Kwame Nkrumah University Science & Technology	Hoerauf, A (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.							Abiose A, 2000, LANCET, V356, P1523, DOI 10.1016/S0140-6736(05)73271-2; Awadzi K, 1995, TROP MED PARASITOL, V46, P213; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; REMME J, 1986, B WORLD HEALTH ORGAN, V64, P667; Richards F, 2000, LANCET, V355, P1663, DOI 10.1016/S0140-6736(00)02235-2	5	183	189	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1415	1416		10.1016/S0140-6736(00)04581-5	http://dx.doi.org/10.1016/S0140-6736(00)04581-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356444				2022-12-28	WOS:000168478200018
J	Klug, A				Klug, A			Structural biology - A marvellous machine for making messages	SCIENCE			English	Editorial Material							RNA-POLYMERASE-II; ACCURATE INITIATION; SACCHAROMYCES-CEREVISIAE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; TRANSCRIPTION; YEAST; COMPLEXES; CRYSTALLIZATION; HOLOENZYME		MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Klug, A (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; Gnatt A, 1997, J BIOL CHEM, V272, P30799, DOI 10.1074/jbc.272.49.30799; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Leuther KK, 1996, CELL, V85, P773, DOI 10.1016/S0092-8674(00)81242-8; LUE NF, 1987, P NATL ACAD SCI USA, V84, P8839, DOI 10.1073/pnas.84.24.8839; MATSUI T, 1980, J BIOL CHEM, V255, P1992; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Poglitsch CL, 1999, CELL, V98, P791, DOI 10.1016/S0092-8674(00)81513-5; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; UZGIRIS EE, 1983, NATURE, V301, P125, DOI 10.1038/301125a0; WEIL PA, 1979, CELL, V18, P469; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	17	16	17	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1844	1846		10.1126/science.1062384	http://dx.doi.org/10.1126/science.1062384			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397933				2022-12-28	WOS:000169200700032
J	Duan, LM; Cirac, JI; Zoller, P				Duan, LM; Cirac, JI; Zoller, P			Geometric manipulation of trapped ions for quantum computation	SCIENCE			English	Article							LOGIC GATE; ENTANGLEMENT; COMPUTER; PHASE	We propose an experimentally feasible scheme to achieve quantum computation based solely on geometric manipulations of a quantum system. The desired geometric operations are obtained by driving the quantum system to undergo appropriate adiabatic cyclic evolutions. Our implementation of the all-geometric quantum computation is based on Laser manipulation of a set of trapped ions. An all-geometric approach, apart from its fundamental interest, offers a possible method for robust quantum computation.	Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria	University of Innsbruck	Duan, LM (corresponding author), Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria.	Luming.Duan@uibk.ac.at	Zoller, Peter/O-1639-2014; Cirac, J. Ignacio/A-9105-2017	Zoller, Peter/0000-0003-4014-1505; Cirac, J. Ignacio/0000-0003-3359-1743				BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Cirac JI, 2000, NATURE, V404, P579, DOI 10.1038/35007021; DIVINCENZO DP, 1995, SCIENCE, V270, P255, DOI 10.1126/science.270.5234.255; Falci G, 2000, NATURE, V407, P355, DOI 10.1038/35030052; Jones JA, 2000, NATURE, V403, P869, DOI 10.1038/35002528; KWIAT PG, 1991, PHYS REV LETT, V66, P588, DOI 10.1103/PhysRevLett.66.588; LLOYD S, 1995, PHYS REV LETT, V75, P346, DOI 10.1103/PhysRevLett.75.346; Molmer K, 1999, PHYS REV LETT, V82, P1835, DOI 10.1103/PhysRevLett.82.1835; Pachos J, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.052318; Pachos J, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.010305; Roos C, 1999, PHYS REV LETT, V83, P4713, DOI 10.1103/PhysRevLett.83.4713; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Shapere A., 1989, GEOMETRIC PHASES PHY; WILCZEK F, 1984, PHYS REV LETT, V52, P2111, DOI 10.1103/PhysRevLett.52.2111; Zanardi P, 1999, PHYS LETT A, V264, P94, DOI 10.1016/S0375-9601(99)00803-8	18	605	619	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1695	1697		10.1126/science.1058835	http://dx.doi.org/10.1126/science.1058835			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387469	Green Submitted			2022-12-28	WOS:000169031800038
J	Stokroos, I; Litinetsky, L; van der Want, JJL; Ishay, JS				Stokroos, I; Litinetsky, L; van der Want, JJL; Ishay, JS			Magnetic minerals - Keystone-like crystals in cells of hornet combs	NATURE			English	Article									Univ Groningen, Fac Med Sci, Dept Cell Biol, Grad Sch Brain Cognit & Neurosci, NL-9713 EZ Groningen, Netherlands; Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel	University of Groningen; Tel Aviv University; Sackler Faculty of Medicine	Stokroos, I (corresponding author), Univ Groningen, Fac Med Sci, Dept Cell Biol, Grad Sch Brain Cognit & Neurosci, Oostersingel 69-2, NL-9713 EZ Groningen, Netherlands.	physio7@post.tau.ac.il	van der Want, Johannes/AAA-8058-2019	van der Want, Johannes/0000-0002-7485-4434				Ishay Jacob S., 1996, Scanning Microscopy, V10, P187; ISHAY JS, 1982, INSECT SOC, V29, P34, DOI 10.1007/BF02224526; Jongebloed WL, 1999, J ELECTRON MICROSC, V48, P63, DOI 10.1093/oxfordjournals.jmicro.a023652; SPRADBERY JP, 1973, WASPS; Welham NJ, 1998, J MATER SCI, V33, P1795, DOI 10.1023/A:1004388818110; Wilson GS, 1999, GEOL SOC SPEC PUBL, V151, P95, DOI 10.1144/GSL.SP.1999.151.01.10	6	16	16	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					654	654		10.1038/35079679	http://dx.doi.org/10.1038/35079679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395756				2022-12-28	WOS:000169112500030
J	Poole, PJ; Black, PN				Poole, PJ; Black, PN			Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LONG-TERM TREATMENT; CHRONIC-BRONCHITIS; DOUBLE-BLIND; N-ACETYLCYSTEINE; IODINATED GLYCEROL; TRIAL; TOLERABILITY; MULTICENTER; PREVENTION; EFFICACY	Objective To assess the effects of oral mucolytics in adults with stable chronic bronchitis and chronic obstructive pulmonary disease. Design Systematic review of randomised controlled trials that compared at least two months of regular oral mucolytic drugs with placebo. Studies Twenty three randomised controlled trials in outpatients in Europe and United States. Main outcome measures Exacerbations, days of illness, lung function, adverse events. Results Compared with placebo, the number of exacerbations was significantly reduced in subjects taking oral mucolytics (weighted mean difference -0.07 per month, 95% confidence interval -0.08 to -0.05, P < 0.0001). Based on the annualised rate of exacerbations in the control subjects of 2.7 a year, this is a 29% reduction. The number needed to treat for one subject to have no exacerbation in the study period would be 6. Days of illness also fell (weighted mean difference -0.56, -0.77 to -0.35, P < 0.0001). The number of subjects who had no exacerbations in the Study period was greater in the mucolytic group (odds ratio 2.22, 95% confidence interval 1.93 to 2.54, P < 0.0001). There was no difference in lung function or in adverse events reported between treatments. Conclusions In chronic bronchitis and chronic obstructive pulmonary disease, treatment with mucolytics is associated with a reduction in acute exacerbations and days of illness. As these drugs have to be taken long term, they could be most useful in patients who have repeated, prolonged, or severe exacerbations of chronic obstructive pulmonary disease.	Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland	Poole, PJ (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland, New Zealand.	p.poole@auckland.ac.nz						Allegra L, 1996, RESPIRATION, V63, P174; BOMAN G, 1983, EUR J RESPIR DIS, V64, P405; BONTOGNALI E, 1991, ACTA THERAP, V17, P155; *BRIT MED ASS, 2000, BRIT NAT FORM; CASTIGLIONI CL, 1986, RESPIRATION, V50, P202, DOI 10.1159/000194928; CEGLA U H, 1988, Praxis und Klinik der Pneumologie, V42, P715; CHRISTENSEN SB, 1971, SCAND J RESPIR DIS, V52, P48; Collet JP, 1997, AM J RESP CRIT CARE, V156, P1719, DOI 10.1164/ajrccm.156.6.9612096; CREMONINI C, 1986, Clinica Terapeutica, V116, P121; Del Donno M, 1998, Monaldi Arch Chest Dis, V53, P714; EDWARDS GF, 1976, CHEST, V70, P506, DOI 10.1378/chest.70.4.506; Ekberg-Jansson A, 1999, EUR RESPIR J, V13, P829, DOI 10.1034/j.1399-3003.1999.13d22.x; FEINLEIB M, 1989, AM REV RESPIR DIS, V140, pS9, DOI 10.1164/ajrccm/140.3_Pt_2.S9; Fletcher CM, 1976, NATURAL HIST CHRONIC; Grandjean EM, 2000, PHARMACOL RES, V42, P39, DOI 10.1006/phrs.1999.0647; GRASSI C, 1976, EUR J CLIN PHARMACOL, V9, P393, DOI 10.1007/BF00606554; Grassi C, 1994, ITALIAN J CHEST DIS, V48, P17; GRILLAGE M, 1985, BRIT J CLIN PRACT, V39, P395; HANSEN NCG, 1994, RESP MED, V88, P531, DOI 10.1016/S0954-6111(05)80337-3; JACKSON IM, 1984, J INT MED RES, V12, P198, DOI 10.1177/030006058401200312; MACFARLANE JT, 1985, THORAX, V40, P832; MAESEN FPV, 1980, EUR J RESPIR DIS, V61, P110; Meister R, 1999, ARZNEIMITTELFORSCH, V49, P351; Nowak D, 1999, EUR RESPIR J, V14, P381; OLIVIERI D, 1987, RESPIRATION, V51, P42, DOI 10.1159/000195274; PARR GD, 1987, BRIT J DIS CHEST, V81, P341, DOI 10.1016/0007-0971(87)90182-3; Pela R, 1999, RESPIRATION, V66, P495, DOI 10.1159/000029447; PETTY TL, 1990, CHEST, V97, P75, DOI 10.1378/chest.97.1.75; POOLE PJ, 2000, COCHRANE DATABASE SY; POZZI E, 1980, EUR J RESPIR DIS, V61, P93; Rahman I, 1997, THORAX, V52, P565, DOI 10.1136/thx.52.6.565; RASMUSSEN JB, 1988, EUR RESPIR J, V1, P351; REDLINE S, 1991, CHRONIC OBSTRUCTIVE; Rubin BK, 1996, CHEST, V109, P348, DOI 10.1378/chest.109.2.348; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Sepe N, 1981, GAZZETTA MED ITALIAN, V140, P467	36	127	137	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2001	322	7297					1271	1274		10.1136/bmj.322.7297.1271	http://dx.doi.org/10.1136/bmj.322.7297.1271			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375228	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000169027800017
J	Shu, DG; Chen, L; Han, J; Zhang, XL				Shu, DG; Chen, L; Han, J; Zhang, XL			An early Cambrian tunicate from China	NATURE			English	Article							EVOLUTIONARY HISTORY; VERTEBRATES; FOSSIL	Like the Burgess Shales of Canada, the Chengjiang Lagerstatte from the Lower Cambrian of China is renowned for the detailed preservation as fossils of delicate, soft-bodied creatures(1-9), providing an insight into the Cambrian explosion. The fossils of possible hemichordate chordates(5-7) and vertebrates(9) have attracted particular attention. Tunicates, or urochordates, comprise the most basal chordate clade(10), and details of their evolution could be important in understanding the sequence of character acquisition that led to the emergence of chordates and vertebrates(11-18). However, definitive fossils of tunicates from the Cambrian are scarce or debatable(4,9,19-24). Here we report a probable tunicate Cheungkongella ancestralis from the Chengjiang fauna. It resembles the extant ascidian tunicate genus Styela whose morphology could be useful in understanding the origin of the vertebrates.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China	Northwest University Xi'an; Northwest University Xi'an	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.	dgshu@sein.sxgb.com.cn						Berrill N.J., 1955, ORIGIN VERTEBRATES; Briggs D.E.G., 1994, FOSSILS BURGESS SHAL; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; CARTER GS, 1957, SYST ZOOL, V6, P187; CHEN JY, 1995, NATURE, V377, P720, DOI 10.1038/377720a0; Conway Morris S, 1982, ATLAS BURGESS SHALE, P26; Degan Shu, 1995, Beringeria Special Issue, V2, P203; Di Gregorio A, 1998, CURR OPIN GENET DEV, V8, P457, DOI 10.1016/S0959-437X(98)80118-4; GARSTANG WALTER, 1928, QUART JOUR MICROS SCI, V72, P51; Gee H., 1996, BACKBONE VIEWS ORIGI; Hou Xianguang, 1997, Fossils and Strata, V45, P1; JOLLIE M, 1982, ZOOL J LINN SOC-LOND, V75, P167, DOI 10.1111/j.1096-3642.1982.tb01946.x; Lehnert Oliver, 1999, Acta Universitatis Carolinae Geologica, V43, P447; LOHMANN H, 1922, MITT ZOOL MUS HAMBUR, V38, P69; MEGLITSCH PA, 1991, INVERTEBRATE ZOOLOGY, P576; MUELLER K J, 1977, Lethaia, V10, P107; Nielsen C., 1997, ANIMAL EVOLUTION INT; Ogasawara M, 1999, ZOOL SCI, V16, P559, DOI 10.2108/zsj.16.559; ROMER AS, 1971, VERTEBRATE STORY; Satoh N., 1994, DEV BIOL ASCIDIANS; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Shu D, 1999, NATURE, V400, P746, DOI 10.1038/23445; Shu DG, 1995, ALCHERINGA, V19, P333, DOI 10.1080/03115519508619512; Shu DG, 1996, NATURE, V384, P157, DOI 10.1038/384157a0; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Swalla BJ, 2000, SYST BIOL, V49, P52, DOI 10.1080/10635150050207384; Wada H, 1998, MOL BIOL EVOL, V15, P1189, DOI 10.1093/oxfordjournals.molbev.a026026; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; ZHANG AY, 1987, SCI CHINA SER B, V30, P888; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	30	83	100	2	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					472	473		10.1038/35078069	http://dx.doi.org/10.1038/35078069			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373678				2022-12-28	WOS:000168858700047
J	Bottiger, BW; Bode, C; Kern, S; Gries, A; Gust, R; Glatzer, R; Bauer, H; Motsch, J; Martin, E				Bottiger, BW; Bode, C; Kern, S; Gries, A; Gust, R; Glatzer, R; Bauer, H; Motsch, J; Martin, E			Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a perspective clinical trial	LANCET			English	Article							HOSPITAL CARDIAC-ARREST; MASSIVE PULMONARY-EMBOLISM; ACUTE MYOCARDIAL-INFARCTION; PLASMINOGEN-ACTIVATOR; UTSTEIN STYLE; BOLUS INJECTION; FIBRINOLYSIS; UROKINASE; AGENTS	Background During cardiopulmonary resuscitation (CPR), thrombolysis can help to stabilise patients with pulmonary embolism and myocardial infarction. Moreover, thrombolysis during CPR has beneficial effects on cerebral reperfusion after cardiac arrest. We investigated this new therapeutic approach in patients in whom conventional CPR had been unsuccessful. Methods We assessed, in a prospective study, patients undergoing CPR after out-of-hospital cardiac arrest for cardiological reasons in whom return of spontaneous circulation was not achieved within 15 min. According to the Ustein criteria, our control group consisted of patients who were assessed during 1 year. After this year patients were treated with a bolus of 5000 U of heparin and 50mg, over 2 min, of tissue-type plasminogen activator (rt-PA treated group). This intervention was repeated if return of spontaneous circulation was not achieved within the following 30 min. For controls only CPR was given. Findings Overall, 90 patients were included; heparin and rt-PA were given to 40 patients. There were no bleeding complications related to the CPR procedures. Of the rt-PA group, 68% (27) had return of spontaneous circulation and 58% (23) were admitted to a cardiac intensive care unit, compared with 44% (22; p=0.026) and 30% (15; p=0.009) of the controls, respectively. At 24 h after cardiac arrest a larger proportion of the rt-PA group than of the controls was alive (35% [14] vs 22% [11], p=0.171), and 15% (six) of rt-PA-treated patients and 8% (four) of controls could be discharged from hospital. Interpretation After initially unsuccessful out-of-hospital CPR, thrombolytic therapy combined with heparin is safe and might improve patient outcome. On the basis of our data a randomised controlled trial might be regarded as ethical.	Univ Heidelberg, Dept Anaesthesiol, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Internal Med, D-69120 Heidelberg, Germany; Univ Freiburg, Dept Internal Med, D-7800 Freiburg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Freiburg	Bottiger, BW (corresponding author), Univ Heidelberg, Dept Anaesthesiol, D-69120 Heidelberg, Germany.							BODE C, 1994, ANN HEMATOL, V69, pS35, DOI 10.1007/BF02215957; BOTTIGER BW, 1995, CIRCULATION, V92, P2572, DOI 10.1161/01.CIR.92.9.2572; Bottiger BW, 1999, HEART, V82, P674, DOI 10.1136/hrt.82.6.674; BOTTIGER BW, 1994, CHEST, V106, P1281, DOI 10.1378/chest.106.4.1281; BOTTIGER BW, 1994, RESUSCITATION, V28, P45, DOI 10.1016/0300-9572(94)90054-X; BOTTIGER BW, 1997, FIBRINOLYSIS S2, V1, P93; CROWELL JW, 1956, AM J PHYSIOL, V186, P283, DOI 10.1152/ajplegacy.1956.186.2.283; CROWELL JW, 1955, SURGERY, V38, P696; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; DARIUS H, 1986, J AM COLL CARDIOL, V8, P125, DOI 10.1016/S0735-1097(86)80102-4; *EM CARD CAR COMM, 1992, JAMA-J AM MED ASSOC, V268, P2171; FISCHER FD, 1995, MECH MATER, V21, P1, DOI 10.1016/0167-6636(94)00070-0; Fischer M, 1996, INTENS CARE MED, V22, P1214; Fischer M, 1997, RESUSCITATION, V33, P233, DOI 10.1016/S0300-9572(96)01022-2; Gando S, 1997, THROMB HAEMOSTASIS, V77, P278; Gaszynski W, 1975, Anaesth Resusc Intensive Ther, V3, P125; GOLDHABER SZ, 1992, J AM COLL CARDIOL, V20, P24, DOI 10.1016/0735-1097(92)90132-7; HARTVEIT F, 1970, J PATHOL, V102, P54, DOI 10.1002/path.1711020111; HEKMATPANAH J, 1973, NEUROLOGY, V23, P174, DOI 10.1212/WNL.23.2.174; HOLMBERG S, 1992, RESUSCITATION, V24, P103, DOI 10.1016/0300-9572(92)90015-5; Kim YH, 1999, SCIENCE, V284, P647, DOI 10.1126/science.284.5414.647; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; LANGDON RW, 1989, ANN EMERG MED, V18, P678, DOI 10.1016/S0196-0644(89)80527-X; LIN SR, 1978, INVEST RADIOL, V13, P490, DOI 10.1097/00004424-197811000-00003; Newman DH, 2000, ANN EMERG MED, V35, P472, DOI 10.1067/mem.2000.105600; Safar P, 1996, STROKE, V27, P105, DOI 10.1161/01.STR.27.1.105; Schiele Rudolf, 1996, Journal of the American College of Cardiology, V27, p279A; SCHOLZ KH, 1992, AM J CARDIOL, V69, P724, DOI 10.1016/0002-9149(92)90494-J; SILFVAST T, 1991, J INTERN MED, V229, P331, DOI 10.1111/j.1365-2796.1991.tb00355.x; Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302; Tiffany PA, 1998, ANN EMERG MED, V31, P124, DOI 10.1016/S0196-0644(98)70295-1	31	202	221	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1583	1585		10.1016/S0140-6736(00)04726-7	http://dx.doi.org/10.1016/S0140-6736(00)04726-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377646				2022-12-28	WOS:000168830100012
J	Lohr, M; Hoffmeyer, A; Kroger, JC; Freund, M; Hain, J; Holle, A; Karle, P; Knofel, WT; Liebe, S; Muller, P; Nizze, H; Renner, M; Saller, RM; Wagner, T; Hauenstein, K; Gunzburg, WH; Salmons, B				Lohr, M; Hoffmeyer, A; Kroger, JC; Freund, M; Hain, J; Holle, A; Karle, P; Knofel, WT; Liebe, S; Muller, P; Nizze, H; Renner, M; Saller, RM; Wagner, T; Hauenstein, K; Gunzburg, WH; Salmons, B			Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma	LANCET			English	Article							CYP2B1	Pancreatic cancer can seldom be resected, and chemotherapy has only a limited effect on survival or tumour load. We did a phase I/II trial in 14 patients with pancreatic cancer to assess the safety of local activation of low-dose ifosfamide. We encapsulated genetically modified allogeneic cells, which expressed a cytochrome P450 enzyme, in cellulose sulphate and delivered them by supraselective angiography to the tumour vasculature. These cells locally activated systemically administered ifosfamide. The tumours of four patients regressed after treatment, and those of the other ten individuals who completed the study remained stable. Median survival was doubled in the treatment group by comparison with historic controls, and 1-year survival rate was three times better. Further studies of this cell-therapy-based treatment combined with chemotherapy for inoperable pancreatic cancer are warranted.	Univ Rostock, Dept Med, Div Gastroenterol, Rostock, Germany; Univ Rostock, Dept Med, Div Haematol, Rostock, Germany; Univ Rostock, Dept Med, Div Oncol, Rostock, Germany; Univ Rostock, Dept Diagnost & Intervent Radiol, Rostock, Germany; Univ Rostock, Dept Pathol, Rostock, Germany; Bavarian Nord Res Inst, Martinsried, Germany; Med Univ Lubeck, Div Haematol & Oncol, D-23538 Lubeck, Germany; Univ Vet Sci, Inst Virol, Vienna, Austria; Univ Hamburg, Dept Surg, Hamburg, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock; Bavarian Nordic; University of Lubeck; University of Veterinary Medicine Vienna; University of Hamburg	Salmons, B (corresponding author), Austrian Nord Biotherapeut, A-1210 Vienna, Austria.		Gunzburg, Walter/ABI-6076-2020; Salmons, Brian/E-3001-2010; Löhr, Matthias/A-3692-2012	Gunzburg, Walter/0000-0001-8907-1021; Salmons, Brian/0000-0002-9490-9447; Löhr, Matthias/0000-0002-7647-198X				Gunzburg WH, 2001, TRENDS MOL MED, V7, P30, DOI 10.1016/S1471-4914(00)01865-7; Kroger JC, 1999, ANN NY ACAD SCI, V880, P374, DOI 10.1111/j.1749-6632.1999.tb09541.x; Lohr M, 1998, GENE THER, V5, P1070, DOI 10.1038/sj.gt.3300671; Lohr M, 1999, J MOL MED, V77, P393, DOI 10.1007/s001090050366; OBERTI F, 1995, NEW ENGL J MED, V332, P1256	5	171	177	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1591	1592		10.1016/S0140-6736(00)04749-8	http://dx.doi.org/10.1016/S0140-6736(00)04749-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377651				2022-12-28	WOS:000168830100017
J	Hodell, DA; Brenner, M; Curtis, JH; Guilderson, T				Hodell, DA; Brenner, M; Curtis, JH; Guilderson, T			Solar forcing of drought frequency in the Maya lowlands	SCIENCE			English	Article							CLIMATE VARIABILITY; YUCATAN-PENINSULA; RECORD; LAKE; NIGERIA; AFRICA; EVENTS; CARBON; MEXICO; BE-10	We analyzed lake-sediment cores from the Yucatan Peninsula, Mexico, to reconstruct the climate history of the region over the past 2600 years. Time series analysis of sediment proxies, which are sensitive to the changing ratio of evaporation to precipitation (oxygen isotopes and gypsum precipitation), reveal a recurrent pattern of drought with a dominant periodicity of 208 years. This cycle is similar to the documented 206-year period in records of cosmogenic nuclide production (carbon-14 and beryllium-10) that is thought to reflect variations in solar activity. We conclude that a significant component of century-scale variability in Yucatan droughts is explained by solar forcing. Furthermore, some of the maxima in the 208-year drought cycle correspond with discontinuities in Maya cultural evolution, suggesting that the Maya were affected by these bicentennial oscillations in precipitation.	Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA; Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA	State University System of Florida; University of Florida; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Hodell, DA (corresponding author), Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA.	dhodell@geology.ufl.edu		Hodell, David/0000-0001-8537-1588				Bard E, 1997, EARTH PLANET SC LETT, V150, P453, DOI 10.1016/S0012-821X(97)00082-4; Beer J, 2000, QUATERNARY SCI REV, V19, P403, DOI 10.1016/S0277-3791(99)00072-4; BRADBURY JP, 1981, SCIENCE, V214, P1299, DOI 10.1126/science.214.4527.1299; COVICH A, 1974, LIMNOL OCEANOGR, V19, P682, DOI 10.4319/lo.1974.19.4.0682; Curtis JH, 1996, QUATERNARY RES, V46, P37, DOI 10.1006/qres.1996.0042; DAHLIN BH, 1983, CLIMATIC CHANGE, V5, P245, DOI 10.1007/BF02423521; ENGLEMAN EE, 1985, CHEM GEOL, V53, P125, DOI 10.1016/0009-2541(85)90025-7; GASSE F, 1994, EARTH PLANET SC LETT, V126, P435, DOI 10.1016/0012-821X(94)90123-6; Gill Richardson, 2000, GREAT MAYA DROUGHTS; HAIGH JD, 1994, NATURE, V370, P544, DOI 10.1038/370544a0; Hansen Richard D., 1990, EXCAVATIONS TIGRE CO; HASTENRATH S, 1976, J ATMOS SCI, V33, P202, DOI 10.1175/1520-0469(1976)033<0202:VILLCA>2.0.CO;2; HASTENRATH S, 1981, TELLUS, V33, P453, DOI 10.1111/j.2153-3490.1981.tb01771.x; HAUG GH, UNPUB; Higuera-Gundy A, 1999, QUATERNARY RES, V52, P159, DOI 10.1006/qres.1999.2062; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; HODELL DA, 1991, NATURE, V352, P790, DOI 10.1038/352790a0; Holmes JA, 1999, PALAEOGEOGR PALAEOCL, V148, P169, DOI 10.1016/S0031-0182(98)00182-5; HORN SP, 1992, BIOTROPICA, V24, P354, DOI 10.2307/2388605; Laird KR, 1996, NATURE, V384, P552, DOI 10.1038/384552a0; Lowe JW, 1985, DYNAMICS APOCALYPSE; METCALFE SE, 1995, HOLOCENE, V5, P196, DOI 10.1177/095968369500500207; METCALFE SE, 1994, BRIT GEOMOR, P131; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Peterson LC, 1991, PALEOCEANOGRAPHY, V6, P99, DOI 10.1029/90PA02497; RAISBECK GM, 1990, PHILOS T R SOC A, V330, P463, DOI 10.1098/rsta.1990.0027; Ramsey CB, 1998, RADIOCARBON, V40, P461; REID GC, 1988, SECULAR SOLAR GEOMAG, P225; RIND D, 1993, QUATERNARY SCI REV, V12, P357, DOI 10.1016/S0277-3791(05)80002-2; RIND DH, 1995, NATURAL CLIMATE VARI, P187; ROSENMEIER MF, UNPUB; Street-Perrott FA, 2000, HOLOCENE, V10, P293, DOI 10.1191/095968300678141274; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Stuiver M., 1993, HOLOCENE, V3, P289, DOI DOI 10.1177/095968369300300401; van Geel B, 1999, QUATERNARY SCI REV, V18, P331, DOI 10.1016/S0277-3791(98)00088-2; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; von Grafenstein U, 1999, PALAEOGEOGR PALAEOCL, V148, P133, DOI 10.1016/S0031-0182(98)00180-1	37	396	423	0	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1367	1370		10.1126/science.1057759	http://dx.doi.org/10.1126/science.1057759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359010				2022-12-28	WOS:000168862900043
J	Johnston, WK; Unrau, PJ; Lawrence, MS; Glasner, ME; Bartel, DP				Johnston, WK; Unrau, PJ; Lawrence, MS; Glasner, ME; Bartel, DP			RNA-catalyzed RNA polymerization: Accurate and general RNA-templated primer extension	SCIENCE			English	Article							NONTEMPLATED NUCLEOTIDE ADDITION; FIDELITY; RIBOZYME; REPLICATION; ORIGIN; SITES	The RNA world hypothesis regarding the early evolution of Life relies on the premise that some RNA sequences can catalyze RNA replication. In support of this conjecture, we describe here an RNA molecule that catalyzes the type of polymerization needed for RNA replication. The ribozyme uses nucleoside triphosphates and the coding information of an RNA template to extend an RNA primer by the successive addition of up to 14 nucleotides-more than a complete turn of an RNA helix. Its polymerization activity is general in terms of the sequence and the Length of the primer and template RNAs, provided that the 3' terminus of the primer pairs with the template. Its polymerization is also quite accurate: when primers extended by 11 nucleotides were cloned and sequenced, 1088 of 1100 sequenced nucleotides matched the template.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu		Glasner, Margaret/0000-0003-1818-1965				Bartel D.P, 1999, RNA WORLD 2 NAT MOD, V37, P143; Bartel David P., 1999, Trends in Cell Biology, V9, pM9, DOI 10.1016/S0962-8924(99)01669-4; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; BAUSCH JN, 1983, J BIOL CHEM, V258, P1978; Bergman NH, 2000, BIOCHEMISTRY-US, V39, P3115, DOI 10.1021/bi992654u; CECH TR, 1986, P NATL ACAD SCI USA, V83, P4360, DOI 10.1073/pnas.83.12.4360; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; DOUDNA JA, 1991, SCIENCE, V251, P1605, DOI 10.1126/science.1707185; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; EKLAND EH, 1995, NUCLEIC ACIDS RES, V23, P3231, DOI 10.1093/nar/23.16.3231; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; Glasner ME, 2000, BIOCHEMISTRY-US, V39, P15556, DOI 10.1021/bi002174z; GREEN R, 1992, SCIENCE, V258, P1910, DOI 10.1126/science.1470913; Hager AJ, 1996, CHEM BIOL, V3, P717, DOI 10.1016/S1074-5521(96)90246-X; Joyce G. F., 1993, COLD SPRING HARB SYM, V24, P49; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; KUNKEL TA, 1992, BIOESSAYS, V14, P303, DOI 10.1002/bies.950140503; LOEB LA, 1982, ANNU REV BIOCHEM, V51, P429, DOI 10.1146/annurev.bi.51.070182.002241; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; ORGEL LE, 1986, J THEOR BIOL, V123, P127, DOI 10.1016/S0022-5193(86)80149-7; PACE NR, 1985, ORIGINS LIFE EVOL B, V16, P97, DOI 10.1007/BF01809465; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; STEINHAUER DA, 1986, J VIROL, V57, P219, DOI 10.1128/JVI.57.1.219-228.1986; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; TUSCHL T, 1993, BIOCHEMISTRY-US, V32, P11658, DOI 10.1021/bi00094a023; Unrau PJ, 1998, NATURE, V395, P260, DOI 10.1038/26193; UNRAU PJ, UNPUB; WARD CD, 1992, J VIROL, V66, P3784, DOI 10.1128/JVI.66.6.3784-3793.1992; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835	31	436	457	4	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1319	1325		10.1126/science.1060786	http://dx.doi.org/10.1126/science.1060786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11358999	Green Submitted			2022-12-28	WOS:000168862900032
J	Pope, KO; Pohl, MED; Jones, JG; Lentz, DL; von Nagy, C; Vega, FJ; Quitmyer, IR				Pope, KO; Pohl, MED; Jones, JG; Lentz, DL; von Nagy, C; Vega, FJ; Quitmyer, IR			Origin and environmental setting of ancient agriculture in the lowlands of mesoamerica	SCIENCE			English	Article							MAIZE	Archaeological research in the Gulf Coast of Tabasco reveals the earliest record of maize cultivation in Mexico. The first farmers settled along beach ridges and lagoons of the Grijalva River delta. Pollen from cultivated Zea appears with evidence of forest clearing about 5100 calendar years B.C. (yr B.C.) [6200 C-14 years before the present (yr B.P.)]. Large Zea sp. pollen, typical of domesticated maize (Zea mays), appears about 5000 calendar yr B.C. (6000 yr B.P.). A Manihot sp. pollen grain dated to 4600 calendar yr B.C. (5800 yr B.P.) may be from domesticated manioc. About 2500 calendar yr B.C. (4000 yr B.P.), domesticated sunflower seeds and cotton pollen appear as farming expanded.	Geo Eco Arc Res, Aquasco, MD 20608 USA; Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA; Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; New York Bot Garden, Bronx, NY 10458 USA; Tulane Univ, Dept Anthropol, New Orleans, LA 70118 USA; Natl Autonomous Univ Mexico, Inst Geol, Mexico City 04510, DF, Mexico; Florida Museum Nat Hist, Dept Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; Florida State University; Texas A&M University System; Texas A&M University College Station; New York Botanical Garden; Tulane University; Universidad Nacional Autonoma de Mexico	Pope, KO (corresponding author), Geo Eco Arc Res, 16305 St Marys Church Rd, Aquasco, MD 20608 USA.			Lentz, David/0000-0003-0516-7654; Vega Vera, Francisco Javier/0000-0001-5445-8832				Benz BF, 2001, P NATL ACAD SCI USA, V98, P2104, DOI 10.1073/pnas.98.4.2104; COE MD, 1980, ARCHAEOLOGY SAN LORE, V1; DOEBLEY J, 1990, ECON BOT, V44, P6, DOI 10.1007/BF02860472; LAUCK RG, 1994, OLMECAS MESOAMERICA, P93; LENTZ DL, IN PRESS EC BOT; MacNeish R. S., 1967, PREHISTORY TEHUACAN, P290; MacNeish RS, 2000, LAT AM ANTIQ, V11, P3, DOI 10.2307/1571668; Olsen KM, 1999, P NATL ACAD SCI USA, V96, P5586, DOI 10.1073/pnas.96.10.5586; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno DR, 2000, NATURE, V407, P894, DOI 10.1038/35038055; Piperno DR, 2001, P NATL ACAD SCI USA, V98, P2101, DOI 10.1073/pnas.98.4.2101; Pohl M.D., 1996, LATIN AM ANTIQ, V7, P355, DOI [DOI 10.2307/972264, 10.2307/972264]; Rust W. F., 1994, Corn and culture in the prehistoric New World., P181; Sauer J. D., 1993, HIST GEOGRAPHY CROP; Smith B. D., 1998, EMERGENCE AGR; THOM BG, 1967, J ECOL, V55, P301, DOI 10.2307/2257879; WHITEHEAD DR, 1965, B TORREY BOT CLUB, V99, P7	17	167	179	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1370	1373		10.1126/science.292.5520.1370	http://dx.doi.org/10.1126/science.292.5520.1370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359011				2022-12-28	WOS:000168862900044
J	Evan, GI; Vousden, KH				Evan, GI; Vousden, KH			Proliferation, cell cycle and apoptosis in cancer	NATURE			English	Article							S-PHASE ENTRY; TYROSINE KINASE INHIBITORS; C-MYC; ONCOGENIC RAS; TRANSCRIPTION FACTOR; TRANSGENIC MICE; STEM-CELLS; P53 LOSS; IN-VIVO; GROWTH	Beneath the complexity and idiopathy of every cancer lies a limited number of 'mission critical' events that have propelled the tumour cell and its progeny into uncontrolled expansion and invasion. One of these is deregulated cell proliferation, which, together with the obligate compensatory suppression of apoptosis needed to support it, provides a minimal 'platform' necessary to support further neoplastic progression. Adroit targeting of these critical events should have potent and specific therapeutic consequences.	Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA; NCI, Frederick, MD 20842 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Evan, GI (corresponding author), Univ Calif San Francisco, Ctr Canc, 2340 Sutter St, San Francisco, CA 94143 USA.							ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; ASKEW DS, 1991, ONCOGENE, V6, P1915; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Brandvold KA, 2000, ONCOGENE, V19, P2780, DOI 10.1038/sj.onc.1203589; Breit S, 2000, CANCER RES, V60, P4596; Chen YNP, 1999, P NATL ACAD SCI USA, V96, P4325, DOI 10.1073/pnas.96.8.4325; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Elend M, 1999, CURR BIOL, V9, pR936, DOI 10.1016/S0960-9822(00)80109-8; Esteller M, 2000, CANCER RES, V60, P129; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; EVAN GI, 1993, CURR OPIN GENET DEV, V3, P44, DOI 10.1016/S0959-437X(05)80339-9; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Ferbeyre G, 2000, GENE DEV, V14, P2015; Frame S, 1998, PHILOS T ROY SOC B, V353, P839, DOI 10.1098/rstb.1998.0248; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; Greenhalgh DA, 1996, CANCER RES, V56, P4413; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HARRINGTON EA, 1994, CURR OPIN GENET DEV, V4, P120, DOI 10.1016/0959-437X(94)90100-7; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HIRAKAWA T, 1988, P NATL ACAD SCI USA, V85, P1519, DOI 10.1073/pnas.85.5.1519; Huang YQ, 2000, J BIOL CHEM, V275, P6462, DOI 10.1074/jbc.275.9.6462; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janz A, 2000, NUCLEIC ACIDS RES, V28, P2268, DOI 10.1093/nar/28.11.2268; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; KLEFSTROM J, 1994, EMBO J, V13, P5442, DOI 10.1002/j.1460-2075.1994.tb06879.x; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Krek W, 2000, NAT CELL BIOL, V2, pE121, DOI 10.1038/35017129; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lutz W, 1998, ONCOGENE, V17, P339, DOI 10.1038/sj.onc.1200201; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Morin MJ, 2000, ONCOGENE, V19, P6574, DOI 10.1038/sj.onc.1204102; Ngo CV, 2000, CELL GROWTH DIFFER, V11, P201; O'Dwyer ME, 2000, CURR OPIN ONCOL, V12, P594, DOI 10.1097/00001622-200011000-00013; OLLER AR, 1989, MUTAT RES, V216, P149, DOI 10.1016/0165-1161(89)90001-0; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2000, CURR OPIN GENET DEV, V10, P100, DOI 10.1016/S0959-437X(99)00046-5; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangfelt O, 2000, FRONT BIOSCI-LANDMRK, V5, pD479, DOI 10.2741/Sangfelt; Schmitt CA, 1999, J PATHOL, V187, P127; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Stambolic V, 1999, ONCOGENE, V18, P6094, DOI 10.1038/sj.onc.1203126; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; WAGNER AJ, 1993, MOL CELL BIOL, V13, P2432, DOI 10.1128/MCB.13.4.2432; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Wang XJ, 2000, MOL CARCINOGEN, V29, P67, DOI 10.1002/1098-2744(200010)29:2<67::AID-MC3>3.0.CO;2-2; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	89	2544	2718	13	404	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					342	348		10.1038/35077213	http://dx.doi.org/10.1038/35077213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357141				2022-12-28	WOS:000168710000056
J	Gillman, MW; Rifas-Shiman, SL; Camargo, CA; Berkey, CS; Frazier, AL; Rockett, HRH; Field, AE; Colditz, GA				Gillman, MW; Rifas-Shiman, SL; Camargo, CA; Berkey, CS; Frazier, AL; Rockett, HRH; Field, AE; Colditz, GA			Risk of overweight among adolescents who were breastfed as infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; NUTRITION EXAMINATION SURVEYS; CHILDHOOD OBESITY; FOLLOW-UP; ENDOCRINE RESPONSES; FEEDING PRACTICES; YOUNG ADULTHOOD; NATIONAL-HEALTH; CHILDREN; GROWTH	Context Overweight during adolescence predicts short- and long-term morbidity as well as obesity in adulthood. The prevalence of overweight among adolescents is high and continues to increase. Physiological and behavioral mechanisms and preliminary epidemiologic data suggest that breastfeeding could lower the risk of subsequent obesity in adolescence. Objective To examine the extent to which overweight status among adolescents is associated with the type of infant feeding (breast milk vs infant formula) and duration of breastfeeding. Design, Setting, and Subjects Survey of 8186 girls and 7155 boys, aged 9 to 14 years, who are participants in the Growing Up Today Study, a nationwide cohort study of diet, activity, and growth. In the fall of 1996 we mailed a questionnaire to each of the subjects, and in the spring of 1997, we mailed a supplemental questionnaire to their mothers, who are participants in the Nurses' Health Study II. Main Outcome Measure Overweight status defined as body mass index exceeding the 95th percentile for age and sex from US national data. Results In the first 6 months of life, 9553 subjects (62%) were only or mostly fed breast milk, and 4744 (31%) were only or mostly fed infant formula. A total of 7186 subjects (48%) were breastfed for at least 7 months while 4613 (31%) were breastfed for 3 months or less. At ages 9 to 14 years, 404 girls (5%) and 635 boys (9%) were overweight. Among subjects who had been only or mostly fed breast milk, compared with those only or mostly fed formula, the odds ratio (OR) for being overweight was 0.78 (95% confidence interval [CI], 0.66-0.91), after adjustment for age, sex, sexual maturity, energy intake, time watching television, physical activity, mother's body mass index, and other variables reflecting social, economic, and lifestyle factors. Compared with subjects who had been breastfed for 3 months or less, those who had been breastfed for at least 7 months had an adjusted OR for being overweight of 0.80 (95% CI, 0.67-0.96). Timing of introduction of solid foods, infant formula, or cow's milk was not related to risk of being overweight, Conclusion Infants who were fed breast milk more than infant formula, or who were breastfed for longer periods, had a lower risk of being overweight during older childhood and adolescence.	Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care, Dept Amulatory Care & Prevent, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02215 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Gillman, MW (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care, Dept Amulatory Care & Prevent, 126 Brookline Ave,Suite 200, Boston, MA 02215 USA.		Camargo, Carlos A./C-2145-2008; Field, Alison/AAA-4508-2021; Colditz, Graham/A-3963-2009	Camargo, Carlos A./0000-0002-5071-7654; Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [R01CA050385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046834] Funding Source: NIH RePORTER; NCI NIH HHS [CA 50385] Funding Source: Medline; NIDDK NIH HHS [DK 46834] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGRAS WS, 1990, J PEDIATR-US, V116, P805, DOI 10.1016/S0022-3476(05)82677-0; Barker DJP, 1998, MOTHERS BABIES DIS L; Baughcum AE, 1998, ARCH PEDIAT ADOL MED, V152, P1010; Berkey CS, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e56; Birch LL, 1998, PEDIATRICS, V101, P539; Butte NF, 1998, J NUTR, V128, p381S, DOI 10.1093/jn/128.2.381S; *CDC, 2001, CDC GROWTH CHARTS US; *COMM NUTR AM AC P, 1998, PED NUTR HDB; DEWEY KG, 1991, J PEDIATR-US, V119, P538, DOI 10.1016/S0022-3476(05)82401-1; DEWEY KG, 1995, PEDIATRICS, V96, P495; Elliott KG, 1997, OBES RES, V5, P538, DOI 10.1002/j.1550-8528.1997.tb00574.x; Ellis KJ, 1999, AM J EPIDEMIOL, V150, P939, DOI 10.1093/oxfordjournals.aje.a010102; FORD K, 1990, AM J CLIN NUTR, V52, P451, DOI 10.1093/ajcn/52.3.451; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; FRENCH SA, 1995, OBES RES, V3, P479, DOI 10.1002/j.1550-8528.1995.tb00179.x; Goodman E, 2000, PEDIATRICS, V106, P52, DOI 10.1542/peds.106.1.52; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; HAAGA JG, 1988, DEMOGRAPHY, V25, P307, DOI 10.2307/2061296; HAMOSH M, 1988, J PEDIATR GASTR NUTR, V7, P10, DOI 10.1097/00005176-198801000-00004; HAUNER H, 1995, EUR J CLIN INVEST, V25, P90, DOI 10.1111/j.1365-2362.1995.tb01532.x; Hilson JA, 1997, AM J CLIN NUTR, V66, P1371, DOI 10.1093/ajcn/66.6.1371; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Institute of Medicine, 1991, NUTR LACT; KARK JD, 1984, J EPIDEMIOL COMMUN H, V38, P218, DOI 10.1136/jech.38.3.218; KRAMER MS, 1981, J PEDIATR-US, V98, P883, DOI 10.1016/S0022-3476(81)80579-3; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; LANTING CI, 1994, LANCET, V344, P1319, DOI 10.1016/S0140-6736(94)90692-0; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LUCAS A, 1980, LANCET, V1, P1267; LUCAS A, 1981, ACTA PAEDIATR SCAND, V70, P195, DOI 10.1111/j.1651-2227.1981.tb05541.x; MCGILL HC, 1996, NUTR REV, V54, P531; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; NEWCOMB PA, 1994, NEW ENGL J MED, V330, P81, DOI 10.1056/NEJM199401133300201; OCallaghan MJ, 1997, J PAEDIATR CHILD H, V33, P311, DOI 10.1111/j.1440-1754.1997.tb01607.x; RICHEDWARDS JW, 1994, AM J OBSTET GYNECOL, V171, P171, DOI 10.1016/0002-9378(94)90465-0; ROLLS BA, 1986, PHYSIOL BEHAV, V38, P185, DOI 10.1016/0031-9384(86)90153-8; RUTISHAUSER IHE, 1992, J EPIDEMIOL COMMUN H, V46, P559, DOI 10.1136/jech.46.6.559; SAMUELS SE, 1985, AM J CLIN NUTR, V42, P504, DOI 10.1093/ajcn/42.3.504; SHANNON B, 1991, J AM DIET ASSOC, V91, P675; Strauss RS, 1999, INT J OBESITY, V23, P904, DOI 10.1038/sj.ijo.0800971; Strbak V, 1991, Endocr Regul, V25, P53; Thorogood M, 1979, J R Coll Gen Pract, V29, P427; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Troiano RP, 1998, PEDIATRICS, V101, P497; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; VOBECKY JS, 1988, J CLIN EPIDEMIOL, V41, P261, DOI 10.1016/0895-4356(88)90130-8; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; ZIVE MM, 1992, AM J CLIN NUTR, V55, P1104, DOI 10.1093/ajcn/55.6.1104	52	482	509	3	48	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2461	2467		10.1001/jama.285.19.2461	http://dx.doi.org/10.1001/jama.285.19.2461			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429ZC	11368698	Bronze			2022-12-28	WOS:000168547600027
J	Salkind, AR; Cuddy, PG; Foxworth, JW				Salkind, AR; Cuddy, PG; Foxworth, JW			Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMEDIATE HYPERSENSITIVITY REACTIONS; BETA-LACTAM ANTIBIOTICS; CLINICAL-EXPERIENCE; DIAGNOSTIC-TEST; ORAL CHALLENGE; SKIN; AMOXICILLIN; RISK; METAANALYSIS; AMPICILLIN	Context Clinicians frequently withhold antibiotics that contain penicillin based on patients' self-reported clinical history of an adverse reaction to penicillin and the clinicians' own misunderstandings about the characteristics of a true penicillin allergy. Objectives To determine the likelihood of true penicillin allergy with consideration of clinical history and to evaluate the diagnostic value added by appropriate skin testing, Data Sources MEDLINE was searched for relevant English-language articles dated 1966 to October 2000. Bibliographies were searched to identify additional articles, Study Selection We included original studies describing the precision of skin testing in diagnosis of penicillin allergy. We excluded studies that did not use both minor and major determinants, provide an explicit definition of penicillin allergy, or list the specific criteria necessary for a positive skin test result. Fourteen studies met the inclusion criteria, Data Extraction Three authors independently reviewed and abstracted data from all articles and reached consensus about any discrepancies. Data Synthesis Patients' self-reported history has low accuracy for diagnosis of true penicillin allergy. By evaluating studies comparing clinical history to the skin test for penicillin allergy among patients with and without a positive history for penicillin allergy, positive and negative likelihood ratios were calculated. History of penicillin allergy had a positive likelihood ratio of 1.9 (95% confidence interval [CI], 1.5-2.5), while absence of history of penicillin allergy had a negative likelihood ratio of 0.5 (95% CI, 0.4-0.6). Conclusions Only 10% to 20% of patients reporting a history of penicillin allergy are truly allergic when assessed by skin testing. Taking a detailed history of a patient's reaction to penicillin may allow clinicians to exclude true penicillin allergy, allowing these patients to receive penicillin. Patients with a concerning history of type I penicillin allergy who have a compelling need for a drug containing penicillin should undergo skin testing. Virtually all patients with a negative skin test result can take penicillin without serious sequelae.	Univ Missouri, Sch Med, Green Unit 4, Dept Med, Kansas City, MO 64108 USA; Univ Missouri, Sch Med, Infect Dis Sect, Kansas City, MO 64108 USA; Univ Missouri, Sch Med, Clin Pharmacol Sect, Kansas City, MO 64108 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Salkind, AR (corresponding author), Univ Missouri, Sch Med, Green Unit 4, Dept Med, 2411 Holmes St, Kansas City, MO 64108 USA.	salkinda@umkc.edu		Cuddy, Paul G./0000-0002-8471-3352				ADKINSON NF, 1971, NEW ENGL J MED, V285, P22, DOI 10.1056/NEJM197107012850104; ADKINSON NF, 1984, J ALLERGY CLIN IMMUN, V74, P567, DOI 10.1016/0091-6749(84)90108-8; ANNE S, 1995, ANN ALLERG ASTHMA IM, V74, P167; [Anonymous], 1999, Ann Allergy Asthma Immunol, V83, P665; ARNDT KA, 1976, JAMA-J AM MED ASSOC, V235, P918, DOI 10.1001/jama.235.9.918; BIERMAN CW, 1969, J ALLERGY, V43, P267, DOI 10.1016/0021-8707(69)90147-6; Bisno AL, 1997, CLIN INFECT DIS, V25, P574, DOI 10.1086/513768; BLANCA M, 1989, J ALLERGY CLIN IMMUN, V83, P381, DOI 10.1016/0091-6749(89)90122-X; BOUSQUET J, 1993, ALLERGY PRINCIPLES P, P573; CHANDRA RK, 1980, ARCH DIS CHILD, V55, P857, DOI 10.1136/adc.55.11.857; deShazo RD, 1997, JAMA-J AM MED ASSOC, V278, P1895, DOI 10.1001/jama.278.22.1895; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; DICKERSIN K, 1992, EPIDEMIOL REV, V14, P154, DOI 10.1093/oxfordjournals.epirev.a036084; Dodek P, 1999, CLIN INFECT DIS, V29, P1251, DOI 10.1086/313435; GADDE J, 1993, JAMA-J AM MED ASSOC, V270, P2456, DOI 10.1001/jama.270.20.2456; GELL PGH, 1975, CLIN ASPECTS IMMUNOL, P761; GREEN GR, 1977, J ALLERGY CLIN IMMUN, V60, P339, DOI 10.1016/0091-6749(77)90064-1; Harris AD, 1999, AM J MED, V107, P166, DOI 10.1016/S0002-9343(99)00190-4; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; IDSOE O, 1968, B WORLD HEALTH ORGAN, V38, P159; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; KARCHMER AW, 1991, ANN INTERN MED, V115, P739, DOI 10.7326/0003-4819-115-9-739; KERNS DL, 1973, AM J DIS CHILD, V125, P187, DOI 10.1001/archpedi.1973.04160020023004; KIRK CR, 1988, BRIT MED J, V296, P1236, DOI 10.1136/bmj.296.6631.1236; LANG DM, 1991, ANN INTERN MED, V115, P270, DOI 10.7326/0003-4819-115-4-270; Levin Stuart, 1995, V15, P19; LEVINE BB, 1969, J ALLERGY, V43, P231, DOI 10.1016/0021-8707(69)90066-5; LEVINE BB, 1966, NEW ENGL J MED, V275, P1115, DOI 10.1056/NEJM196611172752009; LIN RY, 1992, ARCH INTERN MED, V152, P930, DOI 10.1001/archinte.152.5.930; Macy E, 1998, J ALLERGY CLIN IMMUN, V102, P281, DOI 10.1016/S0091-6749(98)70097-1; Macy E, 1997, J ALLERGY CLIN IMMUN, V100, P586, DOI 10.1016/S0091-6749(97)70159-3; MENDELSON LM, 1984, J ALLERGY CLIN IMMUN, V73, P76, DOI 10.1016/0091-6749(84)90487-1; NORITAKE DT, 1986, MIL MED, V151, P395, DOI 10.1093/milmed/151.1.395; NORMAN PS, 1997, MANUAL CLIN LAB IMMU, P875; OSWALD NTA, 1983, BRIT MED J, V287, P265, DOI 10.1136/bmj.287.6387.265; Pichichero ME, 1998, J PEDIATR-US, V132, P137, DOI 10.1016/S0022-3476(98)70499-8; REDELMEIER DA, 1990, ARCH INTERN MED, V150, P1939, DOI 10.1001/archinte.150.9.1939; Romano A, 1999, J ALLERGY CLIN IMMUN, V103, P1186, DOI 10.1016/S0091-6749(99)70197-1; Romano A, 1997, CLIN EXP ALLERGY, V27, P1425, DOI 10.1111/j.1365-2222.1997.tb02987.x; SAXON A, 1987, ANN INTERN MED, V107, P204, DOI 10.7326/0003-4819-107-2-204; SAXON A, 1983, REV INFECT DIS S2, V5, P368; SHAPIRO S, 1969, LANCET, V2, P969; SHEPHERD GM, 1991, IMMUNOL ALLERGY CLIN, V11, P611; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; SOGN DD, 1992, ARCH INTERN MED, V152, P1025, DOI 10.1001/archinte.152.5.1025; SOLLEY GO, 1982, J ALLERGY CLIN IMMUN, V69, P238, DOI 10.1016/0091-6749(82)90105-1; SULLIVAN TJ, 1981, J ALLERGY CLIN IMMUN, V68, P171, DOI 10.1016/0091-6749(81)90180-9; SURTEES SJ, 1991, BRIT MED J, V302, P1051, DOI 10.1136/bmj.302.6784.1051; VEGA JM, 1994, ALLERGY, V49, P317, DOI 10.1111/j.1398-9995.1994.tb02275.x; WARRINGTON RJ, 1978, CAN MED ASSOC J, V118, P787; WEISS ME, 1988, CLIN ALLERGY, V18, P515, DOI 10.1111/j.1365-2222.1988.tb02904.x; Wright AJ, 1999, MAYO CLIN PROC, V74, P290, DOI 10.4065/74.3.290; 1997, MMWR MORB MORTAL WKL, V47, P40	53	184	194	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2498	2505		10.1001/jama.285.19.2498	http://dx.doi.org/10.1001/jama.285.19.2498			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429ZC	11368703				2022-12-28	WOS:000168547600032
J	Scurr, JH; Machin, SJ; Bailey-King, S; Mackie, IJ; McDonald, S; Smith, PDC				Scurr, JH; Machin, SJ; Bailey-King, S; Mackie, IJ; McDonald, S; Smith, PDC			Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial	LANCET			English	Article							VENOUS THROMBOSIS; NATURAL-HISTORY; AIR-TRAVEL; DIAGNOSIS; THROMBOEMBOLISM; ULTRASOUND; ASSOCIATION; US	Background The true frequency of deep-vein thrombosis (DVT) during long-haul air travel is unknown. We sought to determine the frequency of DVT in the lower limb during long-haul economy-class air travel and the efficacy of graduated elastic compression stockings in its prevention. Methods We recruited 89 male and 142 female passengers over 50 years of age with no history of thromboembolic problems. Passengers were randomly allocated to one of two groups: one group wore class-I below-knee graduated elastic compression stockings, the other group did not. All the passengers made journeys lasting more than 8 h per flight (median total duration 24 h), returning to the UK within 6 weeks. Duplex ultrasonography was used to assess the deep veins before and after travel. Blood samples were analysed for two specific common gene mutations, factor V Leiden (NL) and prothrombin G20210A (PGM), which predispose to venous thromboembolism. A sensitive D-dimer assay was used to screen for the development of recent thrombosis. Findings 12/116 passengers (10%; 95% CI 4.8-16.0%) developed symptomless DVT in the calf (five men. seven women). None of these passengers wore elastic compression stockings, and two were heterozygous for FVL. Four further patients who wore elastic compression stockings, had varicose veins and developed superficial thrombophlebitis. One of these passengers was heterozygous for both FVL and PGM. None of the passengers who wore class-I compression stockings developed DVT (95% CI 0-3.2%). Interpretation We conclude that symptomless DVT might occur in up to 10% of long-haul airline travellers. Wearing of elastic compression stockings during long-haul air travel is associated with a reduction in symptomless DVT.	UCL Royal Free & Univ Coll Med Sch, Dept Surg, London, England; UCL Royal Free & Univ Coll Med Sch, Dept Haematol, London, England; Stamford Hosp, London, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	Scurr, JH (corresponding author), Lister Hosp, Chelsea Bridge Rd, London SW1W 8RH, England.	medleg@mailbox.co.uk	MACKIE, Ian J/C-1587-2008					Bendz B, 2000, LANCET, V356, P1657, DOI 10.1016/S0140-6736(00)03165-2; BOUNAMEAUX H, 1994, THROMB HAEMOSTASIS, V71, P1; COLDITZ GA, 1986, LANCET, V2, P143; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; COON WW, 1977, ANN SURG, V186, P149, DOI 10.1097/00000658-197708000-00006; Cornuz J, 1999, RADIOLOGY, V211, P637, DOI 10.1148/radiology.211.3.r99jn24637; DALEN JE, 1975, PROG CARDIOVASC DIS, V17, P259, DOI 10.1016/S0033-0620(75)80017-X; Eklof B, 1996, DERMATOL SURG, V22, P637, DOI 10.1111/j.1524-4725.1996.tb00610.x; Ferrari E, 1999, CHEST, V115, P440, DOI 10.1378/chest.115.2.440; Forbes K, 1998, CLIN RADIOL, V53, P752, DOI 10.1016/S0009-9260(98)80318-8; KAKKAR VV, 1969, LANCET, V2, P230; Kazmers A, 1999, AM SURGEON, V65, P1124; KNIFFIN WD, 1994, ARCH INTERN MED, V154, P861, DOI 10.1001/archinte.154.8.861; Kraaijenhagen RA, 2000, LANCET, V356, P1492, DOI 10.1016/S0140-6736(00)02878-6; Krunes U, 1998, VASA-J VASCULAR DIS, V27, P172; LOWE GDO, 1992, BMJ-BRIT MED J, V305, P567; Mantoni M, 1997, ACTA RADIOL, V38, P327; Meissner MH, 1997, J VASC SURG, V26, P749, DOI 10.1016/S0741-5214(97)70086-7; MILNE R, 1992, J ROY COLL PHYS LOND, V26, P47; NEGUS D, 1969, LANCET, V2, P645; NICOLAIDES AN, 1975, THROMBOEMBOLISM AETI, P193; Nissen P, 1997, VASA-J VASCULAR DIS, V26, P239; OShaughnessy AM, 1997, INT ANGIOL, V16, P142; Patel A, 1998, J ENDOUROL, V12, P51, DOI 10.1089/end.1998.12.51; Ribier G, 1997, REV MED INTERNE, V18, P601, DOI 10.1016/S0248-8663(97)82460-5; ROBERTSON PL, 1995, MED J AUSTRALIA, V163, P515, DOI 10.5694/j.1326-5377.1995.tb124716.x; Robinson KS, 1998, CAN J SURG, V41, P368; SAHIAR F, 1994, AVIAT SPACE ENVIR MD, V65, P957; Westrich GH, 1998, CLIN ORTHOP RELAT R, P125	29	289	304	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2001	357	9267					1485	1489		10.1016/S0140-6736(00)04645-6	http://dx.doi.org/10.1016/S0140-6736(00)04645-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377600				2022-12-28	WOS:000168614300012
J	Kadotani, H; Kadotani, T; Young, T; Peppard, PE; Finn, L; Colrain, IM; Murphy, GM; Mignot, E				Kadotani, H; Kadotani, T; Young, T; Peppard, PE; Finn, L; Colrain, IM; Murphy, GM; Mignot, E			Association between apolipoprotein E epsilon 4 and sleep-disordered breathing in adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; APNEA SYNDROME; HYPERTENSION	Context Apolipoprotein E epsilon4 (ApoE epsilon4) is a well-known risk factor for Alzheimer disease and cardiovascular disease. Sleep-disordered breathing occurs in Alzheimer disease patients and increases risks for cardiovascular disease. Complex interactions among sleep, brain pathology, and cardiovascular disease may occur in ApoE epsilon4 carriers, Objective To study whether genetic variation at the level of ApoE is associated with sleep-disordered breathing or sleep abnormalities in the general population. Design, Setting, and Participants Ongoing longitudinal cohort study of sleep disorders at a US university beginning in 1989, providing a population-based probability sample of 791 middle-aged adults (mean [SD] age, 49 [8] years; range, 32-68 years). Main Outcome Measure Nocturnal polysomnography to evaluate apnea-hypopnea index. Results The probability of moderate-to-severe sleep-disordered breathing (apnea-hypopnea index greater than or equal to 15%) was significantly higher in participants with epsilon4, independent of age, sex, body mass index, and ethnicity (12.0% vs 7.0%; P=.003). Mean (SEM) apnea-hypopnea index was also significantly higher in participants with ApoE epsilon4 (6.5 [0.6] vs 4.8 [0.3]; P=.01). These effects increased with the number of ApoE epsilon4 alleles carried. Conclusions A significant portion of sleep-disordered breathing is associated with ApoE epsilon4 in the general population.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Stanford, CA 94305 USA; Kobe Univ, Sch Med, Dept Pediat, Kobe, Hyogo 650, Japan; Univ Wisconsin, Dept Prevent Med, Madison, WI 53706 USA; Stanford Univ, Sleep Disorders Clin, Palo Alto, CA USA; Vet Affairs Sierra Pacific Mental Illness Res Edu, Palo Alto, CA USA	Stanford University; Kobe University; University of Wisconsin System; University of Wisconsin Madison; Stanford University	Mignot, E (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Stanford, CA 94305 USA.		Kadotani, Hiroshi/A-7908-2015	Kadotani, Hiroshi/0000-0001-7474-3315	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH040041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014124, T32AG000164] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR03186] Funding Source: Medline; NHLBI NIH HHS [R01HL62252] Funding Source: Medline; NIA NIH HHS [R01 AG14124, T32 AG00164] Funding Source: Medline; NIMH NIH HHS [P30 MH40041] Funding Source: Medline; NINDS NIH HHS [P50 NS23724] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asada T, 2000, SLEEP, V23, P629; Bassetti C, 1999, SLEEP, V22, P217, DOI 10.1093/sleep/22.2.217; Engleman HM, 2000, SLEEP, V23, pS102; GUILLEMINAULT C, 1995, CHEST, V107, P1545, DOI 10.1378/chest.107.6.1545; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; MONTPLAISIR J, 1992, SLEEP, V15, pS17, DOI 10.1093/sleep/15.suppl_6.S17; Murphy GM, 1997, AM J PSYCHIAT, V154, P603; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; PETIT D, 1993, NEUROBIOL AGING, V14, P141, DOI 10.1016/0197-4580(93)90089-T; PRINZ PN, 1982, J AM GERIATR SOC, V30, P86, DOI 10.1111/j.1532-5415.1982.tb01279.x; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Redline S, 1997, AM J RESP CRIT CARE, V155, P186, DOI 10.1164/ajrccm.155.1.9001310; Saarelainen S, 1998, CLIN GENET, V53, P147; SIEST G, 1995, CLIN CHEM, V41, P1068; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2000, SLEEP, V23, pS122	19	173	182	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2888	2890		10.1001/jama.285.22.2888	http://dx.doi.org/10.1001/jama.285.22.2888			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BP	11401610	Bronze			2022-12-28	WOS:000169156300028
J	Sandalow, DB; Bowles, IA				Sandalow, DB; Bowles, IA			Climate change - Fundamentals of treaty-making on climate change	SCIENCE			English	Article									World Resources Inst, Washington, DC 20002 USA; Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA	Harvard University; Conservation International	Sandalow, DB (corresponding author), World Resources Inst, 10 G St NE, Washington, DC 20002 USA.							AUSTIN D, 1998, CONTRIBUTIONS CLIMAT; CROWLEY T, 1991, SERIES GEOLOGY GEOPH, V18; *DOE, 2001, INT EN ANN 1999; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; HOUGHTON JT, 1990, SUMMARY POLICYMAKERS; *INT EN AG, 1998, EN STAT BAL OECD NON; IPCC, 2013, SUMM POL CLIM CHANG; ONEILL P, 1998, SPRING M AL ASS WASH; *UN, 1998, KYOT PROT UN FRAM CO; UN, 1992, FRAM CONV CLIM CHANG; United Nations, 1987, MONTR PROT SUBST DEP; US Department of Energy Energy Information Administration, 2001, INT EN OUTL 2001; Watson RT, 2000, LAND USE LAND USE CH	13	8	8	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1839	1840		10.1126/science.1062174	http://dx.doi.org/10.1126/science.1062174			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397932				2022-12-28	WOS:000169200700025
J	Arp, G; Reimer, A; Reitner, J				Arp, G; Reimer, A; Reitner, J			Photosynthesis-induced biofilm calcification and calcium concentrations in phanerozoic oceans	SCIENCE			English	Article							ALKALINE SALT LAKES; CARBONATE MINERALOGY; SEAWATER CHEMISTRY; CYANOBACTERIA	Photosynthetic carbon assimilation is commonly invoked as the cause of calcium carbonate precipitation in cyanobacterial biofilms that results in the formation of calcareous stromatolites. However, biofilm calcification patterns in recent lakes and simulation of photosynthetically induced rise in calcium carbonate supersaturation demonstrate that this mechanism applies only in settings Low in dissolved inorganic carbon and high in calcium. Taking into account paleo-partial pressure curves for carbon dioxide, we show that Phanerozoic oceans sustaining calcified cyanobacteria must have had considerably higher calcium concentrations than oceans of today. In turn, the enigmatic lack of calcified cyanobacteria in stromatolite-bearing Precambrian sequences can now be explained as a result of high dissolved inorganic carbon concentrations.	Univ Gottingen, Gottinger Zentrum Geowissensch, Abt Geobiol, D-37077 Gottingen, Germany	University of Gottingen	Arp, G (corresponding author), Univ Gottingen, Gottinger Zentrum Geowissensch, Abt Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany.	garp@gwdg.de						[Anonymous], 1994, EARLY LIFE EARTH; Arp G, 1999, SEDIMENT GEOL, V126, P159, DOI 10.1016/S0037-0738(99)00038-X; Arp G, 1999, EUR J PHYCOL, V34, P393, DOI 10.1080/09670269910001736452; Arp G, 1998, PALAIOS, V13, P581, DOI 10.2307/3515349; AWRAMIK SM, 1971, SCIENCE, V174, P825, DOI 10.1126/science.174.4011.825; Berner RA, 1998, PHILOS T ROY SOC B, V353, P75, DOI 10.1098/rstb.1998.0192; BERTRANDSARFATI J, 1981, PRECAMBRIAN RES, V15, P353, DOI 10.1016/0301-9268(81)90057-7; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; Gebelein C. D., 1976, STROMATOLITES, P499; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; GROTZINGER JP, 1993, J GEOL, V101, P235, DOI 10.1086/648218; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; Kempe Stephan, 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P61; KNOLL AH, 1993, PALAIOS, V8, P512, DOI 10.2307/3515029; Knoll AH, 1992, EARLY ORGANIC EVOLUT, P450, DOI DOI 10.1007/978-3-642-76884-2_35; Laval B, 2000, NATURE, V407, P626, DOI 10.1038/35036579; Mann S., 1989, BIOMINERALIZATION CH; Merz M.U., 1992, FACIES, V26, P81, DOI [10.1007/BF02539795, DOI 10.1007/BF02539795]; PARKHURST D, 1990, 8096 US GEOL SURV; PENTECOST A, 1985, GEOMICROBIOL J, V4, P285, DOI 10.1080/01490458509385936; PENTECOST A, 1986, BIOMINERALIZATION LO, P73; RIDING R, 1992, J GEOL SOC LONDON, V149, P979, DOI 10.1144/gsjgs.149.6.0979; RIDING R, 1982, NATURE, V299, P814, DOI 10.1038/299814a0; RIDING R, 1977, Palaeontology (Oxford), V20, P33; Riding R., 1991, CALCAREOUS ALGAE STR, DOI DOI 10.1007/978-3-642-52335-9_2; RIDING R, 1994, EARLY LIFE EARTH, P426; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Simkiss K, 1989, BIOMINERALIZATION CE; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Stumm W, 1996, AQUATIC CHEM; Thompson JB, 1997, LIMNOL OCEANOGR, V42, P133	32	342	389	3	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1701	1704		10.1126/science.1057204	http://dx.doi.org/10.1126/science.1057204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387471				2022-12-28	WOS:000169031800040
J	Holland, DM				Holland, DM			Explaining the Weddell Polynya - a large ocean eddy shed at Maud Rise	SCIENCE			English	Article							SEAMOUNT; MODEL	Satellite observations have shown the occasional occurrence of a Large opening in the sea-ice cover of the Weddell Sea, Antarctica, a phenomenon known as the Weddell Polynya, The transient appearance, position, size, and shape of the polynya is explained here by a mechanism by which modest variations in the large-scale oceanic flow past the Maud Rise seamount cause a horizontal cyclonic eddy to be shed from its northeast flank. The shed eddy transmits a divergent Ekman stress into the sea ice, Leading to a crescent-shaped opening in the pack. Atmospheric thermodynamical interaction further enhances the opening by inducing oceanic convection. A sea-ice-ocean computer model simulation vividly demonstrates how this mechanism fully accounts for the characteristics that mark Weddell Polynya events.	NYU, Courant Inst Math Sci, Ctr Atmosphere Ocean Sci, New York, NY 10012 USA; NYU, Fac Arts & Sci, New York, NY 10012 USA	New York University; New York University	Holland, DM (corresponding author), NYU, Courant Inst Math Sci, Ctr Atmosphere Ocean Sci, 251 Mercer St, New York, NY 10012 USA.	holland@cims.nyu.edu						Alverson K, 1996, J PHYS OCEANOGR, V26, P2196, DOI 10.1175/1520-0485(1996)026<2196:TPOOOD>2.0.CO;2; Bleck R, 1998, NATO ADV SCI I C-MAT, V516, P423; CARSEY FD, 1980, MON WEATHER REV, V108, P2032, DOI 10.1175/1520-0493(1980)108<2032:MOOTWP>2.0.CO;2; DRINKWATER MR, 2001, ERS 1 2 SYNTHETIC AP; Ekman VW., 1905, ARKIV MAT ASTRON FIZ, V2, P1; GASPAR P, 1988, J PHYS OCEANOGR, V18, P161, DOI 10.1175/1520-0485(1988)018<0161:MTSCOT>2.0.CO;2; GLOWIENKAHENSE R, 1995, BEITR PHYS ATMOS, V68, P303; Goldner DR, 1997, DEEP-SEA RES PT I, V44, P719, DOI 10.1016/S0967-0637(96)00131-8; GOURETSKI VV, 1993, DEEP-SEA RES PT I, V40, P561, DOI 10.1016/0967-0637(93)90146-T; Holland DM, 2001, PROG OCEANOGR, V48, P403; Holland DM, 2001, J CLIMATE, V14, P1585, DOI 10.1175/1520-0442(2001)014<1585:AIOSSI>2.0.CO;2; HUPPERT HE, 1976, DEEP-SEA RES, V23, P655, DOI 10.1016/S0011-7471(76)80013-7; MARTINSON DG, 1981, J PHYS OCEANOGR, V11, P466, DOI 10.1175/1520-0485(1981)011<0466:ACMFTW>2.0.CO;2; McPhee MG, 1996, B AM METEOROL SOC, V77, P1221, DOI 10.1175/1520-0477(1996)077<1221:TAZFE>2.0.CO;2; MOTOI T, 1987, J PHYS OCEANOGR, V17, P2241, DOI 10.1175/1520-0485(1987)017<2241:AMFTFO>2.0.CO;2; Muench RD, 2001, J GEOPHYS RES-OCEANS, V106, P2423, DOI 10.1029/2000JC000531; *NOAA NAT GEOPH, 1988, DAT ANN 88MGG02 DIG; Olbers D., 1992, HYDROGRAPHIC ATLAS S; OU HW, 1991, J PHYS OCEANOGR, V21, P1835, DOI 10.1175/1520-0485(1991)021<1835:SEOASO>2.0.CO;2; PARKINSON CL, 1979, J GEOPHYS RES-OCEANS, V84, P311, DOI 10.1029/JC084iC01p00311; Timmermann R, 1999, J PHYS OCEANOGR, V29, P1251, DOI 10.1175/1520-0485(1999)029<1251:FAMOAP>2.0.CO;2; Verron J, 1986, GEOPHYS ASTRO FLUID, V35, P257, DOI 10.1080/03091928608245895; WADHAMS P, 2000, ICE OCEAN, P73; Zwally H.J., 1983, NASA	24	73	78	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1697	1700		10.1126/science.1059322	http://dx.doi.org/10.1126/science.1059322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387470				2022-12-28	WOS:000169031800039
J	Lemke, P				Lemke, P			Climate - Open windows to the polar oceans	SCIENCE			English	Editorial Material									Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Lemke, P (corresponding author), Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany.		Lemke, Peter/B-6393-2013	Lemke, Peter/0000-0001-5739-3149				BECKMANN A, UNPUB; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07; CARSEY FD, 1980, MON WEATHER REV, V108, P2032, DOI 10.1175/1520-0493(1980)108<2032:MOOTWP>2.0.CO;2; GORDON AL, 1978, J PHYS OCEANOGR, V8, P600, DOI 10.1175/1520-0485(1978)008<0600:DACWOM>2.0.CO;2; Holland DM, 2001, SCIENCE, V292, P1697, DOI 10.1126/science.1059322; MITCHELL JFB, 1995, NATURE, V376, P501, DOI 10.1038/376501a0; SMITH SD, 1990, J GEOPHYS RES-OCEANS, V95, P9461, DOI 10.1029/JC095iC06p09461	7	13	15	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1670	1671		10.1126/science.1061186	http://dx.doi.org/10.1126/science.1061186			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387464				2022-12-28	WOS:000169031800031
J	Teleman, AA; Strigini, M; Cohen, SM				Teleman, AA; Strigini, M; Cohen, SM			Shaping morphogen gradients	CELL			English	Review							HEDGEHOG; CELLS; DPP		European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Cohen, SM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Teleman, Aurelio/V-8470-2019; Teleman, Aurelio A/E-6864-2013; Cohen, Stephen M/G-9930-2011	Teleman, Aurelio/0000-0002-4237-9368; Teleman, Aurelio A/0000-0002-4237-9368; Cohen, Stephen M/0000-0003-2858-9163; Strigini, Maura/0000-0002-1734-8877				Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Baeg GH, 2001, DEVELOPMENT, V128, P87; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; BRISCOE J, IN PRESS MOL CELL; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Moline MM, 1999, DEVELOPMENT, V126, P4375; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2	18	119	119	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					559	562		10.1016/S0092-8674(01)00377-4	http://dx.doi.org/10.1016/S0092-8674(01)00377-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389824	Bronze			2022-12-28	WOS:000169123200001
J	Bence, NF; Sampat, RM; Kopito, RR				Bence, NF; Sampat, RM; Kopito, RR			Impairment of the ubiquitin-proteasome system by protein aggregation	SCIENCE			English	Article							MULTICATALYTIC PROTEINASE; GLUTAMINE REPEATS; DEGRADATION; NEURODEGENERATION; PROTEOLYSIS; INHIBITOR; DISEASE; ARREST; CELLS; SCA1	Intracellular deposition of aggregated and ubiquitylated proteins is a prominent cytopathological feature of most neurodegenerative disorders. Whether protein aggregates themselves are pathogenic or are the consequence of an underlying molecular lesion is unclear. Here, we report that protein aggregation directly impaired the function of the ubiquitin-proteasome system. Transient expression of two unrelated aggregation-prone proteins, a huntingtin fragment containing a pathogenic polyglutamine repeat and a folding mutant of cystic fibrosis transmembrane conductance regulator, caused nearly complete inhibition of the ubiquitin-proteasome system. Because of the central role of ubiquitin-dependent proteolysis in regulating fundamental cellular events such as cell division and apoptosis, our data suggest a potential mechanism Linking protein aggregation to cellular disregulation and cell death.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Kopito, RR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; HOWARD M, 1995, AM J PHYSIOL, V269, pC1595; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; KWAK S, 1991, NEUROSCI LETT, V128, P21, DOI 10.1016/0304-3940(91)90751-E; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Mayer R J, 1989, Prog Clin Biol Res, V317, P809; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Raina A K, 2000, Prog Cell Cycle Res, V4, P235; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Schulz JB, 1999, CURR OPIN NEUROL, V12, P433, DOI 10.1097/00019052-199908000-00010; SHERWOOD SW, 1993, P NATL ACAD SCI USA, V90, P3353, DOI 10.1073/pnas.90.8.3353; Wigley WC, 1999, J CELL BIOL, V145, P481; Wojcik C, 1996, EUR J CELL BIOL, V70, P172; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	24	1704	1762	2	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1552	1555		10.1126/science.292.5521.1552	http://dx.doi.org/10.1126/science.292.5521.1552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375494				2022-12-28	WOS:000168963800047
J	Elbashir, SM; Harborth, J; Lendeckel, W; Yalcin, A; Weber, K; Tuschl, T				Elbashir, SM; Harborth, J; Lendeckel, W; Yalcin, A; Weber, K; Tuschl, T			Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells	NATURE			English	Article							DOUBLE-STRANDED-RNA; DROSOPHILA CELLS; PROTEIN-KINASE; GENE; METHYLATION; INHIBITION	RNA interference (RNAi) is the process of sequence-specific, post-transcriptional gene silencing in animals and plants, initiated by double-stranded RNA (dsRNA) that is homologous in sequence to the silenced gene(1-4). The mediators of sequence-specific messenger RNA degradation are 21- and 22-nucleotide small interfering RNAs (siRNAs) generated by ribonuclease III cleavage from longer dsRNAs(5-9). Here we show that 21-nucleotide siRNA duplexes specifically suppress expression of endogenous and heterologous genes in different mammalian cell lines, including human embryonic kidney (293) and HeLa cells. Therefore, 21-nucleotide siRNA duplexes provide a new tool for studying gene function in mammalian cells and may eventually be used as gene-specific therapeutics.	Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37033 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Biochem & Cell Biol, D-37033 Gottingen, Germany	Max Planck Society; Max Planck Society	Tuschl, T (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37033 Gottingen, Germany.		hu, jenny/AAK-8712-2020; Yalcin, Abdullah/AAG-4175-2019	Yalcin, Abdullah/0000-0001-8604-4749				Bahramian MB, 1999, MOL CELL BIOL, V19, P274; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harborth J, 1999, EMBO J, V18, P1689, DOI 10.1093/emboj/18.6.1689; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; KREIS T, 1999, GUIDEBOOK CYTOSKE 2B; KREIS T, 1999, GUIDEBOOK CYTOSKE 3A; Macejak DG, 2000, HEPATOLOGY, V31, P769, DOI 10.1002/hep.510310331; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; MINKS MA, 1979, J BIOL CHEM, V254, P180; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; ROBER RA, 1990, EXP CELL RES, V190, P185, DOI 10.1016/0014-4827(90)90184-C; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R; Ui-Tei K, 2000, FEBS LETT, V479, P79, DOI 10.1016/S0014-5793(00)01883-4; Wang MB, 2001, RNA, V7, P16, DOI 10.1017/S1355838201001224; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	31	7407	9468	34	1109	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					494	498		10.1038/35078107	http://dx.doi.org/10.1038/35078107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373684				2022-12-28	WOS:000168858700053
J	Comi, G; Filippi, M; Barkhof, F; Durelli, L; Edan, G; Fernandez, O; Hartung, HP; Seeldrayers, P; Sorensen, PS; Rovaris, M; Martinelli, V; Hommes, OR				Comi, G; Filippi, M; Barkhof, F; Durelli, L; Edan, G; Fernandez, O; Hartung, HP; Seeldrayers, P; Sorensen, PS; Rovaris, M; Martinelli, V; Hommes, OR		Early Treatment Multiple Sclerosis	Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study	LANCET			English	Article							CLINICALLY ISOLATED SYNDROMES; ENHANCED MRI LESIONS; PROGNOSTIC VALUE; OPTIC NEURITIS; AXONAL DAMAGE; BRAIN MRI; FOLLOW-UP; DEMYELINATION; DISABILITY; GUIDELINES	Background Interferon beta reduces activity in multiple sclerosis as measured clinically and by magnetic resonance imaging (MRI). We assessed the effect of interferon beta-1a on the occurrence of relapses in patients after first presentation with neurological events, who are at high risk of conversion to clinically definite multiple sclerosis. Methods Eligible patients had had a first episode of neurological dysfunction suggesting multiple sclerosis within the previous 3 months and had strongly suggestive brain MRI findings. Patients were randomly assigned interferon beta-1a 22 mug or placebo subcutaneously once weekly for 2 years. Neurological and clinical assessments were done every 6 months and brain MRI every 12 months. Analyses excluded one patient assigned placebo who received no study injections. Findings 241 (78%) of 308 randomised patients received study treatment for 2 years; 278 (90%) remained in the study until termination. 57 (85%) of 67 who stopped therapy did so after conversion to clinically definite multiple sclerosis. Fewer patients developed clinically definite multiple sclerosis in the interferon group than in the placebo group (52/154 [34%] vs 69/154 [45%]; p=0.047). The time at which 30% of patients had converted to clinically definite multiple sclerosis was 569 days in the interferon group and 252 in the placebo group (p=0.034). The annual relapse rates were 0.33 and 0.43 (p=0.045). The number of new T2-weighted MRI lesions and the increase in lesion burden were significantly lower with active treatment. Interpretation Interferon beta-1a treatment at an early stage of multiple sclerosis had significant positive effects on clinical and MRI outcomes.	IRCCS Osped San Raffaele, Dept Neurosci, Multiple Sclerosis Ctr, I-20132 Milan, Italy; Vrije Univ Amsterdam, Med Ctr, Dept Radiol, Multiple Sclerosis Magnet Resonance Ctr, Amsterdam, Netherlands; Univ Turin, Dept Neurosci, Turin, Italy; Univ Rennes, Neurol Clin, Rennes, France; Hosp Carlos Haya, Serv Neurol, Malaga, Spain; Karl Franzens Univ Graz, Dept Neurol, Graz, Austria; CHU Charleroi, Dept Neurol, Charleroi, Italy; Free Univ Brussels, Hop Erasme, B-1070 Brussels, Belgium; Rigshosp, Dept Neurol, DK-2100 Copenhagen, Denmark; European Charcot Fdn, Nijmegen, Netherlands	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vrije Universiteit Amsterdam; University of Turin; Universite de Rennes; Hospital Carlos Haya; University of Graz; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Rigshospitalet; University of Copenhagen	Comi, G (corresponding author), IRCCS Osped San Raffaele, Dept Neurosci, Multiple Sclerosis Ctr, Via Olgettina 60, I-20132 Milan, Italy.		Rovaris, Marco/AAA-6040-2020; Edan, Gilles/AAI-5944-2020; Barkhof, Frederik/AAJ-6226-2020; Martinelli, Vittorio/AAN-7240-2020; Filippi, Massimo/K-1755-2018	Rovaris, Marco/0000-0001-9691-1957; Barkhof, Frederik/0000-0003-3543-3706; Filippi, Massimo/0000-0002-5485-0479; Sorensen, Per Soelberg/0000-0002-2818-3780				Barkhof F, 1997, NEUROLOGY, V49, P1682, DOI 10.1212/WNL.49.6.1682; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Brex PA, 2000, NEUROLOGY, V54, P1689, DOI 10.1212/WNL.54.8.1689; Brodsky M, 1997, NEUROLOGY, V49, P1404; Calabresi PA, 1997, NEUROLOGY, V48, P1446, DOI 10.1212/WNL.48.5.1446; Comi G, 2000, CURR OPIN NEUROL, V13, P235, DOI 10.1097/00019052-200006000-00001; CONFAVREUX C, 1980, BRAIN, V103, P281, DOI 10.1093/brain/103.2.281; Davie CA, 1999, J NEUROL NEUROSUR PS, V67, P710, DOI 10.1136/jnnp.67.6.710; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers G, 1999, NEUROLOGY, V53, P679; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; FILIPPI M, 1994, NEUROLOGY, V44, P635, DOI 10.1212/WNL.44.4.635; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Goodkin DE, 2000, NEUROLOGY, V54, P2352; Iannucci G, 2000, AM J NEURORADIOL, V21, P1034; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; MARTINELLI V, 1991, ACTA NEUROL SCAND, V84, P231, DOI 10.1111/j.1600-0404.1991.tb04944.x; MILLER DH, 1991, J NEUROL NEUROSUR PS, V54, P683, DOI 10.1136/jnnp.54.8.683; O'Riordan JI, 1998, BRAIN, V121, P495, DOI 10.1093/brain/121.3.495; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rovaris M, 1997, J NEUROL, V244, P266, DOI 10.1007/s004150050083; *SEC PROGR EFF CLI, IN PRESS NEUROLOGY; SIPE JC, 1984, NEUROLOGY, V34, P1368, DOI 10.1212/WNL.34.10.1368; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Yong VW, 1998, NEUROLOGY, V51, P682	32	796	831	0	32	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1576	1582		10.1016/S0140-6736(00)04725-5	http://dx.doi.org/10.1016/S0140-6736(00)04725-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377645				2022-12-28	WOS:000168830100011
J	Missouris, CG; Swift, PA; Singer, DRJ				Missouris, CG; Swift, PA; Singer, DRJ			Cocaine use and acute left ventricular dysfunction	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION		Univ Hosp, Dept Cardiol, London SE13 6LH, England; Univ London St Georges Hosp, Sch Med, Dept Pharmacol & Clin Pharmacol, London, England; Univ London St Georges Hosp, Sch Med, Blood Pressure Unit, London, England	St Georges University London; St Georges University London	Missouris, CG (corresponding author), Wexham Pk Hosp, Slough SL2 4HL, Berks, England.							MOLITERNO DJ, 1994, AM J MED, V96, P492, DOI 10.1016/0002-9343(94)90087-6; MOLITERNO DJ, 1994, NEW ENGL J MED, V330, P454, DOI 10.1056/NEJM199402173300702; OM A, 1992, AM J CARDIOL, V69, P1549, DOI 10.1016/0002-9149(92)90701-Y; SMITH HWB, 1987, ANN INTERN MED, V107, P13, DOI 10.7326/0003-4819-107-1-13; Weber JE, 2000, ACAD EMERG MED, V7, P873, DOI 10.1111/j.1553-2712.2000.tb02064.x	5	17	17	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1586	1586		10.1016/S0140-6736(00)04727-9	http://dx.doi.org/10.1016/S0140-6736(00)04727-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377647				2022-12-28	WOS:000168830100013
J	Brejc, K; van Dijk, WJ; Klaassen, RV; Schuurmans, M; van der Oost, J; Smit, AB; Sixma, TK				Brejc, K; van Dijk, WJ; Klaassen, RV; Schuurmans, M; van der Oost, J; Smit, AB; Sixma, TK			Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors	NATURE			English	Article							TORPEDO ACETYLCHOLINE-RECEPTOR; MAIN IMMUNOGENIC REGION; ALPHA-SUBUNIT; MOLECULAR DISSECTION; EXTRACELLULAR DOMAIN; IDENTIFICATION; SITE; RESIDUES; AGONIST; LOCATION	Pentameric ligand gated ion-channels, or Cys-loop receptors, mediate rapid chemical transmission of signals. This superfamily of allosteric transmembrane proteins includes the nicotinic acetylcholine (nAChR), serotonin 5-HT3, gamma -aminobutyric-acid (GABA(A) and GABA(C)) and glycine receptors. Biochemical and electrophysiological information on the prototypic nAChRs is abundant but structural data at atomic resolution have been missing. Here we present the crystal structure of molluscan acetylcholine-binding protein (AChBP), a structural and functional homologue of the amino-terminal ligand-binding domain of an nAChR alpha -subunit. In the AChBP homopentamer, the protomers have an immunoglobulin-like topology. Ligand-binding sites are located at each of five subunit interfaces and contain residues contributed by biochemically determined 'loops' A to F. The subunit interfaces are highly variable within the ion-channel family, whereas the conserved residues stabilize the protomer fold. This AChBP structure is relevant for the development of drugs against, for example, Alzheimer's disease and nicotine addiction.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Free Univ Amsterdam, Fac Biol, Neurosci Res Inst, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; Vrije Universiteit Amsterdam	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	sixma@nki.nl	van+der+Oost, John/Y-2548-2019; Smit, August B/E-8410-2011	Sixma, Titia K/0000-0001-6180-0632				Alexeev T, 1999, EUR J BIOCHEM, V259, P310, DOI 10.1046/j.1432-1327.1999.00041.x; Arias HR, 2000, NEUROCHEM INT, V36, P595, DOI 10.1016/S0197-0186(99)00154-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEROUKHIM R, 1995, NEURON, V15, P323, DOI 10.1016/0896-6273(95)90037-3; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; FU DX, 1994, J BIOL CHEM, V269, P26152; Galzi JL, 1996, EMBO J, V15, P5824, DOI 10.1002/j.1460-2075.1996.tb00969.x; GALZI JL, 1990, J BIOL CHEM, V265, P10430; Green WN, 1998, J NEUROSCI, V18, P5555; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; HEMMINGSEN JM, 1994, PROTEIN SCI, V3, P1927, DOI 10.1002/pro.5560031104; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAO PN, 1986, J BIOL CHEM, V261, P8085; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; Le Novere N, 1999, BIOPHYS J, V76, P2329, DOI 10.1016/S0006-3495(99)77390-X; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; MACHOLD J, 1995, EUR J BIOCHEM, V234, P427, DOI 10.1111/j.1432-1033.1995.427_b.x; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; OLEARY ME, 1994, AM J PHYSIOL, V266, pC648, DOI 10.1152/ajpcell.1994.266.3.C648; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; Schrattenholz A, 1998, J BIOL CHEM, V273, P32393, DOI 10.1074/jbc.273.49.32393; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tierney ML, 2000, J MOL BIOL, V303, P185, DOI 10.1006/jmbi.2000.4137; TZARTOS SJ, 1991, MOL NEUROBIOL, V5, P1, DOI 10.1007/BF02935610; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VALENZUELA CF, 1994, BIOPHYS J, V66, P674, DOI 10.1016/S0006-3495(94)80841-0; Wells GB, 1998, J BIOL CHEM, V273, P964, DOI 10.1074/jbc.273.2.964; West AP, 1997, J BIOL CHEM, V272, P25468, DOI 10.1074/jbc.272.41.25468; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	50	1527	1568	6	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					269	276		10.1038/35077011	http://dx.doi.org/10.1038/35077011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357122				2022-12-28	WOS:000168710000037
J	Ponder, BAJ				Ponder, BAJ			Cancer genetics	NATURE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENOME CHANGES; METHYLATION; GENES; EXPRESSION; TUMORIGENESIS; MUTATIONS; NEOPLASIA; MODIFIER; RISK	Cancer genetics has for many years focused on mutational events that have their primary effect within the cancer cell. Recently that focus has widened, with evidence of the importance of epigenetic events and of cellular interactions in cancer development. The role of common genetic variation in determining the range of individual susceptibility within the population is increasingly recognized, and will be addressed using information from the Human Genome Project. These new research directions will highlight determinants of cancer that lie outside the cancer cell, suggest new targets for intervention, and inform the design of strategies for prevention in groups at increased risk.	Univ Cambridge, Hutchison MRC Res Ctr, CRC, Dept Oncol, Cambridge CB2 2XZ, England	University of Cambridge	Ponder, BAJ (corresponding author), Univ Cambridge, Hutchison MRC Res Ctr, CRC, Dept Oncol, Hills Rd, Cambridge CB2 2XZ, England.	bajp@mole.bio.cam.ac.uk	Onken, Michael D/H-5620-2013; Harbour, J. William/B-1448-2015	Onken, Michael D/0000-0003-4082-1105; Harbour, J. William/0000-0002-1104-9809				AMES BN, 1990, SCIENCE, V249, P970, DOI 10.1126/science.2136249; Balmain A, 1998, TRENDS GENET, V14, P139, DOI 10.1016/S0168-9525(98)01422-X; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; BISHOP JM, 1981, CELL, V23, P5; BRODEUR GM, 1998, GENETIC BASIS HUMAN, P161; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Chakravarti A, 2001, NATURE, V409, P822, DOI 10.1038/35057281; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; COMINGS DE, 1973, P NATL ACAD SCI USA, V70, P3324, DOI 10.1073/pnas.70.12.3324; Cordon-Cardo C, 1999, J EXP MED, V190, P1367, DOI 10.1084/jem.190.10.1367; Cormier RT, 2000, CANCER RES, V60, P3965; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; EASTON DF, 1993, AM J HUM GENET, V53, P305; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; ENGLER P, 1991, CELL, V65, P939, DOI 10.1016/0092-8674(91)90546-B; FEARON ER, 1998, GENETIC BASIS HUMAN, P229; Feinberg AP, 2001, NAT GENET, V27, P9, DOI 10.1038/83825; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443; Haber D, 1997, NAT GENET, V16, P320, DOI 10.1038/ng0897-320; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARRIS H, 1988, CANCER RES, V48, P3302; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; JERNSTROM H, IN PRESS CANC EPIDEM; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kinzler KW, 1998, GENETIC BASIS HUMAN, P565; Klausner RD, 1999, ONCOGENE, V18, P5249, DOI 10.1038/sj.onc.1203089; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Neal D E, 2000, Lancet Oncol, V1, P17, DOI 10.1016/S1470-2045(00)00005-X; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Olden K, 2000, NAT REV GENET, V1, P149, DOI 10.1038/35038586; Olumi AF, 1999, CANCER RES, V59, P5002; ORBORNE RJ, 2000, CANCER RES, V60, P3706; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; PARK M, 1998, GENETIC BASIS HUMAN, P205; PETO J, 1980, BANBURY REPORT, V4; Ponder B, 1997, SCIENCE, V278, P1050, DOI 10.1126/science.278.5340.1050; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; PONDER BAJ, 1990, TRENDS GENET, V6, P213, DOI 10.1016/0168-9525(90)90181-5; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RENAN MJ, 1993, MOL CARCINOGEN, V7, P139; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Rothman N, 2001, BBA-REV CANCER, V1471, pC1, DOI 10.1016/S0304-419X(00)00021-4; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SAPIENZA C, 1990, MOL CARCINOGEN, V3, P118, DOI 10.1002/mc.2940030303; SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Suzuki S, 2000, CANCER RES, V60, P5382; Thomas HV, 1997, BRIT J CANCER, V76, P401, DOI 10.1038/bjc.1997.398; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Vogelstein B., 1998, GENETIC BASIS HUMAN; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; Williams JA, 2001, CARCINOGENESIS, V22, P209, DOI 10.1093/carcin/22.2.209; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472	73	405	430	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					336	341		10.1038/35077207	http://dx.doi.org/10.1038/35077207			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357140				2022-12-28	WOS:000168710000055
J	O'Shea, JC; Hafley, GE; Greenberg, S; Hasselblad, V; Lorenz, TJ; Kitt, MM; Strony, J; Tcheng, JE				O'Shea, JC; Hafley, GE; Greenberg, S; Hasselblad, V; Lorenz, TJ; Kitt, MM; Strony, J; Tcheng, JE		ESPRIT Investigators	Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention - The ESPRIT trial: A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	73rd Scientific Sessions of the American-Heart-Association	NOV 12-15, 2000	NEW ORLEANS, LOUISIANA	Amer Heart Assoc			REVASCULARIZATION PROCEDURES; ARTERY DISEASE; CELL-ADHESION; MECHANISMS; RECEPTORS; OUTCOMES; IIIA	Context The Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) trial showed the efficacy of adjunctive, double-bolus eptifibatide therapy in reducing ischemic complications of nonurgent coronary stent implantation at 48 hours and at 30 days. Objective To determine whether the beneficial effects of eptifibatide persist at 6 months after treatment. Design Follow-up study of a randomized, double-blind, placebo-controlled, crossover-permitted trial conducted from June 1999 through February 2000, Setting Ninety-two tertiary care centers in the United States and Canada. Participants A total of 2064 patients scheduled to undergo nonurgent percutaneous coronary intervention with stent implantation. Intervention Patients were randomly assigned to receive placebo or eptifibatide (two 180-mug/kg boluses 10 minutes apart and continuous infusion of 2.0 mug/kg per minute), started immediately before stent implantation and continued for 18 to 24 hours. Complete follow-up data were available for 988 (95.0%) of 1040 patients given eptifibatide and 977 (95.4%) of 1024 patients given placebo. Main Outcome Measures Composite rates of death or myocardial infarction (MI); death, MI, or target vessel revascularization; and their individual components 6 months after enrollment, compared between the 2 groups. Results By 6 months, the composite end point of death or MI had occurred in 7.5% of eptifibatide-treated patients and in 11.5% of placebo-treated patients (hazard ratio [HR], 0.63; 95% confidence interval [CI], 0.47-0.84; P=.002), The composite of death, Mi, or target vessel revascularization was 14.2% in eptifibatide-treated patients vs 18.3% in placebo-treated patients (HR, 0.75; 95% CI,0.60-0.93; P =.008), Most of this benefit accrued early (<48 hours after initiation of therapy) and was maintained through 6 months. Six-month mortality in the eptifibatide group was 0.8% vs 1.4% in the placebo group (HR, 0.56; 95% CI, 0.24-1.34; P=.19) and target vessel revascularization occurred in 8.6% of the eptifibatide group vs 9.4% of the placebo group (HR, 0.91;95% CI, 0.68-1.22; P=.51). Conclusion Adjunctive eptifibatide therapy during coronary stent implantation provides benefit through 6-month follow-up.	Duke Clin Res Inst, Durham, NC 27705 USA; COR Therapeut Inc, S San Francisco, CA USA; Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA	Duke University; Merck & Company; Schering Plough Corporation	Tcheng, JE (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27705 USA.							Abdelmeguid AE, 1996, CIRCULATION, V94, P3369, DOI 10.1161/01.CIR.94.12.3369; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; Califf RM, 1998, J AM COLL CARDIOL, V31, P241, DOI 10.1016/S0735-1097(97)00506-8; Charo I.F., 1994, HEMOSTASIS THROMBOSI, P489; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Gibson CM, 2000, CIRCULATION, V102, P366; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JANG YS, 1994, J AM COLL CARDIOL, V24, P1591, DOI 10.1016/0735-1097(94)90162-7; Kong DF, 1998, CIRCULATION, V98, P2829, DOI 10.1161/01.CIR.98.25.2829; LEFKOVITS J, 1995, NEW ENGL J MED, V332, P1553, DOI 10.1056/NEJM199506083322306; Madan M, 1998, CIRCULATION, V98, P2629, DOI 10.1161/01.CIR.98.23.2629; O'Shea JC, 2000, AM HEART J, V140, P834, DOI 10.1067/mhj.2000.110458; Ohman EM, 1997, CIRCULATION, V95, P846; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; PHILLIPS DR, 1988, BLOOD, V71, P831; Roe MT, 2001, J AM COLL CARDIOL, V37, P9, DOI 10.1016/S0735-1097(00)01101-3; Tcheng JE, 1997, LANCET, V349, P1422; Tcheng JE, 2000, LANCET, V356, P2037; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 1999, LANCET, V354, P2019, DOI 10.1016/S0140-6736(99)10018-7; Topol EJ, 1997, NEW ENGL J MED, V336, P1689	23	173	180	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2468	2473		10.1001/jama.285.19.2468	http://dx.doi.org/10.1001/jama.285.19.2468			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429ZC	11368699	Bronze			2022-12-28	WOS:000168547600028
J	Wenger, NS; Kanouse, DE; Collins, RL; Liu, HH; Schuster, MA; Gifford, AL; Bozzette, SA; Shapiro, MF				Wenger, NS; Kanouse, DE; Collins, RL; Liu, HH; Schuster, MA; Gifford, AL; Bozzette, SA; Shapiro, MF			End-of-life discussions and preferences among persons with HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN-ASSISTED SUICIDE; NATIONAL PROBABILITY SAMPLES; LOW-PREVALENCE DISEASES; ADVANCE DIRECTIVES; HOMOSEXUAL-MEN; CARE; COMMUNICATION; AIDS; ATTITUDES; BARRIERS	Context Deficits in advance care planning leave many patients and their physicians unprepared for decisions about end-of-life care. Even though the prognosis has im; proved for many persons with human immunodeficiency virus (HIV) infection, a need for planning remains. Objective To evaluate prevalence of end-of-life discussions, use of advance directives, and preferences concerning end-of-life care and their relationship with patient demographics, clinical status, psychosocial variables, and practitioner characteristics among HIV-infected persons. Design, Setting, and Patients Cross-sectional survey of a US probability sample of 2864, which represents 231 400 adults receiving care for HIV, conducted from January 1996 to April 1997. Main Outcome Measures Communication with physician regarding end-of-life issues, completion of an advance directive, preference for aggressiveness of care,and willingness to tolerate future permanent adverse health states. Results A total of 1432 patients (50%) discussed some aspect of end-of-life care with their practitioner and 1088 (38%) completed an advance directive. Patients were more likely to complete an advance directive after a physician discussion (odds ratio [OR], 5.82; 95% confidence interval [CI], 4.50-7.52). Practitioners discussed end-of-life care less with blacks (OR, 0.57; 95% CI, 0.39-0.83) and Latinos (OR, 0.74; 95% CI, 0.55-0.98) than with whites. Women (OR, 1.39; 95% CI, 1.05-1.84) and patients with children in the household (OR, 1.53; 95% CI, 1.12-2.10) communicated the most with practitioners about end-of-life issues. Patients infected with HIV via injection drug use (OR, 0.64; 95% CI, 0.45-0.89) and those with less education communicated the least with physicians about end-of-life issues. Less denial, greater trust in one's practitioner, and longer patient-practitioner relationship were associated with more advance care planning. Conclusions: Half of all persons infected with HIV are at risk of making end-of-life decisions without prior discussions with their health care practitioners. Blacks, Latinos, intravenous drug users, and less educated individuals need advance care planning interventions in clinical HIV programs.	Univ Calif Los Angeles, Dept Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Hlth Serv, Los Angeles, CA 90095 USA; RAND Hlth, Santa Monica, CA USA; San Diego VA Healthcare Syst, Dept Med, La Jolla, CA USA; Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Wenger, NS (corresponding author), Univ Calif Los Angeles, Dept Med, Div Gen Internal Med & Hlth Serv Res, GIM HSR,911 Broxton Plaza, Los Angeles, CA 90095 USA.	nwenger@mednet.ucla.edu	Gifford, Allen L/D-9329-2016	Gifford, Allen L/0000-0001-6442-1128	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS008578] Funding Source: NIH RePORTER; AHRQ HHS [U-01HS08578] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BERRY SH, 1999, MR1090AHCPR RAND; Bindels PJE, 1996, LANCET, V347, P499, DOI 10.1016/S0140-6736(96)91138-1; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; COULTON CJ, 1990, J CLIN EPIDEMIOL, V43, pS51, DOI 10.1016/0895-4356(90)90219-F; Curtis JR, 1997, J GEN INTERN MED, V12, P736, DOI 10.1046/j.1525-1497.1997.07158.x; Curtis JR, 1999, AIDS, V13, P1123, DOI 10.1097/00002030-199906180-00017; Curtis JR, 2000, ARCH INTERN MED, V160, P1690, DOI 10.1001/archinte.160.11.1690; DUAN N, 1999, MR1060AHCPR RAND; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; EMANUEL LL, 1995, J AM GERIATR SOC, V43, P440, DOI 10.1111/j.1532-5415.1995.tb05821.x; FOWLER FJ, 1995, MED DECIS MAKING, V15, P195, DOI 10.1177/0272989X9501500301; Frankel MR, 1999, HEALTH SERV RES, V34, P969; FRANKL D, 1989, AM J MED, V86, P645, DOI 10.1016/0002-9343(89)90436-1; HAAS JS, 1993, ARCH INTERN MED, V153, P1241, DOI 10.1001/archinte.153.10.1241; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; Kaldjian LC, 1998, AIDS, V12, P103, DOI 10.1097/00002030-199801000-00012; Kreuter MW, 2000, ARCH FAM MED, V9, P426, DOI 10.1001/archfami.9.5.426; Littrell J, 1996, SOC WORK HEALTH CARE, V23, P43, DOI 10.1300/J010v23n02_03; Loue S, 1995, J LEGAL MED, V16, P461, DOI 10.1080/01947649509510990; Shapiro MF, 1999, HEALTH SERV RES, V34, P951; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; SLOME L, 1992, J ACQ IMMUN DEF SYND, V5, P712; Slome LR, 1997, NEW ENGL J MED, V336, P417, DOI 10.1056/NEJM199702063360606; STEINBROOK R, 1986, NEW ENGL J MED, V314, P457, DOI 10.1056/NEJM198602133140730; TENO J, 1990, J GEN INTERN MED, V5, P490, DOI 10.1007/BF02600877; Tierney WM, 2001, J GEN INTERN MED, V16, P32, DOI 10.1111/j.1525-1497.2001.00215.x; WACHTER RM, 1993, CRIT CARE CLIN, V9, P125, DOI 10.1016/S0749-0704(18)30212-4; Wilson IB, 1997, J GEN INTERN MED, V12, P784, DOI 10.1046/j.1525-1497.1997.07166.x	30	53	54	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2880	2887		10.1001/jama.285.22.2880	http://dx.doi.org/10.1001/jama.285.22.2880			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440BP	11401609				2022-12-28	WOS:000169156300027
J	Roberts, RG; Flannery, TF; Ayliffe, LK; Yoshida, H; Olley, JM; Prideaux, GJ; Laslett, GM; Baynes, A; Smith, MA; Jones, R; Smith, BL				Roberts, RG; Flannery, TF; Ayliffe, LK; Yoshida, H; Olley, JM; Prideaux, GJ; Laslett, GM; Baynes, A; Smith, MA; Jones, R; Smith, BL			New ages for the last Australian megafauna: Continent-wide extinction about 46,000 years ago	SCIENCE			English	Article							HUMAN OCCUPATION; SINGLE; REMAINS; GRAINS; QUARTZ; MODEL	All Australian land mammals, reptiles, and birds weighing more than 100 kilograms, and six of the seven genera with a body mass of 45 to 100 kilograms, perished in the Late Quaternary. The timing and causes of these extinctions remain uncertain. We report burial ages for megafauna from 28 sites and infer extinction across the continent around 46,400 years ago (95% confidence interval, 51,200 to 39,800 years ago). Our results rule out extreme aridity at the Last Glacial Maximum as the cause of extinction, but not other climatic impacts; a "blitzkrieg" model of human-induced extinction: or an extended period of anthropogenic ecosystem disruption.	Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; S Australian Museum, Adelaide, SA 5000, Australia; Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; CSIRO Land & Water, Canberra, ACT 2601, Australia; Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; CSIRO Math & Informat Sci, Melbourne, Vic 3168, Australia; Western Australian Museum, Perth, WA 6000, Australia; Natl Museum Australia, Canberra, ACT 2601, Australia; Australian Natl Univ, Res Sch Pacific & Asian Studies, Dept Archaeol & Nat Hist, Canberra, ACT 0200, Australia; La Trobe Univ, Dept Earth Sci, Melbourne, Vic 3086, Australia	University of Melbourne; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Riverside; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Western Australian Museum; Australian National University; La Trobe University	Roberts, RG (corresponding author), Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia.	rgrobe@unimelb.edu.au	Roberts, Richard Graham/B-8245-2013; Ayliffe, Linda/C-3627-2009	Roberts, Richard Graham/0000-0002-0128-4119; Ayliffe, Linda/0000-0001-7662-5494; Smith, Mike/0000-0002-6177-8217; Prideaux, Gavin/0000-0002-9958-0265				Aitken M.J., 1998, INTRO OPTICAL DATING; Ayliffe LK, 1998, GEOLOGY, V26, P147, DOI 10.1130/0091-7613(1998)026<0147:KPRFSA>2.3.CO;2; BALME J, 1978, Journal of the Royal Society of Western Australia, V61, P33; BAYNES A, 1999, RECORDS W AUSTR MU S, V57, P391; Bowler J.M., 1998, ARCHAEOL OCEAN, V33, P120, DOI DOI 10.1002/J.1834-4453.1998.TB00414.X; Bowler J. M., 1998, ARCHAEOL OCEAN, V33, P156; Field Judith, 1999, Proceedings of the Prehistoric Society, V65, P275; FLANNERY T F, 1990, Archaeology in Oceania, V25, P45; Flannery T.F., 1999, P239; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Horton D.R., 1984, P639; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; Johnson BJ, 1999, SCIENCE, V284, P1150, DOI 10.1126/science.284.5417.1150; Jones, 1968, ARCHAEOLOGY PHYSICAL, V3, P189; Kanfoush SL, 2000, SCIENCE, V288, P1815, DOI 10.1126/science.288.5472.1815; Martin P.S., 1999, EXTINCTIONS NEAR TIM, P17, DOI DOI 10.1007/978-1-4757-5202-1_2; MARTIN PS, 1973, SCIENCE, V179, P969, DOI 10.1126/science.179.4077.969; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Meltzer D.J., 1985, P145; MERRILEES D, 1968, Journal of the Royal Society of Western Australia, V51, P1; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Moriarty KC, 2000, PALAEOGEOGR PALAEOCL, V159, P113, DOI 10.1016/S0031-0182(00)00036-5; Murray Peter, 1991, P1071; NANSON GC, 1992, GEOLOGY, V20, P791, DOI 10.1130/0091-7613(1992)020<0791:WADOAO>2.3.CO;2; Olley JM, 1999, RADIAT MEAS, V30, P207, DOI 10.1016/S1350-4487(99)00040-2; Owen R., 1877, RES FOSSIL REMAINS E; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Prideaux Gavin J., 2000, Journal of Vertebrate Paleontology, V20, p62A; Roberts R.G., 1998, ANCIENT TL, V16, P19; ROBERTS RG, 1994, QUATERNARY SCI REV, V13, P575, DOI 10.1016/0277-3791(94)90080-9; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Roberts RG, 2000, RADIAT MEAS, V32, P459, DOI 10.1016/S1350-4487(00)00104-9; Sachs JP, 1999, SCIENCE, V286, P756, DOI 10.1126/science.286.5440.756; Thorne A, 1999, J HUM EVOL, V36, P591, DOI 10.1006/jhev.1999.0305; Turney CSM, 2001, QUATERNARY RES, V55, P3, DOI 10.1006/qres.2000.2195; van Huet Sanja, 1998, Australian Archaeology, V46, P5; White J. Peter, 1995, Australian Archaeology, V40, P13; WILKINSON CS, 1884, P LINN SOC NEW S WAL, V9, P1207; Yoshida H, 2000, RADIAT MEAS, V32, P439, DOI 10.1016/S1350-4487(99)00287-5	40	319	329	0	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1888	1892		10.1126/science.1060264	http://dx.doi.org/10.1126/science.1060264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397939				2022-12-28	WOS:000169200700042
J	Roth, DA; Tawa, NE; O'Brien, JM; Treco, DA; Selden, RF				Roth, DA; Tawa, NE; O'Brien, JM; Treco, DA; Selden, RF		Factor VIII Transkaryotic Therapy	Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARVOVIRUS B19; FACTOR-IX; THERAPY; CONCENTRATE; EXPRESSION; DISEASE; VARIANT; VIRUSES	Background We tested the safety of a nonviral somatic-cell gene-therapy system in patients with severe hemophilia A. Methods An open-label,phase 1 trial was conducted in six patients with severe hemophilia A. Dermal fibroblasts obtained from each patient by skin biopsy were grown in culture and transfected with a plasmid containing sequences of the gene that encodes factor VIII. Cells that produced factor VIII were selected, cloned, and propagated in vitro. The cloned cells were then harvested and administered to the patients by laparoscopic injection into the omentum. The patients were followed for 12 months after the implantation of the genetically altered cells, An interim analysis was performed. Results There were no serious adverse events related to the use of factor VIII-producing fibroblasts or the implantation procedure. No long-term complications developed, and no inhibitors of factor VIII were detected. In four of the six patients, plasma levels of factor VIII activity rose above the levels observed before the procedure. The increase in factor VIII activity coincided with a decrease in bleeding, a reduction in the use of exogenous factor VIII, or both. In the patient with the highest level of factor VIII activity, the clinical changes lasted approximately 10 months. Conclusions Implantation of genetically altered fibroblasts that produce factor VIII is safe and well tolerated. This form of gene therapy is feasible in patients with severe hemophilia A. (N Engl J Med 2001; 344:1735-42.) Copyright (C) 2001 Massachusetts Medical Society.	Beth Israel Deaconess Med Ctr, Ctr Hemostasis & Thrombosis Res, Dept Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Transkaryot Therapies, Cambridge, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Roth, DA (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Hemostasis & Thrombosis Res, Dept Med, RE-302,41 Ave Louis Pasteur, Boston, MA 02115 USA.	droth@caregroup.harvard.edu						Bartolomei Corsi O, 1988, J Med Virol, V25, P165, DOI 10.1002/jmv.1890250206; DiMichele D, 1998, HEMATOL ONCOL CLIN N, V12, P1315, DOI 10.1016/S0889-8588(05)70054-X; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; Evatt BL, 1998, HAEMOPHILIA, V4, P628, DOI 10.1046/j.1365-2516.1998.440628.x; FLORES G, 1995, HAEMOPHILIA, V1, P115, DOI 10.1111/j.1365-2516.1995.tb00050.x; *GEN SERV ADM, 1992, 209E GEN SERV ADM; HEARTLEIN MW, 1994, P NATL ACAD SCI USA, V91, P10967, DOI 10.1073/pnas.91.23.10967; Hedner U, 1999, THROMB HAEMOSTASIS, V82, P531; Kaufman RJ, 1999, HUM GENE THER, V10, P2091, DOI 10.1089/10430349950017095; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; LOZIER JN, 2000, HEMATOLOGY BASIC PRI, P1883; MANCOJOHNSON MJ, 1994, AM J HEMATOL, V47, P113, DOI 10.1002/ajh.2830470209; MARIANI G, 1993, TRANSFUSION, V33, P814, DOI 10.1046/j.1537-2995.1993.331094054617.x; NILSSON IM, 1992, J INTERN MED, V232, P25, DOI 10.1111/j.1365-2796.1992.tb00546.x; Petrini P, 2001, HAEMOPHILIA, V7, P99, DOI 10.1046/j.1365-2516.2001.00471.x; RICHARD KA, 1997, HEMOPHILIA, P53; SELDEN RF, 1987, NEW ENGL J MED, V317, P1067; SELDEN RF, 1987, SCIENCE, V236, P714, DOI 10.1126/science.3472348; TOOLE JJ, 1986, P NATL ACAD SCI USA, V83, P5939, DOI 10.1073/pnas.83.16.5939; VERMYLEN J, 1994, VOX SANG, V67, P8, DOI 10.1111/j.1423-0410.1994.tb01290.x; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yee TT, 1996, BRIT J HAEMATOL, V93, P457, DOI 10.1046/j.1365-2141.1996.5161062.x	22	272	288	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2001	344	23					1735	1742		10.1056/NEJM200106073442301	http://dx.doi.org/10.1056/NEJM200106073442301			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	439TL	11396439	Bronze			2022-12-28	WOS:000169133600001
J	Chudinovskikh, L; Boehler, R				Chudinovskikh, L; Boehler, R			High-pressure polymorphs of olivine and the 660-km seismic discontinuity	NATURE			English	Article							X-RAY-DIFFRACTION; SYSTEM MG2SIO4-FE2SIO4; MINERAL PHYSICS; PHASE-BOUNDARY; LOWER MANTLE; CALIBRATION; TEMPERATURES; TRANSFORMATIONS; SRB4O7-SM2+; PEROVSKITE	It had long been accepted that the 400-km seismic discontinuity in the Earth's mantle results from the phase transition of (Mg,Fe)(2)SiO4-olivine to its high-pressure polymorph beta -spinel (wadsleyite), and that the 660-km discontinuity results from the breakdown of the higher-pressure polymorph gamma -spinel (ringwoodite) to MgSiO3-perovskite and (Mg,Fe)O-magnesiowustite(1-4). An in situ multi-anvil-press X-ray study(5) indicated, however, that the phase boundary of the latter transition occurs at pressures 2 GPa lower than had been found in earlier studies using multi-anvil recovery experiments(6) and laser-heated diamond-anvil cells(7). Such a lower-pressure phase boundary would be irreconcilable with the accuracy of seismic measurements of the 660-km discontinuity, and would thus require a mineral composition of the mantle that is significantly different from what is currently thought. Here, however, we present measurements made with a laser-heated diamond-anvil cell which indicate that gamma -Mg2SiO4 is stable up to pressure and temperature conditions equivalent to 660-km depth in the Earth's mantle (24 GPa and 1,900 K) and then breaks down into MgSiO3-perovskite and MgO (periclase). We paid special attention to pressure accuracy and thermal pressure in our experiments, and to ensuring that our experiments were performed under nearly hydrostatic, inert pressure conditions using a variety of heating methods. We infer that these factors are responsible for the different results obtained in our experiments compared to the in situ multi-anvil-press study(5).	Max Planck Inst Chem, D-55020 Mainz, Germany	Max Planck Society	Boehler, R (corresponding author), Max Planck Inst Chem, Postfach 3060, D-55020 Mainz, Germany.		Boehler, Reinhard/L-3971-2016	Boehler, Reinhard/0000-0003-0222-6997				ANDERSON OL, 1989, J APPL PHYS, V65, P1534, DOI 10.1063/1.342969; Boehler R, 2000, REV GEOPHYS, V38, P221, DOI 10.1029/1998RG000053; BOEHLER R, 1994, SCIENCE, V265, P723, DOI 10.1126/science.265.5173.723-a; BOEHLER R, 1991, GEOPHYS RES LETT, V18, P1147, DOI 10.1029/91GL01144; BOEHLER R, 1990, HIGH PRES RES, V5, P702; Chopelas A, 1999, AM MINERAL, V84, P233; Chopelas A, 1996, PHYS CHEM MINER, V23, P25, DOI 10.1007/BF00202990; CHOPELAS A, 1994, PHYS CHEM MINER, V21, P352; Datchi F, 1997, J APPL PHYS, V81, P3333, DOI 10.1063/1.365025; GETTING IC, 1970, J APPL PHYS, V41, P4552, DOI 10.1063/1.1658495; HEINZ DL, 1984, J APPL PHYS, V55, P885, DOI 10.1063/1.333139; Irifune T, 1998, SCIENCE, V279, P1698, DOI 10.1126/science.279.5357.1698; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; KATSURA T, 1989, J GEOPHYS RES-SOLID, V94, P15663, DOI 10.1029/JB094iB11p15663; Kuroda K, 2000, PHYS CHEM MINER, V27, P523, DOI 10.1007/s002690000096; LACAM A, 1989, J APPL PHYS, V66, P366, DOI 10.1063/1.343884; LIU LG, 1978, EARTH PLANET SC LETT, V41, P398, DOI 10.1016/0012-821X(78)90171-1; MANGHNANI MH, 1981, PHYSICS SOLIDS HIGH, P47; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; MING LC, 1986, PHYSICA B & C, V139, P174, DOI 10.1016/0378-4363(86)90551-6; NAVROTSKY A, 1994, PHYSICS CHEM EARTH M; Poirier JP, 1991, INTRO PHYSICS EARTHS, P214; RAGAN DD, 1992, J APPL PHYS, V72, P5539, DOI 10.1063/1.351951; RINGWOOD AE, 1991, GEOCHIM COSMOCHIM AC, V55, P2083, DOI 10.1016/0016-7037(91)90090-R; SERGHIOU G, 1995, GEOPHYS RES LETT, V22, P441, DOI 10.1029/94GL02692; SHIMOMURA O, 1982, HIGH PRESSURE RES GE, P49; YEN J, 1992, J APPL PHYS, V72, P5535, DOI 10.1063/1.351950; ZHA CS, 1999, AIRAPT P, V136; ZHAO YS, 1994, PHYS EARTH PLANET IN, V85, P273, DOI 10.1016/0031-9201(94)90118-X	29	62	71	1	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					574	577		10.1038/35079060	http://dx.doi.org/10.1038/35079060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385569				2022-12-28	WOS:000168982500048
J	Pophristic, V; Goodman, L				Pophristic, V; Goodman, L			Hyperconjugation not steric repulsion leads to the staggered structure of ethane	NATURE			English	Article							BOND ORBITAL ANALYSIS; INTERNAL-ROTATION; BARRIERS; ORIGIN	Many molecules can rotate internally around one or more of their bonds so that during a full 360 degrees rotation, they will change between unstable and relatively stable conformations. Ethane is the textbook example of a molecule exhibiting such behaviour: as one of its two methyl (CH3) groups rotates once around the central carbon-carbon bond, the molecule will alternate three times between an unstable eclipsed conformation and the preferred staggered conformation. This structural preference is usually attributed to steric effects(1-7); that is, while ethane rotates towards an eclipsed structure, the electrons in C-H bonds on the different C atoms are drawing closer to each other and therefore experience increased repulsion, introducing a rotation barrier that destabilizes the eclipsed structure(8,9). Stabilization of the staggered structure through rotation-induced weakening of the central C-C bond(10) and hyperconjugation(11,12) has been considered to be involved, but evaluation of the contributions of these effects to ethane's internal rotation barrier and conformational preference remains difficult(13,14). Here we report a series of ethane structure optimizations, where successive removal of different interactions indicates that ethane's staggered conformation is the result of preferential stabilization through hyperconjugation. Removal of hyperconjugation interactions yields the eclipsed structure as the preferred conformation, whereas repulsive forces, either present or absent, have no influence on the preference for a staggered conformation.	Rutgers State Univ, Wright & Rieman Chem Labs, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Goodman, L (corresponding author), Rutgers State Univ, Wright & Rieman Chem Labs, New Brunswick, NJ 08903 USA.	goodman@rutchem.rutgers.edu						Badenhoop JK, 1997, J CHEM PHYS, V107, P5406, DOI 10.1063/1.474248; Badenhoop JK, 1999, INT J QUANTUM CHEM, V72, P269, DOI 10.1002/(SICI)1097-461X(1999)72:4<269::AID-QUA9>3.0.CO;2-8; BADER RFW, 1990, J AM CHEM SOC, V112, P6530, DOI 10.1021/ja00174a012; BRUNCK TK, 1979, J AM CHEM SOC, V101, P1700, DOI 10.1021/ja00501a009; Carey F.A., 2000, ORGANIC CHEM; CHRISTIANSEN PA, 1975, CHEM PHYS LETT, V31, P462, DOI 10.1016/0009-2614(75)85064-0; Frisch M. J., 1998, GAUSSIAN 98; Glendening E. D., 1996, NBO 4 0; Goodman L, 1999, J CHEM PHYS, V110, P4268, DOI 10.1063/1.478310; Jones M, 2000, ORGANIC CHEM, V2nd; Loudon M.., 2002, ORG CHEM, V4, P1135; March J., 1992, ADV ORG CHEM, V4th; McMurry J., 1999, ORGANIC CHEM; REED AE, 1986, J CHEM PHYS, V84, P2428, DOI 10.1063/1.450359; REED AE, 1991, ISR J CHEM, V31, P277, DOI 10.1002/ijch.199100032; SOVERS OJ, 1968, J CHEM PHYS, V49, P2592, DOI 10.1063/1.1670458; Sundberg R, 2000, ADV ORGANIC CHEM; Vollhardt K.P.C., 1998, ORGANIC CHEM STRUCTU; Weinhold F., 1998, ENCY COMPUTATIONAL C, P1792; WEISSKOPF VF, 1975, SCIENCE, V187, P605, DOI 10.1126/science.187.4177.605; WIBERG KB, 1993, J COMPUT CHEM, V14, P1504, DOI 10.1002/jcc.540141213	21	431	437	4	130	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					565	568		10.1038/35079036	http://dx.doi.org/10.1038/35079036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385566				2022-12-28	WOS:000168982500045
J	Shim, SH; Duffy, TS; Shen, GY				Shim, SH; Duffy, TS; Shen, GY			The post-spinel transformation in Mg2SiO4 and its relation to the 660-km seismic discontinuity	NATURE			English	Article							X-RAY-DIFFRACTION; HIGH-PRESSURE EXPERIMENTS; DIAMOND-ANVIL CELL; V-T EQUATION; PHASE-BOUNDARY; THERMAL PRESSURE; LOWER MANTLE; PEROVSKITE; STATE; TEMPERATURE	The 660-km seismic discontinuity in the Earth's mantle has long been identified with the transformation of (Mg,Fe)(2)SiO4 from gamma -spinel (ringwoodite) to (Mg,Fe)SiO3-perovskite and (Mg,Fe)O-magnesiowustite. This has been based on experimental studies of materials quenched from high pressure and temperature(1-3), which have shown that the transformation is consistent with the seismically observed sharpness and the depth of the discontinuity at expected mantle temperatures(4). But the first in situ examination of this phase transformation in Mg2SiO4 using a multi-anvil press(5) indicated that the transformation occurs at a pressure about 2 GPa lower than previously thought (equivalent to similar to 600 km depth) and hence that it may not be associated with the 660-km discontinuity. Here we report the results of an in situ study of Mg2SiO4 at pressures of 20-36 GPa using a combination of double-sided laser-heating and synchrotron X-ray diffraction in a diamond-anvil cell. The phase transformation from gamma -Mg2SiO4 to MgSiO3 perovskite and MgO (periclase) is readily observed in both the forward and reverse directions. In contrast to the in situ multi-anvil-press study(5), we rnd that the pressure and temperature of the post-spinel transformation in Mg2SiO4 is consistent with seismic observations(4,6) for the 660-km discontinuity.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Univ Chicago, CARS, Chicago, IL 60637 USA	Princeton University; University of Chicago	Shim, SH (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.		Shen, Guoyin/D-6527-2011; Duffy, Thomas S/C-9140-2017	Shen, Guoyin/0000-0001-5146-1147; Duffy, Thomas S/0000-0002-5357-1259; Shim, Sang-Heon/0000-0001-5203-6038				ANDERSON OL, 1989, J APPL PHYS, V65, P1534, DOI 10.1063/1.342969; Anderson OL, 1999, PHYS EARTH PLANET IN, V112, P267, DOI 10.1016/S0031-9201(99)00036-9; Boehler R, 2000, REV GEOPHYS, V38, P221, DOI 10.1029/1998RG000053; Dewaele A, 2000, J GEOPHYS RES-SOL EA, V105, P2869, DOI 10.1029/1999JB900364; Fei YW, 1999, AM MINERAL, V84, P272; Fiquet G, 1996, PHYS EARTH PLANET IN, V95, P1, DOI 10.1016/0031-9201(95)03109-X; Funamori N, 1996, J GEOPHYS RES-SOL EA, V101, P8257, DOI 10.1029/95JB03732; HEINZ DL, 1990, GEOPHYS RES LETT, V17, P1161, DOI 10.1029/GL017i008p01161; Helffrich G, 2000, REV GEOPHYS, V38, P141, DOI 10.1029/1999RG000060; Hirose K, 2001, EARTH PLANET SC LETT, V184, P567, DOI 10.1016/S0012-821X(00)00354-X; HOLMES NC, 1989, J APPL PHYS, V66, P2962, DOI 10.1063/1.344177; Irifune T, 1998, SCIENCE, V279, P1698, DOI 10.1126/science.279.5357.1698; ITO E, 1990, SCIENCE, V249, P1275, DOI 10.1126/science.249.4974.1275; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; Jackson I., 1998, EARTHS MANTLE COMPOS, P405; Jamieson J. C., 1982, HIGH PRESSURE RES GE, P27, DOI DOI 10.1007/978-94-009-7867-63; Kavner A, 2001, J APPL PHYS, V89, P1907, DOI 10.1063/1.1335827; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Kuroda K, 2000, PHYS CHEM MINER, V27, P523, DOI 10.1007/s002690000096; LIU L, 1975, GEOPHYS RES LETT, V2, P417, DOI 10.1029/GL002i010p00417; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; MENG Y, 1993, J GEOPHYS RES-SOL EA, V98, P22199, DOI 10.1029/93JB02383; MORISHIMA H, 1994, SCIENCE, V265, P1202, DOI 10.1126/science.265.5176.1202; Rubie DC, 1999, PHASE TRANSIT, V68, P431, DOI 10.1080/01411599908224526; Shen GY, 2001, REV SCI INSTRUM, V72, P1273, DOI 10.1063/1.1343867; Shim SH, 2000, J GEOPHYS RES-SOL EA, V105, P25955, DOI 10.1029/2000JB900183; SINGH AK, 1993, J APPL PHYS, V73, P4278, DOI 10.1063/1.352809; Speziale S, 2001, J GEOPHYS RES-SOL EA, V106, P515, DOI 10.1029/2000JB900318; SVENDSEN B, 1987, GEOPHYS J INT, V91, P667, DOI 10.1111/j.1365-246X.1987.tb01664.x; Vacher P, 1998, PHYS EARTH PLANET IN, V106, P275, DOI 10.1016/S0031-9201(98)00076-4; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0	31	130	141	2	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					571	574		10.1038/35079053	http://dx.doi.org/10.1038/35079053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385568				2022-12-28	WOS:000168982500047
J	Thomas, CD; Bodsworth, EJ; Wilson, RJ; Simmons, AD; Davies, ZG; Musche, M; Conradt, L				Thomas, CD; Bodsworth, EJ; Wilson, RJ; Simmons, AD; Davies, ZG; Musche, M; Conradt, L			Ecological and evolutionary processes at expanding range margins	NATURE			English	Article							BUTTERFLY HESPERIA-COMMA; METAPOPULATION MODELS; FRAGMENTED LANDSCAPES; FLIGHT MORPHOLOGY; CONSERVATION; DYNAMICS; HABITATS; BRITAIN; CLIMATE	Many animals are regarded as relatively sedentary and specialized in marginal parts of their geographical distributions(1,2). They are expected to be slow at colonizing new habitats. Despite this, the cool margins of many species' distributions have expanded rapidly in association with recent climate warming(3-10). We examined four insect species that have expanded their geographical ranges in Britain over the past 20 years. Here we report that two butterfly species have increased the variety of habitat types that they can colonize, and that two bush cricket species show increased fractions of longer-winged (dispersive) individuals in recently founded populations. Both ecological and evolutionary processes are probably responsible for these changes. Increased habitat breadth and dispersal tendencies have resulted in about 3- to 15-fold increases in expansion rates, allowing these insects to cross habitat disjunctions that would have represented major or complete barriers to dispersal before the expansions started. The emergence of dispersive phenotypes will increase the speed at which species invade new environments, and probably underlies the responses of many species to both past(11) and future climate change.	Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Thomas, CD (corresponding author), Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England.		Thomas, Chris D/A-1460-2014; Musche, Martin/Z-5662-2019; Conradt, Larissa/H-6309-2011; Thomas, Chris D/A-1894-2012; Wilson, Robert J/I-8726-2014	Thomas, Chris D/0000-0003-2822-1334; Musche, Martin/0000-0002-9999-0838; Thomas, Chris D/0000-0003-2822-1334; Wilson, Robert J/0000-0003-4477-7068				Asher J, 2001, MILLENNIUM ATLAS BUT; BOURN NAD, 1993, BIOL CONSERV, V63, P67, DOI 10.1016/0006-3207(93)90075-C; Coope G. R., 1995, P55; CWYNAR LC, 1987, AM NAT, V129, P463, DOI 10.1086/284651; Doebeli M, 1997, EVOLUTION, V51, P1730, DOI 10.1111/j.1558-5646.1997.tb05097.x; Haes ECM, 1997, ATLAS GRASSHOPPERS C; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Heath J., 1984, ATLAS BUTTERFLIES BR; Hill JK, 1999, OECOLOGIA, V121, P165, DOI 10.1007/s004420050918; Hill JK, 1999, BIOL CONSERV, V87, P277, DOI 10.1016/S0006-3207(98)00091-3; Hill JK, 1999, P ROY SOC B-BIOL SCI, V266, P1197, DOI 10.1098/rspb.1999.0763; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Marshall JA, 1988, GRASSHOPPERS ALLIED; Moilanen A, 2000, J ANIM ECOL, V69, P143, DOI 10.1046/j.1365-2656.2000.00381.x; NIEMELA J, 1991, OIKOS, V62, P351, DOI 10.2307/3545500; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Perring F.H., 1976, ATLAS BRIT FLORA; Ratnieks F.L.W., 1991, P119; THOMAS CD, 1992, OECOLOGIA, V92, P563, DOI 10.1007/BF00317850; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; THOMAS CD, 1993, J ANIM ECOL, V62, P472, DOI 10.2307/5196; Thomas Chris D., 1997, P359, DOI 10.1016/B978-012323445-2/50020-1; THOMAS JA, 1993, ECOGRAPHY, V16, P278, DOI 10.1111/j.1600-0587.1993.tb00217.x; THOMAS JA, 1986, J APPL ECOL, V23, P365, DOI 10.2307/2404023; Thomas V, 1999, J NURS CARE QUAL, V13, P1, DOI 10.1097/00001786-199906000-00003; Wahlberg N, 1996, SCIENCE, V273, P1536, DOI 10.1126/science.273.5281.1536; WIDGERY J, 2000, ORTHOPTERA RECORDING, P26; Williamson M., 1996, BIOL INVASIONS; WILSON RJ, 1999, SPATIOTEMPORAL DYNAM; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	30	639	665	2	369	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					577	581		10.1038/35079066	http://dx.doi.org/10.1038/35079066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385570	Green Accepted			2022-12-28	WOS:000168982500049
J	Coulson, T; Catchpole, EA; Albon, SD; Morgan, BJT; Pemberton, JM; Clutton-Brock, TH; Crawley, MJ; Grenfell, BT				Coulson, T; Catchpole, EA; Albon, SD; Morgan, BJT; Pemberton, JM; Clutton-Brock, TH; Crawley, MJ; Grenfell, BT			Age, sex, density, winter weather, and population crashes in Soay sheep	SCIENCE			English	Article							DYNAMICS; TRENDS; CYCLES	Quantifying the impact of density, extrinsic climatic fluctuations, and demography on population fluctuations is a persistent challenge in ecology. We analyzed the effect of these processes on the irregular pattern of population crashes of Soay sheep on the St. Kilda archipelago, United Kingdom. Because the age and sex structure of the population fluctuates independently of population size, and because animals of different age and sex respond in different ways to density and weather, identical weather conditions can result in different dynamics in populations of equal size. In addition, the strength of density-dependent processes is a function of the distribution of weather events. Incorporating demographic heterogeneities into population models can influence dynamics and their response to climate change.	Zool Soc London, Inst Zool, London NW1 4RY, England; Univ New S Wales, Univ Coll, Australian Def Force Acad, Sch Math & Stat, Canberra, ACT 2600, Australia; Hill Brathens, Ctr Ecol & Hydrol, Banchory AB31 4BY, Kincardine, Scotland; Univ Kent, Inst Math & Stat, Canterbury CT2 7NF, Kent, England; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Zoological Society of London; Australian Defense Force Academy; University of New South Wales Sydney; UK Centre for Ecology & Hydrology (UKCEH); University of Kent; University of Edinburgh; Imperial College London; University of Cambridge	Coulson, T (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	tnc20@cam.ac.uk	ALBON, Stephen D/C-6304-2011; Coulson, Tim/AAL-8148-2021; Pemberton, Josephine M/F-3100-2010	ALBON, Stephen D/0000-0002-0811-1333; Coulson, Tim/0000-0001-9371-9003; 				Bjornstad ON, 1999, P NATL ACAD SCI USA, V96, P5066, DOI 10.1073/pnas.96.9.5066; Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; Caughley G., 1977, ANAL VERTEBRATE POPU; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Coulson T, 1999, J ANIM ECOL, V68, P658, DOI 10.1046/j.1365-2656.1999.00298.x; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; GRENFELL BT, 1992, NATURE, V355, P823, DOI 10.1038/355823a0; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; HASSELL MP, 1976, J ANIM ECOL, V45, P471, DOI 10.2307/3886; Hilborn Ray, 1997, V28; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Milner JM, 1999, J ANIM ECOL, V68, P1235, DOI 10.1046/j.1365-2656.1999.00366.x; Stearns S.C., 1992, pi; Tuljapurkar S., 1997, STRUCTURED POPULATIO; [No title captured]	17	700	715	6	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1528	1531		10.1126/science.292.5521.1528	http://dx.doi.org/10.1126/science.292.5521.1528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375487				2022-12-28	WOS:000168963800040
J	Marmot, M; Wilkinson, RG				Marmot, M; Wilkinson, RG			Psychosocial and material pathways in the relation between income and health: a response to Lynch et al	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; SOCIOECONOMIC-STATUS; UNITED-STATES; JOB CONTROL; MORTALITY; INEQUALITY; RISK; MEN	Economic and social circumstances affect health through die physiological effects of their emotional and social meanings and the direct effects of material circumstances Material conditions do not adequately explain health inequalities in rich countries The relation between smaller inequalities in income and better population health reflects increased psychosocial wellbeing In rich countries wellbeing is more closely related to relative income than absolute income Social dominance, inequality, autonomy, and the quality of social relations have an impact on psychosocial wellbeing and are among the most powerful explanations for the pattern of population health in rich countries.	UCL, Int Ctr Hlth & Soc, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Univ Sussex, Trafford Ctr Med Res, Brighton BN1 9RY, E Sussex, England	University of London; University College London; University of Brighton; University of Sussex	Marmot, M (corresponding author), UCL, Int Ctr Hlth & Soc, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	M.Marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Medical Research Council [G19/35, G8802774] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acheson D., 1998, INDEPENDENT INQUIRY; [Anonymous], 1999, LUXURY FEVER; [Anonymous], 1999, DEV FREEDOM; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Bosma H, 1997, BRIT MED J, V314, P558, DOI 10.1136/bmj.314.7080.558; BRUHN JG, 1979, ROSETO STORY NORMANS; Brunner E, 1996, LANCET, V347, P1008, DOI 10.1016/S0140-6736(96)90147-6; BRUNNER E, 1999, SOCIAL DETERMINANTS; Brunner EJ, 1997, DIABETOLOGIA, V40, P1341, DOI 10.1007/s001250050830; Chiang TL, 1999, BMJ-BRIT MED J, V319, P1162, DOI 10.1136/bmj.319.7218.1162; DREVER F, 1967, HLTH INEQUALITIES DE, P1; Hales S, 1999, LANCET, V354, P2047, DOI 10.1016/S0140-6736(99)03763-0; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; HSIEH CC, 1999, INCOME INEQUALITY HL; *JOINT HLTH SURV U, 1996, HLTH SURV ENGL 1994; Kahn RS, 2000, BRIT MED J, V321, P1311, DOI 10.1136/bmj.321.7272.1311; Kawachi I, 1999, SOC SCI MED, V48, P21, DOI 10.1016/S0277-9536(98)00286-X; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Keating DP, 1999, DEV HLTH WEALTH NATI; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; Kennedy BP, 1998, BRIT MED J, V317, P917; Kennedy Bruce P., 1997, Ethnicity and Disease, V7, P207; Kristenson M, 1998, INT J BEHAV MED, V5, P17, DOI 10.1207/s15327558ijbm0501_2; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P1074, DOI 10.2105/AJPH.88.7.1074; Marmot M, 2000, BMJ-BRIT MED J, V321, P1124, DOI 10.1136/bmj.321.7269.1124; Marmot M, 2006, SOCIAL DETERMINANTS; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1984, LANCET, V1, P1003; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; MARX K, 1942, SELECTED WORKS, V1; McDonough P, 1997, AM J PUBLIC HEALTH, V87, P1476, DOI 10.2105/AJPH.87.9.1476; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; National Center for Health Statistics, 1999, HLTH US 1999 HLTH AG; PAMUK ER, 1985, POP STUD-J DEMOG, V39, P17, DOI 10.1080/0032472031000141256; Putnam R.D., 2000, BOWLING COLLAPSE REV; Putnam R.D., 1992, MAKING DEMOCRACY WOR; SHIVELY CA, 1994, ARTERIOSCLER THROMB, V14, P721, DOI 10.1161/01.ATV.14.5.721; Sidanius J., 1999, SOCIAL DOMINANCE INT; USLANER EM, 2001, MORAL F TRUST; van Rossum CTM, 2000, J EPIDEMIOL COMMUN H, V54, P178, DOI 10.1136/jech.54.3.178; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; WILKINSON R, 1996, UNHEALTHY SOC AFFICT; Wilkinson RG, 1999, ANN NY ACAD SCI, V896, P48, DOI 10.1111/j.1749-6632.1999.tb08104.x; WILKINSON RG, 1994, DAEDALUS, V123, P61; WILKINSON RG, 1992, BRIT MED J, V304, P165, DOI 10.1136/bmj.304.6820.165; WILKINSON RG, 1999, INCOME INEQUALITY HL, V1; Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x; Wolfson M, 1999, BRIT MED J, V319, P953, DOI 10.1136/bmj.319.7215.953; *WORLD BANK, 2000, WORLD DEV IND 2000; World Bank, 1999, WORLD DEV REP 1998 9; World Health Organization, 2000, WORLD HLTH REP 1999	53	489	497	0	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2001	322	7296					1233	1236		10.1136/bmj.322.7296.1233	http://dx.doi.org/10.1136/bmj.322.7296.1233			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435UV	11358781	Green Submitted, Green Published			2022-12-28	WOS:000168900700034
J	Lloyd, AL; May, RM				Lloyd, AL; May, RM			Epidemiology - How viruses spread among computers and people	SCIENCE			English	Editorial Material							INTERNET; DYNAMICS		Inst Adv Study, Program Theoret Biol, Princeton, NJ 08540 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Institute for Advanced Study - USA; University of Oxford	Lloyd, AL (corresponding author), Inst Adv Study, Program Theoret Biol, Einstein Dr, Princeton, NJ 08540 USA.	alun@alunlloyd.com; robert.may@zoo.ox.ac.uk	Lloyd, Alun/AAN-6639-2020; Lloyd, Alun L/H-4944-2012	Lloyd, Alun/0000-0002-6389-6321; 				Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; ANDERSON R M, 1991; Bailey NTJ, 1975, MATH THEORY INFECT D; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Cohen F. B., 1994, SHORT COURSE COMPUTE; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Kephart JO, 1997, SCI AM, V277, P88, DOI 10.1038/scientificamerican1197-88; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; MAY RM, IN PRESS PHILOS T B; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	15	452	469	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1316	1317		10.1126/science.1061076	http://dx.doi.org/10.1126/science.1061076			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360990	Green Submitted			2022-12-28	WOS:000168862900031
J	Newman, DK				Newman, DK			Microbiology - How bacteria respire minerals	SCIENCE			English	Editorial Material							GEOBACTER-SULFURREDUCENS; REDUCTION; CYTOCHROME; ACCEPTORS; GROWTH; OXIDES		CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Newman, DK (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.							ARNOLD RG, 1988, BIOTECHNOL BIOENG, V32, P1081, DOI 10.1002/bit.260320902; Fortin D, 1997, REV MINERAL, V35, P161; Leeuwenhoek A., 1684, PHIL T, V14, P568; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; Lower SK, 2001, SCIENCE, V292, P1360, DOI 10.1126/science.1059567; Magnuson TS, 2000, FEMS MICROBIOL LETT, V185, P205, DOI 10.1016/S0378-1097(00)00081-1; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Morel F. M. M, 1993, PRINCIPLES APPL AQUA, P244; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Myers JM, 1998, BBA-BIOMEMBRANES, V1373, P237, DOI 10.1016/S0005-2736(98)00111-4; NEVIN KP, 2000, APPL ENVIRON MICROB, V64, P3188; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Roden EE, 1996, ENVIRON SCI TECHNOL, V30, P1618, DOI 10.1021/es9506216; Seeliger S, 1998, J BACTERIOL, V180, P3686, DOI 10.1128/JB.180.14.3686-3691.1998; Zachara JM, 1998, AM MINERAL, V83, P1426, DOI 10.2138/am-1998-11-1232	16	51	54	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1312	1313		10.1126/science.1060572	http://dx.doi.org/10.1126/science.1060572			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360987				2022-12-28	WOS:000168862900028
J	Terry, F				Terry, F			Military involvement in refugee crises: a positive evolution?	LANCET			English	Article									Med Sans Frontieres, F-75011 Paris, France	Doctors Without Borders	Terry, F (corresponding author), Med Sans Frontieres, F-75011 Paris, France.								0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1431	1432		10.1016/S0140-6736(00)04571-2	http://dx.doi.org/10.1016/S0140-6736(00)04571-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356465				2022-12-28	WOS:000168478200037
J	Schafer, S; Shore, W; Hearst, N				Schafer, S; Shore, W; Hearst, N			Is medical school the right place to choose a specialty?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN JOB-SATISFACTION; INTERNAL-MEDICINE; FAMILY-PRACTICE; CAREER; CHOICE; WORKLIFE		Univ Med Ctr, UCSF Fresno Family Practice Residency Program, Fresno, CA USA; Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California San Francisco at Fresno; University of California System; University of California San Francisco	Schafer, S (corresponding author), Univ Med Ctr, UCSF Fresno Family Practice Residency Program, Fresno, CA USA.							BABBOTT D, 1991, ANN INTERN MED, V114, P16, DOI 10.7326/0003-4819-114-1-16; Bauer RL, 1997, ACAD MED, V72, P147, DOI 10.1097/00001888-199702000-00024; BERNAL DL, 1994, VITAL SIGNS WORKING, P88; BLAND CJ, 1995, ACAD MED, V70, P620, DOI 10.1097/00001888-199507000-00013; BREARLEY WD, 1982, J MED EDUC, V57, P449; Burack JH, 1997, ACAD MED, V72, P534, DOI 10.1097/00001888-199706000-00021; Burdi MD, 1999, HEALTH AFFAIR, V18, P134, DOI 10.1377/hlthaff.18.4.134; Campos-Outcalt D, 1992, Fam Pract Res J, V12, P213; Coutts-van Dijk LC, 1997, ACAD MED, V72, P1106, DOI 10.1097/00001888-199712000-00024; Haas JS, 2000, J GEN INTERN MED, V15, P122, DOI 10.1046/j.1525-1497.2000.02219.x; JARECKY RK, 1991, ACAD MED, V66, P756, DOI 10.1097/00001888-199112000-00011; JENNETT PA, 1990, ACAD MED, V65, P48, DOI 10.1097/00001888-199001000-00015; KASSEBAUM DG, 1995, ACAD MED, V70, P937, DOI 10.1097/00001888-199510000-00018; KAUFMAN A, 1989, ACAD MED, V64, P285, DOI 10.1097/00001888-198906000-00001; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; MARTINI CJM, 1994, JAMA-J AM MED ASSOC, V272, P661, DOI 10.1001/jama.272.9.661; McMurray JE, 1997, J GEN INTERN MED, V12, P711, DOI 10.1046/j.1525-1497.1997.07145.x; Miller K E, 1996, Fam Med, V28, P33; Nieman L Z, 1989, Fam Med, V21, P359; Schafer S, 2000, FAM MED, V32, P320; U.S.) C on GME, DHHSPUBL 1998 HRSA, V97, P53; Williams ES, 1999, MED CARE, V37, P1140, DOI 10.1097/00005650-199911000-00006; WILLKE RJ, 1991, MED CARE, V29, P977, DOI 10.1097/00005650-199110000-00004	23	11	11	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2782	2783		10.1001/jama.285.21.2782	http://dx.doi.org/10.1001/jama.285.21.2782			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386939	Bronze			2022-12-28	WOS:000168985800035
J	Schwetz, BA				Schwetz, BA			Oral therapy for CMV retinitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2705	2705						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386912				2022-12-28	WOS:000168985800005
J	Dorling, D; Smith, GD; Shaw, M				Dorling, D; Smith, GD; Shaw, M			Analysis of trends in premature mortality by Labour voting in the 1997 general election	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England	University of Bristol; University of Leeds; University of Bristol	Smith, GD (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314				Davey Smith G, 2001, POVERTY INEQUALITY H, P88; *DEP HLTH, 2001, HLTH IN; LAKIN C, 2001, EC TRENDS, V0569; Smith GD, 1996, BRIT MED J, V313, P1573, DOI 10.1136/bmj.313.7072.1573; Suther H, 2001, ECON J, V111, P85	5	23	23	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2001	322	7298					1336	1337		10.1136/bmj.322.7298.1336	http://dx.doi.org/10.1136/bmj.322.7298.1336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440GQ	11387180	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-28	WOS:000169167900019
J	Johnson, MR; Good, CD; Penny, WD; Barnes, PRJ; Scadding, JW				Johnson, MR; Good, CD; Penny, WD; Barnes, PRJ; Scadding, JW			Lesson of the week - Playing the odds in clinical decision making: lessons from berry aneurysms undetected by magnetic resonance angiography	BRITISH MEDICAL JOURNAL			English	Review							UNRUPTURED INTRACRANIAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; CEREBRAL ANEURYSM; SURGERY; DEATH		Charing Cross Hosp, Div Neurosci & Psychol Med, London W6 8RF, England; UCL, Neurol Inst, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Kings Coll London Hosp, Ctr Neurosci, London SE5 9RS, England	Imperial College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital	Johnson, MR (corresponding author), Charing Cross Hosp, Div Neurosci & Psychol Med, London W6 8RF, England.	m.johnson@ion.ucl.ac.uk		Penny, William/0000-0001-9064-1191				BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Cloft HJ, 1999, STROKE, V30, P317, DOI 10.1161/01.STR.30.2.317; Gross RD, 1999, MAKING MED DECISIONS, V1; HORIKOSHI T, 1994, NEURORADIOLOGY, V36, P203, DOI 10.1007/BF00588131; KASSELL NF, 1990, J NEUROSURG, V73, P37, DOI 10.3171/jns.1990.73.1.0037; Mayer PL, 1996, STROKE, V27, P1558, DOI 10.1161/01.STR.27.9.1558; NeilDwyer G, 1997, J ROY COLL PHYS LOND, V31, P49; RAPS EC, 1993, ARCH NEUROL-CHICAGO, V50, P265, DOI 10.1001/archneur.1993.00540030031010; Roos YBWEM, 1997, J NEUROL NEUROSUR PS, V63, P490, DOI 10.1136/jnnp.63.4.490; Sackett D., 1985, CLIN EPIDEMIOLOGY BA, P59; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Wardlaw JM, 2000, BRAIN, V123, P205, DOI 10.1093/brain/123.2.205; WIEBERS DO, 1987, J NEUROSURG, V66, P23, DOI 10.3171/jns.1987.66.1.0023; Wilcock D, 1996, CLIN RADIOL, V51, P330, DOI 10.1016/S0009-9260(96)80109-7	14	19	20	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2001	322	7298					1347	1349		10.1136/bmj.322.7298.1347	http://dx.doi.org/10.1136/bmj.322.7298.1347			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387186	Green Published, Green Accepted			2022-12-28	WOS:000169167900022
J	Schacter, DL				Schacter, DL			Suppression of unwanted memories: repression revisited?	LANCET			English	Editorial Material									Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Schacter, DL (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.			Schacter, Daniel/0000-0002-2460-6061				Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Conway MA, 2001, NATURE, V410, P319, DOI 10.1038/35066672; Erdelyi M. H, 1985, PSYCHOANALYSIS FREUD; Freud Sigmund, 1959, STANDARD EDITION COM; Loftus Elisabeth F., 1994, MYTH REPRESSED MEMOR; McNally RJ, 1998, J ABNORM PSYCHOL, V107, P596, DOI 10.1037/0021-843X.107.4.596; McNally RJ, 2001, J ABNORM PSYCHOL, V110, P151, DOI 10.1037/0021-843X.110.1.151; PENDERGRAST M, 1996, VICTIMS MEMORY SEX; Schacter D. L., 2001, 7 SINS MEMORY MIND F; Schacter D. L., 1996, SEARCHING MEMORY BRA	10	8	8	1	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1724	1725		10.1016/S0140-6736(00)04931-X	http://dx.doi.org/10.1016/S0140-6736(00)04931-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440BN	11403803				2022-12-28	WOS:000169156200004
J	Kang, JG; Yun, J; Kim, DH; Chung, KS; Fujioka, S; Kim, JI; Dae, HW; Yoshida, S; Takatsuto, S; Song, PS; Park, CM				Kang, JG; Yun, J; Kim, DH; Chung, KS; Fujioka, S; Kim, JI; Dae, HW; Yoshida, S; Takatsuto, S; Song, PS; Park, CM			Light and brassinosteroid signals are integrated via a dark-induced small G protein in etiolated seedling growth	CELL			English	Article							GTP-BINDING PROTEINS; DOWN-REGULATED EXPRESSION; YEAST EXPRESSION; TIP GROWTH; ARABIDOPSIS; BIOSYNTHESIS; PEA; IDENTIFICATION; PLANTS; FAMILY	Plant growth and development are regulated through coordinated interactions between light and phytohormones. Here, we demonstrate that a dark-induced small G protein, pea Pra2, regulates a variant cytochrome P450 that catalyzes C-2 hydroxylation in brassinosteroid biosynthesis. The cytochrome P450 is dark-induced and predominantly expressed in the rapidly elongating zone of etiolated pea epicotyls, where Pra2 is also most abundant. Transgenic plants with reduced Pra2 exhibit a dark-specific dwarfism, which is completely rescued by exogenous brassinolide. Overexpression of the cytochrome P450 results in enhanced hypocotyl growth even in the light, which phenocopies the etiolated hypocotyls. We therefore propose that Pra2 and its orthologs are molecular mediators for the cross-talk between light and brassinosteroids in the etiolation process in plants.	Kumho Life & Environm Sci Lab, Kwangju 500712, South Korea; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; KJIST, Kwangju 500712, South Korea; Joetsu Univ Educ, Dept Chem, Joetsu, Niigata 9438512, Japan	RIKEN; University of Nebraska System; University of Nebraska Lincoln; Gwangju Institute of Science & Technology (GIST); Joetsu University Education	Park, CM (corresponding author), Kumho Life & Environm Sci Lab, Oryong Dong, Kwangju 500712, South Korea.	pssong@unlserve.unl.edu; cmpark@ksc.kumho.co.kr	Park, Chung-Mo/B-6175-2012		NIGMS NIH HHS [GM-36956] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036956] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asami T, 1999, TRENDS PLANT SCI, V4, P348, DOI 10.1016/S1360-1385(99)01456-9; Bibikova TN, 1999, PLANT J, V17, P657, DOI 10.1046/j.1365-313X.1999.00415.x; Bishop GJ, 1999, P NATL ACAD SCI USA, V96, P1761, DOI 10.1073/pnas.96.4.1761; BRIGGS WR, 1965, PLANT PHYSIOL, V40, P934, DOI 10.1104/pp.40.5.934; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Fujioka S, 2000, PHYTOCHEMISTRY, V53, P549, DOI 10.1016/S0031-9422(99)00582-8; Fujioka S, 1997, PHYSIOL PLANTARUM, V100, P710, DOI 10.1034/j.1399-3054.1997.1000335.x; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; HAIZEL T, 1995, PLANT PHYSIOL, V108, P59, DOI 10.1104/pp.108.1.59; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Inaba T, 1999, PLANT PHYSIOL, V120, P491, DOI 10.1104/pp.120.2.491; Inaba T, 2000, J BIOL CHEM, V275, P19723, DOI 10.1074/jbc.M001337200; KIKUCHI A, 1995, METHOD ENZYMOL, V257, P57; Kost B, 1999, CURR OPIN PLANT BIOL, V2, P462, DOI 10.1016/S1369-5266(99)00024-2; Li H, 1999, PLANT CELL, V11, P1731, DOI 10.1105/tpc.11.9.1731; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; MATZKE MA, 1995, TRENDS GENET, V11, P1, DOI 10.1016/S0168-9525(00)88973-8; NAGANO Y, 1995, P NATL ACAD SCI USA, V92, P6314, DOI 10.1073/pnas.92.14.6314; Neff MM, 2000, GENE DEV, V14, P257; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Pan JY, 1996, J BIOL CHEM, V271, P1322, DOI 10.1074/jbc.271.3.1322; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; ROMERO LC, 1991, FEBS LETT, V282, P341, DOI 10.1016/0014-5793(91)80509-2; Schumacher K, 2000, CURR OPIN PLANT BIOL, V3, P79, DOI 10.1016/S1369-5266(99)00038-2; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Ueda T, 2000, PLANT J, V21, P341, DOI 10.1046/j.1365-313x.2000.00681.x; vonArnim A, 1996, ANNU REV PLANT PHYS, V47, P215, DOI 10.1146/annurev.arplant.47.1.215; WANG X, 2000, J BIOL CHEM, V275, P29198; WAXMAN DJ, 1991, METHOD ENZYMOL, V206, P462; YOSHIDA K, 1993, P NATL ACAD SCI USA, V90, P6636, DOI 10.1073/pnas.90.14.6636	36	136	154	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					625	636		10.1016/S0092-8674(01)00370-1	http://dx.doi.org/10.1016/S0092-8674(01)00370-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389832	Bronze			2022-12-28	WOS:000169123200009
J	Sesti, F; Shih, TM; Nikolaeva, N; Goldstein, SAN				Sesti, F; Shih, TM; Nikolaeva, N; Goldstein, SAN			Immunity to K1 killer toxin: Internal TOK1 blockade	CELL			English	Article							DOUBLE-STRANDED-RNA; 2 PORE DOMAINS; SACCHAROMYCES-CEREVISIAE; K+ CHANNEL; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; POTASSIUM CHANNEL; YEAST K+; SECRETION	K1 killer strains of Saccharomyces cerevisiae harbor RNA viruses that mediate secretion of K1, a protein toxin that kills virus-free cells. Recently, external K1 toxin was shown to directly activate TOK1 channels in the plasma membranes of sensitive yeast cells, leading to excess potassium flux and cell death. Here, a mechanism by which killer cells resist their own toxin is shown: internal toxin inhibits TOK1 channels and suppresses activation by external toxin.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA	Yale University; Yale University	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, 295 Congress Ave, New Haven, CT 06536 USA.	steve.goldstein@yale.edu	Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; ALALDROOS K, 1978, CAN J MICROBIOL, V24, P228; ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; BOONE C, 1990, J CELL BIOL, V110, P1833, DOI 10.1083/jcb.110.5.1833; BOONE C, 1986, CELL, V46, P105, DOI 10.1016/0092-8674(86)90864-0; BOSTIAN KA, 1984, CELL, V36, P741, DOI 10.1016/0092-8674(84)90354-4; BOSTIAN KA, 1980, CELL, V19, P403, DOI 10.1016/0092-8674(80)90514-0; BUSSEMAKERS MJG, 1991, PROGR UROLOGIE S, V1, P5; BUSSEY H, 1981, ADV MICROB PHYSIOL, V22, P93, DOI 10.1016/S0065-2911(08)60326-4; BUSSEY H, 1983, MOL CELL BIOL, V3, P1362, DOI 10.1128/MCB.3.8.1362; Eisfeld K, 2000, MOL MICROBIOL, V37, P926, DOI 10.1046/j.1365-2958.2000.02063.x; Fairman C, 1999, J MEMBRANE BIOL, V168, P149, DOI 10.1007/s002329900505; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kjeldsen T, 1999, J BIOTECHNOL, V75, P195, DOI 10.1016/S0168-1656(99)00159-5; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; LOLLE S, 1984, EMBO J, V3, P1383, DOI 10.1002/j.1460-2075.1984.tb01981.x; Lord JM, 1998, J CELL BIOL, V140, P733; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Magliani W, 1997, CLIN MICROBIOL REV, V10, P369, DOI 10.1128/CMR.10.3.369; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; PETTOELLOMANTOVANI M, 1995, GASTROENTEROLOGY, V109, P1900, DOI 10.1016/0016-5085(95)90757-2; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, FEBS LETT, V443, P241, DOI 10.1016/S0014-5793(98)01724-4; Schmitt MJ, 1995, ARCH MICROBIOL, V164, P435; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; SKIPPER N, 1984, EMBO J, V3, P107, DOI 10.1002/j.1460-2075.1984.tb01769.x; STARMER WT, 1987, CAN J MICROBIOL, V33, P783, DOI 10.1139/m87-134; STURLEY SL, 1986, EMBO J, V5, P3381, DOI 10.1002/j.1460-2075.1986.tb04654.x; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; THIELE DJ, 1982, NUCLEIC ACIDS RES, V10, P6903, DOI 10.1093/nar/10.21.6903; Vergani P, 1998, EMBO J, V17, P7190, DOI 10.1093/emboj/17.24.7190; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; WICKNER RB, 1974, J BACTERIOL, V117, P1356, DOI 10.1128/JB.117.3.1356-1357.1974; Wickner RB, 1996, ANNU REV GENET, V30, P109, DOI 10.1146/annurev.genet.30.1.109; WICKNER RB, 1976, GENETICS, V82, P429; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D; ZHU H, 1991, MOL CELL BIOL, V11, P175, DOI 10.1128/MCB.11.1.175	38	22	22	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					637	644		10.1016/S0092-8674(01)00376-2	http://dx.doi.org/10.1016/S0092-8674(01)00376-2			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389833	Bronze			2022-12-28	WOS:000169123200010
J	Zeng, X; Goetz, JA; Suber, LM; Scott, WJ; Schreiner, CM; Robbins, DJ				Zeng, X; Goetz, JA; Suber, LM; Scott, WJ; Schreiner, CM; Robbins, DJ			A freely diffusible form of Sonic hedgehog mediates long-range signalling	NATURE			English	Article							LIMB-PATTERNING ACTIVITY; INDUCTION; PROTEIN; TRANSDUCTION; CYCLOPAMINE; INHIBITION; CLEAVAGE; PRODUCT; CELLS; CHICK	The secreted protein Sonic hedgehog (Shh) exerts many of its patterning effects through a combination of short- and long-range signalling(1-3). Three distinct mechanisms, which are not necessarily mutually exclusive, have been proposed to account for the long-range effects of Shh: simple diffusion of Shh, a relay mechanism in which Shh activates secondary signals, and direct delivery of Shh through cytoplasmic extensions, termed cytonemes. Although there is much data (using soluble recombinant Shh (ShhN)) to support the simple diffusion model of long-range Shh signalling(1,2), there has been little evidence to date for a native form of Shh that is freely diffusible and not membrane-associated. Here we provide evidence for a freely diffusible form of Shh (s-ShhNp) that is cholesterol modified, multimeric and biologically potent. We further demonstrate that the availability of s-ShhNp is regulated by two functional antagonists of the Shh pathway, Patched (Ptc) and Hedgehog-interacting protein (Hip)(4-6). Finally, we show a gradient of s-ShhNp across the anterior-posterior axis of the chick limb, demonstrating the physiological relevance of s-ShhNp.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Robbins, DJ (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.							Bell SM, 2000, METH MOL B, V136, P219; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; CHANG DT, 1994, DEVELOPMENT, V120, P3339; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Goodrich LV, 1999, DEV BIOL, V211, P323, DOI 10.1006/dbio.1999.9311; Guy RK, 2000, P NATL ACAD SCI USA, V97, P7307, DOI 10.1073/pnas.97.13.7307; Incardona JP, 1998, DEVELOPMENT, V125, P3553; JOHNSON RL, 1995, CELL, V81, P313, DOI 10.1016/0092-8674(95)90381-X; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; MARTI E, 1995, DEVELOPMENT, V121, P2537; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Tickle C, 1999, SEMIN CELL DEV BIOL, V10, P345, DOI 10.1006/scdb.1999.0294; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yang Y, 1997, DEVELOPMENT, V124, P4393	28	354	364	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					716	720		10.1038/35079648	http://dx.doi.org/10.1038/35079648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395778				2022-12-28	WOS:000169112500052
J	Pantaloni, D; Le Clainche, C; Carlier, MF				Pantaloni, D; Le Clainche, C; Carlier, MF			Cell biology - Mechanism of actin-based motility	SCIENCE			English	Review							ALDRICH-SYNDROME PROTEIN; DEPOLYMERIZING FACTOR COFILIN; FILAMENT BARBED ENDS; ARP2/3 COMPLEX; LISTERIA-MONOCYTOGENES; N-WASP; DENDRITIC ORGANIZATION; CAPPING PROTEIN; LEADING-EDGE; POLYMERIZATION	Spatially controlled polymerization of actin is that the origin of cell motility and is responsible for the formation of cellular protrusions Like lamellipodia. The pathogens Listeria monocytogenes and Shigella flexneri, which undergo actin-based propulsion, are acknowledged models of the Leading edge of lamellipodia. Actin-based motility of the bacteria or of functionalized microspheres can be reconstituted in vitro from only five pure proteins. Movement results from the regulated site-directed treadmilling of actin filaments, consistent with observations of actin dynamics in living motile cells and with the biochemical properties of the components of the synthetic motility medium.	CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Carlier, MF (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Ave Terrasse, F-91198 Gif Sur Yvette, France.	carlier@lebs.cnrs-gif.fr	Le Clainche, Christophe/A-4782-2015	Le Clainche, Christophe/0000-0001-5659-677X				Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Beckerle MC, 1998, CELL, V95, P741, DOI 10.1016/S0092-8674(00)81697-9; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Boquet I, 2000, CELL, V102, P797, DOI 10.1016/S0092-8674(00)00068-4; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; BOUJEMAA R, UNPUB; Bray D., 2000, CELL MOVEMENTS MOL M; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CUNNINGHAM CC, 1991, SCIENCE, V251, P1233, DOI 10.1126/science.1848726; DABIRI GA, 1990, P NATL ACAD SCI USA, V87, P6068, DOI 10.1073/pnas.87.16.6068; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; FECHHEIMER M, 1993, J CELL BIOL, V123, P1, DOI 10.1083/jcb.123.1.1; Gerbal F, 2000, BIOPHYS J, V79, P2259, DOI 10.1016/S0006-3495(00)76473-3; Gerbal F, 2000, EUR BIOPHYS J BIOPHY, V29, P134, DOI 10.1007/s002490050258; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Huang M, 1999, CURR BIOL, V9, P979, DOI 10.1016/S0960-9822(99)80428-X; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Kaverina I, 2000, CURR BIOL, V10, P739, DOI 10.1016/S0960-9822(00)00544-3; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Kuo SC, 2000, NATURE, V407, P1026, DOI 10.1038/35039544; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; MACHESKY LM, 1999, P NATL ACAD SCI USA, V95, P6181; MARCHAND JB, 1995, J CELL BIOL, V130, P331, DOI 10.1083/jcb.130.2.331; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Noireaux V, 2000, BIOPHYS J, V78, P1643, DOI 10.1016/S0006-3495(00)76716-6; Olbris DJ, 2000, BBA-MOL CELL RES, V1495, P140, DOI 10.1016/S0167-4889(99)00156-1; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Roberts TM, 2000, J CELL BIOL, V149, P7, DOI 10.1083/jcb.149.1.7; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; SAFER D, 1994, BIOESSAYS, V16, P473, DOI 10.1002/bies.950160706; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; SUN HQ, 1995, J CELL BIOL, V129, P147, DOI 10.1083/jcb.129.1.147; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; THERIOT JA, 1994, CELL, V76, P505, DOI 10.1016/0092-8674(94)90114-7; TILNEY LG, 1992, J CELL BIOL, V118, P71, DOI 10.1083/jcb.118.1.71; van Oudenaarden A, 1999, NAT CELL BIOL, V1, P493, DOI 10.1038/70281; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Yang CS, 2000, J CELL BIOL, V150, P1001, DOI 10.1083/jcb.150.5.1001	69	534	554	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1502	1506		10.1126/science.1059975	http://dx.doi.org/10.1126/science.1059975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11379633				2022-12-28	WOS:000168963800033
J	Berrey, MM; van Burik, JA				Berrey, MM; van Burik, JA			Symmetric peripheral gangrene.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Washington, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle	Berrey, MM (corresponding author), Univ Washington, Seattle, WA 98109 USA.		Young, Jo-Anne H/G-2617-2013	Young, Jo-Anne H/0000-0003-4182-341X					0	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1593	1593		10.1056/NEJM200105243442105	http://dx.doi.org/10.1056/NEJM200105243442105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372011				2022-12-28	WOS:000168829700005
J	Jewitt, D; Aussel, H; Evans, A				Jewitt, D; Aussel, H; Evans, A			The size and albedo of the Kuiper-belt object (20000) Varuna	NATURE			English	Article							NUCLEUS	Observations over the last decade have revealed the existence of a large number of bodies orbiting the Sun beyond Neptune(1). Known as the Kuiper-belt objects (KBOs), they are believed to be formed in the outer reaches of the protoplanetary disk around the young Sun, and have been little altered since then. They are probably the source of short-period comets(2). The KBOs are, however, difficult objects to study because of their distance from earth, so even basic physical properties such as their sizes and albedos remain unknown. Previous size estimates came from assuming an albedo with the canonical value being 0.04. Here we report simultaneous measurements of the thermal emission and reflected optical light of the bright KBO (20000) Varuna, which allow us to determine independently both the size and the albedo. Varuna has an equivalent circular diameter of D = 900 (+129)(-145) km and a red geometric albedo of p(R) = 0.070(-0.017)(+0.030). Its surface is darker than Pluto's, suggesting that it is largely devoid of fresh ice, but brighter than previously assumed for KBOs.	Inst Astron, Honolulu, HI 96822 USA; SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Jewitt, D (corresponding author), Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.							AHEARN MF, 1989, ASTROPHYS J, V347, P1155, DOI 10.1086/168204; ALLEN DA, 1970, NATURE, V227, P158, DOI 10.1038/227158a0; Altenhoff W. J., 1995, ASTRON ASTROPHYS, V293, P41; Barger AJ, 1999, ASTROPHYS J, V518, pL5, DOI 10.1086/312054; Bowell E., 1989, ASTEROIDS, VII, P524; CAMPINS H, 1987, ASTROPHYS J, V316, P847, DOI 10.1086/165249; Davies J.R., 1993, 5698 IAU; DUNCAN M, 1988, ASTROPHYS J, V328, pL69, DOI 10.1086/185162; FARNHAM TL, 2001, 7583 IAU; Fernandez YR, 2000, ICARUS, V147, P145, DOI 10.1006/icar.2000.6431; Harris D.L., 1961, PLANETS SATELLITES, P272; Holland WS, 1999, MON NOT R ASTRON SOC, V303, P659, DOI 10.1046/j.1365-8711.1999.02111.x; Jewitt D, 1998, ASTROPHYS J, V499, pL103, DOI 10.1086/311356; JEWITT D, 1992, ASTRON J, V104, P398, DOI 10.1086/116247; Jewitt D. C., 2000, Protostars and planets 4, P1201; KELLER HU, 1987, ASTRON ASTROPHYS, V187, P807; KNOFEL A, 2000, WR106 MINOR PLANET E; LANDOLT AU, 1992, ASTRON J, V104, P340, DOI 10.1086/116242; LEBOFSKY LA, 1986, ICARUS, V68, P239, DOI 10.1016/0019-1035(86)90021-7; MCMILLAN R, 2000, WR106 MINOR PLANET E; MILLIS RL, 1988, ASTROPHYS J, V324, P1194, DOI 10.1086/165974; Russell H. N., 1916, ASTROPHYS J, V43, P173, DOI [10.1086/142244, DOI 10.1086/142244]; SPENCER JR, 1989, ICARUS, V78, P337, DOI 10.1016/0019-1035(89)90182-6; THOLEN DJ, 1997, PLUTO CHARON, P193; Thomas N, 2000, ASTROPHYS J, V534, P446, DOI 10.1086/308724	25	62	64	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					446	447		10.1038/35078008	http://dx.doi.org/10.1038/35078008			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373669				2022-12-28	WOS:000168858700038
J	Farber, SA; Pack, M; Ho, SY; Johnson, LD; Wagner, DS; Dosch, R; Mullins, MC; Hendrickson, HS; Hendrickson, EK; Halpern, ME				Farber, SA; Pack, M; Ho, SY; Johnson, LD; Wagner, DS; Dosch, R; Mullins, MC; Hendrickson, HS; Hendrickson, EK; Halpern, ME			Genetic analysis of digestive physiology using fluorescent phospholipid reporters	SCIENCE			English	Article							ZEBRAFISH; A(2); CHOLESTEROL; ENZYMES; ASSAYS	Zebrafish are a valuable model for mammalian lipid metabolism; larvae process lipids similarly through the intestine and hepatobiliary system and respond to drugs that block cholesterol synthesis in humans. After ingestion of fluorescently quenched phospholipids, endogenous lipase activity and rapid transport of cleavage products results in intense gall bladder fluorescence. Genetic screening identifies zebrafish mutants, such as fat free, that show normal digestive organ morphology but severely reduced phospholipid and cholesterol processing. Thus, fluorescent lipids provide a sensitive readout of lipid metabolism and are a powerful tool for identifying genes that mediate vertebrate digestive physiology.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Mol Probes Inc, Eugene, OR 97402 USA; Univ Washington, Dept Chem, Seattle, WA 98133 USA	Carnegie Institution for Science; Jefferson University; University of Pennsylvania; University of Pennsylvania; University of Washington; University of Washington Seattle	Farber, SA (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.		Wagner, Daniel S/C-9379-2009; Dosch, Roland/H-9633-2019; Farber, Steven A/G-5851-2012	Wagner, Daniel S/0000-0002-0595-2436; Dosch, Roland/0000-0001-9247-8586; Farber, Steven A/0000-0002-8037-7312	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054942] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 54942] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cormier RT, 1997, NAT GENET, V17, P88, DOI 10.1038/ng0997-88; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; FARBER S, UNPUB; Farber SA, 1999, J BIOL CHEM, V274, P19338, DOI 10.1074/jbc.274.27.19338; Frolov A, 2000, J BIOL CHEM, V275, P12769, DOI 10.1074/jbc.275.17.12769; Goto T., 1997, Hepatology, V26, p295A; Hendrickson HS, 1999, ANAL BIOCHEM, V276, P27, DOI 10.1006/abio.1999.4280; HENDRICKSON HS, 1994, ANAL BIOCHEM, V219, P1, DOI 10.1006/abio.1994.1223; HOFMANN A, COMMUNICATION; HOMAN R, 2001, INTESTINAL LIPID MET, P81; Honkanen R.E., 1985, AM J PHYSIOL, V249, P399; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; NAWROCKI JW, 1995, ARTERIOSCL THROM VAS, V15, P678, DOI 10.1161/01.ATV.15.5.678; Pack M, 1996, DEVELOPMENT, V123, P321; Rubin M, 1999, LIPIDS, V34, P571, DOI 10.1007/s11745-999-0400-x; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; SHERIDAN MA, 1988, COMP BIOCHEM PHYS B, V90, P679, DOI 10.1016/0305-0491(88)90322-7; STROBAND HWJ, 1979, HISTOCHEMISTRY, V64, P235, DOI 10.1007/BF00495024; Tocher Douglas R., 1995, Biochemistry and Molecular Biology of Fishes, V4, P119; WESTERFIELD M, 1995, ZEABRAFISH BOOK	21	249	258	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1385	1388		10.1126/science.1060418	http://dx.doi.org/10.1126/science.1060418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359013				2022-12-28	WOS:000168862900049
J	Conraads, V; Goethals, M				Conraads, V; Goethals, M			Atrial parasystole after heart transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Hosp, B-2610 Edegem, Belgium		Conraads, V (corresponding author), Univ Hosp, B-2610 Edegem, Belgium.			Conraads, Viviane/0000-0002-5819-1503					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1515	1515		10.1056/NEJM200105173442005	http://dx.doi.org/10.1056/NEJM200105173442005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357155				2022-12-28	WOS:000168677200005
J	Leaning, J				Leaning, J			Ethics of research in refugee populations	LANCET			English	Article									Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Leaning, J (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							GILLON R, 1994, BRIT MED J, V309, P184, DOI 10.1136/bmj.309.6948.184; The Sphere Project, 2000, HUM CHART MIN STAND; World Health Organization, 1997, WHOEHA981	3	88	89	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1432	1433		10.1016/S0140-6736(00)04572-4	http://dx.doi.org/10.1016/S0140-6736(00)04572-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356466				2022-12-28	WOS:000168478200038
J	Andersson, JO; Doolittle, WF; Nesbo, CL				Andersson, JO; Doolittle, WF; Nesbo, CL			Genomics - Are there bugs in our genome?	SCIENCE			English	Editorial Material							LATERAL GENE-TRANSFER; EVOLUTION; SEQUENCE		Dalhousie Univ, Canadian Inst Adv Res, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada	Canadian Institute for Advanced Research (CIFAR); Dalhousie University	Andersson, JO (corresponding author), Dalhousie Univ, Canadian Inst Adv Res, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada.	joanders@is.dal.ca; ford@is.dal.ca; cnesbo@is.dal.ca		Doolittle, W. Ford/0000-0002-4675-8832				Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x; de Koning AP, 2000, MOL BIOL EVOL, V17, P1769, DOI 10.1093/oxfordjournals.molbev.a026275; Doolittle WE, 1998, TRENDS GENET, V14, P307; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Field J, 2000, MOL MICROBIOL, V38, P446, DOI 10.1046/j.1365-2958.2000.02143.x; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ponting CP, 2001, TRENDS GENET, V17, P235, DOI 10.1016/S0168-9525(01)02282-X; Rujan T, 2001, TRENDS GENET, V17, P113, DOI 10.1016/S0168-9525(00)02209-5; Salzberg SL, 2001, SCIENCE, V292, P1903, DOI 10.1126/science.1061036; Sicheritz-Ponten T, 2001, NUCLEIC ACIDS RES, V29, P545, DOI 10.1093/nar/29.2.545; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	14	56	61	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1848	1850		10.1126/science.1062241	http://dx.doi.org/10.1126/science.1062241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11358998				2022-12-28	WOS:000169200700035
J	John, P				John, P			Applied physics - Toward diamond lasers	SCIENCE			English	Editorial Material									Heriot Watt Univ, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland	Heriot Watt University	John, P (corresponding author), Heriot Watt Univ, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland.	p.john@hw.ac.uk						Koizumi S, 2001, SCIENCE, V292, P1899, DOI 10.1126/science.1060258; OKANO K, 1990, APPL PHYS A-MATER, V51, P344, DOI 10.1007/BF00324317; Sakaguchi I, 1999, PHYS REV B, V60, pR2139, DOI 10.1103/PhysRevB.60.R2139; Schreck M, 2001, APPL PHYS LETT, V78, P192, DOI 10.1063/1.1337648; STUTZMAN M, COMMUNICATION; *TECHN INS FROST S, 2000, D219 TECHN INS FROST	6	9	11	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1847	1848		10.1126/science.1061766	http://dx.doi.org/10.1126/science.1061766			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397935				2022-12-28	WOS:000169200700034
J	Beltrami, AP; Urbanek, K; Kajstura, J; Yan, SM; Finato, N; Bussani, R; Nadal-Ginard, B; Silvestri, F; Leri, A; Beltrami, CA; Anversa, P				Beltrami, AP; Urbanek, K; Kajstura, J; Yan, SM; Finato, N; Bussani, R; Nadal-Ginard, B; Silvestri, F; Leri, A; Beltrami, CA; Anversa, P			Evidence that human cardiac myocytes divide after myocardial infarction (Publication with Expression of Concern. See vol. 379, pg. 1870, 2018)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Publication with Expression of Concern							HEMATOPOIETIC STEM-CELLS; ISCHEMIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; HEART-FAILURE; PROLIFERATION; DIFFERENTIATION; TRANSPLANTATION; HYPERTROPHY; INDUCTION; DIVISION	Background The scarring of the heart that results from myocardial infarction has been interpreted as evidence that the heart is composed of myocytes that are unable to divide. However, recent observations have provided evidence of proliferation of myocytes in the adult heart. Therefore, we studied the extent of mitosis among myocytes after myocardial infarction in humans. Methods Samples from the border of the infarct and from areas of the myocardium distant from the infarct were obtained from 13 patients who had died 4 to 12 days after infarction. Ten normal hearts were used as controls. Myocytes that had entered the cell cycle in preparation for cell division were measured by labeling of the nuclear antigen Ki-67, which is associated with cell division. The fraction of myocyte nuclei that were undergoing mitosis was determined, and the mitotic index (the ratio of the number of nuclei undergoing mitosis to the number not undergoing mitosis) was calculated. The presence of mitotic spindles, contractile rings, karyokinesis, and cytokinesis was also recorded. Results In the infarcted hearts, Ki-67 expression was detected in 4 percent of myocyte nuclei in the regions adjacent to the infarcts and in 1 percent of those in regions distant from the infarcts. The reentry of myocytes into the cell cycle resulted in mitotic indexes of 0.08 percent and 0.33 percent, respectively, in the zones adjacent to and distant from the infarcts. Events characteristic of cell division - the formation of the mitotic spindles, the formation of contractile rings, karyokinesis, and cytokinesis - were identified; these features demonstrated that there was myocyte proliferation after myocardial infarction. Conclusions Our results challenge the dogma that the adult heart is a postmitotic organ and raise the possibility that the regeneration of myocytes may contribute to the increase in muscle mass of the myocardium. (N Engl J Med 2001;344:1750-7.) Copyright (C) 2001 Massachusetts Medical Society.	New York Med Coll, Dept Med, Valhalla, NY 10595 USA; Univ Udine, Dept Pathol, I-33100 Udine, Italy; Univ Trieste, Dept Pathol, Trieste, Italy	New York Medical College; University of Udine; University of Trieste	Anversa, P (corresponding author), New York Med Coll, Dept Med, Vosburgh Pavil,Rm 302, Valhalla, NY 10595 USA.	piero_anversa@nymc.edu	Finato, Nicoletta/A-7351-2010; Beltrami, Antonio/C-5291-2008; beltrami, carlo a/A-8026-2008	Beltrami, Antonio/0000-0002-0679-2710; Yan, Shaomin/0000-0001-7642-3972; Bussani, Rossana/0000-0001-8241-9726	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL043023, R01HL038132, R01HL039902] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-38132, HL-43023, HL-39902] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; ANVERSA P, 1990, PROG CARDIOVASC DIS, V33, P49, DOI 10.1016/0033-0620(90)90039-5; Anversa P, 2000, CIRC RES, V86, P121, DOI 10.1161/01.RES.86.2.121; Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151; BODINE DM, 1994, BLOOD, V84, P1482; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Guerra S, 1999, CIRC RES, V85, P856, DOI 10.1161/01.RES.85.9.856; HALL PA, 1990, CELL TISSUE KINET, V23, P505, DOI 10.1111/j.1365-2184.1990.tb01343.x; HALL PA, 1990, J CLIN PATHOL, V43, P184, DOI 10.1136/jcp.43.3.184; HALL PA, 1993, ONCOGENE, V8, P203; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; KAJSTURA J, 1995, CIRCULATION, V92, P2306, DOI 10.1161/01.CIR.92.8.2306; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Leor J, 1996, CIRCULATION, V94, P332; LINZBACH AJ, 1960, AM J CARDIOL, V5, P370, DOI 10.1016/0002-9149(60)90084-9; LOUD AV, 1984, LAB INVEST, V50, P250; MacCallum DE, 2000, J PATHOL, V191, P286; MacCallum DE, 2000, J PATHOL, V190, P537; Moreau V, 1999, CURR OPIN CELL BIOL, V11, P152, DOI 10.1016/S0955-0674(99)80019-2; Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Orlic D, 1998, BLOOD, V91, P3247, DOI 10.1182/blood.V91.9.3247.3247_3247_3254; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; PARODI O, 1993, CIRCULATION, V88, P509, DOI 10.1161/01.CIR.88.2.509; QUAINI F, 1994, CIRC RES, V75, P1050, DOI 10.1161/01.RES.75.6.1050; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SKALLI O, 1988, AM J PATHOL, V130, P515; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wolf WA, 1999, CELL MOL LIFE SCI, V55, P108, DOI 10.1007/s000180050274; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037	40	1044	1247	0	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2001	344	23					1750	1757		10.1056/NEJM200106073442303	http://dx.doi.org/10.1056/NEJM200106073442303			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	439TL	11396441	Bronze			2022-12-28	WOS:000169133600003
J	Schwetz, BA				Schwetz, BA			Safety of aristolochic acid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2705	2705						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386912				2022-12-28	WOS:000168985800004
J	Engelhardt, KAM; Ritchie, ME				Engelhardt, KAM; Ritchie, ME			Effects of macrophyte species richness on wetland ecosystem functioning and services	NATURE			English	Article							PLANT DIVERSITY; BIODIVERSITY; PRODUCTIVITY; PHOSPHORUS; PATTERNS; DISTURBANCE; GRASSLANDS; EPIPHYTES; REGIMES; ALGAE	Wetlands provide many important ecosystem services to human society(1-5), which may depend on how plant diversity influences biomass production and nutrient retention(4,6-8). Vascular aquatic plant diversity may not necessarily enhance wetland ecosystem functioning, however, because competition among these plant species can be strong, often resulting in the local dominance of a single species(4,9). Here we have manipulated the species richness of rooted, submerged aquatic plant (macrophyte) communities in experimental wetland mesocosms. We found higher algal and total plant (algal plus macrophyte) biomass, as well as lower loss of total phosphorus, in mesocosms with a greater richness of macrophyte species. Greater plant biomass resulted from a sampling effect; that is, the increased chance in species mixtures that algal production would be facilitated by the presence of a less competitive species-in this case, crisped pondweed. Lower losses of total phosphorus resulted from the greater chance in species mixtures of a high algal biomass and the presence of sago pondweed, which physically filter particulate phosphorus from the water(2,10,11). These indirect and direct effects of macrophyte species richness on algal production, total plant biomass and phosphorus loss suggest that management practices that maintain macrophyte diversity may enhance the functioning and associated services of wetland ecosystems.	Utah State Univ, Dept Fisheries & Wildlife, Logan, UT 84322 USA; Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Engelhardt, KAM (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Soil & Water Conservat Res Lab, 301 Braddock Rd, Frostburg, MD 21532 USA.		Engelhardt, Katharina AM/H-8755-2013					Bedford BL, 1999, ECOLOGY, V80, P2151, DOI 10.1890/0012-9658(1999)080[2151:PINAAP]2.0.CO;2; BUNN SE, 1993, OECOLOGIA, V96, P85, DOI 10.1007/BF00318034; BURKHOLDER JM, 1990, LIMNOL OCEANOGR, V35, P736, DOI 10.4319/lo.1990.35.3.0736; BURKHOLDER JM, 1989, J PHYCOL, V25, P55, DOI 10.1111/j.0022-3646.1989.00055.x; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Fischer JM, 2000, ESTUARIES, V23, P565, DOI 10.2307/1353146; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; HARGEBY A, 1994, HYDROBIOLOGIA, V279, P83, DOI 10.1007/BF00027843; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jeppesen E, 1999, HYDROBIOLOGIA, V395, P419, DOI 10.1023/A:1017071602549; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Mitsch W. J., 1993, WETLANDS; MITSCH WJ, 1995, ECOL APPL, V5, P830, DOI 10.2307/1941991; MOELLER RE, 1988, AQUAT BOT, V32, P261, DOI 10.1016/0304-3770(88)90120-9; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; Pollock MM, 1998, ECOLOGY, V79, P94; Robinson GGC, 1997, WETLANDS, V17, P182, DOI 10.1007/BF03161408; Symstad AJ, 1998, OIKOS, V81, P389, DOI 10.2307/3547058; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Troumbis AY, 2000, OIKOS, V90, P549, DOI 10.1034/j.1600-0706.2000.900313.x; Ward JV, 1998, BIOL CONSERV, V83, P269, DOI 10.1016/S0006-3207(97)00083-9; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Wetzel R. G, 1990, VERH INT VEREIN LIMN, V24, P6, DOI DOI 10.1080/03680770.1989.11898687; Wetzel R. G., 1991, LIMNOLOGICAL ANAL; Wilson MA, 1999, ECOL APPL, V9, P772, DOI 10.1890/1051-0761(1999)009[0772:EVOFES]2.0.CO;2; Wu XY, 1998, WETLANDS, V18, P9, DOI 10.1007/BF03161438	30	288	342	19	333	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					687	689		10.1038/35079573	http://dx.doi.org/10.1038/35079573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395769				2022-12-28	WOS:000169112500043
J	Bugoslavsky, Y; Cohen, LF; Perkins, GK; Polichetti, M; Tate, TJ; Gwilliam, R; Caplin, AD				Bugoslavsky, Y; Cohen, LF; Perkins, GK; Polichetti, M; Tate, TJ; Gwilliam, R; Caplin, AD			Enhancement of the high-magnetic field critical current density of superconducting MgB2 by proton irradiation	NATURE			English	Article								Magnesium diboride, MgB2, has a relatively high superconducting transition temperature(1), placing it between the families of low- and high-temperature (copper oxide based) superconductors. Supercurrent flow in MgB2 is unhindered by grain boundaries(2,3), making it potentially attractive for technological applications in the temperature range 20-30 K. But in the bulk material, the critical current density (J(c)) drops rapidly with increasing magnetic field strength(4). The magnitude and field dependence of the critical current are related to the presence of structural defects that can 'pin' the quantized magnetic vortices that permeate the material, and a lack of natural defects in MgB2 may be responsible for the rapid decline of J(c) with increasing field strength(3). Here we show that modest levels of atomic disorder induced by proton irradiation enhance the pinning of vortices, thereby significantly increasing J(c) at high field strengths. We anticipate that either chemical doping or mechanical processing should generate similar levels of disorder, and so achieve performance that is technologically attractive in an economically viable way.	Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Ctr High Temp Superconduct, London SW7 2BZ, England; Moscow Gen Phys Inst, Moscow 117942, Russia; Univ Salerno, Dipartimento Fis, INFM, I-84081 Salerno, Italy; Univ Surrey, EPSRC Ion Beam Ctr, Surrey GU2 7RX, England	Imperial College London; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Salerno; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Surrey	Bugoslavsky, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Ctr High Temp Superconduct, Prince Consort Rd, London SW7 2BZ, England.			Cohen, Lesley/0000-0002-5123-5171; gwilliam, russell/0000-0002-1488-755X; POLICHETTI, Massimiliano/0000-0002-4534-3301				BEAN CP, 1964, REV MOD PHYS, V36, P31, DOI 10.1103/RevModPhys.36.31; Bud'ko SL, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.220503; Bugoslavsky Y, 2001, NATURE, V410, P563, DOI 10.1038/35069029; Eom CB, 2001, NATURE, V411, P558, DOI 10.1038/35079018; KARKIN AE, 2001, CONDMAT0103344; Larbalestier DC, 2001, NATURE, V410, P186, DOI 10.1038/35065559; Morrow G, 2000, IEEE T APPL SUPERCON, V10, P744, DOI 10.1109/77.828339; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Vase P, 2000, SUPERCOND SCI TECH, V13, pR71, DOI 10.1088/0953-2048/13/7/201; ZIEGLER JF, 2000, STOPPING RANGE IONS	10	276	286	0	51	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					561	563		10.1038/35079024	http://dx.doi.org/10.1038/35079024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385564	Green Submitted			2022-12-28	WOS:000168982500043
J	Luo, ZX; Crompton, AW; Sun, AL				Luo, ZX; Crompton, AW; Sun, AL			A new mammaliaform from the Early Jurassic and evolution of mammalian characteristics	SCIENCE			English	Article							MORGANUCODON; DIVERSITY; ECOLOGY; SKULL	A fossil from the Early Jurassic (Sinemurian, similar to 195 million years ago) represents a new Lineage of mammaliaforms, the extinct groups more closely related to the living mammals than to nonmammaliaform cynodonts. it has an enlarged era nial cavity, but no postdentary trough on the mandible, indicating separation of the middle ear bones from the mandible. This extends the earliest record of these crucial mammalian features by some 45 million years and suggests that separation of the middle ear bones from the mandible and the expanded brain vault could be correlated. It shows that several key mammalian evolutionary innovations in the ear region, the temporomandibular joint, and the brain vault evolved incrementally through mammaliaform evolution and Long before the differentiation of the Living mammal groups. With an estimated body weight of only 2 grams, its coexistence with other Larger mammaliaforms with similar "triconodont-like" teeth for insectivory within the same fauna suggests a great trophic diversity within the mammaliaform insectivore feeding guild, as inferred from the range of body sizes.	Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Harvard University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA.	Luoz@carnegiemuseums.org	Luo, Zhe-XI/AAU-2263-2021					ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; [Anonymous], 1996, INDIA MIN; Bloch JI, 1998, J MAMMAL, V79, P804, DOI 10.2307/1383090; Cifelli RL, 1998, J VERTEBR PALEONTOL, V18, P237, DOI 10.1080/02724634.1998.10011048; Clemens W.A., 1980, Zitteliana, V5, P51; Crompton A.W., 1974, Bulletin Br Mus nat Hist (Geol), V24, P399; CROMPTON AW, 1993, MAMMAL PHYLOGENY, P30; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; FRASER NC, 1985, NATURE, V314, P161, DOI 10.1038/314161a0; Gingerich P.D., 1984, SIZE SCALING PRIMATE, P257; Hahn G., 1988, Palaeovertebrata (Montpellier), V18, P155; HERRING SW, 1993, AM ZOOL, V33, P472; Hopson J.A., 1986, P83; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; JENKINS FA, 1983, SCIENCE, V222, P1233, DOI 10.1126/science.222.4629.1233; JENKINS FA, 1997, NATURE, V385, P315; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; Ji Q, 1999, NATURE, V398, P326; Kemp T.S., 1982, P1; KERMACK DORIS M., 1968, J LINN SOC LONDON ZOOL, V47, P407; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; KIELANJAWOROWSK.Z, 1997, LETHAIA, V29, P249; KielanJaworowska Z, 1997, ACTA PALAEONTOL POL, V42, P201; KIELBOWICZ RB, 1986, CRIT STUD MASS COMM, V3, P21, DOI 10.1080/15295038609366627; Kuhn H. J., 1971, Abh Senckenb Naturf Ges, V528, P1; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Lucas Spencer G., 1993, Journal of Vertebrate Paleontology, V13, P309; LUO ZX, 1994, J VERTEBR PALEONTOL, V14, P341, DOI 10.1080/02724634.1994.10011564; LUO ZX, 1994, IN THE SHADOW OF THE DINOSAURS, P98; LUO ZX, 1995, J VERTEBR PALEONTOL, V15, P113, DOI 10.1080/02724634.1995.10011211; Musser AM, 1998, PHILOS T R SOC B, V353, P1063, DOI 10.1098/rstb.1998.0266; Nummela Sirpa, 1997, Comments on Theoretical Biology, V4, P387; PARRINGTON FR, 1978, PHILOS T ROY SOC B, V282, P177, DOI 10.1098/rstb.1978.0012; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Sidor CA, 1998, PALEOBIOLOGY, V24, P254; Sigogneau-Russell Denise, 1995, Acta Palaeontologica Polonica, V40, P245; Smith KK, 1997, EVOLUTION, V51, P1663, DOI 10.1111/j.1558-5646.1997.tb01489.x; VANVALKENBURGH B, 1995, TRENDS ECOL EVOL, V10, P71, DOI 10.1016/S0169-5347(00)88980-6; VONMAIER W, 1989, Z ZOOL SYST EVOL, V27, P149; VONMAIER W, 1993, MAMMAL PHYLOGENY, P165; WIBLE JR, 1993, MAMMAL PHYLOGENY, P45; Zeller U., 1987, Mammalia Depicta, P17; Zeller U., 1989, ABHANDLUNGEN SENCKEN, V545, P1; Zeller U., 1993, MAMMAL PHYLOGENY, P95	49	172	180	5	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1535	1540		10.1126/science.1058476	http://dx.doi.org/10.1126/science.1058476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375489				2022-12-28	WOS:000168963800042
J	Adam, D				Adam, D			Plans for GM livestock fail the poor	NATURE			English	News Item																		Reichhardt T, 2000, NATURE, V406, P10, DOI 10.1038/35017657; 2001, NATURE, V409, P749	2	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					403	403		10.1038/35078211	http://dx.doi.org/10.1038/35078211			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373634	Bronze			2022-12-28	WOS:000168858700007
J	Brockie, B				Brockie, B			GM cows face slaughter in multiple sclerosis experiment	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					402	402		10.1038/35078202	http://dx.doi.org/10.1038/35078202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373631	Bronze			2022-12-28	WOS:000168858700004
J	Blomley, MJK; Cooke, JC; Unger, EC; Monaghan, MJ; Cosgrove, DO				Blomley, MJK; Cooke, JC; Unger, EC; Monaghan, MJ; Cosgrove, DO			Science, medicine, and the future - Microbubble contrast agents: a new era in ultrasound	BMJ-BRITISH MEDICAL JOURNAL			English	Review							STIMULATED ACOUSTIC-EMISSION; DIAGNOSTIC ULTRASOUND; ALBUMIN MICROBUBBLES; EARLY EXPERIENCE; US; ENHANCEMENT; LIVER; ECHOCARDIOGRAPHY; METASTASES; PULSE		Hammersmith Hosp, Imperial Coll Sch Med, London W12 0HS, England; Univ Arizona, Tucson, AZ USA	Imperial College London; University of Arizona	Blomley, MJK (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, London W12 0HS, England.	m.blomley@ic.ac.uk						Albrecht T, 1999, LANCET, V353, P1579, DOI 10.1016/S0140-6736(98)06373-9; Albrecht T, 1998, RADIOLOGY, V207, P339, DOI 10.1148/radiology.207.2.9577478; ALBRECHT T, IN PRESS AJR AM J RO; APFEL RE, 1991, ULTRASOUND MED BIOL, V17, P179, DOI 10.1016/0301-5629(91)90125-G; Blomley MJK, 1999, ULTRASOUND MED BIOL, V25, P1341, DOI 10.1016/S0301-5629(99)00081-2; Blomley MJK, 1998, RADIOLOGY, V209, P862, DOI 10.1148/radiology.209.3.9844688; Blomley MJK, 1999, RADIOLOGY, V210, P409, DOI 10.1148/radiology.210.2.r99fe47409; BLOMLEY MJK, IN PRESS RADIOLOGY; BURNS PN, 2000, HDB CONTRAST ECHOCAR, P154; Cheng SC, 1998, AM J CARDIOL, V81, p41G, DOI 10.1016/S0002-9149(98)00053-8; Cohen JL, 1998, J AM COLL CARDIOL, V32, P746, DOI 10.1016/S0735-1097(98)00311-8; Cosgrove D, 1996, CLIN RADIOL, V51, P1; Cwajg J, 2000, AM HEART J, V139, P675, DOI 10.1016/S0002-8703(00)90047-4; Czitrom D, 1999, HEART, V81, P12, DOI 10.1136/hrt.81.1.12; Darge K, 1999, RADIOLOGY, V210, P201, DOI 10.1148/radiology.210.1.r99ja40201; Forsberg F, 1999, RADIOLOGY, V210, P125, DOI 10.1148/radiology.210.1.r99ja11125; Harvey CJ, 2000, LANCET, V355, P807, DOI 10.1016/S0140-6736(99)04545-6; Harvey CJ, 1999, RADIOLOGY, V213P, P166; HARVEY CJ, IN PRESS RADIOLOGY; Kim TK, 2000, RADIOLOGY, V216, P411, DOI 10.1148/radiology.216.2.r00jl21411; Miller MW, 2000, ULTRASOUND MED BIOL, V26, pS59, DOI 10.1016/S0301-5629(00)00166-6; Mulvagh SL, 2000, J AM SOC ECHOCARDIOG, V13, P331, DOI 10.1067/mje.2000.105462; Nanda N.C., 1997, ADV ECHO IMAGING USI, P115, DOI [10.1007/978-94-011-5704-9_6, DOI 10.1007/978-94-011-5704-9_6]; Porter TR, 1996, J ULTRAS MED, V15, P577; Price RJ, 1998, CIRCULATION, V98, P1264, DOI 10.1161/01.CIR.98.13.1264; RIES F, 1993, STROKE, V24, P1903, DOI 10.1161/01.STR.24.12.1903; Russell SJ, 1997, BRIT MED J, V315, P1289, DOI 10.1136/bmj.315.7118.1289; Shohet RV, 2000, CIRCULATION, V101, P2554, DOI 10.1161/01.CIR.101.22.2554; Strandell A, 1999, ULTRASOUND OBST GYN, V14, P200, DOI 10.1046/j.1469-0705.1999.14030200.x; Wu YQ, 1998, INVEST RADIOL, V33, P880, DOI 10.1097/00004424-199812000-00006	30	288	315	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2001	322	7296					1222	1225		10.1136/bmj.322.7296.1222	http://dx.doi.org/10.1136/bmj.322.7296.1222			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11358777	Green Published			2022-12-28	WOS:000168900700031
J	Prusiner, SB				Prusiner, SB			Shattuck lecture - Neurodegenerative diseases and prions.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CREUTZFELDT-JAKOB-DISEASE; DOMINANT-NEGATIVE INHIBITION; TO-PERSON TRANSMISSION; ALPHA-SYNUCLEIN; ALZHEIMER-DISEASE; AMYLOID-BETA; TAU GENE; SPONGIFORM ENCEPHALOPATHY; POLYGLUTAMINE DISEASES; CEREBROSPINAL-FLUID		Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prusiner, SB (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, Box 0518, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS014069, P50NS014069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770, P01AG002132] Funding Source: NIH RePORTER; NIA NIH HHS [AG02132, AG10770] Funding Source: Medline; NINDS NIH HHS [NS14069] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Balter M, 2000, SCIENCE, V289, P1452, DOI 10.1126/science.289.5484.1452; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; BERNOULLI C, 1977, LANCET, V1, P478; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BOBOWICK AR, 1973, NEW ENGL J MED, V288, P1047, DOI 10.1056/NEJM197305172882005; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; BRUCE ME, 1989, NEUROSCI LETT, V102, P1, DOI 10.1016/0304-3940(89)90298-X; BRUN A, 1993, DEMENTIA, V4, P126, DOI 10.1159/000107311; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; CATHALA F, 1987, P467; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Cleveland DW, 2000, NAT MED, V6, P1320, DOI 10.1038/82122; COCHIUS JI, 1990, AUST NZ J MED, V20, P592, DOI 10.1111/j.1445-5994.1990.tb01322.x; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; DCARMOND SJ, 1997, GREENFIELDS NEUROPAT, P235; De Strooper B, 2000, J CELL SCI, V113, P1857; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DEARMOND SJ, 1987, NEUROLOGY, V37, P1271, DOI 10.1212/WNL.37.8.1271; DeArmond SJ, 1999, COLD SPRING HARBOR M, V38, P585; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; DLOUHY SR, 1992, NAT GENET, V1, P64, DOI 10.1038/ng0492-64; DUFFY P, 1974, NEW ENGL J MED, V290, P692; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FRADKIN JE, 1991, JAMA-J AM MED ASSOC, V265, P880, DOI 10.1001/jama.265.7.880; GABIZON R, 1993, AM J HUM GENET, V53, P828; Gambetti P, 1999, COLD SPRING HARBOR M, V38, P509; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; GERTZ HJ, 1988, NEUROLOGY, V38, P1481, DOI 10.1212/WNL.38.9.1481; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Ghiso J, 1997, FEBS LETT, V408, P105, DOI 10.1016/S0014-5793(97)00400-6; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; GIBBS CJ, 1994, J NEUROL NEUROSUR PS, V57, P757, DOI 10.1136/jnnp.57.6.757; Goedert M, 1999, NAT MED, V5, P454, DOI 10.1038/7454; HANSEN L, 1990, NEUROLOGY, V40, P1; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Holman RC, 1996, EMERG INFECT DIS, V2, P333, DOI 10.3201/eid0204.960409; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HSIAO K, 1989, ANN NEUROL, V26, P137; HUDSON AJ, 1981, BRAIN, V104, P217, DOI 10.1093/brain/104.2.217; Hughes TA, 2000, NEUROLOGY, V54, P1596, DOI 10.1212/WNL.54.8.1596; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Johnson RT, 1998, NEW ENGL J MED, V339, P1994, DOI 10.1056/NEJM199812313392707; KAHANA E, 1974, SCIENCE, V183, P90, DOI 10.1126/science.183.4120.90; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kawas C, 1999, ALZHEIMER DIS, P95; KERTESZ A, 1998, PICKS DIS PICK COMPL, P301; KIRSCHBAUM WR, 1968, JAKOB CREUTZFELDT DI, P251; Kitagaki H, 1998, RADIOLOGY, V208, P431, DOI 10.1148/radiology.208.2.9680572; LILIENFELD DE, 1994, NEURODEGENER DIS, P399; Lin X, 1999, NEURON, V24, P499, DOI 10.1016/S0896-6273(00)81104-6; Liu H, 1999, BIOCHEMISTRY-US, V38, P5362, DOI 10.1021/bi982878x; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARSDEN CD, 1977, LANCET, V1, P345; Martin JB, 1999, NEW ENGL J MED, V341, P1407; MASTERS CL, 1979, ANN NEUROL, V5, P177, DOI 10.1002/ana.410050212; MASTERS CL, 1981, BRAIN, V104, P559, DOI 10.1093/brain/104.3.559; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; NEVIN S, 1960, BRAIN, V83, P519, DOI 10.1093/brain/83.4.519; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Orr HT, 2000, CELL, V101, P1, DOI 10.1016/S0092-8674(00)80617-0; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269; Perrier V, 2000, P NATL ACAD SCI USA, V97, P6073, DOI 10.1073/pnas.97.11.6073; PETERSEN RB, 1992, NEUROLOGY, V42, P1859, DOI 10.1212/WNL.42.10.1859; PHILLIPS N, 2000, BSE INQUIRY REPORT, V2; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; POULTER M, 1992, BRAIN, V115, P675, DOI 10.1093/brain/115.3.675; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prusiner SB, 1999, COLD SPRING HARBOR M, V38, P67; PRUSINER SB, 1984, NEW ENGL J MED, V310, P661, DOI 10.1056/NEJM198403083101021; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; *PUBL HLTH SERV IN, 1997, REP HUM GROWTH HORM, V14, P1; Ridley RM, 1996, NEURODEGENERATION, V5, P219, DOI 10.1006/neur.1996.0030; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROOS R, 1973, BRAIN, V96, P1; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Scott MR, 1997, J VIROL, V71, P9032, DOI 10.1128/JVI.71.12.9032-9044.1997; SEBOUN E, 1997, MOL GENETIC BASIS NE, P631; Seipelt M, 1999, J NEUROL NEUROSUR PS, V66, P172, DOI 10.1136/jnnp.66.2.172; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shibuya S, 1998, ANN NEUROL, V43, P826, DOI 10.1002/ana.410430618; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; St George-Hyslop PH, 1999, ALZHEIMER DIS, P311; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; SWASH M, 2000, AMYOTROPHIC LATERAL, P3; TANGE RA, 1990, EUR ARCH OTO-RHINO-L, V247, P199; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; *UN DEP EC SOC AFF, 1999, WORLD POP PROSP 1998, V2, P1; Valle, 1995, METABOLIC BASIS INHE, P4159; van den Pol AN, 2000, NEURON, V27, P415, DOI 10.1016/S0896-6273(00)00050-7; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; Will RG, 1999, COLD SPRING HARBOR M, V38, P465; Will RG, 1999, LANCET, V353, P979, DOI 10.1016/S0140-6736(99)01160-5; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000; 1997, MMWR MORB MORTAL WKL, V46, P1066	120	568	603	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1516	1526		10.1056/NEJM200105173442006	http://dx.doi.org/10.1056/NEJM200105173442006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357156				2022-12-28	WOS:000168677200006
J	Raoult, D; Fournier, PE; Fenollar, F; Jensenius, M; Prioe, T; de Pina, JJ; Caruso, G; Jones, N; Laferl, H; Rosenblatt, JE; Marrie, TJ				Raoult, D; Fournier, PE; Fenollar, F; Jensenius, M; Prioe, T; de Pina, JJ; Caruso, G; Jones, N; Laferl, H; Rosenblatt, JE; Marrie, TJ			Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDITERRANEAN SPOTTED-FEVER; BITE FEVER; EPIDEMIOLOGICAL FEATURES; PROTEIN ROMPA; INFECTIONS; CONORII; MICROIMMUNOFLUORESCENCE; SEROEPIDEMIOLOGY; DIFFERENTIATION; ANTIBODIES	Background: African tick-bite fever occurs after contact with ticks that carry Rickettsia africae and that parasitize cattle and game. Sporadic reports suggest that this infection has specific clinical and epidemiologic features. Methods: We studied patients who were tested for a rickettsial disease after returning from a visit to Africa or Guadeloupe. To assess the value of the microimmunofluorescence assay, Western blotting, and cross-adsorption assays, we compared the results of these tests in 39 patients in whom African tick-bite fever had been confirmed by the polymerase-chain-reaction assay, cell culture, or both; 50 patients with documented R. conorii infection; and 50 blood donors. These diagnostic criteria were then applied to 376 additional patients who had returned from southern Africa and 2 who had returned from Guadeloupe and whose serum was being tested for rickettsial disease. Results: In the 39 patients with direct evidence of R. africae infection, the combination of microimmunofluorescence assay, Western blotting, and cross-adsorption assays showing antibodies specific for R. africae had a sensitivity of 0.56; however, each test had a positive predictive value and a specificity of 1.0. An additional 80 patients were found to have an R. africae infection on the basis of these serologic criteria. Infections with R. africae were acquired by visitors to 11 African countries and Guadeloupe. The illness was generally mild and was characterized by a rash in 46 percent of the patients; the rash was usually maculopapular or vesicular and rarely purpuric. Ninety-five percent of patients had an inoculation eschar or eschars, and 54 percent of these patients had multiple eschars, a finding that is unusual in patients with rickettsial infection. Conclusions: In this series, R. africae was the cause of nearly all cases of tick-bite rickettsiosis in patients who became ill after a trip to sub-Saharan Africa. (N Engl J Med 2001;344:1504-10.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS,UPRESA 6020, F-13385 Marseille 05, France; Aker Univ Hosp, Dept Internal Med, Oslo, Norway; Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; Hop Instruct Armees Laveran, Biol Lab, Marseille Armees, France; Osped Belluno, Div Malattie Infett, Belluno, Italy; John Radcliffe Hosp, Dept Microbiol & Infect Dis, Oxford OX3 9DU, England; Kaiser Franz Josef Hosp, Dept Med, Vienna, Austria; Mayo Clin, Div Clin Microbiol, Rochester, MN USA; Univ Alberta, Dept Med, Edmonton, AB, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Oslo; Rigshospitalet; University of Copenhagen; ULSS 1 Dolomiti; Ospedale di Belluno; University of Oxford; Kaiser-Franz-Josef Hospital; Mayo Clinic; University of Alberta	Raoult, D (corresponding author), Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS,UPRESA 6020, 27 Blvd Jean Moulin, F-13385 Marseille 05, France.		JONES, NICOLA/AAN-4246-2020; Fournier, Pierre-Edouard/AAC-6155-2021; RAOULT, Didier/A-8434-2008	Fournier, Pierre-Edouard/0000-0001-8463-8885; RAOULT, Didier/0000-0002-0633-5974; DE PINA, Jean Jacques/0000-0002-2081-3936				BABALIS T, 1993, AM J TROP MED HYG, V48, P784, DOI 10.4269/ajtmh.1993.48.784; Brouqui P, 1997, ARCH INTERN MED, V157, P119, DOI 10.1001/archinte.157.1.119; DEAN AD, 1991, EPI INFO VERSION 5 W; DUPONT HT, 1995, CLIN INFECT DIS, V21, P1126, DOI 10.1093/clinids/21.5.1126; Dupont HT, 1997, CLIN INFECT DIS, V25, P139, DOI 10.1086/514496; Fournier PE, 1998, CLIN INFECT DIS, V27, P316, DOI 10.1086/514664; Fournier PE, 1999, EMERG INFECT DIS, V5, P178, DOI 10.3201/eid0501.990127; Fournier PE, 1998, INT J SYST BACTERIOL, V48, P839, DOI 10.1099/00207713-48-3-839; GOLDWASSER RA, 1959, J IMMUNOL, V82, P373; HECHEMY KE, 1983, J CLIN MICROBIOL, V17, P445, DOI 10.1128/JCM.17.3.445-449.1983; HELMICK CG, 1984, J INFECT DIS, V150, P480, DOI 10.1093/infdis/150.4.480; HERREROHERRERO JI, 1993, EUR J EPIDEMIOL, V9, P59, DOI 10.1007/BF00463091; Jensenius M, 1999, SCAND J INFECT DIS, V31, P131, DOI 10.1080/003655499750006155; KELLY P, 1992, LANCET, V340, P982, DOI 10.1016/0140-6736(92)92878-J; KELLY PJ, 1994, J TROP MED HYG, V97, P129; Kelly PJ, 1996, INT J SYST BACTERIOL, V46, P611, DOI 10.1099/00207713-46-2-611; KELLY PJ, 1991, J TROP MED HYG, V94, P304; La Scola B, 2000, CLIN DIAGN LAB IMMUN, V7, P612, DOI 10.1128/CDLI.7.4.612-616.2000; NORVAL RAI, 1983, ZIMBABWE VET J, V13, P3; Parola P, 1998, NEW ENGL J MED, V338, P1391, DOI 10.1056/NEJM199805073381918; Pece S, 1996, MED SCI RES, V24, P435; Pijper A., 1936, Arch Inst Pasteur Tunis, V25, P388; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; RAOULT D, 1989, J CLIN MICROBIOL, V27, P2073, DOI 10.1128/JCM.27.9.2073-2079.1989; RAOULT D, 1986, AM J TROP MED HYG, V35, P845, DOI 10.4269/ajtmh.1986.35.845; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Rotz L, 1998, Del Med J, V70, P285; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Smoak BL, 1996, EMERG INFECT DIS, V2, P217, DOI 10.3201/eid0203.960309; SONENSHINE DE, 1993, BIOL TICKS, V2, P3; TEYSSEIRE N, 1992, J CLIN MICROBIOL, V30, P455, DOI 10.1128/JCM.30.2.455-460.1992; TROUP JM, 1938, LANCET, V2, P1183; WALKER D, 1998, HARRISONS PRINCIPLES, V1, P1045	33	210	214	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1504	1510		10.1056/NEJM200105173442003	http://dx.doi.org/10.1056/NEJM200105173442003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357153	Bronze			2022-12-28	WOS:000168677200003
J	Vandenbroucke, JP; Rosing, J; Bloemenkamp, KWM; Middeldorp, S; Helmerhorst, FM; Bouma, BN; Rosendaal, FR				Vandenbroucke, JP; Rosing, J; Bloemenkamp, KWM; Middeldorp, S; Helmerhorst, FM; Bouma, BN; Rosendaal, FR			Oral contraceptives and the risk of venous thrombosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACTIVATED PROTEIN-C; FACTOR-V-LEIDEN; RANDOMIZED CROSS-OVER; THROMBOEMBOLIC DISEASE; CARDIOVASCULAR-DISEASE; FACTOR-VIII; FACTOR-XI; BLOOD-COAGULATION; PROTHROMBIN GENE; RESISTANCE		Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Obstet Gynecol & Reprod Med, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Thrombosis Haemostasis Res Ctr, NL-2300 RC Leiden, Netherlands; Univ Limburg, Cardiovasc Res Inst, Dept Biochem, NL-6200 MD Maastricht, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Univ Utrecht Hosp, Dept Hematol, Thrombosis & Hemostasis Lab, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hasselt University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Vandenbroucke, JP (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, POB 9600, NL-2300 RC Leiden, Netherlands.	vdbroucke@mail.medfac.leidenuniv.nl	Middeldorp, Saskia/ABI-8197-2020; Rosendaal, Frits/Q-3842-2017; Vandenbroucke, Jan/AAM-3928-2020	Middeldorp, Saskia/0000-0002-1006-6420; Rosendaal, Frits/0000-0003-2558-7496; Vandenbroucke, Jan/0000-0001-5668-6716				Akhter H, 1998, WHO TECH REP SER, V877, P1; Andersen BS, 1998, THROMB HAEMOSTASIS, V79, P28, DOI 10.1055/s-0037-1614213; BADARACC.MA, 1974, BRIT MED J, V1, P215, DOI 10.1136/bmj.1.5901.215; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Barbieri RL, 1999, J CLIN ENDOCR METAB, V84, P1822, DOI 10.1210/jc.84.6.1822; Bennet L, 1998, J INTERN MED, V244, P27, DOI 10.1046/j.1365-2796.1998.00310.x; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; Bloemenkamp KWM, 2000, ARCH INTERN MED, V160, P49, DOI 10.1001/archinte.160.1.49; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; Bloemenkamp KWM, 1999, THROMB HAEMOSTASIS, V82, P1024, DOI 10.1055/s-0037-1614323; BONNAR J, 1987, AM J OBSTET GYNECOL, V157, P1042, DOI 10.1016/S0002-9378(87)80129-1; Bouma BN, 1998, THROMB HAEMOSTASIS, V80, P24; Burnhill MS, 1999, INT J FERTIL WOMEN M, V44, P19; Campbell B, 1996, BMJ-BRIT MED J, V312, P198; CARTER CJ, 1994, PROG CARDIOVASC DIS, V36, P423, DOI 10.1016/S0033-0620(94)80051-0; COLMAN RW, 1994, HEMOSTASIS THROMBOSI, P1283; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; de Visser MCH, 1999, BLOOD, V93, P1271, DOI 10.1182/blood.V93.4.1271.404k22_1271_1276; Dunn N, 1999, BRIT MED J, V318, P1579, DOI 10.1136/bmj.318.7198.1579; Farley TMM, 1999, HUM REPROD UPDATE, V5, P721, DOI 10.1093/humupd/5.6.721; FARLEY TMM, 1995, LANCET, V346, P1582; Farley TMM, 1998, CONTRACEPTION, V57, P211, DOI 10.1016/S0010-7824(98)00019-5; Farmer RDT, 1997, LANCET, V349, P83, DOI 10.1016/S0140-6736(96)07496-X; Farmer RDT, 1998, BRIT MED J, V316, P1090; GIROLAMI A, 1991, BLOOD COAGUL FIBRIN, V2, P673, DOI 10.1097/00001721-199110000-00015; Hannaford PC, 1998, BMJ-BRIT MED J, V316, P984, DOI 10.1136/bmj.316.7136.984; HEIJBOER H, 1990, NEW ENGL J MED, V323, P1512, DOI 10.1056/NEJM199011293232202; Heinemann LAJ, 1997, BRIT MED J, V315, P1502, DOI 10.1136/bmj.315.7121.1502; HELLGREN M, 1995, AM J OBSTET GYNECOL, V173, P210, DOI 10.1016/0002-9378(95)90192-2; HELMRICH SP, 1987, OBSTET GYNECOL, V69, P91; HENKENS CMA, 1995, THROMB HAEMOSTASIS, V73, P402; Herings RMC, 1999, LANCET, V354, P127, DOI 10.1016/S0140-6736(99)01257-X; Herings RMC, 1999, LANCET, V354, P1478; JICK H, 1969, LANCET, V1, P539; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Kluft C, 1997, THROMB HAEMOSTASIS, V78, P315; KOSTER T, 1995, BLOOD, V85, P2756, DOI 10.1182/blood.V85.10.2756.bloodjournal85102756; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; KUHL H, 1990, AM J OBSTET GYNECOL, V163, P363, DOI 10.1016/0002-9378(90)90583-S; Lensen RPM, 1996, BLOOD, V88, P4205, DOI 10.1182/blood.V88.11.4205.bloodjournal88114205; Lewis, 1996, CONTRACEPTION, V54, P121; Lewis MA, 1999, HUM REPROD, V14, P1493, DOI 10.1093/humrep/14.6.1493; Lewis MA, 1996, CONTRACEPTION, V54, P5, DOI 10.1016/0010-7824(96)00112-6; Lidegaard O, 1998, CONTRACEPTION, V57, P291, DOI 10.1016/S0010-7824(98)00033-X; Lowe GDO, 1999, THROMB HAEMOSTASIS, V81, P918; Martinelli I, 1999, ARTERIOSCL THROM VAS, V19, P700, DOI 10.1161/01.ATV.19.3.700; McPherson K, 1996, BRIT MED J, V312, P68; Medicines Commission, 1999, CURRENT PROBLEMS PHA, V25, P12; Meijers JCM, 2000, THROMB HAEMOSTASIS, V84, P9; Middeldorp S, 2000, THROMB HAEMOSTASIS, V84, P4; *NZ DEP HLTH, 1998, DEATHS 3 GEN OR CONT; O'Brien PA, 1999, BMJ-BRIT MED J, V319, P795, DOI 10.1136/bmj.319.7213.795; OLIVIERI O, 1995, BRIT J HAEMATOL, V91, P465, DOI 10.1111/j.1365-2141.1995.tb05323.x; OSTERUD B, 1994, BLOOD COAGUL FIBRIN, V5, P853, DOI 10.1097/00001721-199410000-00030; PABINGER I, 1994, THROMB HAEMOSTASIS, V71, P441; Parkin L, 2000, LANCET, V355, P2133, DOI 10.1016/S0140-6736(00)02382-5; Petitti DB, 1998, CONTRACEPTION, V57, P143, DOI 10.1016/S0010-7824(98)00016-X; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; POULTER NR, 1995, LANCET, V346, P1575; Poulter NR, 2000, LANCET, V355, P2088, DOI 10.1016/S0140-6736(00)02369-2; Poulter NR, 1996, LANCET, V347, P547; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Realini J P, 1997, J Am Board Fam Pract, V10, P315; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; Robert A, 2000, THROMB HAEMOSTASIS, V83, P630; Rodeghiero F, 1999, ANN INTERN MED, V130, P643, DOI 10.7326/0003-4819-130-8-199904200-00004; Rosendaal FR, 1998, THROMB HAEMOSTASIS, V79, P706; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Rosing J, 1997, BRIT J HAEMATOL, V97, P233, DOI 10.1046/j.1365-2141.1997.192707.x; Rosing J, 1999, LANCET, V354, P2036, DOI 10.1016/S0140-6736(99)06092-4; Rosing J, 1998, SEMIN THROMB HEMOST, V24, P329, DOI 10.1055/s-2007-996021; SHEN L, 1994, J BIOL CHEM, V269, P18735; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; Skegg DCG, 2000, BMJ-BRIT MED J, V321, P190, DOI 10.1136/bmj.321.7255.190; Spitzer WO, 1998, AM J OBSTET GYNECOL, V179, pS43, DOI 10.1053/ob.1998.v179.a93059; Spitzer WO, 1996, BRIT MED J, V312, P83; STADEL BV, 1981, NEW ENGL J MED, V305, P612, DOI 10.1056/NEJM198109103051104; STOLLEY PD, 1975, AM J EPIDEMIOL, V102, P197, DOI 10.1093/oxfordjournals.aje.a112148; Stubblefield P G, 1989, Int J Fertil, V34 Suppl, P40; Suissa S, 2000, HUM REPROD, V15, P817, DOI 10.1093/humrep/15.4.817; Szucs T, 1996, MED KLIN, V91, P317; Tans G, 2000, THROMB HAEMOSTASIS, V84, P15, DOI 10.1055/s-0037-1613960; van Tilburg NH, 2000, BLOOD, V95, P2855, DOI 10.1182/blood.V95.9.2855.009k02_2855_2859; Vandenbroucke JP, 1996, BRIT MED J, V313, P1127, DOI 10.1136/bmj.313.7065.1127; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; Vandenbroucke JP, 1997, AM J OBSTET GYNECOL, V177, P887, DOI 10.1016/S0002-9378(97)70289-8; Vandenbroucke JP, 1997, LANCET, V349, P1113, DOI 10.1016/S0140-6736(05)63015-2; Varadi K, 1996, THROMB HAEMOSTASIS, V76, P208; Vasilakis C, 1999, LANCET, V354, P1610, DOI 10.1016/S0140-6736(99)04394-9; Vasilakis C, 1999, CONTRACEPTION, V59, P79, DOI 10.1016/S0010-7824(99)00011-6; VESSEY M, 1986, BRIT MED J, V292, P526, DOI 10.1136/bmj.292.6519.526; VESSEY MP, 1968, BMJ-BRIT MED J, V2, P199, DOI 10.1136/bmj.2.5599.199; VondemBorne PAK, 1997, J CLIN INVEST, V99, P2323, DOI 10.1172/JCI119412; Walker AM, 1998, CONTRACEPTION, V57, P169, DOI 10.1016/S0010-7824(98)00014-6; WEISS N, 1995, LANCET, V346, P1570, DOI 10.1016/S0140-6736(95)91921-X; *WHOD H, 1998, CONTRACEPTION, V57, P315; Winkler UH, 1998, CONTRACEPTION, V57, P203, DOI 10.1016/S0010-7824(98)00020-1	100	377	391	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1527	1535		10.1056/NEJM200105173442007	http://dx.doi.org/10.1056/NEJM200105173442007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357157	Green Published			2022-12-28	WOS:000168677200007
J	Campbell, C				Campbell, C			For and against - Should Nottingham University give back its tobacco money?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Nottingham, Nottingham NG7 2RD, England	University of Nottingham	Campbell, C (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.							*DEP HLTH, 1998, CM4177, P11	1	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1119	1119						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11360900				2022-12-28	WOS:000168628300031
J	Lennox, AS; Osman, LM; Reiter, E; Robertson, R; Friend, J; McCann, I; Skatun, D; Donnan, PT				Lennox, AS; Osman, LM; Reiter, E; Robertson, R; Friend, J; McCann, I; Skatun, D; Donnan, PT			Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							CIGARETTE-SMOKING; ADVICE; SYSTEM; MODEL	Objectives To develop and evaluate, in a primary care setting, a computerised system for generating tailored letters about smoking cessation. Design Randomised controlled trial. Setting Six general practices in Aberdeen, Scotland. Participants 2553 smokers aged 17 to 65. Interventions All participants received a questionnaire asking about their smoking Participants subsequently received either a computer tailored or a non-tailored, standard letter on smoking cessation, or no letter. Main outcome measures Prevalence of validated abstinence at six months; change in intention to stop smoking in the next six months. Results The validated cessation rate at six months was 3.5% (30/857) (95% confidence interval 2.3% to 4.7%) for the tailored letter group, 4.4% (37/846) (3.0% to 5.8%) for the non-tailored letter group, and 2.6% (22/850) (1.5% to 3.7%) for the control (no letter) group. After adjustment for significant covariates, the cessation rate was 66% greater (-4% to 186%; P = 0.07) in die non-tailored letter group than that in the no letter group. Among participants who smoked < 20 cigarettes per day, the cessation rate in the non-tailored letter group was 87% greater (0% to 246%; P = 0.05) than that in the no letter group. Among heavy smokers who did not quit, a 76% higher rate of positive shift in "stage of change" (intention to quit within a particular period of time) was seen compared with those who received no letter (11% to 180%; P = 0.02). The increase in cost for each additional quitter in the non-tailored letter group compared with the no letter group was <pound>89. Conclusions In a large general practice, a brief non-tailored letter effectively increased cessation rates among smokers. A tailored letter was not effective in increasing cessation rates but promoted shift in movement towards cessation ("stage of change") in heavy smokers. As a pragmatic tool to encourage cessation of smoking, a mass mailing of non-tailored letters from general practices is more cost effective than computer tailored letters or no letters.	Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland; Univ Aberdeen, Dept Med & Therapeut, Aberdeen AB25 2AY, Scotland; Univ Aberdeen, Dept Comp Sci, Aberdeen AB25 2AY, Scotland; Univ Aberdeen, Hlth Econ Res Unit, Aberdeen AB25 2AY, Scotland; Univ Dundee, Dept Clin Pharmacol, Med Monitoring Unit, Dundee DD1 9SY, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Dundee	Lennox, AS (corresponding author), Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland.	s.lennox@abdn.ac.uk		Reiter, Ehud/0000-0002-7548-9504; Donnan, Peter/0000-0001-7828-0610				Butler CC, 1999, BRIT J GEN PRACT, V49, P611; CAMPBELL IA, 1990, THORAX, V45, P835; CHAPMAN S, 1993, BMJ-BRIT MED J, V307, P518, DOI 10.1136/bmj.307.6903.518; FIORE MC, 1996, CLIN PRACTICE GUIDEL, V18; GOLDBERG DN, 1994, AM J PREV MED, V10, P267, DOI 10.1016/S0749-3797(18)30578-6; HOSMER DW, 1989, APPL LOGISTIC REGRES; Lennox AS, 1995, HLTH ED J, V54, P48; Lennox AS, 1998, HLTH ED J, V57, P140; MCNEILL AD, 1987, BRIT J ADDICT, V82, P1355; OSTER G, 1986, JAMA-J AM MED ASSOC, V256, P1315, DOI 10.1001/jama.256.10.1315; PHILLIPS O, 1993, ECON BOT, V47, P33, DOI 10.1007/BF02862204; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; RATCLIFFE J, 1997, TOB CONTROL, V6, P1; Raw M, 1999, BMJ-BRIT MED J, V318, P182, DOI 10.1136/bmj.318.7177.182; REID DJ, 1992, TOB CONTROL, V1, P185; Reiter E, 1999, LECT NOTES ARTIF INT, V1620, P389; Sinclair HK, 1999, INT J PHARM PRACT, V7, P107, DOI DOI 10.1111/j.2042-7174.1999.tb00957.x; SLAMA K, 1990, BRIT MED J, V300, P1707, DOI 10.1136/bmj.300.6741.1707; STRECHER VJ, 1994, J FAM PRACTICE, V39, P262; Strecher VJ, 1999, PATIENT EDUC COUNS, V36, P107, DOI 10.1016/S0738-3991(98)00128-1; VELICER WF, 1992, PSYCHOL BULL, V111, P23, DOI 10.1037/0033-2909.111.1.23; VELICER WF, 1993, ADDICT BEHAV, V18, P269, DOI 10.1016/0306-4603(93)90029-9	22	44	44	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1396	1400		10.1136/bmj.322.7299.1396	http://dx.doi.org/10.1136/bmj.322.7299.1396			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397745	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000169284600018
J	Huang, MH; Mao, S; Feick, H; Yan, HQ; Wu, YY; Kind, H; Weber, E; Russo, R; Yang, PD				Huang, MH; Mao, S; Feick, H; Yan, HQ; Wu, YY; Kind, H; Weber, E; Russo, R; Yang, PD			Room-temperature ultraviolet nanowire nanolasers	SCIENCE			English	Article							OPTICAL GAIN; QUANTUM; ZNO	Room-temperature ultraviolet Lasing in semiconductor nanowire arrays has been demonstrated. The self-organized, <0001> oriented zinc oxide nanowires grown on sapphire substrates were synthesized with a simple vapor transport and condensation process. These wide band-gap semiconductor nanowires form natural Laser cavities with diameters varying from 20 to 150 nanometers and Lengths up to 10 micrometers. Under optical excitation, surface-emitting lasing action was observed at 385 nanometers, with an emission Linewidth less than 0.3 nanometer. The chemical flexibility and the one-dimensionality of the nanowires make them ideal miniaturized Laser Light sources. These short-wave-length nanolasers could have myriad applications, including optical computing, information storage, and microanalysis.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Environm Energy Technol Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Sci Mat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Yang, PD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Wu, Yiying/A-3949-2011					Bagnall DM, 1997, APPL PHYS LETT, V70, P2230, DOI 10.1063/1.118824; Cao H, 2000, PHYS REV LETT, V84, P5584, DOI 10.1103/PhysRevLett.84.5584; Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047; Fons P, 2000, APPL PHYS LETT, V77, P1801, DOI 10.1063/1.1311603; Gaul DA, 2000, ADV MATER, V12, P935, DOI 10.1002/1521-4095(200006)12:13<935::AID-ADMA935>3.0.CO;2-J; HARAGUCHI K, 1992, APPL PHYS LETT, V60, P745, DOI 10.1063/1.106556; HASSE MA, 1991, APPL PHYS LETT, V59, P1272; Huang MH, 2001, ADV MATER, V13, P113, DOI 10.1002/1521-4095(200101)13:2<113::AID-ADMA113>3.0.CO;2-H; KAYANUMA Y, 1988, PHYS REV B, V38, P9797, DOI 10.1103/PhysRevB.38.9797; Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314; KLINGSHIRN C, 1992, J CRYST GROWTH, V117, P753, DOI 10.1016/0022-0248(92)90850-I; MEHUYS D, 1995, LASER FOCUS WORLD, V31, P117; Nakamura S, 1996, JPN J APPL PHYS 2, V35, pL74, DOI 10.1143/JJAP.35.L74; Pavesi L, 2000, NATURE, V408, P440, DOI 10.1038/35044012; Saleh B.E.A., 2007, FUNDAMENTALS PHOTONI, V2nd; WEGSCHEIDER W, 1993, PHYS REV LETT, V71, P4071, DOI 10.1103/PhysRevLett.71.4071; Yu P, 1998, J CRYST GROWTH, V184, P601, DOI 10.1016/S0022-0248(98)80126-7	17	8730	9080	83	3436	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1897	1899		10.1126/science.1060367	http://dx.doi.org/10.1126/science.1060367			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397941				2022-12-28	WOS:000169200700044
J	Brown, MM; Rogers, J; Bland, JM				Brown, MM; Rogers, J; Bland, JM		CAVATAS Investigators	Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial	LANCET			English	Article							1001 ANGIOGRAMS; ENDARTERECTOMY; SURGERY; COMPLICATIONS; STROKE; DEATH	Background Percutaneous transluminal angioplasty and stenting (endovascular treatment) can be used to treat carotid stenosis, but risks and benefits are uncertain. We therefore compared endovascular treatment with conventional carotid surgery. Methods In a multicentre clinical trial, we randomly assigned 504 patients with carotid stenosis to endovascular treatment (n=251) or carotid endarterectomy (n=253). For endovascular patients treated successfully, we used stents in 55 (26%) and balloon angioplasty alone in 158 (74%). An independent neurologist followed up patients. Analysis was by intention to treat. Findings The rates of major outcome events within 30 days of first treatment did not differ significantly between endovascular treatment and surgery (6.4% vs 5.9%, respectively, for disabling stroke or death; 10.0% vs 9.9% for any stroke lasting more than 7 days, or death). Cranial neuropathy was reported in 22 (8.7%) surgery patients, but not after endovascular treatment (p<0.0001). Major groin or neck haematoma occurred less often after endovascular treatment than after surgery (three [1.2%] vs 17 [6.7%], p<0.0015). At 1 year after treatment, severe (70-99%) ipsilateral carotid stenosis was more usual after endovascular treatment (25 [14%] vs seven [4%], p<0.001). However, no substantial difference in the rate of ipsilateral stroke was noted with survival analysis up to 3 years after randomisation (adjusted hazard ratio=1.04, 95% CI 0.63-1.70, p=0.9). Interpretation Endovascular treatment had similar major risks and effectiveness at prevention of stroke during 3 years compared with carotid surgery, but with wide Cls. Endovascular treatment had the advantage of avoiding minor complications.	UCL, Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England; St George Hosp, Div Clin Neurosci, London, England; Clin Trial Serv Unit, Oxford, England; Austin & Repatriat Med Ctr, Heidelberg, Vic, Australia; Royal Melbourne Hosp, Melbourne, Vic, Australia; Royal Perth Hosp, Perth, WA, Australia; Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada; Univ Dusseldorf, D-4000 Dusseldorf, Germany; Policlin St Marco, Bergamo, Italy; Hosp Clin Barcelona, Barcelona, Spain; Hosp Univ Virgen del Rocio, Seville, Spain; Univ Hosp, Basel, Switzerland; CHU Vaudois, CH-1011 Lausanne, Switzerland; Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England; St George Hosp, London, England; Atkinson Morleys Hosp, London, England; Walon Ctr, Liverpool, Merseyside, England; Kings Coll London, London WC2R 2LS, England; Royal London, London, England; Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; Withington Hosp, Manchester M20 8LR, Lancs, England; Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales; Gloucestershire Royal Hosp, Gloucester GL1 3NN, England; Queens Med Ctr, Nottingham NG7 2UH, England; Queen Elizabeth Neurosci Ctr, Birmingham, W Midlands, England	University of London; University College London; St Georges University London; University of Oxford; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Royal Melbourne Hospital; Royal Perth Hospital; University of Western Australia; University of Ottawa; Ottawa Hospital Research Institute; Heinrich Heine University Dusseldorf; University of Barcelona; Hospital Clinic de Barcelona; Virgen del Rocio University Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Sheffield; Northern General Hospital; St Georges University London; Walton Centre; University of London; King's College London; University of Edinburgh; Newcastle General Hospital; Cardiff University; Gloucestershire Royal Hospital; University of Nottingham	Brown, MM (corresponding author), UCL, Inst Neurol, Dept Clin Neurol, Queen Sq, London WC1N 3BG, England.	m.brown@ion.ucl.ac.uk	Brown, Martin M/B-3288-2009	Schultz, David/0000-0001-6319-7574; Brown, Martin M/0000-0002-3273-1356				Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Beebe HG, 1996, STROKE, V27, P197, DOI 10.1161/01.STR.27.2.197; BROWN MM, 1992, NEUROL RES, V14, P159, DOI 10.1080/01616412.1992.11740040; Crawley F, 1997, STROKE, V28, P2460, DOI 10.1161/01.STR.28.12.2460; Crawley F, 2000, STROKE, V31, P1329, DOI 10.1161/01.STR.31.6.1329; Diethrich EB, 1996, J ENDOVASC SURG, V3, P42, DOI 10.1583/1074-6218(1996)003<0042:SITCAI>2.0.CO;2; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Ferguson GG, 1999, STROKE, V30, P1751, DOI 10.1161/01.STR.30.9.1751; McCabe DJH, 1999, STROKE, V30, P2483, DOI 10.1161/01.STR.30.11.2483; Naylor AR, 1997, LANCET, V349, P203, DOI 10.1016/S0140-6736(96)07181-4; Naylor AR, 2000, BRIT MED BULL, V56, P539, DOI 10.1258/0007142001903184; Naylor AR, 1998, J VASC SURG, V28, P326, DOI 10.1016/S0741-5214(98)70182-X; Paciaroni M, 1999, STROKE, V30, P1759, DOI 10.1161/01.STR.30.9.1759; ROTHWELL PM, 1994, STROKE, V25, P2440, DOI 10.1161/01.STR.25.12.2440; Rothwell PM, 1997, BMJ-BRIT MED J, V315, P1571, DOI 10.1136/bmj.315.7122.1571; ROTHWELL PM, 1994, STROKE, V25, P2435, DOI 10.1161/01.STR.25.12.2435; Rothwell PM, 1996, STROKE, V27, P260, DOI 10.1161/01.STR.27.2.260; Sidhu PS, 1997, CLIN RADIOL, V52, P654, DOI 10.1016/S0009-9260(97)80027-X; SIVAGURU A, 1999, J NEUROL NEUROSUR PS, V66, P262; SUNDT TM, 1975, MAYO CLIN PROC, V50, P301; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Wholey MH, 1998, CATHETER CARDIO DIAG, V44, P1; Yadav JS, 1997, CIRCULATION, V95, P376, DOI 10.1161/01.cir.95.2.376	23	965	1009	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1729	1737						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403808				2022-12-28	WOS:000169156200009
J	Clarke, M; Horton, R				Clarke, M; Horton, R			Bringing it all together: Lancet-Cochrane collaborate on systematic reviews	LANCET			English	Editorial Material							CONTROLLED-TRIALS; METAANALYSES		UK Cochrane Ctr, Oxford OX2 7LG, England; Lancet, London WC1X 8RR, England	Cochrane Centre	Clarke, M (corresponding author), UK Cochrane Ctr, Oxford OX2 7LG, England.							Clarke M, 1998, JAMA-J AM MED ASSOC, V280, P280, DOI 10.1001/jama.280.3.280; Clarke M, 2001, COCHRANE REV HDB; *COCHR CONTR TRIAL, 2001, COCHR LIB; *COCHR DAT SYST RE, 2001, COCHR LIB; *COCHR METH REG, 2001, COCHR LIB; Horton R, 1999, LANCET, V353, P164, DOI 10.1016/S0140-6736(05)77210-X; Horton R, 2000, LANCET, V356, P2, DOI 10.1016/S0140-6736(00)02420-X; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; OXMAN AD, 1994, BMJ-BRIT MED J, V309, P648, DOI 10.1136/bmj.309.6955.648; Simpson RJS, 1904, BRIT MED J, V1904, P1243	12	212	220	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2001	357	9270					1728	1728		10.1016/S0140-6736(00)04934-5	http://dx.doi.org/10.1016/S0140-6736(00)04934-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403806				2022-12-28	WOS:000169156200007
J	Chittka, L; Schurkens, S				Chittka, L; Schurkens, S			Successful invasion of a floral market - An exotic Asian plant has moved in on Europe's river-banks by bribing pollinators.	NATURE			English	Article							IMPATIENS-GLANDULIFERA; INSECT VISITS; COMPETITION; FLOWERS		Biozentrum, D-97074 Wurzburg, Germany	University of Wurzburg	Chittka, L (corresponding author), Biozentrum, D-97074 Wurzburg, Germany.	chittka@biozentrum.uni-wuerzburg.de	Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732				BEERLING DJ, 1993, J ECOL, V81, P367, DOI 10.2307/2261507; CAMPBELL DR, 1985, ECOLOGY, V66, P554, DOI 10.2307/1940404; Comba L, 1999, ANN BOT-LONDON, V83, P73, DOI 10.1006/anbo.1998.0798; Comba L, 1999, ANN BOT-LONDON, V83, P369, DOI 10.1006/anbo.1998.0835; Corbet SA, 2001, ANN BOT-LONDON, V87, P219, DOI 10.1006/anbo.2000.1322; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; Schurkens S, 2001, ENTOMOL GEN, V25, P115; Toney JC, 1998, NORTHWEST SCI, V72, P198; Waser N.M., 1983, P277; WASER NM, 1978, ECOLOGY, V59, P934, DOI 10.2307/1938545	10	338	362	14	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					653	653		10.1038/35079676	http://dx.doi.org/10.1038/35079676			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395755				2022-12-28	WOS:000169112500029
J	Dye, MJ; Proudfoot, NJ				Dye, MJ; Proudfoot, NJ			Multiple transcript cleavage precedes polymerase release in termination by RNA polymerase II	CELL			English	Article							REPLICATION; ELONGATION; INITIATION; MECHANISM; PATHWAY; SIGNALS; SITES; HIV-1	The requirement of poly(A) signals to elicit transcription termination of RNA polymerase II (pol II) is firmly established. However, little else is known about the actual process of pol II transcription termination. Evidence presented in this paper, based on analysis of nascent transcripts of the human beta- and epsilon -globin genes, demonstrates that pol II transcription termination involves two distinct and temporally separate events. The first event, termed pretermination cleavage (PTC), is mediated by sequence tracts located downstream of the poly(A) site which appear to promote heterogeneous cleavage of the nascent transcript. The second event, in which pol II disengages from the DNA template, requires that polymerase has transcribed both a PTC sequence tract and a functional poly(A) site.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk		Proudfoot, Nicholas/0000-0001-8646-3222				Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Birse CE, 1997, EMBO J, V16, P3633, DOI 10.1093/emboj/16.12.3633; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; CULLEN BR, 1993, CELL, V73, P417, DOI 10.1016/0092-8674(93)90126-B; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5; DYE MJ, 1999, THESIS OXFORD U OXFO; GIARDINA C, 1993, J BIOL CHEM, V268, P23806; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; LABHART P, 1986, CELL, V45, P431, DOI 10.1016/0092-8674(86)90329-6; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Platt T, 1998, COLD SPRING HARBOR M, P541; PROUDFOOT NJ, 1992, NEW BIOL, V4, P369; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; PROUDFOOT NJ, 2000, TRENDS BIOCHEM SCI, V25, P105; REEDER RH, 1994, MOL MICROBIOL, V12, P11, DOI 10.1111/j.1365-2958.1994.tb00989.x; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; TANTRAVAHI J, 1993, MOL CELL BIOL, V13, P578, DOI 10.1128/MCB.13.1.578; TREISMAN R, 1983, P NATL ACAD SCI-BIOL, V80, P7428, DOI 10.1073/pnas.80.24.7428; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	26	89	92	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					669	681		10.1016/S0092-8674(01)00372-5	http://dx.doi.org/10.1016/S0092-8674(01)00372-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389836	Bronze			2022-12-28	WOS:000169123200013
J	Khalifah, P; Nelson, KD; Jin, R; Mao, ZQ; Liu, Y; Huang, Q; Gao, XPA; Ramirez, AP; Cava, RJ				Khalifah, P; Nelson, KD; Jin, R; Mao, ZQ; Liu, Y; Huang, Q; Gao, XPA; Ramirez, AP; Cava, RJ			Non-Fermi-liquid behaviour in La4Ru6O19	NATURE			English	Article							ELECTRONIC-STRUCTURE	Understanding the complexities of electronic and magnetic ground states in solids is one of the main goals of solid-state physics. Transition-metal oxides have proved to be particularly fruitful in this regard, especially for those materials with the perovskite structure, where the special characteristics of transition-metal-oxygen orbital hybridization determine their properties. Ruthenates have recently emerged as an important family of perovskites because of the unexpected evolution from high-temperature ferromagnetism in SrRuO3 to low-temperature superconductivity in Sr2RuO4 (refs 1, 2). Here we show that a ruthenate in a different structural family, La4Ru6O19, displays a number of highly unusual properties, most notably non-Fermi-liquid behaviour. The properties of La4Ru6O19 have no analogy among the thousands of previously characterized transition-metal oxides. Instead, they resemble those of CeCu6-xAux-a widely studied f-electron-based heavy fermion intermetallic compound that is often considered as providing the best example of non-Fermi-liquid behaviour. In the ruthenate, non-Fermi-liquid behaviour appears to arise from just the right balance between the interactions of localized electronic states derived from Ru-Ru bonding and delocalized states derived from Ru-O hybridization.	Princeton Univ, Dept Chem, Princeton, NJ 08540 USA; Princeton Univ, Princeton Mat Inst, Princeton, NJ 08540 USA; Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Univ Maryland, Dept Mat & Nucl Engn, College Pk, MD 20742 USA; Natl Inst Stand & Technol, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; Univ Maryland, Dept Mat & Nucl Engn, Murray Hill, NJ 07974 USA; Lucent Technol, Murray Hill, NJ 07974 USA	Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; Alcatel-Lucent; Lucent Technologies	Cava, RJ (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08540 USA.		Ramirez, Arthur/HGD-6619-2022	Khalifah, Peter/0000-0002-2216-0377; Gao, Xuan/0000-0002-7045-9656				ABRAHAM F, 1977, MATER RES BULL, V12, P43, DOI 10.1016/0025-5408(77)90087-3; ANDRAKA B, 1991, PHYS REV LETT, V67, P2886, DOI 10.1103/PhysRevLett.67.2886; AZUMA M, 1994, PHYS REV LETT, V73, P3463, DOI 10.1103/PhysRevLett.73.3463; COTTON FA, 1978, J SOLID STATE CHEM, V25, P137, DOI 10.1016/0022-4596(78)90097-X; LONGO JM, 1968, J APPL PHYS, V39, P1327, DOI 10.1063/1.1656282; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; MAPLE MB, 1995, J LOW TEMP PHYS, V99, P223, DOI 10.1007/BF00752290; Mazin II, 1997, PHYS REV B, V56, P2556, DOI 10.1103/PhysRevB.56.2556; SACHDEV S, 1999, QUANTUM PHASE TRANSI, P95; Santi G, 1997, J PHYS-CONDENS MAT, V9, P9563, DOI 10.1088/0953-8984/9/44/012; SHAFER MW, 1979, J ELECTROCHEM SOC, V126, P1625, DOI 10.1149/1.2129343; SHAPLYGIN LS, 1978, RUSS J INORG CHEM, V241, P644; vonLohneysen H, 1996, J PHYS-CONDENS MAT, V8, P9689, DOI 10.1088/0953-8984/8/48/003; [No title captured]	14	88	89	2	65	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					669	671		10.1038/35079534	http://dx.doi.org/10.1038/35079534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395763				2022-12-28	WOS:000169112500037
J	Martienssen, R; McCombie, WR				Martienssen, R; McCombie, WR			The first plant genome	CELL			English	Review							ARABIDOPSIS-THALIANA; SEQUENCE		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Martienssen, R (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.org; mccombie@cshl.org		McCombie, W. Richard/0000-0003-1899-0682				Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Altshuler D, 2000, NAT GENET, V26, P135, DOI 10.1038/79839; Baulcombe DC, 2000, SCIENCE, V290, P1108, DOI 10.1126/science.290.5494.1108; Chory J, 2000, PLANT PHYSIOL, V123, P423, DOI 10.1104/pp.123.2.423; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; McCombie WR, 2000, CELL, V100, P377, DOI 10.1016/S0092-8674(00)80673-X; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Paterson AH, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-3-reviews1011; Salanoubat M, 2000, NATURE, V408, P820, DOI 10.1038/35048706; Sheldon CC, 2000, CURR OPIN PLANT BIOL, V3, P418, DOI 10.1016/S1369-5266(00)00106-0; Tabata S, 2000, NATURE, V408, P823, DOI 10.1038/35048507; Theologis A, 2000, NATURE, V408, P816, DOI 10.1038/35048500; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435	20	11	11	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					571	574		10.1016/S0092-8674(01)00382-8	http://dx.doi.org/10.1016/S0092-8674(01)00382-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389827	Bronze			2022-12-28	WOS:000169123200004
J	Reimann, JDR; Freed, E; Hsu, JY; Kramer, ER; Peters, JM; Jackson, PK				Reimann, JDR; Freed, E; Hsu, JY; Kramer, ER; Peters, JM; Jackson, PK			Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex	CELL			English	Article							CHECKPOINT PROTEIN MAD2; F-BOX PROTEINS; SPINDLE CHECKPOINT; CELL-CYCLE; BUDDING YEAST; MITOSIS; PROTEOLYSIS; UBIQUITIN; FAMILY; PHOSPHORYLATION	We have discovered an early mitotic inhibitor, Emi1, which regulates mitosis by inhibiting the anaphase promoting complex/cyclosome (APC). Emi1 is a conserved F box protein containing a zinc binding region essential for APC inhibition. Emi1 accumulates before mitosis and is ubiquitylated and destroyed in mitosis, independent of the APC. Emi1 immunodepletion from cycling Xenopus extracts strongly delays cyclin B accumulation and mitotic entry, whereas nondestructible Emi1 stabilizes APC substrates and causes a mitotic block. Emi1 binds the APC activator Cdc20, and Cdc20 can rescue an Emi1-induced block to cyclin B destruction. Our results suggest that Emi1 regulates progression through early mitosis by preventing premature APC activation, and may help explain the well-known delay between cyclin B/Cdc2 activation and cyclin B destruction.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Canc Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biophys, Stanford, CA 94305 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria	Stanford University; Stanford University; Stanford University; Stanford University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Jackson, PK (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.		Kramer, Edgar/A-9288-2012	Kramer, Edgar/0000-0002-4882-4143; Jackson, Peter/0000-0002-1742-2539	NCI NIH HHS [CA09302] Funding Source: Medline; NIGMS NIH HHS [GM54811, GM07365, GM60439] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060439, T32GM007365, R01GM054811] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Page AM, 1999, ANNU REV BIOCHEM, V68, P583, DOI 10.1146/annurev.biochem.68.1.583; Pfleger CM, 2000, GENE DEV, V14, P655; Regan-Reimann JD, 1999, CURR BIOL, V9, pR762, DOI 10.1016/S0960-9822(00)80006-8; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shteinberg M, 1999, BIOCHEM BIOPH RES CO, V260, P193, DOI 10.1006/bbrc.1999.0884; Straight AF, 1997, METHOD ENZYMOL, V283, P425; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	48	307	314	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					645	655		10.1016/S0092-8674(01)00361-0	http://dx.doi.org/10.1016/S0092-8674(01)00361-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389834	Bronze			2022-12-28	WOS:000169123200011
J	Zhao, C; Takita, J; Tanaka, Y; Setou, M; Nakagawa, T; Takeda, S; Yang, HW; Terada, S; Nakata, T; Takei, Y; Saito, M; Tsuji, S; Hayashi, Y; Hirokawa, N				Zhao, C; Takita, J; Tanaka, Y; Setou, M; Nakagawa, T; Takeda, S; Yang, HW; Terada, S; Nakata, T; Takei, Y; Saito, M; Tsuji, S; Hayashi, Y; Hirokawa, N			Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1B beta	CELL			English	Article							LEFT-RIGHT ASYMMETRY; SYNAPTIC VESICLE; MONOMERIC MOTOR; NMDA RECEPTOR; KINESIN; PROTEIN; TRANSPORT; GENE; MICE; MITOCHONDRIA	The kinesin superfamily motor protein KIF1B has been shown to transport mitochondria. Here, we describe an isoform of KIF1B, KIF1B beta, that is distinct from KIF1B in its cargo binding domain. KIF1B knockout mice die at birth from apnea due to nervous system defects. Death of knockout neurons in culture can be rescued by expression of the beta isoform. The KIF1B heterozygotes have a defect in transporting synaptic vesicle precursors and suffer from progressive muscle weakness similar to human neuropathies. Charcot-Marie-Tooth disease type 2A was previously mapped to an interval containing KIF1B. We show that CMT2A patients contain a loss-of-function mutation in the motor domain of the KIF1B gene. This is clear indication that defects in axonal transport due to a mutated motor protein can underlie human peripheral neuropathy.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1130033, Japan; Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 9518585, Japan	University of Tokyo; University of Tokyo; Niigata University	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan.		Takei, Yosuke/I-1828-2015; Takeda, Sen/I-8462-2012	Takei, Yosuke/0000-0002-5026-8027; Takeda, Sen/0000-0001-7090-2139; Tanaka, Yosuke/0000-0001-5376-5726				BENOTHMANE K, 1993, GENOMICS, V17, P370; Conforti L, 1999, MAMM GENOME, V10, P617, DOI 10.1007/s003359901056; Gong TWL, 1996, MAMM GENOME, V7, P790, DOI 10.1007/s003359900237; Gong TWL, 1999, GENE, V239, P117, DOI 10.1016/S0378-1119(99)00370-4; Goslin K., 1991, CULTURING NERVE CELL, P251; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Kadotani H, 1996, J NEUROSCI, V16, P7859; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kukita Y, 1997, HUM MUTAT, V10, P400, DOI 10.1002/(SICI)1098-1004(1997)10:5<400::AID-HUMU11>3.3.CO;2-1; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; ROBERTSON A, 1993, ACTA NEUROPATHOL, V86, P163, DOI 10.1007/BF00334883; Saito M, 1997, NEUROLOGY, V49, P1630, DOI 10.1212/WNL.49.6.1630; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; SHY ME, 1999, ANN NY ACAD SCI, V883, P34; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431	29	561	598	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					587	597		10.1016/S0092-8674(01)00363-4	http://dx.doi.org/10.1016/S0092-8674(01)00363-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389829	Bronze			2022-12-28	WOS:000169123200006
J	Gao, XJ; Nelson, GW; Karacki, P; Martin, MP; Phair, J; Kaslow, R; Goedert, JJ; Buchbinder, S; Hoots, K; Vlahov, D; O'Brien, SJ; Carrington, M				Gao, XJ; Nelson, GW; Karacki, P; Martin, MP; Phair, J; Kaslow, R; Goedert, JJ; Buchbinder, S; Hoots, K; Vlahov, D; O'Brien, SJ; Carrington, M			Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; HIV-1 INFECTION; HLA-B; HLA-B35; EPITOPES; ALLELE; IDENTIFICATION; RESTRICTION; ASSOCIATION	Background: From studies of genetic polymorphisms and the rate of progression from human immunodeficiency virus type 1 (HIV-1) infection to the acquired immunodeficiency syndrome (AIDS), it appears that the strongest susceptibility is conferred by the major-histocompatibility-complex (MHC) class I type HLA-B*35,Cw*04 allele. However, cytotoxic T-lymphocyte responses have been observed against HIV-1 epitopes presented by HLA-B*3501, the most common HLA-B*35 subtype. We examined subtypes of HLA-B*35 in five cohorts and analyzed the relation of structural differences between HLA-B*35 subtypes to the risk of progression to AIDS. Methods: Genotyping of HLA class I loci was performed for 850 patients who seroconverted and had known dates of HIV-1 infection. Survival analyses with respect to the rate of progression to AIDS were performed to identify the effects of closely related HLA-B*35 subtypes with different peptide-binding specificities. Results: HLA-B*35 subtypes were divided into two groups according to peptide-binding specificity: the HLA-B*35-PY group, which consists primarily of HLA-B*3501 and binds epitopes with proline in position 2 and tyrosine in position 9; and the more broadly reactive HLA-B*35-Px group, which also binds epitopes with proline in position 2 but can bind several different amino acids (not including tyrosine) in position 9. The influence of HLA-B*35 in accelerating progression to AIDS was completely attributable to HLA-B*35-Px alleles, some of which differ from HLA-B*35-PY alleles by only one amino acid residue. Conclusions: This analysis shows that, in patients with HIV-1 infection, a single amino acid change in HLA molecules has a substantial effect on the rate of progression to AIDS. The different consequences of HLA-B*35-PY and HLA-B*35-Px in terms of disease progression highlight the importance of the epitope specificities of closely related class I molecules in the immune defense against HIV-1. (N Engl J Med 2001;344:1668-75.) Copyright (C) 2001 Massachusetts Medical Society.	NCI, FCRDC, Frederick, MD 21702 USA; Sci Applicat Int Corp, Intramural Res Support Program, Frederick, MD USA; Johns Hopkins Sch Med, Baltimore, MD USA; Northwestern Univ, Sch Med, Comprehens AIDS Ctr, Chicago, IL USA; Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; NCI, Viral Epidemiol Branch, Bethesda, MD 20892 USA; San Francisco Dept Publ Hlth, San Francisco, CA USA; Univ Texas, Hlth Sci Ctr, Gulf State Hemophilia Ctr, Houston, TX USA; Johns Hopkins Sch Hyg & Publ Hlth, Baltimore, MD USA; NCI, Lab Genom Divers, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Johns Hopkins University; Johns Hopkins Medicine; Northwestern University; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); San Francisco Department of Public Health; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Carrington, M (corresponding author), NCI, FCRDC, POB B, Frederick, MD 21702 USA.	carringt@mail.ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757	NCI NIH HHS [N0-1-CO-56000] Funding Source: Medline; NIAID NIH HHS [R01-AI-41951] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041951] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1992, MMWR Recomm Rep, V41, P1; BARBER LD, 1995, CURR BIOL, V5, P179, DOI 10.1016/S0960-9822(95)00039-X; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; CEREB N, 1995, TISSUE ANTIGENS, V45, P1, DOI 10.1111/j.1399-0039.1995.tb02408.x; CHERTKOFF LP, 1991, HUM IMMUNOL, V31, P153, DOI 10.1016/0198-8859(91)90020-A; Dean M, 1996, SCIENCE, V274, P1069; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; HAYASHI H, 1990, IMMUNOGENETICS, V32, P195, DOI 10.1007/BF02114973; HILGARTNER MW, 1993, AM J PEDIAT HEMATOL, V15, P208; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HOLM S, 1979, SCAND J STAT, V6, P65; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; ITESCU S, 1992, J ACQ IMMUN DEF SYND, V5, P37; Just J, 1996, HUM IMMUNOL, V45, P78; Just JJ, 1995, HUM IMMUNOL, V44, P156, DOI 10.1016/0198-8859(95)00034-8; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; McKenzie LM, 1999, GENES IMMUN, V1, P120, DOI 10.1038/sj.gene.6363648; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; O'Brien SJ, 2000, ANNU REV GENET, V34, P563, DOI 10.1146/annurev.genet.34.1.563; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Rowland-Jones SL, 1999, IMMUNOL LETT, V66, P9, DOI 10.1016/S0165-2478(98)00179-5; SAHMOUD T, 1993, AIDS, V7, P497, DOI 10.1097/00002030-199304000-00007; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Shiga H, 1996, AIDS, V10, P1075, DOI 10.1097/00002030-199609000-00004; SMERALDI RS, 1986, LANCET, V2, P1187; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Steinle A, 1996, IMMUNOGENETICS, V43, P105; Tomiyama H, 1997, J IMMUNOL, V158, P5026; Vlahov D, 1991, NIDA Res Monogr, V109, P75; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; Weir B.S., 1996, GENETIC DATA ANAL; YASUTOMI Y, 1993, J VIROL, V67, P1707, DOI 10.1128/JVI.67.3.1707-1711.1993; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; 1987, MMWR MORB MORTAL S1, V36, pS3	42	374	393	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2001	344	22					1668	1675		10.1056/NEJM200105313442203	http://dx.doi.org/10.1056/NEJM200105313442203			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YG	11386265	Green Published			2022-12-28	WOS:000168963000003
J	LaBella, VP; Bullock, DW; Ding, Z; Emery, C; Venkatesan, A; Oliver, WF; Salamo, GJ; Thibado, PM; Mortazavi, M				LaBella, VP; Bullock, DW; Ding, Z; Emery, C; Venkatesan, A; Oliver, WF; Salamo, GJ; Thibado, PM; Mortazavi, M			Spatially resolved spin-injection probability for gallium arsenide	SCIENCE			English	Article							ELECTRON-SPIN; SEMICONDUCTOR; METAL; PHOTOELECTRONS; FERROMAGNET; RELAXATION; COHERENCE; EMISSION; GAAS	We report a Large spin-polarized current injection from a ferromagnetic metal into a nonferromagnetic semiconductor, at a temperature of 100 Kelvin. The modification of the spin-injection process by a nanoscale step edge was observed. On flat gallium arsenide [GaAs(110)] terraces, the injection efficiency was 92%, whereas in a 10-nanometer-wide region around a [(1) over bar 11]-oriented step the injection efficiency is reduced by a factor of 6. Alternatively, the spin-relaxation Lifetime was reduced by a factor of 12. This reduction is associated with the metallic nature of the step edge. This study advances the realization of using both the charge and spin of the electron in future semiconductor devices.	Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA; Univ Arkansas, Dept Phys, Pine Bluff, AR 71601 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	LaBella, VP (corresponding author), Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA.	vlabella@uark.edu						ALVARADO SF, 1992, PHYS REV LETT, V68, P1387, DOI 10.1103/PhysRevLett.68.1387; ALVARADO SF, 1995, PHYS REV LETT, V75, P513, DOI 10.1103/PhysRevLett.75.513; ALVARADO SF, 1985, PHYS REV LETT, V55, P2716, DOI 10.1103/PhysRevLett.55.2716; Awschalom DD, 1999, PHYS TODAY, V52, P33, DOI 10.1063/1.882695; BERNDT R, 1995, PHYS REV LETT, V74, P102, DOI 10.1103/PhysRevLett.74.102; BIEGELSEN DK, 1990, PHYS REV LETT, V65, P452, DOI 10.1103/PhysRevLett.65.452; DATTA S, 1990, APPL PHYS LETT, V56, P665, DOI 10.1063/1.102730; FEENSTRA RM, 1987, PHYS REV LETT, V58, P1192, DOI 10.1103/PhysRevLett.58.1192; Fiederling R, 1999, NATURE, V402, P787, DOI 10.1038/45502; FROMME B, 1989, PHYS REV B, V40, P12312, DOI 10.1103/PhysRevB.40.12312; Gardelis S, 1999, PHYS REV B, V60, P7764, DOI 10.1103/PhysRevB.60.7764; Hammar PR, 1999, PHYS REV LETT, V83, P203, DOI 10.1103/PhysRevLett.83.203; Jonker BT, 1997, PHYS REV LETT, V79, P4886, DOI 10.1103/PhysRevLett.79.4886; Jonker BT, 2000, PHYS REV B, V62, P8180, DOI 10.1103/PhysRevB.62.8180; Kikkawa JM, 1999, NATURE, V397, P139, DOI 10.1038/16420; KISKER E, 1980, PHYS REV LETT, V45, P2053, DOI 10.1103/PhysRevLett.45.2053; MILLER RC, 1981, PHYS REV B, V23, P4399, DOI 10.1103/PhysRevB.23.4399; Ohno H, 1996, APPL PHYS LETT, V69, P363, DOI 10.1063/1.118061; Ohno H, 1998, SCIENCE, V281, P951, DOI 10.1126/science.281.5379.951; Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509; PIERCE DT, 1976, PHYS REV B, V13, P5484, DOI 10.1103/PhysRevB.13.5484; Pikus G E, 1984, OPTICAL ORIENTATION, P73; PRINS MWJ, 1995, J PHYS-CONDENS MAT, V7, P9447, DOI 10.1088/0953-8984/7/49/010; PRINZ GA, 1995, PHYS TODAY, V48, P58, DOI 10.1063/1.881459; RENAUD P, 1991, PHYS REV B, V44, P6340, DOI 10.1103/PhysRevB.44.6340; Schmidt G, 2000, PHYS REV B, V62, pR4790, DOI 10.1103/PhysRevB.62.R4790; Wiesendanger R., 1994, SCANNING PROBE MICRO; ZERROUATI K, 1988, PHYS REV B, V37, P1334, DOI 10.1103/PhysRevB.37.1334	28	88	93	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1518	1521		10.1126/science.292.5521.1518	http://dx.doi.org/10.1126/science.292.5521.1518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375485				2022-12-28	WOS:000168963800036
J	Bouquet, F; Marcenat, C; Steep, E; Calemczuk, R; Kwok, WK; Welp, U; Crabtree, GW; Fisher, RA; Phillips, NE; Schilling, A				Bouquet, F; Marcenat, C; Steep, E; Calemczuk, R; Kwok, WK; Welp, U; Crabtree, GW; Fisher, RA; Phillips, NE; Schilling, A			An unusual phase transition to a second liquid vortex phase in the superconductor YBa(2)Cu(3)O(7)	NATURE			English	Article							II SUPERCONDUCTORS; MELTING TRANSITION; MAGNETIC-FIELD; LATTICE; FLUCTUATIONS; DIAGRAM; BI2SR2CACU2O8; VORTICES; CRYSTALS; DISORDER	A magnetic field penetrates a superconductor through an array of 'vortices', each of which carries one quantum of flux that is surrounded by a circulating supercurrent. In this vortex state, the resistivity is determined by the dynamical properties of the vortex 'matter'. For the high-temperature copper oxide superconductors (see ref.1 for a theoretical review), the vortex phase can be a 'solid', in which the vortices are pinned, but the solid can 'melt' into a 'liquid' phase, in which their mobility gives rise to a finite resistance. (This melting phenomenon is also believed to occur in conventional superconductors, but in an experimentally inaccessible part of the phase diagram(2).) For the case of YBa(2)Cu(3)O(7), there are indications of the existence of a critical point, at which the character of the melting changes(3-10). But neither the thermodynamic nature of the melting, nor the phase diagram in the vicinity of the critical point, has been well established. Here we report measurements of specific heat and magnetization that determine the phase diagram in this material to 26 T, well above the critical point. Our results reveal the presence of a reversible second-order transition above the critical point. An unusual feature of this transition-namely, that the high-temperature phase is the less symmetric in the sense of the Landau theory(11)-is in accord with theoretical predictions(12-14) of a transition to a second vortex-liquid phase.	CEA Grenoble, Serv Phys Magnetisme & Supraconduct, Dept Rech Fondamentale Mat Condensee, F-38054 Grenoble, France; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; Univ Zurich, Inst Phys, CH-8057 Zurich, Switzerland	CEA; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Zurich	Bouquet, F (corresponding author), CEA Grenoble, Serv Phys Magnetisme & Supraconduct, Dept Rech Fondamentale Mat Condensee, F-38054 Grenoble, France.	Frederic_Bouquet@Yahoo.Com.immuno		Kwok, Wai-Kwong/0000-0003-0030-084X				BILLON B, 1998, THESIS U GRENOBLE 1; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Bouquet F, 1999, NATO ADV SCI I E-APP, V356, P743; BOUQUET F, 1998, THESIS U GRENOBLE 1; CUBITT R, 1993, NATURE, V365, P407, DOI 10.1038/365407a0; Deligiannis K, 1997, PHYS REV LETT, V79, P2121, DOI 10.1103/PhysRevLett.79.2121; EILENBERGER G, 1967, PHYS REV, V164, P628, DOI 10.1103/PhysRev.164.628; Fendrich JA, 1996, PHYS REV LETT, V77, P2073, DOI 10.1103/PhysRevLett.77.2073; FISHER DS, 1991, PHYS REV B, V43, P130, DOI 10.1103/PhysRevB.43.130; Giamarchi T, 1997, PHYS REV B, V55, P6577, DOI 10.1103/PhysRevB.55.6577; Khaykovich B, 1996, PHYS REV LETT, V76, P2555, DOI 10.1103/PhysRevLett.76.2555; LANDAU LD, 1969, COURSE THEORETICAL P, V5, P257; Liang RX, 1996, PHYS REV LETT, V76, P835, DOI 10.1103/PhysRevLett.76.835; Marcenat C, 2000, PHYSICA C, V341, P949, DOI 10.1016/S0921-4534(00)00749-8; Nguyen AK, 1999, PHYS REV B, V60, P15307, DOI 10.1103/PhysRevB.60.15307; Nishizaki T, 1998, PHYS REV B, V58, P11169, DOI 10.1103/PhysRevB.58.11169; Onsager L., 1949, NUOVO CIM, V6, P279, DOI [DOI 10.1007/BF02780991, 10.1007/BF02780991]; Reichhardt C, 2000, PHYS REV LETT, V84, P1994, DOI 10.1103/PhysRevLett.84.1994; Roulin M, 1998, PHYS REV LETT, V80, P1722, DOI 10.1103/PhysRevLett.80.1722; Roulin M, 1999, NATO ADV SCI I E-APP, V356, P489; SAFAR H, 1993, PHYS REV LETT, V70, P3800, DOI 10.1103/PhysRevLett.70.3800; Schilling A, 1996, NATURE, V382, P791, DOI 10.1038/382791a0; SULLIVAN PF, 1968, PHYS REV, V173, P679, DOI 10.1103/PhysRev.173.679; Tesanovic Z, 1999, PHYS REV B, V59, P6449, DOI 10.1103/PhysRevB.59.6449; TESANOVIC Z, 1995, PHYS REV B, V51, P16204, DOI 10.1103/PhysRevB.51.16204; Williams GA, 1999, PHYS REV LETT, V82, P1201, DOI 10.1103/PhysRevLett.82.1201; ZELDOV E, 1995, NATURE, V375, P373, DOI 10.1038/375373a0	27	94	94	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					448	451		10.1038/35078016	http://dx.doi.org/10.1038/35078016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373670				2022-12-28	WOS:000168858700039
J	Gorelik, LY; Isacsson, A; Galperin, YM; Shekhter, RI; Jonson, M				Gorelik, LY; Isacsson, A; Galperin, YM; Shekhter, RI; Jonson, M			Coherent transfer of Cooper pairs by a movable grain	NATURE			English	Article								Superconducting circuits that incorporate Josephson junctions are of considerable experimental and theoretical interest, particularly in the context of quantum computing(1-5). A nanometre-sized superconducting grain (commonly referred to as a Cooper-pair box(2)) connected to a reservoir by a Josephson junction is an important example of such a system. Although the grain contains a large number of electrons, it has been experimentally demonstrated(6) that its states are given by a superposition of only two charge states (differing by 2e, where e is the electronic charge). Coupling between charge transfer and mechanical motion in nanometre-sized structures has also received considerable attention(7-10). Here we demonstrate theoretically that a movable Cooper-pair box oscillating periodically between two remote superconducting electrodes can serve as a mediator of Josephson coupling, leading to coherent transfer of Cooper pairs between the electrodes. Both the magnitude and the direction of the resulting Josephson current can be controlled by externally applied electrostatic fields.	Chalmers Univ Technol, Dept Appl Sci, SE-41296 Gothenburg, Sweden; Univ Gothenburg, SE-41296 Gothenburg, Sweden; Univ Oslo, Dept Phys, N-0316 Oslo, Norway; Russian Acad Sci, Ioffe Inst, Div Solid State Phys, St Petersburg 194021, Russia; Ctr Adv Study, N-0271 Oslo, Norway	Chalmers University of Technology; University of Gothenburg; University of Oslo; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute	Isacsson, A (corresponding author), Chalmers Univ Technol, Dept Appl Sci, SE-41296 Gothenburg, Sweden.	isac@fy.chalmers.se	Jonson, Mats/D-6545-2011; Isacsson, Andreas/A-6932-2008; Galperin, Yuri/A-1851-2008	Isacsson, Andreas/0000-0001-6908-5696; Galperin, Yuri/0000-0001-7281-9902				Averin DV, 1998, SOLID STATE COMMUN, V105, P659, DOI 10.1016/S0038-1098(97)10001-1; ERBE A, 2000, CONDMAT001429; Falci G, 2000, NATURE, V407, P355, DOI 10.1038/35030052; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; Gorelik LY, 1998, PHYS REV LETT, V80, P4526, DOI 10.1103/PhysRevLett.80.4526; Ioffe LB, 1999, NATURE, V398, P679, DOI 10.1038/19464; LEGGETT AJ, 1991, FOUND PHYS, V21, P353, DOI 10.1007/BF01883640; Makhlin Y, 1999, NATURE, V398, P305, DOI 10.1038/18613; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Park H, 2000, NATURE, V407, P57, DOI 10.1038/35024031; Tuominen MT, 1999, PHYS REV LETT, V83, P3025, DOI 10.1103/PhysRevLett.83.3025	12	52	53	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					454	457		10.1038/35078027	http://dx.doi.org/10.1038/35078027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373672	Green Submitted			2022-12-28	WOS:000168858700041
J	Jean-Baptiste, P; Petit, JR; Lipenkov, VY; Raynaud, D; Barkov, NI				Jean-Baptiste, P; Petit, JR; Lipenkov, VY; Raynaud, D; Barkov, NI			Constraints on hydrothermal processes and water exchange in Lake Vostok from helium isotopes	NATURE			English	Article							ANTARCTIC ICE; MANTLE; GASES; SHEET	Lake Vostok, the largest subglacial lake in Antarctica, is covered by the East Antarctic ice sheet, which varies in thickness between 3,750 and 4,100 m (ref. 1). At a depth of 3,539 m in the drill hole at Vostok station, sharp changes in stable isotopes and the gas content of the ice delineate the boundary between glacier ice and ice accreted through re-freezing of lake water(2). Unlike most gases, helium can be incorporated into the crystal structure of ice during freezing(3), making helium isotopes in the accreted ice a valuable source of information on lake environment. Here we present helium isotope measurements from the deep section of the Vostok ice core that encompasses the boundary between the glacier ice and accreted ice, showing that the accreted ice is enriched by a helium source with a radiogenic isotope signature typical of an old continental province. This result rules out any significant hydrothermal energy input into the lake from high-enthalpy mantle processes, which would be expected to produce a much higher He-3/(4) He ratio. Based on the average helium flux for continental areas, the helium budget of the lake leads to a renewal time of the lake of the order of 5,000 years.	CEA, CNRS, Lab Sci Climat & Environmm, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France; CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Arctic & Antarctic Res Inst, St Petersburg 199397, Russia	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Arctic & Antarctic Research Institute	Jean-Baptiste, P (corresponding author), CEA, CNRS, Lab Sci Climat & Environmm, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France.		Raynaud, Dominique/H-9626-2016; Lipenkov, Vladimir Y/Q-8262-2016; raynaud, dominique/ABG-4718-2020	Lipenkov, Vladimir Y/0000-0003-4221-5440; 				ANDREWS JN, 1985, CHEM GEOL, V49, P339, DOI 10.1016/0009-2541(85)90166-4; CRAIG H, 1976, EARTH PLANET SC LETT, V31, P369, DOI 10.1016/0012-821X(76)90118-7; CRAIG H, 1978, GEOPHYS RES LETT, V5, P897, DOI 10.1029/GL005i011p00897; CRAIG H, 1999, INT C STABL IS IS EF, P1; Craig H., 1982, EOS, V63, P298; DAVY JG, 1970, SOLID STATE COMMUN, V3, P1459; Farley KA, 1998, ANNU REV EARTH PL SC, V26, P189, DOI 10.1146/annurev.earth.26.1.189; HAAS J, 1971, SOLID STATE COMMUN, V9, P2033, DOI 10.1016/0038-1098(71)90354-1; HOOKER PJ, 1985, GEOCHIM COSMOCHIM AC, V49, P2505, DOI 10.1016/0016-7037(85)90118-8; JEANBAPTISTE P, 1993, CR ACAD SCI II, V316, P491; JEANBAPTISTE P, 1992, APPL RADIAT ISOTOPES, V43, P881; Jones S. J., 1971, Physics in Canada, V27; Jouzel J, 1999, SCIENCE, V286, P2138, DOI 10.1126/science.286.5447.2138; Kapitsa AP, 1996, NATURE, V381, P684, DOI 10.1038/381684a0; Mamyrin B.A., 1984, HELIUM ISOTOPES NATU; ONIONS RK, 1983, NATURE, V306, P429, DOI 10.1038/306429a0; SALAMATIN A, 1998, DATA GLACIOL STUD, V85, P233; Savvin A, 2000, ANN GLACIOL-SER, V30, P69, DOI 10.3189/172756400781820831; Siegert MJ, 2000, EARTH-SCI REV, V50, P29, DOI 10.1016/S0012-8252(99)00068-9; Siegert MJ, 2000, NATURE, V403, P643, DOI 10.1038/35001049; Souchez R, 2000, EARTH PLANET SC LETT, V181, P529, DOI 10.1016/S0012-821X(00)00228-4	21	49	49	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					460	462		10.1038/35078045	http://dx.doi.org/10.1038/35078045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373674				2022-12-28	WOS:000168858700043
J	Schlesinger, WH; Lichter, J				Schlesinger, WH; Lichter, J			Limited carbon storage in soil and litter of experimental forest plots under increased atmospheric CO2	NATURE			English	Article							C-13 NATURAL-ABUNDANCE; UNITED-STATES; PINE FOREST; US FORESTS; ENRICHMENT; ACCUMULATION; ECOSYSTEMS; TURNOVER; BIOMASS; CLIMATE	The current rise in atmospheric CO2 concentration is thought to be mitigated in part by carbon sequestration within forest ecosystems(1,2), where carbon can be stored in vegetation or soils. The storage of carbon in soils is determined by the fraction that is sequestered in persistent organic materials, such as humus. In experimental forest plots of loblolly pine (Pinus taeda) exposed to high CO2 concentrations(3,4), nearly half of the carbon uptake is allocated to short-lived tissues, largely foliage. These tissues fall to the ground and decompose, normally contributing only a small portion of their carbon content to refractory soil humic materials(5). Such findings call into question the role of soils as long-term carbon sinks, and show the need for a better understanding of carbon cycling in forest soils. Here we report a significant accumulation of carbon in the litter layer of experimental forest plots after three years of growth at increased CO2 concentrations (565 mul l(-1)). But fast turnover times of organic carbon in the litter layer (of about three years) appear to constrain the potential size of this carbon sink. Given the observation that carbon accumulation in the deeper mineral soil layers was absent, we suggest that significant, long-term net carbon sequestration in forest soils is unlikely.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; Bowdoin Coll, Environm Studies Program, Brunswick, ME 04011 USA	Duke University; Bowdoin College; Bowdoin College	Schlesinger, WH (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.							ANDREWS JA, 1999, THESIS DUKE U; BALESDENT J, 1988, SOIL SCI SOC AM J, V52, P118, DOI 10.2136/sssaj1988.03615995005200010021x; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; CAMBARDELLA CA, 1993, GEODERMA, V56, P449, DOI 10.1016/0016-7061(93)90126-6; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Ciais P, 2000, ECOL APPL, V10, P1574, DOI 10.1890/1051-0761(2000)010[1574:RBCFAI]2.0.CO;2; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; DELCOURT HR, 1980, SCIENCE, V210, P321, DOI 10.1126/science.210.4467.321; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Delucia EH, 1997, ANN BOT-LONDON, V79, P111, DOI 10.1006/anbo.1996.0320; Ellsworth DS, 1999, PLANT CELL ENVIRON, V22, P461, DOI 10.1046/j.1365-3040.1999.00433.x; Finzi AC, 2001, ECOLOGY, V82, P470, DOI 10.1890/0012-9658(2001)082[0470:FLPCAD]2.0.CO;2; FOX TR, 1990, SOIL SCI SOC AM J, V54, P1139, DOI 10.2136/sssaj1990.03615995005400040037x; Gill R, 1999, ECOSYSTEMS, V2, P226; HARRISON K, 1993, GLOBAL BIOGEOCHEM CY, V7, P69, DOI 10.1029/92GB02938; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Jastrow JD, 1996, SOIL SCI SOC AM J, V60, P801, DOI 10.2136/sssaj1996.03615995006000030017x; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; JORGENSEN JR, 1980, SOIL SCI SOC AM J, V44, P1307, DOI 10.2136/sssaj1980.03615995004400060036x; Lichter J, 2000, BIOGEOCHEMISTRY, V50, P73, DOI 10.1023/A:1006337132631; Matamala R, 2000, GLOB CHANGE BIOL, V6, P967, DOI 10.1046/j.1365-2486.2000.00374.x; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; SCHIFFMAN PM, 1989, CAN J FOREST RES, V19, P69, DOI 10.1139/x89-010; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Van Kessel C, 2000, GLOBAL CHANGE BIOL, V6, P435, DOI 10.1046/j.1365-2486.2000.00318.x; Weisberg S, 1985, APPL LINEAR REGRESSI, P114	30	376	437	7	180	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					466	469		10.1038/35078060	http://dx.doi.org/10.1038/35078060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373676				2022-12-28	WOS:000168858700045
J	Robinson, JC				Robinson, JC			The end of managed care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; PLAN	Managed care embodies an effort by employers, the insurance industry, and some elements of the medical profession to establish priorities and decide who gets what from the health care system. After a turbulent decade of trial and error, that experiment can be characterized as an economic success but a political failure. The strategy of giving with one hand while taking away with the other, of offering comprehensive benefits while restricting access through utilization review, has infuriated everyone involved. The protagonists of managed care now are in full retreat, broadening physician panels, removing restrictions, and reverting to fee-for-service payment. Governmental entities are avoiding politically volatile initiatives to balance limited resources and unlimited expectations, By default, if not by design, the consumer is emerging as the locus of priority setting in health care. The shift to consumerism is driven by a widespread skepticism of governmental, corporate, and professional dominance; unprecedented economic prosperity that reduces social tolerance for interference with individual autonomy; and the Internet technology revolution, which broadens access to information and facilitates the mass customization of insurance and delivery.	Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Robinson, JC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.		Embrett, Mark G./H-4466-2014	Embrett, Mark G./0000-0002-3969-0219				AARON H, 1990, SCIENCE, V247, P418, DOI 10.1126/science.2300804; BOORADY C, 2000, HEALTHCARE SERVICES; *BOST WOM HLTH BOO, 1976, OUR BOD OUR SELV; Burns LR, 2000, HEALTH AFFAIR, V19, P7, DOI 10.1377/hlthaff.19.1.7; Bush GW, 2000, JAMA-J AM MED ASSOC, V284, P2108, DOI 10.1001/jama.284.16.2108; Cain MM., 2000, HLTH E PEOPLE ONLINE; CLULOW MD, 2000, FUTURE E HLTH; Freidson E., 1970, PROFESSIONAL DOMINAN; HADORN DC, 1991, JAMA-J AM MED ASSOC, V265, P2218, DOI 10.1001/jama.265.17.2218; HARRIS GE, 1999, MANAGED CARE IND; HAVIGHURST CC, 1995, HLTH CARE CHOICES PR; Illich I., 1976, MED NEMESIS; LEVIT J, 1999, HLTH AFF MILLWOOD, V19, P124; MARHULA DC, 2000, UNITED HLTH GROUP IN; MARHULA DC, 2000, DEFINED CONTRIBUTION; MARSH LC, 1999, MANAGED CARE IND GUI; PAULY MV, 1997, HLTH BENEFITS WORKS; Robinson JC, 1999, HEALTH AFFAIR, V18, P7, DOI 10.1377/hlthaff.18.2.7; ROBINSON JC, 1999, CORPORATE PRACTICE M; ROBINSON JC, IN PRESS HLTH AFF MI; SHERLOCK D, 2001, NEXT STEPS MANAGED C, P1; SHORTELL SM, 1994, HEALTH AFFAIR, V13, P46, DOI 10.1377/hlthaff.13.5.46; SKOCPOL T, 1995, HEALTH AFFAIR, V14, P66, DOI 10.1377/hlthaff.14.1.66; Starr Paul, 1983, SOCIAL TRANSFORMATIO; Thorpe KE, 1999, HEALTH AFFAIR, V18, P213, DOI 10.1377/hlthaff.18.2.213; ZELMAN WA, 1998, MANAGED CARE BLUES C	26	175	175	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2622	2628		10.1001/jama.285.20.2622	http://dx.doi.org/10.1001/jama.285.20.2622			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433LY	11368736				2022-12-28	WOS:000168761900029
J	Kern, KB				Kern, KB			Thrombolytic therapy during cardiopulmonary resuscitation	LANCET			English	Editorial Material							BLOOD-FLOW; EPINEPHRINE; PERFUSION		Univ Arizona, Sarver Heart Ctr, Dept Med, Tucson, AZ 85724 USA	University of Arizona	Kern, KB (corresponding author), Univ Arizona, Sarver Heart Ctr, Dept Med, Tucson, AZ 85724 USA.	kernk@u.arizona.edu						DAVIES MJ, 1989, EUR HEART J, V10, P203, DOI 10.1093/oxfordjournals.eurheartj.a059467; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; HALPERIN HR, 1986, CIRCULATION, V73, P539, DOI 10.1161/01.CIR.73.3.539; KERN KB, 1990, AM HEART J, V120, P324, DOI 10.1016/0002-8703(90)90076-A; MICHAEL JR, 1984, CIRCULATION, V69, P822, DOI 10.1161/01.CIR.69.4.822; RALSTON SH, 1984, ANN EMERG MED, V13, P79, DOI 10.1016/S0196-0644(84)80566-1; Willerson JT, 2000, CIRCULATION, V102, P1	7	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2001	357	9268					1549	1550		10.1016/S0140-6736(00)04780-2	http://dx.doi.org/10.1016/S0140-6736(00)04780-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377640				2022-12-28	WOS:000168830100006
J	Jiggins, CD; Naisbit, RE; Coe, RL; Mallet, J				Jiggins, CD; Naisbit, RE; Coe, RL; Mallet, J			Reproductive isolation caused by colour pattern mimicry	NATURE			English	Article							HELICONIUS BUTTERFLIES; NATURAL-SELECTION; RACE FORMATION; WARNING-COLOR; SPECIATION; REINFORCEMENT; EVOLUTION; CONSEQUENCES; DIVERGENCE	Speciation is facilitated if ecological adaptation directly causes assortative mating(1), but few natural examples are known. Here we show that a shift in colour pattern mimicry was crucial in the origin of two butterfly species. The sister species Heliconius melpomene and Heliconius cydno recently diverged to mimic different model taxa, and our experiments show that their mimetic coloration is also important in choosing mates. Assortative mating between the sister species means that hybridization is rare in nature, and the few hybrids that are produced are nonmimetic, poorly adapted intermediates. Thus, the mimetic shift has caused both pre-mating and post-mating isolation. In addition, individuals from a population of H. melpomene allopatric to H. cydno court and mate with H. cydno more readily than those from a sympatric population. This suggests that assortative mating has been enhanced in sympatry.	UCL, Galton Lab, London NW1 2HE, England; Smithsonian Trop Res Inst, Balboa, Panama; Univ Cambridge Downing Coll, Cambridge CB2 1DQ, England	University of London; University College London; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Cambridge	Jiggins, CD (corresponding author), UCL, Galton Lab, 4 Stephenson Way, London NW1 2HE, England.	jigginsc@naos.si.edu	Naisbit, Russell E/B-9658-2011; mallet, james L.B./B-5114-2008; Jiggins, Chris D/B-9960-2008; Jiggins, Chris/T-4296-2019	Naisbit, Russell E/0000-0003-0190-9323; Jiggins, Chris D/0000-0002-7809-062X; Jiggins, Chris/0000-0002-7809-062X; Mallet, James/0000-0002-3370-0367				Bates H.W., 1862, T LINN SOC LOND, V23, P495; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; CRAIG TP, 1993, EVOLUTION, V47, P1696, DOI 10.1111/j.1558-5646.1993.tb01262.x; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; EDWARDS AWF, 1972, LIKELIHOOD; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; GILBERT LE, IN PRESS ECOLOGY EVO; Kirkpatrick M, 2000, P ROY SOC B-BIOL SCI, V267, P1649, DOI 10.1098/rspb.2000.1191; LINARES M, 1989, ADAPTIVE MICROEVOLUT; MALLET J, 1995, BIOL J LINN SOC, V55, P159, DOI 10.1111/j.1095-8312.1995.tb01057.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; Mallet J, 1998, ENDLESS FORMS, P390; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; MAYNARD SMITH J., 1966, AMER NATUR, V100, P637; McMillan WO, 1997, P NATL ACAD SCI USA, V94, P8628, DOI 10.1073/pnas.94.16.8628; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; TURNER JRG, 1981, ANNU REV ECOL SYST, V12, P99, DOI 10.1146/annurev.es.12.110181.000531; TURNER JRG, 1976, ZOOL J LINN SOC-LOND, V58, P297, DOI 10.1111/j.1096-3642.1976.tb01000.x; VANEWRIGHT RI, 1978, DIVERSITY INSECT FAU, P56	23	491	509	3	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					302	305		10.1038/35077075	http://dx.doi.org/10.1038/35077075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357131	Green Submitted			2022-12-28	WOS:000168710000046
J	Taipale, J; Beachy, PA				Taipale, J; Beachy, PA			The Hedgehog and Wnt signaling pathways in cancer	NATURE			English	Article							BASAL-CELL CARCINOMA; BETA-CATENIN; COLORECTAL-CANCER; SONIC HEDGEHOG; HUMAN HOMOLOG; STEM-CELLS; CUBITUS-INTERRUPTUS; ANIMAL DEVELOPMENT; MUTATIONS; TUMOR	The Wnt and hedgehog (Hh) signalling pathways have long been known to direct growth and patterning during embryonic development. Recent evidence also implicates these pathways in the postembryonic regulation of stem-cell number in epithelia such as those of the skin and intestine, which undergo constant renewal. A pathological role for the Wnt and Hh pathways has emerged from studies showing a high frequency of specific human cancers associated with mutations that constitutively activate the transcriptional response of these pathways. This article focuses on Hh and Wnt signal transduction and reviews evidence suggesting that tumorigenesis associated with pathway activation may result from mis-specification of cells towards stem-cell or stem cell-like fates.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Taipale, J (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.							Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Baeg GH, 2000, CURR OPIN CELL BIOL, V12, P575, DOI 10.1016/S0955-0674(00)00134-4; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Brash DE, 1998, CANCER SURV, V32, P69; Bray S, 1998, CELL, V93, P499, DOI 10.1016/S0092-8674(00)81180-0; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Campbell F, 1996, GUT, V39, P569, DOI 10.1136/gut.39.4.569; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kruger K, 1999, ARCH DERMATOL RES, V291, P253, DOI 10.1007/s004030050405; Lam CW, 1999, ONCOGENE, V18, P833, DOI 10.1038/sj.onc.1202360; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lickert H, 2000, DEVELOPMENT, V127, P3805; Marino S, 2000, GENE DEV, V14, P994; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Miyazawa K, 2000, J NEUROSCI, V20, P5756, DOI 10.1523/JNEUROSCI.20-15-05756.2000; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; MUENKE M, 2001, METABOLIC MOL BASES, P6203; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Park HL, 2000, DEVELOPMENT, V127, P1593; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Pietsch T, 1997, CANCER RES, V57, P2085; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2000, GENE DEV, V14, P1837; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; Schiffer D, 1999, NEUROSCI LETT, V264, P29, DOI 10.1016/S0304-3940(99)00171-8; Shih IM, 2000, CANCER RES, V60, P1671; Sparks AB, 1998, CANCER RES, V58, P1130; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 1998, ADV CANCER RES, V75, P87, DOI 10.1016/S0065-230X(08)60740-X; Tejpar S, 1999, ONCOGENE, V18, P6615, DOI 10.1038/sj.onc.1203041; Tsao JL, 1998, AM J PATHOL, V153, P1189, DOI 10.1016/S0002-9440(10)65663-5; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wei Y, 2000, ONCOGENE, V19, P498, DOI 10.1038/sj.onc.1203356; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	70	1095	1205	1	161	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					349	354		10.1038/35077219	http://dx.doi.org/10.1038/35077219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357142				2022-12-28	WOS:000168710000057
J	Kiefe, CI; Allison, JJ; Williams, OD; Person, SD; Weaver, MT; Weissman, NW				Kiefe, CI; Allison, JJ; Williams, OD; Person, SD; Weaver, MT; Weissman, NW			Improving quality improvement using achievable benchmarks for physician feedback - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE QUALITY; CLINICAL BENCHMARKING; OF-CARE; IMPACT; PERFORMANCE; OUTCOMES; INTERVENTIONS; GUIDELINES; INFLUENZA	Context Performance feedback and benchmarking, common tools for health care improvement, are rarely studied in randomized trials. Achievable Benchmarks of Care (ABCs) are standards of excellence attained by top performers in a peer group and are easily and reproducibly calculated from existing performance data. Objective To evaluate the effectiveness of using achievable benchmarks to enhance typical physician performance feedback and improve care. Design Group-randomized controlled trial conducted in December 1996, with follow-up through 1998. Setting and Participants Seventy community physicians and 2978 fee-for-service Medicare patients with diabetes mellitus who were part of the Ambulatory Care Quality Improvement Project in Alabama. Intervention Physicians were randomly assigned to receive a multimodal improvement intervention, including chart review and physician-specific feedback (comparison group; n=35) or an identical intervention plus achievable benchmark feedback (experimental group; n=35). Main Outcome Measure Preintervention (1994-1995) to postintervention (1997-1998) changes in the proportion of patients receiving influenza vaccination; foot examination; and each of 3 blood tests measuring glucose control, cholesterol level, and triglyceride level, compared between the 2 groups. Results The proportion of patients who received influenza vaccine improved from 40% to 58% in the experimental group (P<.001) vs from 40% to 46% in the comparison group (P=.02). Odds ratios (ORs) for patients of achievable benchmark physicians vs comparison physicians who received appropriate care after the intervention, adjusted for preintervention care and nesting of patients within physicians, were 1.57 (95% confidence interval [CI], 1.26-1.96) for influenza vaccination, 1.33 (95% CI, 1.05-1.69) for foot examination, and 1.33 (95% CI, 1.04-1.69) for long-term glucose control measurement. For serum cholesterol and triglycerides, the achievable benchmark effect was statistically significant only after additional adjustment for physician characteristics (OR, 1.40 [95% CI, 1.08-1.82] and OR, 1.40 [95% CI, 1.09-1.79], respectively). Conclusion Use of achievable benchmarks significantly enhances the effectiveness of physician performance feedback in the setting of a multimodal quality improvement intervention.	Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL 35205 USA; Univ Alabama Birmingham, Ctr Outcomes & Effectiveness Res & Educ, Birmingham, AL 35205 USA; Univ Alabama Birmingham, Div Gen Internal Med, Birmingham, AL 35205 USA; Univ Alabama Birmingham, Sch Nursing, Birmingham, AL 35205 USA; Univ Alabama Birmingham, Dept Hlth Serv Adm, Birmingham, AL 35205 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kiefe, CI (corresponding author), Univ Alabama Birmingham, Div Prevent Med, 1717 11th Ave S,MT 700, Birmingham, AL 35205 USA.	ckiefe@uab.edu		Allison, Jeroan/0000-0003-4472-2112; Weaver, Michael/0000-0002-6630-4758	AHRQ HHS [HS/GM10389, HS09446, HS11124] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010389, U18HS011124, U18HS009446] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; *AL QUAL ASS FDN I, 1996, NARR PROJ DOC; Allison J, 1999, AM J PUBLIC HEALTH, V89, P61, DOI 10.2105/AJPH.89.1.61; Allison J J, 2000, Jt Comm J Qual Improv, V26, P115; American Diabetes Association, 1999, DIABETES CARE S1, V22, pS1; [Anonymous], 2000, Diabetes Care, V23 Suppl 1, pS1; BARNES RV, 1994, JOINT COMM J QUAL IM, V20, P267, DOI 10.1016/S1070-3241(16)30071-2; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; BERWICK DM, 1990, CURING HLTH CARE BES; Bindman AB, 1998, JAMA-J AM MED ASSOC, V279, P675, DOI 10.1001/jama.279.9.675; Brammer T L, 2000, MMWR CDC Surveill Summ, V49, P13; BUNTINX F, 1993, FAM PRACT, V10, P219, DOI 10.1093/fampra/10.2.219; Calkins E, 1995, HMO Pract, V9, P107; CAMP RC, 1994, JOINT COMM J QUAL IM, V20, P229, DOI 10.1016/S1070-3241(16)30067-0; CAMPBELL AB, 1994, JOINT COMM J QUAL IM, V20, P225, DOI 10.1016/S1070-3241(16)30066-9; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Chen J, 2000, AM J MED, V108, P460, DOI 10.1016/S0002-9343(00)00331-4; Col NF, 1996, ARCH INTERN MED, V156, P54, DOI 10.1001/archinte.156.1.54; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; *DIAB QUAL IMPR PR, 1999, DIAB QUAL IMPR PROJ; Fortney J, 1999, MED CARE, V37, P884, DOI 10.1097/00005650-199909000-00005; Glatstein IZ, 1997, FERTIL STERIL, V67, P443, DOI 10.1016/S0015-0282(97)80067-2; Goins RT, 1999, J RURAL HEALTH, V15, P147, DOI 10.1111/j.1748-0361.1999.tb00734.x; GRECO PJ, 1993, NEW ENGL J MED, V329, P1271, DOI 10.1056/NEJM199310213291714; Greer A L, 1988, Int J Technol Assess Health Care, V4, P5; GRIFFITH JR, 1995, REENGINEERING HLTH C; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hayes R P, 1995, Clin Perform Qual Health Care, V3, P15; Heath K, 1997, INT J STD AIDS, V8, P609, DOI 10.1258/0956462971918869; Hennekens C H, 1998, J Card Fail, V4, P239, DOI 10.1016/S1071-9164(98)80014-6; Hennekens CH., 1987, EPIDEMIOLOGY MED CHA, P54; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; JENCKS SF, 1995, JOINT COMM J QUAL IM, V21, P343, DOI 10.1016/S1070-3241(16)30160-2; Kell S H, 1999, Qual Manag Health Care, V7, P11; Kell SH, 1999, J AM GERIATR SOC, V47, P417, DOI 10.1111/j.1532-5415.1999.tb07233.x; Kiefe CI, 1998, INT J QUAL HEALTH C, V10, P443, DOI 10.1093/intqhc/10.5.443; KIEFE CI, 1994, CLIN PERFORM QUAL HL, V2, P190; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LOMAS J, 1990, TURNING PRACTICE GUI, V19; Lurie N, 1998, ARCH FAM MED, V7, P134, DOI 10.1001/archfami.7.2.134; MacLean CH, 2000, JAMA-J AM MED ASSOC, V284, P984, DOI 10.1001/jama.284.8.984; Marshall PS, 1998, AM J HEALTH-SYST PH, V55, P2234, DOI 10.1093/ajhp/55.21.2234; Marteau T., 1998, GETTING RES FINDINGS; Mayfield Jennifer, 1998, Clinical Diabetes, V16, P161; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; McKenzie A, 1999, Aust J Rural Health, V7, P237, DOI 10.1046/j.1440-1584.1999.00227.x; Mohr JJ, 1996, JOINT COMM J QUAL IM, V22, P599, DOI 10.1016/S1070-3241(16)30268-1; Murray DM, 1998, DESIGN ANAL GROUP RA; Nelson EC, 1998, CLIN IMPROVEMENT ACT; Norman P., 1996, PREDICTING HLTH BEHA, P197; OBRIEN MAT, 2000, AUDIT FEEDBACK EFFEC; OBRIEN MAT, 2000, ED OUTREACH VISITS E; OBRIEN MAT, 2000, AUDIT FEEDBACK VERSU; OBRIEN MAT, 2000, LOCAL OPINION LEADER; *OFF CLIN STAND QU, 1999, PEER REV ORG MAN; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Palmer RH, 1997, ANN INTERN MED, V127, P733, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00059; PEMBERTON JK, 1998, PHYSICIAN PERSPECTIV, V15, P202; Preisser JS, 1998, ARCH FAM MED, V7, P346, DOI 10.1001/archfami.7.4.346; Richards C, 1998, AM J PREV MED, V15, P246, DOI 10.1016/S0749-3797(98)00075-0; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Samsa G, 2000, HEALTH SERV RES, V35, P687; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Shortell SM, 1998, MILBANK Q, V76, P593, DOI 10.1111/1468-0009.00107; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Szafran O, 2000, CAN FAM PHYSICIAN, V46, P114; *TEX MED FDN, 1998, NATL PERSPECT, V1, P2; TIERNEY WM, 1995, J AM MED INFORM ASSN, V2, P316, DOI 10.1136/jamia.1995.96073834; *US PUBL HLTH FDN, 1999, RM005 US PUBL HLTH F; Valdez R, 1999, AM J PUBLIC HEALTH, V89, P1715, DOI 10.2105/AJPH.89.11.1715; Weissman NW, 1999, J EVAL CLIN PRACT, V5, P269, DOI 10.1046/j.1365-2753.1999.00203.x; 1999, QUAL LETT HEALTHCARE, V11, P2; 2001, GETTING EVIDENCE PRA	78	342	343	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2871	2879		10.1001/jama.285.22.2871	http://dx.doi.org/10.1001/jama.285.22.2871			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440BP	11401608	Bronze			2022-12-28	WOS:000169156300026
J	Sanders, AR; Gejman, PV				Sanders, AR; Gejman, PV			Influential ideas and experimental progress in schizophrenia genetics research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUSCEPTIBILITY LOCUS; OBSTETRIC COMPLICATIONS; GENOME SCAN; LINKAGE; RISK; 6Q		Univ Chicago, Jules F Knapp Res Ctr, Dept Psychiat, Schizophrenia Genet Res Program, Chicago, IL 60637 USA	University of Chicago	Gejman, PV (corresponding author), Univ Chicago, Jules F Knapp Res Ctr, Dept Psychiat, Schizophrenia Genet Res Program, 924 E 57th St,Room R-010, Chicago, IL 60637 USA.	pgejman@uchicago.eu						American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 1997, GENOMICS, V45, P244; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; CARLSSON A, 1977, PSYCHOL MED, V7, P583, DOI 10.1017/S003329170000622X; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; CROWE RR, 1993, AM J MED GENET, V48, P74, DOI 10.1002/ajmg.1320480203; Dalman C, 1999, ARCH GEN PSYCHIAT, V56, P234, DOI 10.1001/archpsyc.56.3.234; Dolnick E., 1998, MADNESS COUCH BLAMIN; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Freedman R, 2000, AM J MED GENET, V97, P58, DOI 10.1002/(SICI)1096-8628(200021)97:1<58::AID-AJMG8>3.0.CO;2-Y; FRIEDLANDER F, 1997, ORIGINS NAZI GENOCID; GEJMAN PV, 1994, JAMA-J AM MED ASSOC, V271, P204, DOI 10.1001/jama.271.3.204; *GERM FED MIN ED R, 2001, GERM HUM GEN PROJ; GERSHON ES, 1988, ARCH GEN PSYCHIAT, V45, P328; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; GOTTESMAN SJ, 1982, SCHIZOPHRENIA EPIGEN; Hoek HW, 1998, SOC PSYCH PSYCH EPID, V33, P373, DOI 10.1007/s001270050068; Holzman PS, 2000, BRAIN RES REV, V31, P350, DOI 10.1016/S0165-0173(99)00051-X; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; Kendell RE, 2000, BRIT J PSYCHIAT, V176, P516, DOI 10.1192/bjp.176.6.516; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P781; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P527; KETY SS, 1976, SCHIZOPHRENIA BULL, V2, P413, DOI 10.1093/schbul/2.3.413; KRAEPELIN E, 1991, PSYCHIAT LEHRBUCH ST; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; *NAT HUM GEN RES I, 2001, ETH LEG SOC IMPL HUM; NEILL J, 1990, AM J PSYCHOTHER, V44, P499, DOI 10.1176/appi.psychotherapy.1990.44.4.499; OROURKE DH, 1982, AM J HUM GENET, V34, P630; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PROCTOR R, 1989, RACIAL HYGIENE MED N; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sanders AR, 2001, GENOMICS, V72, P1, DOI 10.1006/geno.2000.6411; Schwab SG, 1998, AM J MED GENET, V81, P302, DOI 10.1002/(SICI)1096-8628(19980710)81:4<302::AID-AJMG5>3.3.CO;2-4; SNYDER SH, 1976, AM J PSYCHIAT, V133, P197; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 1998, AM J MED GENET, V81, P296, DOI 10.1002/(SICI)1096-8628(19980710)81:4<296::AID-AJMG4>3.0.CO;2-S; Westergaard T, 1999, ARCH GEN PSYCHIAT, V56, P993, DOI 10.1001/archpsyc.56.11.993	45	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2831	2833		10.1001/jama.285.22.2831	http://dx.doi.org/10.1001/jama.285.22.2831			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440BP	11401586				2022-12-28	WOS:000169156300001
J	Wentrup, C				Wentrup, C			Chemistry - Fleeting molecules extend their stay	SCIENCE			English	Editorial Material							TRIPLET CARBENE		Univ Queensland, Sch Mol & Microbial Sci, Dept Chem, Brisbane, Qld 4072, Australia	University of Queensland	Wentrup, C (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, Dept Chem, Brisbane, Qld 4072, Australia.	wentrup@chemistry.uq.edu.au	Wentrup, Curt/I-5206-2012	Wentrup, Curt/0000-0003-0874-7144				ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; ARDUENGO AJ, 1998, CHEM UNSERER ZEIT, V6, P32; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; Buron C, 2000, SCIENCE, V288, P834, DOI 10.1126/science.288.5467.834; DOERING WV, 1954, J AM CHEM SOC, V76, P6162; Dumas J.B., 1835, ANN CHIM PHYS, V58, P5; GOMBERG M, 1925, CHEM REV, V1, P91; Herrmann WA, 1997, ANGEW CHEM INT EDIT, V36, P2162, DOI 10.1002/anie.199721621; Hirai K, 1999, J AM CHEM SOC, V121, P10213, DOI 10.1021/ja991387c; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Kato T, 2000, J AM CHEM SOC, V122, P998, DOI 10.1021/ja9939542; KLUGER R, 1987, CHEM REV, V87, P863, DOI 10.1021/cr00081a001; NEF JU, 1895, LIEBIGS ANN CHEM, V287, P359; SKELL PS, 1958, J AM CHEM SOC, V80, P2024, DOI 10.1021/ja01541a070; Sole S, 2001, SCIENCE, V292, P1901, DOI 10.1126/science.292.5523.1901; Tomioka H, 1997, ACCOUNTS CHEM RES, V30, P315, DOI 10.1021/ar9602157; Woodcock HL, 2001, J AM CHEM SOC, V123, P4331, DOI 10.1021/ja003552q	18	22	22	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1846	1847		10.1126/science.1062316	http://dx.doi.org/10.1126/science.1062316			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397934				2022-12-28	WOS:000169200700033
J	Gottlieb, MS				Gottlieb, MS			AIDS - Past and future	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS INFECTION; PNEUMOCYSTIS-CARINII PNEUMONIA											BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Church JA, 2000, POSTGRAD MED, V107, P163, DOI 10.3810/pgm.2000.04.988; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Gottlieb MS, 1998, EPIDEMIOLOGY, V9, P365, DOI 10.1097/00001648-199807000-00001; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hirsch MS, 1998, CLIN INFECT DIS, V27, P73, DOI 10.1086/514637; *JOINT UN PROGR HI, 2000, AIDS EP UPD DEC 2000; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; MADHOK R, 1985, LANCET, V1, P524; MASUR H, 1981, NEW ENGL J MED, V305, P1431, DOI 10.1056/NEJM198112103052402; NAHMIAS AJ, 1986, LANCET, V1, P1279; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; ROUECHE B, 1965, 11 BLUE MEN; Sepkowitz KA, 2001, NEW ENGL J MED, V344, P1764, DOI 10.1056/NEJM200106073442306; Shilts R., 1987, BAND PLAYED POLITICS; SIEGAL FP, 1981, NEW ENGL J MED, V305, P1439, DOI 10.1056/NEJM198112103052403; Sontag S., 1989, AIDS ITS METAPHORS; US Department of Health and Human Services, 2001, GUID US ANT AG HIV I; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400; 1981, MMWR MORB MORTAL WKL, V30, P250	21	33	39	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2001	344	23					1788	1791		10.1056/NEJM200106073442312	http://dx.doi.org/10.1056/NEJM200106073442312			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	439TL	11396450				2022-12-28	WOS:000169133600012
J	Sacco, RL; Benson, RT; Kargman, DE; Boden-Albala, B; Tuck, C; Lin, IF; Cheng, JF; Paik, MC; Shea, S; Berglund, L				Sacco, RL; Benson, RT; Kargman, DE; Boden-Albala, B; Tuck, C; Lin, IF; Cheng, JF; Paik, MC; Shea, S; Berglund, L			High-density lipoprotein cholesterol and ischemic stroke in the elderly - The northern Manhattan stroke study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; SERUM-CHOLESTEROL; CARDIOVASCULAR-DISEASE; CEREBRAL INFARCTION; HDL CHOLESTEROL; ARTERY-DISEASE; RACE-ETHNICITY; PLASMA-LIPIDS	Context Elevated high-density lipoprotein cholesterol (HDL-C) levels have been shown to be protective against cardiovascular disease. However, the association of specific lipoprotein classes and ischemic stroke has not been well defined, particularly in higher risk minority populations. Objective To evaluate the association between HDL-C and ischemic stroke in an elderly, racially or ethnically diverse population. Design Population-based, incident case-control study conducted July 1993 through June 1997. Setting A multiethnic community in northern Manhattan, New York, NY. Participants Cases (n = 539) of first ischemic stroke (67% aged greater than or equal to 65 years; 55% women; 53% Hispanic, 28% black, and 19% white) were enrolled and matched by age, sex, and race or ethnicity to stroke-free community residents (controls; n=905). Main Outcome Measure Independent association of fasting HDL-C levels, determined at enrollment, with ischemic stroke, including atherosclerotic and nonatherosclerotic ischemic stroke subtypes. Results After risk factor adjustment, a protective effect was observed for HDL-C levels of at least 35 mg/dL (0.91 mmol/L) (odds ratio [OR], 0.53; 95% confidence interval [CI], 0.39-0.72). A dose-response relationship was observed (OR, 0.65; 95% CI, 0.47-0.90 and OR, 0.31; 95% CI,0.21-0.46) for HDL-C levels of 35 to 49 mg/dL (0.91-1.28 mmol/L) and at least 50 mg/dL (1.29 mmol/L), respectively. The protective effect of a higher HDL-C level was significant among participants aged 75 years or older (OR, 0.51;95% CI,0.27-0.94), was more potent for the atherosclerotic stroke subtype (OR, 0.20; 95% CI, 0.08-0.50), and was present in all 3 racial or ethnic groups studied. Conclusions Increased HDL-C levels are associated with reduced risk of ischemic stroke in the elderly and among different racial or ethnic groups. These data add to the evidence relating lipids to stroke and support HDL-C as an important modifiable stroke risk factor.	Columbia Univ, Mailman Sch Publ Hlth, Dept Neurol, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Gertrude H Sergievsky Ctr, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Med, Div Gen Med, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Med, Div Prevent Med & Nutr, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Irving Ctr Clin Res, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Coll Phys & Surg, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Div Epidemiol, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Div Sociomed Sci, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Div Biostat, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Sacco, RL (corresponding author), Neurol Inst, 710 W 168th St, New York, NY 10032 USA.	rsl1@columbia.edu	Albala, Bernadette Boden/J-5703-2013; Sacco, Ralph/Y-9278-2019	Albala, Bernadette Boden/0000-0001-5664-2342; Berglund, Lars/0000-0001-6705-1791; Boden-Albala, Bernadette/0000-0002-3752-329X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027517, T32NS007153, R01NS029993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG015294] Funding Source: NIH RePORTER; NCRR NIH HHS [2 M01 RR00645] Funding Source: Medline; NIA NIH HHS [AG15294] Funding Source: Medline; NINDS NIH HHS [R01 NS27517, T32 NS07153, R01 NS29993] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ballantyne CM, 1999, CIRCULATION, V99, P736, DOI 10.1161/01.CIR.99.6.736; BENFANTE R, 1994, STROKE, V25, P814, DOI 10.1161/01.STR.25.4.814; BIHARIVARGA M, 1981, ATHEROSCLEROSIS, V40, P337, DOI 10.1016/0021-9150(81)90144-1; Blauw GJ, 1997, STROKE, V28, P946, DOI 10.1161/01.STR.28.5.946; Bureau of the Census, 1990, 1990 CENS POP HOUS; Casper ML, 1997, ANN EPIDEMIOL, V7, P146, DOI 10.1016/S1047-2797(96)00113-5; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; CORTI MC, 1995, JAMA-J AM MED ASSOC, V274, P539, DOI 10.1001/jama.274.7.539; Crouse JR, 1999, AM J CARDIOL, V83, P1476, DOI 10.1016/S0002-9149(99)00153-8; DEMPSEY RJ, 1990, NEUROSURGERY, V27, P343, DOI 10.1227/00006123-199009000-00001; FINEEDELSTEIN JS, 1994, NEUROLOGY, V44, P1046, DOI 10.1212/WNL.44.6.1046; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gan R, 1997, NEUROLOGY, V48, P1204, DOI 10.1212/WNL.48.5.1204; GENEST JJ, 1991, AM J CARDIOL, V67, P1185, DOI 10.1016/0002-9149(91)90924-A; GOLDBOURT U, 1977, AM J EPIDEMIOL, V105, P75, DOI 10.1093/oxfordjournals.aje.a112358; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; Gorelick PB, 1997, NEUROEPIDEMIOLOGY, V16, P107, DOI 10.1159/000109679; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; HEISS G, 1991, AM J EPIDEMIOL, V134, P250, DOI 10.1093/oxfordjournals.aje.a116078; HOWARD G, 1994, STROKE, V25, P2120, DOI 10.1161/01.STR.25.11.2120; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kargman DE, 1998, ATHEROSCLEROSIS, V139, P391, DOI 10.1016/S0021-9150(98)00085-9; KITTNER SJ, 1990, JAMA-J AM MED ASSOC, V264, P1267, DOI 10.1001/jama.264.10.1267; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; LINDENSTROM E, 1994, BMJ-BRIT MED J, V309, P11, DOI 10.1136/bmj.309.6946.11; MACKNESS MI, 1993, BIOCHEM J, V294, P829, DOI 10.1042/bj2940829; MENDEZ I, 1987, NEUROLOGY, V37, P507, DOI 10.1212/WNL.37.3.507; MILLER GJ, 1975, LANCET, V1, P16; MURAI A, 1981, STROKE, V12, P167, DOI 10.1161/01.STR.12.2.167; NUBIOLA AR, 1981, ARCH NEUROL-CHICAGO, V38, P468, DOI 10.1001/archneur.1981.00510070102026; OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752; Packard CJ, 1998, CIRCULATION, V97, P1440; PEDERSEN TR, 1995, LANCET, V345, P1274; QIZILBASH N, 1991, BRIT MED J, V303, P605, DOI 10.1136/bmj.303.6803.605; Qizilbash N, 1995, LANCET, V346, P1647; QIZILBASH N, 1992, CEREBROVASC DIS, V2, P127, DOI 10.1159/000109004; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; RUBINS HB, 1995, AM J CARDIOL, V75, P1196, DOI 10.1016/S0002-9149(99)80761-9; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacco RL, 1998, STROKE, V29, P380, DOI 10.1161/01.STR.29.2.380; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Sacco RL, 1997, STROKE, V28, P929, DOI 10.1161/01.STR.28.5.929; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SAGIV M, 1994, INT J SPORTS MED, V15, P261, DOI 10.1055/s-2007-1021057; SALONEN R, 1988, ARTERIOSCLEROSIS, V8, P788, DOI 10.1161/01.ATV.8.6.788; SRIDHARAN R, 1992, NEUROEPIDEMIOLOGY, V11, P24, DOI 10.1159/000110903; Tanne David, 1997, Stroke, V28, P250; TASKINEN MR, 1987, AM HEART J, V113, P458, DOI 10.1016/0002-8703(87)90614-4; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; White HD, 2000, NEW ENGL J MED, V343, P317, DOI 10.1056/NEJM200008033430502; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOO J, 1990, STROKE, V21, P1407, DOI 10.1161/01.STR.21.10.1407; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801; YAARI S, 1981, LANCET, V1, P1011; ZIMETBAUM P, 1992, ARTERIOSCLER THROMB, V12, P416, DOI 10.1161/01.ATV.12.4.416	61	211	223	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2729	2735		10.1001/jama.285.21.2729	http://dx.doi.org/10.1001/jama.285.21.2729			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386928				2022-12-28	WOS:000168985800025
J	Liu, T; DeCostanzo, AJ; Liu, XX; Wang, HY; Hallagan, S; Moon, RT; Malbon, CC				Liu, T; DeCostanzo, AJ; Liu, XX; Wang, HY; Hallagan, S; Moon, RT; Malbon, CC			G protein signaling from activated rat Frizzled-1 to the beta-catenin-Lef-Tcf pathway	SCIENCE			English	Article							F9 TERATOCARCINOMA CELLS; ADRENERGIC RECEPTORS; WNT; DIFFERENTIATION; MEMBER; FAMILY; XWNT-8	The frizzled receptors, which mediate development and display seven hydrophobic, membrane-spanning segments, are cell membrane-localized. We constructed a chimeric receptor with the ligand-binding and transmembrane segments from the beta (2)-adrenergic receptor (beta (2)AR) and the cytoplasmic domains from rat Frizzled-1 (Rfz1). Stimulation of mouse F9 clones expressing the chimera (beta (2)AR-Rfz1) with the beta -adrenergic agonist isoproterenol stimulated stabilization of beta -catenin, activation. of a beta -catenin-sensitive promoter, and formation of primitive endoderm. The response was blocked by inactivation of pertussis toxin-sensitive, heterotrimeric guanine nucleotide-binding proteins (G proteins) and by depletion of G alphaq and G alphao. Thus, G proteins are elements of Wnt/Frizzled-1 signaling to the beta -catenin-lymphoid-enhancer factor (LEF)-T cell factor (Tcf) pathway.	SUNY Stony Brook, Univ Med Ctr, Dept Mol Pharmacol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Univ Med Ctr, Dept Physiol, Diabet & Metab Dis Res Ctr, Stony Brook, NY 11794 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Ctr Dev Biol, Seattle, WA 98195 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Malbon, CC (corresponding author), SUNY Stony Brook, Univ Med Ctr, Dept Mol Pharmacol, Stony Brook, NY 11794 USA.		malbon, craig/ABF-3604-2020; Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408				Bao J, UNPUB; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CHAN SDH, 1992, J BIOL CHEM, V267, P25202; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; MAGUIRE ME, 1976, MOL PHARMACOL, V12, P335; MALBAN CC, UNPUB; MALBON CC, 1980, J BIOL CHEM, V255, P8692; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; MOON RT, 1993, DEVELOPMENT, V119, P97; Polakis P, 2000, GENE DEV, V14, P1837; ROS M, 1988, J BIOL CHEM, V263, P4362; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; Wu CL, 2000, DEVELOPMENT, V127, P2773; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	20	203	209	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1718	1722		10.1126/science.1060100	http://dx.doi.org/10.1126/science.1060100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387477				2022-12-28	WOS:000169031800046
J	Lloyd, S				Lloyd, S			Quantum computing - Computation from geometry	SCIENCE			English	Editorial Material									MIT, Dept Med Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lloyd, S (corresponding author), MIT, Dept Med Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	slloyd@mit.edu						BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; DIVINCENZO DP, 1995, SCIENCE, V270, P255, DOI 10.1126/science.270.5234.255; Duan LM, 2001, SCIENCE, V292, P1695, DOI 10.1126/science.1058835; Jones JA, 2000, NATURE, V403, P869, DOI 10.1038/35002528; LLOYD S, 1993, SCIENCE, V261, P1569, DOI 10.1126/science.261.5128.1569; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Pachos J, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.052318; Pachos J, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.010305; SHOR PW, 1994, AN S FDN CO, P124; Zanardi P, 1999, PHYS LETT A, V264, P94, DOI 10.1016/S0375-9601(99)00803-8	10	6	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1669	1669		10.1126/science.1062065	http://dx.doi.org/10.1126/science.1062065			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387463				2022-12-28	WOS:000169031800030
J	Menand, T; Tait, SR				Menand, T; Tait, SR			A phenomenological model for precursor volcanic eruptions	NATURE			English	Article							SOUFRIERE HILLS VOLCANO; PROPAGATION; MONTSERRAT; FRACTURE; ROCK	Intense explosions of relatively short duration frequently precede large explosive and effusive volcanic eruptions-by as much as weeks to months in the case of very viscous magmas(1-6). In some cases, such pre-eruption activity has served as a sufficient warning to those living in the vicinity to evacuate and avoid calamity(1). Precursor events seem to be related to the formation of a magma pathway to the surface, but their precise interpretation is a longstanding puzzle. It has been inferred from theoretical studies that exsolution of volatiles might create an almost separate gas pocket at the tip of a propagating dyke(7-9). Here we explain the role that such a process may have, using a laboratory study of the transient propagation of a liquid-filled crack with a gas pocket at its tip that grows with time. We show that once the gas pocket acquires sufficient buoyancy to overcome the fracture resistance of the host solid the dynamics of the gas pocket, rather than those of the liquid, determine the velocity of the crack tip. Furthermore, we rnd that the gas can ultimately separate from the liquid. We propose that fast-moving, gas-rich pockets reaching the surface ahead of the main liquid-filled fissure could be the origin of many precursor eruptions.	Inst Phys Globe Paris, Lab Dynam Syst Geol, F-75252 Paris 05, France	UDICE-French Research Universities; Universite Paris Cite	Menand, T (corresponding author), Univ Cambridge, BP Inst Multiphase Flow, Madingley Rise,Madingley Rd, Cambridge CB3 0EZ, England.		Tait, Stephen/E-8258-2017	Menand, Thierry/0000-0001-6241-7846				Aspinall WP, 1998, GEOPHYS RES LETT, V25, P3397, DOI 10.1029/98GL00858; Barenblatt GI, 1962, ADV APPL MECH, V7, P55, DOI DOI 10.1016/S0065-2156(08)70121-2; Daag AS, 1996, FIRE AND MUD, P409; EINARSSON P, 1980, J GEOPHYS-Z GEOPHYS, V47, P160; Foshang W.F., 1956, GEO B, V965-D, P355, DOI DOI 10.3133/B965; FOXWORTHY BL, 1982, US GEOL SURV, V1249, P1; Gardner JE, 1998, GEOL SOC AM BULL, V110, P173, DOI 10.1130/0016-7606(1998)110<0173:PEAGPA>2.3.CO;2; Griffith A.A., 1921, PHILOS T R SOC LOND, V221, P163, DOI [10.1098/rsta.1921.0006, DOI 10.1098/RSTA.1921.0006]; Harlow DH, 1996, FIRE AND MUD, P285; HEIKEN G, 1984, J GEOPHYS RES, V89, P8441, DOI 10.1029/JB089iB10p08441; HEIMPEL AM, 1994, MAGMATIC SYSTEMS, P223; Irwin GR., 1957, J APPL MECH, V79, P361, DOI [10.1115/1.4011547, DOI 10.1111/J.1460-2695.2012.01707.X]; KOYAGUCHI T, 1994, J VOLCANOL GEOTH RES, V59, P261, DOI 10.1016/0377-0273(94)90081-7; LIPMAN PW, 1981, US GEOL SURV PROF PA, V1250, P1; LISTER JR, 1990, J FLUID MECH, V210, P263, DOI 10.1017/S0022112090001288; MIMATSU M, 1995, SHOWA SHINZAN DIARY; Newhall CG, 1996, FIRE MUD ERUPTIONS L; Richards Jr R, 1966, EXP MECH, V6, P30, DOI DOI 10.1007/BF02327111; RUBIN AM, 1993, J GEOPHYS RES-SOL EA, V98, P15919, DOI 10.1029/93JB01391; Rubin AM, 1998, J GEOPHYS RES-SOL EA, V103, P20901, DOI 10.1029/98JB01349; TAKADA A, 1990, J GEOPHYS RES-SOLID, V95, P8471, DOI 10.1029/JB095iB06p08471; White RA, 1996, FIRE AND MUD, P307; Young SR, 1998, GEOPHYS RES LETT, V25, P3681, DOI 10.1029/98GL01406; Young SR, 1998, GEOPHYS RES LETT, V25, P3389, DOI 10.1029/98GL01405	24	52	52	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					678	680		10.1038/35079552	http://dx.doi.org/10.1038/35079552			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395766				2022-12-28	WOS:000169112500040
J	Paul, PM; Toma, ES; Breger, P; Mullot, G; Auge, F; Balcou, P; Muller, HG; Agostini, P				Paul, PM; Toma, ES; Breger, P; Mullot, G; Auge, F; Balcou, P; Muller, HG; Agostini, P			Observation of a train of attosecond pulses from high harmonic generation	SCIENCE			English	Article							IONIZATION	In principle, the temporal beating of superposed high harmonics obtained by focusing a femtosecond laser pulse in a gas jet can produce a train of very short intensity spikes, depending on the relative phases of the harmonics. We present a method to measure such phases through two-photon, two-color photoionization. We found that the harmonics are Locked in phase and form a train of 250-attosecond pulses in the time domain, Harmonic generation may be a promising source for attosecond time-resolved measurements.	FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands; Ctr Etud Saclay, CEA, DRECAM, SPAM, F-91191 Gif Sur Yvette, France; ENSTA, Lab Opt Appl, CNRS, UMR 7639, F-91761 Palaiseau, France	AMOLF; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut Polytechnique de Paris	Muller, HG (corresponding author), FOM, Inst Atom & Mol Phys, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	muller@amolf.nl	Balcou, Philippe/I-4624-2017	Balcou, Philippe/0000-0002-5546-6436				Antoine P, 1996, PHYS REV LETT, V77, P1234, DOI 10.1103/PhysRevLett.77.1234; Antoine P, 1997, PHYS REV A, V56, P4960, DOI 10.1103/PhysRevA.56.4960; AYMAR M, 1980, J PHYS B-AT MOL OPT, V13, pL287, DOI 10.1088/0022-3700/13/9/002; Becker W, 1997, PHYS REV A, V56, P645, DOI 10.1103/PhysRevA.56.645; Christov IP, 1998, PHYS REV A, V57, pR2285, DOI 10.1103/PhysRevA.57.R2285; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Drescher M, 2001, SCIENCE, V291, P1923, DOI 10.1126/science.1058561; FARKAS G, 1992, PHYS LETT A, V168, P447, DOI 10.1016/0375-9601(92)90534-S; HARRIS SE, 1993, OPT COMMUN, V100, P487, DOI 10.1016/0030-4018(93)90250-9; KAPLAN AE, 1994, PHYS REV LETT, V73, P1243, DOI 10.1103/PhysRevLett.73.1243; KLARSFELD S, 1979, J PHYS B-AT MOL OPT, V12, pL553, DOI 10.1088/0022-3700/12/18/004; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Papadogiannis NA, 1999, PHYS REV LETT, V83, P4289, DOI 10.1103/PhysRevLett.83.4289; Salieres P., 1999, ADV ATOM MOL OPT PHY, V41, P83; Schins JM, 1996, J OPT SOC AM B, V13, P197, DOI 10.1364/JOSAB.13.000197; Sekikawa T, 1999, PHYS REV LETT, V83, P2564, DOI 10.1103/PhysRevLett.83.2564; Sokolov AV, 2000, PHYS REV LETT, V85, P562, DOI 10.1103/PhysRevLett.85.562; Toma ES, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.061801; Veniard V, 1996, PHYS REV A, V54, P721, DOI 10.1103/PhysRevA.54.721	19	1944	1977	16	387	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1689	1692		10.1126/science.1059413	http://dx.doi.org/10.1126/science.1059413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387467				2022-12-28	WOS:000169031800036
J	Natelson, BH				Natelson, BH			Chronic fatigue syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; COGNITIVE-BEHAVIOR THERAPY; ORTHOSTATIC INTOLERANCE; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; SUBSTANCE-P; FIBROMYALGIA; DEPRESSION; HYPOTENSION; DEFINITION		Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurosci, Chron Fatigue Syndrome Cooperat Res Ctr, Newark, NJ 07103 USA; Vet Affairs Med Ctr, E Orange, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Natelson, BH (corresponding author), New Jersey Med Sch, Fatigue Res Ctr, 88 Ross St, E Orange, NJ 07018 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI032246] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32246] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOUHOLAIGAH I, 1995, JAMA-J AM MED ASSOC, V274, P961, DOI 10.1001/jama.274.12.961; BUCHWALD D, 1994, ARCH INTERN MED, V154, P2049, DOI 10.1001/archinte.154.18.2049; Christodoulou C, 1998, J NEUROL NEUROSUR PS, V64, P431, DOI 10.1136/jnnp.64.4.431; Cook DB, 2001, INT J NEUROSCI, V107, P1, DOI 10.3109/00207450109149754; De Meirleir K, 2000, AM J MED, V108, P99, DOI 10.1016/S0002-9343(99)00300-9; Deale A, 1997, AM J PSYCHIAT, V154, P408; DELUCA J, 1995, J NEUROL NEUROSUR PS, V58, P38, DOI 10.1136/jnnp.58.1.38; DeLuca J, 1997, J NEUROL NEUROSUR PS, V62, P151, DOI 10.1136/jnnp.62.2.151; Evengard B, 1998, PAIN, V78, P153, DOI 10.1016/S0304-3959(98)00134-1; FRIEDBERG F, 1994, CLIN INFECT DIS, V18, pS105, DOI 10.1093/clinids/18.Supplement_1.S105; FRIEDBERG F, 2000, J CHRONIC FATIGUE SY, V5, P149; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GOLD D, 1990, JAMA-J AM MED ASSOC, V264, P48, DOI 10.1001/jama.264.1.48; HICKIE I, 1995, PSYCHOL MED, V25, P925, DOI 10.1017/S0033291700037417; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; Hotopf M, 1996, J NEUROL NEUROSUR PS, V60, P504, DOI 10.1136/jnnp.60.5.504; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Johnson SK, 1996, PSYCHOSOM MED, V58, P50, DOI 10.1097/00006842-199601000-00008; Johnson SK, 1996, J AFFECT DISORDERS, V39, P21, DOI 10.1016/0165-0327(96)00015-8; JOHNSON SK, 1996, J PSYCHIAT RES, V31, P9; KATON W, 1992, ARCH INTERN MED, V152, P1604, DOI 10.1001/archinte.152.8.1604; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; LaManca JJ, 1999, CLIN PHYSIOL, V19, P111; Lange G, 1999, J NEUROL SCI, V171, P3, DOI 10.1016/S0022-510X(99)00243-9; Lerner AM, 1997, INFECT DIS CLIN PRAC, V6, P327; LLOYD AR, 1993, AM J MED, V94, P197, DOI 10.1016/0002-9343(93)90183-P; Natelson BH, 1999, J AFFECT DISORDERS, V53, P179, DOI 10.1016/S0165-0327(98)00118-9; Natelson BH., 1998, FACING FIGHTING FATI; Parker J C, 1993, Arthritis Care Res, V6, P207, DOI 10.1002/art.1790060407; Poole J, 2000, ARCH INTERN MED, V160, P3461, DOI 10.1001/archinte.160.22.3461; Rowe PC, 2001, JAMA-J AM MED ASSOC, V285, P52, DOI 10.1001/jama.285.1.52; RUSSELL IJ, 1994, ARTHRITIS RHEUM-US, V37, P1593, DOI 10.1002/art.1780371106; Schondorf R, 1999, J AUTONOM NERV SYST, V75, P192, DOI 10.1016/S0165-1838(98)00177-5; Scott LV, 1999, FUNCT NEUROL, V14, P3; Sharpe M, 1996, BRIT MED J, V312, P22, DOI 10.1136/bmj.312.7022.22; Stewart JM, 1999, PEDIATRICS, V103, P116, DOI 10.1542/peds.103.1.116; STRAYER DR, 1994, CLIN INFECT DIS, V18, pS88, DOI 10.1093/clinids/18.Supplement_1.S88; Streeten D. H., 1998, J CHRONIC FATIGUE SY, V4, P3, DOI 10.1300/J092v04n01_02; Streeten DHP, 1998, CLIN AUTON RES, V8, P119, DOI 10.1007/BF02267822; STROBER W, 1994, CHRONIC FATIGUE SYND, P207; Thompson D, 1998, AM J PSYCHIAT, V155, P824; vonMikecz A, 1997, ARTHRITIS RHEUM-US, V40, P295; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wessely S, 1998, CHRONIC FATIGUE ITS; White PD, 1998, BRIT J PSYCHIAT, V173, P475, DOI 10.1192/bjp.173.6.475; Zhang QW, 1999, CLIN DIAGN LAB IMMUN, V6, P6, DOI 10.1128/CDLI.6.1.6-13.1999; Zhang QW, 2000, CHRONOBIOL INT, V17, P95, DOI 10.1081/CBI-100101035	47	23	26	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2557	2559		10.1001/jama.285.20.2557	http://dx.doi.org/10.1001/jama.285.20.2557			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433LY	11368714				2022-12-28	WOS:000168761900002
J	Parker, RA; Hartman, EE				Parker, RA; Hartman, EE			A 36-year-old woman who smokes cigarettes, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																		Rigotti NA, 2000, JAMA-J AM MED ASSOC, V284, P741, DOI 10.1001/jama.284.6.741	1	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2636	2636		10.1001/jama.285.20.2636	http://dx.doi.org/10.1001/jama.285.20.2636			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433LY	11368738				2022-12-28	WOS:000168761900031
J	Lisse, CM; Christian, DJ; Dennerl, K; Meech, KJ; Petre, R; Weaver, HA; Wolk, SJ				Lisse, CM; Christian, DJ; Dennerl, K; Meech, KJ; Petre, R; Weaver, HA; Wolk, SJ			Charge exchange-induced X-ray emission from comet C/1999 S4 (LINEAR)	SCIENCE			English	Article							EXTREME-ULTRAVIOLET EMISSION; SOLAR-WIND; HYAKUTAKE; P/HALLEY; SPECTRA	Using soft x-ray observations of the bright new comet C/1999 S4 (LIN EAR) with the Chandra x-ray observatory, we have detected x-ray line emission created by charge exchange between highly ionized solar wind minor ions and neutral gases in the comet's coma. The emission morphology was symmetrically crescent shaped and extended out to 300,000 kilometers from the nucleus. The emission spectrum contains 6 lines at 320, 400, 490, 560, 600, and 670 electron volts, attributable to electron capture and radiative deexcitation by the solar wind species C+5, C+6, N+7, O+7, and O+8. A contemporaneous T-day soft x-ray Light curve obtained using the Extreme Ultraviolet Explorer demonstrates a large increase in the comet's emission coincident with a strong solar flare on 14 and 15 July 2000.	Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Comp Sci Corp, Sci Operat, Baltimore, MD 21218 USA; Max Planck Inst Extraterr Phys, D-85740 Garching, Germany; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Harvard Smithsonian Ctr Astrophys, Chandra Xray Ctr, Cambridge, MA 02138 USA	University System of Maryland; University of Maryland College Park; Max Planck Society; University of Hawaii System; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Johns Hopkins University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Lisse, CM (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	lisse@astro.umd.edu	Meech, Karen/CAH-1412-2022; Lisse, Carey M/B-7772-2016; Weaver, Harold A/D-9188-2016	Lisse, Carey M/0000-0002-9548-1526; Weaver, Harold A/0000-0003-0951-7762; Wolk, Scott/0000-0002-0826-9261; Christian, Damian/0000-0003-1746-3020; Meech, Karen/0000-0002-2058-5670				Beiersdorfer P, 2001, ASTROPHYS J, V549, pL147, DOI 10.1086/319143; Bingham R, 1997, SCIENCE, V275, P49, DOI 10.1126/science.275.5296.49; Bingham R, 2000, ASTROPHYS J SUPPL S, V127, P233, DOI 10.1086/313361; Bockelee-Morvan D, 2001, SCIENCE, V292, P1339, DOI 10.1126/science.1058512; Cravens TE, 1997, GEOPHYS RES LETT, V24, P105, DOI 10.1029/96GL03780; Dennerl K, 1997, SCIENCE, V277, P1625, DOI 10.1126/science.277.5332.1625; Farnham TL, 2001, SCIENCE, V292, P1348, DOI 10.1126/science.1058886; FEIGELSON E, 2000, B AM ASTRON SOC, V32; FLAMMER KR, 1991, IAU C, V121, P1125; Greenwood JB, 2000, ASTROPHYS J, V533, pL175, DOI 10.1086/312615; Haberli RM, 1997, SCIENCE, V276, P939, DOI 10.1126/science.276.5314.939; Kharchenko V, 2000, J GEOPHYS RES-SPACE, V105, P18351, DOI 10.1029/1999JA000203; KIDGER M, 2000, 7467 IAU; Krasnopolsky VA, 1997, SCIENCE, V277, P1488, DOI 10.1126/science.277.5331.1488; Krasnopolsky VA, 2001, ASTROPHYS J, V549, P629, DOI 10.1086/319064; Lisse CM, 1997, EARTH MOON PLANETS, V77, P283, DOI 10.1023/A:1006274812124; Lisse CM, 1999, ICARUS, V141, P316, DOI 10.1006/icar.1999.6176; Lisse CM, 1996, SCIENCE, V274, P205, DOI 10.1126/science.274.5285.205; LISSE CM, UNPUB; MIKUNZ H, COMMUNICATION; MUKAI T, 1987, ASTRON ASTROPHYS, V187, P129; Mumma MJ, 1997, ASTROPHYS J, V491, pL125, DOI 10.1086/311071; Neugebauer M, 1998, J GEOPHYS RES-SPACE, V103, P14587, DOI 10.1029/98JA00798; NEUGEBAUER M, 1987, ASTRON ASTROPHYS, V187, P21; Northrop TG, 1997, ICARUS, V127, P246, DOI 10.1006/icar.1997.5694; Northrop TG, 1997, ICARUS, V128, P480, DOI 10.1006/icar.1997.5762; Owens A, 1998, ASTROPHYS J, V493, pL47, DOI 10.1086/311119; REME H, 1987, ASTRON ASTROPHYS, V187, P33; SCHELIECHER DG, 2001, COMMUNICATION; SCHELIECHER DG, 2000, 7455 IAU; Schwadron NA, 2000, ASTROPHYS J, V544, P558, DOI 10.1086/317176; Uchida M, 1998, ASTROPHYS J, V498, P863, DOI 10.1086/305566; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606; Wegmann R, 1998, PLANET SPACE SCI, V46, P603, DOI 10.1016/S0032-0633(97)00196-7	34	131	132	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1343	1348		10.1126/science.292.5520.1343	http://dx.doi.org/10.1126/science.292.5520.1343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359004				2022-12-28	WOS:000168862900037
J	Gogotsi, Y; Welz, S; Ersoy, DA; McNallan, MJ				Gogotsi, Y; Welz, S; Ersoy, DA; McNallan, MJ			Conversion of silicon carbide to crystalline diamond-structured carbon at ambient pressure	NATURE			English	Article							SHOCK COMPRESSION; GROWTH; COATINGS; GRAPHITE	Synthetic diamond is formed commercially using high-pressure(1), chemical-vapour-deposition(2) and shock-wave(3) processes, but these approaches have serious limitations owing to low production volumes and high costs. Recently suggested alternative methods of diamond growth include plasma activation(4), high pressures(5), exotic precursors(6,7) or explosive mixtures(8), but they suffer from very low yield and are intrinsically limited to small volumes or thin films. Here we report the synthesis of nano- and micro-crystalline diamond-structured carbon, with cubic and hexagonal structure, by extracting silicon from silicon carbide in chlorine-containing gases at ambient pressure and temperatures not exceeding 1,000 degreesC. The presence of hydrogen in the gas mixture leads to a stable conversion of silicon carbide to diamond-structured carbon with an average crystallite size ranging from 5 to 10 nanometres. The linear reaction kinetics allows transformation to any depth, so that the whole silicon carbide sample can be converted to carbon. Nanocrystalline coatings of diamond-structured carbon produced by this route show promising mechanical properties, with hardness values in excess of 50 GPa and Young's moduli up to 800 GPa. Our approach should be applicable to large-scale production of crystalline diamond-structured carbon.	Drexel Univ, Dept Mat Engn, Philadelphia, PA 19104 USA; Univ Illinois, Dept Civil & Mat Engn, Chicago, IL 60607 USA	Drexel University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gogotsi, Y (corresponding author), Drexel Univ, Dept Mat Engn, Philadelphia, PA 19104 USA.	gogotsi@drexel.edu	Gogotsi, Yury/B-2167-2008	Gogotsi, Yury/0000-0001-9423-4032				ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913; BUNDY FP, 1955, NATURE, V176, P51, DOI 10.1038/176051a0; BURKHARD G, 1994, JPN J APPL PHYS 2, V33, pL876, DOI 10.1143/JJAP.33.L876; Daulton TL, 1996, SCIENCE, V271, P1260, DOI 10.1126/science.271.5253.1260; Ersoy DA, 2000, TRIBOL T, V43, P809, DOI 10.1080/10402000008982412; GOGOTSI Y, 2001, P NATO ASI FUNCT GRA, P239; GOGOTSI Y, 1999, P NATO ARW NAN FILMS, P25; Gogotsi YG, 1997, J MATER CHEM, V7, P1841, DOI 10.1039/a701126a; Gogotsi YG, 1998, CERAM ENG SCI PROC, V19, P87; GOGOTSI YG, 1994, NATURE, V367, P628, DOI 10.1038/367628a0; Gogotsi YG, 1995, J MATER CHEM, V5, P2313, DOI 10.1039/jm9950502313; Gogotsi YG, 1996, DIAM RELAT MATER, V5, P151, DOI 10.1016/0925-9635(95)00341-X; GRANNEN KJ, 1994, J MATER RES, V9, P2154, DOI 10.1557/JMR.1994.2154; Gruen DM, 1999, ANNU REV MATER SCI, V29, P211, DOI 10.1146/annurev.matsci.29.1.211; GRUEN DM, 1994, J APPL PHYS, V75, P1758, DOI 10.1063/1.356367; Heera V, 2000, APPL PHYS LETT, V76, P2847, DOI 10.1063/1.126493; HIRAI H, 1991, SCIENCE, V253, P772, DOI 10.1126/science.253.5021.772; HOUGH RM, 1995, NATURE, V378, P41, DOI 10.1038/378041a0; Kofstad P., 1988, HIGH TEMPERATURE COR, DOI DOI 10.1002/CRAT.2170240408; Kyutt RN, 1999, PHYS SOLID STATE+, V41, P1359, DOI 10.1134/1.1130998; LANNON JM, 1995, J APPL PHYS, V77, P3823, DOI 10.1063/1.358558; LEUNG I, 1990, NATURE, V346, P352, DOI 10.1038/346352a0; Li YD, 1998, SCIENCE, V281, P246, DOI 10.1126/science.281.5374.246; REGUEIRO MN, 1992, NATURE, V355, P237, DOI 10.1038/355237a0; ROSSI M, 1993, APPL PHYS LETT, V63, P2765, DOI 10.1063/1.110328; Roy R., 1996, INNOVATIONS MAT RES, V1, P65; SILVA SRP, 1994, J MATER SCI, V29, P4962, DOI 10.1007/BF01151085; SPITSYN BV, 1994, HDB CRYSTAL GROWTH A, V3, P401; WANG JT, 1994, J ELECTROCHEM SOC, V141, P278, DOI 10.1149/1.2054699; Zarrabian M, 1997, APPL PHYS LETT, V70, P2535, DOI 10.1063/1.118912; Zhao XZ, 1997, NATURE, V385, P513, DOI 10.1038/385513a0; Zheng J, 2000, J MATER CHEM, V10, P1039, DOI 10.1039/b000038h	32	210	218	8	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					283	287		10.1038/35077031	http://dx.doi.org/10.1038/35077031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357125				2022-12-28	WOS:000168710000040
J	Brown, DWG				Brown, DWG			Foot and mouth disease in human beings	LANCET			English	Editorial Material									Cent Publ Hlth Lab, Enter Resp & Neurol Virus Lab, London NW9 5HT, England	Public Health England	Brown, DWG (corresponding author), Cent Publ Hlth Lab, Enter Resp & Neurol Virus Lab, London NW9 5HT, England.							ARMSTRONG R, 1967, BMJ-BRIT MED J, V4, P529, DOI 10.1136/bmj.4.5578.529; BAUER K, 1997, ARCH VIROL, V13, P95; PILZ W, 1965, ZENTBL BAKTERIOLOG P, V198, P154; SELLERS R F, 1970, Journal of Hygiene, V68, P565; SELLERS RF, 1971, VET REC, V89, P447, DOI 10.1136/vr.89.16.447-a; 1967, LANCET, V1, P961; 2001, CDR WEEKLY      0503, P3	7	4	4	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1463	1463		10.1016/S0140-6736(00)04670-5	http://dx.doi.org/10.1016/S0140-6736(00)04670-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377592				2022-12-28	WOS:000168614300004
J	Schellenberg, D; Menendez, C; Kahigwa, E; Aponte, J; Vidal, J; Tanner, M; Mshinda, H; Alonso, P				Schellenberg, D; Menendez, C; Kahigwa, E; Aponte, J; Vidal, J; Tanner, M; Mshinda, H; Alonso, P			Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial	LANCET			English	Article							FALCIPARUM-MALARIA; AFRICAN CHILDREN; IMMUNE-RESPONSE; SPF66 VACCINE; ENDEMIC AREA; CHEMOPROPHYLAXIS; MORTALITY; MORBIDITY	Background Clinical malaria and severe anaemia are major causes of paediatric hospital admission and death in many malaria-endemic settings. In the absence of an effective and affordable vaccine, control programmes continue to rely on case management while attempting the large-scale deployment of insecticide-treated nets. We did a randomised, placebo-controlled trial to assess the efficacy and safety of intermittent sulphadoxine-pyrimethamine treatment on the rate of malaria and severe anaemia in infants in a rural area of Tanzania. Methods We randomly assigned 701 children living in Ifakara, southern Tanzania, sulphadoxine-pyrimethamine or placebo at 2, 3, and 9 months of age. All children received iron supplementation between 2 and 6 months of age. The intervention was given alongside routine Vaccinations delivered through WHO's Expanded Program on Immunisation (EPI). The primary outcome measures were first or only episode of clinical malaria, and severe anaemia in the period from recruitment to 1 year of age. Morbidity monitoring through a hospital-based passive case-detection system was complemented by cross-sectional surveys at 12 and 18 months of age. Results were expressed in terms of protective efficacy (100 [1-hazard ratio] %) and analysis was by intention to treat. Findings 40 children dropped out (16 died, 11 migrated, 12 parents withdrew consent, and one for other reasons). Intermittent sulphadoxine-pyrimethamine treatment was well tolerated and no drug-attributable adverse events were recorded. During the first year of life, the rate of clinical malaria (events per person-year at risk) was 0.15 in the sulphadoxine-pyrimethamine group versus 0.36 in the placebo group (protective efficacy 59% [95% CI 41-72]), and the rate of severe anaemia was 0.06 in the sulphadoxine-pyrimethamine group versus 0.11 in the placebo group (50% [8-73]). Serological responses to EPI vaccines were not affected by the intervention. Interpretation This new approach to malaria control reduced the rate of clinical malaria and severe anaemia by delivering an available and affordable drug through the existing EPI system. Data are urgently needed to assess the potential cost-effectiveness of intermittent treatment in areas with different patterns of malaria endemicity.	Hosp Clin Barcelona, Unidad Epidemiol, E-08036 Barcelona, Spain; Hosp Clin Barcelona, Dept Microbiol, E-08036 Barcelona, Spain; Hosp Clin Barcelona, IDIBAPS, E-08036 Barcelona, Spain; Ifakara Hlth Res & Dev Ctr, Kilombero, Tanzania; Swiss Trop Inst, CH-4002 Basel, Switzerland; Minist Hlth, St Francis Designated Dist Hosp, Dar Es Salaam, Tanzania	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Alonso, P (corresponding author), Hosp Clin Barcelona, Unidad Epidemiol, Villarroel 170, E-08036 Barcelona, Spain.	alonso@medicina.ub.es	Alonso, Pedro L/AAZ-3645-2020; Menéndez, Clara/Q-3446-2016	Alonso, Pedro L/0000-0003-3292-3443; Menéndez, Clara/0000-0002-2641-6907; Schellenberg, David/0000-0001-8222-0186				Acosta CJ, 1999, TROP MED INT HEALTH, V4, P368, DOI 10.1046/j.1365-3156.1999.00406.x; ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BRADLEYMOORE AM, 1985, ANN TROP MED PARASIT, V79, P563, DOI 10.1080/00034983.1985.11811963; COLBOURNE MJ, 1955, T R SOC TROP MED HYG, V49, P357; GREENWOOD AM, 1981, ANN TROP MED PARASIT, V75, P261, DOI 10.1080/00034983.1981.11687439; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; GREENWOOD BM, 1988, LANCET, V1, P1121; HOGH B, 1994, ACTA TROP, V57, P265, DOI 10.1016/0001-706X(94)90072-8; Kollaritsch H, 1997, J INFECT DIS, V175, P871, DOI 10.1086/513984; LAING ABG, 1984, B WORLD HEALTH ORGAN, V62, P41; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; MENON A, 1990, T ROY SOC TROP MED H, V84, P768, DOI 10.1016/0035-9203(90)90071-L; *MIN HLTH, 1998, NAT GUID DIAGN TREAT; PAPPAIOANOU M, 1986, NEW ENGL J MED, V314, P280, DOI 10.1056/NEJM198601303140504; PRINGLE G, 1966, B WORLD HEALTH ORGAN, V34, P269; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; SCHELLENBERG JRM, 2001, INDEPTH MONOGRAPH SE, V1; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; *UN REP TANZ MOH, 2000, MAL CONTR SER, V1	21	233	236	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2001	357	9267					1471	1477		10.1016/S0140-6736(00)04643-2	http://dx.doi.org/10.1016/S0140-6736(00)04643-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377597				2022-12-28	WOS:000168614300009
J	Eaton, L				Eaton, L			UK senior scientists support animal genetic modification	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1382	1382						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397734				2022-12-28	WOS:000169284600008
J	Grupe, A; Germer, S; Usuka, J; Aud, D; Belknap, JK; Klein, RF; Ahluwalia, MK; Higuchi, R; Peltz, G				Grupe, A; Germer, S; Usuka, J; Aud, D; Belknap, JK; Klein, RF; Ahluwalia, MK; Higuchi, R; Peltz, G			In silico mapping of complex disease-related traits in mice	SCIENCE			English	Article							ALCOHOL PREFERENCE; ALLERGIC-ASTHMA; INBRED MICE; LOCI; MOUSE; GENES; IDENTIFICATION; DISCOVERY; DRINKING; MODELS	Experimental murine genetic models of complex human disease show great potential for understanding human disease pathogenesis. To reduce the time required for analysis of such models from many months down to milliseconds, a computational method for predicting chromosomal regions regulating phenotypic traits and a murine database of single nucleotide polymorphisms were developed. After entry of phenotypic information obtained from inbred mouse strains, the phenotypic and genotypic information is analyzed in silico to predict the chromosomal regions regulating the phenotypic trait.	Roche Biosci, Dept Genet & Genome, Palo Alto, CA 94303 USA; Roche Mol Syst, Alameda, CA 94501 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Oregon Hlth Sci Univ, Portland, OR 97201 USA; Portland Vet Affairs Med Ctr, Portland, OR 97201 USA	Roche Holding; Roche Holding; Stanford University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System	Peltz, G (corresponding author), Roche Biosci, Dept Genet & Genome, Palo Alto, CA 94303 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, R01HG002322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760] Funding Source: NIH RePORTER; NHGRI NIH HHS [1 R01 HG02322-01, T32HG-00044] Funding Source: Medline; NIAAA NIH HHS [P60 AA010760] Funding Source: Medline; NIAMS NIH HHS [R01 AR044659, R01 AR044659-07] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Beamer WG, 1999, MAMM GENOME, V10, P1043, DOI 10.1007/s003359901159; Belknap JK, 1997, BEHAV GENET, V27, P55, DOI 10.1023/A:1025615409383; Buck KJ, 1997, J NEUROSCI, V17, P3946; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Dwyer-Nield LD, 2000, AM J PHYSIOL-LUNG C, V279, pL326, DOI 10.1152/ajplung.2000.279.2.L326; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; KLEIN RF, IN PRESS J BONE MINE; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Melo JA, 1996, NAT GENET, V13, P147, DOI 10.1038/ng0696-147; MUCENSKI ML, 1986, MOL CELL BIOL, V6, P4236, DOI 10.1128/MCB.6.12.4236; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Phillips TJ, 1998, MAMM GENOME, V9, P936; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Tarantino LM, 1998, ALCOHOL CLIN EXP RES, V22, P1099; Wielowieyski A, 1999, MAMM GENOME, V10, P623, DOI 10.1007/s003359901057; Williams RW, 1998, J NEUROSCI, V18, P138; Zhang YM, 1999, HUM MOL GENET, V8, P601, DOI 10.1093/hmg/8.4.601; Zhou G, 1999, INVEST OPHTH VIS SCI, V40, P817; 1998, JAX NOTES, V475	22	232	247	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1915	1918		10.1126/science.1058889	http://dx.doi.org/10.1126/science.1058889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397946				2022-12-28	WOS:000169200700050
J	Berkley, JA; Mwangi, I; Ngetsa, CJ; Mwarumba, S; Lowe, BS; Marsh, K; Newton, CRJC				Berkley, JA; Mwangi, I; Ngetsa, CJ; Mwarumba, S; Lowe, BS; Marsh, K; Newton, CRJC			Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa	LANCET			English	Article							CEREBRAL MALARIA; REAGENT STRIPS	Background The diagnosis of acute bacterial meningitis in children is difficult in sub-Saharan Africa, because the clinical features overlap with those of other common diseases, and laboratory facilities are inadequate in many areas. We have assessed the value of non-laboratory tests and incomplete laboratory data in diagnosing childhood acute bacterial meningitis in this setting. Methods We prospectively studied 905 children undergoing lumbar puncture at a rural district hospital in Kenya over 1 year. We related microbiological findings and cerebrospinal-fluid (CSF) laboratory measurements to tests that would typically be available at such a hospital. Findings Acute bacterial meningitis was proven in 45 children (5.0% [95% CI 3.7-6.6]) and probable in 26 (2.9% [1.9-4.2]). 21 of the 71 cases of proven or probable acute bacterial meningitis had neither neck stiffness nor turbid CSF. In eight of 45 children with proven disease the CSF leucocyte count was less than 10x10(6)/L or leucocyte counting was not possible because of blood-staining. The presence of either a leucocyte count of 50x10(6)/L or more or a CSF/blood glucose ratio of 0.10 or less detected all but two of the 45 children with proven acute bacterial meningitis; these two samples were grossly blood-stained. Interpretation The diagnosis of childhood acute bacterial meningitis is likely to be missed in a third of cases at district hospitals in sub-Saharan Africa without adequate and reliable laboratory resources. CSF culture facilities are expensive and difficult to maintain, and greater gains could be achieved with facilities for accurate leucocyte counting and glucose measurement.	Ctr GEog Med Res Coast, Kilifi, Kenya; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 9DU, England; Inst Child Hlth, Neurosci Unit, London, England	University of Oxford; University of London; University College London	Berkley, JA (corresponding author), Ctr GEog Med Res Coast, POB 230, Kilifi, Kenya.		Newton, Charles/C-6222-2009; Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019	Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; Berkley, James/0000-0002-1236-849X				Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; BONADIO WA, 1992, PEDIATR INFECT DIS J, V11, P423, DOI 10.1097/00006454-199206000-00001; Bonev V, 1997, LANCET, V349, P287, DOI 10.1016/S0140-6736(05)64902-1; COMMEY JOO, 1994, E AFR MED J, V71, P113; FELGENHAUER K, 1985, J NEUROL, V232, P157, DOI 10.1007/BF00313892; FISHMAN RA, 1992, CEREBROSPINAL FLUID, P183; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Molyneux E, 1996, LANCET, V348, P1170, DOI 10.1016/S0140-6736(05)65304-4; Molyneux E, 1998, TROP MED INT HEALTH, V3, P610, DOI 10.1046/j.1365-3156.1998.00278.x; MOOSA AA, 1995, LANCET, V345, P1290, DOI 10.1016/S0140-6736(95)90931-1; NEWTON CRJC, 1991, LANCET, V337, P573, DOI 10.1016/0140-6736(91)91638-B; Palmer A, 1999, J TROP PEDIATRICS, V45, P51, DOI 10.1093/tropej/45.1.51; SCHIMDLEY JW, 1981, ANN NEUROL, V9, P81; Snow Robert W., 1994, Afr J Health Sci, V1, P71; *WHO, 1997, WHOCHD986; WRIGHT PW, 1993, PEDIATR INFECT DIS J, V12, P37, DOI 10.1097/00006454-199301000-00009	16	73	76	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1753	1757		10.1016/S0140-6736(00)04897-2	http://dx.doi.org/10.1016/S0140-6736(00)04897-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403812				2022-12-28	WOS:000169156200013
J	Stanhope, R				Stanhope, R			Use of a specific aromatase inhibitor in delayed puberty	LANCET			English	Editorial Material							CONSTITUTIONAL DELAY; SHORT STATURE; FINAL HEIGHT; GROWTH; BOYS; TESTOSTERONE; DEFICIENCY; SECRETION; MUTATION; HORMONE		Great Ormond St Hosp Children, Dept Endocrinol, London WC1N 1EH, England; Middlesex Hosp, UCLH, London WC1N 1EH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London	Stanhope, R (corresponding author), Great Ormond St Hosp Children, Dept Endocrinol, London WC1N 1EH, England.							ALBANESE A, 1995, J PEDIATR-US, V126, P545, DOI 10.1016/S0022-3476(95)70347-0; ALBANESE A, 1993, EUR J PEDIATR, V152, P293, DOI 10.1007/BF01956736; BOYAR RM, 1974, J CLIN INVEST, V54, P609, DOI 10.1172/JCI107798; Carani C, 1997, NEW ENGL J MED, V337, P91, DOI 10.1056/NEJM199707103370204; EASTMAN CJ, 1971, AUST NZ J MED, V1, P154, DOI 10.1111/j.1445-5994.1971.tb02283.x; FINKELSTEIN JS, 1992, NEW ENGL J MED, V326, P600, DOI 10.1056/NEJM199202273260904; MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; STANHOPE R, 1985, ARCH DIS CHILD, V60, P379, DOI 10.1136/adc.60.4.379; URUENA M, 1992, EUR J PEDIATR, V151, P15, DOI 10.1007/BF02073882	10	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1723	1724		10.1016/S0140-6736(00)04930-8	http://dx.doi.org/10.1016/S0140-6736(00)04930-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403802				2022-12-28	WOS:000169156200003
J	Strieter, RM; Belperio, JA				Strieter, RM; Belperio, JA			Chemokine receptor polymorphism in transplantation immunology: no longer just important in AIDS	LANCET			English	Editorial Material							ALLOGRAFT-REJECTION; RANTES		Univ Calif Los Angeles, Sch Med, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Strieter, RM (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA.							Belperio JA, 2000, J IMMUNOL, V165, P461, DOI 10.4049/jimmunol.165.1.461; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Grone HJ, 1999, FASEB J, V13, P1371, DOI 10.1096/fasebj.13.11.1371; Hall IP, 1999, LANCET, V354, P1264, DOI 10.1016/S0140-6736(99)03425-X; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Horuk R, 2001, J BIOL CHEM, V276, P4199, DOI 10.1074/jbc.M007457200; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; NADEAU KC, 1995, P NATL ACAD SCI USA, V92, P8729, DOI 10.1073/pnas.92.19.8729; Segerer S, 2001, AM J KIDNEY DIS, V37, P518; Sellebjerg F, 2000, J NEUROIMMUNOL, V102, P98, DOI 10.1016/S0165-5728(99)00166-6; Zapico I, 2000, GENES IMMUN, V1, P288, DOI 10.1038/sj.gene.6363673; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	13	8	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1725	1726		10.1016/S0140-6736(00)04932-1	http://dx.doi.org/10.1016/S0140-6736(00)04932-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403804				2022-12-28	WOS:000169156200005
J	Lecuit, M; Vandormael-Pournin, S; Lefort, J; Huerre, M; Gounon, P; Dupuy, C; Babinet, C; Cossart, P				Lecuit, M; Vandormael-Pournin, S; Lefort, J; Huerre, M; Gounon, P; Dupuy, C; Babinet, C; Cossart, P			A transgenic model for listeriosis: Role of internalin in crossing the intestinal barrier	SCIENCE			English	Article							CELL-ADHESION MOLECULES; E-CADHERIN; TYROSINE KINASE; SURFACE PROTEIN; L-MONOCYTOGENES; RECEPTOR; ENTRY; EXPRESSION; SYSTEM; GASTROENTERITIS	Listeria monocytogenes is responsible for severe food-borne infections, but the mechanisms by which bacteria cross the intestinal barrier are unknown. Listeria monocytogenes expresses a surface protein, internalin, that interacts with a host receptor, E-cadherin, to promote entry into human epithelial cells. Murine E-cadherin, in contrast to guinea pig E-cadherin, does not interact with internalin, excluding the mouse as a model for addressing internalin function in vivo. In guinea pigs and transgenic mice expressing human E-cadherin, internalin was found to mediate invasion of enterocytes and crossing of the intestinal barrier. These results illustrate how relevant animal models for human infections can be generated.	Inst Pasteur, Unite Interact Bacteries Cellules, CNRS, Unite Rech Associee 1960, F-75724 Paris 15, France; Inst Pasteur, Unite Biol Dev, CNRS, Unite Rech Associee 1960, F-75724 Paris, France; Inst Pasteur, Unite Pharmacol Cellulaire, F-75724 Paris 15, France; Inst Pasteur, Unite Histopathol, F-75724 Paris 15, France; Inst Pasteur, Stn Cent Microscopie Electron, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, CNRS, Unite Rech Associee 1960, F-75724 Paris 15, France.		Lecuit, Marc/J-4073-2013; Lecuit, Marc/M-4126-2019	Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063				Aureli P, 2000, NEW ENGL J MED, V342, P1236, DOI 10.1056/NEJM200004273421702; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Dalton CB, 1997, NEW ENGL J MED, V336, P100, DOI 10.1056/NEJM199701093360204; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; FIGARELLABRANGER D, 1995, ACTA NEUROPATHOL, V89, P248; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; LORBER B, 1996, CLIN INFECT DIS, V24, P1; Marra A, 1997, INFECT IMMUN, V65, P3412, DOI 10.1128/IAI.65.8.3412-3421.1997; Mayhew TM, 1999, HISTOL HISTOPATHOL, V14, P257, DOI 10.14670/HH-14.257; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Oldstone MBA, 1999, CELL, V98, P629, DOI 10.1016/S0092-8674(00)80050-1; Pron B, 1998, INFECT IMMUN, V66, P747, DOI 10.1128/IAI.66.2.747-755.1998; RACZ P, 1972, LAB INVEST, V26, P694; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Schulte R, 2000, CELL MICROBIOL, V2, P173, DOI 10.1046/j.1462-5822.2000.00047.x; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119	22	448	470	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1722	1725		10.1126/science.1059852	http://dx.doi.org/10.1126/science.1059852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387478				2022-12-28	WOS:000169031800047
J	Rizki, A; Lundblad, V				Rizki, A; Lundblad, V			Defects in mismatch repair promote telomerase-independent proliferation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HUMAN CANCER; RECOMBINATION; YEAST; MAINTENANCE; SENESCENCE; MUTATIONS; SEQUENCES; REMOVAL; HOMOLOG	Mismatch repair has a central role in maintaining genomic stability by repairing DNA replication errors and inhibiting recombination between non-identical (homeologous) sequences(1,2). Defects in mismatch repair have been linked to certain human cancers, including hereditary non-polyposis colorectal cancer (HNPCC) and sporadic tumours(3-5). A crucial requirement for tumour cell proliferation is the maintenance of telomere length(6), and most tumours achieve this by reactivating telomerase(7). In both yeast and human cells, however, telomerase-independent telomere maintenance can occur as a result of recombination-dependent exchanges between often imperfectly matched telomeric sequences(8-12). Here we show that loss of mismatch-repair function promotes cellular proliferation in the absence of telomerase. Defects in mismatch repair, including mutations that correspond to the same amino-acid changes recovered from HNPCC tumours(13), enhance telomerase-independent survival in both Saccharomyces cerevisiae and a related budding yeast with a degree of telomere sequence homology that is similar to human telomeres. These results indicate that enhanced telomeric recombination in human cells with mismatch-repair defects may contribute to cell immortalization and hence tumorigenesis.	Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Lundblad, V (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.							ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; Datta A, 2000, MOL CELL, V6, P593, DOI 10.1016/S1097-2765(00)00058-7; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; MCEACHERN MJ, 1994, P NATL ACAD SCI USA, V91, P3453, DOI 10.1073/pnas.91.8.3453; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; MODRICH P, 1994, SCIENCE, V266, P1959, DOI 10.1126/science.7801122; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nicholson A, 2000, GENETICS, V154, P133; RAYSSIGUIER C, 1989, NATURE, V342, P389; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Studamire B, 1999, MOL CELL BIOL, V19, P7558; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tran HT, 1999, MOL CELL BIOL, V19, P2000	23	106	107	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					713	716		10.1038/35079641	http://dx.doi.org/10.1038/35079641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395777				2022-12-28	WOS:000169112500051
J	Birring, SS; Heartin, E; Williams, TJ; Brightling, CE; Pavord, ID				Birring, SS; Heartin, E; Williams, TJ; Brightling, CE; Pavord, ID			Peak expiratory flow sequence in acute exacerbations of asthma	BRITISH MEDICAL JOURNAL			English	Article							DEEP INHALATION		Gen Hosp Kettering, Dept Resp Med, Kettering NN16 8UZ, Northants, England; Univ Hosp Leicester NHS Trust, Dept Resp Med, Inst Lung Hlth, Leicester LE3 9QP, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester	Birring, SS (corresponding author), Gen Hosp Kettering, Dept Resp Med, Kettering NN16 8UZ, Northants, England.		Birring, Surinder/GWU-6967-2022	Pavord, Ian/0000-0002-4288-5973; brightling, chris/0000-0002-9345-4903				BURNS CB, 1985, J APPL PHYSIOL, V59, P1590, DOI 10.1152/jappl.1985.59.5.1590; LIM TK, 1987, AM REV RESPIR DIS, V135, P591; PELLEGRINO R, 1990, AM REV RESPIR DIS, V142, P822, DOI 10.1164/ajrccm/142.4.822	3	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 26	2001	322	7297					1281	1281		10.1136/bmj.322.7297.1281	http://dx.doi.org/10.1136/bmj.322.7297.1281			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375231	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000169027800020
J	Wyss, A				Wyss, A			Paleontology - Digging up fresh clues about the origin of mammals	SCIENCE			English	Editorial Material							DEFINITIONS		Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Wyss, A (corresponding author), Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA.							[Anonymous], 1987, 4 C LAT PAL; DEQUEIROZ K, 1994, SYST BIOL, V43, P497, DOI 10.1093/sysbio/43.4.497; DEQUEIROZ K, 1990, SYST ZOOL, V39, P307, DOI 10.2307/2992353; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Ji Q, 1999, NATURE, V402, P898; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; Rougier G.W., 1993, THESIS U NACL BUENOS; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856	9	7	8	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1496	1497		10.1126/science.1061106	http://dx.doi.org/10.1126/science.1061106			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11379630				2022-12-28	WOS:000168963800029
J	DeMaria, CD; Soong, TW; Alseikhan, BA; Alvania, RS; Yue, DT				DeMaria, CD; Soong, TW; Alseikhan, BA; Alvania, RS; Yue, DT			Calmodulin bifurcates the local Ca2+ signal that modulates P/Q-type Ca2+ channels	NATURE			English	Article							PRESYNAPTIC CALCIUM CURRENT; RAT BRAIN-STEM; CA2+-DEPENDENT INACTIVATION; TARGET SEQUENCE; FACILITATION; BINDING; ACTIVATION; DOMAINS; SYNAPSE; SUBUNIT	Acute modulation of P/Q-type (alpha (1A)) calcium channels by neuronal activity-dependent changes in intracellular Ca2+ concentration may contribute to short-term synaptic plasticity(1-3), potentially enriching the neurocomputational capabilities of the brain(4,5). An unconventional mechanism for such channel modulation has been proposed(6,7) in which calmodulin (CaM) may exert two opposing effects on individual channels, initially promoting ('facilitation') and then inhibiting ('inactivation') channel opening. Here we report that such dual regulation arises from surprising Ca2+-transduction capabilities of CaM. First, although facilitation and inactivation are two competing processes, both require Ca2+-CaM binding to a single 'IQ-like' domain on the carboxy tail of alpha (8)(1A); a previously identified 'CBD' CaM-binding site(6,7) has no detectable role. Second, expression of a CaM mutant with impairment of all four of its Ca2+-binding sites (CaM1234) eliminates both forms of modulation. This result confirms that CaM is the Ca2+ sensor for channel regulation, and indicates that CaM may associate with the channel even before local Ca2+ concentration rises. Finally, the bifunctional capability of CaM arises from bifurcation of Ca2+ signalling by the lobes of CaM: Ca2+ binding to the amino-terminal lobe selectively initiates channel inactivation, whereas Ca2+ sensing by the carboxy-terminal lobe induces facilitation. Such lobe-specific detection provides a compact means to decode local Ca2+ signals in two ways, and to separately initiate distinct actions on a single molecular complex.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Program Mol & Cellular Syst Physiol, Baltimore, MD 21205 USA; Natl Inst Neurosci, Singapore 308433, Singapore; Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	Johns Hopkins University; Johns Hopkins University; National Neuroscience Institute (NNI); National University of Singapore	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, 720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu		Alvania, Rebecca/0000-0002-3846-0702; Soong, Tuck Wah/0000-0002-0876-0325				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Barth A, 1998, J BIOL CHEM, V273, P2174, DOI 10.1074/jbc.273.4.2174; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Colecraft HM, 2000, J GEN PHYSIOL, V115, P175, DOI 10.1085/jgp.115.2.175; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Erickson MG, 2001, BIOPHYS J, V80, p196A; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; KINCAID RL, 1988, METHOD ENZYMOL, V159, P605; KINK JA, 1990, CELL, V62, P165, DOI 10.1016/0092-8674(90)90250-I; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; OHYA Y, 1994, SCIENCE, V263, P963, DOI 10.1126/science.8310294; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Song LS, 1998, J PHYSIOL-LONDON, V512, P677, DOI 10.1111/j.1469-7793.1998.677bd.x; Sutton R, 1999, BAKKEN RES, V1, P401; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	30	323	334	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					484	489		10.1038/35078091	http://dx.doi.org/10.1038/35078091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373682				2022-12-28	WOS:000168858700051
J	Adler, MW				Adler, MW			ABC of AIDS - Development of the epidemic	BRITISH MEDICAL JOURNAL			English	Review																			0	21	21	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2001	322	7296					1226	1229		10.1136/bmj.322.7296.1226	http://dx.doi.org/10.1136/bmj.322.7296.1226			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11358778	Green Submitted, Green Published			2022-12-28	WOS:000168900700032
J	Carr, AJ; Gibson, B; Robinson, PG				Carr, AJ; Gibson, B; Robinson, PG			Measuring quality of life - Is quality of life determined by expectations or experience?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE	Health related quality of life is the gap between our expectations of health and our experience of it Perception of quality of life varies between individuals and is dynamic within them People with different expectations will report that they have a different quality of life even when they have the same clinical condition People whose health has changed may report the same level of quality of life when measures are repeated Current measures do not take account of expectations and cannot distinguish between changes in the experience of disease and changes in expectations of health.	Univ Nottingham, City Hosp Nottingham, Nottingham NG5 1PB, England; Guys Hosp, Sch Med & Dent, London SE1 9RT, England; Kings Coll Hosp London, Sch Med & Dent, London SE1 9RT, England; St Thomas Hosp, Sch Med & Dent, London SE1 9RT, England; Guys Hosp, Sch Med & Dent, London SE5 9RW, England; Kings Coll Hosp London, Sch Med & Dent, London SE5 9RW, England; St Thomas Hosp, Sch Med & Dent, London SE5 9RW, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; Guy's & St Thomas' NHS Foundation Trust	Carr, AJ (corresponding author), Univ Nottingham, City Hosp Nottingham, Nottingham NG5 1PB, England.	alison.carr@nottingham.ac.uk		Gibson, Barry J/0000-0003-1413-4950				ADDINGTONHALL J, IN PRESS BMJ; Allison PJ, 1997, SOC SCI MED, V45, P221, DOI 10.1016/S0277-9536(96)00339-5; Becker M H, 1980, J Community Health, V6, P113, DOI 10.1007/BF01318980; BULLINGER M, 1993, QUAL LIFE RES, V2, P451, DOI 10.1007/BF00422219; BUUNK BP, 1990, J PERS SOC PSYCHOL, V59, P1238, DOI 10.1037/0022-3514.59.6.1238; CALMAN KC, 1984, J MED ETHICS, V10, P124, DOI 10.1136/jme.10.3.124; CHAMBERLAIN K, 1992, SOC INDIC RES, V26, P101, DOI 10.1007/BF00304394; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; ENGLERT JS, 1994, PHARMACOPSYCHIATRY, V27, P34, DOI 10.1055/s-2007-1014325; EVANS RW, 1991, LANCET, V338, P636, DOI 10.1016/0140-6736(91)90649-A; Freire P., 1970, PEDAGOGY OPPRESSED; FREUND J, 1972, CLIN PHARMACOL THER, V13, P172; GREER S, 1984, SOC SCI MED, V18, P345, DOI 10.1016/0277-9536(84)90124-2; HASHISH I, 1988, PAIN, V33, P303, DOI 10.1016/0304-3959(88)90289-8; HEADEY B, 1984, SOC INDIC RES, V15, P203, DOI 10.1007/BF00668671; Locker D, 1996, J Dent Educ, V60, P494; Macentee MI, 1997, SOC SCI MED, V45, P1449, DOI 10.1016/S0277-9536(97)00077-4; RABKIN JG, 1990, AM J PSYCHIAT, V147, P1622; ROBERTS AH, 1993, CLIN PSYCHOL REV, V13, P375, DOI 10.1016/0272-7358(93)90010-J; Ross C K, 1987, J Health Care Mark, V7, P16; THOMAS KB, 1987, BRIT MED J, V294, P1200, DOI 10.1136/bmj.294.6581.1200; WARE JE, 1981, AM J PUBLIC HEALTH, V71, P620, DOI 10.2105/AJPH.71.6.620	22	504	530	3	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2001	322	7296					1240	1243		10.1136/bmj.322.7296.1240	http://dx.doi.org/10.1136/bmj.322.7296.1240			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435UV	11358783	Green Published			2022-12-28	WOS:000168900700039
J	Ireland, J				Ireland, J			In praise of mercury sphygmomanometers - Electronic readings of blood pressure seem to be higher than readings obtained with mercury sphygmomanometers	BRITISH MEDICAL JOURNAL			English	Letter																		Lawes EG, 2000, BRIT MED J, V321, P1534	1	3	4	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2001	322	7296					1249	1249						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11388188				2022-12-28	WOS:000168900700052
J	Huelsken, J; Vogel, R; Erdmann, B; Cotsarelis, G; Birchmeier, W				Huelsken, J; Vogel, R; Erdmann, B; Cotsarelis, G; Birchmeier, W			beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin	CELL			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; HYPOHIDROTIC ECTODERMAL DYSPLASIA; ANTERIOR-POSTERIOR AXIS; ALPHA-CATENIN; MICE LACKING; FUNCTIONAL INTERACTION; EMBRYONIC HEART; COLON-CARCINOMA; HUMAN HOMOLOG; FEATHER BUDS	beta -Catenin is an essential molecule in Wnt/wingless signaling, which controls decisive steps in embryogenesis. To study the role of beta -catenin in skin development, we introduced a conditional mutation of the gene in the epidermis and hair follicles using Cre/loxP technology. When beta -catenin is mutated during embryogenesis, formation of placodes that generate hair follicles is blocked. We show that beta -catenin is required genetically downstream of tabby/downless and upstream of bmp and shh in placode formation. If beta -catenin is deleted after hair follicles have formed, hair is completely lost after the first hair cycle. Further analysis demonstrates that beta -catenin is essential for fate decisions of skin stem cells: in the absence of beta -catenin, stem cells rail to differentiate into follicular keratinocytes, but instead adopt an epidermal fate.	Max Delbrueck Ctr Mol Med, D-13092 Berlin, Germany; Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Pennsylvania	Birchmeier, W (corresponding author), Max Delbrueck Ctr Mol Med, Robert Roessle Str 10, D-13092 Berlin, Germany.	wbirch@mdc-berlin.de	Huelsken, Joerg/AAC-9581-2021	Huelsken, Joerg/0000-0003-3105-9606				Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Akiyama M, 2000, J INVEST DERMATOL, V114, P321, DOI 10.1046/j.1523-1747.2000.00857.x; Barker N, 2000, ADV CANCER RES, V77, P1; Barsh G, 1999, NAT GENET, V22, P315, DOI 10.1038/11876; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chen CWJ, 1997, DEV BIOL, V188, P181, DOI 10.1006/dbio.1997.8643; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Chuong CM, 1996, J INVEST DERMATOL, V107, P639, DOI 10.1111/1523-1747.ep12584254; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; Crowe R, 1998, DEVELOPMENT, V125, P767; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Hulsken J, 2000, J CELL SCI, V113, P3545; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kishimoto J, 2000, GENE DEV, V14, P1181; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Kofron M, 1997, DEVELOPMENT, V124, P1553; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Lyle S, 1998, J CELL SCI, V111, P3179; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nieset JE, 1997, J CELL SCI, V110, P1013; NOCKA K, 1990, EMBO J, V9, P3287, DOI 10.1002/j.1460-2075.1990.tb07528.x; Noramly S, 1999, DEVELOPMENT, V126, P3509; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Oro AE, 1998, CELL, V95, P575, DOI 10.1016/S0092-8674(00)81624-4; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Palka HL, 1997, J CELL SCI, V110, P2359; Panteleyev AA, 1999, AM J PATHOL, V155, P159, DOI 10.1016/S0002-9440(10)65110-3; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Saitoh A, 1998, EXP CELL RES, V243, P150, DOI 10.1006/excr.1998.4152; SNAITH MR, 1995, GENE, V166, P173, DOI 10.1016/0378-1119(95)00579-8; Song HK, 1996, P NATL ACAD SCI USA, V93, P10246, DOI 10.1073/pnas.93.19.10246; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; TANDA N, 1995, BIOCHEM BIOPH RES CO, V211, P123, DOI 10.1006/bbrc.1995.1786; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thorey IS, 1998, MOL CELL BIOL, V18, P3081, DOI 10.1128/MCB.18.5.3081; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wang JW, 1996, ONCOGENE, V13, P1537; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Widelitz RB, 2000, DEV BIOL, V219, P98, DOI 10.1006/dbio.1999.9580; Widelitz RB, 1999, DEVELOPMENT, V126, P2577; Wilson N, 1999, Exp Dermatol, V8, P367; Winter H, 1998, J INVEST DERMATOL, V111, P955, DOI 10.1046/j.1523-1747.1998.00456.x; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	90	1050	1130	9	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					533	545		10.1016/S0092-8674(01)00336-1	http://dx.doi.org/10.1016/S0092-8674(01)00336-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371349	Bronze			2022-12-28	WOS:000168840700012
J	Koenig, F; Knittel, J; Stepp, H				Koenig, F; Knittel, J; Stepp, H			Diagnosing cancer in vivo	SCIENCE			English	Article							5-AMINOLEVULINIC ACID; CONFOCAL MICROSCOPE; BLADDER-CARCINOMA; OPTICAL BIOPSY; FLUORESCENCE		Humboldt Univ, Charite Med Sch, Dept Urol, D-1086 Berlin, Germany; Univ Tubingen, Dept Minimally Invas Surg, D-72074 Tubingen, Germany; Univ Munich Grosshadern, Dept Urol, Laser Forschungslab, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; University of Munich	Koenig, F (corresponding author), Humboldt Univ, Charite Med Sch, Dept Urol, D-1086 Berlin, Germany.	frank.koenig@charite.de	Knittel, Joachim/C-5854-2009; Stepp, Herbert/E-1990-2013					Abulafia O, 1999, Obstet Gynecol Surv, V54, P253, DOI 10.1097/00006254-199904000-00022; Benaron DA, 1997, SCIENCE, V276, P2002, DOI 10.1126/science.276.5321.2002; Bom N, 1998, Eur J Ultrasound, V7, P9, DOI 10.1016/S0929-8266(98)00007-X; DABBS T, 1992, APPL OPTICS, V31, P3030, DOI 10.1364/AO.31.003030; Dickensheets DL, 1996, OPT LETT, V21, P764, DOI 10.1364/OL.21.000764; Dickensheets DL, 1998, J MICROELECTROMECH S, V7, P38, DOI 10.1109/84.661382; Dijkstra J, 1999, INT J CARDIAC IMAG, V15, P513, DOI 10.1023/A:1006334517720; GMITRO AF, 1993, OPT LETT, V18, P565, DOI 10.1364/OL.18.000565; Hamilton PW, 1998, ANAL QUANT CYTOL, V20, P443; Ikeda N, 1998, LUNG CANCER-J IASLC, V19, P161, DOI 10.1016/S0169-5002(97)00095-0; Jichlinski P, 1997, LASER SURG MED, V20, P402, DOI 10.1002/(SICI)1096-9101(1997)20:4<402::AID-LSM5>3.0.CO;2-U; KIEMENEY LALM, 1993, J UROLOGY, V150, P60, DOI 10.1016/S0022-5347(17)35397-1; Knittel J, 2001, OPT COMMUN, V188, P267, DOI 10.1016/S0030-4018(00)01164-0; Koenig F, 1999, BJU INT, V83, P129, DOI 10.1046/j.1464-410X.1999.00917.x; Koenig F, 1999, UROLOGY, V53, P853, DOI 10.1016/S0090-4295(98)00628-1; KORAITIM M, 1995, J UROLOGY, V154, P375, DOI 10.1016/S0022-5347(01)67051-4; Kriegmair M, 1996, J UROLOGY, V155, P105, DOI 10.1016/S0022-5347(01)66559-5; RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215; Spitzer M, 1998, AM J OBSTET GYNECOL, V179, P544, DOI 10.1016/S0002-9378(98)70393-X; Stepp H, 1995, P SOC PHOTO-OPT INS, V2627, P13, DOI 10.1117/12.228884; Tearney GJ, 1998, OPT LETT, V23, P1152, DOI 10.1364/OL.23.001152; Tearney GJ, 1997, J UROLOGY, V157, P1915, DOI 10.1016/S0022-5347(01)64900-0; Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037; Uchida K, 1998, Endoscopy, V30 Suppl 1, pA14, DOI 10.1055/s-2007-1001457	24	57	58	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1401	+		10.1126/science.292.5520.1401	http://dx.doi.org/10.1126/science.292.5520.1401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360991				2022-12-28	WOS:000168862900052
J	Peto, J				Peto, J			Cancer epidemiology in the last century and the next decade	NATURE			English	Article							LUNG-CANCER; BREAST-CANCER; GENETIC POLYMORPHISMS; BETA-CAROTENE; RISK; MORTALITY; SMOKING; TOBACCO; MESOTHELIOMA; CARCINOGENESIS	By the early 1980s, epidemiologists had identified many important causes of cancer. They had also proposed the 'multi-stage' model of cancer, although none of the hypothesized events in human carcinogenesis had then been identified. The remarkable advances in cell and molecular biology over the past two decades have transformed the scope and methods of cancer epidemiology. There have been a few new discoveries based purely on traditional methods, and many long-suspected minor risks have been estimated more precisely. But modern epidemiological studies often depend on genetic, biochemical or viral assays that had not been developed 20 years ago.	Inst Canc Res, Sutton SM2 5NG, Surrey, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine	Peto, J (corresponding author), Inst Canc Res, Sutton SM2 5NG, Surrey, England.							Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Ambrosone CB, 1996, JAMA-J AM MED ASSOC, V276, P1494, DOI 10.1001/jama.276.18.1494; American Institute for Cancer Research/World Cancer Research Fund American Institute for Cancer Research, 1997, FOOD NUTR PREV CANC; Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; [Anonymous], 1994, IARC MON EV CARC RIS, V61; [Anonymous], 1997, IARC MON EV CARC RIS, V70; [Anonymous], 1996, IARC MON EV CARC RIS; Bennett WP, 1999, JNCI-J NATL CANCER I, V91, P2009, DOI 10.1093/jnci/91.23.2009; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; BLACK D, 1987, LANCET, V2, P1277; Bonassi S, 2000, CANCER RES, V60, P1619; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carbone M, 2000, ANTICANCER RES, V20, P875; CARTWRIGHT RA, 1982, LANCET, V2, P842; CASAGRANDE JT, 1979, LANCET, V2, P170; Cullen MR, 1998, LANCET, V351, P1377, DOI 10.1016/S0140-6736(05)79440-X; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DOLL R, 1978, CANCER RES, V38, P3573; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Doll R, 1996, BRIT MED BULL, V52, P35, DOI 10.1093/oxfordjournals.bmb.a011531; DOLL R, IN PRESS OXFORD TXB; DOLL R, 1986, POSSIBILITIES PREVEN, V13; Doll R, 1955, BRIT J IND MED, V12, P81; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; HALPERN MT, 1993, JNCI-J NATL CANCER I, V85, P457, DOI 10.1093/jnci/85.6.457; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; Hankinson SE, 1999, J NATL CANCER I, V91, P629, DOI 10.1093/jnci/91.7.629; Hein DW, 2000, CANCER EPIDEM BIOMAR, V9, P29; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Houlston Richard S., 1996, P208; Houlston RS, 1999, CANCER EPIDEM BIOMAR, V8, P675; *IARC, 1994, IARC MON EV CARC RIS, V59; IARC, 1993, IARC MON EV CARC RIS, V56; IARC, 1986, IARC MON EV CARC RIS, V38; *IARC, 1999, IARC MON EV CARC RIS, V72; *IARC, 1995, IARC MON EV CARC RIS, V64; Janin N, 2000, ADV CANCER RES, V77, P189; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Johns LE, 2000, MUTAGENESIS, V15, P399, DOI 10.1093/mutage/15.5.399; Josefson D, 2001, BRIT MED J, V322, P945, DOI 10.1136/bmj.322.7292.945; KHRAPKO K, 1994, NUCLEIC ACIDS RES, V22, P364, DOI 10.1093/nar/22.3.364; KINLEN LJ, 1979, BRIT MED J, V2, P1461, DOI 10.1136/bmj.2.6203.1461; Kinlen LJ, 1998, CANCER CAUSE CONTROL, V9, P237; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Ma J, 1997, CANCER RES, V57, P1098; McDonald AD, 1997, ANN OCCUP HYG, V41, P707, DOI 10.1016/S0003-4878(97)00020-3; NEWCOMB PA, 1994, NEW ENGL J MED, V330, P81, DOI 10.1056/NEJM199401133300201; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Pankow JS, 1997, J NATL CANCER I, V89, P549, DOI 10.1093/jnci/89.8.549; Parkin DM, 1999, CANCER SURV, V33, P5; PARKIND M, IN PRESS EUR J CAN S; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Peto J, 1984, IARC Sci Publ, P359; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; PETO J, 1980, BANBURY REPORT, V4, P203; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Peto R, 1994, MORTALITY TOBACCO DE; Peto R, 1986, IARC SCI PUBL, V58, P43; PIKE MC, 1983, NATURE, V303, P767, DOI 10.1038/303767a0; Ponten F, 1997, ONCOGENE, V15, P1059, DOI 10.1038/sj.onc.1201435; Roberts SA, 1999, AM J HUM GENET, V65, P784, DOI 10.1086/302544; Schiller J T, 2001, J Natl Cancer Inst Monogr, P50; Swerdflow A. J., 1997, P643; VENITT S, 1995, ENV MUTAGENESIS, P1; WAGNER J C, 1960, Br J Ind Med, V17, P260; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WALD N, 1981, BRIT MED J, V282, P763, DOI 10.1136/bmj.282.6266.763; Weinberg CR, 1999, J NATL CANCER I, V91, P1985, DOI 10.1093/jnci/91.23.1985; *WHO, 1964, 276 WHO; Woodage T, 1998, NAT GENET, V20, P62, DOI 10.1038/1722; *WORK GROUP DIET C, 1998, DEP HLTH REP HLTH SO, V48; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001; zur Hausen H, 2001, LANCET, V357, P381, DOI 10.1016/S0140-6736(00)03652-7	81	452	491	0	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					390	395		10.1038/35077256	http://dx.doi.org/10.1038/35077256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357148				2022-12-28	WOS:000168710000063
J	Einterz, EM				Einterz, EM			International aid and medical practice in the less-developed world: doing it right	LANCET			English	Editorial Material									Dist Kolofata, Extreme Nord, Cameroon		Einterz, EM (corresponding author), Dist Kolofata, BP 111, Extreme Nord, Cameroon.			Einterz, Ellen/0000-0002-0818-847X					0	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1524	1525		10.1016/S0140-6736(00)04640-7	http://dx.doi.org/10.1016/S0140-6736(00)04640-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377628				2022-12-28	WOS:000168614300039
J	Sepkowitz, KA				Sepkowitz, KA			AIDS - The first 20 years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; IMMUNE-DEFICIENCY-SYNDROME; PNEUMOCYSTIS-CARINII-PNEUMONIA; OPPORTUNISTIC INFECTION; HIV-1 INFECTION; KAPOSIS-SARCOMA; PLUS INDINAVIR; DOUBLE-BLIND; PHASE-II; VIRUS		Mem Sloan Kettering Canc Ctr, Clin Infect Dis Serv, Dept Med, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Sepkowitz, KA (corresponding author), Mem Sloan Kettering Canc Ctr, Clin Infect Dis Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA.	sepkowik@mskcc.org						ABRAMS DI, 1989, ANN INTERN MED, V110, P183, DOI 10.7326/0003-4819-110-3-183; *ACQ IMM DEF SYNDR, 1983, MMWR-MORBID MORTAL W, V32, P101; *ACQ IMM DEF SYNDR, 1983, MMWR-MORBID MORTAL W, V31, P700; *ACQ IMM DEF SYNDR, 1983, MMWR-MORBID MORTAL W, V32, P358; *ACQ IMM DEF SYNDR, 1982, MMWR-MORBID MORTAL W, V31, P577; [Anonymous], 1998, MMWR Recomm Rep, V47, P43; [Anonymous], 2000, NATURE, V406, P15, DOI 10.1038/35017662; [Anonymous], 1993, AIDS Res Hum Retroviruses, V9, P83; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1995, MMWR Recomm Rep, V44, P1; [Anonymous], SCI OPP PUBL NEEDS I; [Anonymous], 1983, MMWR-MORBID MORTAL W, V31, P697; ARNO PETER S., 1992, ODDS STORY AIDS DRUG, P109; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Birmingham K, 2000, NAT MED, V6, P117, DOI 10.1038/72177; BYERS VS, 1994, AIDS RES HUM RETROV, V10, P413, DOI 10.1089/aid.1994.10.413; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Celentano DD, 1998, AIDS, V12, pF29, DOI 10.1097/00002030-199805000-00004; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P665; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P334; Centers for Disease Control (CDC), 1981, MMWR-MORBID MORTAL W, V30, P250; Chun TW, 2001, P NATL ACAD SCI USA, V98, P253, DOI 10.1073/pnas.98.1.253; CLUMECK N, 1983, LANCET, V1, P642; CONTE JE, 1983, NEW ENGL J MED, V309, P740, DOI 10.1056/NEJM198309223091228; COTTER SM, 1975, J AM VET MED ASSOC, V166, P449; Duesberg P, 1998, GENETICA, V104, P85, DOI 10.1023/A:1003405220186; *FDA, 1997, FED REGISTER, V62, P49694; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FRANCIS DP, 1983, J NATL CANCER I, V71, P1; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gebo KA, 1999, AIDS, V13, P963, DOI 10.1097/00002030-199905280-00013; GINGELL B, 1988, GMHC NEWSLETTER EXPT, V2, P11; GOEDERT JJ, 1982, LANCET, V1, P412; GOTTLIEB MS, 1991, ANN INTERN MED, V115, P84, DOI 10.7326/0003-4819-115-2-84; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HARDY WD, 1973, NATURE, V244, P266, DOI 10.1038/244266a0; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Kolata Gina, 1992, NY TIMES, pC3; LEONIDAS JR, 1983, ANN INTERN MED, V98, P1020, DOI 10.7326/0003-4819-98-6-1020; Leveton Lauren B., 1995, HIV BLOOD SUPPLY ANA, P49; LEVY JA, 1983, LANCET, V2, P78; MASUR H, 1982, ANN INTERN MED, V97, P533, DOI 10.7326/0003-4819-97-4-533; MAVLIGIT GM, 1984, JAMA-J AM MED ASSOC, V251, P237, DOI 10.1001/jama.251.2.237; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, SCIENCE, V275, P14; MILDVAN D, 1991, J ACQ IMMUN DEF SYND, V4, P945; Monterroso ER, 2000, J ACQ IMMUN DEF SYND, V25, P63, DOI 10.1097/00126334-200009010-00009; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PEDERSEN C, 1990, NEW ENGL J MED, V323, P1360; PERT CB, 1986, P NATL ACAD SCI USA, V83, P9254, DOI 10.1073/pnas.83.23.9254; PETERSEN M, 2001, NY TIMES        0315, pA14; Petersen Melody, 2001, NY TIMES        0424, pA1; *PHARM RES MAN AM, 2000, NEW MED DEV ANN SUMM; *PHARM RES MAN AM, 1989, NEW MED DEV ANN SUMM; ROSENBERG T, 2001, NY TIMES MAGAZI 0128, P26; RUIZ MS, 2001, TIME LOSE GETTING MO; SCHOOLEY RT, 1990, ANN INTERN MED, V112, P247, DOI 10.7326/0003-4819-112-4-247; SHAFER RW, 1989, J ACQ IMMUN DEF SYND, V2, P389; Shilts R., 1987, BAND PLAYED POLITICS; SONNABEND J, 1983, JAMA-J AM MED ASSOC, V249, P2370, DOI 10.1001/jama.249.17.2370; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Stewart GT, 2000, NATURE, V407, P286, DOI 10.1038/35030200; Stolberg S G, 2001, N Y Times Web, pA16; STOLBERG SG, 2001, NY TIMES        0310, pA4; Thompson KA, 1996, EUR J CLIN MICROBIOL, V15, P580, DOI 10.1007/BF01709367; UNAIDS/WHO, 2000, AIDS EP UPD DEC 2000; WATERSON AP, 1983, BMJ-BRIT MED J, V286, P743, DOI 10.1136/bmj.286.6367.743; 1996, MMWR MORB MORTAL WKL, V45, P121; 1984, MMWR MORB MORTAL WKL, V33, P4; 1982, MMWR MORB MORTAL WKL, V31, P507; 1982, MMWR MORB MORTAL WKL, V31, P513; 1982, MMWR MORB MORTAL WKL, V31, P365; 1997, MMWR MORB MORTAL WKL, V46, P165; 1982, MMWR MORB MORTAL WKL, V31, P652; 1982, MMWR MORB MORTAL WKL, V31, P353; 1982, MMWR MORB MORTAL WKL, V31, P305; 1982, MMWR MORB MORTAL WKL, V31, P360; 1981, MMWR MORB MORTAL WKL, V30, P305	81	273	293	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2001	344	23					1764	1772		10.1056/NEJM200106073442306	http://dx.doi.org/10.1056/NEJM200106073442306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	439TL	11396444				2022-12-28	WOS:000169133600006
J	Ankum, WM; Wieringa-de Waard, M; Bindels, PJE				Ankum, WM; Wieringa-de Waard, M; Bindels, PJE			Regular view - Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SUSPECTED ECTOPIC PREGNANCY; RANDOMIZED-TRIAL; EXPECTANT MANAGEMENT; SPONTANEOUS-ABORTION; SURGICAL EVACUATION; COMPARING EXPECTANT; MEDICAL-MANAGEMENT; CURETTAGE		Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1012 WX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Ankum, WM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, POB 22700, NL-1100 DE Amsterdam, Netherlands.	w.m.ankum@amc.uva.nl						*AMB SENT PRACT NE, 1998, J AM BOARD FAM PRACT, V1, P15; ANKUM WM, 1993, HUM REPROD, V8, P1307, DOI 10.1093/oxfordjournals.humrep.a138247; Ankum WM, 2000, BRIT MED J, V321, P1235, DOI 10.1136/bmj.321.7271.1235; Ballagh SA, 1998, AM J OBSTET GYNECOL, V179, P1279, DOI 10.1016/S0002-9378(98)70147-4; Banerjee S, 1999, ULTRASOUND OBST GYN, V14, P231, DOI 10.1046/j.1469-0705.1999.14040231.x; Blohm F, 1997, LANCET, V349, P995, DOI 10.1016/S0140-6736(97)24014-6; Charles C, 1999, BRIT MED J, V319, P780, DOI 10.1136/bmj.319.7212.780; Chipchase J, 1997, BRIT J OBSTET GYNAEC, V104, P840, DOI 10.1111/j.1471-0528.1997.tb12030.x; Chung TKH, 1999, FERTIL STERIL, V71, P1054, DOI 10.1016/S0015-0282(99)00128-4; Chung TKH, 1998, AUST NZ J OBSTET GYN, V38, P61, DOI 10.1111/j.1479-828X.1998.tb02960.x; Coulter A, 1999, BRIT MED J, V319, P719, DOI 10.1136/bmj.319.7212.719; DEJONGE ETM, 1995, BRIT MED J, V311, P662, DOI 10.1136/bmj.311.7006.662; *DUTCH SOC GEN PRA, 1989, HUIS WETENSCH, V32, P138; ELREFAEY H, 1992, BRIT MED J, V305, P1399, DOI 10.1136/bmj.305.6866.1399; Everett C, 1997, BRIT MED J, V315, P32, DOI 10.1136/bmj.315.7099.32; FLIKWEERT S, 1997, HUIS WETENSCH; HINSHAW HKS, 1997, PROBLEMS EARLY PREGN, P284; Johnson N, 1997, EUR J OBSTET GYN R B, V72, P213, DOI 10.1016/S0301-2115(96)02668-1; Jurkovic D, 1998, BRIT J OBSTET GYNAEC, V105, P670, DOI 10.1111/j.1471-0528.1998.tb10184.x; Nielsen S, 1999, BRIT J OBSTET GYNAEC, V106, P804, DOI 10.1111/j.1471-0528.1999.tb08401.x; NIELSEN S, 1995, LANCET, V345, P84, DOI 10.1016/S0140-6736(95)90060-8; Nielsen S, 1996, HUM REPROD, V11, P1767; Towle A, 1999, BRIT MED J, V319, P766, DOI 10.1136/bmj.319.7212.766; Wiebe E, 1998, Fam Med, V30, P293; Wiebe E, 1999, CAN FAM PHYSICIAN, V45, P2364; 1998, REPORT CONFIDENTIAL	26	51	51	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2001	322	7298					1343	1346		10.1136/bmj.322.7298.1343	http://dx.doi.org/10.1136/bmj.322.7298.1343			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387184	Green Published, Green Submitted			2022-12-28	WOS:000169167900021
J	Koivisto, UM; Hubbard, AL; Mellman, R				Koivisto, UM; Hubbard, AL; Mellman, R			A novel cellular phenotype for familial hypercholesterolemia due to a defect in polarized targeting of LDL receptor	CELL			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; PLASMA-MEMBRANE PROTEINS; MDCK CELLS; EPITHELIAL-CELLS; MONOCLONAL-ANTIBODIES; DOMAIN; GENE; ENDOCYTOSIS; TRAFFICKING; GOLGI	Basolateral targeting of membrane proteins in polarized epithelial cells typically requires cytoplasmic domain sorting signals. In the familial hypercholesterolemia (FH)-Turku LDL receptor allele, a mutation of glycine 823 residue affects the signal required for basolateral targeting in MDCK cells. We show that the mutant receptor is mistargeted to the apical surface in both MDCK and hepatic epithelial cells, resulting in reduced endocytosis of LDL from the basolateral/sinusoidal surface. Consequently, virally encoded mutant receptor fails to mediate cholesterol clearance in LDL receptor-deficient mice, suggesting that a defect in polarized LDL receptor expression in hepatocytes underlies the hypercholesterolemia in patients harboring this allele. This evidence directly links the pathogenesis of a human disease to defects in basolateral targeting signals, providing a genetic confirmation of these signals in maintaining epithelial cell polarity.	Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Ludwig Institute for Cancer Research; Yale University; Johns Hopkins University	Mellman, R (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.				NIDDK NIH HHS [DK44375] Funding Source: Medline; NIGMS NIH HHS [GM28765] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044375] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ameen NA, 2000, TRAFFIC, V1, P76, DOI 10.1034/j.1600-0854.2000.010111.x; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HUETTINGER M, 1984, J CLIN INVEST, V74, P1017, DOI 10.1172/JCI111469; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Ihrke G, 1998, J CELL BIOL, V141, P115, DOI 10.1083/jcb.141.1.115; IHRKE G, 1993, J CELL BIOL, V123, P1761, DOI 10.1083/jcb.123.6.1761; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Keller P, 1997, J CELL SCI, V110, P3001; Kipp H, 2000, J BIOL CHEM, V275, P15917, DOI 10.1074/jbc.M909875199; KNIGHT A, 1995, MOL BIOL CELL, V6, P597, DOI 10.1091/mbc.6.5.597; KOIVISTO UM, 1995, AM J HUM GENET, V57, P789; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Powell-Braxton L, 1998, NAT MED, V4, P934, DOI 10.1038/nm0898-934; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Tuma PL, 1999, J CELL BIOL, V145, P1089, DOI 10.1083/jcb.145.5.1089; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; YOKODE M, 1992, J CELL BIOL, V117, P39, DOI 10.1083/jcb.117.1.39; Yu Q, 2000, J CLIN INVEST, V105, P741, DOI 10.1172/JCI7997	41	76	78	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					575	585		10.1016/S0092-8674(01)00371-3	http://dx.doi.org/10.1016/S0092-8674(01)00371-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389828	Bronze			2022-12-28	WOS:000169123200005
J	Esch, HE; Zhang, SW; Srinivasan, MV; Tautz, J				Esch, HE; Zhang, SW; Srinivasan, MV; Tautz, J			Honeybee dances communicate distances measured by optic flow	NATURE			English	Article								In honeybees, employed foragers recruit unemployed hive mates to food sources by dances from which a human observer can read the distance and direction of the food source(1). When foragers collect food in a short, narrow tunnel, they dance as if the food source were much farther away. Dancers gauge distance by retinal image flow on the way to their destination. Their visually driven odometer misreads distance because the close tunnel walls increase optic flow(2). We examined how hive mates interpret these dances. Here we show that recruited bees search outside in the direction of the tunnel at exaggerated distances and not inside the tunnel where the foragers come from. Thus, dances must convey information about the direction of the food source and the total amount of image motion en route to the food source, but they do not convey information about absolute distances. We also found that perceived distances on various outdoor routes from the same hive could be considerably different. Navigational errors are avoided as recruits and dancers tend to fly in the same direction. Reported racial differences in honeybee dances(1) could have arisen merely from differences in the environments in which these bees flew.	Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia; Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany	University of Notre Dame; Australian National University; University of Wurzburg	Esch, HE (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.		Srinivasan, Mandyam V/G-5571-2010; Zhang, Shaowu/C-9139-2009	Zhang, Shaowu/0000-0002-3551-5587				Esch HE, 1996, J EXP BIOL, V199, P155; HERAN H, 1959, Z VERGL PHYSIOL, V42, P103, DOI 10.1007/BF00298733; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; von Frisch K, 1969, DANCE LANGUAGE ORIEN	4	184	190	1	71	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					581	583		10.1038/35079072	http://dx.doi.org/10.1038/35079072			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385571				2022-12-28	WOS:000168982500050
J	Daly, K; Beale, R; Chang, RWS				Daly, K; Beale, R; Chang, RWS			Reduction in mortality after inappropriate early discharge from intensive care unit: logistic regression triage model	BRITISH MEDICAL JOURNAL			English	Article							SOCIETY APACHE-II; AFTER-DISCHARGE; CASE-MIX; BRITAIN; IRELAND; SYSTEM	Objective To develop a predictive moder to triage patients for discharge from intensive care units to reduce mortality after discharge. Design Logistic regression analyses and modelling of data from patients who were discharged from intensive care units. Setting Guy's hospital intensive care unit and 19 other UK intensive care units from 1989 to 1998. Participants 5475 patients for the development of the model and 8449 for validation. Main outcome measures Mortality after discharge and power of triage model. Results Mortality after discharge from intensive care was up to 12.4%. The triage model identified patients at risk from death on the ward with a sensitivity of 65.5% and specificity of 87.6%, and an area under the receiver operating curve of 0.86. Variables in the model were age, end stage disease, length of stay in unit, cardiothoracic surgery, and physiology In the validation dataset the 34% of the patients identified as at risk had a discharge mortality of 25% compared with a 4% mortality among those not at risk. Conclusions The discharge mortality of at risk patients may be reduced by 39% if they remain in intensive care units for another 45 hours. The discharge triage model to identify patients at risk from too early and inappropriate discharge from intensive care may help doctors to make the difficult clinical decision of whom to discharge to make roam for a patient requiring urgent admission to the unit. If confirmed, this study has implications on the provision of resources.	Univ London St Georges Hosp, London SW17 0QT, England	St Georges University London	Chang, RWS (corresponding author), Univ London St Georges Hosp, London SW17 0QT, England.		Beale, Richard J/J-7831-2013					Audit Commission, 1999, CRIT SUCC PLAC EFF E; BION J, 1995, BMJ-BRIT MED J, V310, P682, DOI 10.1136/bmj.310.6981.682; CHANG RWS, 1988, INTENS CARE MED, V14, P558, DOI 10.1007/BF00263530; CULLEN DJ, 1984, CRIT CARE MED, V12, P102, DOI 10.1097/00003246-198402000-00004; DALY K, 1995, INTENSIVE CARE ME S1, V21, P81; DRAGSTED L, 1990, EUR J ANAESTH, V7, P159; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; Goldhill DR, 1998, CRIT CARE MED, V26, P1337, DOI 10.1097/00003246-199808000-00017; Hensher M, 1999, BRIT MED J, V319, P845, DOI 10.1136/bmj.319.7213.845; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; METCALF MA, 1995, STUDY INTENSIVE CARE; MUNN J, 1995, ANAESTHESIA, V50, P1017, DOI 10.1111/j.1365-2044.1995.tb05942.x; RIDLEY S, 1992, ANAESTHESIA, V47, P116, DOI 10.1111/j.1365-2044.1992.tb02006.x; Ridley SA, 1999, ANAESTHESIA, V54, P521, DOI 10.1046/j.1365-2044.1999.00801.x; ROWAN KM, 1993, BRIT MED J, V307, P977, DOI 10.1136/bmj.307.6910.977; ROWAN KM, 1993, BRIT MED J, V307, P972, DOI 10.1136/bmj.307.6910.972; Ryan DW, 1996, BRIT MED J, V312, P654; Smith L, 1999, INTENS CARE MED, V25, P1061, DOI 10.1007/s001340051012; Vincent JL, 1997, INTENS CARE MED, V23, P1181, DOI 10.1007/s001340050479; Wallis CB, 1997, ANAESTHESIA, V52, P9, DOI 10.1111/j.1365-2044.1997.003-az002.x; *WORK GROUP, 1996, GUID ADM DISCH INT C	22	120	121	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 26	2001	322	7297					1274	1276A		10.1136/bmj.322.7297.1274	http://dx.doi.org/10.1136/bmj.322.7297.1274			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375229	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000169027800018
J	Stamp, G; Kruzins, G; Crowther, C				Stamp, G; Kruzins, G; Crowther, C			Perineal massage in labour and prevention of perineal trauma: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILDBIRTH; PREGNANCY	Objective To determine the effects of perineal massage in the second stage of labour on perineal outcomes. Design Randomised controlled trial. Participants at 36 weeks' gestation, women expecting normal birth of a singleton were asked to join the study. Women became eligible to be randomised in labour if they progressed to full dilatation of the cervix or 8 cm or more if nulliparous or 5 cm or more if multiparous. 1340 were randomised into the trial. Intervention Massage and sc-etching of the perineum during the second stage of labour with a water soluble lubricant. Main outcome measures Primary outcomes: rates of intact perineum, episiotomies, and first, second, third, and fourth degree tears. Secondary outcomes: pain at three and 10 days postpartum and pain, dyspareunia, resumption of sexual intercourse, and urinary and faecal incontinence and urgency three months postpartum. Results Rates of intact perineums, first and second degree tears, and episiotomies were similar in the massage and the control groups. There were fewer third degree tears in the massage group (12 (1.7%) v 23 (3.6%); absolute risk 2.11, relative risk 0.45; 95% confidence interval 0.23 to 0.93, P < 0.04), though the trial was underpowered to measure this rarer outcome. Groups did not differ in any of the secondary outcomes at the three assessment points. Conclusions The practice of perineal massage in labour does not increase the likelihood of an intact perineum or reduce the risk of pain, dyspareunia, or urinary and faecal problems.	Univ S Australia, Ctr Res Nursing & Hlth Care, Adelaide, SA 5000, Australia; N Adelaide Hlth Serv, Adelaide, SA 5000, Australia; Womens & Childrens Hosp, Adelaide, SA 5006, Australia; Univ Adelaide, Womens & Childrens Hosp, Dept Obstet & Gynaecol, Adelaide, SA, Australia	University of South Australia; Womens & Childrens Hospital Australia; University of Adelaide; Womens & Childrens Hospital Australia	Stamp, G (corresponding author), Univ S Australia, Ctr Res Nursing & Hlth Care, N Terrace, Adelaide, SA 5000, Australia.	georgie.stamp@unisa.edu.au						BALL JA, 1993, MYLES TXB MIDWIVES, P478; CAROLI G, 2001, COCHRANE DATABASE SY; CHAN A, 1998, PREGNANCY OUTCOME S; DEAN AG, 1994, EPIINFO VERSION L WO; Enkin M, 2000, KEIRSE CHALMERS; FLINT C, 1986, SENSITIVE MIDWIFERY, P101; GASKIN IM, 1978, SPIRITUAL MIDWIFERY, P360; Johanson R, 2000, LANCET, V355, P250, DOI 10.1016/S0140-6736(00)00020-9; Kitzinger S, 1984, EPISIOTOMY 2 STAGE L, V2nd; KLEIN MC, 1994, AM J OBSTET GYNECOL, V171, P591, DOI 10.1016/0002-9378(94)90070-1; Labrecque H, 2000, AM J OBSTET GYNECOL, V182, P76, DOI 10.1016/S0002-9378(00)70493-5; Labrecque M, 1999, AM J OBSTET GYNECOL, V180, P593, DOI 10.1016/S0002-9378(99)70260-7; MYLES MF, 1953, TXB MIDWIVES, P304; Renfrew MJ, 1998, BIRTH-ISS PERINAT C, V25, P143; Shipman MK, 1997, BRIT J OBSTET GYNAEC, V104, P787, DOI 10.1111/j.1471-0528.1997.tb12021.x; SLEEP J, 1984, BRIT MED J, V289, P587, DOI 10.1136/bmj.289.6445.587; Sleep J, 1989, EFFECTIVE CARE PREGN, P1129; SLEEP J, 1993, MYLES TXB MIDWIVES, P199; Stamp GE, 1997, MIDWIFERY, V13, P100, DOI 10.1016/S0266-6138(97)90063-2; STAMP GE, IN PRESS AUST J MID	20	65	70	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2001	322	7297					1277	1280		10.1136/bmj.322.7297.1277	http://dx.doi.org/10.1136/bmj.322.7297.1277			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375230	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000169027800019
J	Nemergut, ME; Mizzen, CA; Stukenberg, T; Allis, CD; Macara, IG				Nemergut, ME; Mizzen, CA; Stukenberg, T; Allis, CD; Macara, IG			Chromatin docking and exchange activity enhancement of RCC1 by histones H2A and H2B	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; DNA-REPLICATION; RAN; NUCLEOPLASMIN; CYTOPLASM; RANGAP1; MITOSIS; PROTEIN; GTPASE	The Ran guanosine triphosphatase (GTPase) controls nucleocytoplasmic transport, mitotic spindle formation, and nuclear envelope assembly. These functions rely on the association of the Ran-specific exchange factor, RCC1 (regulator of chromosome condensation 1), with chromatin. We find that RCC1 binds directly to mononucleosomes and to histones H2A and H2B. RCC1 utilizes these histones to bind Xenopus sperm chromatin, and the binding of RCC1 to nucleosomes or histones stimulates the catalytic activity-of RCC1, We propose that the docking of RCC1 to H2A/H2B establishes the polarity of the Ran-CTP gradient that drives nuclear envelope assembly, nuclear transport, and other nuclear events.	Univ Virginia, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biochem, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Nemergut, ME (corresponding author), Univ Virginia, Ctr Cell Signaling, Hosp W RM 7191,POB 800577 HSC, Charlottesville, VA 22908 USA.			Nemergut, Michael/0000-0002-6803-1765; Stukenberg, Todd/0000-0002-6788-2111	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050526] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-50526] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; DASSO M, 1992, MOL CELL BIOL, V12, P3337, DOI 10.1128/MCB.12.8.3337; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; de la Barre AE, 2000, EMBO J, V19, P379, DOI 10.1093/emboj/19.3.379; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Karantza V, 1996, BIOCHEMISTRY-US, V35, P2037, DOI 10.1021/bi9518858; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Leno GH, 1998, METHOD CELL BIOL, V53, P497; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nemergut ME, 2000, J CELL BIOL, V149, P835, DOI 10.1083/jcb.149.4.835; NEMERGUT ME, UNPUB; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; RICH G, 1995, VENEREOLOGY, V8, P270; SEINO H, 1992, J CELL SCI, V102, P393; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429	20	180	186	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1540	1543		10.1126/science.292.5521.1540	http://dx.doi.org/10.1126/science.292.5521.1540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375490				2022-12-28	WOS:000168963800043
J	Daley, J				Daley, J			A 58-year-old woman dissatisfied with her care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	23rd Annual Meeting of the Society-for-General-Internal Medicine	MAY 05-06, 2000	BOSTON, MASSACHUSETTS	Soc Gen Internal Med			PATIENT SATISFACTION; HEALTH-CARE; SELF-MANAGEMENT; HOSPITAL-CARE; MEDICAL-CARE; QUALITY; OUTCOMES; EDUCATION; SERVICE; IMPROVE		Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Hosp, Partners Healthcare Syst, Dept Med, Inst Hlth Policy,Ctr Hlth Syst Design & Evaluat, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Partners Healthcare System	Daley, J (corresponding author), Care of Hartman EE, Beth Israel Deaconess Med Ctr, Div Gen Med, 330 Brookline Ave,LY318, Boston, MA 02215 USA.							*AM HOSP ASS, 1997, REAL CHECK, V2; APPEL A, 1998, BOSTON GLOBE    1115; BARRY MJ, 1995, MED CARE, V33, P771, DOI 10.1097/00005650-199508000-00003; Berwick DM, 1997, JOINT COMM J QUAL IM, V23, P245, DOI 10.1016/S1070-3241(16)30314-5; BERWICK DM, 1995, IMPROVING CLIN PRACT, P3; Besserman E, 1998, Qual Manag Health Care, V6, P43; BRODY DS, 1989, J GEN INTERN MED, V4, P506, DOI 10.1007/BF02599549; CLEARY PD, 1991, HEALTH AFFAIR, V10, P254, DOI 10.1377/hlthaff.10.4.254; Cleary PD, 1999, BRIT MED J, V319, P720, DOI 10.1136/bmj.319.7212.720; CLEARY PD, 1988, INQUIRY-J HEALTH CAR, V25, P25; Cleary PD, 1997, JAMA-J AM MED ASSOC, V278, P1608, DOI 10.1001/jama.278.19.1608; Crosby SS, 2000, JAMA-J AM MED ASSOC, V283, P1109, DOI 10.1001/jama.283.9.1109; Deber RB, 1996, J GEN INTERN MED, V11, P377, DOI 10.1007/BF02600052; DELBANCO TL, 1992, ANN INTERN MED, V116, P414, DOI 10.7326/0003-4819-116-5-414; DEVINE EC, 1992, PATIENT EDUC COUNS, V19, P129, DOI 10.1016/0738-3991(92)90193-M; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; EdgmanLevitan S, 1996, HEALTH AFFAIR, V15, P42, DOI 10.1377/hlthaff.15.4.42; Fetzer S J, 1999, J Perianesth Nurs, V14, P95, DOI 10.1016/S1089-9472(99)80024-0; Fetzer SJ., 1999, J PERIANESTH NURS, V14, P112; Gerteis M., 1993, PATIENTS EYES UNDERS; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; GRIFFIN N, 1986, JAMA-J AM MED ASSOC, V256, P1032; Gustafson DH, 1999, QUAL HEALTH CARE, V8, P49, DOI 10.1136/qshc.8.1.49; GUSTAFSON DH, 1998, WHAT EVERYONE HLTH C; HART CWL, 1990, HARVARD BUS REV, V68, P148; Hickey ML, 1996, JOINT COMM J QUAL IM, V22, P336, DOI 10.1016/S1070-3241(16)30237-1; HOWANITZ PJ, 1991, ARCH PATHOL LAB MED, V115, P867; JONES TO, 1995, HARVARD BUS REV, V73, P88; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; KEANE BS, 1998, MANAGING PATIENT EXP; Kelley L, 1997, AM J EMERG MED, V15, P570, DOI 10.1016/S0735-6757(97)90159-5; Kenagy JW, 1999, JAMA-J AM MED ASSOC, V281, P661, DOI 10.1001/jama.281.7.661; Kilo C M, 1998, Qual Manag Health Care, V6, P1; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Lahdensuo A, 1996, BRIT MED J, V312, P748; Laine C, 1996, ANN INTERN MED, V125, P640, DOI 10.7326/0003-4819-125-8-199610150-00003; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; *LEW GROUP, 2000, IMP MED BAL BUDG REF; Lohr K., 1990, MED STRATEGY QUALITY; Lohr K N, 1992, QRB Qual Rev Bull, V18, P120; LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403; Lundgren A, 1999, J CLIN NURS, V8, P577, DOI 10.1046/j.1365-2702.1999.00299.x; METERKO M, 1990, MED CARE S, V28; Minnick AF, 1997, MED CARE, V35, P399, DOI 10.1097/00005650-199704000-00009; MURRAY M, 1998, IT COMM J QUAL IMPRO, V24, P423; *NAT COMM QUAL ASS, 2000, STAT MAN CAR QUAL 20; Niles N, 1996, JOINT COMM J QUAL IM, V22, P323, DOI 10.1016/S1070-3241(16)30236-X; Nolan T.W., 1996, REDUCING DELAYS WAIT; Palmer R.H., 1991, STRIVING QUALITY HLT, P1; PICHERT JW, 1988, JT COMM J QUAL IMPRO, V24, P303; Reiley P, 1996, JOINT COMM J QUAL IM, V22, P311, DOI 10.1016/S1070-3241(16)30235-8; Rogers G, 1999, INT J QUAL HEALTH C, V11, P251, DOI 10.1093/intqhc/11.3.251; ROTER DL, 1995, ARCH INTERN MED, V115, P1887; RUBIN HR, 1993, JAMA-J AM MED ASSOC, V270, P835, DOI 10.1001/jama.270.7.835; Schlesinger, 1997, SERVICE PROFIT CHAIN; SOBEL DS, 1995, PSYCHOSOM MED, V57, P234, DOI 10.1097/00006842-199505000-00005; TYE L, 1998, BOSTON GLOBE    1113; vom Eigen KA, 1999, MED CARE, V37, P33, DOI 10.1097/00005650-199901000-00006; Wachter RM, 1998, JAMA-J AM MED ASSOC, V279, P1560, DOI 10.1001/jama.279.19.1560; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Young GJ, 1997, HEALTH CARE MANAGE R, V22, P72, DOI 10.1097/00004010-199710000-00010; YOUNG GJ, 1998, HLTH SERV RES, V24, P143; Zimmerman B., 1998, EDGEWARE INSIGHTS CO	65	16	16	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2629	2635		10.1001/jama.285.20.2629	http://dx.doi.org/10.1001/jama.285.20.2629			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433LY	11368737				2022-12-28	WOS:000168761900030
J	Ohki, I; Shimotake, N; Fujita, N; Jee, JG; Ikegami, T; Nakao, M; Shirakawa, M				Ohki, I; Shimotake, N; Fujita, N; Jee, JG; Ikegami, T; Nakao, M; Shirakawa, M			Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA	CELL			English	Article							TRANSCRIPTIONAL REPRESSOR MECP2; HISTONE DEACETYLASE COMPLEX; RETT-SYNDROME MUTATIONS; PROTEIN MBD1; ASSOCIATION; NUCLEOSOME; GENE; NMR; METHYLTRANSFERASE; CHROMATIN	In vertebrates, the biological consequences of DNA methylation are often mediated by protein factors containing conserved methyl-CpG binding domains (MBDs). Mutations in the MBD protein MeCP2 cause the neurodevelopmental disease Rett syndrome. We report here the solution structure of the MBD of the human methylation-dependent transcriptional regulator MBD1 bound to methylated BRA. DNA binding causes a loop in MBD1 to fold into a major and novel DNA binding interface. Recognition of the methyl groups and CG sequence at the methylation site is due to five highly conserved residues that form a hydrophobic patch. The structure indicates how MBD may access nucleosomal DNA without encountering steric interference from core histones, and provides a basis to interpret mutations linked to Rett syndrome in MeCP2.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Kanagawa 2300045, Japan; Kumamoto Univ, Sch Med, Dept Tumor Genet & Biol, Kumamoto 8600811, Japan	Nara Institute of Science & Technology; Yokohama City University; Kumamoto University	Shirakawa, M (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300101, Japan.		Ikegami, Takahisa/I-9626-2017; Ohki, Izuru/C-7883-2013; Ohki, Izuru/O-4816-2019	Ikegami, Takahisa/0000-0002-1429-1844; Ohki, Izuru/0000-0002-0667-5936				Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BRUENGER AT, 1993, XPLOR 3 1 SYSTEM XRA; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Connolly KM, 2000, J MOL BIOL, V300, P841, DOI 10.1006/jmbi.2000.3888; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Dragich J, 2000, HUM MOL GENET, V9, P2365, DOI 10.1093/hmg/9.16.2365; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Fujita N, 2000, MOL CELL BIOL, V20, P5107, DOI 10.1128/MCB.20.14.5107-5118.2000; Fujita N, 1999, MOL CELL BIOL, V19, P6415; Guschin D, 1998, BIOCHEMISTRY-US, V37, P8629, DOI 10.1021/bi9805846; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; Katoh E, 1999, J AM CHEM SOC, V121, P2607, DOI 10.1021/ja984041v; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee KM, 1998, BIOCHEMISTRY-US, V37, P8622, DOI 10.1021/bi980499y; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MEEHAN RR, 1989, CELL, V69, P905; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohki I, 1999, EMBO J, V18, P6653, DOI 10.1093/emboj/18.23.6653; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; VUISTER GW, 1998, BIOL MAGN RESON, P195; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wakefield RID, 1999, J MOL BIOL, V291, P1055, DOI 10.1006/jmbi.1999.3023; Wojciak JM, 1999, NAT STRUCT BIOL, V6, P366; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; YAMAZAKI T, 1995, J AM CHEM SOC, V117, P3556, DOI 10.1021/ja00117a025; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	48	238	249	2	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					487	497		10.1016/S0092-8674(01)00324-5	http://dx.doi.org/10.1016/S0092-8674(01)00324-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371345	Bronze			2022-12-28	WOS:000168840700008
J	Turner, BL; Haygarth, PM				Turner, BL; Haygarth, PM			Biogeochemistry - Phosphorus solubilization in rewetted soils	NATURE			English	Article									Inst Grassland & Environm Res, Soil Sci Grp, Okehampton EX20 2SB, Devon, England		Turner, BL (corresponding author), ARS, USDA, NW Irrigat & Soils Res Lab, Kimberly, ID 83341 USA.		Haygarth, Philip Matthew/F-6790-2014; Turner, Benjamin L/E-5940-2011	Turner, Benjamin L/0000-0002-6585-0722				BIRCH H. F., 1960, Plant and Soil, V12, P81, DOI 10.1007/BF01377763; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; HOUGHTON JT, 1992, CLIMATE CHANGE IPCC; Pote DH, 1999, J ENVIRON QUAL, V28, P170, DOI 10.2134/jeq1999.00472425002800010020x; SALEMA MP, 1982, SOIL BIOL BIOCHEM, V14, P15, DOI 10.1016/0038-0717(82)90071-2; Turner BL, 2000, SOIL SCI SOC AM J, V64, P1090, DOI 10.2136/sssaj2000.6431090x	6	309	326	12	165	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					258	258		10.1038/35077146	http://dx.doi.org/10.1038/35077146			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357117				2022-12-28	WOS:000168710000032
J	Yamaguchi, Y; Filipovska, J; Yano, K; Furuya, A; Inukai, N; Narita, T; Wada, T; Sugimoto, S; Konarska, MM; Handa, H				Yamaguchi, Y; Filipovska, J; Yano, K; Furuya, A; Inukai, N; Narita, T; Wada, T; Sugimoto, S; Konarska, MM; Handa, H			Stimulation of RNA polymerase II elongation by hepatitis delta antigen	SCIENCE			English	Article							TRANSCRIPTION ELONGATION; VIRUS; DSIF; REPLICATION; INITIATION; GENOME; SPT4; GENE	Transcription elongation by RNA polymerase II (RNAPII) is negatively regulated by the human factors DRB-sensitivity inducing factor (DSIF) and negative elongation factor (NELF). A 66-kilodalton subunit of NELF (NELF-A) shows limited sequence similarity to hepatitis delta antigen (HDAg), the viral protein required for replication of hepatitis delta virus (HDV). The host RNAPII has been implicated in HDV replication, but the detailed mechanism and the role of HDAg in this process are not understood. We show that HDAg binds RNAPII directly and stimulates transcription by displacing NELF and promoting RNAPII elongation. These results suggest that HDAg may regulate RNAPII elongation during both cellular messenger RNA synthesis and HDV RNA replication.	Tokyo Inst Technol, Frontier Collaborat Res Ctr, Yokohama, Kanagawa 2268503, Japan; Rockefeller Univ, New York, NY 10021 USA; Tokyo Res Labs, Tokyo 1948533, Japan	Tokyo Institute of Technology; Rockefeller University	Handa, H (corresponding author), Tokyo Inst Technol, Frontier Collaborat Res Ctr, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	hhanda@bio.titech.ac.jp	Filipovska, Julija/AAI-5306-2021; Konarska, Maria M./AAT-2572-2021; Yamaguchi, Yuki/B-9390-2015; Konarska, Maria/ABG-6405-2020	Yamaguchi, Yuki/0000-0002-0197-614X; Konarska, Maria M./0000-0001-9235-1702				Bichko VV, 1996, J VIROL, V70, P8064, DOI 10.1128/JVI.70.11.8064-8070.1996; Brazas R, 1996, SCIENCE, V274, P90, DOI 10.1126/science.274.5284.90; CASEY JL, 1993, P NATL ACAD SCI USA, V90, P9016, DOI 10.1073/pnas.90.19.9016; CHANG FL, 1991, P NATL ACAD SCI USA, V88, P8490, DOI 10.1073/pnas.88.19.8490; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Corpet F, 1998, NUCLEIC ACIDS RES, V26, P323, DOI 10.1093/nar/26.1.323; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; Garber ME, 1999, CURR OPIN IMMUNOL, V11, P460, DOI 10.1016/S0952-7915(99)80077-6; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; KUO MYP, 1989, J VIROL, V63, P1945, DOI 10.1128/JVI.63.5.1945-1950.1989; LAI MMC, 1995, ANNU REV BIOCHEM, V64, P259, DOI 10.1146/annurev.bi.64.070195.001355; Lo K, 1998, VIROLOGY, V247, P178, DOI 10.1006/viro.1998.9253; Modahl LE, 2000, J VIROL, V74, P7375, DOI 10.1128/JVI.74.16.7375-7380.2000; Robertson HD, 1996, SCIENCE, V274, P66, DOI 10.1126/science.274.5284.66; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wei Y, 1998, J VIROL, V72, P2089, DOI 10.1128/JVI.72.3.2089-2096.1998; Wright TJ, 1999, GENOMICS, V59, P203, DOI 10.1006/geno.1999.5871; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 1998, GENES CELLS, V3, P9, DOI 10.1046/j.1365-2443.1998.00162.x	23	117	122	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2001	293	5527					124	127		10.1126/science.1057925	http://dx.doi.org/10.1126/science.1057925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11387440				2022-12-28	WOS:000169780300043
J	Walter, LC; Covinsky, KE				Walter, LC; Covinsky, KE			Cancer screening in elderly patients - A framework for individualized decision making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL-OCCULT-BLOOD; QUALITY-OF-LIFE; CARCINOMA IN-SITU; BREAST-CANCER; COLORECTAL-CANCER; COST-EFFECTIVENESS; CONTROLLED TRIAL; CERVICAL-CANCER; OLDER WOMEN; FOLLOW-UP	Considerable uncertainty exists about the use of cancer screening tests in older people, as illustrated by the different age cutoffs recommended by various guideline panels. We suggest that a framework to guide individualized cancer screening decisions in older patients may be more useful to the practicing clinician than age guidelines, Like many medical decisions, cancer screening decisions require weighing quantitative information, such as risk of cancer death and likelihood of beneficial and adverse screening outcomes, as well as qualitative factors, such as individual patients' values and preferences, Our framework first anchors decisions through quantitative estimates of life expectancy, risk of cancer death, and screening outcomes based on published data. Potential benefits of screening are presented as the number needed to screen to prevent 1 cancer-specific death, based on the estimated life expectancy during which a patient will be screened. Estimates reveal substantial variability in the likelihood of benefit for patients of similar ages with varying life expectancies. In fact, patients with life expectancies of less than 5 years are unlikely to derive any survival benefit from cancer screening. We also consider the likelihood of potential harm from screening according to patient factors and test characteristics. Some of the greatest harms of screening occur by detecting cancers that would never have become clinically significant. This becomes more likely as life expectancy decreases. Finally, since many cancer screening decisions in older adults cannot be answered solely by quantitative estimates of benefits and harms, considering the estimated outcomes according to the patient's own values and preferences is the final step for making informed screening decisions.	Vet Affairs Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Walter, LC (corresponding author), Vet Affairs Med Ctr, Div Geriatr, 111G,4150 Clement St, San Francisco, CA 94121 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS000006] Funding Source: NIH RePORTER; AHRQ HHS [K02HS00006-01] Funding Source: Medline; PHS HHS [T-32] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Barratt A, 1999, JAMA-J AM MED ASSOC, V281, P2029, DOI 10.1001/jama.281.21.2029; Bennahum DA, 1997, CLIN GERIATR MED, V13, P33; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1037, DOI 10.1001/jama.281.11.1037; CASSEL CK, 1992, J GERONTOL, V47, P126; COSTANZA ME, 1994, CANCER-AM CANCER SOC, V74, P2046, DOI 10.1002/1097-0142(19941001)74:7+<2046::AID-CNCR2820741710>3.0.CO;2-U; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1007/s11606-006-5041-5; Cruickshank ME, 1997, BRIT J OBSTET GYNAEC, V104, P586, DOI 10.1111/j.1471-0528.1997.tb11537.x; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; DIXON JM, 1988, BRIT J SURG, V75, P918, DOI 10.1002/bjs.1800750931; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P2493, DOI 10.1001/jama.263.18.2493; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; Essink-Bot ML, 1998, J NATL CANCER I, V90, P925, DOI 10.1093/jnci/90.12.925; EUSEBI V, 1989, SEMIN DIAGN PATHOL, V6, P165; FISCHHOFF B, 1999, MONOGR NAT CANC I, V25, P7; Fonseca R, 1997, ANN INTERN MED, V127, P1013, DOI 10.7326/0003-4819-127-11-199712010-00013; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; HARRIS R, 1995, ANN INTERN MED, V122, P539, DOI 10.7326/0003-4819-122-7-199504010-00011; HUGHES JE, 1987, CANCER SURV, V6, P455; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LAARA E, 1987, LANCET, V1, P1247; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; Lurie JD, 1999, J NATL CANCER I, V91, P1641, DOI 10.1093/jnci/91.19.1641; MALENKA DJ, 1992, J GEN INTERN MED, V92, P121; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Marshall KG, 1996, CAN MED ASSOC J, V155, P169; MAZUR DJ, 1993, J GEN INTERN MED, V8, P374, DOI 10.1007/BF02600076; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; MOSKOWITZ M, 1986, RADIOLOGY, V161, P37, DOI 10.1148/radiology.161.1.3532183; *NAT CTR HLTH STAT, 2000, LIF TABL US 1997; National Hospice Organization, 1996, MED GUID DET PROGN S; PAGE DL, 1982, CANCER, V49, P751, DOI 10.1002/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y; Pignone M, 2000, ANN INTERN MED, V133, P761, DOI 10.7326/0003-4819-133-10-200011210-00008; Pignone M, 1999, J GEN INTERN MED, V14, P432, DOI 10.1046/j.1525-1497.1999.00018.x; Prevost TC, 1998, AM J EPIDEMIOL, V148, P609; Ransohoff DF, 1997, ANN INTERN MED, V127, P1029, DOI 10.7326/0003-4819-127-11-199712010-00016; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Ries L. A. G., 1999, SEER CANC STAT REV 1; Robinson B, 1997, CLIN GERIATR MED, V13, P97; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Smith RA, 2000, CA-CANCER J CLIN, V50, P34, DOI 10.3322/canjclin.50.1.34; Sox HC, 1998, J GEN INTERN MED, V13, P424, DOI 10.1046/j.1525-1497.1998.00126.x; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; WARDLE J, 1992, J PSYCHOSOM RES, V36, P609, DOI 10.1016/0022-3999(92)90051-3; WARREN R, 1988, BRIT MED J, V297, P969, DOI 10.1136/bmj.297.6654.969; Weingarten S, 1999, ANN INTERN MED, V130, P454, DOI 10.7326/0003-4819-130-5-199903020-00023; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Welch HG, 1998, J NATL CANCER I, V90, P1389, DOI 10.1093/jnci/90.18.1389; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; YANCIK R, 1994, CANCER, V74, P1995, DOI 10.1002/1097-0142(19941001)74:7+<1995::AID-CNCR2820741702>3.0.CO;2-Y	64	664	670	0	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2750	2756		10.1001/jama.285.21.2750	http://dx.doi.org/10.1001/jama.285.21.2750			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386931				2022-12-28	WOS:000168985800028
J	Kelley, AM; Michalet, X; Weiss, S				Kelley, AM; Michalet, X; Weiss, S			Chemical physics - Single-molecule spectroscopy comes of age	SCIENCE			English	Editorial Material							ROOM-TEMPERATURE		Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Biophys Sci Div, Berkeley, CA 94720 USA	Kansas State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kelley, AM (corresponding author), Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA.		Michalet, Xavier/A-9704-2009; weiss, shimon/B-4164-2009	Michalet, Xavier/0000-0001-6602-7693; weiss, shimon/0000-0002-0720-5426				Bartko AP, 1999, J PHYS CHEM B, V103, P3053, DOI 10.1021/jp9846330; Deschenes LA, 2001, SCIENCE, V292, P255, DOI 10.1126/science.1056430; Eggeling C, 2001, J BIOTECHNOL, V86, P163, DOI 10.1016/S0168-1656(00)00412-0; Enderlein J, 1999, CHEM PHYS, V247, P1, DOI 10.1016/S0301-0104(99)00097-X; Harms R. H., 1996, Journal of Applied Poultry Research, V5, P1, DOI 10.1093/japr/5.1.1; Helmer M, 1999, NATURE, V401, P225, DOI 10.1038/45704; Lounis B, 2000, NATURE, V407, P491, DOI 10.1038/35035032; Mei E, 2000, J PHYS CHEM B, V104, P9973, DOI 10.1021/jp001011h; MOERNER WE, 1989, PHYS REV LETT, V62, P2535, DOI 10.1103/PhysRevLett.62.2535; *PHYS CHEM DIV, 2001, AM CHEM SOC NAT M SA; Prummer M, 2000, ANAL CHEM, V72, P443, DOI 10.1021/ac991116k; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tinnefeld P., 2000, SINGLE MOL, V1, P215; Uppenbrink J, 1999, SCIENCE, V283, P1667, DOI 10.1126/science.283.5408.1667; Veerman JA, 1999, PHYS REV LETT, V83, P2155, DOI 10.1103/PhysRevLett.83.2155; Visser JWM, 1999, CYTOMETRY, V36, P161, DOI 10.1002/(SICI)1097-0320(19990701)36:3<161::AID-CYTO1>3.0.CO;2-Z; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yu J, 2000, SCIENCE, V289, P1327, DOI 10.1126/science.289.5483.1327	19	35	38	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1671	1672						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387465				2022-12-28	WOS:000169031800032
J	Zheng, BH; Albrecht, U; Kaasik, K; Sage, M; Lu, WQ; Vaishnav, S; Li, Q; Sun, ZS; Eichele, G; Bradley, A; Lee, CC				Zheng, BH; Albrecht, U; Kaasik, K; Sage, M; Lu, WQ; Vaishnav, S; Li, Q; Sun, ZS; Eichele, G; Bradley, A; Lee, CC			Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock	CELL			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; DROSOPHILA-PERIOD; POSITIONAL CLONING; PROTEIN; HEME; EXPRESSION; TRANSCRIPTION; PACEMAKER; COMPONENT; ORTHOLOG	Mice carrying a null mutation in the Period 1 (mPer1) gene were generated using embryonic stem cell technology. Homozygous mPer1 mutants display a shorter circadian period with reduced precision and stability. Mice deficient in both mPer1 and mPer2 do not express circadian rhythms. While mPER2 regulates clock gene expression at the transcriptional level, mPER1 is dispensable for the rhythmic RNA expression of mPer1 and mPer2 and may instead regulate mPER2 at a posttranscriptional level. Studies of clock-controlled genes (CCGs) reveal a complex pattern of regulation by mPER1 and mPER2, suggesting independent controls by the two proteins over some output pathways. Genes encoding key enzymes in heme biosynthesis are under circadian control and are regulated by mPER1 and mPER2. Together, our studies show that mPER1 and mPER2 have distinct and complementary roles in the mouse clock mechanism.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Bradley, A (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	abradley@sanger.ac.uk; ching@bcm.tmc.edu	Sun, Zhongsheng/AAS-4883-2020; Albrecht, Urs/A-9831-2011; Jansen, Heiko T./A-5770-2008	Sun, Zhongsheng/0000-0002-7640-5026; Albrecht, Urs/0000-0002-0663-8676; Jansen, Heiko T./0000-0003-0178-396X; Bradley, Allan/0000-0002-2349-8839				Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Albrecht U, 1997, MOL CELLULAR METHODS, P23; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Bracewell R. N., 1986, HARTLEY TRANSFORM; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Clayton JD, 2001, NATURE, V409, P829, DOI 10.1038/35057006; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Festing MFW, 1999, MAMM GENOME, V10, P836, DOI 10.1007/s003359901099; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HAMILTON JW, 1991, ARCH BIOCHEM BIOPHYS, V289, P387, DOI 10.1016/0003-9861(91)90428-L; KAPPAS A, 1968, Seminars in Hematology, V5, P323; KIKUCHI G, 1981, MOL CELL BIOCHEM, V37, P27, DOI 10.1007/BF02355885; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Lucas KA, 2000, PHARMACOL REV, V52, P375; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Pellequer JL, 1999, CURR BIOL, V9, pR416, DOI 10.1016/S0960-9822(99)80257-7; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Young MW, 2000, SCI AM, V282, P64, DOI 10.1038/scientificamerican0300-64; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	53	661	694	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					683	694		10.1016/S0092-8674(01)00380-4	http://dx.doi.org/10.1016/S0092-8674(01)00380-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389837	Bronze			2022-12-28	WOS:000169123200014
J	Annas, GJ				Annas, GJ			Testing poor pregnant women for cocaine - Physicians as police investigators.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GJ, 1991, NEW ENGL J MED, V325, P740, DOI 10.1056/NEJM199109053251020; Annas GJ, 2001, NEW ENGL J MED, V344, P152, DOI 10.1056/NEJM200101113440220; ANNAS GJ, 1989, HASTINGS CENT REP, V19, P1935; Chavkin W, 2001, JAMA-J AM MED ASSOC, V285, P1626, DOI 10.1001/jama.285.12.1626; Frank DA, 2001, JAMA-J AM MED ASSOC, V285, P1613, DOI 10.1001/jama.285.12.1613; GANTZ LH, 1989, AM J PUBLIC HEALTH, V79, P1427; GREEN V, 1993, DOPED UP KNOCKED UP; Mariner Wendy K, 1990, Crim Justice Ethics, V9, P30; Paltrow Lynn M, 1990, Crim Justice Ethics, V9, P41; Roberts Dorothy, 1999, J HLTH CARE LAW POLI, V3, P72; SIEGEL B, 1994, LA TIMES        0807, P14	11	17	17	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2001	344	22					1729	1732		10.1056/NEJM200105313442219	http://dx.doi.org/10.1056/NEJM200105313442219			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	436YG	11386286	Green Published			2022-12-28	WOS:000168963000028
J	Nadler, MJS; Hermosura, MC; Inabe, K; Perraud, AL; Zhu, QQ; Stokes, AJ; Kurosaki, T; Kinet, JP; Penner, R; Scharenberg, AM; Fleig, A				Nadler, MJS; Hermosura, MC; Inabe, K; Perraud, AL; Zhu, QQ; Stokes, AJ; Kurosaki, T; Kinet, JP; Penner, R; Scharenberg, AM; Fleig, A			LTRPC7 is a Mg center dot ATP-regulated divalent cation channel required for cell viability	NATURE			English	Article								The molecular mechanisms that regulate basal or background entry of divalent cations into mammalian cells are poorly understood. Here we describe the cloning and functional characterization of a Ca2+ - and Mg2+-permeable divalent cation channel, LTRPC7 (nomenclature compatible with that proposed in ref. 1), a new member of the LTRPC family of putative ion channels. Targeted deletion of LTRPC7 in DT-40 B cells was lethal, indicating that LTRPC7 has a fundamental and nonredundant role in cellular physiology. Electrophysiological analysis of HEK-293 cells overexpressing recombinant LTRPC7 showed large currents regulated by millimolar levels of intracellular Mg.ATP and Mg.GTP with the permeation properties of a voltage-independent divalent cation influx pathway. Analysis of several cultured cell types demonstrated small magnesium-nucleotide-regulated metal ion currents (MagNuM) with regulation and permeation properties essentially identical to the large currents observed in cells expressing recombinant LTRPC7. Our data indicate that LTRPC7, by virtue of its sensitivity to physiological Mg.ATP levels, may be involved in a fundamental process that adjusts plasma membrane divalent cation fluxes according to the metabolic state of the cell.	Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Hawaii, Queens Med Ctr, Biomed Res Ctr, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Osaka 5708506, Japan; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; The Queen's Medical Center; University of Hawaii System; University of Hawaii System; Kansai Medical University; Harvard University; Beth Israel Deaconess Medical Center	Scharenberg, AM (corresponding author), Univ Washington, Dept Pediat & Immunol, Seattle, WA 98195 USA.		Kurosaki, Tomohiro/D-1306-2009; Stokes, Alexander/B-1086-2015	Kurosaki, Tomohiro/0000-0002-6352-304X; Stokes, Alexander/0000-0002-3526-4685; Fleig, Andrea/0000-0001-8396-7249; Penner, Reinhold/0000-0002-5366-1537				Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Luthi D, 1999, EXP PHYSIOL, V84, P231, DOI 10.1111/j.1469-445X.1999.01799.x; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884	5	736	768	2	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					590	595		10.1038/35079092	http://dx.doi.org/10.1038/35079092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385574				2022-12-28	WOS:000168982500053
J	Ashcroft, R; Pfeffer, N				Ashcroft, R; Pfeffer, N			Ethics behind closed doors: do research ethics committees need secrecy?	BRITISH MEDICAL JOURNAL			English	Article							ACCOUNTABILITY; SUGGESTIONS; PERFORMANCE; CHALLENGES; MEDICINES		Imperial Coll Sch Med, Dept Primary Hlth Care & Gen Practice, London W2 1PG, England; Univ N London, Sch Community Hlth Psychol & Social Work, London N5 2AD, England	Imperial College London; London Metropolitan University	Ashcroft, R (corresponding author), Imperial Coll Sch Med, Dept Primary Hlth Care & Gen Practice, London W2 1PG, England.							Abraham J, 1999, BRIT MED J, V318, P46; ALBERTI KGM, 2000, BRIT MED J, V320, P157; *AUSTR NAT HLTH ME, 1999, NAT STAND ETH COND R; BENDALL C, 1994, STAND OP POC LOC RES; Blunt J, 1998, BMJ-BRIT MED J, V316, P58, DOI 10.1136/bmj.316.7124.58; *CAN RES COUNC, 1998, B MED ETHICS, V143, P13; Collins Harry, 1992, CHANGING ORDER REPLI; CRAFT N, 1994, BRIT MED J, V309, P1640, DOI 10.1136/bmj.309.6969.1640a; Dal-Re R, 1999, J MED ETHICS, V25, P268, DOI 10.1136/jme.25.3.268; *DEP HLTH, 2000, GUID MAK PROP COND G; *DEP HLTH, 1994, STAND LOC RES ETH CO; *DEP HLTH, 2000, RES GOV NHS GUID GOO; *DEP HLTH, 1997, ETH COMM REV MULT RE; *DEP HLTH, 2000, DRAFT RES GOV FRAM H; *DEP HLTH, 2000, PAT PUBL INV NEWS NH; [Department of Health DoH], 1991, LOC RES ETH COMM; FOSTER CG, 1995, J MED ETHICS, V21, P214, DOI 10.1136/jme.21.4.214; *NHS EX, 2000, COD PRACT OP NHS; *NHS EX W MIDL REG, 2000, REP RES FRAM N STAFF; NICHOLSON R, 2000, STUDY LOCAL RES ETH; *NZ LAW COMM, 2000, 37 NZ LAW COMM; *NZ MIN HLTH, 1996, NAT STAND RES ETH CO; *OFF SCI TECHN, 2000, US SCI ADV POL MAK; Roberts I, 1998, LANCET, V352, P726, DOI 10.1016/S0140-6736(98)07600-4; Royal College of Physicians, 1996, GUID PRACT ETH COMM; Savulescu J, 1996, BMJ-BRIT MED J, V313, P1390, DOI 10.1136/bmj.313.7069.1390; Shalala D, 2000, NEW ENGL J MED, V343, P808, DOI 10.1056/NEJM200009143431112; Slowther A, 1999, J ROY COLL PHYS LOND, V33, P202; The World Medical Association, 1996, REC GUID PHYS BIOM R; *US DEP HHS, 1998, I REV BOARDS TIM REF; *US FDA, 2000, GUID I REV BOARDS CL; Woodward B, 1999, JAMA-J AM MED ASSOC, V282, P1947, DOI 10.1001/jama.282.20.1947; World Health Organization, 2000, OP GUID ETH COMM REV; 2000, INT C HARM HARM TRIP	34	29	29	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 26	2001	322	7297					1294	1296		10.1136/bmj.322.7297.1294	http://dx.doi.org/10.1136/bmj.322.7297.1294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375236	Green Published			2022-12-28	WOS:000169027800025
J	Tashkin, DP; Kanner, R; Bailey, W; Buist, S; Anderson, P; Nides, MA; Gonzales, D; Dozier, G; Patel, MK; Jamerson, BD				Tashkin, DP; Kanner, R; Bailey, W; Buist, S; Anderson, P; Nides, MA; Gonzales, D; Dozier, G; Patel, MK; Jamerson, BD			Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial	LANCET			English	Article							SUSTAINED-RELEASE BUPROPION; INTERVENTION	Background Tobacco smoking is associated with chronic obstructive pulmonary disease (COPD) in more than 80% of cases. Our aim was to investigate the effect of sustained-release bupropion (amfebutamone) (SR) in promoting abstinence from smoking in patients with COPD. Methods In a double-blind, randomised, placebo-controlled trial 404 individuals with mild or moderate CORD who smoked 15 or more cigarettes per day, were assigned bupropion SR (150 mg twice daily) or placebo for 12 weeks. All patients received smoking cessation counselling. Study medication was taken for 1 week before patients attempted to stop smoking. The primary efficacy endpoint was the complete and continuous abstinence from smoking from the beginning of week 4 to the end of week 7. Participants were followed up at month 6. Analysis was by intention to treat. Findings All patients were chronic smokers with a smoking history of about 51 pack-years. Continuous smoking abstinence rates from week 4 to 7 were significantly higher in participants receiving bupropion SR than in those receiving placebo (28% [57/204] vs 16% [32/200], p=0.003). Continuous abstinence rates from weeks 4 to 12 (18% [36/204] vs 10% [20/200]) and weeks 4 to 26 (16% [32/204] vs 9% [18/200]) were also higher in participants receiving bupropion SR than in those taking placebo (p<0.05). Furthermore, symptoms of tobacco craving and withdrawal were attenuated in those receiving bupropion SR. Seven individuals discontinued study medication because of adverse events. Interpretation Bupropion; SR is a well-tolerated and effective aid to smoking cessation in people with mild to moderate COPD.	Univ Calif Los Angeles, Sch Med, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; Univ Utah, Salt Lake City, UT 84112 USA; UAB Pulm Med, Birmingham, AL 35294 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA; Glaxo Wellcome Inc, Res & Dev, Res Triangle Pk, NC 27709 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham; Oregon Health & Science University; University of Arkansas System; University of Arkansas Medical Sciences; GlaxoSmithKline	Tashkin, DP (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA.	dtashkin@mednet.ucla.edu		Gonzales, David/0000-0002-4323-198X				ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; BJORNSON W, 1995, AM J PUBLIC HEALTH, V85, P223, DOI 10.2105/AJPH.85.2.223; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; CROWLEY TJ, 1995, PSYCHOPHARMACOLOGY, V119, P193, DOI 10.1007/BF02246161; Fleiss J. L., 1981, STAT METHODS RATES P, V2; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hurd S, 2000, CHEST, V117, P1; Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Kanner RE, 1999, AM J MED, V106, P410, DOI 10.1016/S0002-9343(99)00056-X; Killen JD, 1997, EXP CLIN PSYCHOPHARM, V5, P137, DOI 10.1037/1064-1297.5.2.137; Parrott S, 1998, THORAX, V53, pAS1; Pauwels RA, 2000, CHEST, V117, P20, DOI 10.1378/chest.117.2_suppl.20S; PIRIE PL, 1992, AM J PUBLIC HEALTH, V82, P1238, DOI 10.2105/AJPH.82.9.1238; Roche N, 1997, Respirology, V2, P215, DOI 10.1111/j.1440-1843.1997.tb00082.x; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; SCHAPIRA RM, 1995, J GEN INTERN MED, V10, P40, DOI 10.1007/BF02599577; Sullivan SD, 2000, CHEST, V117, P5; *US SURG GEN, 1980, HLTH CONS SMOK WOM R; Welsch SK, 1999, EXP CLIN PSYCHOPHARM, V7, P354, DOI 10.1037/1064-1297.7.4.354	22	277	288	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2001	357	9268					1571	1575		10.1016/S0140-6736(00)04724-3	http://dx.doi.org/10.1016/S0140-6736(00)04724-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377644				2022-12-28	WOS:000168830100010
J	Jallepalli, PV; Waizenegger, IC; Bunz, F; Langer, S; Speicher, MR; Peters, JM; Kinzler, KW; Vogelstein, B; Lengauer, C				Jallepalli, PV; Waizenegger, IC; Bunz, F; Langer, S; Speicher, MR; Peters, JM; Kinzler, KW; Vogelstein, B; Lengauer, C			Securin is required for chromosomal stability in human cells	CELL			English	Article							SISTER-CHROMATID SEPARATION; MITOTIC CHECKPOINT GENES; KINETOCHORE LOCALIZATION; SPINDLE CHECKPOINT; HUMAN HOMOLOG; ANAPHASE; PROTEIN; LACKING; COHESIN; INHIBITOR	Abnormalities of chromosome number are the most common genetic aberrations in cancer. The mechanisms regulating the fidelity of mitotic chromosome transmission in mammalian cells are therefore of great interest. Here we show that human cells without an hSecurin gene lose chromosomes at a high frequency. This loss was linked to abnormal anaphases during which cells underwent repetitive unsuccessful attempts to segregate their chromosomes. The abnormal mitoses were associated with biochemical defects in the activation of separin, the sister-separating protease, rendering it unable to cleave the cohesin subunit Scc1 efficiently. These results illuminate the function of mammalian securin and show that it is essential for the maintenance of euploidy.	Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA; Howard Hughes Med Inst, Baltimore, MD 21231 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Munich, Inst Anthropol & Human Genet, D-80333 Munich, Germany	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Munich	Lengauer, C (corresponding author), Johns Hopkins Oncol Ctr, 1650 Orleans St, Baltimore, MD 21231 USA.	lengauer@jhmi.edu	Speicher, Michael R/B-5362-2013	Speicher, Michael R/0000-0003-0105-955X	NCI NIH HHS [CA 62924, CA 57345, CA 43460] Funding Source: Medline; NIGMS NIH HHS [GM 41690, GM07309] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057345, P50CA062924, R01CA043460, R37CA057345, R37CA043460] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Duesberg P, 1999, ANTICANCER RES, V19, P4887; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Gardner RD, 2000, TRENDS CELL BIOL, V10, P154, DOI 10.1016/S0962-8924(00)01727-X; Gemma A, 2000, GENE CHROMOSOME CANC, V29, P213, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1027>3.0.CO;2-G; Glotzer M, 1999, CURR BIOL, V9, pR531, DOI 10.1016/S0960-9822(99)80329-7; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Imai Y, 1999, JPN J CANCER RES, V90, P837, DOI 10.1111/j.1349-7006.1999.tb00824.x; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; LOEB LA, 1991, CANCER RES, V51, P3075; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Martinez-Exposito MJ, 1999, P NATL ACAD SCI USA, V96, P8493, DOI 10.1073/pnas.96.15.8493; Masramon L, 2000, CANCER GENET CYTOGEN, V121, P17, DOI 10.1016/S0165-4608(00)00219-3; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	52	336	360	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					445	457		10.1016/S0092-8674(01)00340-3	http://dx.doi.org/10.1016/S0092-8674(01)00340-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371342	Bronze			2022-12-28	WOS:000168840700005
J	Stearns, T				Stearns, T			Centrosome duplication: A centriolar pas de deux	CELL			English	Review							SPINDLE POLE; CELL-CYCLE		Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.			Stearns, Tim/0000-0002-0671-6582				Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Lingle WL, 2000, CURR TOP DEV BIOL, V49, P313; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; O'Connell KF, 1998, GENETICS, V149, P1303; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; TOKUYAMA Y, 2001, J BIOL CHEM; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vidwans SJ, 1999, J CELL BIOL, V147, P1371, DOI 10.1083/jcb.147.7.1371; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Wojcik EJ, 2000, CURR BIOL, V10, P1131, DOI 10.1016/S0960-9822(00)00703-X	20	65	67	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					417	420		10.1016/S0092-8674(01)00366-X	http://dx.doi.org/10.1016/S0092-8674(01)00366-X			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371338	Bronze			2022-12-28	WOS:000168840700001
J	Mao, BY; Wu, W; Li, Y; Hoppe, D; Stannek, P; Glinka, A; Niehrs, C				Mao, BY; Wu, W; Li, Y; Hoppe, D; Stannek, P; Glinka, A; Niehrs, C			LDL-receptor-related protein 6 is a receptor for Dickkopf proteins	NATURE			English	Article							SPEMANN ORGANIZER; SIGNAL-TRANSDUCTION; SECRETED PROTEINS; HEAD INDUCTION; WNT; XENOPUS; ACTIVATION; EXPRESSION; ANTAGONIST; CERBERUS	Wnt glycoproteins have been implicated in diverse processes during embryonic patterning in metazoa. They signal through frizzled-type seven-transmembrane-domain receptors to stabilize beta -catenin(1,2). Wnt signalling is antagonized by the extracellular Wnt inhibitor dickkopf1 (dkk1), which is a member of a multigene family(3). dkk1 was initially identified as a head inducer in Xenopus embryos but the mechanism by which it blocks Wnt signalling is unknown. LDL-receptor-related protein 6 (LRP6) is required during Wnt/beta -catenin signalling in Drosophila, Xenopus and mouse, possibly acting as a co-receptor for Wnt(4-6). Here we show that LRP6 (ref. 7) is a specific, high-affinity receptor for Dkk1 and Dkk2. Dkk1 blocks LRP6-mediated Wnt/beta -catenin signalling by interacting with domains that are distinct from those required for Wnt/Frizzled interaction. dkk1 and LRP6 interact antagonistically during embryonic head induction in Xenopus where LRP6 promotes the posteriorizing role of Wnt/beta -catenin signalling. Thus, DKKs inhibit Wnt co-receptor function, exemplifying the modulation of LRP signalling by antagonists.	Deutsch Krebsforschungszentrum, Div Mol Embryol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Mao, Bingyu/L-9955-2014	Mao, Bingyu/0000-0002-7993-3158				Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brannon M, 1996, DEV BIOL, V180, P344, DOI 10.1006/dbio.1996.0306; Brown SP, 1998, J AGING PHYS ACTIV, V6, P248, DOI 10.1123/japa.6.3.248; Carnac G, 1996, DEVELOPMENT, V122, P3055; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X	26	835	898	4	45	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					321	325		10.1038/35077108	http://dx.doi.org/10.1038/35077108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357136				2022-12-28	WOS:000168710000051
J	Neff, U; Burns, SJ; Mangini, A; Mudelsee, M; Fleitmann, D; Matter, A				Neff, U; Burns, SJ; Mangini, A; Mudelsee, M; Fleitmann, D; Matter, A			Strong coherence between solar variability and the monsoon in Oman between 9 and 6 kyr ago	NATURE			English	Article							INDIAN MONSOON; SUMMER MONSOON; ASIAN MONSOON; CLIMATE; RAINFALL; PERIOD; RECONSTRUCTION; RADIOCARBON; SEDIMENT; RECORD	Variations in the amount of solar radiation reaching the Earth are thought to influence climate, but the extent of this influence on timescales of millennia to decades is unclear. A number of climate records show correlations between solar cycles and climate(1), but the absolute changes in solar intensity over the range of decades to millennia are small(2) and the influence of solar flux on climate is not well established. The formation of stalagmites in northern Oman has recorded past northward shifts of the intertropical convergence zone(3), whose northward migration stops near the southern shoreline of Arabia in the present climate(4). Here we present a high-resolution record of oxygen isotope variations, for the period from 9.6 to 6.1 kyr before present, in a Th-U-dated stalagmite from Oman. The delta O-18 record from the stalagmite, which serves as a proxy for variations in the tropical circulation and monsoon rainfall, allows us to make a direct comparison of the delta O-18 record with the Delta C-14 record from tree rings(5), which largely reflects changes in solar activity(6,7). The excellent correlation between the two records suggests that one of the primary controls on centennial- to decadal-scale changes in tropical rainfall and monsoon intensity during this time are variations in solar radiation.	Heidelberg Acad Sci, D-69120 Heidelberg, Germany; Univ Leipzig, Inst Meteorol, D-04103 Leipzig, Germany; Univ Bern, Inst Geol, CH-3012 Bern, Switzerland	Leipzig University; University of Bern	Burns, SJ (corresponding author), Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA.		Kushnir, Yochanan/B-4472-2013; Burns, Stephen/H-9419-2013; Mudelsee, Manfred/C-6063-2018	Mudelsee, Manfred/0000-0002-2364-9561				Beer J, 2000, QUATERNARY SCI REV, V19, P403, DOI 10.1016/S0277-3791(99)00072-4; BRYSON RA, 1981, QUATERNARY RES, V16, P135, DOI 10.1016/0033-5894(81)90041-7; Burns SJ, 1998, GEOLOGY, V26, P499, DOI 10.1130/0091-7613(1998)026<0499:SBPRFN>2.3.CO;2; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; Cook ER, 1998, HOLOCENE, V8, P9, DOI 10.1191/095968398677793725; DICKSON RR, 1984, J CLIM APPL METEOROL, V23, P171, DOI 10.1175/1520-0450(1984)023<0171:ESCVIM>2.0.CO;2; Frank N, 2000, QUATERNARY RES, V54, P38, DOI 10.1006/qres.2000.2135; GASSE F, 1990, NATURE, V346, P141, DOI 10.1038/346141a0; Haigh JD, 1996, SCIENCE, V272, P981, DOI 10.1126/science.272.5264.981; HASTENRATH S, 1985, CLIMATE CIRCULATION; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; Hoyt D.V., 1997, ROLE SUN CLIMATE CHA; *IAE AG, 1992, IAE TECHN REP SER, V331, P781; IVANOVICH M, 1993, URANIUM SERIES DISEQ; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; LAMB HF, 1995, NATURE, V373, P134, DOI 10.1038/373134a0; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Liu KB, 1998, GEOLOGY, V26, P135, DOI 10.1130/0091-7613(1998)026<0135:APROHC>2.3.CO;2; MEEHL GA, 1994, J CLIMATE, V7, P1033, DOI 10.1175/1520-0442(1994)007<1033:IOTLSI>2.0.CO;2; Overpeck J, 1996, CLIM DYNAM, V12, P213, DOI 10.1007/BF00211619; RITCHIE JC, 1985, NATURE, V314, P352, DOI 10.1038/314352a0; Rozanski K., 1993, AM GEOPHYSICAL UNION, V78, P1, DOI DOI 10.1029/GM078P0001; Schulz M, 1997, COMPUT GEOSCI, V23, P929, DOI 10.1016/S0098-3004(97)00087-3; SIROCKO F, 1993, NATURE, V364, P322, DOI 10.1038/364322a0; Solanki SK, 1999, GEOPHYS RES LETT, V26, P2465, DOI 10.1029/1999GL900370; SONTAKKE NA, 1993, J CLIMATE, V6, P1807, DOI 10.1175/1520-0442(1993)006<1807:COAISM>2.0.CO;2; Stocker TF, 1996, PALEOCEANOGRAPHY, V11, P773, DOI 10.1029/96PA02640; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Stuiver M., 1993, HOLOCENE, V3, P289, DOI DOI 10.1177/095968369300300401; Wang L, 1999, MAR GEOL, V156, P245, DOI 10.1016/S0025-3227(98)00182-0	30	541	599	5	119	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					290	293		10.1038/35077048	http://dx.doi.org/10.1038/35077048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357127				2022-12-28	WOS:000168710000042
J	Ghebrehewet, S; Quigley, C				Ghebrehewet, S; Quigley, C			Health professionals' attitudes to MMR vaccine - Format of "green book" should be changed	BRITISH MEDICAL JOURNAL			English	Letter									Ctr Communicable Dis Surveillance, Chester CH1 4EF, Cheshire, England; Publ Hlth Lab, Cheshire & Wirral Communicable Dis Unit, Chester CH2 1UL, Cheshire, England		Ghebrehewet, S (corresponding author), Ctr Communicable Dis Surveillance, Chester CH1 4EF, Cheshire, England.							GHEBREHEWET S, 1999, MFPHM            OCT; HMSO, 1996, IMM INF DIS; LAKHANI A, 1986, REPORT INVESTIGATION; Petrovic M, 2001, BRIT MED J, V322, P82, DOI 10.1136/bmj.322.7278.82; WATSON JC, 1998, MMWR-MORBID MORTAL W, V47, P33	5	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1120	1120						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11360902				2022-12-28	WOS:000168628300033
J	Silove, D; Steel, Z; Mollica, RF				Silove, D; Steel, Z; Mollica, RF			Detention of asylum seekers: assault on health, human rights, and social development	LANCET			English	Article									Univ New S Wales, Sch Psychiat, Psychiat Res & Teaching Unit, Sydney, NSW 2107, Australia; Harvard Univ, Sch Med, Harvard Program Refugee Trauma, Boston, MA USA	University of New South Wales Sydney; Harvard University; Harvard Medical School	Silove, D (corresponding author), Univ New S Wales, Sch Psychiat, Psychiat Res & Teaching Unit, Sydney, NSW 2107, Australia.			Steel, Zachary/0000-0002-5048-2920				*HUM RIGHTS WATCH, 2000, LOCK AW IMM DET JAIL; Thompson M., 1998, MENTAL HLTH WELL BEI, P27	2	53	53	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1436	1437		10.1016/S0140-6736(00)04575-X	http://dx.doi.org/10.1016/S0140-6736(00)04575-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356469				2022-12-28	WOS:000168478200041
J	Gao, YQ; Marcus, RA				Gao, YQ; Marcus, RA			Strange and unconventional isotope effects in ozone formation	SCIENCE			English	Article							COLLISIONAL ENERGY-TRANSFER; HEAVY OZONE; MOLECULAR-OXYGEN; UNIMOLECULAR PROCESSES; INTRAMOLECULAR THEORY; POLYATOMIC-MOLECULES; STRATOSPHERIC OZONE; TROPOSPHERIC OZONE; EXCHANGE-REACTION; FORMATION RATES	The puzzling mass-independent isotopic enrichment in ozone formation contrasts markedly with the more recently observed large unconventional mass-dependent ratios of the individual ozone formation rate constants in certain systems. An RRKM (Rice, Ramsperger, Kassel, Marcus)-based theory is used to treat both effects. Restrictions of symmetry on how energy is shared among the rotational/vibrational states of the ozone isotopomer, together with an analysis of the competition between the transition states of its two exit channels, permit the calculation of isotope effects consistent with a wide array of experimental results.	CALTECH, Arthur Amos Noyes Lab Chem Phys, Pasadena, CA 91125 USA	California Institute of Technology	Marcus, RA (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Mail Code 127-72, Pasadena, CA 91125 USA.	ram@caltech.edu						ABBAS MM, 1987, J GEOPHYS RES-ATMOS, V92, P13231, DOI 10.1029/JD092iD11p13231; ANDERSON SM, 1987, GEOPHYS RES LETT, V14, P91, DOI 10.1029/GL014i001p00091; ANDERSON SM, 1985, J CHEM PHYS, V83, P1648, DOI 10.1063/1.449402; Anderson SM, 1997, J CHEM PHYS, V107, P5385, DOI 10.1063/1.474247; BAINSSAHOTA SK, 1987, J PHYS CHEM-US, V91, P4370, DOI 10.1021/j100300a031; Bao HM, 2000, NATURE, V406, P176, DOI 10.1038/35018052; BARKER JR, 1993, INT REV PHYS CHEM, V12, P305, DOI 10.1080/01442359309353284; BIGELEISEN J, 1947, J CHEM PHYS, V15, P261, DOI 10.1063/1.1746492; BRUNETTI B, 1981, J CHEM PHYS, V74, P6734, DOI 10.1063/1.441130; CARLI B, 1988, J GEOPHYS RES-ATMOS, V93, P3851, DOI 10.1029/JD093iD04p03851; Christensen LK, 1996, J MOL SPECTROSC, V175, P220, DOI 10.1006/jmsp.1996.0027; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; GAO YF, UNPUB; Gellene GI, 1996, SCIENCE, V274, P1344, DOI 10.1126/science.274.5291.1344; GILBERT RG, 1995, AUST J CHEM, V48, P1787, DOI 10.1071/CH9951787; Gilbert RG., 1990, THEORY UNIMOLECULAR; Gross A, 1997, CHEM PHYS, V217, P1, DOI 10.1016/S0301-0104(97)84555-7; Guenther J, 1999, CHEM PHYS LETT, V306, P209, DOI 10.1016/S0009-2614(99)00469-8; HASE WL, 1976, J CHEM PHYS, V64, P2442, DOI 10.1063/1.432545; Hathorn BC, 2000, J CHEM PHYS, V113, P9497, DOI 10.1063/1.1321045; Hathorn BC, 1999, J CHEM PHYS, V111, P4087, DOI 10.1063/1.480267; Hathorn BC, 2001, J PHYS CHEM A, V105, P5586, DOI 10.1021/jp003849a; HEIDENREICH JE, 1986, J CHEM PHYS, V84, P2129, DOI 10.1063/1.450373; HEIDENREICH JE, 1983, J CHEM PHYS, V78, P892, DOI 10.1063/1.444791; HIPPLER H, 1990, J CHEM PHYS, V93, P6560, DOI 10.1063/1.458972; Holbrook K.A., 1996, UNIMOLECULAR REACTIO; Irion FW, 1996, GEOPHYS RES LETT, V23, P2377, DOI 10.1029/96GL01695; Janssen C, 1999, J CHEM PHYS, V111, P7179, DOI 10.1063/1.480045; Johnston JC, 1997, J GEOPHYS RES-ATMOS, V102, P25395, DOI 10.1029/97JD02075; KAYE JA, 1983, J GEOPHYS RES-OCEANS, V88, P8447, DOI 10.1029/JC088iC13p08447; KAYE JA, 1986, J GEOPHYS RES-ATMOS, V91, P7865, DOI 10.1029/JD091iD07p07865; Kim SK, 1996, J PHYS CHEM-US, V100, P9202, DOI 10.1021/jp961066c; KLIPPENSTEIN SJ, 1989, J CHEM PHYS, V91, P2280, DOI 10.1063/1.457035; KNOCHENMUSS R, 1995, J PHYS CHEM-US, V99, P3881, DOI 10.1021/j100011a066; Krankowsky D, 2000, GEOPHYS RES LETT, V27, P2593, DOI 10.1029/2000GL011812; Krankowsky D, 1996, SCIENCE, V274, P1324, DOI 10.1126/science.274.5291.1324; KRANKOWSKY D, 1995, GEOPHYS RES LETT, V22, P1713, DOI 10.1029/95GL01436; LEFORESTIER C, 1994, J CHEM PHYS, V101, P3806, DOI 10.1063/1.467498; LENDVAY G, 1995, ADV CHEM K, V2, P481; Luerssen B, 2000, CHEM PHYS LETT, V316, P331, DOI 10.1016/S0009-2614(99)01302-0; MARCUS RA, 1970, J CHEM PHYS, V52, P1018, DOI 10.1063/1.1673009; MARCUS RA, 1952, J CHEM PHYS, V20, P359, DOI 10.1063/1.1700424; Marcus RA, 2001, J CHEM PHYS, V114, P9807, DOI 10.1063/1.1370552; MARCUS RA, 1965, J CHEM PHYS, V43, P2658, DOI 10.1063/1.1697191; MATSUHISA Y, 1978, GEOCHIM COSMOCHIM AC, V42, P173, DOI 10.1016/0016-7037(78)90130-8; MAUERSBERGER K, 1987, GEOPHYS RES LETT, V14, P80, DOI 10.1029/GL014i001p00080; MAUERSBERGER K, 1981, GEOPHYS RES LETT, V8, P935, DOI 10.1029/GL008i008p00935; MAUERSBERGER K, 1993, GEOPHYS RES LETT, V20, P1031, DOI 10.1029/93GL01080; Mauersberger K, 1999, SCIENCE, V283, P370, DOI 10.1126/science.283.5400.370; Meier A, 1996, GEOPHYS RES LETT, V23, P551, DOI 10.1029/96GL00374; MORTON J, 1989, CHEM PHYS LETT, V154, P143, DOI 10.1016/S0009-2614(89)87276-8; MORTON J, 1990, J GEOPHYS RES-ATMOS, V95, P901, DOI 10.1029/JD095iD01p00901; OREF I, 1979, ACCOUNTS CHEM RES, V12, P166, DOI 10.1021/ar50137a002; QUACK M, 1977, BER BUNSEN PHYS CHEM, V81, P329, DOI 10.1002/bbpc.19770810318; SCHUELER B, 1990, GEOPHYS RES LETT, V17, P1295, DOI 10.1029/GL017i009p01295; SEHESTED J, 1995, J GEOPHYS RES-ATMOS, V100, P20979, DOI 10.1029/95JD02345; Sehested J, 1998, J GEOPHYS RES-ATMOS, V103, P3545, DOI 10.1029/97JD03124; SMITH GP, 1978, INT J CHEM KINET, V10, P489, DOI 10.1002/kin.550100507; STACE AJ, 1978, J CHEM PHYS, V68, P3028, DOI 10.1063/1.436169; THIEMENS MH, 1987, GEOPHYS RES LETT, V14, P624, DOI 10.1029/GL014i006p00624; THIEMENS MH, 1988, GEOPHYS RES LETT, V15, P639, DOI 10.1029/GL015i007p00639; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; THIEMENS MH, 1990, GEOPHYS RES LETT, V17, P717, DOI 10.1029/GL017i006p00717; THIEMENS MH, 1995, SCIENCE, V270, P969, DOI 10.1126/science.270.5238.969; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Tyuterev VG, 1999, J MOL SPECTROSC, V198, P57, DOI 10.1006/jmsp.1999.7928; WARDLAW DM, 1988, ADV CHEM PHYS, V70, P231, DOI 10.1002/9780470141199.ch7; WEINKAUF R, 1994, J PHYS CHEM-US, V98, P8381, DOI 10.1021/j100085a019; Weston RE, 1999, CHEM REV, V99, P2115, DOI 10.1021/cr9800154; Wiegell MR, 1997, INT J CHEM KINET, V29, P745, DOI 10.1002/(SICI)1097-4601(1997)29:10<745::AID-KIN3>3.0.CO;2-M; Wolf S, 2000, J CHEM PHYS, V113, P2684, DOI 10.1063/1.1305890; YANG JM, 1987, GEOCHIM COSMOCHIM AC, V51, P2011, DOI 10.1016/0016-7037(87)90189-X	74	272	279	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					259	263		10.1126/science.1058528	http://dx.doi.org/10.1126/science.1058528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11387441				2022-12-28	WOS:000169875200047
J	Block, SD				Block, SD			Psychological considerations, growth, and transcendence at the end of life - The art of the possible	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERMINALLY-ILL; CANCER-PATIENTS; PSYCHIATRIC MORBIDITY; DEPRESSION; ILLNESS; HALOPERIDOL; PATIENT; CARE; PREVALENCE; MANAGEMENT		Dana Farber Canc Inst, Dept Adult Psychosocial Oncol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Block, SD (corresponding author), Dana Farber Canc Inst, Dept Adult Psychosocial Oncol, 44 Binney St, Boston, MA 02115 USA.	sblock@partners.org						Adams F, 1986, Psychosomatics, V27, P33; AHLES TA, 1983, PAIN, V17, P277, DOI 10.1016/0304-3959(83)90100-8; Akechi T, 1996, SUPPORT CARE CANCER, V4, P390, DOI 10.1007/BF01788847; ALEXANDER PJ, 1993, ACTA ONCOL, V32, P623, DOI 10.3109/02841869309092441; American Board of Internal Medicine, 1996, CAR DYING ID PROM PH; Barkwell D P, 1991, J Palliat Care, V7, P5; Barnard D., 2011, CROSSING NARRATIVES, DOI [10.1093/acprof:oso/9780195123432.001.0001, DOI 10.1093/ACPROF:OSO/9780195123432.001.0001]; BERGER AM, 1998, PRINCIPLES PRACTICE; BLOCH SD, 1994, ARCH INTERN MED, V154, P2039, DOI 10.1001/archinte.154.18.2039; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; BLOCK SD, 1997, HARVARD MED ALUMNI B, V70, P37; BOLUND C, 1985, J PSYCHOSOC ONCOL, V3, P17; Bolund C., 1985, J PSYCHOSOC ONCOL, V3, P31; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Brandberg Y., 1992, PSYCHOONCOLOGY, V1, P71, DOI [10.1002/pon.2960010204, DOI 10.1002/PON.2960010204]; BREITBART B, 1998, OXFORD TXB PALLIATIV, P933; BREITBART W, 1995, J PAIN SYMPTOM MANAG, V10, P131, DOI 10.1016/0885-3924(94)00075-V; Breitbart W, 1996, AM J PSYCHIAT, V153, P231; Breitbart W, 1987, Oncology (Williston Park), V1, P49; BROWN JT, 1983, JAMA-J AM MED ASSOC, V250, P378, DOI 10.1001/jama.250.3.378; BRUERA E, 1989, PAIN, V39, P13, DOI 10.1016/0304-3959(89)90169-3; BRUERA E, 1992, J PAIN SYMPTOM MANAG, V7, P192, DOI 10.1016/0885-3924(92)90074-R; BRUERA E, 1990, PSYCHOSOCIAL ASPECTS, V9, P308; BUKBERG J, 1984, PSYCHOSOM MED, V46, P199, DOI 10.1097/00006842-198405000-00002; CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Cassem EH, 2000, HANDBOOK OF PSYCHIATRY IN PALLIATIVE MEDICINE, P13; CASSEM EH, 1995, PSYCHOSOMATICS, V36, pS2, DOI 10.1016/S0033-3182(95)71698-X; CELLA DF, 1991, J CLIN ONCOL, V9, P1500, DOI 10.1200/JCO.1991.9.8.1500; Chesney M, 1996, INT J STD AIDS, V7, P75, DOI 10.1258/0956462961917690; Chochinov HM, 2000, PSYCHOSOMATICS, V41, P500, DOI 10.1176/appi.psy.41.6.500; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; CLAYTON PJ, 1974, CAN PSYCHIAT ASSOC J, V19, P309, DOI 10.1177/070674377401900312; CLIPP EC, 1992, CANCER, V69, P1074, DOI 10.1002/1097-0142(19920215)69:4<1074::AID-CNCR2820690440>3.0.CO;2-L; COLON EA, 1991, PSYCHOSOMATICS, V32, P420, DOI 10.1016/S0033-3182(91)72045-8; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; DEAN C, 1987, J PSYCHOSOM RES, V31, P385, DOI 10.1016/0022-3999(87)90059-6; DeFlorio M, 1995, DEPRESSION, V3, P66; DEROGATIS LR, 1979, JAMA-J AM MED ASSOC, V242, P1504, DOI 10.1001/jama.242.14.1504; DEROGATIS LR, 1983, JAMA-J AM MED ASSOC, V249, P751, DOI 10.1001/jama.249.6.751; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; Erikson E.H., 1963, CHILDHOOD SOC; Fainsinger R, 1991, J Palliat Care, V7, P5; FLEISHMAN SB, 1994, AM J PSYCHIAT, V151, P763; Foley KM, 1998, OXFORD TXB PALLIATIV, P310; Frankl V. E., 1964, MANS SEARCH MEANING; GLAUS A, 1993, SUPPORT CARE CANCER, V1, P305, DOI 10.1007/BF00364968; Greisinger AJ, 1997, CANCER PRACT, V5, P147; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; KEITEL MA, 1990, J SURG ONCOL, V43, P148, DOI 10.1002/jso.2930430305; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; KOENIG HG, 1995, PSYCHOSOMATICS, V36, P369, DOI 10.1016/S0033-3182(95)71646-2; Krupnick J.L., 1984, BEREAVEMENT REACTION, P99; KUBLERROSS E, 1979, DEATH DYING; LEVINE PM, 1978, CANCER, V42, P1385, DOI 10.1002/1097-0142(197809)42:3<1385::AID-CNCR2820420349>3.0.CO;2-0; Lindemann E, 1944, AM J PSYCHIAT, V101, P141, DOI 10.1176/ajp.101.2.141; LUNDBERG JC, 1998, TXB PSYCHOONCOLOGY, P45; Mansell D, 2000, ARCH INTERN MED, V160, P2991, DOI 10.1001/archinte.160.19.2991; MASSIE MJ, 1990, J CLIN PSYCHIAT, V51, P12; MASSIE MJ, 1983, AM J PSYCHIAT, V140, P1048; MASSIE MJ, 1987, MED CLIN N AM, V71, P243, DOI 10.1016/S0025-7125(16)30868-9; MCCORMICK TR, 1995, WESTERN J MED, V163, P236; MCIVER B, 1994, J PAIN SYMPTOM MANAG, V9, P341, DOI 10.1016/0885-3924(94)90193-7; MENZA MA, 1988, HEART LUNG, V17, P238; Parkes Collin Murray, 1972, BEREAVEMENT STUDIES; Pattison E., 1978, PSYCHOSOCIAL CARE DY, P133; Pereira J, 1997, CANCER-AM CANCER SOC, V79, P835; PLATT MM, 1994, J NEUROPSYCH CLIN N, V6, P66; PLUMB M, 1981, PSYCHOSOM MED, V43, P243, DOI 10.1097/00006842-198106000-00006; PLUMB MM, 1977, PSYCHOSOM MED, V39, P264, DOI 10.1097/00006842-197707000-00007; PORTENOY RK, 1994, QUAL LIFE RES, V3, P183, DOI 10.1007/BF00435383; Saunders Cicely., 1967, MANAGEMENT TERMINAL; Schulz R, 1995, J PSYCHOSOC ONCOL, V13, P21, DOI 10.1300/J077V13N03_02; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Sipahimalani A, 1998, PSYCHOSOMATICS, V39, P422, DOI 10.1016/S0033-3182(98)71301-5; Sipahimalani A, 1997, Ann Clin Psychiatry, V9, P105, DOI 10.1023/A:1026209520113; SMITH CK, 1981, J FAM PRACTICE, V12, P283; Smith Elizabeth D., 1993, Journal of Psychosocial Oncology, V11, P89; SPIEGEL D, 1994, CANCER, V74, P2570, DOI 10.1002/1097-0142(19941101)74:9<2570::AID-CNCR2820740927>3.0.CO;2-3; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sternbach RA, 1974, PAIN PATIENTS TRAITS; STILES WB, 1979, SOC SCI MED-MED SOC, V13, P335, DOI 10.1016/0271-7123(79)90055-5; SYRJALA KL, 1995, PAIN, V61, P69, DOI 10.1016/0304-3959(94)00153-6; TEMOSHOK L, 1987, CANCER SURV, V6, P545; TSUANG MM, 1971, J AM GERIATR SOC, V19, P593, DOI 10.1111/j.1532-5415.1971.tb02580.x; Ventafridda V, 1990, J Palliat Care, V6, P7; Weisman AD, 1980, PSYCHOSOCIAL SCREENI; WEISMAN AD, 1976, CANC BEHAV DIMENSION, P96; WEISMAN AD, 1987, JAMA-J AM MED ASSOC, V258, P3125; WEISMAN AD, 1972, DYING DENYING; WELLISCH D K, 1989, Journal of Psychosocial Oncology, V7, P55, DOI 10.1300/J077v07n01_05; Wilson KG, 2000, HANDBOOK OF PSYCHIATRY IN PALLIATIVE MEDICINE, P25; WOODFORD.JM, 1970, J PSYCHOSOM RES, V14, P365, DOI 10.1016/0022-3999(70)90002-4; WORDEN JW, 1975, J PSYCHOSOM RES, V19, P69, DOI 10.1016/0022-3999(75)90052-5; Yalom I.D., 1980, EXISTENTIAL PSYCHOTH	99	187	188	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2898	2905		10.1001/jama.285.22.2898	http://dx.doi.org/10.1001/jama.285.22.2898			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440BP	11401612				2022-12-28	WOS:000169156300030
J	Franklin, MC; Wang, JM; Steitz, TA				Franklin, MC; Wang, JM; Steitz, TA			Structure of the replicating complex of a pol alpha family DNA polymerase	CELL			English	Article							I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; KINETIC CHARACTERIZATION; ACTIVE-SITE; REVERSE-TRANSCRIPTASE; ANGSTROM RESOLUTION; MUTATIONAL ANALYSIS; TERNARY COMPLEXES; B-DNA; BACTERIOPHAGE-T4	We describe the 2.6 Angstrom resolution crystal structure of RB69 DNA polymerase with primer-template DNA and dTTP, capturing the step just before primer extension. This ternary complex structure in the human DNA polymerase alpha family shows a 60 degrees rotation of the fingers domain relative to the ape-protein structure, similar to the fingers movement in pol I family polymerases. Minor groove interactions near the primer 3' terminus suggest a common fidelity mechanism for pol I and pol alpha family polymerases. The duplex product DNA orientation differs by 40 degrees between the polymerizing mode and editing mode structures. The role of the thumb in this DNA motion provides a model for editing in the pol alpha family.	Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA; Yale Univ, Dept Chem, New Haven, CT 06511 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009		NIGMS NIH HHS [GM57510] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Bankier A T, 1983, Mol Biol Med, V1, P21; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Berdis AJ, 1996, P NATL ACAD SCI USA, V93, P12822, DOI 10.1073/pnas.93.23.12822; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; BLASCO MA, 1995, J BIOL CHEM, V270, P2735, DOI 10.1074/jbc.270.6.2735; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; COWART M, 1989, BIOCHEMISTRY-US, V28, P1975, DOI 10.1021/bi00431a004; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Dressman HK, 1997, P NATL ACAD SCI USA, V94, P8042, DOI 10.1073/pnas.94.15.8042; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; EPSTEIN RH, 1963, COLD SPRING HARB SYM, V28, P375, DOI 10.1101/SQB.1963.028.01.053; Frey B, 1995, BIOCHEMICA, V2, P34; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gardner AF, 1999, NUCLEIC ACIDS RES, V27, P2545, DOI 10.1093/nar/27.12.2545; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUGHES MB, 1987, GENETICS, V115, P393; HUNTER WN, 1987, NUCLEIC ACIDS RES, V15, P6589, DOI 10.1093/nar/15.16.6589; HUNTER WN, 1987, J BIOL CHEM, V262, P9962; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Jang SB, 1998, BIOCHEMISTRY-US, V37, P11726, DOI 10.1021/bi980758j; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karam JD, 2000, PROG NUCLEIC ACID RE, V64, P65, DOI 10.1016/S0079-6603(00)64002-3; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kool ET, 1998, BIOPOLYMERS, V48, P3, DOI 10.1002/(SICI)1097-0282(1998)48:1<3::AID-BIP2>3.0.CO;2-7; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; LIN TC, 1994, J BIOL CHEM, V269, P19286; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan BC, 1999, BIOCHEMISTRY-US, V38, P2826, DOI 10.1021/bi982122y; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pavlov AR, 2000, NUCLEIC ACIDS RES, V28, P4657, DOI 10.1093/nar/28.23.4657; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; REHAKRANTZ LJ, 1989, J VIROL, V63, P4762, DOI 10.1128/JVI.63.11.4762-4766.1989; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Saturno J, 1995, J BIOL CHEM, V270, P31235, DOI 10.1074/jbc.270.52.31235; Saturno J, 1998, J MOL BIOL, V283, P633, DOI 10.1006/jmbi.1998.2121; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; STOCKI SA, 1995, J MOL BIOL, V254, P15, DOI 10.1006/jmbi.1995.0595; TUERK C, 1990, J MOL BIOL, V213, P749, DOI 10.1016/S0022-2836(05)80261-X; WANG CC, 1995, J BIOL CHEM, V270, P26558, DOI 10.1074/jbc.270.44.26558; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Wu P, 1998, BIOCHEMISTRY-US, V37, P14748, DOI 10.1021/bi980835a; Yang GW, 1999, BIOCHEMISTRY-US, V38, P8094, DOI 10.1021/bi990653w; Zhao YX, 1999, STRUCTURE, V7, P1189, DOI 10.1016/S0969-2126(00)80053-2; [No title captured]	69	471	483	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					657	667		10.1016/S0092-8674(01)00367-1	http://dx.doi.org/10.1016/S0092-8674(01)00367-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389835	Bronze			2022-12-28	WOS:000169123200012
J	Schliekelman, P; Garner, C; Slatkin, M				Schliekelman, P; Garner, C; Slatkin, M			Natural selection and resistance to HIV	NATURE			English	Article							HAPLOTYPES; PREVALENCE		Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schliekelman, P (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.							ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gregson S, 1996, AIDS, V10, P1689, DOI 10.1097/00002030-199612000-00014; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; *UN, 2000, JOINT UN PROGR HIV A; United States Census Bureau, 2000, CENS; Wilkinson D, 2000, J ACQ IMMUN DEF SYND, V23, P405	8	49	51	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					545	546		10.1038/35079176	http://dx.doi.org/10.1038/35079176			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385558				2022-12-28	WOS:000168982500037
J	He, S; MacLeod, DIA				He, S; MacLeod, DIA			Orientation-selective adaptation and tilt after-effect from invisible patterns	NATURE			English	Article							PRIMARY VISUAL-CORTEX; GRATINGS; VISION	Exposure to visual patterns of high contrast (for example, gratings formed by alternating white and black bars) creates after-effects in perception. We become temporarily insensitive to faint test patterns that resemble the pre-exposed pattern (such as gratings of the same orientation), and we require more contrast to detect them(1). Moreover, if the test pattern is slightly tilted relative to the pre-exposed one, this tilt may be perceptually exaggerated: we experience a tilt after-effect(2,3). Here we show that these visual after-effects occur even if the pre-exposed grating is too fine to be perceptually resolved. After looking at a very fine grating, so high in spatial frequency that it was perceptually indistinguishable from a uniform field, observers required more contrast to detect a test grating presented at the same orientation than one presented at the orthogonal orientation. They also experienced a tilt aftereffect that depended on the relation of the test pattern's tilt to the unseen orientation of the pre-exposed pattern. Because these after-effects are due to changes in orientation-sensitive mechanisms in visual cortex(4-6), our observations imply that extremely fine details, even those too fine to be seen, can penetrate the visual system as far as the cortex, where they are represented neurally without conscious awareness.	Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego	He, S (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.							Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V186, P558, DOI 10.1113/jphysiol.1966.sp008056; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; COLTHEART M, 1971, PSYCHOL REV, V78, P114, DOI 10.1037/h0030639; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; He S, 1996, J OPT SOC AM A, V13, P1139, DOI 10.1364/JOSAA.13.001139; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; LEGRAND Y, 1937, REV OPT, V16, P201; LEVI DM, 1979, SCIENCE, V206, P852, DOI 10.1126/science.493988; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; McMahon MJ, 2000, J NEUROSCI, V20, P2043; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; RATLIFF F, 1965, MACH BANDS QUANTITAT, P1; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SEKIGUCHI N, 1993, J OPT SOC AM A, V10, P2118, DOI 10.1364/JOSAA.10.002118; Smallman HS, 1996, J NEUROSCI, V16, P1852; WOLFE JM, 1984, VISION RES, V24, P1959, DOI 10.1016/0042-6989(84)90030-0	19	120	124	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					473	476		10.1038/35078072	http://dx.doi.org/10.1038/35078072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373679				2022-12-28	WOS:000168858700048
J	Oren, R; Ellsworth, DS; Johnsen, KH; Phillips, N; Ewers, BE; Maier, C; Schafer, KVR; McCarthy, H; Hendrey, G; McNulty, SG; Katul, GG				Oren, R; Ellsworth, DS; Johnsen, KH; Phillips, N; Ewers, BE; Maier, C; Schafer, KVR; McCarthy, H; Hendrey, G; McNulty, SG; Katul, GG			Soil fertility limits carbon sequestration by forest ecosystems in a CO2-enriched atmosphere	NATURE			English	Article							TERRESTRIAL ECOSYSTEMS; NITROGEN LIMITATION; ELEVATED CO2; GROWTH; AIR; ENRICHMENT; FEEDBACKS; BIOSPHERE; BALANCE; BUDGET	Northern mid-latitude forests are a large terrestrial carbon sink(1-4). Ignoring nutrient limitations, large increases in carbon sequestration from carbon dioxide (CO2) fertilization are expected in these forests(5). Yet, forests are usually relegated to sites of moderate to poor fertility, where tree growth is often limited by nutrient supply, in particular nitrogen(6,7). Here we present evidence that estimates of increases in carbon sequestration of forests, which is expected to partially compensate for increasing CO2 in the atmosphere, are unduly optimistic(8). In two forest experiments on maturing pines exposed to elevated atmospheric CO2, the CO2-induced biomass carbon increment without added nutrients was undetectable at a nutritionally poor site, and the stimulation at a nutritionally moderate site was transient, stabilizing at a marginal gain after three years. However, a large synergistic gain from higher CO2 and nutrients was detected with nutrients added. This gain was even larger at the poor site (threefold higher than the expected additive effect) than at the moderate site (twofold higher). Thus, fertility can restrain the response of wood carbon sequestration to increased atmospheric CO2. Assessment of future carbon sequestration should consider the limitations imposed by soil fertility, as well as interactions with nitrogen deposition.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; Brookhaven Natl Lab, Dept Environm Sci, Upton, NY 11973 USA; US Forest Serv, So Res Stn, Res Triangle Pk, NC 27709 USA; Boston Univ, Dept Geog, Boston, MA 02215 USA; US Forest Serv, So Global Climate Change Program, Raleigh, NC 27606 USA	Duke University; University of Michigan System; University of Michigan; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Agriculture (USDA); United States Forest Service; Boston University; United States Department of Agriculture (USDA); United States Forest Service	Oren, R (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.	ramoren@duke.edu	McCarthy, Heather/Q-9347-2019; Katul, Gabriel G/A-7210-2008; Oren, Ram/AAC-5326-2019; Ewers, Brent E/A-9696-2008	Katul, Gabriel G/0000-0001-9768-3693; Oren, Ram/0000-0002-5654-1733; McNulty, Steven/0000-0003-4518-5646; McCarthy, Heather R/0000-0002-2219-5182; Ewers, Brent/0000-0001-6647-7475; Ellsworth, David/0000-0002-9699-2272				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Albaugh TJ, 1998, FOREST SCI, V44, P317; BAZZAZ FA, 1993, OECOLOGIA, V96, P478, DOI 10.1007/BF00320504; Berntson GM, 1996, PLANT SOIL, V187, P119, DOI 10.1007/BF00017085; Bolin B, 1999, SCIENCE, V285, P1851; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; COMINS HN, 1993, ECOL APPL, V3, P666, DOI 10.2307/1942099; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; ELLSWORTH DS, 1995, OECOLOGIA, V104, P139, DOI 10.1007/BF00328578; Field CB, 1999, SCIENCE, V285, P544, DOI 10.1126/science.285.5427.544; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Houghton RA, 1998, GLOBAL BIOGEOCHEM CY, V12, P25, DOI 10.1029/97GB02729; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; IDSO SB, 1993, GLOBAL BIOGEOCHEM CY, V7, P537, DOI 10.1029/93GB01164; Kicklighter DW, 1999, TELLUS B, V51, P343, DOI 10.1034/j.1600-0889.1999.00017.x; KORNER C, 1995, PLANT CELL ENVIRON, V18, P1101, DOI 10.1111/j.1365-3040.1995.tb00622.x; Linder S, 1995, ECOL B COPENHAGEN, V44, P178, DOI DOI 10.2307/20113161; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Naidu SL, 1998, CAN J FOREST RES, V28, P1116, DOI 10.1139/cjfr-28-8-1116; Norby RJ, 1998, NATURE, V396, P17, DOI 10.1038/23812; Oren R, 1998, ECOL APPL, V8, P990, DOI 10.1890/1051-0761(1998)008[0990:WBDTSL]2.0.CO;2; Oren R., 1996, P75; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Sokal Robert R., 1969, BIOMETRY; Tans PP, 1998, SCIENCE, V281, P183, DOI 10.1126/science.281.5374.183; Tissue DT, 1996, TREE PHYSIOL, V16, P49; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Wullschleger S., 1995, BIOTIC FEEDBACKS GLO, P85	30	795	844	8	425	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					469	472		10.1038/35078064	http://dx.doi.org/10.1038/35078064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373677	Green Published			2022-12-28	WOS:000168858700046
J	Berland, GK; Elliott, MN; Morales, LS; Algazy, JI; Kravitz, RL; Broder, MS; Kanouse, DE; Munoz, JA; Puyol, JA; Lara, M; Watkins, KE; Yang, H; McGlynn, EA				Berland, GK; Elliott, MN; Morales, LS; Algazy, JI; Kravitz, RL; Broder, MS; Kanouse, DE; Munoz, JA; Puyol, JA; Lara, M; Watkins, KE; Yang, H; McGlynn, EA			Health information on the Internet - Accessibility, quality, and readability in English and Spanish	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; DEPRESSION; OBESITY; ACCESS; SITES; GRAPH; CARE	Context Despite the substantial amount of health-related information available on the Internet, little is known about the accessibility, quality, and reading grade level of that health information. Objective To evaluate health information on breast cancer, depression, obesity, and childhood asthma available through English- and Spanish-language search engines and Web sites. Design and Setting Three unique studies were performed from July 2000 through December 2000, Accessibility of 14 search engines was assessed using a structured search experiment. Quality of 25 health Web sites and content provided by 1 search engine was evaluated by 34 physicians using structured implicit review (interrater reliability >0.90). The reading grade level of text selected for structured implicit review was established using the Fry Readability Graph method. Main Outcome Measures For the accessibility study, proportion of links leading to relevant content; for quality, coverage and accuracy of key clinical elements; and grade level reading formulas. Results Less than one quarter of the search engine's first pages of links led to relevant content (20% of English and 12% of Spanish). On average, 45% of the clinical elements on English- and 22% on Spanish-language Web sites were more than minimally covered and completely accurate and 24% of the clinical elements on English- and 53% on Spanish-language Web sites were not covered at all. All English and 86% of Spanish Web sites required high school level or greater reading ability. Conclusion Accessing health information using search engines and simple search terms is not efficient. Coverage of key information on English- and Spanish-language Web sites is poor and inconsistent, although the accuracy of the information provided is generally good. High reading levels are required to comprehend Web-based health information.	RAND Hlth, Santa Monica, CA USA; RAND Grad Sch, Santa Monica, CA USA; Univ Calif Los Angeles, Robert Wood Johnson Clin Scholars Program, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Univ Calif Davis, Davi Sch Med, Davis, CA 95616 USA	RAND Corporation; RAND Corporation; Pardee RAND Graduate School; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Davis	Berland, GK (corresponding author), 1700 Main St,M-29, Santa Monica, CA 90407 USA.		Fahimifar, Sepideh/M-5303-2019; Kravitz, Richard/AAF-7425-2021	Kravitz, Richard/0000-0001-5575-529X	NIA NIH HHS [P30 AG021684] Funding Source: Medline; NIMHD NIH HHS [P20 MD000148] Funding Source: Medline; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD000148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021684] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; AMBRE J, 1999, CRITERIA ASSESSING Q; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; BAUR C, 2000, MED GEN MED     0926, pE35; Beredjiklian PK, 2000, J BONE JOINT SURG AM, V82A, P1540, DOI 10.2106/00004623-200011000-00004; BIERMANN JS, 2000, CANCER, V86, P381; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Cole MG, 1999, AM J PSYCHIAT, V156, P1182; *CYB HLTH, 2000, 17 CYB HLTH; Davison K, 1997, Clin Perform Qual Health Care, V5, P64; Edejer TTT, 2000, BRIT MED J, V321, P797, DOI 10.1136/bmj.321.7264.797; Eysenbach G., 2000, J MED INTERNET RE S2, V2; FOX S, 2000, ONLINE HLTH CARE REV; FOX S, 2001, MORE ONLINE DOING MO; FRY E, 1977, J READING, V21, P242; FRY EB, 1969, READ TEACH, V22, P534; GILLIAM B, 1980, READING TEACHER  JAN, P46; GINZBERG E, 1991, JAMA-J AM MED ASSOC, V265, P238, DOI 10.1001/jama.265.2.238; Goldman J, 2000, HEALTH AFFAIR, V19, P140, DOI 10.1377/hlthaff.19.6.140; Griffiths KM, 2000, BMJ-BRIT MED J, V321, P1511, DOI 10.1136/bmj.321.7275.1511; *HLTH NET FDN, 2000, HON COD COND MED HLT; Impicciatore P, 1997, BMJ-BRIT MED J, V314, P1875, DOI 10.1136/bmj.314.7098.1875; *INT COM CORP SEAR, 2000, SEARCH ENG RANK WEB; *INT COM CORP SEAR, 2000, SEARCH ENG ALL CHART; *INT HEALTHC COAL, 2000, TIPS HLTH CONS FIND; Jiang YL, 2000, AM J ORTHOD DENTOFAC, V118, P4, DOI 10.1067/mod.2000.104492; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kim P, 1999, BMJ-BRIT MED J, V318, P647, DOI 10.1136/bmj.318.7184.647; Kincaid J Peter, 1975, TECHNICAL REPORT; Kirrsch IS., 1993, ADULT LITERACY AM, P201; LINDE K, 1998, COCHRANE REV CD ROM; Lopez David, 1996, ETHNIC LOS ANGELES, P139; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; McClung HJ, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.6.e2; McLellan F, 1998, LANCET S2, V352, pS1139, DOI DOI 10.1016/S0140-6736(98)90301-4]; *MED METR INC, 2000, INT RAT JUN; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mulrow, 1999, TREATMENT DEPRESSION; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; National Heart Lung and Blood Institute, 1998, NIH PUBL, V98-4083; *PC DAT, 2000, TOP 20 HEALTHC SIT S; Rippen H, 2000, J MED INTERNET RES, V2, DOI 10.2196/jmir.2.2.e9; Smith DH, 1997, AM J RESP CRIT CARE, V156, P787, DOI 10.1164/ajrccm.156.3.9611072; Soot LC, 1999, J VASC SURG, V30, P84, DOI 10.1016/S0741-5214(99)70179-5; *US CENS BUR, 2001, POP RAC HISP LAT OR; *US PREV SERV TASK, 1996, SCREEN BREAST CANC G; WILSON K, 1998, REV ANTIDEPRESSANT D; Winchester DP, 1998, CA-CANCER J CLIN, V48, P83, DOI 10.3322/canjclin.48.2.83; Winker MA, 2000, JAMA-J AM MED ASSOC, V283, P1600, DOI 10.1001/jama.283.12.1600; Yanovski SZ, 2000, ARCH INTERN MED, V160, P2581, DOI 10.1001/archinte.160.17.2581; 2000, HLTH INTERNET ETHICS	52	786	796	0	77	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2612	2621		10.1001/jama.285.20.2612	http://dx.doi.org/10.1001/jama.285.20.2612			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433LY	11368735	Bronze, Green Accepted			2022-12-28	WOS:000168761900028
J	Bradley, EH; Holmboe, ES; Mattera, JA; Roumanis, SA; Radford, MJ; Krumholz, HM				Bradley, EH; Holmboe, ES; Mattera, JA; Roumanis, SA; Radford, MJ; Krumholz, HM			A qualitative study of increasing beta-blocker use after myocardial infarction - Why do some hospitals succeed?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE GUIDELINES; OF-CARE; MEDICARE PATIENTS; MANAGEMENT; IMPROVEMENT; IMPACT; OUTCOMES	Context Based on evidence that beta -blockers can reduce mortality in patients with acute myocardial infarction (AMI), many hospitals have initiated performance improvement efforts to increase prescription of beta -blockers at discharge, Determination of the factors associated with such improvements may provide guidance to hospitals that have been less successful in increasing beta -blocker use, Objectives To identify factors that may influence the success of improvement efforts to increase beta -blocker use after AMI and to develop a taxonomy for classifying such efforts. Design, Setting, and Participants Qualitative study in which data were gathered from in-depth interviews conducted in March-June 2000 with 45 key physician, nursing, quality management, and administrative participants at 8 US hospitals chosen to represent a range of hospital sizes, geographic regions, and changes in beta -blocker use rates between October 1996 and September 1999. Main Outcome Measures initiatives, strategies, and approaches to improve care for patients with AMI. Results The interviews revealed 6 broad factors that characterized hospital-based improvement efforts: goals of the efforts, administrative support, support among clinicians, design and implementation of improvement initiatives, use of data, and modifying variables. Hospitals with greater improvements in beta -blocker use over time demonstrated 4 characteristics not found in hospitals with less or no improvement: shared goals for improvement, substantial administrative support, strong physician leadership advocating beta -blocker use, and use of credible data feedback, Conclusions This study provides a context for understanding efforts to improve care in the hospital setting by describing a taxonomy for classifying and evaluating such efforts. In addition, the study suggests possible elements of successful efforts to increase beta -blocker use for patients with AMI.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557	AHRQ HHS [R01 HS10407] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010407] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AGUSTI A, 1994, EUR J CLIN PHARMACOL, V46, P95; AUDET AM, 1990, ANN INTERN MED, V113, P709, DOI 10.7326/0003-4819-113-9-709; Berwick D. M, 1990, CURING HLTH CARE NEW; Blumenthal D, 1998, MILBANK Q, V76, P625, DOI 10.1111/1468-0009.00108; BLUMENTHAL D, 1995, IMPROVING CLIN PRACT; Bogardus ST, 1998, J GEN INTERN MED, V13, P675, DOI 10.1046/j.1525-1497.1998.00203.x; BRAND DA, 1995, J AM COLL CARDIOL, V26, P1432, DOI 10.1016/0735-1097(95)00362-2; Carman JM, 1996, HEALTH CARE MANAGE R, V21, P48; CONSTAS MA, 1992, AM EDUC RES J, V29, P253, DOI 10.3102/00028312029002253; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; CRECO PJ, 1993, NEW ENGL J MED, V329, P1271; CROCKETT SE, 1998, BETA BLOCKER PROPHYL; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; French WJ, 2000, AM J CARDIOL, V85, p5B; Glaser B.G., 1965, AWARENESS DYING; GURWITZ JH, 1992, AM J MED, V93, P605, DOI 10.1016/0002-9343(92)90192-E; KARLSON BW, 1994, CLIN CARDIOL, V17, P311, DOI 10.1002/clc.4960170608; KOSECOFF J, 1987, JAMA-J AM MED ASSOC, V258, P2708, DOI 10.1001/jama.258.19.2708; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McCracken G., 1988, LONG INTERVIEW, V13; Miles M., 2013, QUALITATIVE DATA ANA; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Shortell SM, 2000, MED CARE, V38, P207, DOI 10.1097/00005650-200002000-00010; Shortell SM, 1998, MILBANK Q, V76, P593, DOI 10.1111/1468-0009.00107; SIAL SH, 1994, J GEN INTERN MED, V9, P599, DOI 10.1007/BF02600301; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; Weiner BJ, 1997, HEALTH SERV RES, V32, P491; Weiner BJ, 1996, MED CARE RES REV, V53, P397, DOI 10.1177/107755879605300402; WHITFORD DL, 1994, BMJ-BRIT MED J, V309, P1268, DOI 10.1136/bmj.309.6964.1268; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	35	226	227	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2604	2611		10.1001/jama.285.20.2604	http://dx.doi.org/10.1001/jama.285.20.2604			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433LY	11368734	Bronze			2022-12-28	WOS:000168761900027
J	Lazarus, SC; Boushey, HA; Fahy, JV; Chinchilli, VM; Lemanske, RF; Sorkness, CA; Kraft, M; Fish, JE; Peters, SP; Craig, T; Drazen, JM; Ford, JG; Israel, E; Martin, RJ; Mauger, EA; Nachman, SA; Spahn, JD; Szefler, SJ				Lazarus, SC; Boushey, HA; Fahy, JV; Chinchilli, VM; Lemanske, RF; Sorkness, CA; Kraft, M; Fish, JE; Peters, SP; Craig, T; Drazen, JM; Ford, JG; Israel, E; Martin, RJ; Mauger, EA; Nachman, SA; Spahn, JD; Szefler, SJ		Natl Heart Lung Blood Inst Asthma	Long-acting beta(2)-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; BRONCHOALVEOLAR LAVAGE; AIRWAY INFLAMMATION; SALMETEROL; BUDESONIDE; BECLOMETHASONE; ALBUTEROL; SYMPTOMS	Context Long-acting beta (2)-agonists are prescribed for patients with persistent asthma and are sometimes used without inhaled corticosteroids (ICSs). No evidence exists, however, to support their use as monotherapy in adults with persistent asthma. Objective To examine the effectiveness of salmeterol xinafoate, a long-acting beta (2)- agonist, as replacement therapy in patients whose asthma is well controlled by low-dose triamcinolone acetonide, an ICS. Design and Setting A 28-week, randomized, blinded, placebo-controlled, parallel group trial conducted at 6 National Institutes of Health-sponsored, university-based ambulatory care centers from February 1997 to January 1999. Participants One hundred sixty-four patients aged 12 through 65 years with persistent asthma that was well controlled during a 6-week run-in period of treatment with inhaled triamcinolone (400 mug twice per day). Interventions Patients were randomly assigned to continue triamcinolone therapy (400 mug twice per day; n = 54) or switch to salmeterol (42 mug twice per day; n = 54) or to placebo (n = 56) for 16 weeks, after which all patients received placebo for an additional 6-week run-out period. Main Outcome Measures Change in morning and evening peak expiratory flow (PEF), forced expiratory volume in 1 second (FEV1), self-assessed asthma symptom scores, rescue albuterol use, asthma-specific quality-of-life scores, treatment failure, asthma exacerbation, bronchial reactivity, and markers of airway inflammation, compared among the 3 treatment groups. Results During the 16-week randomized treatment period, no significant differences between the salmeterol and triamcinolone groups were observed for conventional outcomes of clinical studies of asthma therapy-morning PEF, evening PEF, asthma symptom scores, rescue albuterol sulfate use, or quality of life. Both active treatments were superior to placebo. However, the salmeterol group had more treatment failures than the triamcinolone group (13/54 [24%] vs 3/54 [6%]; P=.004), as well as more asthma exacerbations (11/54 [20%] vs 4/54 [7%]; P=.04), greater increases in median (interquartile range) sputum eosinophils (2.4% [0.0% to 10.6%] vs -0.1% [-0.7% to 0.3%]; P<.001), eosinophil cationic protein (71 [-2 to 430] U/L vs -4 [-31 to 56] U/L; P=.005), and tryptase (3.1 [2.1 to7.6] ng/mL vs 0.0 [0.0 to 0.7] ng/mL; P<.001). The duration of benefit when patients were switched from active treatment to placebo after 22 weeks of randomized treatment was not significantly longer in the triamcinolone group than in the salmeterol group. Conclusions Patients with persistent asthma well controlled by low doses of triamcinolone cannot be switched to salmeterol monotherapy without risk of clinically significant loss of asthma control.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Milton S Hershey Med Ctr, Hershey, PA USA; Univ Wisconsin, Sch Med, Madison, WI USA; Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; Natl Jewish Med & Res Ctr, Denver, CO USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harlem Hosp Med Ctr, New York, NY USA	University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Jewish Health; Jefferson University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lazarus, SC (corresponding author), Univ Calif San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 USA.	lazma@itsa.ucsf.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL056443, U10HL051810, U10HL051823, U10HL051843, U10HL051845, U10HL051834, U10HL051831] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-03186] Funding Source: Medline; NHLBI NIH HHS [U10 HL-56443, U10 HL-51845, U10 HL-51843, U10 HL-51810, U10 HL-51834, U10 HL-51831, U10 HL-51823] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Boulet LP, 1997, CURR THER RES CLIN E, V58, P240, DOI 10.1016/S0011-393X(97)80020-3; COSTAIN D, 1990, BRIT MED J, V301, P797; DALONZO GE, 1994, JAMA-J AM MED ASSOC, V271, P1412, DOI 10.1001/jama.271.18.1412; FAHY JV, 1994, J ALLERGY CLIN IMMUN, V93, P1031, DOI 10.1016/S0091-6749(94)70052-4; GARDINER PV, 1994, AM J RESP CRIT CARE, V150, P1006, DOI 10.1164/ajrccm.150.4.7921429; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Kraft M, 1997, CHEST, V111, P1249, DOI 10.1378/chest.111.5.1249; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Li X, 1999, AM J RESP CRIT CARE, V160, P1493, DOI 10.1164/ajrccm.160.5.9811052; McIvor RA, 1998, AM J RESP CRIT CARE, V158, P924; MORLEY J, 1990, EUR RESPIR J, V3, P228; *NAT ASTHM ED PREV, 1997, 2 NIH NAT ASTHM ED P; Nathan RA, 1999, ANN ALLERG ASTHMA IM, V82, P521, DOI 10.1016/S1081-1206(10)63159-6; National Asthma Education and Prevention Program, 1991, EXP PAN REP GUID DIA; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Overbeek SE, 1996, CHEST, V110, P35, DOI 10.1378/chest.110.1.35; PAGE CP, 1991, LANCET, V337, P717, DOI 10.1016/0140-6736(91)90289-2; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; PEARLMAN DS, 1992, NEW ENGL J MED, V327, P1420, DOI 10.1056/NEJM199211123272004; Silkoff PE, 1997, AM J RESP CRIT CARE, V155, P260, DOI 10.1164/ajrccm.155.1.9001322; TASHKIN DP, 1992, AM REV RESPIR DIS, V145, P301, DOI 10.1164/ajrccm/145.2_Pt_1.301; Verberne AAPH, 1997, AM J RESP CRIT CARE, V156, P688, DOI 10.1164/ajrccm.156.3.9611067; Wallin A, 1999, AM J RESP CRIT CARE, V159, P79, DOI 10.1164/ajrccm.159.1.9801007; Woolcock A, 1996, AM J RESP CRIT CARE, V153, P1481, DOI 10.1164/ajrccm.153.5.8630590	31	296	310	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2583	2593		10.1001/jama.285.20.2583	http://dx.doi.org/10.1001/jama.285.20.2583			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433LY	11368732				2022-12-28	WOS:000168761900025
J	Bockelee-Morvan, D; Biver, N; Moreno, R; Colom, P; Crovisier, J; Gerard, E; Henry, F; Lis, DC; Matthews, H; Weaver, HA; Womack, M; Festou, MC				Bockelee-Morvan, D; Biver, N; Moreno, R; Colom, P; Crovisier, J; Gerard, E; Henry, F; Lis, DC; Matthews, H; Weaver, HA; Womack, M; Festou, MC			Outgassing behavior and composition of comet C/1999 S4 (LINEAR) during its disruption	SCIENCE			English	Article							HALE-BOPP; JCMT; IRAM; O1	The gas activity of comet C/1999 S4 (LINEAR) was monitored at radio wavelengths during its disruption. A runaway fragmentation of the nucleus may have begun around 18 July 2000 and proceeded until 23 July. The mass in small icy debris (less than or equal to 30-centimeter radius) was comparable to the mass in the Large fragments seen in optical images. The mass budget after breakup suggests a small nucleus (similar to 100- to 300-meter radius) that had been losing debris for weeks. The HNC, H2CO, H2S, and CS abundances relative to H2O measured during breakup are consistent with those obtained in other comets. However, a deficiency in CH3OH and CO is observed.	Observ Paris, F-92195 Meudon, France; Inst Radioastron Millimetr, F-38406 St Martin Dheres, France; CALTECH, Dept Phys, Pasadena, CA 91125 USA; Joint Astron Ctr, Hilo, HI 96720 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA; St Cloud State Univ, St Cloud, MN 56301 USA; Observ Midi Pyrenees, F-31400 Toulouse, France	UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; California Institute of Technology; Johns Hopkins University; Minnesota State Colleges & Universities; Saint Cloud State University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bockelee-Morvan, D (corresponding author), Observ Paris, F-92195 Meudon, France.		Womack, Maria/AAE-8510-2019; Weaver, Harold A/D-9188-2016	Womack, Maria/0000-0003-4659-8653; Weaver, Harold A/0000-0003-0951-7762; Lis, Dariusz/0000-0002-0500-4700				Biver N, 2000, ASTRON J, V120, P1554, DOI 10.1086/301529; Biver N, 1999, ASTRON J, V118, P1850, DOI 10.1086/301033; Biver N, 1997, SCIENCE, V275, P1915, DOI 10.1126/science.275.5308.1915; Biver N, 1997, EARTH MOON PLANETS, V78, P5, DOI 10.1023/A:1006229818484; BIVER N, 1997, THESIS U PARIS 7; BOCKELEEMORVAN D, 1994, PLANET SPACE SCI, V42, P193, DOI 10.1016/0032-0633(94)90032-9; BOCKELEEMORVAN D, 1995, ICARUS, V116, P18, DOI 10.1006/icar.1995.1111; CHEN J, 1994, ICARUS, V108, P265, DOI 10.1006/icar.1994.1061; Colom P, 1997, EARTH MOON PLANETS, V78, P37, DOI 10.1023/A:1006206924786; Crifo JF, 1997, ICARUS, V127, P319, DOI 10.1006/icar.1997.5690; Crovisier J, 1996, ASTRON ASTROPHYS, V310, pL17; Farnham TL, 2001, SCIENCE, V292, P1348, DOI 10.1126/science.1058886; Fulle M, 1998, ICARUS, V134, P235, DOI 10.1006/icar.1998.5943; Harmon JK, 1999, PLANET SPACE SCI, V47, P1409, DOI 10.1016/S0032-0633(99)00068-9; KIDGER M, 2000, 7467 IAU; MARSDEN BG, 1996, 6521 IAUC; Mumma MJ, 2001, SCIENCE, V292, P1334, DOI 10.1126/science.1058929; SEKANINA Z, 1984, ICARUS, V58, P81, DOI 10.1016/0019-1035(84)90099-X; SEKANINA Z, 1982, COMETS, P251; Teemu J, 2001, SCIENCE, V292, P1326, DOI 10.1126/science.1060858; VANDRIEL W, 1996, HIGH SENSITIVITY RAD, P229; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606	23	67	67	2	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1339	1343		10.1126/science.1058512	http://dx.doi.org/10.1126/science.1058512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359003				2022-12-28	WOS:000168862900036
J	Appelbaum, FR				Appelbaum, FR			Haematopoietic cell transplantation as immunotherapy	NATURE			English	Article							VERSUS-HOST-DISEASE; ALLOGENEIC BONE-MARROW; MINOR HISTOCOMPATIBILITY ANTIGENS; ACUTE MYELOID-LEUKEMIA; TUMOR GENE WT1; T-LYMPHOCYTES; CLASS-I; HLA SYSTEM; GRAFT; PROTEINASE-3	The graft-versus-tumour effect seen after allogeneic (genetically different) haematopoietic cell transplantation for human malignancies represents the clearest example of the power of the human immune system to eradicate cancer. Recent advances in our understanding of the immunobiology of stem-cell engraftment, tolerance and tumour eradication are allowing clinicians to better harness this powerful effect.	Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Appelbaum, FR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N,D5-310,POB 19024, Seattle, WA 98109 USA.							Anasetti C, 2000, BLOOD, V96, p582A; Appelbaum FR, 1999, SEMIN HEMATOL, V36, P401; BARNES DWH, 1956, BRIT MED J, V2, P626, DOI 10.1136/bmj.2.4993.626; Bergmann L, 1997, BLOOD, V90, P1217, DOI 10.1182/blood.V90.3.1217.1217_1217_1225; Bodmer JG, 1999, TISSUE ANTIGENS, V53, P407, DOI 10.1034/j.1399-0039.1999.530421.x; Bonnett D, 1999, P NATL ACAD SCI USA, V96, P8639, DOI 10.1073/pnas.96.15.8639; Borrello I, 2000, BLOOD, V95, P3011; CHAMPLIN R, 1990, BLOOD, V76, P418; Chen W, 1998, J IMMUNOTHER, V21, P257, DOI 10.1097/00002371-199807000-00003; Childs R, 2000, NEW ENGL J MED, V343, P750, DOI 10.1056/NEJM200009143431101; Dazzi F, 2000, BLOOD, V95, P67, DOI 10.1182/blood.V95.1.67.001k07_67_71; den Haan JMM, 1998, SCIENCE, V279, P1054, DOI 10.1126/science.279.5353.1054; Dermime S, 1996, CLIN CANCER RES, V2, P593; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; Gao LQ, 2000, BLOOD, V95, P2198, DOI 10.1182/blood.V95.7.2198.007k38_2198_2203; Giralt S, 2001, BLOOD, V97, P631, DOI 10.1182/blood.V97.3.631; Goulmy E, 1997, IMMUNOL REV, V157, P125, DOI 10.1111/j.1600-065X.1997.tb00978.x; Greenberg PD, 1999, SCIENCE, V285, P546, DOI 10.1126/science.285.5427.546; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HOROWITZ MM, 1990, BLOOD, V75, P555; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Inoue K, 1997, BLOOD, V89, P1405, DOI 10.1182/blood.V89.4.1405; KERNAN NA, 1994, BONE MARROW TRANSPL, P124; Khouri IF, 1998, J CLIN ONCOL, V16, P2817, DOI 10.1200/JCO.1998.16.8.2817; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; Krenger W, 1997, TRANSPLANTATION, V64, P553, DOI 10.1097/00007890-199708270-00001; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; MCSWEENEY PA, IN PRESS BLOOD; Molldrem J, 1996, BLOOD, V88, P2450, DOI 10.1182/blood.V88.7.2450.bloodjournal8872450; Molldrem JJ, 1997, BLOOD, V90, P2529, DOI 10.1182/blood.V90.7.2529.2529_2529_2534; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Mutis T, 1999, BLOOD, V93, P2336, DOI 10.1182/blood.V93.7.2336.407k26_2336_2341; NASH RA, 1992, BLOOD, V80, P1838; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; Papadopoulos EB, 1998, BLOOD, V91, P1083, DOI 10.1182/blood.V91.3.1083.1083_1083_1090; PARHAM P, 1992, NATURE, V360, P300, DOI 10.1038/360300a0; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Petersdorf EW, 1997, BLOOD, V89, P1818, DOI 10.1182/blood.V89.5.1818.1818_1818_1823; Petersdorf EW, 1998, BLOOD, V92, P3515, DOI 10.1182/blood.V92.10.3515.422k49_3515_3520; RIDDELL SR, 1992, SCIENCE, V257, P238; Sandmaier BM, 2000, BLOOD, V96, p479A; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; SLAVIN S, 2000, NEW FRONTIERS CANC T, P83; SOIFFER RJ, 1994, BLOOD, V84, P964; STORB R, 1973, TRANSPLANTATION, V15, P92, DOI 10.1097/00007890-197301000-00014; STORB R, 1999, HEMATOPOIETIC CELL T, P287; Storek J, 2000, LANCET, V355, P1843, DOI 10.1016/S0140-6736(00)02284-4; Sturrock A, 1996, J BIOL CHEM, V271, P32392, DOI 10.1074/jbc.271.50.32392; STURROCK AB, 1992, J BIOL CHEM, V267, P21193; SULLIVAN KM, 1994, BONE MARROW TRANSPL, P339; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Warren E H, 1998, Curr Opin Hematol, V5, P429, DOI 10.1097/00062752-199811000-00013; Warren EH, 1998, BLOOD, V91, P2197, DOI 10.1182/blood.V91.6.2197; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; WEIDEN PL, 1981, NEW ENGL J MED, V304, P1529, DOI 10.1056/NEJM198106183042507; Yu XZ, 1998, BLOOD, V92, P2963, DOI 10.1182/blood.V92.8.2963.420k13_2963_2970; Yu XZ, 2000, J IMMUNOL, V164, P4564, DOI 10.4049/jimmunol.164.9.4564	60	332	363	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					385	389		10.1038/35077251	http://dx.doi.org/10.1038/35077251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357147	Bronze			2022-12-28	WOS:000168710000062
J	Grohskopf, LA; Roth, VR; Feikin, DR; Arduino, MJ; Carson, LA; Tokars, JI; Holt, SC; Jensen, BJ; Hoffman, RE; Jarvis, WR				Grohskopf, LA; Roth, VR; Feikin, DR; Arduino, MJ; Carson, LA; Tokars, JI; Holt, SC; Jensen, BJ; Hoffman, RE; Jarvis, WR			Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BACTERIAL-CONTAMINATION; TRANSFUSION; BLOOD; SEPSIS	Background: In one month, 10 Serratia liquefaciens bloodstream infections and 6 pyrogenic reactions occurred in outpatients at a hemodialysis center. Methods: We performed a cohort study of all hemodialysis sessions on days that staff members reported S. liquefaciens bloodstream infections or pyrogenic reactions. We reviewed procedures and cultured samples of water, medications, soaps, and hand lotions and swabs from the hands of personnel. Results: We analyzed 208 sessions involving 48 patients. In 12 sessions, patients had S. liquefaciens bloodstream infections, and in 8, patients had pyrogenic reactions without bloodstream infection. Sessions with infections or reactions were associated with higher median doses of epoetin alfa than the 188 other sessions (6500 vs. 4000 U, P = 0.03) and were more common during afternoon or evening shifts than morning shifts (P = 0.03). Sessions with infections or reactions were associated with doses of epoetin alfa of more than 4000 U (multivariate odds ratio, 4.0; 95 percent confidence interval, 1.3 to 12.3). A review of procedures revealed that preservative-free, single-use vials of epoetin alfa were punctured multiple times, and residual epoetin alfa from multiple vials was pooled and administered to patients. S. liquefaciens was isolated from pooled epoetin alfa, empty vials of epoetin alfa, antibacterial soap, and hand lotion. All the isolates were identical by pulsed-field gel electrophoresis. After the practice of pooling epoetin alfa was discontinued and the contaminated soap and lotion were replaced, no further S. liquefaciens bloodstream infections or pyrogenic reactions occurred at this hemodialysis facility. Conclusions: Puncturing single-use vials multiple times and pooling preservative-free epoetin alfa caused this outbreak of bloodstream infections in a hemodialysis unit. To prevent similar outbreaks, dialysis units should use medication vials containing the doses most appropriate to their clinical needs. (N Engl J Med 2001;344:1491-7.) Copyright (C) 2001 Massachusetts Medical Society.	CDCP, Hosp Infect Program, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; CDCP, Prevent Med Residency, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; Colorado Dept Publ Hlth & Environm, Denver, CO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Colorado Department of Public Health & Environment	Grohskopf, LA (corresponding author), CDCP, Hosp Infect Program, 1600 Clifton Rd NE,Mailstop E-69, Atlanta, GA 30333 USA.		Arduino, Matthew/C-1461-2012	Arduino, Matthew/0000-0001-7072-538X				Association for the Advancement of Medical Instrumentation, 1992, AM NAT STAND HEM SYS; Boulton FE, 1998, TRANSFUSION MED, V8, P15; *DHHS, 1997, A019700509 DHHS; DUNCAN KL, 1994, TRANSFUSION, V34, P738, DOI 10.1046/j.1537-2995.1994.34894353473.x; FAVERO FS, 1998, HOSP INFECT, P357; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; *HLTH CAR FIN ADM, 1999, PROGR MEM INT; JEPPSSON B, 1984, ACTA CHIR SCAND, V150, P489; Maslow Joel N., 1993, P563; PETERSEN NJ, 1973, HEALTH LAB SCI, V10, P18; PUCKETT A, 1986, MED LAB SCI, V43, P252; *REN DAT SUST, 1994, SRDS 1994 ANN DAT RE; *REN DAT SYST, 1999, USRDS 199 ANN DAT RE; Roth VR, 2000, TRANSFUSION, V40, P931, DOI 10.1046/j.1537-2995.2000.40080931.x; SERRUYSSCHOUTENS E, 1984, EUR J CLIN MICROBIOL, V3, P316, DOI 10.1007/BF01977480; Tenover FC, 1997, INFECT CONT HOSP EP, V18, P426; WOLF CFW, 1993, TRANSFUSION S, V33, pS151; WOODFIELD DG, 1991, NEW ZEAL MED J, V104, P141	19	96	97	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1491	1497		10.1056/NEJM200105173442001	http://dx.doi.org/10.1056/NEJM200105173442001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357151				2022-12-28	WOS:000168677200001
J	Gage, BF; Waterman, AD; Shannon, W; Boechler, M; Rich, MW; Radford, MJ				Gage, BF; Waterman, AD; Shannon, W; Boechler, M; Rich, MW; Radford, MJ			Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED TRIAL; ANTITHROMBOTIC THERAPY; RISK-FACTORS; COST-EFFECTIVENESS; ISCHEMIC STROKE; ASPIRIN; WARFARIN; ANTICOAGULATION; PROPHYLAXIS; PREVENTION	Context Patients who have atrial frbrillation (AF) have an increased risk of stroke, but their absolute rate of stroke depends on age and comorbid conditions. Objective To assess the predictive value of classification schemes that estimate stroke risk in patients with AF. Design, Setting, and Patients Two existing classification schemes were combined into a new stroke-risk scheme, the CHADS(2) index, and all 3 classification schemes were validated. The CHADS(2) was formed by assigning 1 point each for the presence of congestive heart failure, hypertension, age 75 years or older, and diabetes mellitus and by assigning 2 points for history of stroke or transient ischemic attack. Data from peer review organizations representing 7 states were used to assemble a National Registry of AF (NRAF) consisting of 1733 Medicare beneficiaries aged 65 to 95 years who had nonrheumatic AF and were not prescribed warfarin at hospital discharge. Main Outcome Measure Hospitalization for ischemic stroke, determined by Medicare claims data. Results During 2121 patient-years of follow-up, 94 patients were readmitted to the hospital for ischemic stroke (stroke rate, 4.4 per 100 patient-years). As indicated by a ----c statistic greater than 0.5, the 2 existing classification schemes predicted stroke better than chance: ---c of 0.68 (95% confidence interval [CI], 0.65-0.71) for the scheme developed by the Atrial Fibrillation Investigators (AFI) and ---c of 0.74 (95% CI, 0.71-0.76) for the Stroke Prevention in Atrial Fibrillation (SPAF) III scheme. However, with a ---c statistic of 0.82 (95% CI, 0.80-0.84), the CHADS2 index was the most accurate predictor of stroke. The stroke rate per 100 patient-years without antithrombotic therapy increased by a factor of 1.5 (95% CI, 1.3-1.7) for each 1-point increase in the CHADS(2) score: 1.9 (95% CI, 1.2-3.0) for a score of 0; 2.8 (95% CI, 2.0-3.8) for 1; 4.0 (95% CI, 3.1-5.1) for 2; 5.9 (95% CI, 4.6-7.3) for 3; 8.5 (95% CI, 6.3-11.1) for 4; 22.5 (95% CI, 8.2-17.5) for 5; and 18.2 (95% CI, 10.5-27.4) for 6. Conclusion The 2 existing classification schemes and especially a new stroke risk index, CHADS(2), can quantify risk of stroke for patients who have AF and may aid in selection of antithrombotic therapy.	Washington Univ, Sch Med, Div Cardiol, St Louis, MO USA; Innovat Emergency Management Inc, Baton Rouge, LA USA; Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Washington Univ, Sch Med, Div Gen Med Sci, St Louis, MO 63110 USA	Washington University (WUSTL); Yale University; Washington University (WUSTL)	Gage, BF (corresponding author), Washington Univ, Sch Med, Div Gen Med Sci, Washington Univ Sch Med Campus,Box 8005,660 S Euc, St Louis, MO 63110 USA.		Rich, Michael/AAD-6167-2022; Waterman, Amy D./H-8467-2019	Rich, Michael/0000-0002-4243-9391; Waterman, Amy D./0000-0002-7799-0060; Gage, Brian/0000-0002-4727-8742; Radford, Martha/0000-0001-7503-9557	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010133] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS10133] Funding Source: Medline; NCI NIH HHS [500-99-CA02] Funding Source: Medline; NIH HHS [500-99-NH01] Funding Source: Medline; PHS HHS [500-99-VT01, 500-96-P612, 500-99-LA02, 500-96-P549, 500-99-ME01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allison P. D., 1995, SURVIVAL ANAL USING; ANDERSON DC, 1992, ANN INTERN MED, V116, P1, DOI 10.7326/0003-4819-116-1-1; Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273; ANDERSON DC, 1992, ANN INTERN MED, V116, P6; Benesch C, 1997, NEUROLOGY, V49, P660, DOI 10.1212/WNL.49.3.660; Blackshear JL, 1996, LANCET, V348, P633; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; Ezekowitz M, 1998, ARCH INTERN MED, V158, P1316; Feinberg WM, 1999, J GEN INTERN MED, V14, P56, DOI 10.1046/j.1525-1497.1999.00281.x; FLEGEL KM, 1989, STROKE, V20, P1000, DOI 10.1161/01.STR.20.8.1000; FOULKES MA, 1994, NEUROEPIDEMIOLOGY, V13, P19, DOI 10.1159/000110354; GAGE BF, 1995, JAMA-J AM MED ASSOC, V274, P1839, DOI 10.1001/jama.274.23.1839; Gage BF, 1998, STROKE, V29, P1083, DOI 10.1161/01.STR.29.6.1083; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Go AS, 2000, CIRCULATION, V102, P11, DOI 10.1161/01.CIR.102.1.11; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 1999, HEART, V82, P539, DOI 10.1136/hrt.82.5.539; Hellemons BSP, 1999, BMJ-BRIT MED J, V319, P958, DOI 10.1136/bmj.319.7215.958; Howitt A, 1999, BMJ-BRIT MED J, V318, P1324, DOI 10.1136/bmj.318.7194.1324; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; Kopecky SL, 1999, ARCH INTERN MED, V159, P1118, DOI 10.1001/archinte.159.10.1118; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Laupacis A, 1998, CHEST, V114, p579S, DOI 10.1378/chest.114.5_Supplement.579S; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Laupacis Andreas, 1997, Archives of Internal Medicine, V157, P1237; Lee E, 2013, STAT METHODS SURVIVA; Man-Son-Hing M, 1999, JAMA-J AM MED ASSOC, V282, P737, DOI 10.1001/jama.282.8.737; Mooney CZ, 1993, BOOTSTRAPPING NONPAR, DOI DOI 10.4135/9781412983532; MOULTON AW, 1991, AM J MED, V91, P156, DOI 10.1016/0002-9343(91)90008-L; Pearce LA, 2000, AM J MED, V109, P45, DOI 10.1016/S0002-9343(00)00440-X; Rothman K., 1998, MODERN EPIDEMIOLOGY; *STROK PREV ATR FI, 1995, J STROKE CEREBROVASC, V5, P147; Sudlow M, 1998, LANCET, V352, P1167, DOI 10.1016/S0140-6736(98)01401-9; VANLATUM JC, 1995, STROKE, V26, P801, DOI 10.1161/01.STR.26.5.801; Yuan Z, 1998, AM J PUBLIC HEALTH, V88, P395, DOI 10.2105/AJPH.88.3.395	38	3621	3749	2	136	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2864	2870		10.1001/jama.285.22.2864	http://dx.doi.org/10.1001/jama.285.22.2864			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BP	11401607	Bronze			2022-12-28	WOS:000169156300025
J	Torgerson, DJ; Bell-Syer, SEM				Torgerson, DJ; Bell-Syer, SEM			Hormone replacement therapy and prevention of nonvertebral fractures - A meta-analysis of randomized trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSTMENOPAUSAL WOMEN; ESTROGEN REPLACEMENT; HIP FRACTURE; BONE MASS; OSTEOPOROSIS; RISK; HEART; COMBINATION; ALENDRONATE; ESTRADIOL	Context Hormone replacement therapy (HRT) is widely considered to reduce fractures, but this belief is based on observational data; evidence from randomized trials is lacking. Objective To conduct a systematic review of all randomized trials of HRT that have reported or collected nonvertebral fracture data but that may not have focused on fracture prevention. Data Sources The MEDLINE, EMBASE, Science Citation Index, and Cochrane Controlled Trials Register databases were searched from 1997 through 2000 and a search was conducted of all recent systematic reviews to identify older studies. Authors were contacted to establish whether fracture data had been collected but not reported. Researchers in the field and pharmaceutical companies also were contacted to try to identify unpublished studies. Study Selection Trials were included in which participants had been randomized to at least 12 months of therapy and data on nonvertebral fractures at any other site and due to any cause were available. Of 70 initially identified studies, 22 were included in the analysis. Data Extraction Both investigators extracted data independently and appraised trial quality according to the Jadad scale, which assesses the methods of randomization, concealment allocation, and reporting of withdrawals and dropouts. Disagreements were resolved by discussion. Data Synthesis There was an overall 27% reduction in nonvertebral fractures in a pooled analysis (reduction favoring HRT in relative risk [RR], 0.73; 95% confidence interval [CI], 0.56-0.94; P=.02). This effect was greater among women randomized to HRT who had a mean age younger than 60 years (RR, 0.67; 95% CI, 0.46-0.98; P=.03), Among women with a mean age of 60 years or older, there was a reduced effect (RR, 0.88; 95% CI, 0.71-1.08; P=.22). For hip and wrist fractures alone, the effectiveness of HRT appeared more marked (RR, 0.60; 95% CI, 0.40-0.91; P=.02), particularly for women younger than 60 years (RR, 0.45; 95% CI, 0.26-0.79; P=.005). Conclusions Our meta-analysis of randomized controlled trials of HRT noted a statistically significant reduction in nonvertebral fractures. However, this effect may be attenuated in older women.	Univ York, Dept Hlth Studies, Heslington YO10 5DQ, England; Univ York, Ctr Hlth Econ, Heslington YO10 5DQ, England	University of York - UK; University of York - UK	Torgerson, DJ (corresponding author), Univ York, Dept Hlth Studies, Genesis 6,Univ Rd, Heslington YO10 5DQ, England.	djt6@york.ac.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275				AITKEN JM, 1973, BMJ-BRIT MED J, V3, P515, DOI 10.1136/bmj.3.5879.515; Alexandersen P, 1999, J CLIN ENDOCR METAB, V84, P3013, DOI 10.1210/jc.84.9.3013; Barrett-Connor E, 1998, BMJ-BRIT MED J, V317, P457; Bjarnason NH, 2000, BONE, V26, P561, DOI 10.1016/S8756-3282(00)00272-6; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; Cauley JA, 2001, AM J MED, V110, P442, DOI 10.1016/S0002-9343(01)00647-7; Cheng S, 2000, OSTEOPOROSIS INT, V11, pS175; Cohen FJ, 1998, CALCIFIED TISSUE INT, V63, P277, DOI 10.1007/s002239900526; Delmas PD, 2000, OSTEOPOROSIS INT, V11, P177, DOI 10.1007/PL00004180; Eiken P, 1997, BRIT J OBSTET GYNAEC, V104, P702, DOI 10.1111/j.1471-0528.1997.tb11981.x; Ettinger B, 1999, MENOPAUSE, V6, P282, DOI 10.1097/00042192-199906040-00003; Fitzpatrick LA, 2000, MAYO CLIN PROC, V75, P559, DOI 10.4065/75.6.559; Formica CA, 1998, OSTEOPOROSIS INT, V8, P1, DOI 10.1007/s001980050040; Freedman M, 2001, J NATL CANCER I, V93, P51, DOI 10.1093/jnci/93.1.51; Gallagher JC, 1999, J BONE MINER RES, V14, pS209; Genant HK, 1997, ARCH INTERN MED, V157, P2609, DOI 10.1001/archinte.157.22.2609; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; HUTCHINSON TA, 1979, LANCET, V2, P705; Ismail AA, 2000, OSTEOPOROSIS INT, V11, P248, DOI 10.1007/s001980050288; Komulainen MH, 1998, MATURITAS, V31, P45, DOI 10.1016/S0378-5122(98)00085-1; Lees B, 2001, OSTEOPOROSIS INT, V12, P251, DOI 10.1007/s001980170113; LINDSAY R, 1990, OBSTET GYNECOL, V76, P290; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Michaelsson K, 1998, OSTEOPOROSIS INT, V8, P540, DOI 10.1007/s001980050096; Michaelsson K, 1998, BMJ-BRIT MED J, V316, P1858; Moher D., 1999, HEALTH TECHNOL ASSES, V3, pi, DOI [DOI 10.3310/HTA3120, 10.3310/hta3120]; Mosekilde L, 2000, MATURITAS, V36, P181, DOI 10.1016/S0378-5122(00)00158-4; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; NACHTIGALL LE, 1979, OBSTET GYNECOL, V53, P277; NAESSEN T, 1990, ANN INTERN MED, V113, P95, DOI 10.7326/0003-4819-113-2-95; Orr-Walker BJ, 2000, ARCH INTERN MED, V160, P2161, DOI 10.1001/archinte.160.14.2161; Ravn P, 1999, ANN INTERN MED, V131, P935, DOI 10.7326/0003-4819-131-12-199912210-00005; Recker RR, 1999, ANN INTERN MED, V130, P897, DOI 10.7326/0003-4819-130-11-199906010-00005; Reginster JY, 2000, CALCIFIED TISSUE INT, V67, P191, DOI 10.1007/s002230001135; *ROYAL COLL PHYS, 1997, BMJ-BRIT MED J, V315, P149; Stevenson JC, 2000, OSTEOPOROSIS INT, V11, pS25; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Weiss SR, 1999, OBSTET GYNECOL, V94, P330, DOI 10.1016/S0029-7844(99)00313-0; Wimalawansa SJ, 1998, AM J MED, V104, P219, DOI 10.1016/S0002-9343(98)00029-1; WINDELER J, 1995, BRIT MED J, V310, P454, DOI 10.1136/bmj.310.6977.454	44	345	362	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2891	2897		10.1001/jama.285.22.2891	http://dx.doi.org/10.1001/jama.285.22.2891			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BP	11401611				2022-12-28	WOS:000169156300029
J	Arterburn, D; Noel, PH				Arterburn, D; Noel, PH			Extracts from "Clinical Evidence" - Obesity	BRITISH MEDICAL JOURNAL			English	Review							PRIMARY PULMONARY-HYPERTENSION; WEIGHT-LOSS; CONTROLLED TRIAL; DOUBLE-BLIND; APPETITE-SUPPRESSANT; UNITED-STATES; ORLISTAT; SIBUTRAMINE; EFFICACY; PLACEBO		Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA; US Dept Vet Affairs, S Texas Vet Hlth Care Syst, VERDICT, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Arterburn, D (corresponding author), Univ Texas, Hlth Sci Ctr, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.			Noel, Polly/0000-0002-1519-7489				Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; [Anonymous], 1998, CLIN GUID ID EV TREA; Apfelbaum M, 1999, AM J MED, V106, P179, DOI 10.1016/S0002-9343(98)00411-2; Bray GA, 1999, OBES RES, V7, P189, DOI 10.1002/j.1550-8528.1999.tb00701.x; BRAY GA, 2000, UPTODATE, V8; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235; Douketis JD, 1999, CAN MED ASSOC J, V160, P513; *EUR AG EV MED PRO, 1998, EUR PUBL ASS REP EPA; Finer N, 2000, INT J OBESITY, V24, P306, DOI 10.1038/sj.ijo.0801128; GAASCH WH, 2000, UPTODATE, V8; GARDIN JM, 2000, JAMA-J AM MED ASSOC, V283, P703; GOLDSTEIN DJ, 1994, INT J OBESITY, V18, P129; GREENWAY FL, 1992, AM J CLIN NUTR, V55, P203; Hagiwara M, 2000, JPN CIRC J, V64, P218, DOI 10.1253/jcj.64.218; Hanotin C, 1998, INT J OBESITY, V22, P32, DOI 10.1038/sj.ijo.0800540; Hauptman J, 2000, ARCH FAM MED, V9, P160, DOI 10.1001/archfami.9.2.160; Hollander PA, 1998, DIABETES CARE, V21, P1288, DOI 10.2337/diacare.21.8.1288; HORWITZ RI, 2001, PHENYLPROPANOLAMINE; Jones S.P., 1995, INT J OBES S2, V19, P41; Khan LK, 2001, ANN INTERN MED, V134, P282, DOI 10.7326/0003-4819-134-4-200102200-00011; Lindgarde F, 2000, J INTERN MED, V248, P245, DOI 10.1046/j.1365-2796.2000.00720.x; LITTLE JD, 1993, INT CLIN PSYCHOPHARM, V8, P67, DOI 10.1097/00004850-199300810-00012; Luque CA, 1999, ANN PHARMACOTHER, V33, P968, DOI 10.1345/aph.18319; McKay R H, 1973, Curr Med Res Opin, V1, P489, DOI 10.1185/03007997309111712; McMahon FG, 2000, ARCH INTERN MED, V160, P2185, DOI 10.1001/archinte.160.14.2185; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mulrow CD, 1998, PSYCHOPHARMACOL BULL, V34, P409; MUNRO JF, 1968, BRIT MED J, V1, P352, DOI 10.1136/bmj.1.5588.352; OKANE M, 1994, DIABETIC MED, V11, P105, DOI 10.1111/j.1464-5491.1994.tb00238.x; OST LG, 1976, ADDICT BEHAV, V1, P331, DOI 10.1016/0306-4603(76)90041-1; Peleg R, 2000, ISRAEL MED ASSOC J, V2, P712; POSTON WS, 2000, J TEXAS MED, V96, P48; Rossner S, 2000, OBES RES, V8, P49, DOI 10.1038/oby.2000.8; Scheen AJ, 1999, INT J OBESITY, V23, P47; SILVERSTONE J T, 1965, Br J Clin Pract, V19, P395; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; STUNKARD AJ, 1980, LANCET, V2, P1045; THOMAS SHL, 1995, BRIT HEART J, V74, P660; *U YORK, 1997, SYST REV INT PREV TR; *US FOOD DRUG ADM, 2001, PHEN PPA INF PAG; VERNACE BJ, 1974, OBESITY BARIAT MED, V3, P124; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P581, DOI 10.1038/clpt.1992.68; WEINTRAUB M, 1991, CLIN PHARMACOL THER, V50, P330, DOI 10.1038/clpt.1991.144; Weissman NJ, 1998, NEW ENGL J MED, V339, P725, DOI 10.1056/NEJM199809103391103; Yanovski SZ, 1996, JAMA-J AM MED ASSOC, V276, P1907, DOI 10.1001/jama.276.23.1907; 1999, CAN FAM PHYSICIAN, V45, P2331	48	25	27	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1406	1409		10.1136/bmj.322.7299.1406	http://dx.doi.org/10.1136/bmj.322.7299.1406			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397749	Green Published			2022-12-28	WOS:000169284600020
J	Pell, JP; Sirel, JM; Marsden, AK; Ford, I; Cobbe, SM				Pell, JP; Sirel, JM; Marsden, AK; Ford, I; Cobbe, SM			Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study	BRITISH MEDICAL JOURNAL			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; EMERGENCY MEDICAL TECHNICIANS; AMERICAN-HEART-ASSOCIATION; HEALTH-PROFESSIONALS; CLINICAL-EXPERIENCE; UTSTEIN STYLE; MANAGEMENT; STATEMENT; SCOTLAND; EFFICACY	Objectives To determine the association between ambulance response time and survival from out of hospital cardiopulmonary arrest and to estimate the effect of reducing response times. Design Cohort study. Setting Scottish Ambulance Service. Subjects All out of hospital cardiopulmonary arrests due to cardiac disease attended by the Scottish Ambulance Service during May 1991 to March 1998. Main outcome measures Survival rate to hospital discharge and potential improvement from reducing response times. Results Of 13 822 arrests not witnessed by ambulance crews but attended by them within 15 minutes, complete data were available for 10 554 (76%). Of these patients, 653 (6%) survived to hospital discharge. After other significant covariates were adjusted for, shorter response time was significantly associated with increased probability of receiving defibrillation and survival to discharge among those defibrillated. Reducing the 90th centile for response time to 8 minutes increased the predicted survival to 8%, and reducing it to 5 minutes increased survival to 10-11% (depending on the model used). Conclusions Reducing ambulance response times to 5 minutes could almost double the survival rate for cardiac arrests not witnessed by ambulance crews.	Univ Glasgow, Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland; Scottish Ambulance Serv Headquarters, Edinburgh, Midlothian, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Cobbe, SM (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland.		Ford, Ian/ABE-6145-2020	Pell, Jill/0000-0002-8898-7035				BEAGLEHOLE R, 1986, BMJ-BRIT MED J, V292, P33, DOI 10.1136/bmj.292.6512.33; COBB LA, 1992, CIRCULATION, V85, P98; COBBE SM, 1991, BRIT MED J, V302, P1517, DOI 10.1136/bmj.302.6791.1517; CUMMINS RO, 1987, JAMA-J AM MED ASSOC, V257, P1605, DOI 10.1001/jama.257.12.1605; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; CUMMINS RO, 1989, ANN EMERG MED, V18, P1269, DOI 10.1016/S0196-0644(89)80257-4; Dracup K, 1997, ANN INTERN MED, V126, P645, DOI 10.7326/0003-4819-126-8-199704150-00010; Evans T, 1998, BMJ-BRIT MED J, V316, P1031; Kuisma M, 1996, HEART, V76, P18, DOI 10.1136/hrt.76.1.18; *NHS, 1996, REV AMB PERF STAND F; Nichol G, 1996, ANN EMERG MED, V27, P711, DOI 10.1016/S0196-0644(96)70188-9; Norris RM, 1998, BMJ-BRIT MED J, V316, P1065; Rayner M, 1998, CORONARY HEART DIS S; SEDGWICK ML, 1992, RESUSCITATION, V24, P73, DOI 10.1016/0300-9572(92)90175-C; STULTS KR, 1986, CIRCULATION, V73, P701, DOI 10.1161/01.CIR.73.4.701; STULTS KR, 1984, NEW ENGL J MED, V310, P219, DOI 10.1056/NEJM198401263100403; WEAVER WD, 1986, AM J CARDIOL, V57, P1017, DOI 10.1016/0002-9149(86)90667-3; WEAVER WD, 1988, NEW ENGL J MED, V319, P661, DOI 10.1056/NEJM198809153191101	19	164	165	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1385	1388		10.1136/bmj.322.7299.1385	http://dx.doi.org/10.1136/bmj.322.7299.1385			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397740	Green Submitted, Bronze, Green Accepted, Green Published			2022-12-28	WOS:000169284600014
J	Gottifredi, V; Prives, C				Gottifredi, V; Prives, C			Molecular biology - Getting p53 out of the nucleus	SCIENCE			English	Editorial Material							RING-FINGER DOMAIN; HDM2; PHOSPHORYLATION; EXPORT; DEGRADATION; PROMOTE; PATHWAY		Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Gottifredi, V (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.		Gottifredi, Vanesa/AAI-1788-2019	Gottifredi, Vanesa/0000-0001-9656-5951				Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Kapoor M, 2000, ONCOGENE, V19, P358, DOI 10.1038/sj.onc.1203300; Lain S, 1999, EXP CELL RES, V253, P315, DOI 10.1006/excr.1999.4672; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Prives C, 1999, J PATHOL, V187, P112; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; ZHANG T, IN PRESS J BIOL CHEM; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	16	47	49	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1851	1852		10.1126/science.1062238	http://dx.doi.org/10.1126/science.1062238			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397937				2022-12-28	WOS:000169200700037
J	Salzberg, SL; White, O; Peterson, J; Eisen, JA				Salzberg, SL; White, O; Peterson, J; Eisen, JA			Microbial genes in the human genome: Lateral transfer or gene loss?	SCIENCE			English	Article							SEQUENCE; EVOLUTION; BACTERIA	The human genome was analyzed for evidence that genes had been Laterally transferred into the genome from prokaryotic organisms. Protein sequence comparisons of the proteomes of human, fruit fly, nematode worm, yeast, mustard weed, eukaryotic parasites, and all completed prokaryote genomes were performed, and all genes shared between human and each of the other groups of organisms were collected. About 40 genes were found to be exclusively shared by humans and bacteria and are candidate examples of horizontal transfer from bacteria to vertebrates. Gene Loss combined with sample size effects and evolutionary rate variation provide an alternative, more biologically plausible explanation.	Inst Genome Res, Rockville, MD 20850 USA	J. Craig Venter Institute	Salzberg, SL (corresponding author), Inst Genome Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	salzberg@tigr.org	Salzberg, Steven L/F-6162-2011; Eisen, Jonathan A./H-2706-2019; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Eisen, Jonathan A./0000-0002-0159-2197; Salzberg, Steven/0000-0002-8859-7432	NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1993, J MOL EVOL, V36, P290, DOI 10.1007/BF00160485; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Braun EL, 2000, GENOME RES, V10, P416, DOI 10.1101/gr.10.4.416; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Doolittle WF, 1999, TRENDS CELL BIOL, V9, pM5, DOI 10.1016/S0962-8924(99)01664-5; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gogarten JP, 1999, BIOL BULL, V196, P359, DOI 10.2307/1542970; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li W. H, 1997, MOL EVOLUTION; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Nelson KE, 2000, NAT BIOTECHNOL, V18, P1049, DOI 10.1038/80235; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	23	199	208	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1903	1906		10.1126/science.1061036	http://dx.doi.org/10.1126/science.1061036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11358996				2022-12-28	WOS:000169200700047
J	Nirenberg, S; Carcieri, SM; Jacobs, AL; Latham, PE				Nirenberg, S; Carcieri, SM; Jacobs, AL; Latham, PE			Retinal ganglion cells act largely as independent encoders	NATURE			English	Article							VISUAL INFORMATION; X-CELL; Y-CELL; HYPOTHESIS; POPULATION; LIGHT	Correlated firing among neurons is widespread in the visual system. Neighbouring neurons, in areas from retina to cortex, tend to fire together more often than would be expected by chance. The importance of this correlated firing for encoding visual information is unclear and controversial(1-5). Here we examine its importance in the retina. We present the retina with natural stimuli and record the responses of its output cells, the ganglion cells. We then use information theoretic techniques to measure the amount of information about the stimuli that can be obtained from the cells under two conditions: when their correlated firing is taken into account, and when their correlated firing is ignored. We rnd that more than 90% of the information about the stimuli can be obtained from the cells when their correlated firing is ignored. This indicates that ganglion cells act largely independently to encode information, which greatly simplifies the problem of decoding their activity.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Nirenberg, S (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	sheilan@ucla.edu						Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chichilnisky E. J., 1999, Society for Neuroscience Abstracts, V25, P1042; Cover TM., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; DODD RL, 1988, PROGRAM NEUROSCIENCE, P153; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Nirenberg S, 1998, CURR OPIN NEUROBIOL, V8, P488, DOI 10.1016/S0959-4388(98)80036-6; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; PENN JS, 1984, VISION RES, V24, P1673, DOI 10.1016/0042-6989(84)90325-0; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; RODIECK RW, 1967, J NEUROPHYSIOL, V30, P1043, DOI 10.1152/jn.1967.30.5.1043; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shannon C. E., 1949, MATH THEORY COMMUNIC; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336	26	217	226	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					698	701		10.1038/35079612	http://dx.doi.org/10.1038/35079612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395773				2022-12-28	WOS:000169112500047
J	Siller, S				Siller, S			Sexual selection and the maintenance of sex	NATURE			English	Article							DELETERIOUS MUTATIONS; AFFECTING FITNESS; EVOLUTION; ADVANTAGE; EPISTASIS; PLANTS	Sex is expensive. A population of females that reproduce asexually should prima facie have twice the growth rate of an otherwise equivalent anisogamous sexual population lacking paternal care, or a population with modes of paternal care that can be co-opted by parthenogenetic females(1-6). The two leading theories for the maintenance of sex require either synergistic interactions between deleterious mutations, or antagonistic epistasis between beneficial mutations(5). Current evidence is equivocal as to whether the required levels of epistasis exist(6-10). Here I show that a third factor, differential male mating success (or, more generally, higher variance in male than in female fitness), can drastically reduce mutational load in sexual populations with or without any form of epistasis. Differential mating success has the further advantage of being ubiquitous, and is likely to have preceded or evolved concurrently with anisogamy(11).	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Siller, S (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	steven.siller@zoo.ox.ac.uk						ARNOLD SJ, 1994, AM NAT, V144, pS1, DOI 10.1086/285650; ATMAR W, 1991, ANIM BEHAV, V41, P195, DOI 10.1016/S0003-3472(05)80471-3; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; BELL G, 1982, MASTERPIECE NATURE E; DALE S, 1992, BEHAV ECOL SOCIOBIOL, V30, P165, DOI 10.1007/BF00166699; de Visser JAGM, 1998, GENET RES, V71, P39, DOI 10.1017/S0016672397003091; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Fisher R.A., 1930, GENETICAL THEORY NAT; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Hurst Laurence D., 1996, Trends in Ecology and Evolution, V11, P46, DOI 10.1016/0169-5347(96)81041-X; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Keightley PD, 1999, GENETICS, V153, P515; Kodric-Brown A, 1987, EVOL ECOL, V1, P95, DOI 10.1007/BF02067393; KOESLAG PD, 1994, J THEOR BIOL, V166, P251, DOI 10.1006/jtbi.1994.1023; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1988, GENETICS, V120, P853; Kondrashov AS, 2001, TRENDS GENET, V17, P75, DOI 10.1016/S0168-9525(00)02188-0; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MANNING JT, 1984, J THEOR BIOL, V108, P215, DOI 10.1016/S0022-5193(84)80067-3; Maynard Smith J., 1971, GROUP SELECTION, P163; PETRIE M, 1991, ANIM BEHAV, V41, P323, DOI 10.1016/S0003-3472(05)80484-1; Rohlf F. J., 1994, STAT TABLES; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; TRIVERS RL, 1976, EVOLUTION, V30, P253, DOI 10.1111/j.1558-5646.1976.tb00908.x; West SA, 1998, GENETICS, V149, P435; West SA, 1999, J EVOLUTION BIOL, V12, P1003	28	179	179	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					689	692		10.1038/35079578	http://dx.doi.org/10.1038/35079578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395770				2022-12-28	WOS:000169112500044
J	Higginson, IJ; Carr, AJ				Higginson, IJ; Carr, AJ			Measuring quality of life - Using quality of life measures in the clinical setting	BRITISH MEDICAL JOURNAL			English	Article							RHEUMATOID-ARTHRITIS; OF-LIFE; OUTCOME MEASURES; HEALTH; CARE; CANCER		Univ London Kings Coll, Dept Palliat Care & Policy, London SE5 9PJ, England; Ned Med Sch, St Christophers Hospice, London SE5 9PJ, England; Univ Nottingham, City Hosp, Nottingham NG3 5DE, England	University of London; King's College London; University of London; King's College London; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Higginson, IJ (corresponding author), Univ London Kings Coll, Dept Palliat Care & Policy, London SE5 9PJ, England.		Higginson, Irene J/C-7309-2012	Higginson, Irene J/0000-0002-3687-1313				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; ADDINGTONAHLL J, IN PRESS BMJ; BOWLING A, 1995, MEASURING DIS REV QU; Bruera E, 1991, J Palliat Care, V7, P6; Carr AJ, 2001, BMJ-BRIT MED J, V322, P1240, DOI 10.1136/bmj.322.7296.1240; Carr AJ, 1996, BRIT J RHEUMATOL, V35, P921; CARR AJ, 2001, IN PRESS BMJ; Carr Alison, 1996, Arthritis and Rheumatism, V39, pS261; Crombie I K, 1993, Qual Health Care, V2, P47, DOI 10.1136/qshc.2.1.47; Davies HTO, 2000, QUAL HEALTH CARE, V9, P111, DOI 10.1136/qhc.9.2.111; DEYO RA, 1992, MED CARE, V30, pMS176, DOI 10.1097/00005650-199205001-00015; FEINSTEIN AR, 1992, MED CARE S, V30, pS50; FITZPATRICK R, 1998, HLTH TECHNOL ASSESS, V2, P18; Hearn J, 1999, QUAL HEALTH CARE, V8, P219, DOI 10.1136/qshc.8.4.219; HIGGINSON I, 1994, OUTCOMES CLIN PRACTI, P28; Higginson I J, 1996, Eur J Cancer Care (Engl), V5, P233, DOI 10.1111/j.1365-2354.1996.tb00240.x; HIGGINSON IJ, 1992, J PUBLIC HEALTH MED, V14, P50; Higginson IJ, 1997, QUAL HEALTH CARE, V6, P120, DOI 10.1136/qshc.6.3.120; Higginson Irene J., 1994, Palliative Medicine, V8, P282, DOI 10.1177/026921639400800403; KAZIS LE, 1990, J CLIN EPIDEMIOL, V43, P1243, DOI 10.1016/0895-4356(90)90025-K; KIRWAN JR, 1983, ANN RHEUM DIS, V42, P648, DOI 10.1136/ard.42.6.648; Maguire P, 1999, PALLIATIVE MED, V13, P45, DOI 10.1177/026921639901300106; MOUNT BM, 1983, J CHRON DIS, V36, P731, DOI 10.1016/0021-9681(83)90068-1; OBOYLE CA, 1992, LANCET, V339, P1088, DOI 10.1016/0140-6736(92)90673-Q; Patterson C., 1996, BMJ-BRIT MED J, V312, P1016; ROSSER RM, 1985, MEASURING SOCIAL BEN; RUTA DA, 1994, MED CARE, V32, P1109, DOI 10.1097/00005650-199411000-00004; Stowers K, 1999, ARTHRITIS RHEUM, V42, pS388; Thornicroft G, 2000, QUAL HEALTH CARE, V9, P84, DOI 10.1136/qhc.9.2.84	29	563	592	2	28	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 26	2001	322	7297					1297	1300		10.1136/bmj.322.7297.1297	http://dx.doi.org/10.1136/bmj.322.7297.1297			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375237	Green Published			2022-12-28	WOS:000169027800026
J	Hawton, K; Townsend, E; Deeks, J; Appleby, L; Gunnell, D; Bennewith, O; Cooper, J				Hawton, K; Townsend, E; Deeks, J; Appleby, L; Gunnell, D; Bennewith, O; Cooper, J			Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UK	Objective To evaluate the effects on suicidal behaviour of legislation limiting the size of packs of paracetamol and salicylates sold over the counter. Setting UK population, with detailed monitoring of data from five liver units and seven general hospitals, between September 1996 and September 1999. Subjects People who died by suicidal or accidental overdose with paracetamol or salicylates, or who died of undetermined causes; patients admitted to liver units with hepatic paracetamol poisoning; patients presenting to general hospitals with self poisoning after taking paracetamol or salicylates. Main outcome measures Mortality from paracetamol or salicylate overdose; numbers of patients referred to liver units or listed for liver transplant; numbers of transplantations; numbers of overdoses and tablets taken; blood concentrations of the drugs; prothrombin times; sales to pharmacies and other outlets of paracetamol and salicylates. Results Numbers of tablets per pack of paracetamol and salicylates decreased markedly in the year after the change in legislation on 16 September 1998. The annual number of deaths from paracetamol poisoning decreased by 21% (95% confidence interval 5% to 34%) and the number from salicylates decreased by 48% (11% to 70%). Liver transplant rates after paracetamol poisoning decreased by 66% (55% to 74%). The rate of non-fatal self poisoning with paracetamol in any form decreased by 11% (5% to 16%), mainly because of a 15% (8% to 21%) reduction in overdoses of paracetarnol in non-compound form. The average number of tablets taken in paracetarnol overdoses decreased by 7% (0% to 12%), and the proportion involving > 32 tablets decreased by 17% (4% to 28%). The average number of tablets taken in salicylate overdoses did not decrease, but 34% fewer (2% to 56%) salicylate overdoses involved > 32 tablets. After the legislation mean blood concentrations of salicylates after overdose decreased, as did prothrombin times; mean blood concentrations of paracetamol did not change. Conclusion Legislation restricting pack sizes of paracetamol and salicylates in the United Kingdom has had substantial beneficial effects on mortality and morbidity associated with self poisoning using these drugs.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England; Inst Hlth Sci, Imperial Canc Res Fund, NHS Ctr Stat Med, Oxford OX3 7LF, England; Univ Manchester, Withington Hosp, Dept Psychiat, Sch Psychiat & Behav Sci, Manchester M20 8LR, Lancs, England; Univ Manchester, Manchester & Salford Self Harm Project, Manchester M20 8LR, Lancs, England	University of Bristol; University of Oxford; University of Oxford; University of Manchester; University of Manchester	Hawton, K (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England.	keith.hawton@psych.ox.ac.uk	Gunnell, David/ABE-6653-2020; Townsend, Ellen/M-6266-2015; Deeks, Jon/AAV-5745-2020	Gunnell, David/0000-0002-0829-6470; Deeks, Jon/0000-0002-8850-1971; Townsend, Ellen/0000-0002-4677-5958				Atcha Z, 2000, HLTH STAT Q, V7, P5; Bialas MC, 1996, QJM-INT J MED, V89, P893; BRAY GP, 1993, BRIT MED J, V306, P157, DOI 10.1136/bmj.306.6871.157; Charlton J., 1992, Population Trends, P10; Gunnell D, 1997, J EPIDEMIOL COMMUN H, V51, P175, DOI 10.1136/jech.51.2.175; Gunnell D, 1997, CURRENT PROBLEMS PHA, V23, P9; HARRISON PM, 1990, BMJ-BRIT MED J, V301, P964, DOI 10.1136/bmj.301.6758.964; HAWTON K, 1995, BRIT MED J, V310, P164, DOI 10.1136/bmj.310.6973.164; Hawton K, 1997, BRIT J PSYCHIAT, V171, P556, DOI 10.1192/bjp.171.6.556; Hawton K, 1996, BRIT J PSYCHIAT, V168, P43, DOI 10.1192/bjp.168.1.43; OGRADY J, 1999, MEDICINE, V27, P80; Poulin C, 2000, LANCET, V355, P2009, DOI 10.1016/S0140-6736(00)02342-4; Prince MI, 2000, LANCET, V355, P2047, DOI 10.1016/S0140-6736(00)02354-0; SPOONER JB, 1993, PHARM J         0522, P706; Turvill JL, 2000, LANCET, V355, P2048, DOI 10.1016/S0140-6736(00)02355-2	15	203	206	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2001	322	7296					1203	1207		10.1136/bmj.322.7296.1203	http://dx.doi.org/10.1136/bmj.322.7296.1203			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11358770	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000168900700022
J	Farnham, TL; Schleicher, DG; Woodney, LM; Birch, PV; Eberhardy, CA; Levy, L				Farnham, TL; Schleicher, DG; Woodney, LM; Birch, PV; Eberhardy, CA; Levy, L			Imaging and photometry of comet C/1999 S4 (LINEAR) before perihelion and after breakup	SCIENCE			English	Article							DUST	We analyzed photometric measurements and images of comet C/LINEAR before perihelion and after its breakup. Results from our photometry data include a lower limit of 0.44 kilometer for the radius of the nucleus before breakup, and a determination that it was depleted in carbon-chain molecules relative to most other comets. Our imaging and modeling results, which include a constraint on the rotational state of the nucleus, indicate that the disintegration likely started on 18 or 19 July 2000. The total mass delectable in the dust tail after the breakup was 3 x 10(8) kilograms, comparable to one of the fragments in the Hubble Space Telescope images; we therefore infer that most of the comet's original mass is hidden in remnants between 1 millimeter and 50 meters in diameter.	Univ Texas, Dept Astron, Austin, TX 78712 USA; Lowell Observ, Flagstaff, AZ 86001 USA; Perth Observ, Bickley, WA 6076, Australia; Univ Washington, Dept Astron, Seattle, WA 98195 USA; No Arizona Univ, Dept Phys & Astron, Flagstaff, AZ 86011 USA	University of Texas System; University of Texas Austin; University of Washington; University of Washington Seattle; Northern Arizona University	Farnham, TL (corresponding author), Univ Texas, Dept Astron, RLM 15308, Austin, TX 78712 USA.							AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; Bockelee-Morvan D, 2001, SCIENCE, V292, P1339, DOI 10.1126/science.1058512; COCHRAN AL, 2000, B AM ASTRON SOC, V32, P1070; COWAN JJ, 1979, MOON PLANETS, V21, P155, DOI 10.1007/BF00897085; FARNHAM TL, 2000, ICARUS, V180, P147; FINSON ML, 1968, ASTROPHYS J, V154, P353, DOI 10.1086/149762; FULLE M, 1993, ASTRON ASTROPHYS, V276, P582; JEWITT D, 1986, ASTROPHYS J, V310, P937, DOI 10.1086/164745; KAMMERER A, 2000, INT COMET Q, V22, P71; KIDGER M, 2000, 7467 IAU; Levison HF, 1997, ICARUS, V127, P13, DOI 10.1006/icar.1996.5637; Mumma MJ, 2001, SCIENCE, V292, P1334, DOI 10.1126/science.1058929; SCHLEICHER D, 2000, 7455 IAU; Teemu J, 2001, SCIENCE, V292, P1326, DOI 10.1126/science.1060858; TOZZI GP, UNPUB; WANIAK W, 1992, ICARUS, V100, P154, DOI 10.1016/0019-1035(92)90026-4; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606; WHIPPLE FL, 1978, MOON PLANETS, V18, P343, DOI 10.1007/BF00896489	18	50	50	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1348	1353		10.1126/science.1058886	http://dx.doi.org/10.1126/science.1058886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359005				2022-12-28	WOS:000168862900038
J	Chavis, P; Westbrook, G				Chavis, P; Westbrook, G			Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse	NATURE			English	Article							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULES; D-ASPARTATE RECEPTOR; TYROSINE PHOSPHORYLATION; TRANSMITTER RELEASE; EXCITATORY SYNAPSES; NMDA RECEPTORS; ALPHA-IIB-BETA-3; ALPHA-V-BETA-3; ALPHA-5-BETA-1	Coordinated signalling between presynaptic terminals and their postsynaptic targets is essential for the development and function of central synapses. In addition to diffusible molecules(1), this bidirectional flow of information could involve direct interactions through cell-adhesion molecules(2,3). Here, we show that one class of cell-adhesion molecule, the integrins, are required for the functional maturation of hippocampal synapses in vitro. At immature synapses, a high probability of glutamate release (P-r) was correlated with the expression of postsynaptic NMDA (N-methyl-D-aspartate) receptors containing the NR2B subunit. The activity-dependent reduction in P-r and a switch in the subunit composition of synaptic NMDA receptors was prevented by chronic blockade with peptides containing the integrin-binding site Arg-Gly-Asp (RGD), or by a functional antibody against the beta3 integrin subunit. Active synapses, monitored by the uptake of antibodies against the intraluminal domain of synaptotagmin I, also had beta3 subunit immunoreactivity. Our results provide evidence that integrin-mediated signalling is essential for the orchestrated maturation of central excitatory synapses.	Univ Portland, Vollum Inst Oregon Hlth Sci, Portland, OR 97201 USA	University of Portland	Chavis, P (corresponding author), CNRS, UPR 9023, 141 Rue Cardonille, F-34094 Montpellier, France.		Chavis, Pascale/M-8312-2016	Chavis, Pascale/0000-0002-3038-1014				Aplin AE, 1998, PHARMACOL REV, V50, P197; Blaess S, 1998, J NEUROCHEM, V71, P2615, DOI 10.1046/j.1471-4159.1998.71062615.x; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Chavis P, 1998, NEURON, V20, P773, DOI 10.1016/S0896-6273(00)81015-6; CHAVIS P, 1998, SOC NEUR ABS; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Staubli U, 1998, J NEUROSCI, V18, P3460; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	27	249	255	0	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					317	321		10.1038/35077101	http://dx.doi.org/10.1038/35077101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357135				2022-12-28	WOS:000168710000050
J	Yamaguchi, A				Yamaguchi, A			Sex differences in vocal learning in birds	NATURE			English	Article									Univ Calif Davis, Anim Commun Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Yamaguchi, A (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ay64@columbia.edu						BEECHER MD, 1994, P NATL ACAD SCI USA, V91, P1450, DOI 10.1073/pnas.91.4.1450; EALES LA, 1987, ANIM BEHAV, V35, P1336; FENSON L, 1994, MONOGR SOC RES CHILD, V59, pR5; LEMON RE, 1965, CAN J ZOOL, V44, P191; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; NELSON DA, 1995, ANIM BEHAV, V50, P83, DOI 10.1006/anbe.1995.0223; Nelson DA, 1998, ANIM BEHAV, V56, P487, DOI 10.1006/anbe.1998.0805; SMITH PC, 1969, THESIS U W ONTARIO; Yamaguchi A, 1998, CONDOR, V100, P504, DOI 10.2307/1369716	9	30	31	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					257	258		10.1038/35077143	http://dx.doi.org/10.1038/35077143			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357116				2022-12-28	WOS:000168710000031
J	Smith, JB; Lamanna, MC; Lacovara, KJ; Dodson, P; Smith, JR; Poole, JC; Giegengack, R; Attia, Y				Smith, JB; Lamanna, MC; Lacovara, KJ; Dodson, P; Smith, JR; Poole, JC; Giegengack, R; Attia, Y			A giant sauropod dinosaur from an Upper Cretaceous mangrove deposit in Egypt	SCIENCE			English	Article							PREDATORY DINOSAUR; SAHARA	We describe a giant titanosaurid sauropod dinosaur discovered in coastal deposits in the Upper Cretaceous Bahariya Formation of Egypt, a unit that has produced three Tyrannosaurus-sized theropods and numerous other vertebrate taxa, Paralititan stromeri is the first tetrapod reported from Bahariya since 1935. Its 1.69-meter-long humerus is Longer than that of any known Cretaceous sauropod. The autochthonous scavenged skeleton was preserved in mangrove deposits, raising the possibility that titanosaurids and their predators habitually entered such environments.	Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; Drexel Univ, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; Egyptian Geol Survey & Min Author, Egyptian Geol Museum, Cairo, Egypt	University of Pennsylvania; Drexel University; University of Pennsylvania; Drexel University	Smith, JB (corresponding author), Univ Penn, Dept Earth & Environm Sci, 240 S 33rd St, Philadelphia, PA 19104 USA.	smithjb@sas.upenn.edu	Dodson, Peter/A-9544-2009					Andrejeko M.J., 1983, TASKS VEGETATION SCI; Boureau E., 1951, CR SOMM SEANCES SOC, V7, P107; Cridland A.A., 1964, PALAEONTOLOGY, V7, P186; CURTICE BD, 1996, CONTINENTAL JURASSIC, P87; DAVIS RA, 1992, QUATERNARY COASTS US, P193; Dominik W, 1985, BERLINER GEOWISSENSC, V62, P1; Duke NC, 1992, TROPICAL MANGROVE EC, P63, DOI DOI 10.1029/CE041P0063; Ellison AM, 1999, GLOBAL ECOL BIOGEOGR, V8, P95, DOI 10.1046/j.1365-2699.1999.00126.x; Fassell ML, 1999, GEOL S AM S, P121; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Jain SL, 1997, J VERTEBR PALEONTOL, V17, P114, DOI 10.1080/02724634.1997.10010958; Jianu CM, 1999, GEOL MIJNBOUW, V78, P335, DOI 10.1023/A:1003855416962; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Lavocat R., 1954, C GEOLOGIQUE INT ALG, V15, P65; Lydekker R., 1893, ANALES MUSEO LA PLAT, V2, P1; Paul Gregory S., 1997, P129; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Salgado Leonardo, 1993, Ameghiniana, V30, P265; Salgado Leonardo, 1996, Ameghiniana, V33, P355; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Shinaq R., 1998, FREIBERGER FORSCH, V6, P39; Stromer E., 1932, ABHANDLUNGEN BAYERIS, V10, P1; STROMER E, 1936, ABH BAYER AKAD WISS, V33, P1; Taquet P, 1998, CR ACAD SCI II A, V327, P347, DOI 10.1016/S1251-8050(98)80054-2; THANIKAIMONI G, 1987, MANGROVE PALYNOLOGY, P1; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115	32	114	118	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1704	1706		10.1126/science.1060561	http://dx.doi.org/10.1126/science.1060561			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387472	Green Submitted			2022-12-28	WOS:000169031800041
J	Szakonyi, G; Guthridge, JM; Li, DW; Young, K; Holers, VM; Chen, XJS				Szakonyi, G; Guthridge, JM; Li, DW; Young, K; Holers, VM; Chen, XJS			Structure of complement receptor 2 in complex with its C3d ligand	SCIENCE			English	Article							EPSTEIN-BARR-VIRUS; CRYSTAL-STRUCTURE; LYMPHOCYTES-B; BINDING-SITE; IMMUNE-RESPONSE; CR-2; CD21; ANTIGEN; CELLS; INFECTION	Complement receptor 2 (CR2/CD21) is an important receptor that amplifies B lymphocyte activation by bridging the innate and adaptive immune systems. CR2 Ligands include complement C3d and Epstein-Barr virus glycoprotein 350/ 220. We describe the x-ray structure of this CR2 domain in complex with C3d at 2.0 angstroms, The structure reveals extensive main chain interactions between C3d and only one short consensus repeat (SCR) of CR2 and substantial SCR side-side packing, These results provide a detailed understanding of receptor-ligand interactions in this protein family and reveal potential target sites for molecular drug design.	Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Immunol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Chen, XJS (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA.		Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263; Guthridge, Joel/0000-0002-9308-237X	NCI NIH HHS [R0-1 CA53615] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA053615] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BRANDEN C, 1999, INTRO PROTEIN STRUCT, P16; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAREL JC, 1990, J BIOL CHEM, V265, P12293; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Casasnovas JM, 1999, EMBO J, V18, P2911, DOI 10.1093/emboj/18.11.2911; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; Fearon DT, 1998, SEMIN IMMUNOL, V10, P355, DOI 10.1006/smim.1998.0137; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; GUTHRIDGE JM, IN PRESS BIOCHEMISTR; HEBELL T, 1991, SCIENCE, V254, P102, DOI 10.1126/science.1718035; KALLI KR, 1991, J IMMUNOL, V147, P590; LAW SKA, 1995, FOCUS SERIES; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; MARTIN DR, 1994, J VIROL, V68, P4716, DOI 10.1128/JVI.68.8.4716-4726.1994; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MOLINA H, 1995, J IMMUNOL, V154, P5426; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; POZNANSKY MC, 1989, J IMMUNOL, V143, P1254; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Prodinger WM, 1998, J IMMUNOL, V161, P4604; RAO PE, 1985, CELL IMMUNOL, V93, P549, DOI 10.1016/0008-8749(85)90159-5; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Wiles AP, 1997, J MOL BIOL, V272, P253, DOI 10.1006/jmbi.1997.1241	29	126	145	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1725	1728		10.1126/science.1059118	http://dx.doi.org/10.1126/science.1059118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387479				2022-12-28	WOS:000169031800048
J	Turecek, R; Trussell, LO				Turecek, R; Trussell, LO			Presynaptic glycine receptors enhance transmitter release at a mammalian central synapse	NATURE			English	Article							GAMMA-AMINOBUTYRIC ACID; RAT BRAIN-STEM; CALCIUM CURRENTS; GABA(B) RECEPTOR; BIPOLAR CELLS; NEURONS; NEUROTRANSMITTER; FACILITATION; INHIBITION; MODULATION	Glycine and GABA(A) (gamma -aminobutyric acid A) receptors are inhibitory neurotransmitter-gated Cl- channels localized in postsynaptic membranes. In some cases, GABA(A) receptors are also found presynaptically, but they retain their inhibitory effect as their activation reduces excitatory transmitter release(1-4). Here we report evidence for presynaptic ionotropic glycine receptors, using pre- and postsynaptic recordings of a calyceal synapse in the medial nucleus of the trapezoid body (MNTB). Unlike the classical action of glycine, presynaptic glycine receptors triggered a weakly depolarizing Cl- current in the nerve terminal. The depolarization enhanced transmitter release by activating Ca2+ channels and increasing resting intraterminal Ca2+ concentrations. Repetitive activation of glycinergic synapses on MNTB neurons also enhanced glutamatergic synaptic currents, indicating that presynaptic glycine receptors are activated by glycine spillover. These results reveal a novel site of action of the transmitter glycine, and indicate that under certain conditions presynaptic Cl- channels may increase transmitter release.	Oregon Hearing Res Ctr & Vollum Inst, Portland, OR 97201 USA		Trussell, LO (corresponding author), Oregon Hearing Res Ctr & Vollum Inst, L-335A,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Turecek, Rostislav/H-2706-2014; Turecek, Rostislav/AAL-3523-2020	Turecek, Rostislav/0000-0003-4978-7556				Akaike N, 1996, PROG BIOPHYS MOL BIO, V65, P251, DOI 10.1016/S0079-6107(96)00013-2; Atluri PP, 1998, J NEUROSCI, V18, P8214; BANKS MI, 1992, J NEUROSCI, V12, P2819; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Dittman JS, 1997, J NEUROSCI, V17, P9048; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P151, DOI 10.1098/rspb.1993.0022; Funabiki K, 1998, J PHYSIOL-LONDON, V508, P851, DOI 10.1111/j.1469-7793.1998.851bp.x; GROTHE B, 1994, J NEUROSCI, V14, P1701, DOI 10.1523/JNEUROSCI.14-03-01701.1994; Isaacson JS, 1998, J NEUROPHYSIOL, V80, P1571, DOI 10.1152/jn.1998.80.3.1571; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Martin AR, 1977, HDB PHYSL 1, V1, P329, DOI 10.1002/cphy.cp010110; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Pouzat C, 1999, J NEUROSCI, V19, P1675; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; Takahashi T, 1998, J NEUROSCI, V18, P3138; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; WU SH, 1992, J NEUROSCI, V12, P3084, DOI 10.1523/JNEUROSCI.12-08-03084.1992; ZHANG SLJ, 1995, J PHYSIOL-LONDON, V483, P583, DOI 10.1113/jphysiol.1995.sp020608	27	231	239	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					587	590		10.1038/35079084	http://dx.doi.org/10.1038/35079084			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385573				2022-12-28	WOS:000168982500052
J	Mindel, A; Tenant-Flowers, M				Mindel, A; Tenant-Flowers, M			ABC of AIDS - Natural history and management of early HIV infection	BRITISH MEDICAL JOURNAL			English	Article														Mindel, Adrian/0000-0002-8780-9982					0	28	30	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 26	2001	322	7297					1290	1293		10.1136/bmj.322.7297.1290	http://dx.doi.org/10.1136/bmj.322.7297.1290			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375235	Green Published			2022-12-28	WOS:000169027800024
J	Shepherd, DS; Claussen, MJ; Kurtz, SE				Shepherd, DS; Claussen, MJ; Kurtz, SE			Evidence for a solar system-size accretion disk around the massive protostar G192.16-3.82	SCIENCE			English	Article							MOLECULAR OUTFLOWS; STAR-FORMATION; JET; EVOLUTION; CEPHEUS; CLOUD; FLUX	Seven-millimeter continuum observations of a massive bipolar outflow source, (;G192.16-3.82, were made at a milli-arc-second. resolution with a; capability that Links the National Radio Astronomy Observatory's Very Large Array radio interferometer with the Very Long Baseline Array antenna, Located in Pie Town, New Mexico. The observations provide evidence for a true accretion disk that is about the size of our solar system and located around a massive star. A model of the radio emission suggests the presence of a binary protostellar system, The primary protostar, G192 S1, at the center of the outflow, with a protostar mass of about 8 to 10 times the solar mass, is surrounded by an accretion disk with a diameter of 130 astronomical units (AU). The mass of the disk is on the order of the protostar mass. The outflow is poorly collimated with a full opening angle of about 40 degrees; there is no indication of a more highly collimated jetlike component. The companion source, G192 S2, is Located 80 AU north of the primary source.	Natl Radio Astron Observ, Socorro, NM 87801 USA; Univ Nacl Autonoma Mexico, Inst Astron, Mexico City 04510, DF, Mexico	National Radio Astronomy Observatory (NRAO); Universidad Nacional Autonoma de Mexico	Shepherd, DS (corresponding author), Natl Radio Astron Observ, POB 0, Socorro, NM 87801 USA.	dshepher@aoc.nrao.edu						Bell KR, 1997, ASTROPHYS J, V486, P372, DOI 10.1086/304514; BERESFORD R, UNPUB; Cabrit S., 1997, IAU S, V182, P163; Calvet N., 2000, Protostars and planets 4, P377; Cesaroni R, 1999, ASTRON ASTROPHYS, V345, P949; CHURCHWELL E, 1991, NATO ADV SCI I C-MAT, V342, P221; Codella C, 1996, ASTRON ASTROPHYS, V311, P971; Devine D, 1999, ASTRON J, V117, P2919, DOI 10.1086/300871; Eisloffel J., 2000, Protostars and planets 4, P815; Fendt C, 1998, ASTRON ASTROPHYS, V334, P750; Guilloteau S, 1999, ASTRON ASTROPHYS, V348, P570; HILDEBRAND RH, 1983, Q J ROY ASTRON SOC, V24, P267; HODAPP KW, 1994, ASTROPHYS J SUPPL S, V94, P615, DOI 10.1086/192084; Hollenbach D. J., 2000, Protostars and planets 4, P401; Hure JM, 2000, ASTRON ASTROPHYS, V358, P378; JENSEN ELN, 1994, ASTROPHYS J, V429, pL29, DOI 10.1086/187405; Konigl A., 2000, Protostars and planets 4, P759; Kramer C, 1998, ASTRON ASTROPHYS, V329, pL33; Lubow S.H., 2000, PROTOSTARS PLANETS 4, P731; Marti J, 1999, ASTRON ASTROPHYS, V345, pL5; Mathieu R. D., 2000, Protostars and planets 4, P703; Moscadelli L, 2000, ASTRON ASTROPHYS, V360, P663; Motte F, 1998, ASTRON ASTROPHYS, V336, P150; Najita J. R., 2000, Protostars and planets 4, P457; Narayanan G, 1996, ASTROPHYS J, V466, P844, DOI 10.1086/177559; Ouyed R, 1999, MON NOT R ASTRON SOC, V309, P233, DOI 10.1046/j.1365-8711.1999.02828.x; PANAGIA N, 1973, ASTRON J, V78, P929, DOI 10.1086/111498; POLLACK JB, 1994, ASTROPHYS J, V421, P615, DOI 10.1086/173677; PRINGLE JE, 1992, MON NOT R ASTRON SOC, V258, P811, DOI 10.1093/mnras/258.4.811; PUDRITZ RE, 1997, IAU S, V182, P259; Reipurth B, 2000, ASTRON J, V120, P3177, DOI 10.1086/316865; RODRIGUEZ LF, 1994, ASTROPHYS J, V430, pL65, DOI 10.1086/187439; Saraceno P, 1996, ASTRON ASTROPHYS, V309, P827; SARGENT AI, 1995, DISKS OUTFLOWS YOUNG, P1; Sault RJ, 1995, ASTR SOC P, V77, P433; Shepherd DS, 1998, ASTROPHYS J, V507, P861, DOI 10.1086/306362; Shepherd DS, 1999, ASTROPHYS J, V523, P690, DOI 10.1086/307755; Shepherd DS, 1996, ASTROPHYS J, V472, P225, DOI 10.1086/178057; Shepherd DS, 2000, ASTROPHYS J, V535, P833, DOI 10.1086/308873; SHU FH, 1997, IAU S, V182, P225; SNELL RL, 1990, ASTROPHYS J, V352, P139, DOI 10.1086/168521; Stone J. M., 2000, Protostars and planets 4, P589; Terquem C, 1999, ASTROPHYS J, V512, pL131, DOI 10.1086/311880; Testi L, 1998, ASTROPHYS J, V508, pL91, DOI 10.1086/311724; THOMPSON RI, 1984, ASTROPHYS J, V283, P165, DOI 10.1086/162287; YORKE HW, 1995, ASTROPHYS J, V443, P199, DOI 10.1086/175514	48	87	87	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1513	1518		10.1126/science.1059475	http://dx.doi.org/10.1126/science.1059475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375484				2022-12-28	WOS:000168963800035
J	Hinks, DG; Claus, H; Jorgensen, JD				Hinks, DG; Claus, H; Jorgensen, JD			The complex nature of superconductivity in MgB2 as revealed by the reduced total isotope effect	NATURE			English	Article							TRANSITION-TEMPERATURE	Magnesium diboride, MgB2, was recently observed to become superconducting(1) at 39 K, which is the highest known transition temperature for a non-copper-oxide bulk material. Isotope-effect measurements, in which atoms are substituted by isotopes of different mass to systematically change the phonon frequencies, are one of the fundamental tests of the nature of the super-conducting mechanism in a material. In a conventional Bardeen-Cooper-Schrieffer (BCS) superconductor, where the mechanism is mediated by electron-phonon coupling, the total isotope-effect coefficient (in this case, the sum of both the Mg and B coefficients) should be about 0.5. The boron isotope effect was previously shown to be large(2) and that was sufficient to establish that MgB2 is a conventional superconductor, but the Mg effect has not hitherto been measured. Here we report the determination of the Mg isotope effect, which is small but measurable. The total reduced isotope-effect coefficient is 0.32, which is much lower than the value expected for a typical BCS superconductor. The low value could be due to complex materials properties, and would seem to require both a large electron-phonon coupling constant and a value of mu* (the repulsive electron-electron interaction) larger than found for most simple metals.	Argonne Natl Lab, Div Mat Sci, Chicago, IL 60438 USA; Univ Illinois, Dept Phys, Chicago, IL 60607 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hinks, DG (corresponding author), Argonne Natl Lab, Div Mat Sci, Chicago, IL 60438 USA.	hinks@anl.gov						AN JM, 2001, CONDMAT0102391; Bud'ko SL, 2001, PHYS REV LETT, V86, P1877, DOI 10.1103/PhysRevLett.86.1877; CARBOTTE JP, 1990, REV MOD PHYS, V62, P1027, DOI 10.1103/RevModPhys.62.1027; Cheon KO, 1999, PHYSICA C, V312, P35, DOI 10.1016/S0921-4534(98)00667-4; COOPER AS, 1970, P NATL ACAD SCI USA, V67, P313, DOI 10.1073/pnas.67.1.313; GARLAND JW, 1963, PHYS REV LETT, V11, P114, DOI 10.1103/PhysRevLett.11.114; KARAPETROV G, 2001, CONDMAT0102312; KARAPETROV G, IN PRESS PHYS REV LE; KONG Y, IN PRESS PHYS REV B; KONG Y, 2001, CONDMAT0102499; KORTUS J, 2001, CONDMAT0101446; Kostic P, 1996, PHYS REV B, V53, P791, DOI 10.1103/PhysRevB.53.791; KREMER RK, 2001, CONDMAT0102432; LAWRIE DD, 1995, PHYSICA C, V245, P159, DOI 10.1016/0921-4534(95)00088-7; LEYAROVSKA L, 1979, J LESS-COMMON MET, V67, P249, DOI 10.1016/0022-5088(79)90100-0; MCMILLAN WL, 1968, PHYS REV, V167, P331, DOI 10.1103/PhysRev.167.331; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; OSBORN R, 2001, CONDMAT0103064; OSBORN R, IN PRESS PHYS REV LE; RUBIOBOLLINGER G, 2001, CONDMAT0102242; SCHMIDT H, IN PRESS PHYS REV B; Schmidt H., CONDMAT0102389; SHARONI A, CONDMAT0102325; SHARONI A, 2001, CONDMAT0102325; SHARONI A, IN PRESS PHYS REV B; YILDIRIM T, 2001, CONDMAT0103469; [No title captured]	28	292	303	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					457	460		10.1038/35078037	http://dx.doi.org/10.1038/35078037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373673	Green Submitted			2022-12-28	WOS:000168858700042
J	O'Rorke, JE; Richardson, WS				O'Rorke, JE; Richardson, WS			Evidence based management of hypertension - What to do when blood pressure is difficult to control	BRITISH MEDICAL JOURNAL			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RESISTANT HYPERTENSION; METAANALYSIS; PREVALENCE; PATIENT	Consider the following causes for apparently resistant blood pressure: inaccurate measurement, antagonising substances such as non-steroidal anti-inflammatory drugs, aggravating conditions such as obesity or sleep apnoea, suboptimal treatment regimens, non-compliance When apparent resistance remains unexplained or when there are clues suggesting white coat hypertension, consider this and arrange for multiple measurements by self monitoring, visits to or by nurses or health visitors, or ambulatory monitoring If hypertension is still unexplained, or for patients who fit specific patterns of higher risk, consider a selective, sequential evaluation for secondary causes of hypertension, starting with relatively common conditions, such as renovascular causes and renal parenchymal disease Work closely with patients to identify preferred and feasible solutions for correcting any cause that is found Consider referral of patients with severe or persistently resistant hypertension to a centre specialising in its diagnosis and treatment.	Univ Texas, Div Gen Internal Med, San Antonio, TX 78249 USA	University of Texas System	O'Rorke, JE (corresponding author), Univ Texas, Div Gen Internal Med, San Antonio, TX 78249 USA.							BAUM C, 1985, ARTHRITIS RHEUM, V28, P686, DOI 10.1002/art.1780280613; Coca A, 1998, J HYPERTENS, V16, pS45; DAVIS BA, 1979, NEW ENGL J MED, V301, P1273, DOI 10.1056/NEJM197912063012307; Gandhi S, 1996, POSTGRAD MED, V100, P97, DOI 10.3810/pgm.1996.10.94; GANDHI S, 1996, POSTGRAD MED, V97, P107; GIFFORD RW, 1969, MILBANK FUND Q, V47, P170, DOI 10.2307/3349261; HOUSTON MC, 1995, ARCH INTERN MED, V155, P1049, DOI 10.1001/archinte.155.10.1049; JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011; KAPLAN NM, 2000, WHOU SHOULD BE SCREE; Krijnen P, 1998, ANN INTERN MED, V129, P705, DOI 10.7326/0003-4819-129-9-199811010-00005; LEWIN A, 1985, ARCH INTERN MED, V145, P424, DOI 10.1001/archinte.145.3.424; MULROW CD, 2000, COCHRANE DATABASE SY; Oparil S, 1998, AM FAM PHYSICIAN, V57, P1007; POPE JE, 1993, ARCH INTERN MED, V153, P477, DOI 10.1001/archinte.153.4.477; RONCAGLIONI MC, 1992, CIRCULATION, V85, P2065, DOI 10.1161/01.CIR.85.6.2065; RUILOPE LM, 1995, J HUM HYPERTENS, V9, pS3; SETARO JF, 1992, NEW ENGL J MED, V327, P543; SINCLAIR AM, 1987, ARCH INTERN MED, V147, P1289, DOI 10.1001/archinte.147.7.1289; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; STEPHENSON BJ, 1993, JAMA-J AM MED ASSOC, V269, P2779, DOI 10.1001/jama.269.21.2779; TUCKER RM, 1977, MAYO CLIN PROC, V52, P549; TURNBULL JM, 1995, JAMA-J AM MED ASSOC, V274, P1299, DOI 10.1001/jama.274.16.1299; WILLIAMS GH, 1998, HARRISONS PRINCIPLES, P1382; YAKOVLEVITCH M, 1991, ARCH INTERN MED, V151, P1786, DOI 10.1001/archinte.151.9.1786	24	23	27	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2001	322	7296					1229	1232		10.1136/bmj.322.7296.1229	http://dx.doi.org/10.1136/bmj.322.7296.1229			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11358779	Green Published			2022-12-28	WOS:000168900700033
J	Amara, RR; Villinger, F; Altman, JD; Lydy, SL; O'Neil, SP; Staprans, SI; Montefiori, DC; Xu, Y; Herndon, JG; Wyatt, LS; Candido, MA; Kozyr, NL; Earl, PL; Smith, JM; Ma, HL; Grimm, BD; Hulsey, ML; Miller, J; McClure, HM; McNicholl, JM; Moss, B; Robinson, HL				Amara, RR; Villinger, F; Altman, JD; Lydy, SL; O'Neil, SP; Staprans, SI; Montefiori, DC; Xu, Y; Herndon, JG; Wyatt, LS; Candido, MA; Kozyr, NL; Earl, PL; Smith, JM; Ma, HL; Grimm, BD; Hulsey, ML; Miller, J; McClure, HM; McNicholl, JM; Moss, B; Robinson, HL			Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RHESUS-MONKEYS; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEINS; PATHOGENIC SIV; INFECTION; REPLICATION; RESPONSES; TYPE-1; ASSAY	Heterologous prime/boost regimens have the potential for raising high Levels of immune responses. Here we report that DNA priming followed by a recombinant modified vaccinia Ankara (rMVA) booster controlled a highly pathogenic immunodeficiency virus challenge in a rhesus macaque model. Both the DNA and rMVA components of the vaccine expressed multiple immunodeficiency virus proteins. Two DNA inoculations at 0 and 8 weeks and a single rMVA booster at 24 weeks effectively controlled an intrarectal challenge administered 7 months after the booster. These findings provide hope that a relatively simple multiprotein DNA/MVA vaccine can help to control the acquired immune deficiency syndrome epidemic.	Emory Univ, Vaccine Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Sch Med, Vaccine Res Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; Ctr Dis Control & Prevent, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30330 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Centers for Disease Control & Prevention - USA	Robinson, HL (corresponding author), Emory Univ, Vaccine Res Ctr, Atlanta, GA 30329 USA.	hrobins@rmy.emory.edu	Amara, Rama/AAO-8136-2021	Moss, Bernard/0000-0002-2154-8564	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI043045, ZIAAI000416, Z01AI000416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA012121] Funding Source: NIH RePORTER; NCRR NIH HHS [P51 RR000165] Funding Source: Medline; NIAID NIH HHS [P01 AI 43045] Funding Source: Medline; NIDA NIH HHS [P30 DA 12121] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Egan MA, 2000, J VIROL, V74, P7485, DOI 10.1128/JVI.74.16.7485-7495.2000; Gorelick RJ, 1999, VIROLOGY, V253, P259, DOI 10.1006/viro.1998.9513; Goulder PJR, 1999, AIDS, V13, pS121; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Karlsson GB, 1997, J VIROL, V71, P4218, DOI 10.1128/JVI.71.6.4218-4225.1997; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MONTEFIORI DC, 1988, J CLIN MICROBIOL, V26, P231, DOI 10.1128/JCM.26.2.231-235.1988; Montefiori DC, 1998, J VIROL, V72, P3427, DOI 10.1128/JVI.72.4.3427-3431.1998; Ourmanov I, 2000, J VIROL, V74, P2740, DOI 10.1128/JVI.74.6.2740-2751.2000; Power CA, 1999, J IMMUNOL METHODS, V227, P99, DOI 10.1016/S0022-1759(99)00074-5; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Robinson HL, 1999, NAT MED, V5, P526, DOI 10.1038/8406; Robinson R, 2000, J GEOPHYS RES-SOL EA, V105, P16139, DOI 10.1029/2000JB900012; Sauter MM, 1996, J CELL BIOL, V132, P795, DOI 10.1083/jcb.132.5.795; Staprans Silvija I., 1996, P167; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338	19	972	1039	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					69	74		10.1126/science.1058915	http://dx.doi.org/10.1126/science.1058915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11393868				2022-12-28	WOS:000167995200037
J	Addington-Hall, J; Kalra, L				Addington-Hall, J; Kalra, L			Measuring quality of life - Who should measure quality of life?	BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE; CANCER-PATIENTS; SIGNIFICANT OTHERS; HEALTH-STATUS; ASSESSMENTS; RATINGS; CARE; PERCEPTIONS; DISABILITY; DOCTORS		Guys Kings Coll & St Thomas Hosp, Sch Med & Dent, Dept Palliat Care & Policy, London SE5 9PJ, England; Guys Kings Coll & St Thomas Hosp, Sch Med & Dent, Dept Stroke, London SE5 9PJ, England	University of London; King's College London; University of London; King's College London	Addington-Hall, J (corresponding author), Guys Kings Coll & St Thomas Hosp, Sch Med & Dent, Dept Palliat Care & Policy, London SE5 9PJ, England.							Adang EMM, 1998, TRANSPL INT, V11, P11, DOI 10.1007/s001470050095; Carr AJ, 2001, BMJ-BRIT MED J, V322, P1240, DOI 10.1136/bmj.322.7296.1240; CLIPP EC, 1992, CANCER, V69, P1074, DOI 10.1002/1097-0142(19920215)69:4<1074::AID-CNCR2820690440>3.0.CO;2-L; Cohen S R, 1992, J Palliat Care, V8, P40; EBRAHIM S, 1991, AGE AGEING, V20, P37, DOI 10.1093/ageing/20.1.37; EPSTEIN AM, 1989, MED CARE, V27, pS91, DOI 10.1097/00005650-198903001-00008; Hallan S, 1999, J INTERN MED, V246, P309, DOI 10.1046/j.1365-2796.1999.00531.x; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; Husted S A, 1985, Cancer Nurs, V8, P159; Jennings B M, 1981, Cancer Nurs, V4, P485; Manara AR, 1998, ANAESTHESIA, V53, P523, DOI 10.1046/j.1365-2044.1998.t01-1-00407.x; McMillan SC, 1998, CANCER PRACT, V6, P282, DOI 10.1046/j.1523-5394.1998.00023.x; Nekolaichuk CL, 1999, PALLIATIVE MED, V13, P311, DOI 10.1191/026921699675854885; Pellegrino ED, 2000, JAMA-J AM MED ASSOC, V283, P1065, DOI 10.1001/jama.283.8.1065; Pierre U, 1998, J CLIN EPIDEMIOL, V51, P983, DOI 10.1016/S0895-4356(98)00090-0; ROTHMAN ML, 1991, MED CARE, V29, P115, DOI 10.1097/00005650-199102000-00004; Rothwell PM, 1997, BMJ-BRIT MED J, V314, P1580, DOI 10.1136/bmj.314.7094.1580; Sloan JA, 1998, J CLIN ONCOL, V16, P3662, DOI 10.1200/JCO.1998.16.11.3662; Sneeuw KCA, 1999, BRIT J CANCER, V81, P87, DOI 10.1038/sj.bjc.6690655; Sneeuw KCA, 1998, J CLIN EPIDEMIOL, V51, P617, DOI 10.1016/S0895-4356(98)00040-7; Sneeuw KCA, 1997, J CLIN ONCOL, V15, P1206, DOI 10.1200/JCO.1997.15.3.1206; Spiller Juliet A., 1993, Palliative Medicine, V7, P109, DOI 10.1177/026921639300700204; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; SPRANGERS MAG, 1992, J CLIN EPIDEMIOL, V45, P743, DOI 10.1016/0895-4356(92)90052-O; Stephens RJ, 1997, QUAL LIFE RES, V6, P225; Stewart AL, 1999, J PAIN SYMPTOM MANAG, V17, P93, DOI 10.1016/S0885-3924(98)00131-6; Vigano A, 2000, PALLIATIVE MED, V14, P363, DOI 10.1191/026921600701536192; Waldron D, 1999, J CLIN ONCOL, V17, P3603, DOI 10.1200/JCO.1999.17.11.3603	28	188	192	1	23	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1417	1420		10.1136/bmj.322.7299.1417	http://dx.doi.org/10.1136/bmj.322.7299.1417			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397754	Green Published			2022-12-28	WOS:000169284600023
J	Roper, NA; Bilous, RW; Kelly, WF; Unwin, NC; Connolly, VM				Roper, NA; Bilous, RW; Kelly, WF; Unwin, NC; Connolly, VM			Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study	BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; SOCIOECONOMIC-STATUS; SOCIAL DEPRIVATION; RISK-FACTORS; MELLITUS; COHORT; PEOPLE; PREVALENCE; DISEASE; ADULTS	Objectives To establish the age and sex specific mortality for people with diabetes in comparison with local and national background populations; to investigate the relationship between mortality and material deprivation in an unselected population with diabetes. Design Longitudinal study, using a population based district diabetes register. Setting South Tees, United Kingdom. Participants All people known to have diabetes living in Middlesbrough and Redcar and Cleveland local authorities on 1 January 1994. Main outcome measure Death, from any cause, between 1 January 1994 and 31 December 1999. Results Over the six years of the study 1205 (24.9%) of 4842 participants died. All cause standardised mortality ratios for type 1 diabetes were 641 (95% confidence interval 406 to 962) in women and 294 (200 to 418) in men, and those for type 2 diabetes were 160 (147 to 174) in women and 141 (130 to 152) in men. Cause specific standardised mortality ratios were increased for ischaemic heart disease, cerebrovascular disease, and renal disease; no reductions in mortality from other causes were seen. The risk of premature death increased significantly with increasing material deprivation (P < 0.001). Conclusions Diabetes is associated with excess mortality, even in an area with high background death rates from cardiovascular disease. This excess mortality is evident in all age groups, most pronounced in young people with type 1 diabetes, and exacerbated by material deprivation. Aggressive approaches to the management of cardiovascular risk factors could reduce the excess mortality in people with diabetes.	Middlesbrough Gen Hosp, Diabet Care Ctr, Middlesbrough TS5 5AZ, Cleveland, England; Univ Newcastle Upon Tyne, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Diabet & Epidemiol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Roper, NA (corresponding author), Middlesbrough Gen Hosp, Diabet Care Ctr, Middlesbrough TS5 5AZ, Cleveland, England.			Unwin, Nigel/0000-0002-1368-1648				Chaturvedi N, 1998, BMJ-BRIT MED J, V316, P100; Connolly VM, 1996, DIABETES CARE, V19, P419, DOI 10.2337/diacare.19.5.419; CROXSON SCM, 1994, DIABETIC MED, V11, P250, DOI 10.1111/j.1464-5491.1994.tb00267.x; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Devis T, 1990, POPUL TRENDS, V60, P23; Diabetes care and research in Europe, 1990, DIABETIC MED, V7, P360; *DOC GEIG, 1970, SCI TABL; Evans JMM, 2000, DIABETIC MED, V17, P478, DOI 10.1046/j.1464-5491.2000.00309.x; Gatling W, 1997, DIABETIC MED, V14, P316, DOI 10.1002/(SICI)1096-9136(199704)14:4<316::AID-DIA328>3.0.CO;2-0; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Jones ME, 1998, AM J EPIDEMIOL, V148, P1012; KELLY WF, 1993, BRIT MED J, V307, P1115, DOI 10.1136/bmj.307.6912.1115; Koskinen SVP, 1998, AM J PUBLIC HEALTH, V88, P765, DOI 10.2105/AJPH.88.5.765; Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x; MOSS SE, 1991, AM J PUBLIC HEALTH, V81, P1158, DOI 10.2105/AJPH.81.9.1158; MUGGEO M, 1995, DIABETOLOGIA, V38, P318, DOI 10.1007/s001250050288; *OFF POP CENS SURV, 1994, SER DH2, V2126; *OFF POP CENS SURV, 1994, SER DH1, V2730; PHILLIMORE P, 1994, BRIT MED J, V308, P1125, DOI 10.1136/bmj.308.6937.1125; Raymond NT, 1995, J EPIDEMIOL COMMUN H, V49, P570, DOI 10.1136/jech.49.6.570; Robinson N, 1998, DIABETIC MED, V15, P205, DOI 10.1002/(SICI)1096-9136(199803)15:3<205::AID-DIA519>3.0.CO;2-#; Townsend PP., 1988, HLTH DEPRIVATION INE; Unwin N, 1996, DIABETIC MED, V13, P72, DOI 10.1002/(SICI)1096-9136(199601)13:1<72::AID-DIA21>3.3.CO;2-K; WAUGH NR, 1989, DIABETOLOGIA, V32, P103, DOI 10.1007/BF00505181; WONG JSK, 1991, DIABETIC MED, V8, P135, DOI 10.1111/j.1464-5491.1991.tb01559.x	25	231	234	1	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1389	1393		10.1136/bmj.322.7299.1389	http://dx.doi.org/10.1136/bmj.322.7299.1389			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397742	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000169284600015
J	Arafah, BM				Arafah, BM			Increased need for thyroxine in women with hypothyroidism during estrogen therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	81st Annual Meeting of the Endocrine-Society	JUN 12-16, 1999	SAN DIEGO, CALIFORNIA	Endocrine Soc			PREGNANCY; DISEASE; SERUM	Background Women with hypothyroidism that is being treated with thyroxine often need higher doses when they are pregnant. Whether this need can be attributed solely to estrogen-induced increases in serum thyroxine-binding globulin or whether other factors are involved is not known. Methods In 11 postmenopausal women with normal thyroid function and 25 postmenopausal women with hypothyroidism treated with thyroxine, I assessed thyroid function before they started estrogen therapy and every 6 weeks for 48 weeks thereafter. The women with hypothyroidism included 18 women receiving thyroxine-replacement therapy and 7 women receiving thyrotropin-suppressive thyroxine therapy. On each occasion, serum thyroxine, free thyroxine, thyrotropin, and thyroxine-binding globulin were measured. Results In the women with normal thyroid function, the serum free thyroxine and thyrotropin concentrations did not change, whereas at 12 weeks the mean (+/- SD) serum thyroxine concentration had increased from 8.0 +/-0.9 mug per deciliter (103 +/- 12 nmol per liter) to 10.4 +/-1.5 mug per deciliter (134 +/- 19 nmol per liter, P< 0.001) and the serum thyroxine-binding globulin concentration had increased from 20.3<plus/minus>3.5 mg per liter to 31.3 +/-3.2 mg per liter (P<0.001). The women with hypothyroidism had similar increases in serum thyroxine and thyroxine-binding globulin concentrations during estrogen therapy, but their serum free thyroxine concentration decreased from 1.7<plus/minus>0.4 ng per deciliter (22 +/-5 pmol per liter) to 1.4 +/-0.3 ng per deciliter (18 +/-4 pmol per liter, P<0.001) and their serum thyrotropin concentration increased from 0.9<plus/minus>1.1 to 3.2 +/-3.1 muU per milliliter (P<0.001). The serum thyrotropin concentrations increased to more than 7 <mu>U per milliliter in 7 of the 18 women in the thyroxine-replacement group and to more than 1 muU per milliliter in 3 of the 7 women in the thyrotropin-suppression group. Conclusions In women with hypothyroidism treated with thyroxine, estrogen therapy may increase the need for thyroxine. (N Engl J Med 2001;344:1743-9.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Hosp Cleveland, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Div Clin & Mil Endocrinol, Cleveland, OH 44106 USA	University Hospitals of Cleveland; Case Western Reserve University	Arafah, BM (corresponding author), Univ Hosp Cleveland, Div Clin & Mol Endocrinol, 11100 Euclid Ave, Cleveland, OH 44106 USA.							AIN KB, 1987, J CLIN ENDOCR METAB, V65, P689, DOI 10.1210/jcem-65-4-689; ARAFAH BM, 1994, ANN INTERN MED, V121, P247, DOI 10.7326/0003-4819-121-4-199408150-00002; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; DOWLING JT, 1960, J CLIN INVEST, V39, P1119, DOI 10.1172/JCI104127; MANDEL SJ, 1990, NEW ENGL J MED, V323, P91, DOI 10.1056/NEJM199007123230204; MANDEL SJ, 1993, ANN INTERN MED, V119, P492, DOI 10.7326/0003-4819-119-6-199309150-00009; Robbins J, 1978, Recent Prog Horm Res, V34, P477; SKJOLDEBRAND L, 1982, ACTA ENDOCRINOL-COP, V100, P504, DOI 10.1530/acta.0.1000504; TOFT AD, 1994, NEW ENGL J MED, V331, P174; TOFT AD, 1994, NEW ENGL J MED, V331, P1035; UTIGER RD, 1990, NEW ENGL J MED, V323, P126; Wilson JD, 1998, WILLIAMS TXB ENDOCRI, P397; ZANINOVICH AA, 1972, ACTA ENDOCRINOL-COP, V71, P491, DOI 10.1530/acta.0.0710491	13	153	157	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2001	344	23					1743	1749		10.1056/NEJM200106073442302	http://dx.doi.org/10.1056/NEJM200106073442302			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	439TL	11396440				2022-12-28	WOS:000169133600002
J	Carek, PJ; Anderson, KD				Carek, PJ; Anderson, KD			Residency selection process and the match: Does anyone believe anybody?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROGRAM		Med Univ S Carolina, Dept Family Med, Charleston, SC 29425 USA; Michigan State Univ, Dept Surg, E Lansing, MI 48824 USA	Medical University of South Carolina; Michigan State University	Carek, PJ (corresponding author), Med Univ S Carolina, Dept Family Med, Charleston, SC 29425 USA.							Anderson, 2000, Curr Surg, V57, P460, DOI 10.1016/S0149-7944(00)00309-3; Anderson KD, 1999, AM J SURG, V177, P237, DOI 10.1016/S0002-9610(99)00019-7; Carek PJ, 2000, FAM MED, V32, P258; Kikano G E, 1994, Fam Med, V26, P492; Magill M K, 1992, Fam Med, V24, P500; Skinner B D, 1999, Fam Med, V31, P559; Teichman JMH, 2000, J UROLOGY, V163, P1878; Willard M, 1992, Fam Med, V24, P502	8	13	13	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2784	2785		10.1001/jama.285.21.2784	http://dx.doi.org/10.1001/jama.285.21.2784			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386940				2022-12-28	WOS:000168985800036
J	Rybczynski, N; Reisz, RR				Rybczynski, N; Reisz, RR			Earliest evidence for efficient oral processing in a terrestrial herbivore	NATURE			English	Article							EVOLUTION	Herbivores can increase their digestion rate by mechanically reducing particle size through oral trituration(1). Groups of terrestrial vertebrates with the greatest capacity to reduce tough plant foods orally are also the most abundant and diverse, as exemplified by ornithopod dinosaurs during the Mesozoic and extant artiodactyl and perissodactyl mammals(2). Thus, the effective oral processing of high-fibre plant material seems to represent an evolutionary innovation of both functional and macroevolutionary significance. However, evidence for oral processing is poorly documented in the fossil record, especially during the initial stages of terrestrial vertebrate diversification(3,4). Here we report on the basal anomodont Suminia getmanovi, the only known Palaeozoic vertebrate in which unequivocal specializations in its cranium and teeth for high-fibre herbivory are well preserved. We propose that the capacity to comminute tough plant foods was critical to the diversification of anomodonts, the most diverse, widely dispersed and abundant group of Palaeozoic terrestrial vertebrates, and to the onset of modern terrestrial ecosystems.	Univ Toronto, Dept Zool, Mississauga, ON L5L 1C6, Canada; Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27708 USA	University of Toronto; University Toronto Mississauga; Duke University	Reisz, RR (corresponding author), Univ Toronto, Dept Zool, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.							BJORNDAL KA, 1990, PHYSIOL ZOOL, V63, P710, DOI 10.1086/physzool.63.4.30158172; COSTA RL, 1981, J PALEONTOL, V55, P635; Dimichele William A., 1992, P205; Galton P.M., 1986, P203; Hotton N. III, 1986, P71; Hotton Nicholas III, 1997, P207; IVACHNENKO MF, 1994, PALEONTOLOG J, V28, P96; King G.M., 1996, REPTILES HERBIVORY; KING GM, 1994, J ZOOL, V232, P651, DOI 10.1111/j.1469-7998.1994.tb04620.x; NORMAN DB, 1985, AM NAT, V126, P151, DOI 10.1086/284406; Popowics TE, 1997, ANN ZOOL FENN, V34, P73; Reisz Robert R., 2000, P9, DOI 10.1017/CBO9780511549717.003; RENSBERGER JM, 1973, J PALEONTOL, V47, P515; RENSBERGER JM, 1975, J PALEONTOL, V49, P10; Rybczynski N, 2000, ZOOL J LINN SOC-LOND, V130, P329, DOI 10.1006/zjls.1999.0218; Sues HD, 1998, TRENDS ECOL EVOL, V13, P141, DOI 10.1016/S0169-5347(97)01257-3; THROCKMORTON GS, 1976, J MORPHOL, V148, P363, DOI 10.1002/jmor.1051480307	17	40	41	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					684	687		10.1038/35079567	http://dx.doi.org/10.1038/35079567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395768				2022-12-28	WOS:000169112500042
J	Casti, JL				Casti, JL			Formally speaking - Mathematical theorems can be created by formalization of everyday expressions	NATURE			English	Editorial Material									Tech Univ Vienna, Inst Econometr Operat Res & Syst Theory, A-1040 Vienna, Austria	Technische Universitat Wien	Casti, JL (corresponding author), Tech Univ Vienna, Inst Econometr Operat Res & Syst Theory, Argentinierstr 8, A-1040 Vienna, Austria.								0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					527	527		10.1038/35079200	http://dx.doi.org/10.1038/35079200			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385544	Bronze			2022-12-28	WOS:000168982500025
J	Morrison, J; Carroll, L; Twaddle, S; Cameron, I; Grimshaw, J; Leyland, A; Baillie, H; Watt, G				Morrison, J; Carroll, L; Twaddle, S; Cameron, I; Grimshaw, J; Leyland, A; Baillie, H; Watt, G			Pragmatic randomised controlled trial to evaluate guidelines for the management of infertility across the primary care-secondary care interface	BRITISH MEDICAL JOURNAL			English	Article							CLINICAL GUIDELINES	Objective To investigate the effect of clinical guidelines on the management of infertility across the primary care-secondary care interface. Design Cluster randomised controlled trial. Setting General practices and NHS hospitals accepting referrals for infertility in the Greater Glasgow Health Board area. Participants All 221 general practices in Glasgow; 214 completed the trial. Intervention General practices in the intervention arm received clinical guidelines developed locally. Control practices received them one year later. Dissemination of the guidelines included educational meetings. Main outcome measures The time from presentation to referral, investigations completed in general practice, the number and content of visits as a hospital outpatient, the time to reach a management plan, and costs for referrals from the two groups. Results Data on 689 referrals were collected. No significant difference was found in referral rates for infertility. Fewer than 1% of couples were referred inappropriately early. Referrals from intervention practices were significantly more likely to have all relevant investigations carried out (odds ratio 1.32, 95% confidence interval 1.00 to 1.75, P = 0.025). 70% of measurements of serum progesterone concentrations during the midluteal phase and 34% of semen analyses were repeated at least once in hospital, despite having been recorded as normal when checked in general practice. No difference was found in the proportion of referrals in which a management plan was reached within one year in the mean duration between first appointment and date of management plan. NHS costs were not significantly affected. Conclusions Dissemination of infertility guidelines by commonly used methods results in a modest increase in referrals having recommended investigations completed in general practice, but ther are no detectable differences in outcome for patients or reduction in costs. Clinicians in secondary care tended to fail to respond to changes in referral practice by doctors. Guidelines that aim to improved the referral process need to be disseminated and implemented so as to lead to changes in both primary care and secondary care.	Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland; Stobhill NHS Trust, Dept Res & Dev, Glasgow G21 3UW, Lanark, Scotland; Univ Glasgow, Queen Mothers Hosp, Dept Obstet & Gynaecol, Glasgow G3 8SJ, Lanark, Scotland; Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Aberdeen; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Glasgow	Morrison, J (corresponding author), Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland.		Grimshaw, Jeremy/D-8726-2013; Leyland, Alastair/C-6069-2011	Leyland, Alastair/0000-0003-3741-7099; Grimshaw, Jeremy/0000-0001-8015-8243				Carstairs V., 1991, DEPRIVATION HLTH SCO; EMSLIE C, 1993, BRIT MED J, V306, P1728, DOI 10.1136/bmj.306.6894.1728; HEALY DL, 1994, LANCET, V343, P1539, DOI 10.1016/S0140-6736(94)92941-6; THOMAS R, 1998, EVALUATION GUIDELINE; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; 1992, EFFECTIVE HLTH CARE, V3, P1	6	29	29	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 26	2001	322	7297					1282	1284		10.1136/bmj.322.7297.1282	http://dx.doi.org/10.1136/bmj.322.7297.1282			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375232	Bronze, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000169027800021
J	Knowlton, N				Knowlton, N			Ecology - Coral reef biodiversity - Habitat size matters	SCIENCE			English	Editorial Material							SPECIES RICHNESS; DESTRUCTION; PATTERNS		Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Smithsonian Trop Res Inst, Balboa, Panama	University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian Tropical Research Institute	Knowlton, N (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.							Ayre DJ, 2000, EVOLUTION, V54, P1590; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cornell HV, 2000, CORAL REEFS, V19, P37, DOI 10.1007/s003380050224; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Harmelin-Vivien M.L., 1989, Ecological Studies, V69, P21; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Karlson RH, 1998, ECOL MONOGR, V68, P259, DOI 10.1890/0012-9615(1998)068[0259:SDVILV]2.0.CO;2; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; Paulay Gustav, 1997, P298; REAKAKUDLA ML, 1997, BIODIVERSITY, V2, P83; SMALL AM, 1998, ATOLL RES B, V458, P1, DOI DOI 10.5479/SI.00775630.458.1; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Wilkinson CR, 1999, MAR FRESHWATER RES, V50, P867, DOI 10.1071/MF99121	17	21	26	6	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1493	+		10.1126/science.1061690	http://dx.doi.org/10.1126/science.1061690			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11379628				2022-12-28	WOS:000168963800027
J	Bradford, L; O'Tierney, P				Bradford, L; O'Tierney, P			Three-person rule was not set by Nobel himself	NATURE			English	Letter									Queens Univ, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Bradford, L (corresponding author), Queens Univ, Dept Anat & Cell Biol, Botterel Hall,9th Floor, Kingston, ON K7L 3N6, Canada.							1998, NATURE, V396, P614	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					413	413		10.1038/35078244	http://dx.doi.org/10.1038/35078244			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373644	Bronze			2022-12-28	WOS:000168858700016
J	Vicsek, T				Vicsek, T			A question of scale	NATURE			English	Article									Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary	Eotvos Lorand University	Vicsek, T (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Pazmany P Stny 1A, H-1117 Budapest, Hungary.		Vicsek, Tamas/A-3305-2009					[Anonymous], 1987, STAT MECH; Coleman JS., 1990, FDN SOCIAL THEORY; VICSEK T, 2001, SCALING FLUCTUATIONS	3	93	102	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					421	421		10.1038/35078161	http://dx.doi.org/10.1038/35078161			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373653	Green Submitted			2022-12-28	WOS:000168858700024
J	Vacanti, CA; Bonassar, LJ; Vacanti, MP; Shufflebarger, J				Vacanti, CA; Bonassar, LJ; Vacanti, MP; Shufflebarger, J			Replacement of an avulsed phalanx with tissue-engineered bone.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORALLINE HYDROXYAPATITE; INDUCED OSTEOGENESIS; DEFECTS; REPAIR; TRANSPLANTATION; IMPLANTS; INGROWTH; ALLOGRAFTS; SUBSTITUTE; GRAFTS		Univ Massachusetts, Sch Med, Ctr Tissue Engn, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Anesthesiol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Div Plast Surg, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Vacanti, CA (corresponding author), Univ Massachusetts, Sch Med, Ctr Tissue Engn, 55 Lake Ave N, Worcester, MA 01655 USA.		Bonassar, Lawrence J/C-2103-2016	Bonassar, Lawrence J/0000-0003-1094-6433				*AM MED ASS, 1993, JAMA-J AM MED ASSOC, V3, P15; BAY BK, 1993, BONE, V14, P225, DOI 10.1016/8756-3282(93)90145-Z; BOLANDER ME, 1986, J BONE JOINT SURG AM, V68A, P1264, DOI 10.2106/00004623-198668080-00018; BUCKGRAMCKO D, 1990, HAND CLIN, V6, P643; CHESTERMAN P J, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P184; Eufinger H, 2000, J CRANIO MAXILL SURG, V28, P31, DOI 10.1054/jcms.2000.0105; FRIEDLAENDER GE, 1984, ANNU REV MED, V35, P311, DOI 10.1146/annurev.me.35.020184.001523; GATTI AM, 1990, BIOMATERIALS, V11, P513, DOI 10.1016/0142-9612(90)90068-2; GLOWACKI J, 1985, CLIN PLAST SURG, V12, P233; Gosain AK, 1999, PLAST RECONSTR SURG, V103, P1443, DOI 10.1097/00006534-199904050-00013; GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P274; Haddock SM, 1999, J BIOMED MATER RES, V47, P71, DOI 10.1002/(SICI)1097-4636(199910)47:1<71::AID-JBM10>3.0.CO;2-U; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kim TH, 1995, MATER RES SOC SYMP P, V394, P91, DOI 10.1557/PROC-394-91; KRUKOWSKI M, 1990, J ORAL MAXIL SURG, V48, P468, DOI 10.1016/0278-2391(90)90233-R; Langer R, 1995, Tissue Eng, V1, P151, DOI 10.1089/ten.1995.1.151; Lexer E, 1908, ARCH KLIN CHIR, V6, P939; MANKIN HJ, 1987, ORTHOP CLIN N AM, V18, P275; MARTIN RB, 1989, BIOMATERIALS, V10, P481, DOI 10.1016/0142-9612(89)90090-2; MARTIN RB, 1993, BIOMATERIALS, V14, P341, DOI 10.1016/0142-9612(93)90052-4; MULLIKEN JB, 1984, J SURG RES, V37, P487, DOI 10.1016/0022-4804(84)90218-X; MULLIKEN JB, 1980, PLAST RECONSTR SURG, V65, P553, DOI 10.1097/00006534-198005000-00001; NAKAHARA H, 1990, CLIN ORTHOP RELAT R, P223; NAKAHARA H, 1992, CLIN ORTHOP RELAT R, P291; Nunes CR, 1997, J BIOMED MATER RES, V36, P560; OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289; Puelacher WC, 1996, INT J ORAL MAX SURG, V25, P223, DOI 10.1016/S0901-5027(96)80035-X; Robinson D, 1999, Ann Transplant, V4, P91; ROUX FX, 1988, J NEUROSURG, V69, P510, DOI 10.3171/jns.1988.69.4.0510; ROZEMA FR, 1990, J ORAL MAXIL SURG, V48, P1305, DOI 10.1016/0278-2391(90)90487-M; Saitoh A, 1996, PLAST RECONSTR SURG, V98, P706, DOI 10.1097/00006534-199609001-00017; SPRINGFIELD DS, 1987, ORTHOP CLIN N AM, V18, P249; SZABO G, 1993, MECH PROPERTIES BONE, V16, P197; Thaller S R, 1993, J Craniofac Surg, V4, P79, DOI 10.1097/00001665-199304000-00005; TOMFORD WW, 1995, J BONE JOINT SURG AM, V77A, P1742, DOI 10.2106/00004623-199511000-00017; VACANTI CA, 1994, CLIN PLAST SURG, V21, P445	36	241	268	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1511	1514		10.1056/NEJM200105173442004	http://dx.doi.org/10.1056/NEJM200105173442004			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357154				2022-12-28	WOS:000168677200004
J	Van Dyck, L				Van Dyck, L			Research in the EU: better times to come?	LANCET			English	Editorial Material									European Life Sci Forum, D-69117 Heidelberg, Germany		Van Dyck, L (corresponding author), European Life Sci Forum, D-69117 Heidelberg, Germany.							2001, WORKING DOCUMENT COM; 2001, PROPOSAL DECISION EU; 2001, EUROPEAN RES AREA; 2001, EUROSTAT PUBLICATION	4	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1465	1466		10.1016/S0140-6736(00)04673-0	http://dx.doi.org/10.1016/S0140-6736(00)04673-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377595				2022-12-28	WOS:000168614300007
J	Santagata, S; Boggon, TJ; Baird, CL; Gomez, CA; Zhao, J; Shan, WS; Myszka, DG; Shapiro, L				Santagata, S; Boggon, TJ; Baird, CL; Gomez, CA; Zhao, J; Shan, WS; Myszka, DG; Shapiro, L			G-protein signaling through tubby proteins	SCIENCE			English	Article							MOLECULAR CHARACTERIZATION; PLASMA-MEMBRANE; RECESSIVE MUTATIONS; STRUCTURAL BASIS; PHOSPHOLIPASE-C; GENE FAMILY; OBESITY; MOUSE; MICE; SEROTONIN	Dysfunction of the tubby protein results in maturity-onset obesity in mice. Tubby has been implicated as a transcription regulator, but details of the molecular mechanism underlying its function remain unclear. Here we show that tubby functions in signal transduction from heterotrimeric GTP-binding protein (G protein)-coupled receptors. Tubby Localizes to the plasma membrane by binding phosphatidylinositol 4,5-bisphosphate through its carboxyl terminal "tubby domain." X-ray crystallography reveals the atomic-level basis of this interaction and implicates tubby domains as phosphorylated-phosphatidylinositol binding factors. Receptor-mediated activation of G protein alpha (q) (G alpha (q)) releases tubby from the plasma membrane through the action of phospholipase C-beta, triggering translocation of tubby to the cell nucleus. The localization of tubby-like protein 3 (TULP3) is similarly regulated. These data suggest that tubby proteins function as membrane-bound transcription regulators that translocate to the nucleus in response to phosphoinositide hydrolysis, providing a direct link between G-protein signaling and the regulation of gene expression.	NYU, Mt Sinai Sch Med, Struct Biol Program, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA; Univ Utah, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA	Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; Utah System of Higher Education; University of Utah	Shapiro, L (corresponding author), NYU, Mt Sinai Sch Med, Struct Biol Program, Room 16-20,1425 Madison Ave, New York, NY 10029 USA.	shapiro@inka.mssm.edu	Baird, Cheryl L/F-6569-2011; Santagata, Sandro/A-7714-2009; Baird, Cheryl/AGM-0065-2022	Santagata, Sandro/0000-0002-7528-9668				Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Banerjee P, 1998, NAT GENET, V18, P177, DOI 10.1038/ng0298-177; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, XPLOR VRSION 3 1 SYS; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; COLEMAN DL, 1990, J HERED, V81, P424, DOI 10.1093/oxfordjournals.jhered.a111019; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Hartman JL, 1996, J BIOL CHEM, V271, P22591, DOI 10.1074/jbc.271.37.22591; He W, 2000, MOL BRAIN RES, V81, P109, DOI 10.1016/S0169-328X(00)00164-9; Horvath CM, 1997, CURR OPIN CELL BIOL, V9, P233, DOI 10.1016/S0955-0674(97)80067-1; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jian XY, 1999, J BIOL CHEM, V274, P11573, DOI 10.1074/jbc.274.17.11573; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Kapeller R, 1999, J BIOL CHEM, V274, P24980, DOI 10.1074/jbc.274.35.24980; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kretzschmar M, 2000, BREAST CANCER RES, V2, P107, DOI 10.1186/bcr42; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Mehrotra B, 2000, BIOCHEMISTRY-US, V39, P9679, DOI 10.1021/bi000487o; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISHINA PM, 1994, METABOLISM, V43, P549, DOI 10.1016/0026-0495(94)90194-5; Nishina PM, 1998, GENOMICS, V54, P215, DOI 10.1006/geno.1998.5567; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; North MA, 1997, P NATL ACAD SCI USA, V94, P3128, DOI 10.1073/pnas.94.7.3128; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Sargent PA, 1997, PSYCHOPHARMACOLOGY, V133, P309, DOI 10.1007/s002130050407; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; Stevens J, 2000, NUTR REV, V58, P129, DOI 10.1111/j.1753-4887.2000.tb01847.x; Stubdal H, 2000, MOL CELL BIOL, V20, P878, DOI 10.1128/MCB.20.3.878-882.2000; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VICKERS JD, 1993, J PHARMACOL EXP THER, V266, P1156; Wang HY, 1995, MOL PHARMACOL, V48, P988; WHO Consultation, 2000, WHO TECH REP SER, V894, P1	58	272	282	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2041	2050		10.1126/science.1061233	http://dx.doi.org/10.1126/science.1061233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11375483				2022-12-28	WOS:000169284700038
J	Hannan, EL; Magaziner, J; Wang, JJ; Eastwood, EA; Silberzweig, SB; Gilbert, M; Morrison, RS; McLaughlin, MN; Orosz, GM; Siu, AL				Hannan, EL; Magaziner, J; Wang, JJ; Eastwood, EA; Silberzweig, SB; Gilbert, M; Morrison, RS; McLaughlin, MN; Orosz, GM; Siu, AL			Mortality and locomotion 6 months after hospitalization for hip fracture - Risk factors and risk-adjusted hospital outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FUNCTIONAL STATUS; PROXIMAL FEMUR; SURVIVAL; WOMEN; OLDER; CARE; EXPERIENCE; PREDICTORS; MOBILITY; RECOVERY	Context Hip fracture is a common clinical problem that leads to considerable mortality and disability. A need exists for a practical means to monitor and improve outcomes, including function, for patients with hip fracture, Objectives To identify and compare the importance of significant prefracture predictors of functional status and mortality at 6 months for patients hospitalized with hip fracture and to compare risk-adjusted outcomes for hospitals providing initial care. Design Prospective study with data obtained from medical records and through structured interviews with patients and proxies. Setting and Participants A total of 571 adults aged 50 years or older with hip fracture who were admitted to 4 New York, NY, metropolitan hospitals between August 1997 and August 1998. Main Outcome Measures In-hospital and 6-month mortality; locomotion at 6 months; and adverse outcomes at 6 months, defined as death or needing assistance to ambulate, compared by hospital, adjusting for patient risk factors. Results The in-hospital mortality rate was 1.6%. At 6 months, the mortality rate was 13.5%, and another 12.8% needed total assistance to ambulate. Laboratory values were strong predictors of mortality but were not significantly associated with locomotion. Age and prefracture residence at a nursing home were significant predictors of locomotion (P=.02 for both) but were not significantly associated with mortality. Adjustment for baseline characteristics either substantially augmented or diminished interhospital differences in outcomes. Two hospitals had 1 outcome (functional status or mortality) that was significantly worse than the overall mean while the other outcome was nonsignificantly better than average. Conclusions Mortality and functional status ideally should be considered both together and individually to distinguish effects limited to one or the other outcome. Hospital performance for these 2 measures may differ substantially after adjustment, probably because different processes of care are important to each outcome.	SUNY Albany, Dept Hlth Policy Management & Behav, Sch Publ Hlth, Rensselaer, NY 12144 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Mt Sinai Sch Med, Dept Hlth Policy, New York, NY USA; Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; Mt Sinai Sch Med, Dept Orthopaed, New York, NY USA; Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA; Mt Sinai Sch Med, Dept Med, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; University System of Maryland; University of Maryland Baltimore; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Hannan, EL (corresponding author), SUNY Albany, Dept Hlth Policy Management & Behav, Sch Publ Hlth, 1 Univ Pl, Rensselaer, NY 12144 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS009459] Funding Source: NIH RePORTER; AHRQ HHS [U18HS09459-0] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AG HLTH CAR POL R, 1999, AHCPR PUBL; APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1572, DOI 10.1056/NEJM199005313222205; Carson JL, 1998, JAMA-J AM MED ASSOC, V279, P199, DOI 10.1001/jama.279.3.199; CEDER L, 1980, CLIN ORTHOP RELAT R, P173; COBEY JC, 1976, CLIN ORTHOP RELAT R, P258; Diamond TH, 1997, MED J AUSTRALIA, V167, P412, DOI 10.5694/j.1326-5377.1997.tb126646.x; DOLK T, 1989, UPSALA J MED SCI, V94, P209, DOI 10.3109/03009738909178565; FINSEN V, 1995, ANN CHIR GYNAECOL FE, V84, P291; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOLT EM, 1994, INJURY, V25, P91, DOI 10.1016/0020-1383(94)90109-0; HOSMER DW, 1989, APPL LOGISTIC REGRES; JENSEN JS, 1984, INJURY, V15, P411; JETTE AM, 1987, ARCH PHYS MED REHAB, V68, P735; Kane RL, 1998, J AM GERIATR SOC, V46, P1525, DOI 10.1111/j.1532-5415.1998.tb01537.x; Kane RL, 1996, J AM GERIATR SOC, V44, P242, DOI 10.1111/j.1532-5415.1996.tb00909.x; KENNIE DC, 1988, BRIT MED J, V297, P1083, DOI 10.1136/bmj.297.6656.1083; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Koval KJ, 1998, CLIN ORTHOP RELAT R, P22; KOVAL KJ, 1995, CLIN ORTHOP RELAT R, P150; Koval KJ, 1996, J ORTHOP TRAUMA, V10, P531, DOI 10.1097/00005131-199611000-00004; KYO T, 1993, CLIN ORTHOP RELAT R, P215; LUYAO GL, 1994, AM J PUBLIC HEALTH, V84, P1287, DOI 10.2105/AJPH.84.8.1287; Lyons Anthony R., 1997, American Journal of Medicine, V103, p51S, DOI 10.1016/S0002-9343(97)90027-9; Magaziner J, 1997, AM J EPIDEMIOL, V146, P418, DOI 10.1093/oxfordjournals.aje.a009295; Magaziner J, 1997, AM J PUBLIC HEALTH, V87, P1630, DOI 10.2105/AJPH.87.10.1630; Magaziner J, 1996, AM J EPIDEMIOL, V143, P283; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, P1065, DOI 10.1016/0895-4356(88)90076-5; MAGAZINER J, 1989, AM J PUBLIC HEALTH, V79, P274, DOI 10.2105/AJPH.79.3.274; Magaziner J, 1990, J GERONTOL, V45, P101; MAROTTOLI RA, 1994, AM J PUBLIC HEALTH, V84, P1807, DOI 10.2105/AJPH.84.11.1807; Morrison RS, 1998, ANN INTERN MED, V128, P1010, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00010; MULLEN JO, 1992, CLIN ORTHOP RELAT R, P214; Nettleman MD, 1996, J GEN INTERN MED, V11, P765, DOI 10.1007/BF02598997; PITTO RP, 1994, INT ORTHOP, V18, P109, DOI 10.1007/BF02484420; Svensson O, 1996, J BONE JOINT SURG BR, V78B, P115, DOI 10.1302/0301-620X.78B1.0780115; TODD CJ, 1995, BRIT MED J, V310, P904, DOI 10.1136/bmj.310.6984.904; TURCOTTE R, 1990, CLIN ORTHOP RELAT R, P132; WEATHERALL M, 1994, NEW ZEAL MED J, V107, P308; Young Y, 1997, J AM GERIATR SOC, V45, P288, DOI 10.1111/j.1532-5415.1997.tb00942.x	39	317	335	1	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2736	2742		10.1001/jama.285.21.2736	http://dx.doi.org/10.1001/jama.285.21.2736			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386929	Bronze			2022-12-28	WOS:000168985800026
J	Barbour, V				Barbour, V			Immunology approaches the bedside	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Barbour, V (corresponding author), Lancet, London WC1X 8RR, England.			Barbour, Virginia/0000-0002-2358-2440					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1728	1728		10.1016/S0140-6736(00)04935-7	http://dx.doi.org/10.1016/S0140-6736(00)04935-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403807				2022-12-28	WOS:000169156200008
J	Gouldstone, A; Van Vliet, KJ; Suresh, S				Gouldstone, A; Van Vliet, KJ; Suresh, S			Nanoindentation - Simulation of defect nucleation in a crystal	NATURE			English	Article							INDENTATION		MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gouldstone, A (corresponding author), Harvard Univ, Sch Publ Hlth, Physiol Program, Boston, MA 02215 USA.	ssuresh@mit.edu	Suresh, Subra/B-8289-2008	Suresh, Subra/0000-0002-6223-6831				BRAGG WL, 1947, P ROY SOC LOND A MAT, V190, P474; GEORGES JM, 1986, NATURE, V320, P342, DOI 10.1038/320342a0; Gerberich WW, 1996, ACTA MATER, V44, P3585, DOI 10.1016/1359-6454(96)00010-9; Gouldstone A, 2000, ACTA MATER, V48, P2277, DOI 10.1016/S1359-6454(00)00009-4; Johnson KL, 1985, CONTACT MECH, DOI 10.1201/b17110-2; MCCLINTOCK FA, 1965, P INT C FRACT, V1, P75; SHI LT, 1982, PHILOS MAG A, V46, P255, DOI 10.1080/01418618208239918; Suresh S, 1999, SCRIPTA MATER, V41, P951, DOI 10.1016/S1359-6462(99)00245-6	8	225	230	3	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					656	656		10.1038/35079687	http://dx.doi.org/10.1038/35079687			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395759				2022-12-28	WOS:000169112500033
J	Lewis, PM; Dunn, MP; McMahon, JA; Logan, M; Martin, JF; St-Jacques, B; McMahon, AP				Lewis, PM; Dunn, MP; McMahon, JA; Logan, M; Martin, JF; St-Jacques, B; McMahon, AP			Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1	CELL			English	Article							DEVELOPING CHICK LIMB; MOUSE PATCHED GENE; VERTEBRATE LIMB; FEEDBACK LOOP; TRANSDUCING HEDGEHOG; POLARIZING ACTIVITY; PATTERNING ACTIVITY; HEPARAN-SULFATE; NEURAL-TUBE; TOUT-VELU	Sonic hedgehog (Shh) signaling from the posterior zone of polarizing activity (ZPA) is the primary determinant of anterior-posterior polarity in the vertebrate limb field. An active signal is produced by an autoprocessing reaction that covalently links cholesterol to the N-terminal signaling moiety (N-Shh(p)), tethering N-Shh(p) to the cell membrane. We have addressed the role played by this lipophilic modification in Shh-mediated patterning of mouse digits. Both the distribution and activity of N-Shh(p) indicate that N-Shh(p) acts directly over a few hundred microns. In contrast, N-Shh, a form that lacks cholesterol, retains similar biological activity to N-Shh(p), but signaling is posteriorly restricted. Thus, cholesterol modification is essential for the normal range of signaling. It also appears to be necessary for appropriate modulation of signaling by the Shh receptor, Ptc1.	Harvard Univ, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75235 USA	Harvard University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McMahon, AP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Biolabs, 16 Divin Ave, Cambridge, MA 02138 USA.		McMahon, Andrew P/ABE-7520-2020	Dunn, Matthew/0000-0002-1320-4235	NINDS NIH HHS [NS 33642] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033642, R37NS033642] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Charite J, 2000, DEVELOPMENT, V127, P2461; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Duprez DM, 1996, DEVELOPMENT, V122, P1821; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gruneberg H, 1963, PATHOLOGY DEV; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; HINCHLIFFE JR, 1983, DEV EVOLUTION, P99; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; HONIG LS, 1981, NATURE, V291, P72, DOI 10.1038/291072a0; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lee J, 1997, DEVELOPMENT, V124, P2537; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lin X, 1998, BIOCHEM BIOPH RES CO, V248, P738, DOI 10.1006/bbrc.1998.9050; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; MARTI E, 1995, DEVELOPMENT, V121, P2537; Martin JF, 2000, GENESIS, V26, P225, DOI 10.1002/(SICI)1526-968X(200004)26:4<225::AID-GENE10>3.0.CO;2-F; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Motoyama J, 1998, NAT GENET, V18, P104, DOI 10.1038/ng0298-104; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Osborne TF, 1998, CURR OPIN LIPIDOL, V9, P137, DOI 10.1097/00041433-199804000-00010; Pearse RV, 1998, J EXP ZOOL, V282, P677, DOI 10.1002/(SICI)1097-010X(19981215)282:6<677::AID-JEZ4>3.0.CO;2-F; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; SMITH JC, 1978, NATURE, V272, P612, DOI 10.1038/272612a0; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Stickens D, 1997, BIOCHEM MOL MED, V61, P16, DOI 10.1006/bmme.1997.2588; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; Tabin CJ, 1997, TRENDS CELL BIOL, V7, P442, DOI 10.1016/S0962-8924(97)01159-8; TAYLOR AM, 1993, MECH DEVELOP, V42, P89, DOI 10.1016/0925-4773(93)90101-3; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Theil T, 1999, CELL TISSUE RES, V296, P75, DOI 10.1007/s004410051268; TICKLE C, 1981, NATURE, V289, P295, DOI 10.1038/289295a0; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; Vervoort M, 2000, BIOESSAYS, V22, P460, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;460::AID-BIES8&gt;3.0.CO;2-G; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; WOLPERT L, 1989, CELL TO CELL SIGNALLING : FROM EXPERIMENTS TO THEORETICAL MODELS, P133; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	69	387	400	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					599	612		10.1016/S0092-8674(01)00369-5	http://dx.doi.org/10.1016/S0092-8674(01)00369-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389830	Bronze			2022-12-28	WOS:000169123200007
J	Liang, WJ; Bockrath, M; Bozovic, D; Hafner, JH; Tinkham, M; Park, H				Liang, WJ; Bockrath, M; Bozovic, D; Hafner, JH; Tinkham, M; Park, H			Fabry-Perot interference in a nanotube electron waveguide	NATURE			English	Article							CARBON NANOTUBES; QUANTUM WIRES; TRANSPORT; OSCILLATIONS; CONDUCTANCE; TRANSISTOR; RESISTORS	The behaviour of traditional electronic devices can be understood in terms of the classical diffusive motion of electrons. As the size of a device becomes comparable to the electron coherence length, however, quantum interference between electron waves becomes increasingly important, leading to dramatic changes in device properties(1-8). This classical-to-quantum transition in device behaviour suggests the possibility for nanometer-sized electronic elements that make use of quantum coherence(1,2,7,8). Molecular electronic devices are promising candidates for realizing such device elements because the electronic motion in molecules is inherently quantum mechanical(9,10) and it can be modified by well defined chemistry(11-13). Here we describe an example of a coherent molecular electronic device whose behaviour is explicitly dependent on quantum interference between propagating electron waves-a Fabry-Perot electron resonator based on individual single-walled carbon nanotubes with near-perfect ohmic contacts to electrodes. In these devices, the nanotubes act as coherent electron waveguides(14-16), with the resonant cavity formed between the two nanotube-electrode interfaces. We use a theoretical model based on the multichannel Landauer-Buttiker formalism(17-19) to analyse the device characteristics and rnd that coupling between the two propagating modes of the nanotubes caused by electron scattering at the nanotube-electrode interfaces is important.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Park, H (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.		Hafner, Jason H/A-7959-2008; Park, Hongkun/R-9842-2019	Hafner, Jason H/0000-0002-6943-4232; Park, Hongkun/0000-0001-9576-8829				ANDO T, 1998, MESOSCOPIC PHYSICS E; Bachtold A, 1999, NATURE, V397, P673, DOI 10.1038/17755; Bockrath M, 2001, SCIENCE, V291, P283, DOI 10.1126/science.291.5502.283; Bockrath M, 1997, SCIENCE, V275, P1922, DOI 10.1126/science.275.5308.1922; BUTTIKER M, 1985, PHYS REV B, V31, P6207, DOI 10.1103/PhysRevB.31.6207; BUTTIKER M, 1986, PHYS REV B, V33, P3020, DOI 10.1103/PhysRevB.33.3020; CAHAY M, 1988, PHYS REV B, V37, P10125, DOI 10.1103/PhysRevB.37.10125; Chen J, 1999, SCIENCE, V286, P1550, DOI 10.1126/science.286.5444.1550; Collier CP, 2000, SCIENCE, V289, P1172, DOI 10.1126/science.289.5482.1172; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Datta S., 1997, ELECT TRANSPORT MESO; Debray P, 2000, PHYS REV B, V61, P10950, DOI 10.1103/PhysRevB.61.10950; Dekker C, 1999, PHYS TODAY, V52, P22, DOI 10.1063/1.882658; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; Hecht E., 1987, OPTICS; Ji Y, 2000, SCIENCE, V290, P779, DOI 10.1126/science.290.5492.779; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; McEuen PL, 1999, PHYS REV LETT, V83, P5098, DOI 10.1103/PhysRevLett.83.5098; Nygard J, 2000, NATURE, V408, P342, DOI 10.1038/35042545; Park H, 2000, NATURE, V407, P57, DOI 10.1038/35024031; Sohn L.L., 1997, MESOSCOPIC ELECT TRA; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Tans SJ, 1998, NATURE, V394, P761, DOI 10.1038/29494; Topinka MA, 2000, SCIENCE, V289, P2323, DOI 10.1126/science.289.5488.2323; Tsukagoshi K, 1999, NATURE, V401, P572, DOI 10.1038/44108; VANWEES BJ, 1989, PHYS REV LETT, V62, P2523, DOI 10.1103/PhysRevLett.62.2523; Venema LC, 1999, SCIENCE, V283, P52, DOI 10.1126/science.283.5398.52; White CT, 1998, NATURE, V393, P240, DOI 10.1038/30420	30	791	805	6	231	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					665	669		10.1038/35079517	http://dx.doi.org/10.1038/35079517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395762				2022-12-28	WOS:000169112500036
J	Cohen, J				Cohen, J			Knife-edge of design	NATURE			English	Editorial Material									Univ Warwick, Inst Math, Coventry CV4 7AL, W Midlands, England	University of Warwick	Cohen, J (corresponding author), Univ Warwick, Inst Math, Coventry CV4 7AL, W Midlands, England.							COHEN J, 1999, SCI SPECTRA, V16, P14; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; NNIO J, 2000, BIOESSAYS, V22, P396; Sakkas D, 1999, REV REPROD, V4, P31, DOI 10.1530/ror.0.0040031	4	4	4	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					529	529		10.1038/35079203	http://dx.doi.org/10.1038/35079203			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385545	Bronze			2022-12-28	WOS:000168982500026
J	Eom, CB; Lee, MK; Choi, JH; Belenky, LJ; Song, X; Cooley, LD; Naus, MT; Patnaik, S; Jiang, J; Rikel, M; Polyanskii, A; Gurevich, A; Cai, XY; Bu, SD; Babcock, SE; Hellstrom, EE; Larbalestier, DC; Rogado, N; Regan, KA; Hayward, MA; He, T; Slusky, JS; Inumaru, K; Haas, MK; Cava, RJ				Eom, CB; Lee, MK; Choi, JH; Belenky, LJ; Song, X; Cooley, LD; Naus, MT; Patnaik, S; Jiang, J; Rikel, M; Polyanskii, A; Gurevich, A; Cai, XY; Bu, SD; Babcock, SE; Hellstrom, EE; Larbalestier, DC; Rogado, N; Regan, KA; Hayward, MA; He, T; Slusky, JS; Inumaru, K; Haas, MK; Cava, RJ			High critical current density and enhanced irreversibility field in superconducting MgB2 thin films	NATURE			English	Article								The discovery of superconductivity at 39 K in magnesium diboride(1) offers the possibility of a new class of low-cost, high-performance superconducting materials for magnets and electronic applications. This compound has twice the transition temperature of Nb3Sn and four times that of Nb-Ti alloy, and the vital prerequisite of strongly linked current flow has already been demonstrated(2-5). One possible drawback, however, is that the magnetic field at which superconductivity is destroyed is modest. Furthermore, the field which limits the range of practical applications-the irreversibility field H*(T)-is approximately 7 T at liquid helium temperature (4.2 K), significantly lower than about 10 T for Nb-Ti (ref. 6) and similar to 20 T for Nb3Sn (ref. 7). Here we show that MgB2 thin films that are alloyed with oxygen can exhibit a much steeper temperature dependence of H*(T) than is observed in bulk materials, yielding an H* value at 4.2 K greater than 14 T. In addition, very high critical current densities at 4.2 K are achieved: 1 MA cm(-2) at 1 T and 10(5) A cm(-2) at 10 T. These results demonstrate that MgB2 has potential for high-field superconducting applications.	Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA; Univ Wisconsin, Ctr Appl Superconduct, Madison, WI 53706 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Princeton Mat Inst, Princeton, NJ 08544 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Princeton University; Princeton University	Eom, CB (corresponding author), Univ Wisconsin, Dept Mat Sci & Engn, 1509 Univ Ave, Madison, WI 53706 USA.	eom@engr.wisc.edu	Rikel, Mark/ABC-8142-2021; Jiang, Jianyi/F-2549-2017; Eom, Chang-Beom/I-5567-2014; Cooley, Lance/AAE-5646-2021; Larbalestier, David/B-2277-2008; Gurevich, Alex/A-4327-2008; Inumaru, Kei/J-9292-2015; Cooley, Lance D/E-7377-2015; Cooley, Lance/N-4149-2019; Bu, Sang Don/B-1576-2008; Polyanskii, Anatolii A/B-8794-2009; Hayward, Michael/B-8005-2008	Jiang, Jianyi/0000-0002-1094-2013; Larbalestier, David/0000-0001-7098-7208; Gurevich, Alex/0000-0003-0759-8941; Cooley, Lance D/0000-0003-3488-2980; Cooley, Lance/0000-0003-3488-2980; Bu, Sang Don/0000-0003-4883-1308; Hayward, Michael/0000-0002-6248-2063; Patnaik, Prof. Satyabrata/0000-0003-4984-9243; Inumaru, Kei/0000-0001-6876-3854; Hellstrom, Eric/0000-0001-8263-8662; Slusky, Joanna/0000-0003-0842-6340; Lee, Minku/0000-0003-2687-7049; Rikel, Mark/0000-0002-4537-0772				Bud'ko SL, 2001, PHYS REV LETT, V86, P1877, DOI 10.1103/PhysRevLett.86.1877; Bugoslavsky Y, 2001, NATURE, V410, P563, DOI 10.1038/35069029; CAMPBELL AM, 1972, ADV PHYS, V21, P199, DOI 10.1080/00018737200101288; Canfield PC, 2001, PHYS REV LETT, V86, P2423, DOI 10.1103/PhysRevLett.86.2423; DEWHUGHES D, 1987, PHILOS MAG B, V55, P459, DOI 10.1080/13642818708217956; Finnemore DK, 2001, PHYS REV LETT, V86, P2420, DOI 10.1103/PhysRevLett.86.2420; GUREVICH A, 1994, PHYS REV B, V50, P13563, DOI 10.1103/PhysRevB.50.13563; GYORGY EM, 1989, APPL PHYS LETT, V55, P283, DOI 10.1063/1.102387; KANG WN, IN PRESS SCIENCE; Larbalestier DC, 2001, NATURE, V410, P186, DOI 10.1038/35065559; Lee P. J, 1999, WILEY ENCY ELECT ELE, V21, P75; MULLER KH, 2001, CONDMAT0102517; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Slusky JS, 2001, NATURE, V410, P343, DOI 10.1038/35066528; Smathers D. B., 1990, ASM METALS HDB, V2, P1060; Takano Y, 2001, APPL PHYS LETT, V78, P2914, DOI 10.1063/1.1371239; WANG Y, 2001, CONDMAT0103181	18	429	445	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					558	560		10.1038/35079018	http://dx.doi.org/10.1038/35079018			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385563	Green Submitted			2022-12-28	WOS:000168982500042
J	Vijayan, M				Vijayan, M			G.N. Ramachandran (1922-2001) - Obituary	NATURE			English	Biographical-Item									Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Vijayan, M (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.								0	2	2	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					544	544		10.1038/35079236	http://dx.doi.org/10.1038/35079236			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385557				2022-12-28	WOS:000168982500036
J	Mederos, A; Lamberg-Karlovsky, CC				Mederos, A; Lamberg-Karlovsky, CC			Converting currencies in the Old World - Simple arithmetic underpinned trading throughout the Near East during the Bronze Age.	NATURE			English	Article									Univ Complutense, Dept Prehist, E-28040 Madrid, Spain; Harvard Univ, Peabody Museum, Dept Anthropol, Cambridge, MA 02138 USA	Complutense University of Madrid; Harvard University	Mederos, A (corresponding author), Univ Complutense, Dept Prehist, Ciudad Univ, E-28040 Madrid, Spain.		Mederos Martin, Alfredo/E-1972-2014	Mederos Martin, Alfredo/0000-0002-0036-7940				BIBBY TG, 1970, KUML 1970, P345; COURTOIS JC, 1990, RES ORIENTALES, V2, P119; EDZARD DO, 1990, REALLEXIKON ASSYRIOL, V7, P457; FRANK AG, 1993, CURR ANTHROPOL, V34, P383, DOI 10.1086/204184; MCDONALD DM, 1992, ORIGINS METROLOGY; Parise N., 1981, DIALOGHI ARCHEOLOGIA, V3, P155; Powell Marvin A., 1979, STUDIES HONOR TOM B, V203, P71; Roaf M., 1982, IRAQ, V44, P137; ZACCAGNINI C, 1991, 2 C INT STUD FEN PUN, P343; ZACCAGNINI C, 1986, TRAFFICI MICENEI NEL, P303	10	5	5	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					437	437		10.1038/35078143	http://dx.doi.org/10.1038/35078143			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373665				2022-12-28	WOS:000168858700034
J	Njolstad, PR; Sovik, O; Cuesta-Munoz, A; Bjorkhaug, L; Massa, O; Barbetti, F; Undlien, DE; Shiota, C; Magnuson, MA; Molven, A; Matschinsky, FM; Bell, GI				Njolstad, PR; Sovik, O; Cuesta-Munoz, A; Bjorkhaug, L; Massa, O; Barbetti, F; Undlien, DE; Shiota, C; Magnuson, MA; Molven, A; Matschinsky, FM; Bell, GI			Neonatal diabetes mellitus due to complete glucokinase deficiency.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MUTATIONS; GLUCOSE; GENE; HYPERGLYCEMIA; DEFINITION; MUTANTS		Univ Bergen, Haukeland Univ Hosp, Dept Pediat, N-5021 Bergen, Norway; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Bergen, Haukeland Univ Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Diabet Res Ctr, Philadelphia, PA 19104 USA; Ist Sci San Raffaele, I-20132 Milan, Italy; Univ Oslo, Natl Hosp, Inst Immunol, Oslo, Norway; Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	University of Bergen; Haukeland University Hospital; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Bergen; Haukeland University Hospital; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Oslo; National Hospital Norway; Vanderbilt University	Njolstad, PR (corresponding author), Univ Bergen, Haukeland Univ Hosp, Dept Pediat, N-5021 Bergen, Norway.	pal.njolstad@pedi.uib.no	Barbetti, Fabrizio/AAK-9106-2021; Magnuson, Mark/AAY-7172-2021; Barbetti, Fabrizio/I-7351-2018; Magnuson, Mark A/B-1335-2009; Bjørkhaug, Lise/AAA-4356-2021	Barbetti, Fabrizio/0000-0003-4687-980X; Magnuson, Mark/0000-0002-8824-6499; Barbetti, Fabrizio/0000-0003-4687-980X; Magnuson, Mark A/0000-0002-8824-6499; Bjørkhaug, Lise/0000-0002-9695-4559	NIDDK NIH HHS [DK-20595, DK-19525, DK-44840] Funding Source: Medline; Telethon [E.0946] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P30DK019525, P01DK044840, P60DK020595] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Mahalingam B, 1999, DIABETES, V48, P1698, DOI 10.2337/diabetes.48.9.1698; MATSCHINSKY FM, 1996, DIABETES REV, V4, P130; Saker PJ, 1996, DIABETOLOGIA, V39, P1325, DOI 10.1007/s001250050577; Shield JPH, 2000, HORM RES, V53, P7, DOI 10.1159/000053198; SOVIK O, 1988, ACTA ENDOCR-COP    S, V289, P32; St-Onge L, 1999, CURR OPIN GENET DEV, V9, P295, DOI 10.1016/S0959-437X(99)80044-6; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Temple IK, 2000, DIABETES, V49, P1359, DOI 10.2337/diabetes.49.8.1359; Terauchi Y, 2000, DIABETES, V49, P82, DOI 10.2337/diabetes.49.1.82; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666	16	298	316	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1588	1592		10.1056/NEJM200105243442104	http://dx.doi.org/10.1056/NEJM200105243442104			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372010				2022-12-28	WOS:000168829700004
J	Sawaya, GF; Brown, AD; Washington, AE; Garber, AM				Sawaya, GF; Brown, AD; Washington, AE; Garber, AM			Current approaches to cervical-cancer screening.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAPILLOMAVIRUS INFECTION; COST-EFFECTIVENESS; NATURAL-HISTORY; WOMEN; ABNORMALITIES; MEMBERS; SMEARS	A 72-year-old woman has had an annual Papanicolaou (Pap) smear with normal findings (Fig. 1) for the past 30 years. She finds it difficult to undergo pelvic examinations because she has severe arthritis in her hips and vaginal atrophy. She has not been sexually active since the death of her husband 10 years earlier, and she wants to know whether she can stop being screened for cervical neoplasia.	Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Stanford Evidence Based Practice Ctr, San Francisco, CA 94143 USA; Univ Toronto, Dept Hlth Adm, Toronto, ON M5S 1A1, Canada; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Stanford Univ, Ctr Primary Care & Outcomes Res, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Sawaya, GF (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.		Garber, Alan M/F-1476-2010					*ACOG COMM, 2000, ROUT CANC SCREEN; *AG HLTH CAR POL R, 1999, EV CERV CYT EV REP T; [Anonymous], 1986, Br Med J (Clin Res Ed), V293, P659; BELL S, 1995, PREV MED, V24, P610, DOI 10.1006/pmed.1995.1096; BROADSTOCK M, 2000, NZHTA REPORT, V3; Brown AD, 1999, JAMA-J AM MED ASSOC, V281, P347, DOI 10.1001/jama.281.4.347; Cain JM, 2000, SCIENCE, V288, P1753, DOI 10.1126/science.288.5472.1753; Cruickshank ME, 1997, BRIT J OBSTET GYNAEC, V104, P586, DOI 10.1111/j.1471-0528.1997.tb11537.x; Frame P S, 1998, J Am Board Fam Pract, V11, P87; Goldie SJ, 1999, ANN INTERN MED, V130, P97, DOI 10.7326/0003-4819-130-2-199901190-00003; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; JANERICH DT, 1995, AM J PUBLIC HEALTH, V85, P791, DOI 10.2105/AJPH.85.6.791; Kinney W, 1998, GYNECOL ONCOL, V71, P428, DOI 10.1006/gyno.1998.5135; Koutsky LA, 2000, J NATL CANCER I, V92, P397, DOI 10.1093/jnci/92.5.397; Martin-Hirsch P, 1999, LANCET, V354, P1763, DOI 10.1016/S0140-6736(99)02353-3; Martin-Hirsch P, 2000, LANCET, V355, P414; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Myers ER, 2000, OBSTET GYNECOL, V96, P645, DOI 10.1016/S0029-7844(00)00979-0; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; *OFF MED APPL RES, 1996, CERV CANC NIH CONS S, V14, P1; PAYNE N, 2000, LIQUID BASED CYTOLOG; Pearce KF, 1996, NEW ENGL J MED, V335, P1559, DOI 10.1056/NEJM199611213352103; Ries L. A. G., 1999, SEER CANC STAT REV 1; Sawaya GF, 1999, CLIN OBSTET GYNECOL, V42, P922, DOI 10.1097/00003081-199912000-00020; Sawaya GF, 1999, OBSTET GYNECOL, V94, P307, DOI 10.1016/S0029-7844(99)00289-6; Sawaya GF, 2000, ANN INTERN MED, V133, P942, DOI 10.7326/0003-4819-133-12-200012190-00009; Sawaya GF, 2000, OBSTET GYNECOL, V96, P219, DOI 10.1016/S0029-7844(00)00882-6; SHINGLETON HM, 1995, CA-CANCER J CLIN, V45, P305, DOI 10.3322/canjclin.45.5.305; SHY K, 1989, OBSTET GYNECOL, V74, P838; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Sung HY, 2000, CANCER, V88, P2283, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2283::AID-CNCR12>3.3.CO;2-4; VANWIJNGAARDEN WJ, 1993, BRIT MED J, V306, P967, DOI 10.1136/bmj.306.6883.967; VANWIJNGAARDEN WJ, 1993, BRIT MED J, V306, P1373; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	34	69	72	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1603	1607		10.1056/NEJM200105243442107	http://dx.doi.org/10.1056/NEJM200105243442107			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372013	Green Published, Green Submitted			2022-12-28	WOS:000168829700007
J	Little, P; Somerville, J; Williamson, I; Warner, G; Moore, M; Wiles, R; George, S; Smith, A; Peveler, R				Little, P; Somerville, J; Williamson, I; Warner, G; Moore, M; Wiles, R; George, S; Smith, A; Peveler, R			Randomised controlled trial of self management leaflets and booklets for minor illness provided by post	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; CONSULTATIONS; CARE	Objective To assess the effectiveness of providing information by post about managing minor illnesses. Design Randomised controlled trial. Setting Six general practices. Participants Random sample of 4002 patients from the practice registers. Intervention Patients were randomised to receive one of three kinds of leaflet or booklet endorsed by their general practitioner: control (surgery access times), booklet, or summary card. Main outcome measures Attendance with the 42 minor illnesses listed in the booklet. Perceived usefulness of leaflets or booklets, confidence in managing illness, and willingness to wait before seeing the doctor. Results 238 (6%) patients did not receive the intervention as allocated. Of the remaining 3764 patients, 2965 (79%) had notes available for review after one year. Compared with the control group, fewer patients attended commonly with the minor illnesses in the booklet group (greater than or equal to2 consultations a year: odds ratio 0.81, 95% confidence interval 0.67 to 0.99) and the summary card group (0.83; 0.72 to 0.96). Among patients who had attended with respiratory tract infections in the past year there was a reduction in those attending in the booklet group (0.81; 0.62 to 1.07) and summary card group (0.67; 0.51 to 0.89) compared with the control group. The incidence of contacts with minor illness fell slightly compared with die previous year in the booklet (incidence ratio 0.97; 0.84 to 1.13) and summary card groups (0.93; 0.80 to 1.07). More patients in the intervention groups felt greater confidence in managing illness (booklet 32%, card 34%, control 12%, P < 0.001), but there was no difference in willingness to wait score (all groups mean = 32, P = 0.67). Conclusion Most patients find information about minor illness provided by post useful, and it helps their confidence in managing illness. Information may reduce the number attending commonly with minor illness, but the effect on overall contacts is likely to be modest. These data suggest that posting detailed information booklets about minor illness to the general population would have a limited effect.	Aldermoor Hlth Ctr, Primary Med Care Grp, Southampton SO16 5ST, Hants, England; Three Swans Surg, Salisbury, Wilts, England; Univ Southampton, Sch Occupat Therapy & Physiotherapy, Hlth Res Unit, Southampton SO9 5NH, Hants, England; Univ Southampton, Wessex Inst Hlth Res & Dev, Community Clin Sci Hlth Med & Biol Sci Div, Hlth Care Res Unit, Southampton SO9 5NH, Hants, England; Southampton & SW Hants Hlth Commiss, Southampton, Hants, England; Univ Southampton, Dept Psychiat, Community Clin Sci Hlth Med & Biol Sci Div, Mental Hlth Grp, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton; University of Southampton	Little, P (corresponding author), Aldermoor Hlth Ctr, Primary Med Care Grp, Southampton SO16 5ST, Hants, England.		Moore, Michael/C-3447-2011	Moore, Michael/0000-0002-5127-4509; Little, Paul/0000-0003-3664-1873				Banks JC, 1998, BRIT J GEN PRACT, V48, P1595; CarrHill RA, 1996, BRIT MED J, V312, P1008; HANSEN BWL, 1990, PATIENT EDUC COUNS, V16, P147, DOI 10.1016/0738-3991(90)90089-4; Howie JGR, 1999, BMJ-BRIT MED J, V319, P738, DOI 10.1136/bmj.319.7212.738; Lattimer V, 1996, PRIMARY CARE MANAGEM, V6, P3; Little P, 1997, BRIT MED J, V315, P350; Macfarlane JT, 1997, BRIT J GEN PRACT, V47, P719; METZ R, 1997, WHAT SHOULD I DO; MORRELL DC, 1980, BRIT MED J, V280, P769, DOI 10.1136/bmj.280.6216.769; Office of Population Censuses and Surveys, 1994, MORB STAT GEN PRACT; ROLAND M, 1989, J ROY COLL GEN PRACT, V39, P244; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; SWINSCOE T, 1996, STAT SQUARE ONE; TERRY P, 1993, J OCCUP ENVIRON MED, V308, P313; TERRY PE, 1993, J OCCUP ENVIRON MED, V35, P422; WOOD DA, 1994, BRIT MED J, V308, P313, DOI 10.1136/bmj.308.6924.313	16	44	44	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2001	322	7296					1214	1217		10.1136/bmj.322.7296.1214	http://dx.doi.org/10.1136/bmj.322.7296.1214			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11358775	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000168900700027
J	Carroll, KS; Hanna, J; Simon, I; Krise, J; Barbero, P; Pfeffer, SR				Carroll, KS; Hanna, J; Simon, I; Krise, J; Barbero, P; Pfeffer, SR			Role of Rab9 GTPase in facilitating receptor recruitment by TIP47	SCIENCE			English	Article							ENDOSOMES; BIOGENESIS; TRANSPORT	Mannose 6-phosphate receptors (MPRs) deliver lysosomal hydrolases from the Golgi to endosomes and then return to the Golgi complex. TIP47 recognizes the cytoplasmic domains of MPRs and is required for endosome-to-Golgi transport. Here we show that TIP47 also bound directly to the Rab9 guanosine triphosphatase (GTPase) in its active, GTP-bound conformation. Moreover, Rab9 increased the affinity of TIP47 for its cargo. A functional Rab9 binding site was required for TIP47 stimulation of MPR transport in vivo. Thus, a cytosolic cargo selection device may be selectively recruited onto a specific organelle, and vesicle budding might be coupled to the presence of an active Rab GTPase.	Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	pfeffer@cmgm.stanford.edu		Carroll, Kate/0000-0002-7624-9617	NIDDK NIH HHS [DK37332] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037332, R56DK037332, R37DK037332] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Itin C, 1997, J BIOL CHEM, V272, P27737, DOI 10.1074/jbc.272.44.27737; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Krise JP, 2000, J BIOL CHEM, V275, P25188, DOI 10.1074/jbc.M001138200; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425	15	192	200	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1373	1376		10.1126/science.1056791	http://dx.doi.org/10.1126/science.1056791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359012				2022-12-28	WOS:000168862900045
J	Szathmary, E; Jordan, F; Pal, C				Szathmary, E; Jordan, F; Pal, C			Molecular biology and evolution - Can genes explain biological complexity?	SCIENCE			English	Editorial Material									Coll Budapest, Inst Adv Study, H-1014 Budapest, Hungary		Szathmary, E (corresponding author), Coll Budapest, Inst Adv Study, 2 Szentharomsag, H-1014 Budapest, Hungary.		Szathmáry, Eörs/A-5007-2011; Szathmary, Eors/AAS-1202-2021; Jordan, Ferenc/A-9940-2009	Szathmary, Eors/0000-0001-5227-2997; Jordan, Ferenc/0000-0002-0224-6472				ATLAN H, 1990, B MATH BIOL, V52, P335, DOI 10.1007/BF02458575; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Bork P, 2001, NATURE, V409, P818, DOI 10.1038/35057274; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Harary F., 1969, GRAPH THEORY; HIGASHI M, 1991, THEORETICAL STUDIES; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Szathmary E, 1995, MAJOR TRANSITIONS EV; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011	14	87	91	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1315	1316		10.1126/science.1060852	http://dx.doi.org/10.1126/science.1060852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360989				2022-12-28	WOS:000168862900030
J	Blume-Jensen, P; Hunter, T				Blume-Jensen, P; Hunter, T			Oncogenic kinase signalling	NATURE			English	Review							ABL TYROSINE KINASE; MYELOGENOUS LEUKEMIA-CELLS; SRC FAMILY KINASES; C-KIT RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; HEMATOPOIETIC-CELLS; CATALYTIC SUBUNIT; PROTEIN; ACTIVATION; PHOSPHORYLATION	Protein-tyrosine kinases (PTKs) are important regulators of intracellular signal-transduction pathways mediating development and multicellular communication in metazoans. Their activity is normally tightly controlled and regulated. Perturbation of PTK signalling by mutations and other genetic alterations results in deregulated kinase activity and malignant transformation. The lipid kinase phosphoinositide 3-OH kinase (PI(3)K) and some of its downstream targets, such as the protein-serine/threonine kinases Akt and p70 S6 kinase (p70(S6K)), are crucial effectors in oncogenic PTK signalling. This review emphasizes how oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity and provides an update on our knowledge about the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70(S6K) signalling in human malignancies.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Blume-Jensen, P (corresponding author), Serono Reprod Biol Inst, 280 Pond St, Randolph, MA 02368 USA.	blume@salk.edu; hunter@salk.edu						Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Beghini A, 2000, HUM MOL GENET, V9, P2297, DOI 10.1093/oxfordjournals.hmg.a018921; BELLACOSA A, 1993, ONCOGENE, V8, P745; Besmer P, 1991, CURR OPIN CELL BIOL, V3, P939, DOI 10.1016/0955-0674(91)90111-B; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; BLUMEJENSEN P, IN PRESS CANC RES EN; BLUMEJENSEN P, IN PRESS ENCY CANC; Bocciardi R, 1997, ONCOGENE, V15, P2257, DOI 10.1038/sj.onc.1201413; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brennan P, 1999, MOL CELL BIOL, V19, P4729; Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Chen HE, 1996, MOL CELL BIOL, V16, P3685, DOI 10.1128/mcb.16.7.3685; Chian R, 2000, EXP HEMATOL, V28, P1491, DOI 10.1016/S0301-472X(00)00562-2; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Feng LX, 2000, J BIOL CHEM, V275, P25572, DOI 10.1074/jbc.M002218200; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; Gesbert F, 2000, J BIOL CHEM, V275, P39223, DOI 10.1074/jbc.M007291200; Hallek M, 1996, BRIT J HAEMATOL, V94, P5, DOI 10.1046/j.1365-2141.1996.6102053.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ihle JN, 1997, STEM CELLS, V15, P105, DOI 10.1002/stem.5530150814; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Irusta PM, 1998, EMBO J, V17, P6912, DOI 10.1093/emboj/17.23.6912; Jhiang SM, 2000, ONCOGENE, V19, P5590, DOI 10.1038/sj.onc.1203857; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; MASAHIRO A, 2001, P NATL ACAD SCI USA, V98, P136; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Meier R, 1999, J RECEPT SIGNAL TR R, V19, P121, DOI 10.3109/10799899909036639; Meshinchi S, 2001, BLOOD, V97, P89, DOI 10.1182/blood.V97.1.89; Migone TS, 1998, MOL CELL BIOL, V18, P6416, DOI 10.1128/MCB.18.11.6416; Murakami H, 1999, BIOCHEM BIOPH RES CO, V262, P68, DOI 10.1006/bbrc.1999.1186; NOWELL PC, 1960, SCIENCE, V132, P1497; Paullet JE, 1996, MATH MECH SOLIDS, V1, P315, DOI 10.1177/108128659600100303; Pawson T, 2000, GENE DEV, V14, P1027; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Piao XH, 1996, P NATL ACAD SCI USA, V93, P14665, DOI 10.1073/pnas.93.25.14665; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Santos SCR, 2000, ONCOGENE, V19, P1164, DOI 10.1038/sj.onc.1203418; Sasaki T, 2000, NATURE, V406, P897, DOI 10.1038/35022585; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shewchuk LM, 2000, STRUCTURE, V8, P1105, DOI 10.1016/S0969-2126(00)00516-5; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Smith-Hicks CL, 2000, EMBO J, V19, P612, DOI 10.1093/emboj/19.4.612; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Taniguchi M, 1999, CANCER RES, V59, P4297; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; van Weering DHJ, 1998, RECENT RES CANCER, V154, P271; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	92	2878	3183	7	318	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					355	365		10.1038/35077225	http://dx.doi.org/10.1038/35077225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357143				2022-12-28	WOS:000168710000058
J	Krishnan, B; Levine, JD; Lynch, MKS; Dowse, HB; Funes, P; Hall, JC; Hardin, PE; Dryer, SE				Krishnan, B; Levine, JD; Lynch, MKS; Dowse, HB; Funes, P; Hall, JC; Hardin, PE; Dryer, SE			A new role for cryptochrome in a Drosophila circadian oscillator	NATURE			English	Article							LIGHT; CLOCK; PHOTORECEPTOR; RHYTHMS; CRY; TRANSCRIPTION; MELANOGASTER; MUTATION	Cryptochromes are flavin/pterin-containing proteins that are involved in circadian clock function in Drosophila and mice. In mice, the cryptochromes Cry1 and Cry2 are integral components of the circadian oscillator within the brain(1-6) and contribute to circadian photoreception in the retina(7). In Drosophila, cryptochrome (CRY) acts as a photoreceptor that mediates light input to circadian oscillators in both brain and peripheral tissue(8-12). A Drosophila cry mutant, cry(b), leaves circadian oscillator function intact in central circadian pacemaker neurons but renders peripheral circadian oscillators largely arrhythmic. Although this arrhythmicity could be caused by a loss of light entrainment, it is also consistent with a role for CRY in the oscillator. A peripheral oscillator drives circadian olfactory responses in Drosophila antennae(13). Here we show that CRY contributes to oscillator function and physiological output rhythms in the antenna during and after entrainment to light-dark cycles and after photic input is eliminated by entraining flies to temperature cycles. These results demonstrate a photoreceptor-independent role for CRY in the periphery and imply fundamental differences between central and peripheral oscillator mechanisms in Drosophila.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Univ Houston, Biol Clocks Program, Houston, TX 77204 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, NSF, Ctr Biol Timing, Waltham, MA 02454 USA; Univ Maine, Dept Biol Sci, Orono, ME 04469 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Brandeis University; Brandeis University; National Science Foundation (NSF); NSF - Center for Biological Timing; University of Maine System; University of Maine Orono	Hardin, PE (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.		Krishnan, Balaji/M-9914-2019; Krishnan, Balaji/C-7572-2009	Krishnan, Balaji/0000-0003-2074-4165; Hardin, Paul/0000-0002-3370-9011				Brandes C, 1996, NEURON, V16, P687, DOI 10.1016/S0896-6273(00)80088-4; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chatfield C., 1999, ANAL TIME SERIES; Dowse H, 1995, J NEUROGENET, V10, P153, DOI 10.3109/01677069509083461; DOWSE HB, 1991, J THEOR BIOL, V148, P139, DOI 10.1016/S0022-5193(05)80468-0; DOWSE HB, 1989, J THEOR BIOL, V139, P487, DOI 10.1016/S0022-5193(89)80067-0; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Ishikawa T, 1999, GENES CELLS, V4, P57, DOI 10.1046/j.1365-2443.1999.00237.x; Johnson E, 1998, J NEUROGENET, V12, P1, DOI 10.3109/01677069809108552; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; POWER J, 1995, J NEUROGENET, V9, P227, DOI 10.3109/01677069509084159; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106	26	185	195	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					313	317		10.1038/35077094	http://dx.doi.org/10.1038/35077094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357134				2022-12-28	WOS:000168710000049
J	Rosenberg, SA				Rosenberg, SA			Progress in human tumour immunology and immunotherapy	NATURE			English	Article							CYTOTOXIC T-LYMPHOCYTES; ACTIVATED KILLER-CELLS; METASTATIC MELANOMA; RECOMBINANT INTERLEUKIN-2; INFILTRATING LYMPHOCYTES; AUTOLOGOUS TUMOR; ANTIGEN; IDENTIFICATION; CANCER; RESPONSES	Studies of the administration of interleukin-2 to patients with metastatic melanoma or kidney cancer have shown that immunological manipulations can mediate the durable regression of metastatic cancer. The molecular identification of cancer antigens has opened new possibilities for the development of effective immunotherapies for patients with cancer. Clinical studies using immunization with peptides derived from cancer antigens have shown that high levels of lymphocytes with anti-tumour activity can be raised in cancer-bearing patients. Highly avid anti-tumour lymphocytes can be isolated from immunized patients and grown in vitro for use in cell-transfer therapies. Current studies are aimed at understanding the mechanisms that enable the cancer to escape from immune attack.	NCI, Div Clin Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenberg, SA (corresponding author), NCI, Div Clin Sci, Bldg 10,Room 2B42,10 Ctr Dr,MSC 1502, Bethesda, MD 20892 USA.							Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; Brandle D, 1996, J EXP MED, V183, P2501, DOI 10.1084/jem.183.6.2501; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Butterfield LH, 1999, CANCER RES, V59, P3134; Chaux P, 1999, J EXP MED, V189, P767, DOI 10.1084/jem.189.5.767; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chiari R, 1999, CANCER RES, V59, P5785; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; DALLAL RM, 2000, PRINCIPLES PRACTICE, P705; Dudley ME, 2000, CANCER J, V6, P69; Eder JP, 2000, CLIN CANCER RES, V6, P1632; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Gong JL, 2000, J IMMUNOL, V165, P1705, DOI 10.4049/jimmunol.165.3.1705; Gueguen M, 1998, J IMMUNOL, V160, P6188; HEWITT HB, 1976, BRIT J CANCER, V33, P241, DOI 10.1038/bjc.1976.37; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; IOANNIDES CG, 1993, CELL IMMUNOL, V151, P225, DOI 10.1006/cimm.1993.1233; ITOH K, 1988, J EXP MED, V168, P1419, DOI 10.1084/jem.168.4.1419; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; JEROME KR, 1991, CANCER RES, V51, P2908; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Kawashima I, 1998, HUM IMMUNOL, V59, P1, DOI 10.1016/S0198-8859(97)00255-3; KLEIN E, 1960, CANCER RES, V20, P452; Landsteiner K, 1942, P SOC EXP BIOL MED, V49, P688, DOI 10.3181/00379727-49-13670; Li K, 1998, CANCER IMMUNOL IMMUN, V47, P32, DOI 10.1007/s002620050501; LOWY DR, 2001, CANC PRINCIPLES PRAC, P3189; Mandruzzato S, 1997, J EXP MED, V186, P785, DOI 10.1084/jem.186.5.785; Marincola FM, 2000, PRINCIPLES PRACTICE, P601; Marshall JL, 1999, J CLIN ONCOL, V17, P332, DOI 10.1200/JCO.1999.17.1.332; Marshall JL, 2000, J CLIN ONCOL, V18, P3964, DOI 10.1200/JCO.2000.18.23.3964; MUUL LM, 1987, J IMMUNOL, V138, P989; OLD LJ, 1962, ANN NY ACAD SCI, V101, P80, DOI 10.1111/j.1749-6632.1962.tb26446.x; Panelli MC, 2000, J IMMUNOL, V164, P4382, DOI 10.4049/jimmunol.164.8.4382; PAPADOPOULOS EB, 1994, NEW ENGL J MED, V330, P1185, DOI 10.1056/NEJM199404283301703; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Pieper R, 1999, J EXP MED, V189, P757, DOI 10.1084/jem.189.5.757; Restifo NP, 2000, GENE THER, V7, P89, DOI 10.1038/sj.gt.3301117; Robbins PF, 1996, J EXP MED, V183, P1185, DOI 10.1084/jem.183.3.1185; ROSENBERG SA, 1992, JAMA-J AM MED ASSOC, V268, P2416, DOI 10.1001/jama.268.17.2416; ROSENBERG SA, 1987, NEW ENGL J MED, V316, P889, DOI 10.1056/NEJM198704093161501; Rosenberg SA, 1998, ANN SURG, V228, P307, DOI 10.1097/00000658-199809000-00004; Rosenberg SA, 1999, J IMMUNOL, V163, P1690; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Rosenberg SA, 1998, J NATL CANCER I, V90, P1894, DOI 10.1093/jnci/90.24.1894; Rosenberg SA, 1999, IMMUNITY, V10, P281, DOI 10.1016/S1074-7613(00)80028-X; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; ROSENBERG SA, 2000, PRINCIPLES PRACTICE; SalazarOnfray F, 1997, CANCER RES, V57, P4348; Stoler DL, 1999, P NATL ACAD SCI USA, V96, P15121, DOI 10.1073/pnas.96.26.15121; Theobald M, 1995, P NATL ACAD SCI USA, V92, P11993, DOI 10.1073/pnas.92.26.11993; TOPALIAN SL, 1994, P NATL ACAD SCI USA, V91, P9461, DOI 10.1073/pnas.91.20.9461; TSANG KY, 1995, J NATL CANCER I, V87, P982, DOI 10.1093/jnci/87.13.982; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Visseren MJW, 1997, INT J CANCER, V73, P125, DOI 10.1002/(SICI)1097-0215(19970926)73:1<125::AID-IJC19>3.0.CO;2-F; Vissers JLM, 1999, CANCER RES, V59, P5554; Vonderheide RH, 1999, IMMUNITY, V10, P673, DOI 10.1016/S1074-7613(00)80066-7; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; WANG RF, 1995, J EXP MED, V181, P799, DOI 10.1084/jem.181.2.799; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; Wang RF, 1999, J EXP MED, V189, P1659, DOI 10.1084/jem.189.10.1659; Wang RF, 1996, J EXP MED, V184, P2207, DOI 10.1084/jem.184.6.2207; Wang RF, 1998, J IMMUNOL, V161, P3596; WOGLOM WILLIAM H., 1929, CANCER REV, V4, P129; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Yee C, 1996, J IMMUNOL, V157, P4079; Zeng G, 2000, J IMMUNOL, V165, P1153, DOI 10.4049/jimmunol.165.2.1153	74	1100	1216	2	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					380	384		10.1038/35077246	http://dx.doi.org/10.1038/35077246			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357146				2022-12-28	WOS:000168710000061
J	Kondro, W				Kondro, W			Canada needs better drug reporting, says inquest	LANCET			English	News Item																			0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1424	1424		10.1016/S0140-6736(00)04637-7	http://dx.doi.org/10.1016/S0140-6736(00)04637-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356458				2022-12-28	WOS:000168478200031
J	Montaner, J; Hill, A; Acosta, E				Montaner, J; Hill, A; Acosta, E			Practical implications for the interpretation of minimum plasma concentration/inhibitory concentration ratios	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITORS; ANTIVIRAL ACTIVITY; DRUG-RESISTANCE; THERAPY; PHARMACOKINETICS; ADULTS		Univ British Columbia, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England; Univ Alabama, Birmingham, AL USA	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Roche Holding; University of Alabama System; University of Alabama Birmingham	Montaner, J (corresponding author), Univ British Columbia, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada.							Barry M, 1997, CLIN PHARMACOKINET, V32, P194, DOI 10.2165/00003088-199732030-00003; Condra JH, 2000, J INFECT DIS, V182, P758, DOI 10.1086/315782; Cooper D, 1999, LANCET, V353, P2061, DOI 10.1016/S0140-6736(98)10391-4; Drusano GL, 1998, ANTIMICROB AGENTS CH, V42, P2153, DOI 10.1128/AAC.42.9.2153; Durant J, 2000, AIDS, V14, P1333, DOI 10.1097/00002030-200007070-00005; Falloon J, 2000, CLIN INFECT DIS, V30, P313, DOI 10.1086/313667; Gieschke R, 1999, CLIN PHARMACOKINET, V37, P75, DOI 10.2165/00003088-199937010-00005; Hennessy M, 2000, AIDS, V14, pS97; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; HSU A, 2000, 40 INT C ANT AG CHEM; HSYU PH, 2000, 13 INT AIDS C DURB; Kilby JM, 2000, ANTIMICROB AGENTS CH, V44, P2672, DOI 10.1128/AAC.44.10.2672-2678.2000; Levison ME, 2000, INFECT DIS CLIN N AM, V14, P281, DOI 10.1016/S0891-5520(05)70248-8; Molla A, 1998, VIROLOGY, V250, P255, DOI 10.1006/viro.1998.9383; Nascimbeni M, 1999, ANTIMICROB AGENTS CH, V43, P2629, DOI 10.1128/AAC.43.11.2629; OBRIEN WA, 1999, 39 INT C ANT AG CHEM; SAAH A, 1999, 6 C RETR OPP INF CHI; SADLER BM, 2000, 7 C RETR OPP INF JAN; ZHANG K, 1997, 6 EUR ISSX M GOTH SW	19	20	20	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1438	1440		10.1016/S0140-6736(00)04577-3	http://dx.doi.org/10.1016/S0140-6736(00)04577-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356471				2022-12-28	WOS:000168478200043
J	Niemann, T; Nielsen, TT; Thorsgaard, N; Lous, J				Niemann, T; Nielsen, TT; Thorsgaard, N; Lous, J			Differences in therapeutic consequences of exercise testing between a rural and an urban Danish county: population based study	BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY ANGIOGRAPHY		Med Res Unit Ringkobing, DK-6950 Ringkobing, Denmark; Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark; Herning Cent Hosp, Dept Med, DK-7400 Herning, Denmark; Aarhus Univ, Inst Gen Practice, DK-8000 Aarhus C, Denmark; Aarhus Univ, Res Unit Gen Practice, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Niemann, T (corresponding author), Finsensgade 26, DK-7400 Herning, Denmark.							EVERY NR, 1993, NEW ENGL J MED, V329, P546, DOI 10.1056/NEJM199308193290807; GRAY D, 1994, BRIT HEART J, V71, P474; Niemann T, 2000, SCAND CARDIOVASC J, V34, P286, DOI 10.1080/713783124; PILOTE L, 1995, NEW ENGL J MED, V333, P565, DOI 10.1056/NEJM199508313330907	4	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1394	1395		10.1136/bmj.322.7299.1394	http://dx.doi.org/10.1136/bmj.322.7299.1394			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397744	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000169284600017
J	Baud, O; Goulet, O; Canioni, D; Le Deist, F; Radford, I; Rieu, D; Dupuis-Girod, S; Cerf-Bensussan, N; Cavazzana-Calvo, M; Brousse, N; Fischer, A; Casanova, JL				Baud, O; Goulet, O; Canioni, D; Le Deist, F; Radford, I; Rieu, D; Dupuis-Girod, S; Cerf-Bensussan, N; Cavazzana-Calvo, M; Brousse, N; Fischer, A; Casanova, JL			Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; PROTRACTED DIARRHEA; DISEASE; AUTOANTIBODIES; INFANCY; MOUSE		Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, INSERM, Lab Unite 429, F-75015 Paris, France; Hop Necker Enfants Malad, Serv Immunol & Hematol Pediat, F-75015 Paris, France; Hop Necker Enfants Malad, Serv Gastroenterol Pediat, F-75015 Paris, France; Hop Necker Enfants Malad, Serv Anat Pathol, F-75015 Paris, France; Hop Necker Enfants Malad, Lab Cytogenet Hematol, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, Lab E9925, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, Unite 550, Lab Univ Rene Descartes, F-75015 Paris, France; Hop Arnaud Villeneuve, Serv Pediat 2, Montpellier, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier	Casanova, JL (corresponding author), Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, INSERM, Lab Unite 429, 149 Rue Sevres, F-75015 Paris, France.		Casanova, Jean-Laurent/I-3418-2017; Dupuis-Girod, Sophie/D-6268-2014; Cerf-Bensussan, nadine/H-9505-2017	Cerf-Bensussan, nadine/0000-0003-0665-1245; Dupuis-Girod, Sophie/0000-0002-8834-5526; Casanova, Jean-Laurent/0000-0002-7782-4169; Cavazzana, Marina/0000-0002-0264-0891				Aaltonen J, 1999, ANN MED, V31, P111, DOI 10.3109/07853899708998786; Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; [Anonymous], 1999, CLIN EXP IMMUNOL, V118, P1; Benkerrou M, 1997, EUR J IMMUNOL, V27, P2043, DOI 10.1002/eji.1830270831; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BLAIR PJ, 1994, J IMMUNOL, V153, P3764; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; CATASSI C, 1988, J PEDIATR GASTR NUTR, V7, P608, DOI 10.1097/00005176-198807000-00022; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Clark LB, 1999, J IMMUNOL, V162, P2546; DIROCCO M, 1996, ARCH DIS CHILD, V75, pF44; ELLIS D, 1982, AM J DIS CHILD, V136, P323, DOI 10.1001/archpedi.1982.03970400041013; Ferguson PJ, 2000, AM J MED GENET, V90, P390, DOI 10.1002/(SICI)1096-8628(20000228)90:5<390::AID-AJMG9>3.0.CO;2-M; Finel E, 1996, ARCH PEDIATRIE, V3, P782, DOI 10.1016/0929-693X(96)82160-9; Kobayashi I, 1999, GASTROENTEROLOGY, V117, P823, DOI 10.1016/S0016-5085(99)70340-9; KOBAYASHI I, 1995, EUR J PEDIATR, V154, P594, DOI 10.1007/BF02074852; Levy-Labad E, 2001, J PEDIATR-US, V138, P577, DOI 10.1067/mpd.2001.111502; McKusick V.A., 1998, MENDELIAN INHERITANC; MIRAKIAN R, 1986, BRIT MED J, V293, P1132, DOI 10.1136/bmj.293.6555.1132; Peake JE, 1996, ARCH DIS CHILD-FETAL, V74, pF195, DOI 10.1136/fn.74.3.F195; POWELL BR, 1982, J PEDIATR-US, V100, P731, DOI 10.1016/S0022-3476(82)80573-8; SATAKE N, 1993, EUR J PEDIATR, V152, P313, DOI 10.1007/BF01956741; SAVAGE MO, 1985, J PEDIATR GASTR NUTR, V4, P187, DOI 10.1097/00005176-198504000-00006; SAVAGE MO, 1982, LANCET, V1, P966; SEIDMAN EG, 1990, J PEDIATR-US, V117, P929, DOI 10.1016/S0022-3476(05)80140-4; Sleight BJ, 1998, BONE MARROW TRANSPL, V22, P375, DOI 10.1038/sj.bmt.1701306; Straus SE, 1999, ANN INTERN MED, V130, P591, DOI 10.7326/0003-4819-130-7-199904060-00020; Sullivan Kathleen E., 1998, Current Opinion in Pediatrics, V10, P600; UNSWORTH DJ, 1985, J PEDIATR GASTR NUTR, V4, P375, DOI 10.1097/00005176-198506000-00009; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	30	171	177	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2001	344	23					1758	1762		10.1056/NEJM200106073442304	http://dx.doi.org/10.1056/NEJM200106073442304			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	439TL	11396442				2022-12-28	WOS:000169133600004
J	Mannucci, PM; Tuddenham, EGD				Mannucci, PM; Tuddenham, EGD			Medical progress - The hemophilias - From royal genes to gene therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CREUTZFELDT-JAKOB-DISEASE; RECOMBINANT FACTOR-VIII; PREVIOUSLY UNTREATED PATIENTS; COAGULATION-FACTOR-VIII; PARVOVIRUS B19 INFECTION; HIV-POSITIVE PATIENTS; FACTOR-IX; BLEEDING EPISODES; B PATIENTS; INHIBITORS		Maggiore Hosp, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; Maggiore Hosp, Fdn Luigi Villa, Ist Ricovero & Cura Carattere Sci, Milan, Italy; Univ Milan, Milan, Italy; Hammersmith Hosp, Imperial Coll, Sch Med, MRC,Clin Sci Ctr, London, England	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Imperial College London	Mannucci, PM (corresponding author), Maggiore Hosp, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy.		Tuddenham, Edward/AAS-6196-2020; Huang, ZhiXin/H-5123-2017	Tuddenham, Edward/0000-0001-8955-2909; Huang, ZhiXin/0000-0003-0705-1970				Abshire TC, 2000, THROMB HAEMOSTASIS, V83, P811; ADDIEGO J, 1993, LANCET, V342, P462, DOI 10.1016/0140-6736(93)91593-B; Azzi A, 1999, TRANSFUS MED REV, V13, P194, DOI 10.1016/S0887-7963(99)80033-9; Barrow RT, 2000, BLOOD, V95, P564, DOI 10.1182/blood.V95.2.564; Bird A, 1998, HAEMOPHILIA, V4, P481, DOI 10.1046/j.1365-2516.1998.440481.x; BRAY GL, 1994, BLOOD, V83, P2428; CHOO KH, 1982, NATURE, V299, P178, DOI 10.1038/299178a0; COLOMBO M, 1991, AM J HEMATOL, V37, P243, DOI 10.1002/ajh.2830370406; Domingo P, 1998, AIDS, V12, P529; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; EHRENFORTH S, 1992, LANCET, V339, P594, DOI 10.1016/0140-6736(92)90874-3; ESMONDE TFG, 1993, LANCET, V341, P205, DOI 10.1016/0140-6736(93)90068-R; Evatt B, 1998, TRANSFUSION, V38, P817, DOI 10.1046/j.1537-2995.1998.38998409000.x; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; HEYE N, 1994, LANCET, V343, P298, DOI 10.1016/S0140-6736(94)91148-7; HOYER LW, 1994, NEW ENGL J MED, V330, P38, DOI 10.1056/NEJM199401063300108; Ingerslev J, 1996, HAEMOSTASIS, V26, P118; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Keeling DM, 1999, BRIT J HAEMATOL, V105, P1123, DOI 10.1046/j.1365-2141.1999.01460.x; Key NS, 1998, THROMB HAEMOSTASIS, V80, P912; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Lee CA, 1998, THROMB HAEMOSTASIS, V80, P909; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Ludlam CA, 1997, LANCET, V350, P1704, DOI 10.1016/S0140-6736(05)64307-3; Lusher J, 1998, BLOOD COAGUL FIBRIN, V9, P119, DOI 10.1097/00001721-199803000-00002; LUSHER JM, 1987, ANN NY ACAD SCI, V509, P89, DOI 10.1111/j.1749-6632.1987.tb30987.x; LUSHER JM, 1980, NEW ENGL J MED, V303, P421, DOI 10.1056/NEJM198008213030803; LUSHER JM, 1993, NEW ENGL J MED, V328, P453, DOI 10.1056/NEJM199302183280701; LUSHER JM, 1983, BLOOD, V62, P1135; Lusher JM, 2000, BLOOD, V96, p266A; MANNUCCI PM, 1994, ANN INTERN MED, V120, P1, DOI 10.7326/0003-4819-120-1-199401010-00001; Mannucci PM, 1996, BAILLIERE CLIN HAEM, V9, P273, DOI 10.1016/S0950-3536(96)80063-1; Matsui H, 1999, J PEDIAT HEMATOL ONC, V21, P74, DOI 10.1097/00043426-199901000-00022; MCMILLAN CW, 1988, BLOOD, V71, P344; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; MULLIS KB, 1990, SCI AM, V262, P56, DOI 10.1038/scientificamerican0490-56; Osterberg T, 1997, PHARMACEUT RES, V14, P892, DOI 10.1023/A:1012199816852; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PARQUETGERNEZ A, 1988, THROMB HAEMOSTASIS, V59, P202; Pipe SW, 1999, BLOOD, V93, P176, DOI 10.1182/blood.V93.1.176.401k07_176_183; Qian JH, 2000, BLOOD, V95, P1324, DOI 10.1182/blood.V95.4.1324.004k25_1324_1329; RABKIN CS, 1992, JAMA-J AM MED ASSOC, V267, P1090, DOI 10.1001/jama.267.8.1090; Racoosin JA, 1999, HAEMOPHILIA, V5, P266; Roth DA, 2001, NEW ENGL J MED, V344, P1735, DOI 10.1056/NEJM200106073442301; Rudzki Z, 1996, BRIT J HAEMATOL, V94, P400, DOI 10.1046/j.1365-2141.1996.d01-1792.x; Scandella DH, 2000, SEMIN THROMB HEMOST, V26, P137, DOI 10.1055/s-2000-9815; Schwaab R, 2000, BRIT J HAEMATOL, V109, P523, DOI 10.1046/j.1365-2141.2000.02021.x; Schwaab R, 1995, THROMB HAEMOSTASIS, V74, P1402; SCHWARTZ RS, 1990, NEW ENGL J MED, V323, P1800, DOI 10.1056/NEJM199012273232604; SJAMSOEDIN LJM, 1981, NEW ENGL J MED, V305, P717, DOI 10.1056/NEJM198109243051301; Soucie JM, 2000, BLOOD, V96, P437; Stoylova SS, 1999, J BIOL CHEM, V274, P36573, DOI 10.1074/jbc.274.51.36573; Tabor E, 1999, TRANSFUSION, V39, P1160, DOI 10.1046/j.1537-2995.1999.39111160.x; Thorland EC, 1999, HAEMOPHILIA, V5, P101, DOI 10.1046/j.1365-2516.1999.00303.x; TOOLE JJ, 1986, P NATL ACAD SCI USA, V83, P5939, DOI 10.1073/pnas.83.16.5939; TUDDENHAM EGD, 1994, OXFORD MONOGRAPHS ME, V25; van't Veer C, 2000, BLOOD, V95, P1330, DOI 10.1182/blood.V95.4.1330.004k28_1330_1335; White G, 1998, SEMIN HEMATOL, V35, P33; White GC, 1997, THROMB HAEMOSTASIS, V77, P660; Wilde JT, 1999, BRIT J HAEMATOL, V107, P556, DOI 10.1046/j.1365-2141.1999.01748.x; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; YEE TT, 1995, LANCET, V345, P794	64	711	756	1	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2001	344	23					1773	1779		10.1056/NEJM200106073442307	http://dx.doi.org/10.1056/NEJM200106073442307			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	439TL	11396445				2022-12-28	WOS:000169133600007
J	MacKenzie, IZ; Cooke, I				MacKenzie, IZ; Cooke, I			Prospective 12 month study of 30 minute decision to delivery intervals for "emergency" caesarean section	BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	MacKenzie, IZ (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.							[Anonymous], 2000, 7 MAT CHILD HLTH RES, P41; DENNIS J, 1989, AM J OBSTET GYNECOL, V161, P213, DOI 10.1016/0002-9378(89)90269-X; DUNPHY, 1991, J OBSTET GYNAECOL, V11, P241; HANNAH WJ, 1986, CAN MED ASSOC J, V134, P1348; Okunwobi-Smith Y, 2000, BRIT J OBSTET GYNAEC, V107, P467, DOI 10.1111/j.1471-0528.2000.tb13263.x	5	48	48	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2001	322	7298					1334	1335		10.1136/bmj.322.7298.1334	http://dx.doi.org/10.1136/bmj.322.7298.1334			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387178	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000169167900017
J	Cho, H; Mu, J; Kim, JK; Thorvaldsen, JL; Chu, QW; Crenshaw, EB; Kaestner, KH; Bartolomei, MS; Shulman, GI; Birnbaum, MJ				Cho, H; Mu, J; Kim, JK; Thorvaldsen, JL; Chu, QW; Crenshaw, EB; Kaestner, KH; Bartolomei, MS; Shulman, GI; Birnbaum, MJ			Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)	SCIENCE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; GLUCOSE-UPTAKE; C-LAMBDA; EXPRESSION; ACTIVATION; TRANSCRIPTION; HEPATOCYTES; INHIBITION	Glucose homeostasis depends on insulin responsiveness in target tissues, most importantly, muscle and Liver. The critical initial steps in insulin action include phosphorylation of scaffolding proteins and activation of phosphatidylinositol 3-kinase. These early events Lead to activation of the serine-threonine protein kinase Akt, also known as protein kinase B. We show that mice deficient in Akt2 are impaired in the ability of insulin to Lower blood glucose because of defects in the action of the hormone on Liver and skeletal muscle. These data establish Akt2 as an essential gene in the maintenance of normal glucose homeostasis.	Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Yale University; University of Pennsylvania	Birnbaum, MJ (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.		Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Kim, Jason/0000-0002-7185-042X	NIDDK NIH HHS [R01 DK56886, P30 DK50306, R01 DK040936] Funding Source: Medline; NIGMS NIH HHS [GM07229] Funding Source: Medline; PHS HHS [P30 19525] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK056886, R01DK040936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Agati JM, 1998, J BIOL CHEM, V273, P18751, DOI 10.1074/jbc.273.30.18751; Altomare DA, 1996, CYTOGENET CELL GENET, V74, P248, DOI 10.1159/000134426; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; BELLACOSA A, 1993, ONCOGENE, V8, P745; BIRNBAUM MJ, 1992, INT REV CYTOL, V137A, P239; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Brozinick JT, 1998, J BIOL CHEM, V273, P14679, DOI 10.1074/jbc.273.24.14679; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Cherrington AD, 1998, DIABETOLOGIA, V41, P987, DOI 10.1007/s001250051021; Cho H.-G., UNPUB; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Iynedjian PB, 2000, BIOCHEM J, V351, P621, DOI 10.1042/0264-6021:3510621; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kotani K, 1999, J BIOL CHEM, V274, P21305, DOI 10.1074/jbc.274.30.21305; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Murthy SS, 2000, CYTOGENET CELL GENET, V88, P38, DOI 10.1159/000015481; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Summers SA, 1999, J BIOL CHEM, V274, P23858, DOI 10.1074/jbc.274.34.23858; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	33	1446	1525	6	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1728	1731		10.1126/science.292.5522.1728	http://dx.doi.org/10.1126/science.292.5522.1728			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387480				2022-12-28	WOS:000169031800049
J	Dubois, M; Deme, B; Gulik-Krzywicki, T; Dedieu, JC; Vautrin, C; Desert, S; Perez, E; Zemb, T				Dubois, M; Deme, B; Gulik-Krzywicki, T; Dedieu, JC; Vautrin, C; Desert, S; Perez, E; Zemb, T			Self-assembly of regular hollow icosahedra in salt-free catanionic solutions	NATURE			English	Article							VESICLES	Self-assembled structures having a regular hollow icosahedral form (such as those observed for proteins of virus capsids) can occur as a result of biomineralization processes(1), but are extremely rare in mineral crystallites(2). Compact icosahedra made from a boron oxide have been reported(3), but equivalent structures made of synthetic organic components such as surfactants have not hitherto been observed. It is, however, well known that lipids, as well as mixtures of anionic and cationic single chain surfactants, can readily form bilayers(4,5) that can adopt a variety of distinct geometric forms: they can fold into soft vesicles or random bilayers (the so-called sponge phase) or form ordered stacks of flat or undulating membranes(6). Here we show that in salt-free mixtures of anionic and cationic surfactants, such bilayers can self-assemble into hollow aggregates with a regular icosahedral shape. These aggregates are stabilized by the presence of pores located at the vertices of the icosahedra. The resulting structures have a size of about one micrometre and mass of about 10(10) daltons, making them larger than any known icosahedral protein assembly(7) or virus capsid(8). We expect the combination of wall rigidity and holes at vertices of these icosahedral aggregates to be of practical value for controlled drug or DNA release.	CEA Saclay, Serv Chim Mol, F-91191 Gif Sur Yvette, France; Inst Max Von Laue Paul Langevin, F-38042 Grenoble 09, France; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; IMRCP, CNRS, URA 470, F-31062 Toulouse, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut Laue-Langevin (ILL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Dubois, M (corresponding author), CEA Saclay, Serv Chim Mol, F-91191 Gif Sur Yvette, France.	duboism@scm.saclay.cea.fr	ZEMB, Thomas N/E-5958-2010; Demé, Bruno/AAG-1620-2021	Demé, Bruno/0000-0002-9523-7662				CRICK FHC, 1956, NATURE, V177, P473, DOI 10.1038/177473a0; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E; Dubois M, 2000, PROG COLL POL SCI S, V115, P238; Dubois M, 1998, CR ACAD SCI II C, V1, P567, DOI 10.1016/S1387-1609(98)80012-1; Dubois M, 2000, CURR OPIN COLLOID IN, V5, P27, DOI 10.1016/S1359-0294(00)00032-7; Fogden A, 1997, J PHYS II, V7, P229, DOI 10.1051/jp2:1997121; Fogden A, 1997, COLLOID SURFACE A, V129, P157, DOI 10.1016/S0927-7757(97)00034-4; GRACIAA A, 1989, J PHYS CHEM-US, V93, P4167, DOI 10.1021/j100347a055; Hubert H, 1998, NATURE, V391, P376, DOI 10.1038/34885; Hyde ST, 1997, COLLOID SURFACE A, V129, P207, DOI 10.1016/S0927-7757(97)00038-1; KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283; KIMOTO K, 1966, J APPL PHYS, V16, P941; KLUG A, 1959, BIOCHIM BIOPHYS ACTA, V32, P203, DOI 10.1016/0006-3002(59)90570-0; KLUG A., 1960, ADVANCES IN VIRUS RES, V7, P225; NELSON DR, 1989, SOLID STATE PHYS, V42, P1; PARENTE RA, 1985, BIOCHIM BIOPHYS ACTA, V812, P493, DOI 10.1016/0005-2736(85)90324-4; Radtchenko IL, 2000, J COLLOID INTERF SCI, V230, P272, DOI 10.1006/jcis.2000.7068; Regev O, 1999, LANGMUIR, V15, P642, DOI 10.1021/la9803474; SACKMANN E, 1995, HDB BIOL PHYSICS B, V1; SCAMEHORN JF, 1989, SURFACTANT SCI SERIE, V33, pCH10; SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669; Spector MS, 1996, LANGMUIR, V12, P4704, DOI 10.1021/la960218s; THOMAS BN, 1995, SCIENCE, V267, P1635, DOI 10.1126/science.267.5204.1635; Thompson D.W., 1961, GROWTH FORM; WALS J, 1997, MOL CELL, V1, P59; Zemb T, 1999, SCIENCE, V283, P816, DOI 10.1126/science.283.5403.816	26	302	311	4	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					672	675		10.1038/35079541	http://dx.doi.org/10.1038/35079541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395764				2022-12-28	WOS:000169112500038
J	McConnell, JR; Emery, J; Eshed, Y; Bao, N; Bowman, J; Barton, MK				McConnell, JR; Emery, J; Eshed, Y; Bao, N; Bowman, J; Barton, MK			Role of PHABULOSA and PHAVOLUTA in determining radial patterning in shoots	NATURE			English	Article							HD-ZIP; GENE; ARABIDOPSIS; MERISTEM; ENCODES; MEMBERS; LEAVES	The upper side of the angiosperm leaf is specialized for efficient capture of sunlight whereas the lower side is specialized for gas exchange. In Arabidopsis, the establishment of polarity in the leaf probably requires the generation and perception of positional information along the radial (adaxial versus abaxial or central versus peripheral) dimension of the plant. This is because the future upper (adaxial) side of the leaf develops from cells closer to the centre of the shoot, whereas the future under (abaxial) side develops from cells located more peripherally. Here we implicate the Arabidopsis PHABULOSA and PHAVOLUTA genes in the perception of radial positional information in the leaf primordium. Dominant phabulosa (phb)(1) and phavoluta (phv) mutations cause a dramatic transformation of abaxial leaf fates into adaxial leaf fates. They do so by altering the predicted sterol/lipid-binding domains of ATHB14 and ATHB9, proteins of previously unknown function that also contain DNA-binding motifs. This change probably renders the protein constitutively active, implicating this domain as a central regulator of protein function and the PHB and PHV proteins as receptors for an adaxializing signal.	Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Wisconsin, Program Plant Breeding & Plant Genet, Madison, WI 53706 USA; Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis	Barton, MK (corresponding author), Univ Wisconsin, Dept Genet, 445 Henry Mall, Madison, WI 53706 USA.	mkbarton@facstaff.wisc.edu		Bowman, John/0000-0001-7347-3691; Eshed, Yuval/0000-0001-8290-0018				BENFEY PN, 1990, EMBO J, V9, P1677, DOI 10.1002/j.1460-2075.1990.tb08291.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Lynn K, 1999, DEVELOPMENT, V126, P469; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Ratcliffe OJ, 2000, PLANT CELL, V12, P315, DOI 10.1105/tpc.12.3.315; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Sessa G, 1998, PLANT MOL BIOL, V38, P609, DOI 10.1023/A:1006016319613; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; SNOW M, 1959, NEW PHYTOL, V8, P188; SUSSEX I. M., 1955, PHYTOMORPHOLOGY [DELHI], V5, P286; TALBERT PB, 1995, DEVELOPMENT, V121, P2723; WAITES R, 1995, DEVELOPMENT, V121, P2143; Zhong RQ, 1999, PLANT CELL, V11, P2139, DOI 10.1105/tpc.11.11.2139	15	828	1056	5	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					709	713		10.1038/35079635	http://dx.doi.org/10.1038/35079635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395776				2022-12-28	WOS:000169112500050
J	Jin, S; Mavoori, H; Bower, C; van Dover, RB				Jin, S; Mavoori, H; Bower, C; van Dover, RB			High critical currents in iron-clad superconducting MgB2 wires	NATURE			English	Article								Technically useful bulk superconductors must have high transport critical current densities, Jc, at operating temperatures. They also require a normal metal cladding to provide parallel electrical conduction, thermal stabilization, and mechanical protection of the generally brittle superconductor cores. The recent discovery of superconductivity at 39 K in magnesium diboride (MgB2)(1) presents a new possibility for significant bulk applications(2-5), but many critical issues relevant for practical wires remain unresolved. In particular, MgB2 is mechanically hard and brittle and therefore not amenable to drawing into the desired fine-wire geometry. Even the synthesis of moderately dense, bulk MgB2 attaining 39 K superconductivity is a challenge because of the volatility and reactivity of magnesium. Here we report the successful fabrication of dense, metal-clad superconducting MgB2 wires, and demonstrate a transport Jc in excess of 85,000 A cm(-2) at 4.2 K. Our iron-clad fabrication technique takes place at ambient pressure, yet produces dense MgB2 with little loss of stoichiometry. While searching for a suitable cladding material, we found that other materials dramatically reduced the critical current, showing that although MgB2 itself does not show the 'weak-link' effect characteristic of the high-Tc superconductors, contamination does result in weak-link-like behaviour.	Lucent Technol, Agere Syst, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; Broadcom; LSI Corporation	Jin, S (corresponding author), Lucent Technol, Agere Syst, Murray Hill, NJ 07974 USA.		van Dover, Robert/B-6362-2011	van Dover, Robert/0000-0002-6166-5650				Canfield PC, 2001, PHYS REV LETT, V86, P2423, DOI 10.1103/PhysRevLett.86.2423; Eom CB, 2001, NATURE, V411, P558, DOI 10.1038/35079018; Finnemore DK, 2001, PHYS REV LETT, V86, P2420, DOI 10.1103/PhysRevLett.86.2420; Glowacki BA, 2001, SUPERCOND SCI TECH, V14, P193, DOI 10.1088/0953-2048/14/4/304; GRASSO G, 2001, CONDMAT0103563; JIN S, 1987, APPL PHYS LETT, V51, P203, DOI 10.1063/1.98923; JIN S, 1988, APPL PHYS LETT, V52, P2074, DOI 10.1063/1.99751; Larbalestier DC, 2001, NATURE, V410, P186, DOI 10.1038/35065559; MASALSKI T, 1990, BINARY PHASE DIAGRAM, V46, P1434; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Slusky JS, 2001, NATURE, V410, P343, DOI 10.1038/35066528; SUMPTION MD, CONDMAT0102441; TINKHAM M, 1975, INTRO SUPERCONDUCTIV, P185	13	411	433	0	72	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					563	565		10.1038/35079030	http://dx.doi.org/10.1038/35079030			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385565				2022-12-28	WOS:000168982500044
J	Packer, M; Coats, AJS; Fowler, MB; Katus, HA; Krum, H; Mohacsi, P; Rouleau, JL; Tendera, M; Castaigne, A; Roecker, EB; Schultz, MK; DeMets, DL				Packer, M; Coats, AJS; Fowler, MB; Katus, HA; Krum, H; Mohacsi, P; Rouleau, JL; Tendera, M; Castaigne, A; Roecker, EB; Schultz, MK; DeMets, DL		Carvedilol Prospective Randomized	Effect of carvedilol on survival in severe chronic heart failure.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; MORTALITY; ENDOTHELIN-1; CARDIOMYOPATHY; MORBIDITY; METOPROLOL; BLOCKADE; RATS	Background: Beta-blocking agents reduce the risk of hospitalization and death in patients with mild-to-moderate heart failure, but little is known about their effects in severe heart failure. Methods: We evaluated 2289 patients who had symptoms of heart failure at rest or on minimal exertion, who were clinically euvolemic, and who had an ejection fraction of less than 25 percent. In a double-blind fashion, we randomly assigned 1133 patients to placebo and 1156 patients to treatment with carvedilol for a mean period of 10.4 months, during which standard therapy for heart failure was continued. Patients who required intensive care, had marked fluid retention, or were receiving intravenous vasodilators or positive inotropic drugs were excluded. Results: There were 190 deaths in the placebo group and 130 deaths in the carvedilol group. This difference reflected a 35 percent decrease in the risk of death with carvedilol (95 percent confidence interval, 19 to 48 percent; P=0.0014, adjusted for interim analyses). A total of 507 patients died or were hospitalized in the placebo group, as compared with 425 in the carvedilol group. This difference reflected a 24 percent decrease in the combined risk of death or hospitalization with carvedilol. The favorable effects on both end points were seen consistently in all the subgroups we examined. Fewer patients in the carvedilol group than in the placebo group withdrew because of adverse effects or for other reasons (P=0.02). Conclusions: The previously reported benefits of carvedilol with regard to morbidity and mortality in patients with mild-to-moderate heart failure were also found in the patients with severe heart failure who were evaluated in this trial. (N Engl J Med 2001;344:1651-8.) Copyright (C) 2001 Massachusetts Medical Society.	Columbia Univ Coll Phys & Surg, Div Circulatory Physiol, New York, NY 10032 USA; Royal Brompton Hosp, London SW3 6LY, England; Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Univ Klinikum Lubeck, Lubeck, Germany; Monash Univ, Prahran, Vic, Australia; Univ Hosp Bern, CH-3010 Bern, Switzerland; Univ Hlth Network, Toronto, ON, Canada; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Silesian Sch Med, Katowice, Poland; Hop Henri Mondor, Paris, France; Univ Wisconsin, Madison, WI USA	Columbia University; Royal Brompton Hospital; Stanford University; University of Lubeck; Monash University; University of Bern; University Hospital of Bern; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Medical University Silesia; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of Wisconsin System; University of Wisconsin Madison	Packer, M (corresponding author), Columbia Univ Coll Phys & Surg, Div Circulatory Physiol, 630 W 168th St, New York, NY 10032 USA.		Coats, Andrew J Stewart/E-4451-2012; Tendera, Michal/AAA-1875-2022; Arnold, Malcolm/G-2869-2011; Petr, Petr/I-9423-2014	Coats, Andrew J Stewart/0000-0002-2771-4260; Tendera, Michal/0000-0002-0812-6113				COX DR, 1972, J R STAT SOC B, V34, P187; Dandona P, 2000, CIRCULATION, V101, P122, DOI 10.1161/01.CIR.101.2.122; Domanski MJ, 2000, J AM COLL CARDIOL, V35, p202A; DOWNING SE, 1983, CIRC RES, V52, P471, DOI 10.1161/01.RES.52.4.471; GAFFNEY TE, 1963, AM J MED, V34, P320, DOI 10.1016/0002-9343(63)90118-9; Grupp IL, 1998, AM J PHYSIOL-HEART C, V275, pH1338, DOI 10.1152/ajpheart.1998.275.4.H1338; HERSHBERGER RE, 1990, J CARDIOVASC PHARM, V15, P959, DOI 10.1097/00005344-199006000-00014; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hjalmarson A, 1999, LANCET, V353, P2001; Kaddoura S, 1996, CIRCULATION, V93, P2068, DOI 10.1161/01.CIR.93.11.2068; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keith M, 1998, J AM COLL CARDIOL, V31, P1352, DOI 10.1016/S0735-1097(98)00101-6; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lechat P, 2000, EUR HEART J, V21, P297; Lechat P, 1999, LANCET, V353, P9; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ohlstein EH, 1998, J MOL CELL CARDIOL, V30, P167, DOI 10.1006/jmcc.1997.0582; Pacher R, 1996, J AM COLL CARDIOL, V27, P633, DOI 10.1016/0735-1097(95)00520-X; Packer M, 1998, PROG CARDIOVASC DIS, V41, P39, DOI 10.1016/S0033-0620(98)80030-3; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Qin FH, 2000, J AM COLL CARDIOL, V35, p168A; RYDEN L, 1990, LANCET, V336, P1; SACKNERBERNSTEI.J, 1995, CIRCULATION S1, V92, P395; Suzuki M, 1998, CARDIOVASC RES, V39, P589, DOI 10.1016/S0008-6363(98)00166-7; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; The Xamoterol in Severe Heart Failure Study Group, 1990, LANCET, V336, P698; WAAGSTEIN F, 1989, CIRCULATION, V80, P551, DOI 10.1161/01.CIR.80.3.551; WEYL JD, 1985, ARCH INT PHARMACOD T, V275, P4; Whorlow SL, 2000, AM J CARDIOL, V86, P886, DOI 10.1016/S0002-9149(00)01114-0; Willette RN, 1999, J PHARMACOL EXP THER, V289, P48; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	33	2207	2378	3	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2001	344	22					1651	1658		10.1056/NEJM200105313442201	http://dx.doi.org/10.1056/NEJM200105313442201			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YG	11386263				2022-12-28	WOS:000168963000001
J	Sturm, M; Racine, C; Tape, K				Sturm, M; Racine, C; Tape, K			Climate change - Increasing shrub abundance in the Arctic	NATURE			English	Article									USA, Cold Reg Res & Engn Lab, Ft Wainwright, AK 99703 USA; USA, Cold Reg Res & Engn Lab, Hanover, NH 03755 USA; Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); University of Alaska System; University of Alaska Fairbanks	Sturm, M (corresponding author), USA, Cold Reg Res & Engn Lab, POB 35170, Ft Wainwright, AK 99703 USA.		Sturm, Matthew/GXF-6926-2022					Anderson Patricia M., 1993, P386; BILLINGS WD, 1987, QUATERNARY SCI REV, V6, P155; BLISS L C, 1992, P59; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chapin FS, 2000, J CLIMATE, V13, P2002, DOI 10.1175/1520-0442(2000)013<2002:SDAAEI>2.0.CO;2; Epstein HE, 2000, ECOL APPL, V10, P824, DOI 10.1890/1051-0761(2000)010[0824:ATNBMO]2.0.CO;2; McGuire AD, 2000, GLOBAL CHANGE BIOL, V6, P141, DOI 10.1046/j.1365-2486.2000.06017.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; REED JC, 1958, 302 US GEOL SURV; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Sturm M, 2001, J CLIMATE, V14, P336, DOI 10.1175/1520-0442(2001)014<0336:SSIIAT>2.0.CO;2	13	954	1012	10	356	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					546	547		10.1038/35079180	http://dx.doi.org/10.1038/35079180			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385559				2022-12-28	WOS:000168982500038
J	Cowley, MA; Smart, JL; Rubinstein, M; Cordan, MG; Diano, S; Horvath, TL; Cone, RD; Low, MJ				Cowley, MA; Smart, JL; Rubinstein, M; Cordan, MG; Diano, S; Horvath, TL; Cone, RD; Low, MJ			Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus	NATURE			English	Article							CENTRAL MELANOCORTIN SYSTEM; NEUROPEPTIDE-Y RECEPTOR; HYPOTHALAMIC NEURONS; OBESE GENE; MOUSE; MICE; INNERVATION; CHANNELS; RATS; AREA	The administration of leptin(1) to leptin-deficient humans, and the analogous Lep(ob)/Lep(ob) mice, effectively reduces hyperphagia and obesity(2,3). But common obesity is associated with elevated leptin, which suggests that obese humans are resistant to this adipocyte hormone. In addition to regulating long-term energy balance, leptin also rapidly affects neuronal activity(4-6). Proopiomelanocortin (POMC) and neuropeptide-Y types of neurons in the arcuate nucleus of the hypothalamus(7) are both principal sites of leptin receptor expression and the source of potent neuropeptide modulators, melanocortins and neuropeptide Y, which exert opposing effects on feeding and metabolism(8,9). These neurons are therefore ideal for characterizing leptin action and the mechanism of leptin resistance; however, their diffuse distribution makes them difficult to study. Here we report electrophysiological recordings on POMC neurons, which we identified by targeted expression of green fluorescent protein in transgenic mice. Leptin increases the frequency of action potentials in the anorexigenic POMC neurons by two mechanisms: depolarization through a nonspecific cation channel; and reduced inhibition by local orexigenic neuropeptide-Y/GABA (gamma -aminobutyric acid) neurons. Furthermore, we show that melanocortin peptides have an autoinhibitory effect on this circuit. On the basis of our results, we propose an integrated model of leptin action and neuronal architecture in the arcuate nucleus of the hypothalamus.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Buenos Aires, Sch Sci, Dept Biol, RA-1428 Buenos Aires, DF, Argentina; CONICET, Inst Invest Ingn Genet & Biol Mol, RA-1428 Buenos Aires, DF, Argentina; Yale Univ, Sch Med, Dept Obstet & Gynecol, Reprod Neurosci Unit, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA	Oregon Health & Science University; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Yale University; Yale University	Cone, RD (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.		Cowley, Michael A/B-9428-2008	Cowley, Michael A/0000-0001-7811-134X; Low, Malcolm/0000-0002-9900-3708				BAGNOL D, 1999, J NEUROSCI      0825; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cone RD, 1999, TRENDS ENDOCRIN MET, V10, P211, DOI 10.1016/S1043-2760(99)00153-8; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; CSIFFARY A, 1990, BRAIN RES, V506, P215, DOI 10.1016/0006-8993(90)91253-D; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Glaum SR, 1996, MOL PHARMACOL, V50, P230; Grieco P, 2000, J MED CHEM, V43, P4998, DOI 10.1021/jm000211e; Hakansson ML, 1998, J NEUROSCI, V18, P559; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; HORVATH TL, 1992, NEUROSCIENCE, V51, P391, DOI 10.1016/0306-4522(92)90323-T; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; KELLY MJ, 1990, NEUROENDOCRINOLOGY, V52, P268, DOI 10.1159/000125597; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; King PJ, 1999, J NEUROCHEM, V73, P641, DOI 10.1046/j.1471-4159.1999.0730641.x; Lee K, 1999, J PHYSIOL-LONDON, V515, P439, DOI 10.1111/j.1469-7793.1999.439ac.x; Powis JE, 1998, AM J PHYSIOL-REG I, V274, pR1468, DOI 10.1152/ajpregu.1998.274.5.R1468; Shiraishi T, 1999, NUTRITION, V15, P576, DOI 10.1016/S0899-9007(99)00088-X; Slugg RM, 2000, NEUROENDOCRINOLOGY, V72, P208, DOI 10.1159/000054589; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Young JI, 1998, J NEUROSCI, V18, P6631; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	1660	1704	1	143	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					480	484		10.1038/35078085	http://dx.doi.org/10.1038/35078085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373681	Green Published, Green Submitted			2022-12-28	WOS:000168858700050
J	Alexandru, G; Uhlmann, F; Mechtler, K; Poupart, MA; Nasmyth, K				Alexandru, G; Uhlmann, F; Mechtler, K; Poupart, MA; Nasmyth, K			Phosphorylation of the cohesin subunit Scc1 by Polo/Cdc5 kinase regulates sister chromatid separation in yeast	CELL			English	Article							CELL-CYCLE REGULATION; POLO-LIKE KINASES; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PROTEOLYTIC CLEAVAGE; DNA-REPLICATION; PROTEIN-KINASES; ANAPHASE; CHROMOSOME; METAPHASE	At the onset of anaphase, a caspase-related protease (separase) destroys the link between sister chromatids by cleaving the cohesin subunit Scc1. During most of the cell cycle, separase is kept inactive by binding to an inhibitory protein called securin. Separase activation requires proteolysis of securin, which is mediated by an ubiquitin protein ligase called the anaphase-promoting complex. Cells regulate anaphase entry by delaying securin ubiquitination until all chromosomes have attached to the mitotic spindle. Though no longer regulated by this mitotic surveillance mechanism, sister separation remains tightly cell cycle regulated in yeast mutants lacking securin. We show here that the Polo/Cdc5 kinase phosphorylates serine residues adjacent to Scc1 cleavage sites and strongly enhances their cleavage. Phosphorylation of separase recognition sites may be highly conserved and regulates sister chromatid separation independently of securin.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Boehringer Ingelheim Canada Ltd, Laval, PQ H7S 2G5, Canada	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim	Nasmyth, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	nasmyth@nt.imp.univie.ac.at	Mechtler, Karl/AAF-2717-2019	Mechtler, Karl/0000-0002-3392-9946; Alexandru, Gabriela/0000-0002-7058-5644; Nasmyth, Kim/0000-0001-7030-4403; Uhlmann, Frank/0000-0002-3527-6619				Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bae SS, 2000, FASEB J, V14, P1083, DOI 10.1096/fasebj.14.9.1083; Barkett M, 1997, J BIOL CHEM, V272, P29419, DOI 10.1074/jbc.272.47.29419; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Darwiche N, 1999, GENE, V233, P39, DOI 10.1016/S0378-1119(99)00160-2; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Hoque MT, 2001, J BIOL CHEM, V276, P5059, DOI 10.1074/jbc.M007809200; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Mayor T, 1999, FEBS LETT, V452, P92, DOI 10.1016/S0014-5793(99)00534-7; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; PRINGLE JR, 1981, MOL BIOL YEAST SACCH; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	54	306	312	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					459	472		10.1016/S0092-8674(01)00362-2	http://dx.doi.org/10.1016/S0092-8674(01)00362-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371343	Bronze			2022-12-28	WOS:000168840700006
J	Ganguly, K; Schinder, AF; Wong, ST; Poo, M				Ganguly, K; Schinder, AF; Wong, ST; Poo, M			GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition	CELL			English	Article							K-CL COTRANSPORTER; CA3 HIPPOCAMPAL-NEURONS; POSTNATAL RAT BRAINS; DORSAL HORN NEURONS; IN-VITRO; CREB PHOSPHORYLATION; CALCIUM CURRENTS; SENSORY NEURONS; ACTIVATION; EXPRESSION	GABA is the main inhibitory neurotransmitter in the adult brain. Early in development, however, GABAergic synaptic transmission is excitatory and can exert widespread trophic effects. During the postnatal period, GABAergic responses undergo a switch from being excitatory to inhibitory. Here, we show that the switch is delayed by chronic blockade of GABA(A) receptors, and accelerated by increased GABA(A) receptor activation. In contrast, blockade of glutamatergic transmission or action potentials has no effect. Furthermore, GABAergic activity modulated the mRNA levels of KCC2, a K+-Cl- cotransporter whose expression correlates with the switch. Finally, we report that GABA can alter the properties of depolarization-induced Ca2+ influx. Thus, GABA acts as a self-limiting trophic factor during neural development.	Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Poo, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Schinder, Alejandro/0000-0003-4863-8348	NINDS NIH HHS [NS 36999, NS 37831] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999, R01NS037831] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BERNINGER B, 1995, DEVELOPMENT, V121, P2327; Boukhaddaoui H, 2000, EUR J NEUROSCI, V12, P2068, DOI 10.1046/j.1460-9568.2000.00105.x; Caillard O, 1999, J PHYSIOL-LONDON, V518, P109, DOI 10.1111/j.1469-7793.1999.0109r.x; Chameu P, 1999, NEUROSCIENCE, V90, P383, DOI 10.1016/S0306-4522(98)00457-6; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CHERUBINI E, 1990, INT J DEV NEUROSCI, V8, P481, DOI 10.1016/0736-5748(90)90080-L; CONNOR JA, 1987, J NEUROSCI, V7, P1384; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Desmadryl G, 1998, EUR J NEUROSCI, V10, P545, DOI 10.1046/j.1460-9568.1998.00055.x; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GRUOL DL, 1992, J NEUROSCI, V12, P2838; Hilaire C, 1996, NEUROSCIENCE, V75, P1219, DOI 10.1016/0306-4522(96)00347-8; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Ikeda Y, 1997, DEV BRAIN RES, V98, P253, DOI 10.1016/S0165-3806(96)00183-6; Jarolimek W, 1999, J NEUROSCI, V19, P4695; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 1997, J PHYSIOL-LONDON, V498, P763, DOI 10.1113/jphysiol.1997.sp021900; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Lamsa K, 2000, J NEUROPHYSIOL, V83, P359, DOI 10.1152/jn.2000.83.1.359; LEE JJ, 1987, METHOD ENZYMOL, V152, P633; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; Li YX, 1998, J PHYSIOL-LONDON, V509, P847, DOI 10.1111/j.1469-7793.1998.847bm.x; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; MUELLER AL, 1984, J NEUROSCI, V4, P860; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Obrietan K, 1997, J NEUROSCI, V17, P4785; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; Owens DF, 1996, J NEUROSCI, V16, P6414; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rosenstein JM, 1998, CELL TRANSPLANT, V7, P121, DOI 10.1016/S0963-6897(98)00006-2; Schierle GS, 1997, CEREB CORTEX, V7, P130, DOI 10.1093/cercor/7.2.130; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; van den Pol AN, 1998, J NEUROSCI, V18, P10749; Vu TQ, 2000, J NEUROSCI, V20, P1414; WANG J, 1994, EUR J NEUROSCI, V6, P1275, DOI 10.1111/j.1460-9568.1994.tb00317.x; YUSTE R, 1991, NEURON, V6, P334	51	517	530	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					521	532		10.1016/S0092-8674(01)00341-5	http://dx.doi.org/10.1016/S0092-8674(01)00341-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371348	Bronze			2022-12-28	WOS:000168840700011
J	Ilani, S; Yacoby, A; Mahalu, D; Shtrikman, H				Ilani, S; Yacoby, A; Mahalu, D; Shtrikman, H			Microscopic structure of the metal-insulator transition in two dimensions	SCIENCE			English	Article							SINGLE-ELECTRON TRANSISTOR; QUANTUM HALL REGIME; 2 DIMENSIONS; 2-DIMENSIONAL ELECTRON; WIGNER CRYSTAL; B=0; COMPRESSIBILITY; PHASE; GLASS	A single electron transistor is used as a local electrostatic probe to study the underlying spatial structure of the metal-insulator transition in two dimensions. The measurements show that as we approach the transition from the metallic side, a new phase emerges that consists of weakly coupled fragments of the two-dimensional system. These fragments consist of localized charge that coexists with the surrounding metallic phase. As the density is lowered into the insulating phase, the number of fragments increases on account of the disappearing metallic phase. The measurements reveal that the metal-insulator transition is a result of the microscopic restructuring that occurs in the system.	Weizmann Inst Sci, Dept Condensed Matter Phys, Braun Ctr Submicron Res, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ilani, S (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, Braun Ctr Submicron Res, IL-76100 Rehovot, Israel.		Ilani, shahal/K-1377-2012	Ilani, shahal/0000-0001-8589-7723				Abrahams E, 2001, REV MOD PHYS, V73, P251, DOI 10.1103/RevModPhys.73.251; Benenti G, 1999, PHYS REV LETT, V83, P1826, DOI 10.1103/PhysRevLett.83.1826; Chakravarty S, 1999, PHILOS MAG B, V79, P859, DOI 10.1080/13642819908214845; CHUI ST, 1995, PHYS REV LETT, V74, P458, DOI 10.1103/PhysRevLett.74.458; Efros A. L., 1975, J PHYS C SOLID STATE, V8, P49; Hanein Y, 1998, PHYS REV LETT, V80, P1288, DOI 10.1103/PhysRevLett.80.1288; He S, 1998, PHYS REV LETT, V80, P3324, DOI 10.1103/PhysRevLett.80.3324; Ilani S, 2000, PHYS REV LETT, V84, P3133, DOI 10.1103/PhysRevLett.84.3133; Meir Y, 1999, PHYS REV LETT, V83, P3506, DOI 10.1103/PhysRevLett.83.3506; POLLAK M, 1985, ELECT ELECT INTERACT, V10, P287; RUZIN IM, 1992, PHYS REV B, V46, P3999, DOI 10.1103/PhysRevB.46.3999; Shapira S, 1996, PHYS REV LETT, V77, P3181, DOI 10.1103/PhysRevLett.77.3181; Si QM, 1998, PHYS REV LETT, V81, P4951, DOI 10.1103/PhysRevLett.81.4951; Wei YY, 1998, PHYS REV LETT, V81, P1674, DOI 10.1103/PhysRevLett.81.1674; Yoo MJ, 1997, SCIENCE, V276, P579, DOI 10.1126/science.276.5312.579; Yoon J, 1999, PHYS REV LETT, V82, P1744, DOI 10.1103/PhysRevLett.82.1744; Zhitenev NB, 2000, NATURE, V404, P473, DOI 10.1038/35006591	22	87	87	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1354	1357		10.1126/science.1058645	http://dx.doi.org/10.1126/science.1058645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359006	Green Submitted			2022-12-28	WOS:000168862900039
J	Waldman, RJ				Waldman, RJ			Prioritising health care in complex emergencies	LANCET			English	Article									Columbia Univ, Joseph L Mailman Sch Publ Hlth, Ctr Populat & Family Hlth, Programme Hlth Consequences Forced Migrat, New York, NY 10032 USA	Columbia University	Waldman, RJ (corresponding author), Columbia Univ, Joseph L Mailman Sch Publ Hlth, Ctr Populat & Family Hlth, Programme Hlth Consequences Forced Migrat, New York, NY 10032 USA.							*MED SANS FRONT, 1977, REF HLTH APPR EM SIT; The Sphere Project, 2000, HUM CHART MIN STAND	2	18	19	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1427	1429		10.1016/S0140-6736(00)04568-2	http://dx.doi.org/10.1016/S0140-6736(00)04568-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356462	Bronze			2022-12-28	WOS:000168478200034
J	McGuire, SE; Le, PT; Davis, RL				McGuire, SE; Le, PT; Davis, RL			The role of Drosophila mushroom body signaling in olfactory memory	SCIENCE			English	Article							SYNAPTIC VESICLE MEMBRANE; MUTANT DROSOPHILA; SHIBIRE; BODIES; DYNAMIN; MELANOGASTER; SENSITIVITY; EXPRESSION; DEFICIENT; MUTATIONS	The mushroom bodies of the Drosophila brain are important for olfactory learning and memory. To investigate the requirement for mushroom body signaling during the different phases of memory processing, we transiently inactivated neurotransmission through this region of the brain by expressing a temperature-sensitive allele of the shibire dynamin guanosine triphosphatase, which is required for synaptic transmission. Inactivation of mushroom body signaling through alpha/beta neurons during different phases of memory processing revealed a requirement for mushroom body signaling during memory retrieval, but not during acquisition or consolidation.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013; Oka, Yoshitaka/C-9670-2010	Davis, Ronald/0000-0002-5986-7608; Oka, Yoshitaka/0000-0002-3482-3051	NINDS NIH HHS [NS19904] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904, R37NS019904] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armstrong JD, 1998, LEARN MEMORY, V5, P102; Beck CDO, 2000, J NEUROSCI, V20, P2944; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Grant D, 1998, GENETICS, V149, P1019; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Ito K, 1998, LEARN MEMORY, V5, P52; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Lee T, 1999, DEVELOPMENT, V126, P4065; MCGUIRE SE, UNPUB; ROMAN G, IN PRESS BIOESSAYS; Sokal R. R., 1981, BIOMETRY; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	28	333	342	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1330	1333		10.1126/science.1062622	http://dx.doi.org/10.1126/science.1062622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11397912				2022-12-28	WOS:000170492600044
J	Miller, CJ; Nichol, RC; Batuski, DJ				Miller, CJ; Nichol, RC; Batuski, DJ			Acoustic oscillations in the early universe and today	SCIENCE			English	Article							OMEGA	During its first similar or equal to 100,000 years, the universe was a fully ionized plasma with a tight coupling by Thompson scattering between the photons and matter. The trade-off between gravitational collapse and photon pressure causes acoustic oscillations in this primordial fluid. These oscillations will Leave predictable imprints in the spectra of the cosmic microwave background and the present-day matter-density distribution. Recently, the BOOMERANG and MAXIMA teams announced the detection of these acoustic oscillations in the cosmic microwave background (observed at redshift similar or equal to 1000). Here, we compare these CMB detections with the corresponding acoustic oscillations in the matter-density power spectrum (observed at redshift similar or equal to 0.1). These consistent results, from two different cosmological epochs, provide further support for our standard Hot Big Bang model of the universe.	Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA	Carnegie Mellon University; University of Maine System; University of Maine Orono	Miller, CJ (corresponding author), Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA.							Balbi A, 2000, ASTROPHYS J, V545, pL1, DOI 10.1086/317323; DALTON GB, 1994, MNRAS, V271, P47; HAMILTON AJS, UNPUB; Hu W, 1996, ASTROPHYS J, V471, P30, DOI 10.1086/177951; Melchiorri A, 2000, ASTROPHYS J, V536, pL63, DOI 10.1086/312744; Miller AD, 1999, ASTROPHYS J, V524, pL1, DOI 10.1086/312293; MILLER C, UNPUB; MILLER CJ, IN PRESS ASTROPHYS J; NETTERFIELD CB, UNPUB; PEEBLES PJE, 1970, ASTROPHYS J, V162, P815, DOI 10.1086/150713; PEEBLES PJE, 1993, PRINCIPLES PHYSICS C; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; REISS AG, 1995, ASTROPHYS J L, V438, P17; Saunders W, 2000, MON NOT R ASTRON SOC, V317, P55, DOI 10.1046/j.1365-8711.2000.03528.x; Seljak U, 1996, ASTROPHYS J, V469, P437, DOI 10.1086/177793; Tadros H, 1998, MON NOT R ASTRON SOC, V296, P995, DOI 10.1046/j.1365-8711.1998.01441.x	16	15	16	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2302	2303		10.1126/science.1060440	http://dx.doi.org/10.1126/science.1060440			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11375481				2022-12-28	WOS:000169455900049
J	Paukert, JL				Paukert, JL			From medical student to intern: Where are the role models?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESIDENTS; CHOICES		Univ Texas, Hlth Sci Ctr, Dept Surg, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Sch Med, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Paukert, JL (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Surg, San Antonio, TX 78284 USA.							Ambrozy DM, 1997, ACAD MED, V72, P1119, DOI 10.1097/00001888-199712000-00028; FLANAGAN JC, 1954, PSYCHOL BULL, V51, P327, DOI 10.1037/h0061470; Glaser B.G., 1965, AWARENESS DYING; OSBORN EHS, 1993, ACAD MED, V68, P572, DOI 10.1097/00001888-199307000-00018; Paukert JL, 2000, ACAD MED, V75, P843, DOI 10.1097/00001888-200008000-00019; Wright S, 1997, J GEN INTERN MED, V12, P53, DOI 10.1007/s11606-006-0007-1; Wright S, 1996, ACAD MED, V71, P290, DOI 10.1097/00001888-199603000-00024	7	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2781	2781		10.1001/jama.285.21.2781	http://dx.doi.org/10.1001/jama.285.21.2781			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386938				2022-12-28	WOS:000168985800034
J	Tuffnell, DJ; Wilkinson, K; Beresford, N				Tuffnell, DJ; Wilkinson, K; Beresford, N			Interval between decision and delivery by caesarean section - are current standards achievable? Observational case series	BRITISH MEDICAL JOURNAL			English	Article							ANESTHESIA	Objectives To audit interval from decision to delivery in urgent caesarean section to determine whether the current standard of 30 minutes is achievable routinely; to determine whether delay leads to an excess of admissions to special care. Design Three audit cycles over four years followed by a continuous audit over 32 months. Setting Large district general hospital delivering 5500 women each year. Participants All women delivered by urgent caesarean section for abnormal fetal heart rate patterns, cord prolapse, failed instrumental delivery, or suspected placental abruption. Main outcome measures Proportion of women delivered within 30 and 40 minutes of decision. Admission rates to special care by length of interval between decision and delivery Results In the continuous audit 478 of 721 (66.3%) women were delivered in 30 minutes and 637 (88.3%) within 40 minutes; 29 (4.0%) were undelivered at 50 minutes. If the woman was taken to theatre in 10 minutes, 409 of 500 (81.8%) were delivered in 30 minutes and 495 (97%) in 40 minutes. There was no significant difference in the proportion of babies born at 36 weeks or later who were admitted to special care, when analysed by interval from decision to delivery. 36/449 (8%) babies with an interval, from decision to delivery of less than 30 minutes were admitted to special care and 3/23 (13%) with an interval of more than 50 minutes were admitted. Conclusions The current recommendations for the interval between decision and delivery are not being achieved in routine practice. Failure to meet the recommendations does not seem to increase neonatal morbidity.	Bradford NHS Trust, Matern Unit, Bradford BD9 6RJ, W Yorkshire, England		Tuffnell, DJ (corresponding author), Bradford NHS Trust, Matern Unit, Bradford BD9 6RJ, W Yorkshire, England.							*ASS AN GREAT BRIT, 1998, GUID OBST AN SERV; Brown G W, 1995, Int J Obstet Anesth, V4, P214, DOI 10.1016/0959-289X(95)82913-U; CHADWICK HS, 1991, ANESTHESIOLOGY, V74, P242, DOI 10.1097/00000542-199102000-00009; *CLIN NEGL SCHEM T, 1999, CLIN RISK MAN STAND; DWYER JP, 1999, 4 INT SCI M ROYAL CO, P13; *FOC GROUP, 2000, CONF ENQ STILLB DEAT, P41; Hawkins JL, 1997, ANESTHESIOLOGY, V86, P277, DOI 10.1097/00000542-199702000-00002; Johnson RV, 2000, ANAESTHESIA, V55, P179, DOI 10.1046/j.1365-2044.2000.055002179.x; Lucas DN, 2000, J ROY SOC MED, V93, P346, DOI 10.1177/014107680009300703; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; Madej T H, 1993, Qual Health Care, V2, P31, DOI 10.1136/qshc.2.1.31; *OYAL COLL OBST GY, 1995, ORG STAND MAT SERV, P36; *ROYAL COLL OBST G, 1999, SAF CHILDB, P17; 1997, WHY MOTHERS DIE CONF, P91	14	96	98	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2001	322	7298					1330	1333		10.1136/bmj.322.7298.1330	http://dx.doi.org/10.1136/bmj.322.7298.1330			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387177	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000169167900016
J	Ristaino, JB; Groves, CT; Parra, GR				Ristaino, JB; Groves, CT; Parra, GR			PCR amplification of the Irish potato famine pathogen from historic specimens	NATURE			English	Article							PHYTOPHTHORA-INFESTANS; DNA; POPULATIONS; POLYMORPHISMS; SEQUENCES; OOSPORES; ORIGIN	Late blight, caused by the oomycete plant pathogen Phytophthora infestans, is a devastating disease of potato and was responsible for epidemics that led to the Irish potato famine in 1845 (refs 1- 5). Before the 1980s, worldwide populations of P. infestans were dominated by a single clonal lineage, the US-1 genotype or Ib mitochondrial DNA (mtDNA) haplotype, and sexual reproduction was not documented outside Mexico, the centre of diversity of the pathogen(6,7). Here we describe the amplification and sequencing of 100-base-pair fragments of DNA from the internal transcribed spacer region 2 from 28 historic herbarium samples including Irish and British samples collected between 1845 and 1847, confirming the identity of the pathogen. We amplified a variable region of mtDNA that is present in modern Ib haplotypes of P. infestans, but absent in the other known modern haplotypes (Ia, IIa and IIb)(8). Lesions in samples tested were not caused by the Ib haplotype of P. infestans, and so theories that assume that the Ib haplotype is the ancestral strain need to be re-evaluated(4,7). Our data emphasize the importance of using historic specimens when making inferences about historic populations.	N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Ristaino, JB (corresponding author), N Carolina State Univ, Dept Plant Pathol, Box 7616, Raleigh, NC 27695 USA.	Jean_Ristaino@ncsu.edu	Ristaino, Jean Beagle/N-3616-2018	Ristaino, Jean Beagle/0000-0002-9458-0514				Berkeley M.J., 1846, J HORTICULT SOC LOND, V1, P9; CARTER DA, 1990, MYCOL RES, V94, P1123, DOI 10.1016/S0953-7562(09)81344-0; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Day JP, 1997, EUR J PLANT PATHOL, V103, P379, DOI 10.1023/A:1008630522139; DEBARY M, 1876, J R AGR SOC, V2, P239; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Fry WE, 1997, BIOSCIENCE, V47, P363, DOI 10.2307/1313151; GALLEGLY ME, 1958, PHYTOPATHOLOGY, V48, P274; GAVINO PD, 1999, MITOCHONDRIAL DNA EV; GOODWIN SB, 1994, PHYTOPATHOLOGY, V84, P553, DOI 10.1094/Phyto-84-553; GOODWIN SB, 1994, P NATL ACAD SCI USA, V91, P11591, DOI 10.1073/pnas.91.24.11591; Griffith GW, 1998, APPL ENVIRON MICROB, V64, P4007; GUNDERSON JH, 1987, P NATL ACAD SCI USA, V84, P5823, DOI 10.1073/pnas.84.16.5823; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; LANG BF, 1993, GENETICS MAPS LOCUS; Lebreton L, 1998, PLANT PATHOL, V47, P427, DOI 10.1046/j.1365-3059.1998.00265.x; Lucas J.A., 1991, PHYTOPHTHORA, P256; PAABO S, 1989, J BIOL CHEM, V264, P9709; Paquin B, 1997, CURR GENET, V31, P380, DOI 10.1007/s002940050220; PENNY D, 1995, MOL BIOL EVOL, V12, P863; Poinar G, 1999, AM SCI, V87, P446; Ristaino JB, 1998, PHYTOPATHOLOGY, V88, P1120, DOI 10.1094/PHYTO.1998.88.11.1120; SALO WL, 1994, P NATL ACAD SCI USA, V91, P2091, DOI 10.1073/pnas.91.6.2091; Taylor John W., 1994, P166; Trout CL, 1997, PLANT DIS, V81, P1042, DOI 10.1094/PDIS.1997.81.9.1042; WANGSOMBOONDEE T, 2000, PHYTOPATHOLOGY, V90, pS65; White TJ., 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	29	145	164	1	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					695	697		10.1038/35079606	http://dx.doi.org/10.1038/35079606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395772				2022-12-28	WOS:000169112500046
J	Dalton, R				Dalton, R			Arson hampers conservation work	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					509	509		10.1038/35079246	http://dx.doi.org/10.1038/35079246			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385521	Bronze			2022-12-28	WOS:000168982500004
J	Rowland, LP; Shneider, NA				Rowland, LP; Shneider, NA			Medical progress: Amyotrophic lateral sclerosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MOTOR-NEURON DISEASE; CU/ZN SUPEROXIDE-DISMUTASE; HEAVY NEUROFILAMENT SUBUNIT; GLUTAMATE TRANSPORTER EAAT2; TRANSGENIC MOUSE MODEL; UNIT NUMBER ESTIMATION; SPINAL-CORD; CELL-DEATH; NEURODEGENERATIVE DISEASES; INCREASED 3-NITROTYROSINE		Columbia Univ, Coll Phys & Surg, New York, NY USA	Columbia University	Rowland, LP (corresponding author), Columbia Presbyterian Med Ctr, Inst Neurol, New York Presbyterian Hosp, Eleanor & Lou Gehrig MDA ALS Ctr, 701 W 168th St, New York, NY 10032 USA.	lprl@columbia.edu	Shneider, Neil/ABF-5751-2020	Shneider, Neil/0000-0002-3223-7366				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; Al-Chalabi A, 1998, HUM MOL GENET, V7, P2045, DOI 10.1093/hmg/7.13.2045; Albert SM, 1999, NEUROLOGY, V53, P278, DOI 10.1212/WNL.53.2.278; Albert SM, 1999, J NEUROL SCI, V169, P108, DOI 10.1016/S0022-510X(99)00227-0; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; APPEL S, 1999, NEUROBIOLOGY ALS ED, P101; APPEL SH, 1995, ADV NEUROL, V68, P47; ARNOLD A, 1953, J NERV MENT DIS, V117, P135, DOI 10.1097/00005053-195311720-00005; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8; Beaulieu JM, 1999, BIOCHEM CELL BIOL, V77, P41, DOI 10.1139/bcb-77-1-41; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BENHAMIDA M, 1990, BRAIN, V113, P347; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Berger MM, 2000, NEUROLOGY, V54, P20, DOI 10.1212/WNL.54.1.20; BERGERON C, 1994, J NEUROPATH EXP NEUR, V53, P221, DOI 10.1097/00005072-199405000-00002; Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; BRAIT K, 1973, NEUROLOGY, V23, P990, DOI 10.1212/WNL.23.9.990; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; CARPENTER S, 1968, NEUROLOGY, V18, P841, DOI 10.1212/WNL.18.9.841; Carri MT, 1997, FEBS LETT, V414, P365, DOI 10.1016/S0014-5793(97)01051-X; Carriedo SG, 2000, J NEUROSCI, V20, P240, DOI 10.1523/JNEUROSCI.20-01-00240.2000; Ceroni M, 1999, NEUROLOGY, V53, P1064, DOI 10.1212/WNL.53.5.1064; Chan S, 1999, RADIOLOGY, V212, P763, DOI 10.1148/radiology.212.3.r99au35763; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Chaudhry V, 1998, SEMIN NEUROL, V18, P73, DOI 10.1055/s-2008-1040863; Chou SM, 1998, MOL MED, V4, P324, DOI 10.1007/BF03401739; Cleveland DW, 2000, NAT MED, V6, P1320, DOI 10.1038/82122; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Cole N, 1999, SEMIN NEUROL, V19, P407, DOI 10.1055/s-2008-1040855; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; CORBO M, 1992, J NEUROPATH EXP NEUR, V51, P531, DOI 10.1097/00005072-199209000-00008; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; Crow JP, 1997, J NEUROCHEM, V69, P1936; Cruz DC, 1999, NEUROEPIDEMIOLOGY, V18, P101, DOI 10.1159/000069413; Cudkowicz ME, 1998, ANN NEUROL, V43, P703, DOI 10.1002/ana.410430604; Demaerschalk, 2000, Curr Treat Options Neurol, V2, P13, DOI 10.1007/s11940-000-0020-3; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Desnuelle C, 2001, AMYOTROPH LATERAL SC, V2, P9, DOI 10.1080/146608201300079364; Drachman DB, 2000, ANN NEUROL, V48, P792, DOI 10.1002/1531-8249(200011)48:5<792::AID-ANA14>3.3.CO;2-X; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; ELLIOTT JL, 1995, NEUROREPORT, V6, P449, DOI 10.1097/00001756-199502000-00011; Ellis CM, 1999, J NEUROL NEUROSUR PS, V67, P15, DOI 10.1136/jnnp.67.1.15; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Eyer J, 1998, NATURE, V391, P584, DOI 10.1038/35378; Ferracci F, 1999, NEUROLOGY, V53, P852, DOI 10.1212/WNL.53.4.852; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; Friedlander RM, 1998, NATURE, V392, P560; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Ganzini L, 1999, NEUROLOGY, V52, P1434, DOI 10.1212/WNL.52.7.1434; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Gonatas NK, 1998, HISTOCHEM CELL BIOL, V109, P591, DOI 10.1007/s004180050257; Gooch CL, 2000, AMYOTROPH LATERAL SC, V1, P71; Gordon PH, 1997, NEUROLOGY, V48, P1671, DOI 10.1212/WNL.48.6.1671; GURNEY ME, 1995, SCIENCE, V269, P149, DOI 10.1126/science.269.5221.149-a; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Halperin JJ, 1998, J NEUROL SCI, V153, P182, DOI 10.1016/S0022-510X(97)00290-6; HAYS AP, 1990, J NEUROPATH EXP NEUR, V49, P383, DOI 10.1097/00005072-199007000-00003; He BP, 2000, NEUROPATH APPL NEURO, V26, P150, DOI 10.1046/j.1365-2990.2000.026002150.x; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P461, DOI 10.1097/00005072-198409000-00001; Honig LS, 2000, NEUROLOGY, V55, P1082, DOI 10.1212/WNL.55.8.1082; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Hurko O, 2000, J NEUROL SCI, V180, P21, DOI 10.1016/S0022-510X(00)00419-6; Ince PG, 1998, J NEUROPATH EXP NEUR, V57, P895, DOI 10.1097/00005072-199810000-00002; Ince PG, 1998, NEUROPATH APPL NEURO, V24, P104, DOI 10.1046/j.1365-2990.1998.00108.x; Julien JP, 2000, J NEUROL SCI, V180, P7, DOI 10.1016/S0022-510X(00)00422-6; Kaddurah-Daouk R, 2000, NEUROSCI RES COMMUN, V26, P215, DOI 10.1002/1520-6769(200005/06)26:3<215::AID-NRC9>3.0.CO;2-Z; Katz JS, 1997, NEUROLOGY, V48, P700, DOI 10.1212/WNL.48.3.700; Khwaja S, 1998, MUSCLE NERVE, V21, P943; Kikuchi S, 2000, ACTA NEUROPATHOL, V99, P63, DOI 10.1007/PL00007407; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Lacomblez L, 1996, NEUROLOGY, V47, pS242, DOI 10.1212/WNL.47.6_Suppl_4.242S; LEFEBVRE S, 1988, BIOCHEMISTRY-US, V27, P8503, DOI 10.1021/bi00422a031; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; LYNCH T, 1994, NEUROLOGY, V44, P1878, DOI 10.1212/WNL.44.10.1878; MAJOORKRAKAUER D, 1994, NEUROLOGY, V44, P1872, DOI 10.1212/WNL.44.10.1872; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; *MASS GEN HOSP, 1999, NEW ENGL J MED, V340, P1661; McGeer PL, 1997, NEUROLOGY, V49, P400, DOI 10.1212/WNL.49.2.400; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Meyer T, 1999, J NEUROL SCI, V170, P45, DOI 10.1016/S0022-510X(99)00196-3; Miller R, 1999, ANN NEUROL, V46, P494; Miller RG, 1999, J CHILD NEUROL, V14, P173, DOI 10.1177/088307389901400308; Miller RG, 1999, NEUROLOGY, V52, P1311, DOI 10.1212/WNL.52.7.1311; Mitsumoto H, 1999, MUSCLE NERVE, V22, P983, DOI 10.1002/(SICI)1097-4598(199908)22:8<983::AID-MUS1>3.0.CO;2-V; Molinuevo JL, 1999, MUSCLE NERVE, V22, P926, DOI 10.1002/(SICI)1097-4598(199907)22:7<926::AID-MUS17>3.0.CO;2-G; Murphy PL, 2000, NEUROLOGY, V55, P1581, DOI 10.1212/WNL.55.10.1581; Nagai M, 1998, NEUROSCI LETT, V244, P165, DOI 10.1016/S0304-3940(98)00158-X; Olney RK, 2000, MUSCLE NERVE, V23, P193, DOI 10.1002/(SICI)1097-4598(200002)23:2<193::AID-MUS8>3.3.CO;2-D; Openshaw H, 1998, NEUROLOGY, V50, pA31; OREILLEY D, 2000, SAN FRANCISCO E 0314; PESTRONK A, 1988, ANN NEUROL, V24, P73, DOI 10.1002/ana.410240113; Pioro EP, 1999, NEUROLOGY, V53, P71, DOI 10.1212/WNL.53.1.71; Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X; Pullen AH, 2000, J NEUROL SCI, V180, P35, DOI 10.1016/S0022-510X(00)00427-5; Qureshi AI, 1996, ARCH NEUROL-CHICAGO, V53, P987, DOI 10.1001/archneur.1996.00550100061015; Rabkin JG, 2000, PSYCHOSOM MED, V62, P271, DOI 10.1097/00006842-200003000-00020; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Riviere M, 1998, ARCH NEUROL-CHICAGO, V55, P526, DOI 10.1001/archneur.55.4.526; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1995, ADV NEUROL, V68, P7; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; Rothstein JD, 1996, CLIN NEUROSCI, V3, P348; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Rowland LP, 1998, J CHILD NEUROL, V13, P122, DOI 10.1177/088307389801300306; Rowland LP, 1998, NEW ENGL J MED, V339, P987, DOI 10.1056/NEJM199810013391409; Rowland LP, 1998, J NEUROL SCI, V160, pS6, DOI 10.1016/S0022-510X(98)00193-2; Rowland LP, 2000, J NEUROL SCI, V180, P2, DOI 10.1016/S0022-510X(00)00428-7; SALAZAR AM, 1983, ANN NEUROL, V14, P17, DOI 10.1002/ana.410140104; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Shaw PJ, 1997, J NEUROL, V244, pS3, DOI 10.1007/BF03160574; Siklos L, 1998, J NEUROPATH EXP NEUR, V57, P571, DOI 10.1097/00005072-199806000-00005; Simmons Z, 2000, NEUROLOGY, V55, P388, DOI 10.1212/WNL.55.3.388; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Sterneck E, 1996, J NEUROCHEM, V67, P1365; SWANSON NR, 1995, NEUROMUSCULAR DISORD, V5, P457, DOI 10.1016/0960-8966(95)00002-5; Takuma H, 1999, ANN NEUROL, V46, P806, DOI 10.1002/1531-8249(199912)46:6<806::AID-ANA2>3.0.CO;2-S; Terro F, 1998, BRAIN RES, V809, P319, DOI 10.1016/S0006-8993(98)00883-X; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Triggs WJ, 1999, NEUROLOGY, V53, P605, DOI 10.1212/WNL.53.3.605; Trotti, 1999, Nat Neurosci, V2, P848, DOI 10.1038/12227; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; TROY CM, 1990, BRAIN RES, V529, P232, DOI 10.1016/0006-8993(90)90832-V; TROY CM, 1990, NEUROSCIENCE, V36, P217, DOI 10.1016/0306-4522(90)90364-A; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Van den Berg-Vos RM, 2000, ANN NEUROL, V48, P919, DOI 10.1002/1531-8249(200012)48:6<919::AID-ANA13>3.0.CO;2-J; Vanselow BK, 2000, J PHYSIOL-LONDON, V525, P433, DOI 10.1111/j.1469-7793.2000.t01-1-00433.x; Verma A, 1996, ANN NEUROL, V40, P112, DOI 10.1002/ana.410400118; Vincent A, 1996, ANN NEUROL, V40, P691, DOI 10.1002/ana.410400502; Walker MP, 2001, ANN NEUROL, V49, P249; Wechsler IS, 1940, J AMER MED ASSOC, V114, P948; WEINER J, 2000, NEW YORKER      0207, P64; WILLARD M, 1983, CELL, V35, P551, DOI 10.1016/0092-8674(83)90189-7; Williams TL, 1997, ANN NEUROL, V42, P200, DOI 10.1002/ana.410420211; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Wong PC, 1998, CURR OPIN NEUROBIOL, V8, P791, DOI 10.1016/S0959-4388(98)80123-2; Worrall BB, 2000, ARCH NEUROL-CHICAGO, V57, P33, DOI 10.1001/archneur.57.1.33; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L	152	1415	1513	4	135	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2001	344	22					1688	1700		10.1056/NEJM200105313442207	http://dx.doi.org/10.1056/NEJM200105313442207			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YG	11386269				2022-12-28	WOS:000168963000007
J	Frankel, MS; Chapman, AR				Frankel, MS; Chapman, AR			Genetic technologies - Facing inheritable genetic modifications	SCIENCE			English	Article									Amer Assoc Advancement Sci, Sci Program, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Policy Program, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Sci Freedom Responsibil & Law, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Dialogue Sci Eth & Relig Program, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Sci & Human Rights Program, Washington, DC 20005 USA		Frankel, MS (corresponding author), Amer Assoc Advancement Sci, Sci Program, Washington, DC 20005 USA.							Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513; Couzin J, 1998, SCIENCE, V282, P27, DOI 10.1126/science.282.5386.27; Frankel MS., 2000, HUMAN INHERITABLE GE; *NIH, 1995, FED REG         0427, V60, P20737; *NY STAT TASK FORC, 1998, LAW ASS REPR TECHN A; Parens E, 2001, SCIENCE, V292, P397, DOI 10.1126/science.292.5516.397; 1994, GENE TECHNOLOGY 0712	7	7	7	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1303	1303		10.1126/science.1057712	http://dx.doi.org/10.1126/science.1057712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360984				2022-12-28	WOS:000168862900022
J	Kerrick, DM; Connolly, JAD				Kerrick, DM; Connolly, JAD			Metamorphic devolatilization of subducted marine sediments and the transport of volatiles into the Earth's mantle	NATURE			English	Article							CONSEQUENCES; CRUST; CO2; H2O	Volatiles, most notably CO2, are recycled back into the Earth's interior at subduction zones(1,2). The amount of CO2 emitted from arc volcanism appears to be less than that subducted, which implies that a significant amount of CO2 either is released before reaching the depth at which arc magmas are generated or is subducted to deeper depths. Few high-pressure experimental studies(3-5) have addressed this problem and therefore metamorphic decarbonation in subduction zones remains largely unquantified, despite its importance to arc magmatism, palaeoatmospheric CO2 concentrations and the global carbon cycle(6). Here we present computed phase equilibria to quantify the evolution of CO2 and H2O through the subduction-zone metamorphism of carbonate-bearing marine sediments (which are considered to be a major source for CO2 released by arc volcanoes(6)). Our analysis indicates that siliceous limestones undergo negligible devolatilization under subduction-zone conditions. Along high-temperature geotherms clay-rich marls completely devolatilize before reaching the depths at which arc magmatism is generated, but along low-temperature geotherms, they undergo virtually no devolatilization. And from 80 to 180 km depth, little devolatilization occurs for all carbonate-bearing marine sediments. Infiltration of H2O-rich fluids therefore seems essential to promote subarc decarbonation of most marine sediments. In the absence of such infiltration, volatiles retained within marine sediments may explain the apparent discrepancy between subducted and volcanic volatile fluxes and represent a mechanism for return of carbon to the Earth's mantle.	Penn State Univ, Dept Earth Sci, University Pk, PA 16802 USA; Swiss Fed Inst Technol, Dept Earth Sci, CH-8092 Zurich, Switzerland	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kerrick, DM (corresponding author), Penn State Univ, Dept Earth Sci, University Pk, PA 16802 USA.		connolly, james a d/A-7931-2013	connolly, james a d/0000-0001-5060-4281				Alt JC, 1999, GEOCHIM COSMOCHIM AC, V63, P1527, DOI 10.1016/S0016-7037(99)00123-4; Bebout GE, 1995, CHEM GEOL, V126, P191, DOI 10.1016/0009-2541(95)00118-5; BECKER H, 1992, NATURE, V358, P745, DOI 10.1038/358745a0; CALDEIRA K, 1991, GEOLOGY, V19, P204, DOI 10.1130/0091-7613(1991)019<0204:CPCPAT>2.3.CO;2; CONNOLLY JAD, 1990, AM J SCI, V290, P666, DOI 10.2475/ajs.290.6.666; Domanik KJ, 2000, LITHOS, V52, P51, DOI 10.1016/S0024-4937(99)00084-5; HACKER B, 1996, MONOGRAPH AM GEOPHYS, V96, P337; HOLLAND T, 1991, CONTRIB MINERAL PETR, V109, P265, DOI 10.1007/BF00306484; Holland TJB, 1998, J METAMORPH GEOL, V16, P309, DOI 10.1111/j.1525-1314.1998.00140.x; JOHNSON MC, 1999, GEOCHEM GEOPHYS GEOS, V1, P1525; Kerrick DM, 1998, GEOLOGY, V26, P375, DOI 10.1130/0091-7613(1998)026<0375:SOOARO>2.3.CO;2; KERRICK DM, IN PRESS EARTH PLANE; Kirby S. H., 1996, GEOPHYS MONOGR SER, V96, P195, DOI DOI 10.1029/GM096P0195; Marty B, 1998, CHEM GEOL, V145, P233, DOI 10.1016/S0009-2541(97)00145-9; Molina JF, 2000, EARTH PLANET SC LETT, V176, P295, DOI 10.1016/S0012-821X(00)00021-2; Peacock SM, 1999, SCIENCE, V286, P937, DOI 10.1126/science.286.5441.937; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; Schmidt MW, 1998, EARTH PLANET SC LETT, V163, P361, DOI 10.1016/S0012-821X(98)00142-3; Tatsumi Y., 1995, SUBDUCTION ZONE MAGM; YAXLEY GM, 1994, EARTH PLANET SC LETT, V128, P313, DOI 10.1016/0012-821X(94)90153-8	20	347	365	4	97	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					293	296		10.1038/35077056	http://dx.doi.org/10.1038/35077056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357128	hybrid, Green Published			2022-12-28	WOS:000168710000043
J	Smit, AB; Syed, NI; Schaap, D; van Minnen, J; Klumperman, J; Kits, KS; Lodder, H; van der Schors, RC; van Elk, R; Sorgedrager, B; Brejc, K; Sixma, TK; Geraerts, WPM				Smit, AB; Syed, NI; Schaap, D; van Minnen, J; Klumperman, J; Kits, KS; Lodder, H; van der Schors, RC; van Elk, R; Sorgedrager, B; Brejc, K; Sixma, TK; Geraerts, WPM			A glia-derived acetylcholine-binding protein that modulates synaptic transmission	NATURE			English	Article							IDENTIFIED LYMNAEA NEURONS; CULTURED HIPPOCAMPAL-NEURONS; FROG NEUROMUSCULAR-JUNCTION; PERISYNAPTIC SCHWANN-CELLS; ASTROCYTES IN-SITU; INTRACELLULAR CALCIUM; NICOTINIC RECEPTORS; SUBUNIT; SYNAPTOGENESIS; COMMUNICATION	There is accumulating evidence that glial cells actively modulate neuronal synaptic transmission. We identified a glia-derived soluble acetylcholine-binding protein (AChBP), which is a naturally occurring analogue of the ligand-binding domains of the nicotinic acetylcholine receptors (nAChRs). Like the nAChRs, it assembles into a homopentamer with ligand-binding characteristics that are typical for a nicotinic receptor; unlike the nAChRs, however, it lacks the domains to form a transmembrane ion channel. Presynaptic release of acetylcholine induces the secretion of AChBP through the glial secretory pathway. We describe a molecular and cellular mechanism by which glial cells release AChBP in the synaptic cleft, and propose a model for how they actively regulate cholinergic transmission between neurons in the central nervous system.	Free Univ Amsterdam, Fac Biol, Neurosci Res Inst, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; Univ Utrecht, Med Ctr, Dept Cell Biol, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; Ctr Biogenet, NL-3584 CX Utrecht, Netherlands; Organon Teknika BV, Biosci Res Unit, Boxtel, Netherlands	Vrije Universiteit Amsterdam; Netherlands Cancer Institute; University of Calgary; Utrecht University	Smit, AB (corresponding author), Free Univ Amsterdam, Fac Biol, Neurosci Res Inst, Dept Mol & Cellular Neurobiol, De Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.	absmit@bio.vu.nl	Smit, August B/E-8410-2011	Sixma, Titia K/0000-0001-6180-0632				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; BADIO B, 1994, MOL PHARMACOL, V45, P563; Betz H, 1999, ANN NY ACAD SCI, V868, P667, DOI 10.1111/j.1749-6632.1999.tb11343.x; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Calegari F, 1999, J BIOL CHEM, V274, P22539, DOI 10.1074/jbc.274.32.22539; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Corringer PJ, 1998, J NEUROSCI, V18, P648; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DEVILLERSTHIERY A, 1993, J MEMBRANE BIOL, V136, P97, DOI 10.1007/BF02505755; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Edelstein SJ, 1997, J MOL BIOL, V267, P10, DOI 10.1006/jmbi.1996.0861; Feng ZP, 1997, J NEUROSCI, V17, P7839; GARDNER D, 1977, J NEUROPHYSIOL, V40, P349, DOI 10.1152/jn.1977.40.2.349; Green WN, 1999, J GEN PHYSIOL, V113, P163, DOI 10.1085/jgp.113.2.163; GROEBE DR, 1995, J BIOL CHEM, V270, P281, DOI 10.1074/jbc.270.1.281; Hamakawa T, 1999, J NEUROSCI, V19, P9306; JAHROMI BS, 1992, NEURON, V8, P1069, DOI 10.1016/0896-6273(92)90128-Z; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KUFFLER SW, 1975, J PHYSL, V1, P465; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; MURPHY TH, 1993, J NEUROSCI, V13, P2672, DOI 10.1523/JNEUROSCI.13-06-02672.1993; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 1998, J NEUROSCI, V18, P4022; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; PASTI L, 1995, J BIOL CHEM, V270, P15203, DOI 10.1074/jbc.270.25.15203; Pasti L, 1997, J NEUROSCI, V17, P7817; Porter JT, 1996, J NEUROSCI, V16, P5073; Robitaille R, 1997, J PHYSIOL-LONDON, V504, P337, DOI 10.1111/j.1469-7793.1997.337be.x; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; SLOT JW, 1988, METHOD MICROBIOL, V20, P211, DOI 10.1016/S0580-9517(08)70053-9; SMITH SJ, 1992, PROG BRAIN RES, V94, P119; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; VANMINNEN J, 1988, CELL TISSUE RES, V251, P477, DOI 10.1007/BF00215857; Verbitsky M, 2000, NEUROPHARMACOLOGY, V39, P2515, DOI 10.1016/S0028-3908(00)00124-6; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; Wang ZZ, 1996, J BIOL CHEM, V271, P27575, DOI 10.1074/jbc.271.44.27575; WATHEY JC, 1979, BIOPHYS J, V27, P145, DOI 10.1016/S0006-3495(79)85208-X; Wells GB, 1998, J BIOL CHEM, V273, P964, DOI 10.1074/jbc.273.2.964; Woodin MA, 1999, LEARN MEMORY, V6, P307; YEOMAN MS, 1993, J NEUROPHYSIOL, V70, P37, DOI 10.1152/jn.1993.70.1.37; Zwart R, 1997, MOL PHARMACOL, V52, P886, DOI 10.1124/mol.52.5.886	50	435	456	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					261	268		10.1038/35077000	http://dx.doi.org/10.1038/35077000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357121				2022-12-28	WOS:000168710000036
J	Wilson, SI; Rydstrom, A; Trimborn, T; Willert, K; Nusse, R; Jessell, TM; Edlund, T				Wilson, SI; Rydstrom, A; Trimborn, T; Willert, K; Nusse, R; Jessell, TM; Edlund, T			The status of Wnt signalling regulates neural and epidermal fates in the chick embryo	NATURE			English	Article							BETA-CATENIN; NONNEURAL ECTODERM; SOX3 GENES; INDUCTION; EXPRESSION; XENOPUS; CELLS; FGF; GASTRULATION; REQUIREMENT	The acquisition of neural fate by embryonic ectodermal cells is a fundamental step in the formation of the vertebrate nervous system. Neural induction seems to involve signalling by fibroblast growth factors (FGFs) and attenuation of the activity of bone morphogenetic protein (BMP)(1-4). But FGFs, either alone or in combination with BMP antagonists, are not sufficient to induce neural fate in prospective epidermal ectoderm of amniote embryos(1,3,4). These findings suggest that additional signals are involved in the specification of neural fate. Here we show that the state of Wnt signalling is a critical determinant of neural and epidermal fates in the chick embryo. Continual Wnt signalling blocks the response of epiblast cells to FGF signals, permitting the expression and signalling of BMP to direct an epidermal fate. Conversely, a lack of exposure of epiblast cells to Wnt signals permits FGFs to induce a neural fate.	Umea Univ, Dept Microbiol, S-90187 Umea, Sweden; Stanford Univ, Beckman Ctr, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Umea University; Howard Hughes Medical Institute; Stanford University; Columbia University; Howard Hughes Medical Institute	Edlund, T (corresponding author), Umea Univ, Dept Microbiol, S-90187 Umea, Sweden.			Rydstrom, Anna/0000-0002-3404-7195				Dufort D, 1998, DEVELOPMENT, V125, P3015; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; GUGER KA, 1995, DEV BIOL, V172, P115, DOI 10.1006/dbio.1995.0009; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; KELLY GM, 1995, MECH DEVELOP, V53, P261, DOI 10.1016/0925-4773(95)00442-4; Kishi M, 2000, DEVELOPMENT, V127, P791; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; Pera E, 1999, DEVELOPMENT, V126, P63; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Read EM, 1998, INT J DEV BIOL, V42, P763; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Roeser T, 1999, DEVELOPMENT, V126, P2955; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sheng GJ, 1999, MECH DEVELOP, V87, P213, DOI 10.1016/S0925-4773(99)00150-1; Shibamoto S, 1998, GENES CELLS, V3, P659; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	29	215	223	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					325	330		10.1038/35077115	http://dx.doi.org/10.1038/35077115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357137				2022-12-28	WOS:000168710000052
J	Torkki, M; Malmivaara, A; Seitsalo, S; Hoikka, V; Laippala, R; Paavolainen, P				Torkki, M; Malmivaara, A; Seitsalo, S; Hoikka, V; Laippala, R; Paavolainen, P			Surgery vs orthosis vs watchful waiting for hallux valgus - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHEVRON OSTEOTOMY	Context Hallux valgus is a common foot deformation in adults, but evidence for effectiveness of surgical and conservative treatments for this condition is limited. Objective To compare the effectiveness of surgical and orthotic treatment with no treatment in patients with hallux valgus. Design and Setting Randomized controlled trial conducted in 4 general community hospitals in Finland in 1997-1998, with a follow-up period of 12 months. Participants Two hundred nine consecutive patients (mean age, 48 years; 93% women) with a painful bunion and a hallux valgus angle 35 degrees or less. Interventions Patients were randomly assigned to surgery (distal chevron osteotomy; n =71), orthosis (n = 69), or a 1-year waiting list (control group, n = 69). Main Outcome Measures Pain intensity during walking on a visual analog scale (0-100), patient assessment of global improvement, number of painful days, cosmetic disturbance, footwear problems, functional status, and treatment satisfaction, compared among treatment groups. Results Follow-up rates at 6 and 12 months were 99% and 98%, respectively. At 6 months, pain intensity decreased more in the surgical group than in the control group (adjusted mean differences, -20 [95% confidence interval (CI), -28 to -12]) and more in orthosis than in the control groups (adjusted mean difference, -14 [95% CI, -22 to -6. At 1 year, pain intensity decreased more in the surgical than in the control groups (adjusted mean difference, -19 [95% CI, -28 to -10]) and more than in the surgical and orthosis groups (adjusted mean difference, -14 [95% CI, -22 to -5]). At 1 year, 83%, 46%, and 24% in the surgery, orthosis, and control groups, respectively, thought they had improved compared with baseline (number needed to treat), 1.7 between surgical and control groups). Number of painful days, cosmetic disturbance, and footwear problems were least and functional status and satisfaction with treatment were best in the surgical group. Conclusions Surgical osteotomy is an effective treatment for painful hallux valgus. Orthoses provide short-term symptomatic relief.	Univ Helsinki, Cent Hosp, Dept Orthopaed Surg, SF-00260 Helsinki, Finland; Jorvi Hosp Espoo, Dept Orthopaed, Espoo, Finland; Invalid Fdn, ORTON Orthopaed Hosp, Helsinki, Finland; Mehilainen Hosp, Dept Foot Surg, Helsinki, Finland; Finnish Inst Occupat Hlth, Dept Occupat Med, Helsinki, Finland; Tampere Univ Hosp, Res Unit, Tampere, Finland; Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland	University of Helsinki; Helsinki University Central Hospital; Finnish Institute of Occupational Health; Tampere University; Tampere University Hospital; Tampere University	Torkki, M (corresponding author), Univ Helsinki, Cent Hosp, Dept Orthopaed Surg, Topeliuksenkatu 5, SF-00260 Helsinki, Finland.	markus.torkki@hus.fi						[Anonymous], 1998, FINN HOSP DISCH REG; Austin DW, 1981, CLIN ORTHOP RELAT R, V157, P25; Coughlin MJ, 1996, J BONE JOINT SURG AM, V78A, P932, DOI 10.2106/00004623-199606000-00018; FERRARI J, 2000, INTERVENTIONS TREATI; HIRVENSALO E, 1991, FOOT ANKLE, V11, P212, DOI 10.1177/107110079101100405; HORNE G, 1984, CLIN ORTHOP RELAT R, V183, P32; Hutubessy RCW, 1999, PAIN, V80, P201, DOI 10.1016/S0304-3959(98)00204-8; JOHNSON JE, 1991, FOOT ANKLE, V12, P61, DOI 10.1177/107110079101200201; JONES L, 1996, CLIN BIOMECHANICS LO; KITAOKA HB, 1994, FOOT ANKLE INT, V15, P349, DOI 10.1177/107110079401500701; LEWIS RJ, 1981, CLIN ORTHOP RELAT R, P105; Losito J.M., 1996, CLIN BIOMECHANICS LO; Malmivaara A, 1997, SCAND J WORK ENV HEA, V23, P161, DOI 10.5271/sjweh.194; Mann RA, 1997, FOOT ANKLE INT, V18, P255, DOI 10.1177/107110079701800502; Mann RA., 1993, BIOMECHANICS FOOT AN, P43; OSHER L, 1994, HALLUX VALGUS FOREFO; Resch S., 1993, FOOT, V3, P99, DOI 10.1016/0958-2592(93)90074-D; Seibel M, 1988, FOOT FUNCTION PROGRA; SINTONEN H, 1992, QUALITY LIFE ASSESSM; THOMPSON FM, 1994, J BONE JOINT SURG AM, V76A, P1586, DOI 10.2106/00004623-199410000-00022; Valinassy RL, 1996, CLIN BIOMECHANICS LO	21	113	119	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2474	2480		10.1001/jama.285.19.2474	http://dx.doi.org/10.1001/jama.285.19.2474			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429ZC	11368700	Bronze			2022-12-28	WOS:000168547600029
J	Hargreaves, S; Holmes, A; Friedland, JS				Hargreaves, S; Holmes, A; Friedland, JS			Europe's health-care lottery	LANCET			English	Article									Hammersmith Hosp, Imperial Coll, Int Hlth Unit, London W12 0HS, England	Imperial College London	Friedland, JS (corresponding author), Hammersmith Hosp, Imperial Coll, Int Hlth Unit, London W12 0HS, England.			Friedland, Jonathan S/0000-0001-7789-9649; Hargreaves, Sally/0000-0003-2974-4348				MONALDI G, 2000, EU NETWORKS INTEGRAT; RIEDER HL, 1994, EUR RESPIR J, V7, P1545, DOI 10.1183/09031936.94.07081545; Silove D, 2000, JAMA-J AM MED ASSOC, V284, P604, DOI 10.1001/jama.284.5.604	3	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1434	1435		10.1016/S0140-6736(00)04574-8	http://dx.doi.org/10.1016/S0140-6736(00)04574-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356468				2022-12-28	WOS:000168478200040
J	Ziv, E; Cauley, J; Morin, PA; Saiz, R; Browner, WS				Ziv, E; Cauley, J; Morin, PA; Saiz, R; Browner, WS			Association between the T29 -> C polymorphism in the transforming growth factor beta 1 gene and breast cancer among elderly white women the study of osteoporotic fractures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; GROWTH-FACTOR-BETA-1 GENE; MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; RISK; SUSCEPTIBILITY; FREQUENCY; CYP17; BRCA1	Context Transgenic animal experiments suggest that increased expression of transforming growth factor beta1 (TGF-beta1) is protective against early tumor development, particularly in breast cancer. A T -->C (thymine to cytosine) transition in the 29th nucleotide in the coding sequence results in a leucine to proline substitution at the 10th amino acid and is associated with increased serum levels of TGF-beta1. Objective To determine whether an association exists between this TGF-beta1 polymorphism and breast cancer risk. Design, Setting, and Participants The Study of Osteoporotic Fractures, a prospective cohort study of white, community-dwelling women aged 65 years or older who were recruited at 4 US centers between 1986 and 1988. Three thousand seventy-five women who provided sufficient clinical information, buffy coat samples, and adequate consent for genotyping are included in this analysis. Main Outcome Measure Breast cancer cases during a mean (SD) follow-up of 9.3 (1.9) years, verified by medical chart review and compared by genotype. Results Risk of breast cancer was similar in the 1124 women with the T/T genotype (56 cases; 5.4 per 1000 person-years) and the 1493 women with the T/C genotype (80 cases; 5.8 per 1000 person-years) but was significantly lower (P=.01) in the 458 women with the C/C genotype (10 cases; 2.3 per 1000 person-years). In analyses that adjusted for age, age at menarche, age at menopause, estrogen use, parity, body mass index, and bone mineral density, women with the C/C genotype had a significantly lower risk of developing breast cancer compared with women with the T/T or T/C genotype (hazard ratio [HR], 0.36; 95% confidence interval [CI], 0.17-0.75). There was no significant difference between the risk for women with the T/C genotype compared with women with the T/T genotype (adjusted HR, 1.04; 95% CI, 0.73-1.48). Conclusions Our findings suggest that TGF-beta1 genotype is associated with risk of breast cancer in white women aged 65 years or older. Because the T allele is the common variant and confers an increased risk, it may be associated with a large proportion of breast cancer cases.	Vet Affairs Med Ctr, Div Gen Internal Med, San Francisco, CA 94122 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; Axys Pharmaceut Inc, La Jolla, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ziv, E (corresponding author), Vet Affairs Med Ctr, Div Gen Internal Med, Box 111-A1,4150 Clement St, San Francisco, CA 94122 USA.	eziv@itsa.ucsf.edu	Morin, Phillip A/E-9515-2010; Cauley, Jane A/N-4836-2015; Ziv, Elad/L-5396-2014	Cauley, Jane A/0000-0003-0752-4408; Morin, Phillip/0000-0002-3279-1519	NIAMS NIH HHS [AR35582, AR355833, AR35584] Funding Source: Medline; NIA NIH HHS [AG05349, AG05407] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035582, R01AR035584] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ambrosone CB, 1996, JAMA-J AM MED ASSOC, V276, P1494, DOI 10.1001/jama.276.18.1494; Armstrong K, 2000, NEW ENGL J MED, V342, P564, DOI 10.1056/NEJM200002243420807; Arteaga CL, 1996, BREAST CANCER RES TR, V38, P49, DOI 10.1007/BF01803783; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cambien F, 1996, HYPERTENSION, V28, P881, DOI 10.1161/01.HYP.28.5.881; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Coughlin SS, 1999, CANCER EPIDEM BIOMAR, V8, P1023; Dunning AM, 1998, BRIT J CANCER, V77, P2045, DOI 10.1038/bjc.1998.340; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Feigelson HS, 1997, CANCER RES, V57, P1063; FORD D, 1995, AM J HUM GENET, V57, P1457; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Millikan RC, 1998, CANCER EPIDEM BIOMAR, V7, P371; Morin PA, 1999, BIOTECHNIQUES, V27, P538, DOI 10.2144/99273rr02; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Pasche B, 1999, CANCER RES, V59, P5678; PIERCE DF, 1995, P NATL ACAD SCI USA, V92, P4254, DOI 10.1073/pnas.92.10.4254; Rebbeck TR, 1999, CANCER-AM CANCER SOC, V86, P2493, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2493::AID-CNCR6>3.0.CO;2-Z; Reiss M, 1997, BREAST CANCER RES TR, V45, P81, DOI 10.1023/A:1005865812918; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Yamada Y, 1999, AM J MED, V106, P477, DOI 10.1016/S0002-9343(99)00043-1; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Zhang YQ, 1997, NEW ENGL J MED, V336, P611, DOI 10.1056/NEJM199702273360903	24	105	112	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2859	2863		10.1001/jama.285.22.2859	http://dx.doi.org/10.1001/jama.285.22.2859			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BP	11401606	Bronze			2022-12-28	WOS:000169156300024
J	Zhang, YP; Xiong, Y				Zhang, YP; Xiong, Y			A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation	SCIENCE			English	Article							RING-FINGER DOMAIN; STABILIZES P53; MDM2; DEGRADATION; PROTEIN; HDM2; TRANSACTIVATION; LOCALIZATION; PROMOTES; PATHWAY	The p53 protein is present in low amounts in normally growing cells and is activated in response to physiological insults. MDM2 regulates p53 either through inhibiting p53's transactivating function in the nucleus or by targeting p53 degradation in the cytoplasm. We identified a previously unknown nuclear export signal (NES) in the amino terminus of p53, spanning residues 11 to 27 and containing two serine residues phosphorylated after DNA damage, which was required for p53 nuclear export in colloboration with the carboxyl-terminal NES, Serine-15-phosphorylated p53 induced by ultraviolet irradiation was not exported. Thus, DNA damage-induced phosphorylation may achieve optimal p53 activation by inhibiting both MDM2 binding to, and the nuclear export of, p53.	Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Xiong, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.			Zhang, Yi/0000-0002-2789-0811	NATIONAL CANCER INSTITUTE [R01CA065572, K01CA087580] Funding Source: NIH RePORTER; NCI NIH HHS [CA65572, K01 CA087580] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chao C, 2000, P NATL ACAD SCI USA, V97, P11936, DOI 10.1073/pnas.220252297; Chehab NH, 2000, GENE DEV, V14, P278; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2	28	300	311	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1910	1915		10.1126/science.1058637	http://dx.doi.org/10.1126/science.1058637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397945				2022-12-28	WOS:000169200700049
J	Wityk, RJ				Wityk, RJ			Stroke in a healthy 46-year-old man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CAROTID-ARTERY DISSECTION; CONNECTIVE-TISSUE DISORDERS; VERTEBRAL ARTERY; MAGNETIC-RESONANCE; NERVE PALSIES; ANEURYSM; PAIN; COMPLICATIONS; MANIPULATION; HEADACHE	This article presents the case of a healthy 46-year-old man who experienced a dissection of the internal carotid artery. The diagnosis of this condition is not usually clear-cut, especially in a young patient with unremarkable medical history, and because of the similarity of symptoms with migraine, Often there is no obvious cause of a cerebral artery dissection, although subtle abnormalities of connective tissue may be present. Anticoagulation is generally used for therapy, but clinical trials are lacking. Carotid artery dissection should be considered as a cause of stroke in young healthy adults.	Johns Hopkins Univ, Sch Med, Cerebrovasc Div, Baltimore, MD USA	Johns Hopkins University	Wityk, RJ (corresponding author), Meyer 5-181B,600 N Wolfe St, Baltimore, MD 21287 USA.							AOKI N, 1990, STROKE, V21, P1628, DOI 10.1161/01.STR.21.11.1628; BARBOUR PJ, 1994, STROKE, V25, P1201, DOI 10.1161/01.STR.25.6.1201; Bassetti C, 1996, STROKE, V27, P1804, DOI 10.1161/01.STR.27.10.1804; Biller J, 1994, STROKE CHILDREN YOUN; BIOUSSE V, 1994, CEPHALALGIA, V14, P33, DOI 10.1046/j.1468-2982.1994.1401033.x; Brandt T, 1998, ANN NEUROL, V44, P281, DOI 10.1002/ana.410440224; BUI LN, 1993, STROKE, V24, P126, DOI 10.1161/01.STR.24.1.126; CAPLAN LR, 1988, NEUROLOGY, V38, P868, DOI 10.1212/WNL.38.6.868; FISHER CM, 1982, HEADACHE, V22, P60, DOI 10.1111/j.1526-4610.1982.hed2202060.x; GARRETT D, 1993, SURG NEUROL, V39, P282, DOI 10.1016/0090-3019(93)90006-M; GELBERT F, 1991, NEURORADIOLOGY, V33, P111, DOI 10.1007/BF00588245; GOLDSTEIN LB, 1995, STROKE, V26, P480, DOI 10.1161/01.STR.26.3.480; Grau AJ, 1999, ARCH NEUROL-CHICAGO, V56, P851, DOI 10.1001/archneur.56.7.851; Guillon B, 2000, NEUROLOGY, V55, P663, DOI 10.1212/WNL.55.5.663; HUGENHOLTZ H, 1982, NEUROSURGERY, V10, P96, DOI 10.1227/00006123-198201000-00018; Kittner SJ, 1998, NEUROLOGY, V50, P890, DOI 10.1212/WNL.50.4.890; LEE KP, 1995, NEUROLOGY, V45, P1213, DOI 10.1212/WNL.45.6.1213; MAS JL, 1989, NEUROLOGY, V39, P512, DOI 10.1212/WNL.39.4.512; MOKRI B, 1986, ANN NEUROL, V19, P126, DOI 10.1002/ana.410190204; North KN, 1995, ANN NEUROL, V38, P960, DOI 10.1002/ana.410380620; Ojemann RG, 1972, STROKE, V3, P434, DOI 10.1161/01.STR.3.4.434; RAMADAN NM, 1991, NEUROLOGY, V41, P1084, DOI 10.1212/WNL.41.7.1084; ROTHROCK JF, 1989, NEUROLOGY, V39, P686, DOI 10.1212/WNL.39.5.686; SCHIEVINK WI, 1994, NEW ENGL J MED, V330, P393, DOI 10.1056/NEJM199402103300604; Schievink WI, 1998, NEUROLOGY, V50, P1166, DOI 10.1212/WNL.50.4.1166; SCHIEVINK WI, 1993, NEUROLOGY, V43, P1938, DOI 10.1212/WNL.43.10.1938; SCHIEVINK WI, 1994, STROKE, V25, P889, DOI 10.1161/01.STR.25.4.889; SILBERT PL, 1995, NEUROLOGY, V45, P1517, DOI 10.1212/WNL.45.8.1517; Silverman IE, 1998, CLIN NEUROL NEUROSUR, V100, P116, DOI 10.1016/S0303-8467(98)00011-0; STURZENEGGER M, 1993, J NEUROL NEUROSUR PS, V56, P1191, DOI 10.1136/jnnp.56.11.1191; TROSCH RM, 1989, NEW ENGL J MED, V320, P1564	31	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2757	2762		10.1001/jama.285.21.2757	http://dx.doi.org/10.1001/jama.285.21.2757			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386932				2022-12-28	WOS:000168985800029
J	Schwizer, W; Thumshirn, M; Dent, J; Guldenschuh, I; Menne, D; Cathomas, G; Fried, M				Schwizer, W; Thumshirn, M; Dent, J; Guldenschuh, I; Menne, D; Cathomas, G; Fried, M			Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux diease: a randomised controlled trial	LANCET			English	Article							GASTROESOPHAGEAL REFLUX; DUODENAL-ULCER; ACID-SECRETION; DISEASE; ESOPHAGITIS; INFECTION; ERADICATION; PREVALENCE; THERAPY	Background There is little information on the effects of Helicobacter pylori eradication in patients with a primary diagnosis of gastro-oesophageal reflux disease (GORD). Our aim was to investigate the effect of H pylori eradication in this group of patients. Methods We did-a double-blind, randomised, placebo-controlled study in 70 patients with GORD. We assigned individuals to three groups. All patients received lansoprazole 30 mg twice daily for 10 days, followed by 30 mg once daily for 8 weeks. Patients infected with H pylori received either antibiotics (clarithromycin 500 mg and amoxicillin 1000 mg twice daily) or placebo for the first 10 days. Controls were patients not infected with H py(ori. Patients were followed up for 6 months at 2-week intervals for GORD symptoms. At the end of the study we repeated endoscopy and oesophageal and gastric 24 h-pH monitoring. Findings 58 of 70 patients completed our study. At the end of the study 16 of these patients were H pylori-positive (14 placebo and two eradication failures), 13 were negative because of successful H pylori eradication, and 29 were controls. H pylori-positive patients relapsed earlier (54 days) than did those in whom H pylori was eradicated (100 days) (p=0.046). The H pylori-negative control group relapsed after the longest period (110 days). However, time to relapse: was also affected by oesophagitis grade (no oesophagitis 127 days, grade III or IV oesophagitis 18 days). When,results were corrected for the affect of oesophagitis grade, H pylori positive patients relapsed earlier (p=0.086) than H pylori-eradiated patients and controls (p=0.001). Interpretation H pylori infection positively affects the relapse rate of GORD. Eradication of H pylori could, therefore, help to prolong disease-free interval in patients with GORD.	Univ Zurich Hosp, Dept Gastroenterol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; Biomed Software, Tubingen, Germany; Royal Adelaide Hosp, Adelaide, SA 5000, Australia	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Royal Adelaide Hospital	Schwizer, W (corresponding author), Univ Zurich Hosp, Dept Gastroenterol, CH-8091 Zurich, Switzerland.	gasschwi@usz.unizh.ch						Csendes A, 1997, Dis Esophagus, V10, P38; DEMEESTER TR, 1976, ANN SURG, V184, P459, DOI 10.1097/00000658-197610000-00009; Dent J, 1998, DIGESTION, V59, P433, DOI 10.1159/000007521; DENT J, 1988, GUT, V29, P1020, DOI 10.1136/gut.29.8.1020; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; ELOMAR E, 1993, GUT, V34, P1060, DOI 10.1136/gut.34.8.1060; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Hackelsberger A, 1998, EUR J GASTROEN HEPAT, V10, P465, DOI 10.1097/00042737-199806000-00005; Hatlebakk JG, 1997, ALIMENT PHARM THERAP, V11, P1093, DOI 10.1046/j.1365-2036.1997.00246.x; JAMIESON JR, 1992, AM J GASTROENTEROL, V87, P1102; JOHNSON LF, 1974, AM J GASTROENTEROL, V62, P325; Labenz J, 1997, GASTROENTEROLOGY, V112, P1442, DOI 10.1016/S0016-5085(97)70024-6; Lansdorp PM, 1997, N HOR TH SK&B PH US, V1, P1; MALFERTHEINER P, 1998, GASTROENTEROLOGY, V114, pA870; Manes G, 1999, SCAND J GASTROENTERO, V34, P658, DOI 10.1080/003655299750025840; MCCALLUM RW, 1981, GASTROENTEROLOGY, V80, P285; McColl KEL, 2000, AM J GASTROENTEROL, V95, P101; Moayyedi P, 1999, GUT, V44, pA112; Newton M, 1997, GUT, V40, P9, DOI 10.1136/gut.40.1.9; O'Connor HJ, 1999, ALIMENT PHARM THER, V13, P117; OLLYO J B, 1990, Gastroenterology, V98, pA100; Peters FTM, 1999, ALIMENT PHARM THERAP, V13, P921; SAVARY M, 1977, LOESOPHAGE MANUEL AT; Tefera S, 1999, ALIMENT PHARM THER, V13, P915; Therneau T., 1999, PACKAGE SURVIVAL ANA; Vicari JJ, 1998, GASTROENTEROLOGY, V115, P50, DOI 10.1016/S0016-5085(98)70364-6; Werdmuller BFM, 1997, DIGEST DIS SCI, V42, P103, DOI 10.1023/A:1018841222856; Wu JCY, 1999, AM J GASTROENTEROL, V94, P1790, DOI 10.1111/j.1572-0241.1999.01207.x	28	172	180	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2001	357	9270					1738	1742		10.1016/S0140-6736(00)04894-7	http://dx.doi.org/10.1016/S0140-6736(00)04894-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403809				2022-12-28	WOS:000169156200010
J	Polakis, P				Polakis, P			More than one way to skin a catenin	CELL			English	Review							BETA-CATENIN; SIAH-1; EBI; P53; ACTIVATION; APOPTOSIS; PATHWAY; GROWTH		Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Polakis, P (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	ppolakis@gene.com						Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Barker N, 2000, ADV CANCER RES, V77, P1; Boulton SJ, 2000, EMBO J, V19, P5376, DOI 10.1093/emboj/19.20.5376; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Iwao K, 1998, CANCER RES, V58, P1021; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Peifer M, 1997, SCIENCE, V275, P1752, DOI 10.1126/science.275.5307.1752; Polakis P, 2000, GENE DEV, V14, P1837; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tyers M, 1999, SCIENCE, V284, P601, DOI 10.1126/science.284.5414.601	16	79	81	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					563	566		10.1016/S0092-8674(01)00379-8	http://dx.doi.org/10.1016/S0092-8674(01)00379-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389825	Bronze			2022-12-28	WOS:000169123200002
J	Sonier, JE; Brewer, JH; Kiefl, RF; Miller, RI; Morris, GD; Stronach, CE; Gardner, JS; Dunsiger, SR; Bonn, DA; Hardy, WN; Liang, R; Heffner, RH				Sonier, JE; Brewer, JH; Kiefl, RF; Miller, RI; Morris, GD; Stronach, CE; Gardner, JS; Dunsiger, SR; Bonn, DA; Hardy, WN; Liang, R; Heffner, RH			Anomalous weak magnetism in superconducting YBa2Cu3O6+x	SCIENCE			English	Article							POSITIVE MUON; PHASE; RESONANCE; BEHAVIOR; SITES	For some time now, there has been considerable experimental and theoretical effort to understand the role of the normal-state "pseudogap" phase in underdoped high-temperature cuprate superconductors. Recent debate has centered on the question of whether the pseudogap is independent of superconductivity. We provide evidence from zero-field muon spin relaxation measurements in YBa2Cu3O6+x for the presence of small spontaneous static magnetic fields of electronic origin intimately related to the pseudogap transition. Our most significant finding is that, for optimal doping, these weak static magnetic fields appear well below the superconducting transition temperature. The two compositions measured suggest the existence of a quantum critical point somewhat above optimal doping.	Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; TRIUMF, Vancouver, BC V6T 2A3, Canada; Virginia State Univ, Dept Phys, Petersburg, VA 23806 USA; CNR, Chalk River, ON K0J 1P0, Canada; Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Simon Fraser University; University of British Columbia; University of British Columbia; Virginia State University; National Research Council Canada; United States Department of Energy (DOE); Los Alamos National Laboratory	Sonier, JE (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.	jeff_sonier@sfu.ca	Hardy, Walter Newbold/AAN-7827-2020; Brewer, Jess H./B-2737-2013; Gardner, Jason S/GON-6881-2022; Gardner, Jason S/A-1532-2013	Brewer, Jess H./0000-0002-8211-1235; Gardner, Jason S/0000-0002-7823-4072; Gardner, Jason S/0000-0002-7823-4072				ALLOUL H, 1989, PHYS REV LETT, V63, P1700, DOI 10.1103/PhysRevLett.63.1700; Amato A, 1997, REV MOD PHYS, V69, P1119, DOI 10.1103/RevModPhys.69.1119; BOEKEMA C, 1994, HYPERFINE INTERACT, V86, P519, DOI 10.1007/BF02068941; BREWER JH, 1988, PHYS REV LETT, V60, P1073, DOI 10.1103/PhysRevLett.60.1073; BREWER JH, 1990, HYPERFINE INTERACT, V63, P177, DOI 10.1007/BF02396001; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; CLAUS H, 1990, PHYSICA C, V171, P205, DOI 10.1016/0921-4534(90)90131-W; Dai PC, 1999, SCIENCE, V284, P1344, DOI 10.1126/science.284.5418.1344; HSU TC, 1991, PHYS REV B, V43, P2866, DOI 10.1103/PhysRevB.43.2866; KIEFL RF, 1990, PHYS REV LETT, V64, P2082, DOI 10.1103/PhysRevLett.64.2082; KIEFL RF, 1989, PHYS REV LETT, V63, P2136, DOI 10.1103/PhysRevLett.63.2136; Kubo R., 1967, MAGNETIC RESONANCE R; LIANG RX, 1992, PHYSICA C, V195, P51, DOI 10.1016/0921-4534(92)90073-L; Liang RX, 2000, PHYSICA C, V336, P57, DOI 10.1016/S0921-4534(00)00091-5; LORAM JW, 1994, J SUPERCOND, V7, P243, DOI 10.1007/BF00730405; NISHIDA N, 1990, HYPERFINE INTERACT, V63, P183, DOI 10.1007/BF02396002; NISHIDA N, 1988, J PHYS SOC JPN, V57, P597, DOI 10.1143/JPSJ.57.597; NISHIDA N, 1987, JPN J APPL PHYS 2, V26, pL1856, DOI 10.1143/JJAP.26.L1856; Sidis Y, 2001, PHYS REV LETT, V86, P4100, DOI 10.1103/PhysRevLett.86.4100; TAKIGAWA M, 1991, PHYS REV B, V43, P247, DOI 10.1103/PhysRevB.43.247; Tallon JL, 2001, PHYSICA C, V349, P53, DOI 10.1016/S0921-4534(00)01524-0; TALLON JL, 1995, PHYS REV B, V51, P12911, DOI 10.1103/PhysRevB.51.12911; TRANQUADA JM, 1992, PHYS REV B, V46, P5561, DOI 10.1103/PhysRevB.46.5561; Varma CM, 1997, PHYS REV B, V55, P14554, DOI 10.1103/PhysRevB.55.14554; Varma CM, 1999, PHYS REV LETT, V83, P3538, DOI 10.1103/PhysRevLett.83.3538; WALSTEDT RE, 1990, SCIENCE, V248, P1082, DOI 10.1126/science.248.4959.1082; WARREN WW, 1989, PHYS REV LETT, V62, P1193, DOI 10.1103/PhysRevLett.62.1193; WEBER M, 1990, HYPERFINE INTERACT, V63, P207, DOI 10.1007/BF02396004; Wen XG, 1996, PHYS REV LETT, V76, P503, DOI 10.1103/PhysRevLett.76.503; Wuyts B, 1996, PHYS REV B, V53, P9418, DOI 10.1103/PhysRevB.53.9418	31	102	103	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1692	1695		10.1126/science.1060844	http://dx.doi.org/10.1126/science.1060844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387468				2022-12-28	WOS:000169031800037
J	Tooze, SA				Tooze, SA			Cell biology - GGAs tie up the loose ends	SCIENCE			English	Editorial Material							GAMMA-ADAPTIN; TRANS-GOLGI; PROTEINS; FAMILY; DOMAIN; VHS; TRAFFICKING; RECEPTOR; BINDING		Imperial Canc Res Fund, Secretory Pathways Lab, London WC2A 3PX, England	Cancer Research UK	Tooze, SA (corresponding author), Imperial Canc Res Fund, Secretory Pathways Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.			Tooze, Sharon/0000-0002-2182-3116				Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Orsel JG, 2000, P NATL ACAD SCI USA, V97, P9047, DOI 10.1073/pnas.160251397; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	13	9	9	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1663	+		10.1126/science.1062239	http://dx.doi.org/10.1126/science.1062239			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387461				2022-12-28	WOS:000169031800027
J	Zhu, YX; Doray, B; Poussu, A; Lehto, VP; Kornfeld, S				Zhu, YX; Doray, B; Poussu, A; Lehto, VP; Kornfeld, S			Binding of GGA2 to the lysosomal enzyme sorting motif of the mannose 6-phosphate receptor	SCIENCE			English	Article							FACTOR-II RECEPTOR; GAMMA-ADAPTIN; MUTATIONAL ANALYSIS; CYTOPLASMIC DOMAIN; TRANS-GOLGI; PROTEINS; FAMILY; VHS	The GGAs are a multidomain protein family implicated in protein trafficking between the Golgi and endosomes. Here, the VHS domain of GGA2 was shown to bind to the acidic cluster-dileucine motif in the cytoplasmic tail of the cation-independent mannose 6-phosphate receptor (CI-MPR). Receptors with mutations in this motif were defective in lysosomal enzyme sorting. The hinge domain of GGA2 bound clathrin, suggesting that GGA2 could be a link between cargo molecules and clathrin-coated vesicle assembly. Thus, GGA2 binding to the Cl-MPR is important for lysosomal enzyme targeting.	Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Univ Oulu, Dept Pathol, FIN-90410 Oulu, Finland	Washington University (WUSTL); University of Oulu	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, 660 S Euclid Ave, St Louis, MO 63110 USA.			Doray, Balraj/0000-0003-3347-5013	NATIONAL CANCER INSTITUTE [R01CA008759] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-08759] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; CHEN HJ, 1993, J BIOL CHEM, V268, P22338; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; DORAY B, IN PRESS MOL BIOL CE; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; York SJ, 1999, J BIOL CHEM, V274, P1164, DOI 10.1074/jbc.274.2.1164; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5	16	224	230	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1716	1718		10.1126/science.1060896	http://dx.doi.org/10.1126/science.1060896			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387476				2022-12-28	WOS:000169031800045
J	Cronin, TW; Caldwell, RL; Marshall, J				Cronin, TW; Caldwell, RL; Marshall, J			Sensory adaptation - Tunable colour vision in a mantis shrimp	NATURE			English	Article							SYSTEM		Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Queensland, Vis Touch & Hearing Res Ctr, Brisbane, Qld 4072, Australia	University System of Maryland; University of Maryland Baltimore County; University of California System; University of California Berkeley; University of Queensland	Cronin, TW (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA.			Marshall, Justin/0000-0001-9006-6713				CRONIN TW, 1994, VISION RES, V34, P2639, DOI 10.1016/0042-6989(94)90221-6; Cronin TW, 2000, PHILOS T ROY SOC B, V355, P1263, DOI 10.1098/rstb.2000.0680; CRONIN TW, 1989, NATURE, V339, P137, DOI 10.1038/339137a0; CRONIN TW, 1994, VISION RES, V34, P279, DOI 10.1016/0042-6989(94)90087-6; HAWRYSHYN CW, 1989, VISUAL NEUROSCI, V2, P247, DOI 10.1017/S0952523800001164; Marshall J, 1999, NATURE, V401, P873, DOI 10.1038/44751; MARSHALL NJ, 1988, NATURE, V333, P557, DOI 10.1038/333557a0; MCFARLAND WN, 1975, VISION RES, V15, P1063, DOI 10.1016/0042-6989(75)90002-4; SUZUKI T, 1985, ZOOL SCI, V2, P455; TSIN ATC, 1977, SCIENCE, V195, P1358, DOI 10.1126/science.841335	10	60	65	24	101	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					547	548		10.1038/35079184	http://dx.doi.org/10.1038/35079184			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385560				2022-12-28	WOS:000168982500039
J	Ohtaki, T; Shintani, Y; Honda, S; Matsumoto, H; Hori, A; Kanehashi, K; Terao, Y; Kumano, S; Takatsu, Y; Masuda, Y; Ishibashi, Y; Watanabe, T; Asada, M; Yamada, T; Suenaga, M; Kitada, C; Usuki, S; Kurokawa, T; Onda, H; Nishimura, O; Fujino, M				Ohtaki, T; Shintani, Y; Honda, S; Matsumoto, H; Hori, A; Kanehashi, K; Terao, Y; Kumano, S; Takatsu, Y; Masuda, Y; Ishibashi, Y; Watanabe, T; Asada, M; Yamada, T; Suenaga, M; Kitada, C; Usuki, S; Kurokawa, T; Onda, H; Nishimura, O; Fujino, M			Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor	NATURE			English	Article							IDENTIFICATION; CELLS; MOTILITY; CLONING; BINDING; SITES	Metastasis is a major cause of death in cancer patients and involves a multistep process including detachment of cancer cells from a primary cancer, invasion of surrounding tissue, spread through circulation, re-invasion and proliferation in distant organs. KiSS-1 is a human metastasis suppressor gene(1), that suppresses metastases of human melanomas(2) and breast carcinomas(3) without affecting tumorigenicity. However, its gene product and functional mechanisms have not been elucidated. Here we show that KiSS-1 (refs 1, 4) encodes a carboxy-terminally amidated peptide with 54 amino-acid residues, which we have isolated from human placenta as the endogenous ligand of an orphan G-protein-coupled receptor (hOT7T175) and have named 'metastin'. Metastin inhibits chemotaxis and invasion of hOT7T175-transfected CHO cells in vitro and attenuates pulmonary metastasis of hOT7T175-transfected B16-BL6 melanomas in vivo. The results suggest possible mechanisms of action for KiSS-1 and a potential new therapeutic approach.	Takeda Chem Ind Ltd, Pharmaceut Discovery Res Div, Tsukuba, Ibaraki 3004293, Japan; Univ Tsukuba, Inst Clin Med, Dept Obstet & Gynecol, Tsukuba, Ibaraki 3058575, Japan	Takeda Chemical Industries; University of Tsukuba	Ohtaki, T (corresponding author), Takeda Chem Ind Ltd, Pharmaceut Discovery Res Div, Wadai 10, Tsukuba, Ibaraki 3004293, Japan.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Bischof P, 2000, PLACENTA, V21, pS55, DOI 10.1053/plac.2000.0521; Bloomquist BT, 1998, BIOCHEM BIOPH RES CO, V243, P474, DOI 10.1006/bbrc.1998.8133; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Lee DK, 1999, FEBS LETT, V446, P103, DOI 10.1016/S0014-5793(99)00009-5; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1997, INT J CANCER, V71, P1035, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1035::AID-IJC20>3.3.CO;2-T; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; LEE JH, 1997, J NATL CANCER I, V89, P1549; LINDEN J, 1982, J CYCLIC NUCL PROT, V8, P163; Masuda Y, 1996, J PHARMACOL EXP THER, V279, P675; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishimura O, 1998, CHEM PHARM BULL, V46, P1490; Ohtaki T, 1999, J BIOL CHEM, V274, P37041, DOI 10.1074/jbc.274.52.37041; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; West A, 1998, GENOMICS, V54, P145, DOI 10.1006/geno.1998.5566; Yamamura S, 2000, ANN NY ACAD SCI, V905, P301	18	1109	1210	1	60	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					613	617		10.1038/35079135	http://dx.doi.org/10.1038/35079135			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385580				2022-12-28	WOS:000168982500059
J	Perraud, AL; Fleig, A; Dunn, CA; Bagley, LA; Launay, P; Schmitz, C; Stokes, AJ; Zhu, QQ; Bessman, MJ; Penner, R; Kinet, JP; Scharenberg, AM				Perraud, AL; Fleig, A; Dunn, CA; Bagley, LA; Launay, P; Schmitz, C; Stokes, AJ; Zhu, QQ; Bessman, MJ; Penner, R; Kinet, JP; Scharenberg, AM			ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology	NATURE			English	Article							MITOCHONDRIA; ENZYMES	Free ADP-ribose (ADPR), a product of NAD hydrolysis and a breakdown product of the calcium-release second messenger cyclic ADPR (cADPR), has no defined role as an intracellular signalling molecule in vertebrate systems. Here we show that a 350-amino-acid protein (designated NUDT9) and a homologous domain (NUDT9 homology domain) near the carboxy terminus of the LTRPC2/TrpC7 putative cation channel(1) both function as specific ADPR pyrophosphatases. Whole-cell and single-channel analysis of HEK-293 cells expressing LTRPC2 show that LTRPC2 functions as a calcium-permeable cation channel that is specifically gated by free ADPR. The expression of native LTRPC2 transcripts is detectable in many tissues including the U937 monocyte cell line, in which ADPR induces large cation currents (designated I-ADPR) that closely match those mediated by recombinant LTRPC2. These results indicate that intracellular ADPR regulates calcium entry into cells that express LTRPC2.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Hawaii, Queens Med Ctr, Biomed Res Ctr, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; The Queen's Medical Center; University of Hawaii System; University of Hawaii System; Johns Hopkins University	Scharenberg, AM (corresponding author), Univ Washington, Dept Pediat & Immunol, Seattle, WA 98195 USA.		Launay, Pierre/AAH-7076-2019; Stokes, Alexander/B-1086-2015	Stokes, Alexander/0000-0002-3526-4685; Penner, Reinhold/0000-0002-5366-1537; Fleig, Andrea/0000-0001-8396-7249; Dunn, Christopher/0000-0001-7899-0110				AMES BN, 1960, J BIOL CHEM, V235, P769; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Chakraborti T, 1999, CELL SIGNAL, V11, P77, DOI 10.1016/S0898-6568(98)00025-4; Dousa TP, 1996, AM J PHYSIOL-CELL PH, V271, pC1007, DOI 10.1152/ajpcell.1996.271.4.C1007; Guse AH, 2000, J MOL MED, V78, P26, DOI 10.1007/s001090000076; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; KochNolte F, 1997, ADV EXP MED BIOL, V419, P1; Liang M, 1999, ARCH BIOCHEM BIOPHYS, V371, P317, DOI 10.1006/abbi.1999.1463; McConkey DJ, 1996, STEM CELLS, V14, P619, DOI 10.1002/stem.140619; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; Wilding M, 1998, AM J PHYSIOL-CELL PH, V275, pC1277, DOI 10.1152/ajpcell.1998.275.5.C1277	13	694	725	0	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					595	599		10.1038/35079100	http://dx.doi.org/10.1038/35079100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385575				2022-12-28	WOS:000168982500054
J	Gaillard, JM; Festa-Bianchet, M; Yoccoz, NG				Gaillard, JM; Festa-Bianchet, M; Yoccoz, NG			Population ecology - Not all sheep are equal	SCIENCE			English	Editorial Material							DYNAMICS; FITNESS		Univ Lyon, Unite Mixte Rech Biometrie & Biol Evolut 5558, Villeurbanne, France; Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; Norwegian Inst Nat Res, Polar Environm Ctr, Div Arctic Ecol, N-9296 Tromso, Norway	University of Sherbrooke; Norwegian Institute Nature Research	Gaillard, JM (corresponding author), Univ Lyon, Unite Mixte Rech Biometrie & Biol Evolut 5558, Villeurbanne, France.	gaillard@biomserv.univ-lyon.1.fr; mbianche@courrier.usherb.ca; nigel.yoccoz@ninatos.ninaniku.no	Yoccoz, Nigel Gille/A-1493-2008; Yoccoz, Nigel/C-8561-2014	Yoccoz, Nigel/0000-0003-2192-1039; Festa-Bianchet, Marco/0000-0002-2352-3379				Bjornstad ON, 2001, NATURE, V409, P1001, DOI 10.1038/35059003; CEBALLOS G, 1995, CONSERV BIOL, V9, P559, DOI 10.1046/j.1523-1739.1995.09030559.x; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Fowler C.W., 1987, Current Mammalogy, V1, P401; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0	7	6	6	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1499	1500		10.1126/science.1061765	http://dx.doi.org/10.1126/science.1061765			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11379631	Green Submitted			2022-12-28	WOS:000168963800031
J	Dubnau, J; Grady, L; Kitamoto, T; Tully, T				Dubnau, J; Grady, L; Kitamoto, T; Tully, T			Disruption of neurotransmission in Drosophila mushroom body blocks retrieval but not acquisition of memory	NATURE			English	Article							EXPRESSION; DYNAMIN; SHIBIRE; MELANOGASTER; NEURONS; BODIES; BRAIN; ORGANIZATION; MUTATIONS; ANATOMY	Surgical, pharmacological and genetic lesion studies have revealed distinct anatomical sites involved with different forms of learning. Studies of patients with localized brain damage and work in rodent model systems, for example, have shown that the hippocampal formation participates in acquisition of declarative tasks but is not the site of their long-term storage(1,2). Such lesions are usually irreversible, however, which has limited their use for dissecting the temporal processes of acquisition, storage and retrieval of memories(3,4). Studies in bees and flies have similarly revealed a distinct anatomical region of the insect brain, the mushroom body, that is involved specifically in olfactory associative learning(5,6). We have used a temperature-sensitive dynamin transgene, which disrupts synaptic transmission reversibly and on the time-scale of minutes(7), to investigate the temporal requirements for ongoing neural activity during memory formation. Here we show that synaptic transmission from mushroom body neurons is required during memory retrieval but not during acquisition or storage. We propose that the hebbian processes underlying olfactory associative learning reside in mushroom body dendrites or upstream of the mushroom body and that the resulting alterations in synaptic strength modulate mushroom body output during memory retrieval.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; City Hope Natl Med Ctr, Beckman Res Inst, Div Neurosci, Duarte, CA 91010 USA	Cold Spring Harbor Laboratory; City of Hope; Beckman Research Institute of City of Hope	Dubnau, J (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	dubnau@cshl.org		Kitamoto, Toshihiro/0000-0003-0863-8466; Dubnau, Josh/0000-0002-9285-7444				BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, CURR BIOL, V11, pR240, DOI 10.1016/S0960-9822(01)00115-4; DUDAI Y, 1988, J COMP PHYSIOL A, V162, P101, DOI 10.1007/BF01342707; Grant D, 1998, GENETICS, V149, P1019; Hammer M, 1998, LEARN MEMORY, V5, P146; Ito K, 1998, LEARN MEMORY, V5, P52; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; POODRY CA, 1973, DEV BIOL, V32, P373, DOI 10.1016/0012-1606(73)90248-0; RAMASWAMI M, 1993, J NEUROGENET, V9, P73, DOI 10.3109/01677069309083451; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Strausfeld NJ, 1999, J COMP NEUROL, V409, P603; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; YANG MY, 1995, NEURON, V15, P45; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	30	316	327	0	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					476	480		10.1038/35078077	http://dx.doi.org/10.1038/35078077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373680				2022-12-28	WOS:000168858700049
J	Fazel, S; McMillan, J				Fazel, S; McMillan, J			Commentary: A climate of secrecy undermines public trust	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Warneford Hosp, Old Age Psychiat Sect, Oxford OX3 7JX, England; Univ Oxford Univ Coll, Hastings Ctr, Oxford OX1 4BH, England	University of Oxford; University of Oxford	Fazel, S (corresponding author), Univ Oxford, Warneford Hosp, Old Age Psychiat Sect, Oxford OX3 7JX, England.		Fazel, Seena/B-5307-2008; McMillan, John/S-9660-2018	Fazel, Seena/0000-0002-5383-5365; McMillan, John/0000-0002-7507-1861				Berwick DM, 1999, BRIT MED J, V319, P136, DOI 10.1136/bmj.319.7203.136; Horton R, 1999, LANCET, V353, P422, DOI 10.1016/S0140-6736(99)00036-7; 1988, LANCET, V1, P1373	3	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2001	322	7296					1239	1240						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11398785				2022-12-28	WOS:000168900700038
J	Horton, R				Horton, R			Lotronex and the FDA: a fatal erosion of integrity	LANCET			English	Editorial Material							IRRITABLE-BOWEL-SYNDROME; ALOSETRON		Lancet, London WC1X 8RR, England		Horton, R (corresponding author), Lancet, London WC1X 8RR, England.							Camilleri M, 2000, LANCET, V355, P1035, DOI 10.1016/S0140-6736(00)02033-X; De Ponti F, 2001, DRUGS, V61, P317, DOI 10.2165/00003495-200161030-00001; McColl KEL, 2000, LANCET, V356, P164, DOI 10.1016/S0140-6736(05)73177-9	3	58	58	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1544	1545		10.1016/S0140-6736(00)04776-0	http://dx.doi.org/10.1016/S0140-6736(00)04776-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377636				2022-12-28	WOS:000168830100002
J	Wu, AW				Wu, AW			Commentary: Doctors are obliged to be honest with their patients	BRITISH MEDICAL JOURNAL			English	Editorial Material							MISTAKES		Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Hlth Policy, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Management, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wu, AW (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Hlth Policy, 624 N Broadway, Baltimore, MD 21205 USA.							Bosk CL, 1979, FORGIVE REMEMBER MAN, DOI DOI 10.7208/CHICAGO/9780226924687.001.0001; Witman AB, 1996, ARCH INTERN MED, V156, P2565, DOI 10.1001/archinte.156.22.2565; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726; Wu AW, 1997, J GEN INTERN MED, V12, P770, DOI 10.1046/j.1525-1497.1997.07163.x	4	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2001	322	7296					1238	1239						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11398784				2022-12-28	WOS:000168900700037
J	O'Connell, KF; Caron, C; Kopish, KR; Hurd, DD; Kemphues, KJ; Li, YJ; White, JG				O'Connell, KF; Caron, C; Kopish, KR; Hurd, DD; Kemphues, KJ; Li, YJ; White, JG			The C-elegans zyg-1 gene encodes a regulator of centrosome duplication with distinct maternal and paternal roles in the embryo	CELL			English	Article							XENOPUS EGG EXTRACTS; HAMSTER OVARY CELLS; CAENORHABDITIS-ELEGANS; PROTEIN-SYNTHESIS; BODY DUPLICATION; MITOTIC SPINDLE; CYCLIN-E; REPRODUCTION; KINASE; MICROTUBULES	Centrosome duplication is a critical step in assembly of the bipolar mitotic spindle, but the molecular mechanisms regulating this process during the cell cycle and during animal development are poorly understood. Here, we report that the zyg-1 gene of Caenorhabditis elegans is an essential regulator of centrosome duplication. ZYG-1 is a protein kinase specifically required for daughter centriole formation that localizes transiently to centrosomes and acts at least one cell cycle prior to each spindle assembly event. In the embryo, ZYG-1 participates in a unique regulatory scheme whereby paternal ZYG-1 regulates duplication and bipolar spindle assembly during the first cell cycle, and maternal ZYG-1 regulates these processes thereafter. ZYG-1 is therefore a key molecular component of the centrosome/centriole duplication process.	Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Cornell Univ, Genet & Dev Sect, Ithaca, NY 14853 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Cornell University	O'Connell, KF (corresponding author), Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA.	kfoconne@facstaff.wisc.edu		O'Connell, Kevin/0000-0002-9789-288X	NIGMS NIH HHS [GM-54454] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; BLUMENTHAL T, 1995, TRENDS GENET, V11, P132, DOI 10.1016/S0168-9525(00)89026-5; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; KEMPHUES KJ, 1988, GENETICS, V120, P977; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kimble J, 1988, NEMATODE CAENORHABDI, P191; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; MAZIA D, 1960, J BIOPHYS BIOCHEM CY, V7, P1, DOI 10.1083/jcb.7.1.1; Mello C, 1995, METHOD CELL BIOL, V48, P451; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; O'Connell KF, 1998, GENETICS, V149, P1303; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; PHILLIPS SG, 1976, J CELL BIOL, V70, P9, DOI 10.1083/jcb.70.1.9; Ruiz F, 1999, CURR BIOL, V9, P43, DOI 10.1016/S0960-9822(99)80045-1; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; SLUDER G, 1985, J CELL BIOL, V100, P887, DOI 10.1083/jcb.100.3.887; Sluder G, 1999, BIOL CELL, V91, P413, DOI 10.1016/S0248-4900(99)80083-5; Sluder G, 1997, J CELL SCI, V110, P421; STJOHNSTON D, 1992, CELL, V68, P201; Strausfeld UP, 1996, J CELL SCI, V109, P1555; SWOFFORD DL, 1998, PAUP ASTERISK PHYLOG; Tabara H, 1999, DEVELOPMENT, V126, P1; Urbani L, 1999, CURR BIOL, V9, pR315, DOI 10.1016/S0960-9822(99)80201-2; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9; WOOD WB, 1980, DEV BIOL, V74, P446, DOI 10.1016/0012-1606(80)90445-5; WOOD WB, 1994, TRENDS GENET, V10, P49, DOI 10.1016/0168-9525(94)90148-1; Wu XY, 1999, P NATL ACAD SCI USA, V96, P1397, DOI 10.1073/pnas.96.4.1397	46	232	240	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					547	558		10.1016/S0092-8674(01)00338-5	http://dx.doi.org/10.1016/S0092-8674(01)00338-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371350	Bronze			2022-12-28	WOS:000168840700013
J	Dubilier, N; Mulders, C; Ferdelman, T; de Beer, D; Pernthaler, A; Klein, M; Wagner, M; Erseus, C; Thiermann, F; Krieger, J; Giere, O; Amann, R				Dubilier, N; Mulders, C; Ferdelman, T; de Beer, D; Pernthaler, A; Klein, M; Wagner, M; Erseus, C; Thiermann, F; Krieger, J; Giere, O; Amann, R			Endosymbiotic sulphate-reducing and sulphide-oxidizing bacteria in an oligochaete worm	NATURE			English	Article							SULFATE REDUCTION; SEDIMENTS; ANNELIDA; SULFUR; TUBIFICIDAE; DIVERSITY; SYMBIONTS; ECOLOGY; OXYGEN; COAST	Stable associations of more than one species of symbiont within a single host cell or tissue are assumed to be rare in metazoans because competition for space and resources between symbionts can be detrimental to the host(1). In animals with multiple endosymbionts, such as mussels from deep-sea hydrothermal vents(2) and reef-building corals(3), the costs of competition between the symbionts are outweighed by the ecological and physiological flexibility gained by the hosts. A further option for the coexistence of multiple symbionts within a host is if these benefit directly from one another, but such symbioses have not been previously described. Here we show that in the gutless marine oligochaete Olavius algarvensis, endosymbiotic sulphate-reducing bacteria produce sulphide that can serve as an energy source for sulphide-oxidizing symbionts of the host. Thus, these symbionts do not compete for resources but rather share a mutalistic relationship with each other in an endosymbiotic sulphur cycle, in addition to their symbiotic relationship with the oligochaete host.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Tech Univ Munich, Dept Microbiol, D-85350 Freising, Germany; Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden; Univ Hamburg, Inst Zool, D-20146 Hamburg, Germany; Univ Hamburg, Museum Zool, D-20146 Hamburg, Germany	Max Planck Society; Technical University of Munich; Swedish Museum of Natural History; University of Hamburg; University of Hamburg	Dubilier, N (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.		Wagner, Michael/A-7801-2011; Amann, Rudolf I/C-6534-2014; de Beer, Dirk/L-4840-2013; Dubilier, Nicole/I-8203-2018; Ferdelman, Timothy G/A-3758-2013	Wagner, Michael/0000-0002-9778-7684; Amann, Rudolf I/0000-0002-0846-7372; de Beer, Dirk/0000-0001-5274-1781; Dubilier, Nicole/0000-0002-9394-825X; Ferdelman, Timothy G/0000-0002-9701-3793				Barton LL., 1995, SULFATE REDUCING BAC; BUSSMANN I, 1991, MAR ECOL PROG SER, V78, P97, DOI 10.3354/meps078097; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3971, DOI 10.1016/0016-7037(93)90347-Y; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Cottrell MT, 1999, APPL ENVIRON MICROB, V65, P1127; Crank J., 1975, MATH DIFFUSION; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; DUBILIER N, 1995, AM ZOOL, V35, P163; DUBILIER N, 1995, APPL ENVIRON MICROB, V61, P2346, DOI 10.1128/AEM.61.6.2346-2350.1995; Dubilier N, 1999, MAR ECOL PROG SER, V178, P271, DOI 10.3354/meps178271; FENCHEL T, 1992, ARCH MICROBIOL, V158, P394; Ferdelman TG, 1997, GEOCHIM COSMOCHIM AC, V61, P3065, DOI 10.1016/S0016-7037(97)00158-0; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; GIERE O, 1987, MAR BIOL, V93, P641, DOI 10.1007/BF00392801; GIERE O, 1991, MAR ECOL PROG SER, V68, P287; Giere O, 1998, ZOOL ANZ, V237, P209; GIERE O, 1995, ACTA ZOOL-STOCKHOLM, V76, P281, DOI 10.1111/j.1463-6395.1995.tb01000.x; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P49; Krieger J, 2000, MAR BIOL, V137, P239, DOI 10.1007/s002270000355; Kuhnigk T, 1996, SYST APPL MICROBIOL, V19, P139, DOI 10.1016/S0723-2020(96)80039-7; Morvan B, 1996, CURR MICROBIOL, V32, P129, DOI 10.1007/s002849900023; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sahm K, 1999, ENVIRON MICROBIOL, V1, P65, DOI 10.1046/j.1462-2920.1999.00007.x; Szathmary E, 1995, MAJOR TRANSITIONS EV; vandenEnde FP, 1997, FEMS MICROBIOL ECOL, V23, P65, DOI 10.1016/S0168-6496(97)00014-7; Vetter RD, 1998, MAR BIOL, V132, P453, DOI 10.1007/s002270050411; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998	28	160	165	1	56	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					298	302		10.1038/35077067	http://dx.doi.org/10.1038/35077067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357130				2022-12-28	WOS:000168710000045
J	Weller, IVD; Williams, IG				Weller, IVD; Williams, IG			ABC of AIDS - Antiretroviral drugs	BRITISH MEDICAL JOURNAL			English	Article																			0	30	30	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1410	1412		10.1136/bmj.322.7299.1410	http://dx.doi.org/10.1136/bmj.322.7299.1410			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397751	Green Published			2022-12-28	WOS:000169284600021
J	Dennis, DT; Inglesby, TV; Henderson, DA; Bartlett, JG; Ascher, MS; Eitzen, E; Fine, AD; Friedlander, AM; Hauer, J; Layton, M; Lillibridge, SR; McDade, JE; Osterholm, MT; O'Toole, T; Parker, G; Perl, TM; Russell, PK; Tonat, K				Dennis, DT; Inglesby, TV; Henderson, DA; Bartlett, JG; Ascher, MS; Eitzen, E; Fine, AD; Friedlander, AM; Hauer, J; Layton, M; Lillibridge, SR; McDade, JE; Osterholm, MT; O'Toole, T; Parker, G; Perl, TM; Russell, PK; Tonat, K		Working Grp Civilian Biodef	Tularemia as a biological weapon - Medical and public health management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FRANCISELLA-TULARENSIS; PULMONARY TULAREMIA; BORNE TULAREMIA; INFECTION; EPIDEMIC; OUTBREAK; FLUOROQUINOLONES; CIPROFLOXACIN; PATHOGENESIS; STREPTOMYCIN	Objective The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals if tularemia is used as a biological weapon against a civilian population. Participants The working group included 25 representatives from academic medical centers, civilian and military governmental agencies, and other public health and emergency management institutions and agencies. Evidence MEDLINE databases were searched from January 1966 to October 2000, using the Medical Subject Headings Francisella tularensis, Pasteurella tularensis, biological weapon, biological terrorism, bioterrorism, biological warfare, and biowarfare. Review of these references led to identification of relevant materials published prior to 1966, In addition, participants identified other references and sources. Consensus Process Three formal drafts of the statement that synthesized information obtained in the formal evidence-gathering process were reviewed by members of the working group. Consensus was achieved on the final draft. Conclusions A weapon using airborne tularemia would likely result 3 to 5 days later in an outbreak of acute, undifferentiated febrile illness with incipient pneumonia, pleuritis, and hilar lymphadenopathy. Specific epidemiological, clinical, and microbiological findings should lead to early suspicion of intentional tularemia in an alert health system; laboratory confirmation of agent could be delayed. Without treatment, the clinical course could progress to respiratory failure, shock, and death. Prompt treatment with streptomycin, gentamicin, doxycycline, or ciprofloxacin is recommended. Prophylactic use of doxycycline or ciprofloxacin may be useful in the early postexposure period.	Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA; Johns Hopkins Univ, Sch Med, Ctr Civilian Biodef Studies, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Ctr Civilian Biodef Studies, Baltimore, MD USA; Calif Dept Hlth Serv, Viral & Rickettsial Dis Lab, Berkeley, CA 94704 USA; USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; New York City Dept Hlth, Bur Communicable Dis, New York, NY 10013 USA; Kroll Associates, New York, NY USA; Ican Inc, Eden Prairie, MN USA; Dept Hlth & Human Serv, Off Emergency Preparedness, Rockville, MD USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins University; California Department of Health Care Services; New York City Department of Health & Mental Hygiene	Dennis, DT (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, POB 2087, Ft Collins, CO 80522 USA.	dtd1@cdc.gov						ALIBEK K, 1999, BIOHAZARD, P29; ALLUISI EA, 1973, J INFECT DIS, V128, P710, DOI 10.1093/infdis/128.6.710; *AM AC PED, 2000, RED BOOK 2000 REP CO, P645; *AM SOC HLTH SYST, 1999, AHFS DRUG INF 1999, P670; Amoss HL, 1936, J AMER MED ASSOC, V106, P1078, DOI 10.1001/jama.1936.02770130028009; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; AVERY FW, 1967, AM REV RESPIR DIS, V95, P584; BELL JF, 1980, CRC HDB SERIES ZOONO, V2, P161; BEVANGER L, 1988, J CLIN MICROBIOL, V26, P433, DOI 10.1128/JCM.26.3.433-437.1988; BOYCE JM, 1975, J INFECT DIS, V131, P197, DOI 10.1093/infdis/131.2.197; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; *CDCP, 1998, MMWR-MORBID MORTAL W, V46, P71; *CDCP, 2001, BAS LAB PROT PRES ID; *CDCP, 1995, MMWR-MORBID MORTAL W, V43, P3; CHIN J, 2000, CONTROL COMMUNICABLE, P532; CHRISTENSON B, 1984, SCAND J INFECT DIS, V16, P285, DOI 10.3109/00365548409070402; Christopher GW, 1997, JAMA-J AM MED ASSOC, V278, P412, DOI 10.1001/jama.278.5.412; Clarridge JE, 1996, J CLIN MICROBIOL, V34, P1995, DOI 10.1128/JCM.34.8.1995-2000.1996; CROSS JT, 1993, CLIN INFECT DIS, V17, P976, DOI 10.1093/clinids/17.6.976; CROSS JT, 1995, PEDIATR INFECT DIS J, V14, P151; CROSS JT, 2000, PRINCIPLES PRACTICE, P2393; DAHLSTRAND S, 1971, Scandinavian Journal of Infectious Diseases, V3, P7; DENNIS DT, 1998, MAXCY ROSENAU LAST P, P354; ENDERLIN G, 1994, CLIN INFECT DIS, V19, P42, DOI 10.1093/clinids/19.1.42; EVANS ME, 1985, MEDICINE, V64, P251, DOI 10.1097/00005792-198507000-00006; Fortier A H, 1994, Immunol Ser, V60, P349; Francis E, 1928, J CLIN ENDOCRINOL, V7, P411; Francis E, 1937, PUBLIC HEALTH REP, V52, P103, DOI 10.2307/4582067; Francis E, 1925, J AMER MED ASSOC, V84, P1243, DOI 10.1001/jama.1925.02660430001001; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; FRENCH GR, 1999, VACCINES, P728; Garner JS, 1996, INFECT CONT HOSP EP, V17, P54, DOI 10.1017/S0195941700006123; Gelman AC., 1961, STUDIES DIS ECOLOGY, P89; Grunow R, 2000, CLIN DIAGN LAB IMMUN, V7, P86, DOI 10.1128/CDLI.7.1.86-90.2000; Guarner J, 1999, APPL IMMUNOHISTO M M, V7, P122, DOI 10.1097/00022744-199906000-00004; Gurycova D, 1998, EUR J EPIDEMIOL, V14, P797, DOI 10.1023/A:1007537405242; HALSTED CC, 1978, PEDIATRICS, V61, P660; HARRIS S, 1992, ANN NY ACAD SCI, V666, P21, DOI 10.1111/j.1749-6632.1992.tb38021.x; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Higgins JA, 2000, AM J TROP MED HYG, V62, P310, DOI 10.4269/ajtmh.2000.62.310; Hopla C.E., 1974, Advances vet Sci comp Med, V18, P25; Hopla CE, 1994, HDB ZOONOSES, P113; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; JACOBS RF, 1983, PEDIATR INFECT DIS J, V2, P487, DOI 10.1097/00006454-198311000-00019; JELLISON W L, 1955, Public Health Monogr, V28, P1; Jellison W. L., 1974, TULAREMIA N AM 1930, P1; JELLISON WL, 1950, PUBLIC HEALTH REP, V65, P1219, DOI 10.2307/4587477; Johansson A, 2000, PEDIATR INFECT DIS J, V19, P449, DOI 10.1097/00006454-200005000-00011; Johansson A, 2000, J CLIN MICROBIOL, V38, P4180, DOI 10.1128/JCM.38.11.4180-4185.2000; Karpoff SP, 1936, J BACTERIOL, V32, P243, DOI 10.1128/JB.32.3.243-258.1936; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; Khan AS, 2000, LANCET, V356, P1179, DOI 10.1016/S0140-6736(00)02769-0; KLOCK LE, 1973, JAMA-J AM MED ASSOC, V226, P149, DOI 10.1001/jama.226.2.149; Lake GC, 1922, PUBLIC HEALTH REP, V37, P392, DOI 10.2307/4576294; LILLIE RD, 1937, PATHOLOGY TULARAEMIA, P1; Limaye AP, 1999, CLIN INFECT DIS, V29, P922, DOI 10.1086/520458; MARKOWITZ LE, 1985, JAMA-J AM MED ASSOC, V254, P2922, DOI 10.1001/jama.254.20.2922; MARTONE WJ, 1979, JAMA-J AM MED ASSOC, V23, P2315; MASON WL, 1980, AM REV RESPIR DIS, V121, P39; MCCARTHY VP, 1990, PEDIATR INFECT DIS J, V9, P298, DOI 10.1097/00006454-199004000-00018; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; MCCRUMB FR, 1957, T ASSOC AM PHYSICIAN, V70, P74; MIGNANI E, 1988, LANCET, V2, P1423; Ohara Y, 1998, J MED ENTOMOL, V35, P471, DOI 10.1093/jmedent/35.4.471; OVERHOLT EL, 1961, AM J MED, V30, P785, DOI 10.1016/0002-9343(61)90214-5; PARKER RR, 1934, P 5 PAC SCI C, P3367; Pavlov VM, 1996, FEMS IMMUNOL MED MIC, V13, P253, DOI 10.1111/j.1574-695X.1996.tb00247.x; PIKE RM, 1976, HEALTH LAB SCI, V13, P105; POLLITZER R, 1967, HIST INCIDENCE TULAR, P1; POMANSKAIA L. A., 1957, Journal of Microbiology, Epidemiology and Immunobiology, V28, P597; PULLEN RL, 1945, JAMA-J AM MED ASSOC, V129, P495, DOI 10.1001/jama.1945.02860410011003; PUNTIGAM F, 1960, Z HYG INFEKTIONSKR, V147, P162, DOI 10.1007/BF02152053; Rogutskii S.V., 1997, ZH MIKROBIOL EPIDEMI, V2, P33; Russell P, 1998, J ANTIMICROB CHEMOTH, V41, P461, DOI 10.1093/jac/41.4.461; SANDSTROM G, 1992, FEMS MICROBIOL IMMUN, V105, P201, DOI 10.1111/j.1574-6968.1992.tb05902.x; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Saslaw S, 1961, ARCH INTERN MED, V107, P134, DOI DOI 10.1001/ARCHINTE.1961.03620050068007; SAWYER WD, 1966, BACTERIOL REV, V30, P542, DOI 10.1128/MMBR.30.3.542-550.1966; SIL'CHENKO V. S., 1957, ZHUR MIKROBIOL EPIDEMIOL AND IMMUNOBIOL [TRANSL], V28, P788; Simpson WM, 1928, ANN INTERN MED, V1, P1007, DOI 10.7326/0003-4819-1-12-1007; Sjostedt A, 1996, FEMS IMMUNOL MED MIC, V13, P181, DOI 10.1016/0928-8244(95)00100-X; STUART BM, 1945, ARCH INTERN MED, V76, P163, DOI 10.1001/archinte.1945.00210330034007; STUART BM, 1945, AM J MED SCI, V210, P223, DOI 10.1097/00000441-194508000-00013; SUNDERRAJAN EV, 1985, ARCH INTERN MED, V145, P1435, DOI 10.1001/archinte.145.8.1435; SYRJALA H, 1991, EUR J CLIN MICROBIOL, V10, P68, DOI 10.1007/BF01964409; SYRJALA H, 1985, SCAND J INFECT DIS, V17, P371; SYRJALA H, 1986, J LARYNGOL OTOL, V100, P1169, DOI 10.1017/S0022215100100775; SYRJALA H, 1986, J INFECT DIS, V153, P142, DOI 10.1093/infdis/153.1.142; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Tarnvik A, 1996, FEMS IMMUNOL MED MIC, V13, P201, DOI 10.1016/0928-8244(95)00104-2; TEUTSCH SM, 1979, NEW ENGL J MED, V301, P826, DOI 10.1056/NEJM197910113011507; Tucker JB, 1997, JAMA-J AM MED ASSOC, V278, P362, DOI 10.1001/jama.278.5.362; *US DEP HHS, 1999, BIOS MICR BIOM LAB, P17; WARRING WB, 1946, NEW ENGL J MED, V234, P137, DOI 10.1056/NEJM194601312340501; WHITE JD, 1964, J INFECT DIS, V114, P277, DOI 10.1093/infdis/114.3.277; WHITE JD, 1965, JAMA-J AM MED ASSOC, V194, P180; WHO Consultant Group, 1970, HLTH ASP CHEM BIOL W, P105; WONG JD, 1999, MANUAL CLIN MICROBIO, P647; World Health Organization, 1970, HLTH ASP CHEM BIOL W, P75; YOUNG LS, 1969, NEW ENGL J MED, V280, P1253, DOI 10.1056/NEJM196906052802301	102	990	1030	3	123	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2763	2773		10.1001/jama.285.21.2763	http://dx.doi.org/10.1001/jama.285.21.2763			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386933				2022-12-28	WOS:000168985800030
J	Schwetz, BA				Schwetz, BA			Labeling changes for Orlaam	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2705	2705						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386912				2022-12-28	WOS:000168985800006
J	Weller, IVD; Williams, IG				Weller, IVD; Williams, IG			ABC of AIDS - Treatment of infections	BRITISH MEDICAL JOURNAL			English	Article																			0	10	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2001	322	7298					1350	1354		10.1136/bmj.322.7298.1350	http://dx.doi.org/10.1136/bmj.322.7298.1350			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387187	Green Published			2022-12-28	WOS:000169167900023
J	Landick, R				Landick, R			RNA polymerase clamps down	CELL			English	Review							PROMOTER OPEN COMPLEX; ELONGATION COMPLEX; TRANSCRIPTION; MODEL; ANTITERMINATION; TERMINATION; MECHANISM; PROTEIN; DNA		Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Landick, R (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.							Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; CRAMER P, 2001, IN PRESS SCIENCE; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Frankel AD, 1998, CELL, V92, P149, DOI 10.1016/S0092-8674(00)80908-3; GNATT A, 2001, IN PRESS SCIENCE; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; Mogridge J, 1998, MOL CELL, V1, P265, DOI 10.1016/S1097-2765(00)80027-1; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	20	54	54	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					567	570		10.1016/S0092-8674(01)00381-6	http://dx.doi.org/10.1016/S0092-8674(01)00381-6			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389826	Bronze			2022-12-28	WOS:000169123200003
J	Lee, AL; Wand, AJ				Lee, AL; Wand, AJ			Microscopic origins of entropy, heat capacity and the glass transition in proteins	NATURE			English	Article							INELASTIC NEUTRON-SCATTERING; SIDE-CHAIN DYNAMICS; ORDER PARAMETERS; RIBONUCLEASE-A; NMR; RELAXATION; MYOGLOBIN; BINDING; H-2; MOTIONS	Internal motion is central to protein folding(1), to protein stability through the resulting residual entropy(2), and to protein function(1,3-7). Despite its importance, the precise nature of the internal motions of protein macromolecules remains a mystery. Here we report a survey of the temperature dependence of the fast dynamics of methyl-bearing side chains in a calmodulin-peptide complex using site-specific deuterium NMR relaxation methods. The amplitudes of motion had a markedly heterogeneous spectrum and segregated into three largely distinct classes. Other proteins studied at single temperatures tend to segregate similarly. Furthermore, a large variability in the degree of thermal activation of the dynamics in the calmodulin complex indicates a heterogeneous distribution of residual entropy and hence reveals the microscopic origins of heat capacity in proteins. These observations also point to an unexpected explanation for the low-temperature 'glass transition' of proteins. It is this transition that has been ascribed to the creation of protein motional modes that are responsible for biological activity(5-7).	Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wand, AJ (corresponding author), Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA.		Lee, Andrew/GVU-2817-2022					AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Constantine KL, 1998, BIOCHEMISTRY-US, V37, P7965, DOI 10.1021/bi980203o; Diehl M, 1997, BIOPHYS J, V73, P2726, DOI 10.1016/S0006-3495(97)78301-2; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1985, SCIENCE, V229, P337, DOI 10.1126/science.4012322; HARTMANN H, 1982, P NATL ACAD SCI-BIOL, V79, P4967, DOI 10.1073/pnas.79.16.4967; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; Kay LE, 1996, BIOCHEMISTRY-US, V35, P361, DOI 10.1021/bi9522312; Lee AL, 1999, J AM CHEM SOC, V121, P2891, DOI 10.1021/ja983758f; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; LeMaster DM, 1999, J AM CHEM SOC, V121, P1726, DOI 10.1021/ja982988r; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mittermaier A, 1999, J BIOMOL NMR, V13, P181, DOI 10.1023/A:1008387715167; MUHANDIRAM DR, 1995, J AM CHEM SOC, V117, P11536, DOI 10.1021/ja00151a018; NICHOLSON LK, 1992, BIOCHEMISTRY-US, V31, P5253, DOI 10.1021/bi00138a003; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; Reat V, 2000, P NATL ACAD SCI USA, V97, P9961, DOI 10.1073/pnas.97.18.9961; Sokolov AP, 1996, SCIENCE, V273, P1675, DOI 10.1126/science.273.5282.1675; TILTON RF, 1992, BIOCHEMISTRY-US, V31, P2469, DOI 10.1021/bi00124a006; Wand AJ, 1996, BIOCHEMISTRY-US, V35, P6116, DOI 10.1021/bi9530144; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Yang DW, 1998, J MOL BIOL, V276, P939, DOI 10.1006/jmbi.1997.1588; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	28	267	268	0	85	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					501	504		10.1038/35078119	http://dx.doi.org/10.1038/35078119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373686				2022-12-28	WOS:000168858700055
J	Olson, A; Stenlid, J				Olson, A; Stenlid, J			Plant pathogens - Mitochondrial control of fungal hybrid virulence	NATURE			English	Article							HETEROBASIDION-ANNOSUM; M-MEDUSAE; HYBRIDIZATION		Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences	Olson, A (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, SE-75007 Uppsala, Sweden.	ake.olson@mykopat.slu.se	Stenlid, Jan/K-5909-2019					Brasier C, 2000, NATURE, V405, P134, DOI 10.1038/35012193; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Brasier CM, 1998, MYCOL RES, V102, P45, DOI 10.1017/S0953756297004541; ERESK T, 1995, PHYTOPATHOLOGY, V85, P1343; Garbelotto M, 1996, PHYTOPATHOLOGY, V86, P543, DOI 10.1094/Phyto-86-543; GARBELOTTO M, 1996, PHYTOPATHOLOGY S, V86, P28; Garbelotto MM, 1997, MYCOLOGIA, V89, P92, DOI 10.2307/3761177; Korhonen K, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P43; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; SHARMA P, 1993, PHYSIOL MOL PLANT P, V43, P57, DOI 10.1006/pmpp.1993.1040; SPIERS AG, 1994, MYCOL RES, V98, P889, DOI 10.1016/S0953-7562(09)80260-8; t Veld VAMI, 1998, PHYTOPATHOLOGY, V88, P922, DOI 10.1094/PHYTO.1998.88.9.922	12	70	70	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					438	438		10.1038/35078147	http://dx.doi.org/10.1038/35078147			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373666	Bronze			2022-12-28	WOS:000168858700035
J	Arias, AM				Arias, AM			Epithelial mesenchymal interactions in cancer and development	CELL			English	Review							TRANSCRIPTION FACTOR SNAIL; BETA-CATENIN; EPH RECEPTORS; E-CADHERIN; COLORECTAL-CANCER; CELL BEHAVIOR; MORPHOGENESIS; DROSOPHILA; GENE; PATHWAY		Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge	Arias, AM (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.		Martinez Arias, Alfonso/F-1966-2010					Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Arias AM, 1999, CURR OPIN GENET DEV, V9, P447, DOI 10.1016/S0959-437X(99)80068-9; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; BISHOP JM, 1983, CELL, V32, P1018; BISHOP JM, 1981, CELL, V23, P5; Brault V, 2001, DEVELOPMENT, V128, P1253; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Holder N, 1999, DEVELOPMENT, V126, P2033; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Lawrence N, 2000, INT J DEV BIOL, V44, P749; Mellitzer G, 2000, CURR OPIN NEUROBIOL, V10, P400, DOI 10.1016/S0959-4388(00)00095-7; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Polakis P, 1999, ADV EXP MED BIOL, V470, P23; Reinacher-Schick A, 2001, J CELL BIOL, V152, P491, DOI 10.1083/jcb.152.3.491; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; VARMUS HE, 1984, ANNU REV GENET, V18, P553; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Wiechens N, 2001, CURR BIOL, V11, P18, DOI 10.1016/S0960-9822(00)00045-2; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Zhu AJ, 1999, DEVELOPMENT, V126, P2285	41	173	181	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					425	431		10.1016/S0092-8674(01)00365-8	http://dx.doi.org/10.1016/S0092-8674(01)00365-8			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371340	Bronze			2022-12-28	WOS:000168840700003
J	Torrelles, JM; Patel, NA; Gomez, JF; Ho, PTP; Rodriguez, LF; Anglada, G; Garay, G; Greenhill, L; Curiel, S; Canto, J				Torrelles, JM; Patel, NA; Gomez, JF; Ho, PTP; Rodriguez, LF; Anglada, G; Garay, G; Greenhill, L; Curiel, S; Canto, J			Spherical episodic ejection of material from a young star	NATURE			English	Article							THERMAL RADIO JET; WATER MASERS; CEPHEUS-A; MASS OUTFLOW; H2O MASERS; REGIONS; EMISSION; MOTION; HW2	The exact processes by which interstellar matter condenses to form young stars are of great interest, in part because they bear on the formation of planets like our own from the material that fails to become part of the star. Theoretical models suggest that ejection of gas during early phases of stellar evolution is a key mechanism for removing excess angular momentum, thereby allowing material to drift inwards towards the star through an accretion disk(1,2). Such ejections also limit the mass that can be accumulated by the stellar core(1,2). To date, these ejections have been observed to be bipolar and highly collimated, in agreement with theory. Here we report observations at very high angular resolution of the proper motions of an arc of water-vapour masers near a very young, massive star in Cepheus. We rnd that the arc of masers can be fitted to a circle with an accuracy of one part in a thousand, and that the structure is expanding. Only a sphere will always produce a circle in projection, so our observations strongly suggest that the perfectly spherical ejection of material from this star took place about 33 years earlier. The spherical symmetry of the ejecta and its episodic nature are very surprising in the light of present theories.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; CSIC, IEEC, ES-08034 Barcelona, Spain; CSIC, Inst Ciencias Espacio, ES-08034 Barcelona, Spain; INTA, Lab Astrofis Espacial & Fis Fundamental, Madrid 28080, Spain; Univ Nacl Autonoma Mexico, Inst Astron, Morelia 58089, Michoacan, Mexico; CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; Univ Chile, Dept Astron, Santiago, Chile; Univ Nacl Autonoma Mexico, Inst Astron, Mexico City 04510, DF, Mexico	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Consejo Superior de Investigaciones Cientificas (CSIC); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Universidad Nacional Autonoma de Mexico; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Universidad de Chile; Universidad Nacional Autonoma de Mexico	Ho, PTP (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	ho@cfa.harvard.edu	Rodriguez, Luis/U-9365-2019; Gomez, Jose Francisco/D-8392-2016; Ho, Paul/AAZ-5108-2020; Torrelles, Jose Maria/ABD-8181-2020; Garay, Guido/H-8840-2013; Torrelles, Jose Maria/ABF-5543-2020	Ho, Paul/0000-0002-3412-4306; Garay, Guido/0000-0003-1649-7958; Gomez, Jose Francisco/0000-0002-7065-542X; Curiel, Salvador/0000-0003-4576-0436; Torrelles, Jose Maria/0000-0002-6896-6085; Anglada, Guillem/0000-0002-7506-5429				CHEUNG AC, 1969, NATURE, V221, P626, DOI 10.1038/221626a0; Claussen MJ, 1998, ASTROPHYS J, V507, pL79, DOI 10.1086/311669; ELITZUR M, 1992, ASTROPHYS J, V394, P221, DOI 10.1086/171574; Furuya RS, 2000, ASTROPHYS J, V542, pL135, DOI 10.1086/312925; GENZEL R, 1981, ASTROPHYS J, V244, P884, DOI 10.1086/158764; GWINN CR, 1994, ASTROPHYS J, V429, P241, DOI 10.1086/174315; HO PTP, 1982, ASTROPHYS J, V262, P619, DOI 10.1086/160454; HUGHES VA, 1984, ASTROPHYS J, V276, P204, DOI 10.1086/161603; Kaufman MJ, 1996, ASTROPHYS J, V456, P250, DOI 10.1086/176645; Leppanen K, 1998, ASTROPHYS J, V507, P909, DOI 10.1086/306343; LIZANO S, 1995, REV MEX ASTRON ASTRO, V1; Marvel KB, 1997, PUBL ASTRON SOC PAC, V109, P1286, DOI 10.1086/134010; MIYOSHI M, 1995, NATURE, V373, P127, DOI 10.1038/373127a0; Patel NA, 2000, ASTROPHYS J, V538, P268, DOI 10.1086/309126; REID MJ, 1981, ANNU REV ASTRON ASTR, V19, P231, DOI 10.1146/annurev.aa.19.090181.001311; RODRIGUEZ LF, 1994, ASTROPHYS J, V430, pL65, DOI 10.1086/187439; RODRIGUEZ LF, 1980, ASTROPHYS J, V240, pL149, DOI 10.1086/183342; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; Torrelles JM, 1998, ASTROPHYS J, V509, P262, DOI 10.1086/306485; TORRELLES JM, 1993, ASTROPHYS J, V404, pL75, DOI 10.1086/186747; Torrelles JM, 1996, ASTROPHYS J, V457, pL107, DOI 10.1086/309903	21	61	61	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					277	280		10.1038/35077020	http://dx.doi.org/10.1038/35077020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357123				2022-12-28	WOS:000168710000038
J	Beier, M				Beier, M			Visiting the sadness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2425	2426		10.1001/jama.285.19.2425	http://dx.doi.org/10.1001/jama.285.19.2425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429ZC	11368675				2022-12-28	WOS:000168547600001
J	Sasieni, P; Adams, J				Sasieni, P; Adams, J			Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England	LANCET			English	Article							CANCER MORTALITY; CELL CARCINOMAS; TRENDS; WALES; RISK	Background A recent analysis showed little or no effect of screening on the incidence of adenocarcinoma of the cervix between 1971 and 1992. We have used additional data on cancers diagnosed in 1993-94 in England and up to 1997 in five English cancer registries to investigate more recent trends. Methods After imputing the number of adenocarcinomas in women with unknown histology, we fitted an age-cohort model to 8062 adenocarcinomas of the cervix diagnosed in England between 1971 and 1987. Predictions from this model were applied to the more recent data on 5854 cases. Residual effects were plotted against year of diagnosis in each of four age-groups. Findings We estimated the underlying risk of cervical adenocarcinoma to be 14 times (95% CI 11-19) greater in women born in the early 1960s than in cohorts born before 1935. An age-cohort model fitted the data for England well up to 1987, but substantially overestimated the numbers of adenocarcinomas in young women from 1990 onwards. In 1996-97 the incidence rate in women aged 25-54 years was less than 40% of that predicted from the age-cohort model. Interpretation The substantial increase in cervical adenocarcinoma in recent years is largely a birth-cohort effect presumably associated with greater exposure to human papillomavirus after the sexual revolution in the 1960s. The relative decline in younger women observed in more recent years suggests an effect of cervical screening.	Imperial Canc Res Fund, Dept Math Stat & Epidemiol, London WC2A 3PX, England	Cancer Research UK	Sasieni, P (corresponding author), Imperial Canc Res Fund, Dept Math Stat & Epidemiol, 61 Lincolns Inn Fields, London WC2A 3PX, England.	p.sasieni@icrf.icnet.uk		Sasieni, Peter/0000-0003-1509-8744				BERAL V, 1974, LANCET, V1, P1037; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; *INT AG RES CANC, 1995, IARC MON EV CARC RIS; Lacey JV, 1999, CANCER EPIDEM BIOMAR, V8, P1079; McCann J, 1998, J MED SCREEN, V5, P42, DOI 10.1136/jms.5.1.42; MCCULLAGH P, 1989, GEN LINEAR MODELS, P324; *OFF NAT STAT, 1999, SERIES MBI, V26; *OFF NAT STAT, 2000, STAT B; PARKIN DM, 1985, BRIT J OBSTET GYNAEC, V92, P150, DOI 10.1111/j.1471-0528.1985.tb01067.x; Sasieni P, 1999, BRIT MED J, V318, P1244; Sasieni PD, 2000, J ROY STAT SOC A STA, V163, P191, DOI 10.1111/1467-985X.00165; Sasieni PD, 1999, AM J EPIDEMIOL, V149, P869; URSIN G, 1994, LANCET, V344, P1390, DOI 10.1016/S0140-6736(94)90567-3; Vizcaino AP, 1998, INT J CANCER, V75, P536, DOI 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U	15	138	143	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2001	357	9267					1490	1493		10.1016/S0140-6736(00)04646-8	http://dx.doi.org/10.1016/S0140-6736(00)04646-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377601				2022-12-28	WOS:000168614300013
J	Levy, JB; Turner, AN; Rees, AJ; Pusey, CD				Levy, JB; Turner, AN; Rees, AJ; Pusey, CD			Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression	ANNALS OF INTERNAL MEDICINE			English	Article							RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; GOODPASTURES-SYNDROME; MEDIATED DISEASE; NEPHRITIS; DIAGNOSIS; PROGNOSIS; COLLAGEN; THERAPY; ANTIGEN; CHAIN	Background: Anti-glomerular basement membrane (GBM) antibody disease is an autoantibody-mediated disorder that usually presents as rapidly progressive glomerulonephritis, often with pulmonary hemorrhage (the Goodpasture syndrome). It is reported that patients with severe renal failure do not generally recover renal function. Objective: To examine the long-term outcome of severe anti-GBM antibody disease. Design: Retrospective review of patients treated for confirmed anti-GBM antibody disease over 25 years. Setting: A tertiary referral center in the United Kingdom. Patients: 71 treated patients with anti-GBM antibody disease. Intervention: All patients received plasma exchange, prednisolone, and cyclophosphamide, Measurements: Patient and renal survival, renal histology, and antibody levels. Results: Patients who presented with a creatinine concentration less than 500 mu mol/L (5.7 mg/dL) (n = 19) had 100% patient survival and 95% renal survival at 1 year and 84% patient survival and 74% renal survival at last follow-up. In patients who presented with a creatinine concentration of 500 mu mol/L or more (greater than or equal to5.7 mg/dL) (n = 13) but did not require immediate dialysis, patient and renal survival were 83% and 82% at 1 year and 62% and 69% at last follow-up. In patients who presented with dialysis-dependent renal failure (n = 39), patient and renal survival were 65% and 8% at 1 year and 36% and 5% at last follow-up. All patients who required immediate dialysis and had 100% crescents on renal biopsy remained dialysis dependent. Conclusions: Patients with the Goodpasture syndrome and severe renal failure should be considered for urgent immunosuppression therapy, including plasma exchange, to maximize the chance of renal recovery. Patients needing immediate dialysis are less likely to recover.	Hammersmith Hosp, Imperial Coll Sch Med, Renal Sect, London W12 0NN, England; Univ Edinburgh, Royal Infirm, Edinburgh EH3 9YW, Midlothian, Scotland; Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	Imperial College London; Royal Infirmary of Edinburgh; University of Edinburgh; University of Aberdeen	Levy, JB (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Renal Sect, Ducane Rd, London W12 0NN, England.			Turner, Neil/0000-0003-4547-873X				ANDREWS PA, 1995, CLIN NEPHROL, V44, P262; BOLTON WK, 1989, AM J NEPHROL, V9, P368; Bolton WK, 1996, KIDNEY INT, V50, P1753, DOI 10.1038/ki.1996.495; BOUGET J, 1990, ANN MED INTERNE, V141, P409; BRIGGS WA, 1979, MEDICINE, V58, P348, DOI 10.1097/00005792-197909000-00002; Daly C, 1996, RENAL FAILURE, V18, P105, DOI 10.3109/08860229609052780; EWAN PW, 1976, NEW ENGL J MED, V295, P1391, DOI 10.1056/NEJM197612162952502; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; HERODY M, 1993, CLIN NEPHROL, V40, P249; JOHNSON JP, 1985, MEDICINE, V64, P219, DOI 10.1097/00005792-198507000-00003; Katbamna I, 1995, J Clin Lab Immunol, V47, P11; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; Levy JB, 1996, AM J KIDNEY DIS, V27, P573, DOI 10.1016/S0272-6386(96)90169-9; LEVY JB, 2000, COMPREHENSIVE CLIN N; LEVY JB, 1997, NEPHROLOGY, P599; LOCKWOOD CM, 1976, LANCET, V1, P711; LOCKWOOD CM, 1975, BRIT MED J, V2, P252, DOI 10.1136/bmj.2.5965.252; MERKEL F, 1994, NEPHROL DIAL TRANSPL, V9, P372; PETERS DK, 1982, TRANSPLANT P, V14, P513; REES AJ, 1977, BMJ-BRIT MED J, V2, P723, DOI 10.1136/bmj.2.6089.723; SAUS J, 1988, J BIOL CHEM, V263, P13374; SAVAGE COS, 1986, BRIT MED J, V292, P301, DOI 10.1136/bmj.292.6516.301; SIMPSON IJ, 1982, AM J NEPHROL, V2, P301, DOI 10.1159/000166666; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; WALKER RG, 1985, Q J MED, V54, P75; WILSON CB, 1973, KIDNEY INT, V3, P74, DOI 10.1038/ki.1973.14	26	345	359	2	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2001	134	11					1033	1042		10.7326/0003-4819-134-11-200106050-00009	http://dx.doi.org/10.7326/0003-4819-134-11-200106050-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YL	11388816				2022-12-28	WOS:000168963400003
J	Rogers, MAM; Small, D; Buchan, DA; Butch, CA; Stewart, CM; Krenzer, BE; Husovsky, HL				Rogers, MAM; Small, D; Buchan, DA; Butch, CA; Stewart, CM; Krenzer, BE; Husovsky, HL			Home monitoring service improves mean arterial pressure in patients with essential hypertension - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE; MANAGEMENT; CARE	Background: Technological advances in the distribution of information have opened new avenues for patient care. Few trials, however, have used telemedicine to improve blood pressure in patients with essential hypertension. Objective: To determine the efficacy of a telecommunication service in reducing blood pressure. Design: Randomized, controlled trial. Setting: University-affiliate primary care outpatient clinics. Patients: 121 adults with essential hypertension who were under evaluation for a change in antihypertensive therapy. Intervention: A home service consisting of automatic transmission of blood pressure data over telephone lines, computerized conversion of the information into report forms, and weekly electronic transmission of the report forms to physicians and patients. Measurements: 24-hour ambulatory blood pressure monitoring at baseline and exit. The primary end point was change in mean arterial pressure from baseline to exit. Results: Mean arterial pressure decreased by 2.8 mm Hg in patients receiving the home service and increased by 1.3 mm Hg in patients receiving usual care (P = 0.013 for the difference). Mean diastolic blood pressure decreased by 2.0 mm Hg for home service but increased by 2.1 mm Hg for usual care (P = 0.012 for the difference). Mean systolic blood pressure decreased by 4.9 mm Hg for home service and 0.1 mm Hg for patients receiving usual care (P = 0.047 for the difference). Among African-American patients, mean arterial pressure decreased by 9.6 mm Hg in those receiving home service and increased by 5.25 mm Hg in those receiving usual care (P = 0.047). Part of the decrease in blood pressure for home service was due to more frequent changes in the type or dose of antihypertensive medications. Conclusion: This telecommunication service was efficacious in reducing the mean arterial pressure of patients with established essential hypertension.	SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Rogers, MAM (corresponding author), SUNY Upstate Med Univ, Dept Med, 322 CWB,750 E Adams St, Syracuse, NY 13210 USA.			Rogers, Mary/0000-0001-5519-3223				BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Block G, 2000, AM J PREV MED, V18, P284, DOI 10.1016/S0749-3797(00)00119-7; Bondmass MD, 1998, CIRCULATION, V98, P517; BRUNNER HR, 1992, AMBULATORY BLOOD PRE; CARNAHAN JE, 1975, AM J MED SCI, V269, P69, DOI 10.1097/00000441-197501000-00008; Friedman RH, 1996, AM J HYPERTENS, V9, P285, DOI 10.1016/0895-7061(95)00353-3; HAYNES RB, 1976, LANCET, V1, P1265; *HLTH US, 1998, SOC STAT HLTH CHARTB; JOHNSON AL, 1978, CAN MED ASSOC J, V119, P1034; Johnson KA, 1999, ARCH INTERN MED, V159, P2689, DOI 10.1001/archinte.159.22.2689; *JOINT NAT COMM PR, 1997, NIH PUBL; MIDANIK LT, 1991, PUBLIC HEALTH REP, V106, P85; *NCI, 1993, HHHQ DIETSYS AN SOFT; Rogoza AN, 2000, BLOOD PRESS MONIT, V5, P227, DOI 10.1097/00126097-200008000-00006; SOGHIKIAN K, 1992, MED CARE, V30, P855, DOI 10.1097/00005650-199209000-00009; Zarnke KB, 1997, AM J HYPERTENS, V10, P58, DOI 10.1016/S0895-7061(96)00305-6	16	176	178	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2001	134	11					1024	1032		10.7326/0003-4819-134-11-200106050-00008	http://dx.doi.org/10.7326/0003-4819-134-11-200106050-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YL	11388815				2022-12-28	WOS:000168963400002
J	Rushton, DH; Dover, R; Sainsbury, AW; Norris, MJ; Gilkes, JJH; Ramsay, ID				Rushton, DH; Dover, R; Sainsbury, AW; Norris, MJ; Gilkes, JJH; Ramsay, ID			Why should women have lower reference limits for haemoglobin and ferritin concentrations than men?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IRON-DEFICIENCY; SERUM FERRITIN; UNITED-STATES; POPULATION; ABSORPTION; STORES		Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England; Imperial Canc Res Fund, London WC2A 3PX, England; Zool Soc London, Inst Zool, London NW1 4RY, England; Lister Hosp, London SW1W 8RH, England	University of Portsmouth; Cancer Research UK; Zoological Society of London; Lister Hospital	Rushton, DH (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.	rushton@btinternet.com	Rushton, D Hugh/AAE-8491-2020					Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; BOTHWELL TH, 1979, IRON METABOLISM MAN, P7; Bruner AB, 1996, LANCET, V348, P992, DOI 10.1016/S0140-6736(96)02341-0; COOK JD, 1986, BLOOD, V68, P726; COOK JD, 1976, BLOOD, V48, P449; DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305; DILLMANN E, 1979, AM J PHYSIOL, V237, pR337; FRASSINELLIGUNDERSON EP, 1985, AM J CLIN NUTR, V41, P703, DOI 10.1093/ajcn/41.4.703; Hallberg L, 1997, AM J CLIN NUTR, V66, P347, DOI 10.1093/ajcn/66.2.347; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; HALLBERG L, 1982, HUM NUTR-CLIN NUTR, V36, P259; Hallberg L., 1993, HUMAN NUTR DIETETICS; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; HARD S, 1963, ACTA DERM-VENEREOL, V43, P562; Hoffbrand AV, 1993, ESSENTIAL HAEMATOLOG, P419; Jain NC, 1993, ESSENTIALS VET HEMAT; JI G, 1987, J REPROD MED, V32, P822; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lynx, 2000, LYNX HAEM BIOCH DAT; *MIN AGR, 1994, DIET NUTR SURV BRIT, P72; MYERS AM, 1968, LANCET, V2, P261; NELSON M, 1999, 1 HOUS COMM ED EMPL; RUSHTON DH, 1992, CLIN ENDOCRINOL, V36, P421; SCRIMSHAW NS, 1984, J NUTR SCI VITAMINOL, V30, P47, DOI 10.3177/jnsv.30.47; SIMON TL, 1981, JAMA-J AM MED ASSOC, V245, P2038, DOI 10.1001/jama.245.20.2038; VALBERG LS, 1976, CAN MED ASSOC J, V114, P417; VITERI FE, 1972, BRIT J HAEMATOL, V23, P189, DOI 10.1111/j.1365-2141.1972.tb03472.x; WALKER ML, 1995, AM J PRIMATOL, V35, P59, DOI 10.1002/ajp.1350350106	28	71	75	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2001	322	7298					1355	1357		10.1136/bmj.322.7298.1355	http://dx.doi.org/10.1136/bmj.322.7298.1355			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387188	Green Published			2022-12-28	WOS:000169167900024
J	Baron, TH				Baron, TH			Current concepts: Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MALIGNANT BILIARY OBSTRUCTION; COMMON BILE-DUCT; ACUTE COLORECTAL OBSTRUCTION; RANDOMIZED TRIAL; ESOPHAGEAL OBSTRUCTION; PALLIATIVE TREATMENT; COLONIC OBSTRUCTION; COST-EFFECTIVENESS; SURGICAL BYPASS; PRIOR RADIATION		Mayo Clin & Mayo Fdn, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic	Baron, TH (corresponding author), 200 1st St SW,Eisenberg 8A, Rochester, MN 55905 USA.							Adam A, 1997, RADIOLOGY, V202, P344, DOI 10.1148/radiology.202.2.9015054; BALLINGER AB, 1994, GUT, V35, P467, DOI 10.1136/gut.35.4.467; Baron TH, 1998, GASTROINTEST ENDOSC, V47, P277, DOI 10.1016/S0016-5107(98)70327-X; Bethge N, 1996, GASTROINTEST ENDOSC, V44, P283, DOI 10.1016/S0016-5107(96)70165-7; Bethge N, 1998, AM J GASTROENTEROL, V93, P1829; Bethge N, 1997, GASTROINTEST ENDOSC, V45, P300, DOI 10.1016/S0016-5107(97)70275-X; Bethge N, 1996, GASTROINTEST ENDOSC, V43, P596, DOI 10.1016/S0016-5107(96)81592-6; Binkert CA, 1998, RADIOLOGY, V206, P199, DOI 10.1148/radiology.206.1.9423673; Camunez F, 2000, RADIOLOGY, V216, P492, DOI 10.1148/radiology.216.2.r00au12492; Chan ACW, 1999, GASTROINTEST ENDOSC, V49, P462, DOI 10.1016/S0016-5107(99)70043-X; DAVIDS PHP, 1992, LANCET, V340, P1488, DOI 10.1016/0140-6736(92)92752-2; De Gregorio MA, 1998, RADIOLOGY, V209, P117, DOI 10.1148/radiology.209.1.9769821; DePalma GD, 1996, GASTROINTEST ENDOSC, V43, P478; Eschelman DJ, 1996, RADIOLOGY, V200, P717, DOI 10.1148/radiology.200.3.8756921; Feretis C, 1997, GASTROINTEST ENDOSC, V46, P161, DOI 10.1016/S0016-5107(97)70066-X; Freitag L, 1996, CHEST, V110, P1155, DOI 10.1378/chest.110.5.1155; Gupta NK, 1999, EUR RADIOL, V9, P1893, DOI 10.1007/s003300050943; Herdeg C, 1998, Semin Interv Cardiol, V3, P197; Jung GS, 2000, RADIOLOGY, V216, P758, DOI 10.1148/radiology.216.3.r00au05758; Kinsman KJ, 1996, GASTROINTEST ENDOSC, V43, P196; KNYRIM K, 1993, ENDOSCOPY, V25, P207, DOI 10.1055/s-2007-1010294; KNYRIM K, 1993, NEW ENGL J MED, V329, P1302, DOI 10.1056/NEJM199310283291803; Kocher M, 1998, J VASC INTERV RADIOL, V9, P1007, DOI 10.1016/S1051-0443(98)70441-5; Kozarek RA, 1996, GASTROINTEST ENDOSC, V43, P204; Lagattolla NRF, 1998, BRIT J SURG, V85, P261; Lammer J, 1996, RADIOLOGY, V201, P167, DOI 10.1148/radiology.201.1.8816539; Lobato RF, 1999, INT SURG, V84, P159; Low DE, 1998, ANN THORAC SURG, V65, P919, DOI 10.1016/S0003-4975(98)00081-2; Ludwig D, 1998, INT J ONCOL, V13, P583; Mainar A, 1999, RADIOLOGY, V210, P65, DOI 10.1148/radiology.210.1.r99ja0665; Mauro MA, 2000, RADIOLOGY, V215, P659, DOI 10.1148/radiology.215.3.r00jn30659; Morgan RA, 1997, RADIOLOGY, V204, P527, DOI 10.1148/radiology.204.2.9240548; Nicholson DA, 1999, CLIN RADIOL, V54, P212, DOI 10.1016/S0009-9260(99)91153-4; Nitatori T, 1999, Radiat Med, V17, P329; Prat F, 1998, GASTROINTEST ENDOSC, V47, P1, DOI 10.1016/S0016-5107(98)70291-3; Raijman I, 1998, GASTROINTEST ENDOSC, V48, P172, DOI 10.1016/S0016-5107(98)70159-2; Ramirez FC, 1997, GASTROINTEST ENDOSC, V45, P360, DOI 10.1016/S0016-5107(97)70144-5; Repici A, 2000, GASTROINTEST ENDOSC, V52, P735, DOI 10.1067/mge.2000.109803; Roseveare CD, 1998, EUR J GASTROEN HEPAT, V10, P653; Shim CS, 1998, ENDOSCOPY, V30, P345, DOI 10.1055/s-2007-1001280; Siersema PD, 1998, GASTROINTEST ENDOSC, V47, P113, DOI 10.1016/S0016-5107(98)70342-6; SILVIS SE, 1994, GASTROINTEST ENDOSC, V40, P17, DOI 10.1016/S0016-5107(94)70004-4; SMITH AC, 1994, LANCET, V344, P1655, DOI 10.1016/S0140-6736(94)90455-3; SPEER AG, 1987, LANCET, V2, P57, DOI 10.1016/S0140-6736(87)92733-4; SPEER AG, 1988, ANN INTERN MED, V108, P546, DOI 10.7326/0003-4819-108-4-546; SPEER AG, 1988, GASTROINTEST ENDOSC, V34, P412, DOI 10.1016/S0016-5107(88)71407-8; Taal BG, 1997, GASTROINTEST ENDOSC, V46, P424, DOI 10.1016/S0016-5107(97)70035-X; Tamai H, 2000, CIRCULATION, V102, P399; Tham TCK, 1998, GUT, V42, P703, DOI 10.1136/gut.42.5.703; WAGNER HJ, 1993, ENDOSCOPY, V25, P213, DOI 10.1055/s-2007-1010295; Yates MR, 1998, ENDOSCOPY, V30, P266, DOI 10.1055/s-2007-1001253; Yeoh KG, 1999, GASTROINTEST ENDOSC, V49, P466, DOI 10.1016/S0016-5107(99)70044-1; Zamora PO, 2000, J BIOMED MATER RES, V53, P244, DOI 10.1002/(SICI)1097-4636(2000)53:3<244::AID-JBM9>3.0.CO;2-F	53	290	301	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2001	344	22					1681	1687		10.1056/NEJM200105313442206	http://dx.doi.org/10.1056/NEJM200105313442206			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YG	11386268				2022-12-28	WOS:000168963000006
J	Coulter, DM; Bate, A; Meyboom, RHB; Lindquist, M; Edwards, IR				Coulter, DM; Bate, A; Meyboom, RHB; Lindquist, M; Edwards, IR			Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To examine die relation between antipsychotic drugs and myocarditis and cardiomyopathy. Design Data mining using bayesian statistics implemented in a neural network architecture. Setting International database on adverse drug reactions run by the World Health Organization programme for international drug monitoring. Main outcome measures Reports mentioning antipsychotic drugs, cardiomyopathy or myocarditis. Results A strong signal existed for an association between clozapine and cardiomyopathy and myocarditis. An association was also seen with other antipsychotics as a group. The association was based on sufficient cases with adequate documentation and apparent lack of confounding to constitute a signal. Associations between myocarditis or cardiomyopathy and lithium, chlorpromazine, fluphenazine, haloperidol, and risperidone need further investigation. Conclusions Some antipsychotic drugs seem to be linked to cardiomyopathy and myocarditis, The study shows the potential of bayesian neural networks in analysing data on drug safety.	Uppsala Monitoring Ctr, WHO, Collaborating Ctr Int Drug Monitoring, S-75320 Uppsala, Sweden; Univ Otago, Dept Prevent & Social Med, Intens Med Monitoring Programme, Dunedin, New Zealand; Univ Otago, Ctr Adverse React Monitoring, Dunedin, New Zealand	World Health Organization; University of Otago; University of Otago	Edwards, IR (corresponding author), Uppsala Monitoring Ctr, WHO, Collaborating Ctr Int Drug Monitoring, S-75320 Uppsala, Sweden.	ralph.edwards@who-umc.org	Bate, Andrew/J-3799-2019					Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; Edwards IR, 1997, BRIT MED J, V315, P500, DOI 10.1136/bmj.315.7107.500; EDWARDS IR, 1990, LANCET, V336, P156, DOI 10.1016/0140-6736(90)91669-2; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Hand D., 1999, SIGKDD EXPLORATIONS, V1, P16, DOI [10.1145/846170.846171, DOI 10.1145/846170.846171]; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; Jensen V E, 1994, Ugeskr Laeger, V156, P4151; Kilian JG, 1999, LANCET, V354, P1841, DOI 10.1016/S0140-6736(99)10385-4; Olsson S, 1998, DRUG SAFETY, V19, P1, DOI 10.2165/00002018-199819010-00001	9	147	159	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2001	322	7296					1207	1209		10.1136/bmj.322.7296.1207	http://dx.doi.org/10.1136/bmj.322.7296.1207			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11358771	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000168900700023
J	Maio, G				Maio, G			History of medical involvement in torture - then and now	LANCET			English	Article									Univ Luebeck, Inst Hist Med & Sci, D-23552 Luebeck, Germany	University of Lubeck	Maio, G (corresponding author), Univ Luebeck, Inst Hist Med & Sci, D-23552 Luebeck, Germany.							de Montaigne M., 1588, ESSAIS; DuBois P., 1991, TORTURE TRUTH, P63; DUPONTBOUCHAT MS, 1993, HUMAN RIGHTS CULTURA; FIORELLI P, 1953, TORTURA GUIDIZIARIA, P294; Foucault Michael, 1975, DISCIPLINE PUNISH BI; Koch T, 1972, Gegenbaurs Morphol Jahrb, V117, P441; Koelbing H M, 1984, Schweiz Rundsch Med Prax, V73, P1565; Lippman Matthew, 1993, Loyola Los Angel Int Comp Law J, V15, P395; MAIO G, 1999, MALTREATMENT TORTURE, P31; MANNIX D, 1964, HIST TORTURE; NIGHTINGALE EO, 1986, JAMA-J AM MED ASSOC, V255, P2794, DOI 10.1001/jama.255.20.2794; Peters E., 1985, TORTURE; Ruthven M., 1978, TORTURE GRAND CONSPI; Scott, 1959, HIST TORTURE AGES; STOVER E, 1985, BREAKING BODIES MIND; Twining W.L., 1973, NORTH IREL LEG Q, P24; VESTI PB, 1990, DAN MED BULL, V37, P466	17	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1609	1611		10.1016/S0140-6736(00)04729-2	http://dx.doi.org/10.1016/S0140-6736(00)04729-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377667				2022-12-28	WOS:000168830100033
J	Rothwell, PM				Rothwell, PM			The high cost of not funding stroke research: a comparison with heart disease and cancer	LANCET			English	Editorial Material							CASE-FATALITY RATES; INFARCTION; POPULATION; COMMUNITY; NEUROLOGY; PROJECT; HEALTH; BURDEN		Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England	Radcliffe Infirmary	Rothwell, PM (corresponding author), Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Woodstock Rd, Oxford OX2 6HE, England.		Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211				[Anonymous], 1996, GLOBAL BURDEN DIS CO; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; *BRIT HEART FDN, 1998, COR HEART DIS STAT B; *BRIT HEART FDN, 1999, ANN REP MED DEV 1998; GOLDSTEIN M, 1984, STROKE, V15, P172; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; *IMP CANC RES FUND, 1999, SCI REP 1999; *IMP CANC RES FUND, 1999, ANN REP ACC 1999; Janca A, 1997, J NEUROL SCI, V145, P1; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; Menken M, 2000, ARCH NEUROL-CHICAGO, V57, P418, DOI 10.1001/archneur.57.3.418; *MRC, 1998, MED REC COUNC LAUNCH; *MRC, 1999, MRC ANN REP 1998 199; *MRC, 1999, FIELD REV NEUR AC BR; Qizilbash N, 1995, LANCET, V346, P1647; Stegmayr B, 1996, J INTERN MED, V240, P143, DOI 10.1046/j.1365-2796.1996.519857000.x; *STROK ASS, 1998, STROK CAR RED BURD D; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; TOOLE JF, 1984, STROKE, V15, P168, DOI 10.1161/01.STR.15.1.168; Traystman RJ, 1999, STROKE, V30, P1147, DOI 10.1161/01.STR.30.5.1147; Volmink JA, 1998, HEART, V80, P40, DOI 10.1136/hrt.80.1.40; Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	24	107	109	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1612	1616		10.1016/S0140-6736(00)04730-9	http://dx.doi.org/10.1016/S0140-6736(00)04730-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377668				2022-12-28	WOS:000168830100034
J	Sandercock, P				Sandercock, P			Statins for stroke prevention?	LANCET			English	Editorial Material							SERUM-CHOLESTEROL; TRIALS; RISK		Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Sandercock, P (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.		sandercock, peter/GQI-3167-2022	sandercock, peter/0000-0001-8484-0135				Bandyopadhyay S, 2001, QJM-INT J MED, V94, P127, DOI 10.1093/qjmed/94.3.127; Byington RP, 2001, CIRCULATION, V103, P387; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Di Mascio R, 2000, CEREBROVASC DIS, V10, P85, DOI 10.1159/000016035; DOWNS JR, 1995, AM J CARDIOL, V75, P1130; HEBERT PR, 1995, ARCH INTERN MED, V155, P50, DOI 10.1001/archinte.155.1.50; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kelly J, 2000, BMJ-BRIT MED J, V320, P1278, DOI 10.1136/bmj.320.7244.1278; LAW MR, 1994, BRIT MED J, V308, P373, DOI 10.1136/bmj.308.6925.373; Meade T, 1999, EUR HEART J, V20, P725; Oliver MF, 2000, BMJ-BRIT MED J, V320, P459, DOI 10.1136/bmj.320.7233.459; PICKIN DM, 1999, P ROYAL COLL PHYSICI, V29, P31; Qizilbash N, 1995, LANCET, V346, P1647; Rodgers A, 1998, LANCET, V352, P1801; Smith GD, 1999, LANCET, V353, P1097, DOI 10.1016/S0140-6736(05)76452-7; WADE DT, 2000, NATL CLIN GUIDELINES	16	19	20	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1548	1549		10.1016/S0140-6736(00)04779-6	http://dx.doi.org/10.1016/S0140-6736(00)04779-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377639				2022-12-28	WOS:000168830100005
J	Sharples, L; Lomas, D; Caine, N; Wells, F				Sharples, L; Lomas, D; Caine, N; Wells, F		Lung Vol Reduct Surg Trial Project Team	Lung-volume reduction	LANCET			English	Letter							SURGERY; EMPHYSEMA		Papworth Hosp NHS Trust, Res & Dev Unit, Cambridge CB3 8RE, England	Papworth Hospital	Sharples, L (corresponding author), Papworth Hosp NHS Trust, Res & Dev Unit, Papworth Everard, Cambridge CB3 8RE, England.			Sharples, Linda/0000-0003-0894-966X				Cranshaw J, 2001, LANCET, V357, P650, DOI 10.1016/S0140-6736(00)04148-9; Lomas DA, 1997, THORAX, V52, P755, DOI 10.1136/thx.52.9.755; Malthaner RA, 2000, CAN J SURG, V43, P377; Utz JP, 1998, MAYO CLIN PROC, V73, P552, DOI 10.4065/73.6.552	4	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1621	1621		10.1016/S0140-6736(00)04760-7	http://dx.doi.org/10.1016/S0140-6736(00)04760-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11386317				2022-12-28	WOS:000168830100045
J	Wolff, CG; Schroeder, DG; Young, MW				Wolff, CG; Schroeder, DG; Young, MW			Effect of improved housing on illness in children under 5 years old in northern Malawi: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							MALARIA; INFECTIONS; DIARRHEA; RISK; AREA	Objective To evaluate the effects of a Habitat for Humanity housing improvement programme in northern Malawi on the prevalence of childhood illnesses. Design Household based cross sectional study. Setting Rural communities centred near the small northern Malawi town of Ekwendeni. Subjects 318 children under 5 years old. Main outcome measures Prevalence of respiratory, gastrointestinal, and malarial infections according to maternal recall, laboratory, or clinical data. Results Children living in improved homes were less likely to have respiratory gastrointestinal, or malarial illnesses (odds ratio 0.56, 95%, confidence interval 0.35 to 0.91) after confounding factors were controlled for. The reductions in individual diseases were not significant Conclusion Improved housing significantly reduced the burden of disease among children under 5 years old.	Emory Univ, Rollins Sch Publ Hlth, Dept Int Hlth, Atlanta, GA 30322 USA; Ekwendeni Mission Hosp, Dept Primary Hlth Care, Ekwendeni, Malawi	Emory University; Rollins School Public Health	Schroeder, DG (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Int Hlth, 1518 Clifton Rd, Atlanta, GA 30322 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD033468] Funding Source: NIH RePORTER; NICHD NIH HHS [R29-HD33468] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; GENTON B, 1994, T ROY SOC TROP MED H, V88, P537, DOI 10.1016/0035-9203(94)90152-X; Gunawardena DM, 1998, AM J TROP MED HYG, V58, P533, DOI 10.4269/ajtmh.1998.58.533; KO YC, 1992, AM J EPIDEMIOL, V136, P214, DOI 10.1093/oxfordjournals.aje.a116487; MANUNEBO MN, 1994, J TROP MED HYG, V97, P31; MARA DD, 1995, J TROP MED HYG, V98, P41; Pirhonen I, 1996, EUR RESPIR J, V9, P2618, DOI 10.1183/09031936.96.09122618; SCHOFIELD CJ, 1984, T ROY SOC TROP MED H, V78, P285, DOI 10.1016/0035-9203(84)90097-X; Sharma S, 1998, ENVIRON HEALTH PERSP, V106, P291, DOI 10.2307/3434017; UN Centre for Human Settlements, 1996, URB WORLD GLOB REP H; *UN HAB 2 C, 1996, REP UN C HUM SETTL H; WHO, 1988, URB ITS IMPL CHILD H; World Bank, 1993, WORLD DEV REP INV HL; WRIGHT CE, 1991, AM J EPIDEMIOL, V134, P887, DOI 10.1093/oxfordjournals.aje.a116163	14	19	19	2	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2001	322	7296					1209	U21		10.1136/bmj.322.7296.1209	http://dx.doi.org/10.1136/bmj.322.7296.1209			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11358772	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000168900700024
J	Turner, S; Evans, P; Hawkesworth, C				Turner, S; Evans, P; Hawkesworth, C			Ultrafast source-to-surface movement of melt at island arcs from Ra-226-Th-230 systematics	SCIENCE			English	Article							TONGA-KERMADEC ISLAND; U-SERIES DISEQUILIBRIA; LESSER-ANTILLES ARC; URANIUM SERIES; TH-230 DISEQUILIBRIUM; U-238 TH-230-RA-226; MASS-SPECTROMETRY; DYNAMICS BENEATH; ELEMENT TRANSFER; VOLCANIC-ROCKS	Island are lavas have radium-226 excesses that extend to higher values than those observed in mid-ocean ridge or ocean island basalts. The initial ratio of radium-226 to thorium-230 is Largest in the most primitive lavas, which also have the highest barium/thorium ratios, and decreases with increasing magmatic differentiation. Therefore, the radium-226 excesses appear to have been introduced into the base of the mantle melting column by fluids released from the subducting plate. Preservation of this signal requires transport to the surface arguably in only a few hundreds of years and directly constrains the average melt velocity to the order of 1000 meters per year. Thus, melt segregation and channel formation can occur rapidly in the mantle.	Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Labs Govt Geochemist, Teddington PW11 0LY, Middx, England	Open University - UK; University of Bristol	Turner, S (corresponding author), Open Univ, Dept Earth Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.		Turner, Simon/0000-0002-6426-6495	Turner, Simon/0000-0002-6426-6495				BEATTIE P, 1993, NATURE, V363, P63, DOI 10.1038/363063a0; Bourdon B, 1999, SCIENCE, V286, P2491, DOI 10.1126/science.286.5449.2491; Chabaux F, 1999, CHEM GEOL, V153, P171, DOI 10.1016/S0009-2541(98)00160-0; Claude-Ivanaj C, 1998, EARTH PLANET SC LETT, V164, P99, DOI 10.1016/S0012-821X(98)00195-2; COHEN AS, 1993, EARTH PLANET SC LETT, V120, P169, DOI 10.1016/0012-821X(93)90237-4; DAVIDSON JP, 1986, J GEOPHYS RES-SOLID, V91, P5943, DOI 10.1029/JB091iB06p05943; Davies JH, 1999, NATURE, V398, P142, DOI 10.1038/18202; Elliott T, 1997, J GEOPHYS RES-SOL EA, V102, P14991, DOI 10.1029/97JB00788; GILL JB, 1993, GEOCHIM COSMOCHIM AC, V57, P4269, DOI 10.1016/0016-7037(93)90322-N; GILL JB, 1990, GEOCHIM COSMOCHIM AC, V54, P1427, DOI 10.1016/0016-7037(90)90166-I; GOLDSTEIN SJ, 1991, EARTH PLANET SC LETT, V107, P25, DOI 10.1016/0012-821X(91)90041-F; GOLDSTEIN SJ, 1989, EARTH PLANET SC LETT, V96, P134, DOI 10.1016/0012-821X(89)90128-3; Hawkesworth CJ, 1997, SCIENCE, V276, P551, DOI 10.1126/science.276.5312.551; Heath E, 1998, J PETROL, V39, P1721, DOI 10.1093/petrology/39.10.1721; Heath E, 1998, EARTH PLANET SC LETT, V160, P49, DOI 10.1016/S0012-821X(98)00084-3; Hoogewerff JA, 1997, GEOCHIM COSMOCHIM AC, V61, P1057, DOI 10.1016/S0016-7037(97)84621-2; KELEMEN PB, 1993, EARTH PLANET SC LETT, V120, P111, DOI 10.1016/0012-821X(93)90234-Z; Lundstrom CC, 1999, J GEOPHYS RES-SOL EA, V104, P13035, DOI 10.1029/1999JB900081; Lundstrom CC, 2000, CHEM GEOL, V162, P105, DOI 10.1016/S0009-2541(99)00122-9; Lundstrom CC, 1998, EARTH PLANET SC LETT, V157, P167, DOI 10.1016/S0012-821X(98)00039-9; MCDERMOTT F, 1991, EARTH PLANET SC LETT, V104, P1, DOI 10.1016/0012-821X(91)90232-7; MCKENZIE D, 1985, EARTH PLANET SC LETT, V72, P149, DOI 10.1016/0012-821X(85)90001-9; McKenzie D, 2000, CHEM GEOL, V162, P81, DOI 10.1016/S0009-2541(99)00126-6; Pearce J.A., 1993, GEOL SOC SPEC PUBL, V76, P373, DOI 10.1144/GSL.SP.1993.076.01.19; Pickett DA, 1997, EARTH PLANET SC LETT, V148, P259, DOI 10.1016/S0012-821X(97)00037-X; PLANK T, 1988, EARTH PLANET SC LETT, V90, P349, DOI 10.1016/0012-821X(88)90135-5; REAGAN MK, 1994, GEOCHIM COSMOCHIM AC, V58, P4199, DOI 10.1016/0016-7037(94)90273-9; RICHARDSON C, 1994, EARTH PLANET SC LETT, V128, P425, DOI 10.1016/0012-821X(94)90160-0; Ringwood A. E., 1974, J GEOL SOC LONDON, V130, P183, DOI DOI 10.1144/GSJGS.130.3.0183; RUBIN KH, 1988, NATURE, V335, P158, DOI 10.1038/335158a0; SIGMARSSON O, 1990, NATURE, V346, P163, DOI 10.1038/346163a0; Sims KWW, 1999, GEOCHIM COSMOCHIM AC, V63, P4119, DOI 10.1016/S0016-7037(99)00313-0; SPIEGELMAN M, 1993, EARTH PLANET SC LETT, V118, P1, DOI 10.1016/0012-821X(93)90155-3; SPIEGELMAN M, 1987, EARTH PLANET SC LETT, V83, P137, DOI 10.1016/0012-821X(87)90057-4; TATSUMI Y, 1986, J VOLCANOL GEOTH RES, V29, P293, DOI 10.1016/0377-0273(86)90049-1; Turner S, 1997, CHEM GEOL, V139, P145, DOI 10.1016/S0009-2541(97)00031-4; Turner S, 1996, EARTH PLANET SC LETT, V142, P191, DOI 10.1016/0012-821X(96)00078-7; Turner S, 1998, CONTRIB MINERAL PETR, V133, P217, DOI 10.1007/s004100050449; Turner S, 1997, GEOCHIM COSMOCHIM AC, V61, P4855, DOI 10.1016/S0016-7037(97)00281-0; Turner S, 1997, NATURE, V389, P568, DOI 10.1038/39257; Turner S, 2000, EARTH PLANET SC LETT, V179, P581, DOI 10.1016/S0012-821X(00)00141-2; TURNER S, UNPUB; TURNER S, IN PRESS CONTRIB MIN; Turner SP, 1999, GEOLOGY, V27, P963, DOI 10.1130/0091-7613(1999)027<0963:TMDATT>2.3.CO;2; VIGLER N, 1999, EARTH PLANET SC LETT, V174, P81; VOLPE AM, 1993, GEOCHIM COSMOCHIM AC, V57, P1233, DOI 10.1016/0016-7037(93)90060-A; VOLPE AM, 1991, ANAL CHEM, V63, P913, DOI 10.1021/ac00009a015; WILLIAMS CA, 2000, THESIS OPEN U; WILLIAMS RW, 1989, GEOCHIM COSMOCHIM AC, V53, P1607; Wood BJ, 1999, GEOCHIM COSMOCHIM AC, V63, P1613, DOI 10.1016/S0016-7037(98)00302-0; WOODHEAD JD, 1989, CHEM GEOL, V76, P1, DOI 10.1016/0009-2541(89)90124-1; Zellmer G, 2000, EARTH PLANET SC LETT, V174, P265, DOI 10.1016/S0012-821X(99)00266-6; ZELLMER GF, UNPUB	53	137	139	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1363	1366		10.1126/science.1059904	http://dx.doi.org/10.1126/science.1059904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359009				2022-12-28	WOS:000168862900042
J	Anderson, AK; Phelps, EA				Anderson, AK; Phelps, EA			Lesions of the human amygdala impair enhanced perception of emotionally salient events	NATURE			English	Article							MEDIAL TEMPORAL-LOBE; ATTENTIONAL BLINK; MEMORY; RECOGNITION; SUPPRESSION; RESPONSES; FEAR	Commensurate with the importance of rapidly and efficiently evaluating motivationally significant stimuli, humans are probably endowed with distinct faculties(1,2) and maintain specialized neural structures to enhance their detection. Here we consider that a critical function of the human amygdala(3,4) is to enhance the perception of stimuli that have emotional significance. Under conditions of limited attention for normal perceptual awareness-that is, the attentional blink(5,6)-we show that healthy observers demonstrate robust benefits for the perception of verbal stimuli of aversive content compared with stimuli of neutral content. In contrast, a patient with bilateral amygdala damage has no enhanced perception for such aversive stimulus events. Examination of patients with either left or right amygdala resections shows that the enhanced perception of aversive words depends specifically on the left amygdala. All patients comprehend normally the affective meaning of the stimulus events, despite the lack of evidence for enhanced perceptual encoding of these events in patients with left amygdala lesions. Our results reveal a neural substrate for affective influences on perception, indicating that similar neural mechanisms may underlie the affective modulation of both recollective(7-9) and perceptual experience.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA; NYU, Dept Psychol, New York, NY 10003 USA	Yale University; New York University	Anderson, AK (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	adam.k.anderson@stanford.edu						Adolphs R, 2000, J NEUROSCI, V20, P2683; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs R., 2000, AMYGDALA FUNCTIONAL, P587; AMARAL D G, 1992, P1; Amaral DG, 1992, AMYGDALA NEUROBIOLOG, P465; Anderson AK, 2000, PSYCHOL SCI, V11, P106, DOI 10.1111/1467-9280.00224; Anderson AK, 2000, NEUROPSYCHOLOGY, V14, P526, DOI 10.1037/0894-4105.14.4.526; ANDERSON AK, UNPUB J EXP PSYCHOL; BRUNER JS, 1947, J PERS, V16, P69, DOI 10.1111/j.1467-6494.1947.tb01076.x; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Canli T, 2000, J NEUROSCI, V20; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Derryberry D, 1994, HEARTS EYE EMOTIONAL, P166; FUNAYAMA ES, IN PRESS J COGN NEUR; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; KAPP BS, 1990, NEUROCOMPUTATION LEA, P53; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; LeDoux J.E., 1992, EMOTIONAL BRAIN; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Morris JS, 1998, P ROY SOC B-BIOL SCI, V265, P649, DOI 10.1098/rspb.1998.0343; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Phelps EA, 1998, NEUROCASE, V4, P527, DOI 10.1080/13554799808410645; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; SPENCER DD, 1984, NEUROSURGERY, V15, P667, DOI 10.1227/00006123-198411000-00005; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Weinberger Norman M., 1995, P1071; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912	30	930	953	5	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					305	309		10.1038/35077083	http://dx.doi.org/10.1038/35077083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432RT	11357132				2022-12-28	WOS:000168710000047
J	Frankland, PW; O'Brien, C; Ohno, M; Kirkwood, A; Silva, AJ				Frankland, PW; O'Brien, C; Ohno, M; Kirkwood, A; Silva, AJ			alpha-CaMKII-dependent plasticity in the cortex is required for permanent memory	NATURE			English	Article							CALMODULIN KINASE-II; LONG-TERM-MEMORY; RETROGRADE-AMNESIA; HIPPOCAMPAL-FORMATION; MUTANT MICE; VISUAL-CORTEX; CONSOLIDATION; PROTEIN; LESIONS; NEOCORTEX	Cortical plasticity seems to be critical for the establishment of permanent memory traces(1-3). Little is known, however, about the molecular and cellular processes that support consolidation of memories in cortical networks(4,5). Here we show that mice heterozygous for a null mutation of a-calcium-calmodulin kinase II (alpha -CaMKII+/-) show normal learning and memory 1-3 days after training in two hippocampus-dependent tasks. However, their memory is severely impaired at longer retention delays (10-50 days). Consistent with this, we found that alpha -CaMKII+/- mice have impaired cortical, but not hippocampal, long-term potentiation. Our results represent a first step in unveiling the molecular and cellular mechanisms underlying the establishment of permanent memories, and they indicate that alpha -CaMKII may modulate the synaptic events required for the consolidation of memory traces in cortical networks.	Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Mid Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Silva, AJ (corresponding author), Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494				Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CHO YH, 1993, J NEUROSCI, V13, P1759; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; Graham KS, 1999, CURR OPIN NEUROBIOL, V9, P245, DOI 10.1016/S0959-4388(99)80035-X; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Knowlton BJ, 1998, CURR OPIN NEUROBIOL, V8, P293, DOI 10.1016/S0959-4388(98)80154-2; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mumby DG, 1999, BEHAV BRAIN RES, V106, P97, DOI 10.1016/S0166-4328(99)00097-2; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Whishaw IQ, 1997, CURR OPIN NEUROBIOL, V7, P228, DOI 10.1016/S0959-4388(97)80011-6; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	30	319	332	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					309	313		10.1038/35077089	http://dx.doi.org/10.1038/35077089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357133				2022-12-28	WOS:000168710000048
J	Hassey, A; Gerrett, D; Wilson, A				Hassey, A; Gerrett, D; Wilson, A			A survey of validity and utility of electronic patient records in a general practice	BRITISH MEDICAL JOURNAL			English	Article							MORBIDITY; COMPLETENESS; ACCURACY; SCOTLAND; PROJECT	Objective To develop methods of measuring the validity and utility of electronic patient records in general practice. Design A survey of the main functional areas of a practice and use of independent criteria to measure the validity of the practice database. Setting A fully computerised general practice in Skipton, north Yorkshire. Subjects The records of all registered practice patients. Main outcome measures Validity of the main functional areas of the practice clinical system. Measures of the completeness, accuracy, validity, and utility of the morbidity data for 15 clinical diagnoses using recognised diagnostic standards to confirm diagnoses and identify further cases. Development of a method and statistical toolkit to validate clinical databases in general practice. Results The practice electronic patient records were valid, complete, and accurate for prescribed items (99.7%), consultations (98.1%), laboratory tests (100%), hospital episodes (100%), and childhood immunisations (97%). The morbidity data for 15 clinical diagnoses were complete (mean sensitivity = 87%) and accurate (mean positive predictive value = 96%). The presence of the Read codes for the 15 diagnoses was strongly indicative of the true presence of those conditions (mean likelihood ratio = 3917). New interpretations of descriptive statistics are described that can be used to estimate both the number of true cases that are unrecorded and quantify the benefits of validating a clinical database for coded entries. Conclusion This study has developed a method and toolkit for measuring the validity and utility of general practice electronic patient records.	Fisher Med Ctr, Skipton BD23 1EU, England; Univ Derby, Sch Hlth & Community Studies, Derby DE22 3HL, England; Univ Leeds, Res Sch Med, Leeds LS2 9LN, W Yorkshire, England	University of Derby; University of Leeds	Hassey, A (corresponding author), Fisher Med Ctr, Skipton BD23 1EU, England.							ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Department of Health, 2001, BUILD INF COR IMPL N; Department of Health, 2000, NHS PLAN PLAN INV PL; GREENHALGH T., 1997, HOW READ PAPER; Kirk J., 1986, RELIABILITY VALIDITY; Lilford RJ, 1996, BRIT MED J, V313, P603; Mant J, 1997, HLTH TRENDS, V29, P96; McWhinney I, 1997, TXB FAMILY MED; Neal RD, 1996, FAM PRACT, V13, P455, DOI 10.1093/fampra/13.5.455; *NHS, 2000, INF TASK FORC EL PAT; *NHS, 2001, PRIMIS PRIM CAR INF; Pearson N, 1996, BMJ-BRIT MED J, V312, P1517, DOI 10.1136/bmj.312.7045.1517; PRINGLE M, 1995, BRIT J GEN PRACT, V45, P537; *ROYAL COLL GEN PR, 2001, MIQUEST HLTH QUER LA; [Royal College of General Practitioners Office of Population Censuses and Surveys Department of Health], 1995, SER MB5, V3; Sackett D. L., 1997, EVIDENCE BASED MED P; TEASDALE S, 1996, P 1996 AMIA ANN FALL; Whitelaw FG, 1996, BRIT J GEN PRACT, V46, P181; Whitelaw FG, 1996, BRIT J GEN PRACT, V46, P707; WILSON AE, 1995, J EPIDEMIOL COMMUN H, V49, P227, DOI 10.1136/jech.49.3.227; 1997, NEW NHS MODERN DEPEN	23	111	111	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1401	1405		10.1136/bmj.322.7299.1401	http://dx.doi.org/10.1136/bmj.322.7299.1401			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397747	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-28	WOS:000169284600019
J	Deplus, C				Deplus, C			Plate tectonics - Indian ocean actively deforms	SCIENCE			English	Editorial Material							LITHOSPHERE; STRESS; BOUNDARY		Inst Phys Globe Paris, Lab Gravimetrie & Geodynam, F-75252 Paris, France; CNRS, F-75252 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Deplus, C (corresponding author), Inst Phys Globe Paris, Lab Gravimetrie & Geodynam, 4 Pl Jussieu, F-75252 Paris, France.		lgm, ipgp/F-8783-2010; DEPLUS, Christine/A-6798-2011	DEPLUS, Christine/0000-0003-3689-3704				BULL JM, 1992, TECTONICS, V11, P537, DOI 10.1029/91TC02908; BULL JM, 1990, NATURE, V344, P855, DOI 10.1038/344855a0; CHAMOTROOKE N, 1993, GEOLOGY, V21, P1043, DOI 10.1130/0091-7613(1993)021<1043:ISITCI>2.3.CO;2; CLOETINGH S, 1986, TECTONOPHYSICS, V132, P49, DOI 10.1016/0040-1951(86)90024-7; Coblentz DD, 1998, J GEOPHYS RES-SOL EA, V103, P919, DOI 10.1029/97JB02381; Deplus C, 1998, GEOLOGY, V26, P131, DOI 10.1130/0091-7613(1998)026<0131:DEOADI>2.3.CO;2; Gerbault M, 2000, EARTH PLANET SC LETT, V178, P165, DOI 10.1016/S0012-821X(00)00054-6; Gordon RG, 1998, ANNU REV EARTH PL SC, V26, P615, DOI 10.1146/annurev.earth.26.1.615; MINSTER JB, 1978, J GEOPHYS RES, V83, P5331, DOI 10.1029/JB083iB11p05331; Robinson DP, 2001, SCIENCE, V292, P1145, DOI 10.1126/science.1059395; Royer JY, 1997, SCIENCE, V277, P1268, DOI 10.1126/science.277.5330.1268; Tinnon MJ, 1995, J GEOPHYS RES-SOL EA, V100, P24315, DOI 10.1029/95JB02910	12	30	30	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1850	1851		10.1126/science.1061082	http://dx.doi.org/10.1126/science.1061082			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397936				2022-12-28	WOS:000169200700036
J	McDonald, JJ; Teder-Salejarvi, WA; Ward, LM				McDonald, JJ; Teder-Salejarvi, WA; Ward, LM			Multisensory integration and crossmodal attention effects in the human brain	SCIENCE			English	Editorial Material							SPATIAL ATTENTION; AUDITORY-CORTEX; SPEECH		Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada	Simon Fraser University; University of California System; University of California San Diego; University of British Columbia	McDonald, JJ (corresponding author), Simon Fraser Univ, Dept Psychol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	jmcd@sfu.ca; wat@sdepl.ucsd.edu; lward@cortex.psych.ubc.ca		Ward, Lawrence/0000-0003-4431-5015				Bertelson P, 2000, PERCEPT PSYCHOPHYS, V62, P321, DOI 10.3758/BF03205552; Bertelson P., 1999, COGNITIVE CONTRIBUTI, P347, DOI DOI 10.1016/S0166-4115(99)80034-X; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; de Gelder B, 2000, SCIENCE, V289, P1148; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; JACK CE, 1973, PERCEPT MOTOR SKILL, V37, P967, DOI 10.2466/pms.1973.37.3.967; KENNETT S, IN PRESS J COGNIT NE; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; McDonald JJ, 2000, PSYCHOL SCI, V11, P167, DOI 10.1111/1467-9280.00233; MCDONALD JJ, 1999, THESIS U BRIT COLUMB; MEREDITH MA, 1987, J NEUROSCI, V7, P3125; RICHARD C, 1999, THESIS U BRIT COLUMB; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; Stein BE., 1993, MERGING SENSES; TASSINARI G, 1994, VISION RES, V34, P179, DOI 10.1016/0042-6989(94)90330-1; VROOMEN J, IN PRESS PERCEPT PSY; Ward LM, 2000, PERCEPT PSYCHOPHYS, V62, P1258, DOI 10.3758/BF03212127; WELCH RB, 1986, HDB PERCEPTION HUMAN, V1, pCH25	20	71	73	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523												2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397913				2022-12-28	WOS:000169200700051
J	Agodoa, LY; Appel, L; Bakris, GL; Beck, G; Bourgoignie, J; Briggs, JP; Charleston, J; Cheek, D; Cleveland, W; Douglas, JG; Douglas, M; Dowie, D; Faulkner, M; Gabriel, A; Gassman, J; Greene, T; Hall, Y; Hebert, L; Hiremath, L; Jamerson, K; Johnson, CJ; Kopple, J; Kusek, J; Lash, J; Lea, J; Lewis, JB; Lipkowitz, M; Massry, S; Middleton, J; Miller, ER; Norris, K; O'Connor, D; Ojo, A; Phillips, RA; Pogue, V; Rahman, M; Randall, OS; Rostand, S; Schulman, G; Smith, W; Thornley-Brown, D; Tisher, CC; Toto, RD; Wright, JT; Xu, SC				Agodoa, LY; Appel, L; Bakris, GL; Beck, G; Bourgoignie, J; Briggs, JP; Charleston, J; Cheek, D; Cleveland, W; Douglas, JG; Douglas, M; Dowie, D; Faulkner, M; Gabriel, A; Gassman, J; Greene, T; Hall, Y; Hebert, L; Hiremath, L; Jamerson, K; Johnson, CJ; Kopple, J; Kusek, J; Lash, J; Lea, J; Lewis, JB; Lipkowitz, M; Massry, S; Middleton, J; Miller, ER; Norris, K; O'Connor, D; Ojo, A; Phillips, RA; Pogue, V; Rahman, M; Randall, OS; Rostand, S; Schulman, G; Smith, W; Thornley-Brown, D; Tisher, CC; Toto, RD; Wright, JT; Xu, SC		African Amer Study Kidney Dis Hype	Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVERTING-ENZYME-INHIBITION; CALCIUM-CHANNEL BLOCKERS; BLOOD-PRESSURE CONTROL; AFRICAN-AMERICAN; KIDNEY-DISEASE; ANTIHYPERTENSIVE DRUGS; PROGRESSION; ANTAGONISTS; PROTEINURIA; NIFEDIPINE	Context incidence of end-stage renal disease due to hypertension has increased in recent decades, but the optimal strategy for treatment of hypertension to prevent renal failure is unknown, especially among African Americans. Objective To compare the effects of an angiotensin-converting enzyme (ACE) inhibitor (ramipril), a dihydropyridine calcium channel blocker (amlodipine), and a beta -blocker (metoprolol) on hypertensive renal disease progression. Design, Setting, and Participants Interim analysis of a randomized, double-blind, 3 x 2 factorial trial conducted in 1094 African Americans aged 18 to 70 years with hypertensive renal disease (glomerular filtration rate [GFR] of 20-65 mL/min per 1.73 m(2)) enrolled between February. 1995 and September 1998. This report compares the ramipril and amlodipine groups following discontinuation of the amlodipine intervention in September 2000. Interventions Participants were randomly assigned to receive amlodipine, 15 to 10 mg/d (n=217), ramipril, 2.5 to 10 mg/d (n=436), or metoprolol, 50 to 200 mg/d (n=441), with other agents added to achieve 1 of 2 blood pressure goals. Main Outcome Measures The primary outcome measure was the rate of change in GFR; the main secondary outcome was a composite index of the clinical end points of reduction in GFR of more than 50% or 25 mL/min per 1.73 m(2), end-stage renal disease, or death. Results Among participants with a urinary protein to creatinine ratio of >0.22 (corresponding approximately to proteinuria of more than 300 mg/d), the ramipril group had a 36% (2.02 [SE, 0.74] mL/min per 1.73 m(2)/y) slower mean decline in GFR over 3 years (P=.006) and a 48% reduced risk of the clinical end points vs the amlodipine group (95% confidence interval [CI], 20%-66%). In the entire cohort, there was no significant difference in mean GFR decline from baseline to 3 years between treatment groups (P=.38). However,compared with the amlodipine group, after adjustment for baseline covariates the ramipril group had a 38% reduced risk of clinical end points (95% CI, 13% -56%), a 36% slower mean decline in GFR after 3 months (P=.002), and less proteinuria (P<.001). Conclusion Ramipril, compared with amlodipine, retards renal disease progression in patients with hypertensive renal disease and proteinuria and may offer benefit to patients without proteinuria.	Louis Stokes, Cleveland VA Med Ctr, Cleveland, OH 44106 USA; NIDDKD, Bethesda, MD 20892 USA; Johns Hopkins Univ, Dept Prevent Med, Baltimore, MD USA; Rush Presbyterian St Lukes Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA; Cleveland Clin Fdn, Dept Biostat, Cleveland, OH 44195 USA; Univ Miami, Dept Med, Coral Gables, FL 33124 USA; Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA; Case Western Reserve Univ Hosp, Dept Med, Cleveland, OH 44106 USA; Emory Univ, Med Ctr, Dept Med, Atlanta, GA 30322 USA; Harlem Hosp Med Ctr, Dept Med, New York, NY USA; Meharry Med Coll, Dept Med, Nashville, TN 37208 USA; Mt Sinai Sch Med, Dept Med, New York, NY USA; Ohio State Univ, Dept Med, Columbus, OH 43210 USA; Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; Univ Calif Los Angeles, Harbor Med Ctr, Dept Med, Los Angeles, CA 90024 USA; Univ Illinois, Dept Med, Chicago, IL USA; Vanderbilt Univ, Dept Med, Nashville, TN USA; Univ So Calif, Dept Med, Los Angeles, CA USA; Univ Texas, SW Med Ctr, Dept Med, Dallas, TX USA; Martin L King Charles R Drew Med Ctr, Dept Med, Los Angeles, CA USA; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; Howard Univ, Dept Med, Washington, DC 20059 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Florida, Dept Med, Gainesville, FL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; Rush University; Cleveland Clinic Foundation; University of Miami; Medical University of South Carolina; Morehouse School of Medicine; Case Western Reserve University; Case Western Reserve University Hospital; Emory University; Meharry Medical College; Icahn School of Medicine at Mount Sinai; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University; University of Southern California; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Charles R. Drew University of Medicine & Science; University of California System; University of California San Diego; Howard University; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida	Wright, JT (corresponding author), Case Western Reserve Univ, Univ Hosp Cleveland, Clin Hypertens Program, 10900 Euclid Ave,Wood Bldg Room W-165, Cleveland, OH 44106 USA.	jxw20@po.cwru.edu	Appel, Larry/GLT-2608-2022; Middleton, John/U-4471-2019; Toto, Robert/AAQ-3336-2021; Briggs, Josephine P/B-9394-2009; Vanhoutte, Paul M/B-4533-2009	Briggs, Josephine P/0000-0003-0798-1190; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR011104, M01RR000071, M01RR000080, P20RR011145, M01RR000827] Funding Source: NIH RePORTER; NCRR NIH HHS [5M01 RR-00071, M01 RR000052, M01 RR00827, 2P20 RR11104, P20-RR11145, M01 RR-00080] Funding Source: Medline; NIDDK NIH HHS [U01 DK045381, U01 DK045386] Funding Source: Medline; PHS HHS [M01 00032] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSON S, 1991, HYPERTENSION, V17, P288, DOI 10.1161/01.HYP.17.3.288; Bakris GL, 2000, ARCH INTERN MED, V160, P685, DOI 10.1001/archinte.160.5.685; Bakris GL, 1997, HYPERTENSION, V29, P744, DOI 10.1161/01.HYP.29.3.744; Bakris GL, 1996, KIDNEY INT, V50, P1641, DOI 10.1038/ki.1996.480; Coresh J, 1998, AM J KIDNEY DIS, V32, P32, DOI 10.1053/ajkd.1998.v32.pm9669421; DECESARIS R, 1993, J CARDIOVASC PHARM, V22, P208; DEMARIE BK, 1990, ANN INTERN MED, V113, P987, DOI 10.7326/0003-4819-113-12-987; DWORKIN LD, 1991, KIDNEY INT, V39, P1112, DOI 10.1038/ki.1991.141; DWORKIN LD, 1993, KIDNEY INT, V43, P808, DOI 10.1038/ki.1993.114; Griffin KA, 1999, KIDNEY INT, V55, P1849, DOI 10.1046/j.1523-1755.1999.00434.x; Guasch A, 1997, J AM SOC NEPHROL, V8, P793; Hall WD, 1997, AM J KIDNEY DIS, V29, P720, DOI 10.1016/S0272-6386(97)90125-6; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; JAFAR T, IN PRESS ANN INTERN; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Kloke HJ, 1998, KIDNEY INT, V53, P1559, DOI 10.1046/j.1523-1755.1998.00912.x; Koshy S, 2000, CARDIOVASC DRUG THER, V14, P295, DOI 10.1023/A:1007882624572; Kvam FI, 1998, AM J PHYSIOL-RENAL, V275, pF576, DOI 10.1152/ajprenal.1998.275.4.F576; Levey AS, 1996, J AM SOC NEPHROL, V7, P2097; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Little R. J. A., 1987, STAT ANAL MISSING DA; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; MIMRAN A, 1988, DIABETES CARE, V11, P850, DOI 10.2337/diacare.11.10.850; Neal B, 2000, LANCET, V356, P1955; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Perna A, 1996, AM J KIDNEY DIS, V27, P34, DOI 10.1016/S0272-6386(96)90028-1; Rahman M, 1997, ENDOCRIN METAB CLIN, V26, P125, DOI 10.1016/S0889-8529(05)70237-1; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1998, J AM SOC NEPHROL, V9, P2096; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Schluchter MD, 2001, STAT MED, V20, P989, DOI 10.1002/sim.720; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Tarif N, 1997, NEPHROL DIAL TRANSPL, V12, P2244, DOI 10.1093/ndt/12.11.2244; TERWEE PM, 1994, ARCH INTERN MED, V154, P1185, DOI 10.1001/archinte.154.11.1185; US Renal Data System, 1999, USRDS 1999 ANN DAT R; Wang JG, 1996, J HUM HYPERTENS, V10, P735; Weir MR, 1998, AM J KIDNEY DIS, V32, P1, DOI 10.1053/ajkd.1998.v32.pm9669419; Wright JT, 1996, CONTROL CLIN TRIALS, V17, pS3, DOI 10.1016/S0197-2456(96)00081-5	40	683	706	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2719	2728		10.1001/jama.285.21.2719	http://dx.doi.org/10.1001/jama.285.21.2719			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386927	Bronze			2022-12-28	WOS:000168985800024
J	Shlipak, MG; Elmouchi, DA; Herrington, DM; Lin, F; Grady, D; Hlatky, MA				Shlipak, MG; Elmouchi, DA; Herrington, DM; Lin, F; Grady, D; Hlatky, MA		Heart Estrogen progestin Replaceme	The incidence of unrecognized myocardial infarction in women with coronary heart disease	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL CHARACTERISTICS; CARDIOVASCULAR HEALTH; RISK-FACTORS; PROGNOSIS; CLASSIFICATION; PREVALENCE; FRAMINGHAM; PROGRAM; OLDER; ABNORMALITIES	Background: several cohort studies in populations without coronary heart disease have demonstrated that up to 40% of incident myocardial infarctions are clinically unrecognized. Objective: To determine the incidence of unrecognized myocardial infarction in women with coronary heart disease in the Heart and Estrogen/progestin Replacement Study (HERS). Design: Randomized, double-blind, placebo-controlled trial of conjugated estrogens plus medroxyprogesterone or identical placebo with 4.1 years of follow-up. Settings: outpatient and community settings at 20 U.S. clinical centers. Patients: 2763 postmenopausal women younger than 80 years of age with coronary heart disease and an intact uterus. Measurements: Annual electrocardiograms were obtained for all participants during follow-up (mean, 4.1 years) and were evaluated by using the NOVACODE computer algorithm and visual confirmation. A total of 13 715 electrocardiograms were obtained. Suspected unrecognized myocardial infarctions were investigated by comparing a participant's previous surveillance electrocardiograms with the electrocardiograms obtained from all of her intervening hospitalizations. Characteristics of patients with recognized and unrecognized myocardial infarction were compared. Results: Among the 256 nonfatal myocardial infarctions, 11 were unrecognized (4.3% [95% CI, 2.2% to 7.6%]), Seven occurred in women assigned to placebo and 4 occurred in women assigned to hormone therapy (P > 0.2). Women with unrecognized myocardial infarction were less likely to have diabetes mellitus or previous angina and were more likely to have had previous bypass surgery compared with women who had clinically recognized myocardial infarction. Conclusion: The incidence of unrecognized myocardial infarction in women with coronary disease was far lower than that observed in previous studies of populations without coronary heart disease.	Vet Affairs Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA USA; Stanford Univ, Sch Med, Stanford, CA USA; Wake Forest Univ, Sch Med, Winston Salem, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; Stanford University; Wake Forest University	Shlipak, MG (corresponding author), Vet Affairs Med Ctr, Gen Internal Med Sect, 111A-1,4150 Clement St, San Francisco, CA 94121 USA.	shlip@itsa.ucsf.edu		Hlatky, Mark/0000-0003-4686-9441				Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; FURBERG CD, 1992, AM J CARDIOL, V69, P1329, DOI 10.1016/0002-9149(92)91231-R; Grady D, 1998, CONTROL CLIN TRIALS, V19, P314, DOI 10.1016/S0197-2456(98)00010-5; GRIMM RH, 1987, CIRCULATION, V75, P6; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; KANNEL WB, 1984, NEW ENGL J MED, V311, P1144, DOI 10.1056/NEJM198411013111802; KANNEL WB, 1970, GERIATRICS, V25, P75; Kors JA, 2000, AM J EPIDEMIOL, V151, P790, DOI 10.1093/oxfordjournals.aje.a010279; MARGOLIS JR, 1973, AM J CARDIOL, V32, P1, DOI 10.1016/S0002-9149(73)80079-7; MEDALIE JH, 1976, ANN INTERN MED, V84, P526, DOI 10.7326/0003-4819-84-5-526; NADELMANN J, 1990, AM J CARDIOL, V66, P533, DOI 10.1016/0002-9149(90)90477-I; Psaty BM, 1999, ARCH INTERN MED, V159, P1339, DOI 10.1001/archinte.159.12.1339; RAUTAHARJU PM, 1992, J ELECTROCARDIOL, V24, P179; Rautaharju PM, 1998, J ELECTROCARDIOL, V31, P157, DOI 10.1016/S0022-0736(98)90132-7; RAUTAHARJU PM, 1990, METHOD INFORM MED, V29, P362; ROSENMAN RH, 1967, AM J CARDIOL, V19, P776, DOI 10.1016/0002-9149(67)90498-5; Sheifer SE, 2000, J AM COLL CARDIOL, V35, P119, DOI 10.1016/S0735-1097(99)00524-0; SIGURDSSON E, 1995, ANN INTERN MED, V122, P96, DOI 10.7326/0003-4819-122-2-199501150-00003; YANO K, 1984, AM J EPIDEMIOL, V119, P653, DOI 10.1093/oxfordjournals.aje.a113787; YANO K, 1989, ARCH INTERN MED, V149, P1528, DOI 10.1001/archinte.149.7.1528	20	35	36	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2001	134	11					1043	1047		10.7326/0003-4819-134-11-200106050-00010	http://dx.doi.org/10.7326/0003-4819-134-11-200106050-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YL	11388817				2022-12-28	WOS:000168963400004
J	Kerstetter, RA; Bollman, K; Taylor, RA; Bomblies, K; Poethig, RS				Kerstetter, RA; Bollman, K; Taylor, RA; Bomblies, K; Poethig, RS			KANADI regulates organ polarity in Arabidopsis	NATURE			English	Article							RESPONSE REGULATORS; NUCLEAR-LOCALIZATION; ASP PHOSPHORELAY; THALIANA; PROTEIN; GENE; LEAF; MERISTEM; EXPRESSION; ENCODES	Leaves and floral organs are polarized along their adaxial-abaxial (dorsal-ventral) axis. In Arabidopsis, this difference is particularly obvious in the first two rosette leaves, which possess trichomes (leaf hairs) on their adaxial surface but not their abaxial surface(1-3). Mutant alleles of KANADI (KAN) were identified in a screen for mutants that produce abaxial trichomes on these first two leaves. kan mutations were originally identified as enhancers of the mutant floral phenotype of crabs claw (crc), a gene that specifies abaxial identity in carpels(4,5). Here we show that KAN is required for abaxial identity in both leaves and carpels, and encodes a nuclear-localized protein in the GARP family of putative transcription factors. The expression pattern of KAN messenger RNA and the effect of ectopically expressing KAN under the regulation of the cauliflower mosaic virus (CAMV) 35S promoter indicate that KAN may also specify peripheral identity in the developing embryo.	Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Poethig, RS (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.		Poethig, R. Scott/J-7009-2015	Poethig, R. Scott/0000-0001-6592-5862; Bomblies, Kirsten/0000-0002-2434-3863				BARTON MK, 1993, DEVELOPMENT, V119, P823; Behringer FJ, 1992, PLANT MOL BIOL REP, V10, P190, DOI 10.1007/BF02668346; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Chien JC, 1996, PLANT PHYSIOL, V111, P1321, DOI 10.1104/pp.111.4.1321; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Hall LN, 1998, PLANT CELL, V10, P925, DOI 10.1105/tpc.10.6.925; Imamura A, 1999, PLANT CELL PHYSIOL, V40, P733, DOI 10.1093/oxfordjournals.pcp.a029600; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Lohrmann J, 1999, PLANT BIOLOGY, V1, P495, DOI 10.1111/j.1438-8677.1999.tb00775.x; Lynn K, 1999, DEVELOPMENT, V126, P469; Makino S, 2000, PLANT CELL PHYSIOL, V41, P791, DOI 10.1093/pcp/41.6.791; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Patharkar OR, 2000, PLANT J, V24, P679, DOI 10.1046/j.1365-313x.2000.00912.x; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Roberts C, 1997, PCAMBIA VECTOR RELEA; Sakai H, 1998, PLANT CELL PHYSIOL, V39, P1232, DOI 10.1093/oxfordjournals.pcp.a029325; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Telfer A, 1997, DEVELOPMENT, V124, P645; Telfer A, 1994, ARABIDOPSIS, P379, DOI DOI 10.1083/JCB.201205114; VARAGONA MJ, 1992, PLANT CELL, V4, P1213, DOI 10.1105/tpc.4.10.1213; Wykoff DD, 1999, P NATL ACAD SCI USA, V96, P15336, DOI 10.1073/pnas.96.26.15336	25	444	470	4	71	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					706	709		10.1038/35079629	http://dx.doi.org/10.1038/35079629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395775				2022-12-28	WOS:000169112500049
J	Whittington, AT; Vugrek, O; Wei, KJ; Hasenbein, NG; Sugimoto, K; Rashbrooke, MC; Wasteneys, GO				Whittington, AT; Vugrek, O; Wei, KJ; Hasenbein, NG; Sugimoto, K; Rashbrooke, MC; Wasteneys, GO			MOR1 is essential for organizing cortical microtubules in plants	NATURE			English	Article							MITOTIC SPINDLE; HEAT REPEATS; LIVING CELLS; PROTEIN; XMAP215; ORGANIZATION; CYTOSKELETON; MUTATIONS; COMPONENT; DYNAMICS	Microtubules orchestrate cell division and morphogenesis, but how they disassemble and reappear at different subcellular locations is unknown. Microtubule organizing centres are thought to have an important role, but in higher plants microtubules assemble in ordered configurations even though microtubule organizing centres are inconspicuous or absent. Plant cells generate highly organized microtubule arrays that coordinate mitosis, cytokinesis and expansion. Inhibiting microtubule assembly prevents chromosome separation(1), blocks cell division(2) and impairs growth polarity(3). Microtubules are essential for the formation of cell walls, through an array of plasma-membrane-associated cortical microtubules whose control mechanisms are unknown. Using a genetic strategy to identify microtubule organizing factors in Arabidopsis thaliana, we isolated temperature-sensitive mutant alleles of the MICROTUBULE ORGANIZATION 1 (MOR1) gene. Here we show that MOR1 is the plant version of an ancient family of microtubule-associated proteins(4). Point mutations that substitute single amino-acid residues in an amino-terminal HEAT repeat impart reversible temperature-dependent cortical microtubule disruption, showing that MOR1 is essential for cortical microtubule organization.	Australian Natl Univ, Res Sch Biol Sci, Plant Cell Biol Grp, Canberra, ACT 2601, Australia	Australian National University	Wasteneys, GO (corresponding author), Australian Natl Univ, Res Sch Biol Sci, Plant Cell Biol Grp, GPO Box 475, Canberra, ACT 2601, Australia.	geoffw@rsbs.anu.edu.au	Wasteneys, Geoffrey/AGQ-5388-2022; Sugimoto, Keiko/B-3368-2010	Wasteneys, Geoffrey/0000-0002-8746-7994; Sugimoto, Keiko/0000-0002-9209-8230				Andersen SSL, 1998, CELL MOTIL CYTOSKEL, V41, P202, DOI 10.1002/(SICI)1097-0169(1998)41:3<202::AID-CM2>3.0.CO;2-X; Andrade MA, 2000, J MOL BIOL, V298, P521, DOI 10.1006/jmbi.2000.3684; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; BASKIN TI, 1994, PLANT CELL PHYSIOL, V35, P935; BASKIN TI, 1990, ANNU REV PLANT PHYS, V41, P277, DOI 10.1146/annurev.pp.41.060190.001425; Charrasse S, 1998, J CELL SCI, V111, P1371; Charrasse S, 2000, EXP CELL RES, V254, P249, DOI 10.1006/excr.1999.4740; Cullen CF, 1999, J CELL BIOL, V146, P1005, DOI 10.1083/jcb.146.5.1005; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Graf R, 2000, J CELL SCI, V113, P1747; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200; Lloyd C, 2001, NAT REV MOL CELL BIO, V2, P40, DOI 10.1038/35048005; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Mayer U, 1999, EUR J CELL BIOL, V78, P100, DOI 10.1016/S0171-9335(99)80011-9; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Smertenko A, 2000, NAT CELL BIOL, V2, P750, DOI 10.1038/35036390; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Ueda K, 2000, PROTOPLASMA, V213, P28, DOI 10.1007/BF01280502; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; Vasquez RJ, 1999, CELL MOTIL CYTOSKEL, V43, P310, DOI 10.1002/(SICI)1097-0169(1999)43:4<310::AID-CM4>3.3.CO;2-A; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Wasteneys GO, 2000, CURR OPIN PLANT BIOL, V3, P503, DOI 10.1016/S1369-5266(00)00120-5; Wasteneys GO, 1997, J MICROSC-OXFORD, V188, P51, DOI 10.1046/j.1365-2818.1977.2390796.x; Wick S, 2000, NAT CELL BIOL, V2, pE204, DOI 10.1038/35041129	29	342	368	6	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					610	613		10.1038/35079128	http://dx.doi.org/10.1038/35079128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385579				2022-12-28	WOS:000168982500058
J	Iwata, N; Tsubuki, S; Takaki, Y; Shirotani, K; Lu, B; Gerard, NP; Gerard, C; Hama, E; Lee, HJ; Saido, TC				Iwata, N; Tsubuki, S; Takaki, Y; Shirotani, K; Lu, B; Gerard, NP; Gerard, C; Hama, E; Lee, HJ; Saido, TC			Metabolic regulation of brain A beta by neprilysin	SCIENCE			English	Article							ALZHEIMERS-DISEASE; IDENTIFICATION; PROTEIN; GENE; DEGRADATION; CATABOLISM; PRESENILIN; REGION; MICE	Amyloid beta peptide (A beta) the pathogenic agent of Alzheimer's disease (AD), is a physiological metabolite in the brain. We examined the role of neprilysin, a candidate A beta -degrading peptidase, in the metabolism using neprilysin gene-disrupted mice. Neprilysin deficiency resulted in defects both in the degradation of exogenously administered A beta and in the metabolic suppression of the endogenous A beta Levels in a gene dose-dependent manner. The regional Levels of A beta in the neprilysin-deficient mouse brain were in the distinct order of hippocampus, cortex, thalamus/striatum, and cerebellum, where hippocampus has the highest Level and cerebellum the lowest, correlating with the vulnerability to A beta deposition in brains of humans with AD. Our observations suggest that even partial down-regulation of neprilysin activity, which could be caused by aging, can contribute to AD development by promoting A beta accumulation.	RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	RIKEN; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Saido, TC (corresponding author), RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan.	saido@brain.riken.go.jp	Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903				Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; HAOUAS H, 1995, BIOCHEM BIOPH RES CO, V207, P933, DOI 10.1006/bbrc.1995.1275; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Ikeda K, 1999, J BIOL CHEM, V274, P32469, DOI 10.1074/jbc.274.45.32469; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kiryu-Seo S, 2000, P NATL ACAD SCI USA, V97, P4345, DOI 10.1073/pnas.070509897; LI CW, 1995, J BIOL CHEM, V270, P5723, DOI 10.1074/jbc.270.11.5723; Li CW, 1998, ARCH BIOCHEM BIOPHYS, V358, P189, DOI 10.1006/abbi.1998.0855; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; Nakano Y, 1999, EUR J NEUROSCI, V11, P2577, DOI 10.1046/j.1460-9568.1999.00698.x; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Poduslo SE, 1999, HUM GENET, V105, P32, DOI 10.1007/s004390051060; Saido T.C., 2000, NEUROSCI NEWS, V5, P52; Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5; Saria A, 1997, NEUROSCI LETT, V234, P27, DOI 10.1016/S0304-3940(97)00660-5; Sawamura N, 2000, J BIOL CHEM, V275, P27901; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; Shen RQ, 2000, MOL CELL ENDOCRINOL, V170, P131, DOI 10.1016/S0303-7207(00)00326-9; SHIROTANI K, IN PRESS J BIOL CHEM; Takaki Y, 2000, J BIOCHEM-TOKYO, V128, P897, DOI 10.1093/oxfordjournals.jbchem.a022839; Tanzi RE, 1996, NEUROBIOL DIS, V3, P159, DOI 10.1006/nbdi.1996.0016; Tucker HM, 2000, J NEUROSCI, V20, P3937; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X	29	784	833	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1550	1552		10.1126/science.1059946	http://dx.doi.org/10.1126/science.1059946			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375493				2022-12-28	WOS:000168963800046
J	Kawane, K; Fukuyama, H; Kondoh, G; Takeda, J; Ohsawa, Y; Uchiyama, Y; Nagata, S				Kawane, K; Fukuyama, H; Kondoh, G; Takeda, J; Ohsawa, Y; Uchiyama, Y; Nagata, S			Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver	SCIENCE			English	Article							TRANSCRIPTION FACTOR PU.1; DEOXYRIBONUCLEASE-II; MOLECULAR-CLONING; APOPTOTIC CELLS; TGF-BETA; GENE; MACROPHAGES; DIFFERENTIATION; FRAGMENTATION; ABSENCE	Mature erythrocytes in mammals have no nuclei, although they differentiate from nucleated precursor cells. The mechanism by which enucleation occurs is not well understood. Here we show that deoxyribonuclease II (DNase II) is indispensable for definitive erythropoiesis in mouse fetal liver. No live DNase Ii-null mice were born, owing to severe anemia. When mutant fetal liver cells were transferred into Lethally irradiated wild-type mice, mature red blood cells were generated from the mutant cells, suggesting that DNase II functions in a non-cell-autonomous manner. Histochemical analyses indicated that the critical cellular sources of DNase II are macrophages present at the site of definitive erythropoiesis in the fetal Liver. Thus, DNase II in macrophages appears to be responsible for destroying the nuclear DNA expelled from erythroid precursor cells.	Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Cell Biol & Anat, Suita, Osaka 5650871, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka University; Osaka University	Nagata, S (corresponding author), Osaka Univ, Sch Med, Dept Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Nagata, Shigekazu/AAG-3203-2019; Fukuyama, Hidehiro/AAY-6256-2021; Fukuyama, Hidehiro/N-5276-2018	Nagata, Shigekazu/0000-0001-9758-8426; Fukuyama, Hidehiro/0000-0002-6457-0630; Fukuyama, Hidehiro/0000-0002-6457-0630; Kawane, Kohki/0000-0003-1125-9483				ALTER BP, 1982, HEMOGLOBIN, V6, P517, DOI 10.3109/03630268209083764; Appierto V, 1997, GENE, V188, P119, DOI 10.1016/S0378-1119(96)00794-9; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Baker KP, 1998, GENE, V215, P281, DOI 10.1016/S0378-1119(98)00280-7; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; CROCKER PR, 1985, J EXP MED, V162, P993, DOI 10.1084/jem.162.3.993; DYBEDAL I, 1995, BLOOD, V86, P949; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Kondoh G, 1999, J BIOCHEM BIOPH METH, V39, P137, DOI 10.1016/S0165-022X(99)00008-1; Krieser RJ, 2000, GENE, V252, P155, DOI 10.1016/S0378-1119(00)00209-2; McCall K, 1998, SCIENCE, V279, P230, DOI 10.1126/science.279.5348.230; McIlroy D, 2000, GENE DEV, V14, P549; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; RUSSELL ES, 1974, ANN NY ACAD SCI, V241, P25, DOI 10.1111/j.1749-6632.1974.tb21864.x; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shiokawa D, 1999, NUCLEIC ACIDS RES, V27, P4083, DOI 10.1093/nar/27.20.4083; TORRIGLIA A, 1995, J BIOL CHEM, V270, P28579, DOI 10.1074/jbc.270.48.28579; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wu YC, 2000, GENE DEV, V14, P536; Yasuda T, 1998, J BIOL CHEM, V273, P2610, DOI 10.1074/jbc.273.5.2610; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	25	283	296	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1546	1549		10.1126/science.292.5521.1546	http://dx.doi.org/10.1126/science.292.5521.1546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375492				2022-12-28	WOS:000168963800045
J	Yamada, K; Ji, JJ; Yuan, HJ; Miki, T; Sato, S; Horimoto, N; Shimizu, T; Seino, S; Inagaki, N				Yamada, K; Ji, JJ; Yuan, HJ; Miki, T; Sato, S; Horimoto, N; Shimizu, T; Seino, S; Inagaki, N			Protective role ob ATP-sensitive potassium channels in hypoxia-induced generalized seizure	SCIENCE			English	Article							NIGRA PARS-RETICULATA; RAT SUBSTANTIA-NIGRA; SULFONYLUREA RECEPTOR; BINDING-SITES; K+ CHANNELS; NEURONS; LOCALIZATION; CONDUCTANCE; DOPAMINE; ANOXIA	Adenosine triphosphate (ATP)-sensitive potassium (K-ATP) channels are activated by various metabolic stresses, including hypoxia. The substantia nigra pars reticulata (SNr), the area with the highest expression of K-ATP channels in the brain, plays a pivotal role in the control of seizures. Mutant mice lacking the Kir6.2 subunit of K-ATP channels [knockout (KO) mice] were susceptible to generalized seizures after brief hypoxia. In normal mice, SNr neuron activity was inactivated during hypoxia by the opening of the postsynaptic K-ATP channels, whereas in KO mice, the activity of these neurons was enhanced. K-ATP channels exert a depressant effect on SNr neuronal activity during hypoxia and may be involved in the nigral protection mechanism against generalized seizures.	Akita Univ, Sch Med, Dept Physiol, Akita 0108543, Japan; Akita Univ, Sch Med, Dept Psychiat, Akita 0108543, Japan; Japan Sci & Technol Corp, CREST, Akita 0108543, Japan; Chiba Univ, Grad Sch Med, Dept Cellular & Mol Biol, Chuo Ku, Chiba 2608670, Japan	Akita University; Akita University; Japan Science & Technology Agency (JST); Chiba University	Inagaki, N (corresponding author), Akita Univ, Sch Med, Dept Physiol, 1-1-1 Hondo, Akita 0108543, Japan.	inagaki@med.akita-u.ac.jp	MIKI, Takashi/ABD-3995-2020	MIKI, Takashi/0000-0001-5741-1626; Inagaki, Nobuya/0000-0001-8261-2593; Yuan, Hongjie/0000-0002-8127-7145				AMOROSO S, 1990, SCIENCE, V247, P852, DOI 10.1126/science.2305257; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; CHUN J, 1991, BRAIN RES, V568, P159, DOI 10.1016/0006-8993(91)91392-E; DEPAULIS A, 1994, PROG NEUROBIOL, V42, P33, DOI 10.1016/0301-0082(94)90020-5; DESARRO G, 1984, EUR J PHARMACOL, V106, P175, DOI 10.1016/0014-2999(84)90692-7; Dugan Laura L., 1999, P711; FISCH BJ, 1999, FISCH SPEHLMANS EEG, P301; HANSEN AJ, 1982, ACTA PHYSIOL SCAND, V115, P301, DOI 10.1111/j.1748-1716.1982.tb07082.x; HICKS GA, 1994, NEUROSCIENCE, V61, P285, DOI 10.1016/0306-4522(94)90231-3; IADAROLA MJ, 1982, SCIENCE, V218, P1237, DOI 10.1126/science.7146907; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Lamensdorf I, 1999, BRAIN RES, V818, P275, DOI 10.1016/S0006-8993(98)01290-6; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; MOURRE C, 1989, BRAIN RES, V486, P159, DOI 10.1016/0006-8993(89)91288-2; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; OERTEL WH, 1982, BRAIN RES BULL, V9, P463, DOI 10.1016/0361-9230(82)90155-1; Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6; SCHWANSTECHER C, 1993, N-S ARCH PHARMACOL, V348, P113, DOI 10.1007/BF00168546; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Stanford IM, 1996, NEUROSCIENCE, V74, P499, DOI 10.1016/0306-4522(96)00151-0; TURSKI L, 1990, BRAIN RES, V520, P232, DOI 10.1016/0006-8993(90)91710-X; Wu CW, 1996, NEUROREPORT, V7, P2513, DOI 10.1097/00001756-199611040-00022; Yamada K., UNPUB	24	273	285	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1543	1546		10.1126/science.1059829	http://dx.doi.org/10.1126/science.1059829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375491				2022-12-28	WOS:000168963800044
J	Polacek, N; Gaynor, M; Yassin, A; Mankin, AS				Polacek, N; Gaynor, M; Yassin, A; Mankin, AS			Ribosomal peptidyl transferase can withstand mutations at the putative catalytic nucleotide	NATURE			English	Article							TRANSFER-RNA; DOMAIN-V; A-SITES; P-SITES; POSITIONS; BASE; RECONSTITUTION; RESISTANCE	Peptide bond formation is the principal reaction of protein synthesis. It takes place in the peptidyl transferase centre of the large (50S) ribosomal subunit. In the course of the reaction, the polypeptide is transferred from peptidyl transfer RNA to the alpha -amino group of amino acyl-tRNA. The crystallographic structure of the 50S subunit showed no proteins within 18 Angstrom E from the active site, revealing peptidyl transferase as an RNA enzyme(1). Reported unique structural and biochemical features of the universally conserved adenine residue A2451 in 23S ribosomal RNA (Escherichia coli numbering) led to the proposal of a mechanism of rRNA catalysis that implicates this nucleotide as the principal catalytic residue(2,3). In vitro genetics allowed us to test the importance of A2451 for the overall rate of peptide bond formation. Here we report that large ribosomal subunits with mutated A2451 showed significant peptidyl transferase activity in several independent assays. Mutations at another nucleotide, G2447, which is essential to render catalytic properties to A2451 (refs 2, 3), also did not dramatically change the transpeptidation activity. As alterations of the putative catalytic residues do not severely affect the rate of peptidyl transfer the ribosome apparently promotes transpeptidation not through chemical catalysis, but by properly positioning the substrates of protein synthesis.	Univ Illinois, Ctr Pharmaceut Biotechnol MC 870, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mankin, AS (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol MC 870, 900 S Ashland Ave, Chicago, IL 60607 USA.		Polacek, Norbert/AAV-7346-2020; Yassin, Aymen/N-8490-2016	Polacek, Norbert/0000-0001-5317-3990; Yassin, Aymen/0000-0002-4423-164X				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barta A., 2001, SCIENCE, V291, p203a, DOI [10.1126/science.291.5502.203a, DOI 10.1126/SCIENCE.291.5502.203A]; Blaha G, 2000, METHOD ENZYMOL, V317, P292; Bocchetta M, 1998, P NATL ACAD SCI USA, V95, P3525, DOI 10.1073/pnas.95.7.3525; CRICK FHC, 1976, ORIGINS LIFE EVOL B, V7, P389, DOI 10.1007/BF00927934; Green J, 1996, AEROSPACE, V23, P2; Green R, 1997, J MOL BIOL, V266, P40, DOI 10.1006/jmbi.1996.0780; Green R, 1999, BIOCHEMISTRY-US, V38, P1772, DOI 10.1021/bi982246a; HART HE, 1979, MOL IMMUNOL, V16, P265, DOI 10.1016/0161-5890(79)90065-8; KEARSEY SE, 1981, NATURE, V290, P607, DOI 10.1038/290607a0; Khaitovich P, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P229; Khaitovich P, 1999, BIOCHEMISTRY-US, V38, P1780, DOI 10.1021/bi9822473; Khaitovich P, 1999, RNA, V5, P605, DOI 10.1017/S1355838299990295; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Krayevsky A A, 1979, Prog Nucleic Acid Res Mol Biol, V23, P1; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MONRO RE, 1967, J MOL BIOL, V25, P347, DOI 10.1016/0022-2836(67)90146-5; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nierhaus K., 1990, RIBOSOMES PROTEIN SY, P161; NIERHAUS KH, 1980, BIOCHEM INT, V1, P185; OCONNOR M, 1993, P NATL ACAD SCI USA, V90, P9214, DOI 10.1073/pnas.90.19.9214; PORSE BT, 1995, J MOL BIOL, V249, P1, DOI 10.1006/jmbi.1995.0276; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; STEINER G, 1988, EMBO J, V7, P3949, DOI 10.1002/j.1460-2075.1988.tb03281.x; SWANEY SM, 1998, 38 INT C ANT AG CHEM, pC104; Xiong LQ, 2000, J BACTERIOL, V182, P5325, DOI 10.1128/JB.182.19.5325-5331.2000; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375	30	154	165	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					498	501		10.1038/35078113	http://dx.doi.org/10.1038/35078113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373685				2022-12-28	WOS:000168858700054
J	Kim, M; Bertram, M; Pollmann, M; von Oertzen, A; Mikhailov, AS; Rotermund, HH; Ertl, G				Kim, M; Bertram, M; Pollmann, M; von Oertzen, A; Mikhailov, AS; Rotermund, HH; Ertl, G			Controlling chemical turbulence by global delayed feedback: Pattern formation in catalytic CO oxidation on Pt(110)	SCIENCE			English	Article							GINZBURG-LANDAU EQUATION; OPTICAL FEEDBACK; SURFACE-REACTION; STABILIZATION; SYSTEM; SPIRALS; WAVES; CHAOS	Control of spatiotemporal chaos is one of the central problems of nonlinear dynamics. We report on suppression of chemical turbulence by global delayed feedback using, as an example, catalytic carbon monoxide oxidation on a platinum (110) single-crystal surface and carbon monoxide partial pressure as the controlled feedback variable. When feedback intensity was increased, spiral-wave turbulence was transformed into new intermittent chaotic regimes with cascades of reproducing and annihilating local structures on the background of uniform oscillations. The global feedback further led to the development of cluster patterns and standing waves and to the stabilization of uniform oscillations. These findings are reproduced by theoretical simulations.	Max Planck Gesell, Fritz Haber Inst, Phys Chem Abt, D-14195 Berlin, Germany	Max Planck Society; Fritz Haber Institute of the Max Planck Society	Rotermund, HH (corresponding author), Max Planck Gesell, Fritz Haber Inst, Phys Chem Abt, Faradayweg 4-6, D-14195 Berlin, Germany.	rotermun@fhi-berlin.mpg.de						Argentina M, 1997, PHYS REV E, V56, pR2359, DOI 10.1103/PhysRevE.56.R2359; Battogtokh D, 1997, PHYSICA D, V106, P327, DOI 10.1016/S0167-2789(97)00046-8; Battogtokh D, 1996, PHYSICA D, V90, P84, DOI 10.1016/0167-2789(95)00232-4; Bleich ME, 1997, PHYS REV E, V55, P2119, DOI 10.1103/PhysRevE.55.2119; Fanceschini G, 1999, PHYS REV E, V60, P5426, DOI 10.1103/PhysRevE.60.5426; IMBIHL R, 1995, CHEM REV, V95, P697, DOI 10.1021/cr00035a012; JAKUBITH S, 1990, PHYS REV LETT, V65, P3013, DOI 10.1103/PhysRevLett.65.3013; Kim M.J., UNPUB; KRISCHER K, 1992, J CHEM PHYS, V96, P9161, DOI 10.1063/1.462226; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Lin AL, 2000, PHYS REV LETT, V84, P4240, DOI 10.1103/PhysRevLett.84.4240; MartinRegalado J, 1996, PHYS REV A, V54, P5386, DOI 10.1103/PhysRevA.54.5386; MIDDYA U, 1995, J CHEM PHYS, V102, P5029, DOI 10.1063/1.469552; Munkel M, 1997, PHYS REV E, V56, P3868, DOI 10.1103/PhysRevE.56.3868; OTT E, 1990, PHYS REV LETT, V64, P1196, DOI 10.1103/PhysRevLett.64.1196; Ouyang Q, 1996, NATURE, V379, P143, DOI 10.1038/379143a0; Pierre T, 1996, PHYS REV LETT, V76, P2290, DOI 10.1103/PhysRevLett.76.2290; POMEAU Y, 1986, PHYSICA D, V23, P3, DOI 10.1016/0167-2789(86)90104-1; PYRAGAS K, 1992, PHYS LETT A, V170, P421, DOI 10.1016/0375-9601(92)90745-8; Rose KC, 1996, PHYS REV LETT, V76, P3582, DOI 10.1103/PhysRevLett.76.3582; Rotermund HH, 1997, SURF SCI REP, V29, P267; ROTERMUND HH, 1990, NATURE, V343, P355, DOI 10.1038/343355a0; SINGH MC, 1988, SYSTEMS CONTROL ENCY; Sontag E.D., 1998, MATH CONTROL THEORY; Vanag VK, 2000, NATURE, V406, P389, DOI 10.1038/35019038; VESER G, 1993, PHYS REV LETT, V71, P935, DOI 10.1103/PhysRevLett.71.935; von Oertzen A, 2000, J PHYS CHEM B, V104, P3155, DOI 10.1021/jp9927799; von Oertzen A, 1998, J PHYS CHEM B, V102, P4966, DOI 10.1021/jp981285t; ZIMMERMANN EC, 1984, J CHEM PHYS, V81, P1327, DOI 10.1063/1.447764	29	316	323	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1357	1360		10.1126/science.1059478	http://dx.doi.org/10.1126/science.1059478			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359007				2022-12-28	WOS:000168862900040
J	Plaster, NM; Tawil, R; Tristani-Firouzi, M; Canun, S; Bendahhou, S; Tsunoda, A; Donaldson, MR; Iannaccone, ST; Brunt, E; Barohn, R; Clark, J; Deymeer, F; George, AL; Fish, FA; Hahn, A; Nitu, A; Ozdemir, C; Serdaroglu, P; Subramony, SH; Wolfe, G; Fu, YH; Ptacek, LJ				Plaster, NM; Tawil, R; Tristani-Firouzi, M; Canun, S; Bendahhou, S; Tsunoda, A; Donaldson, MR; Iannaccone, ST; Brunt, E; Barohn, R; Clark, J; Deymeer, F; George, AL; Fish, FA; Hahn, A; Nitu, A; Ozdemir, C; Serdaroglu, P; Subramony, SH; Wolfe, G; Fu, YH; Ptacek, LJ			Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome	CELL			English	Article							HYPOKALEMIC PERIODIC PARALYSIS; RECTIFIER POTASSIUM CHANNEL; LONG QT SYNDROME; FUNCTIONAL EXPRESSION; K+ CHANNEL; CARDIAC-ARRHYTHMIA; MOLECULAR-CLONING; GENE; INACTIVATION; SUBUNITS	Andersen's syndrome is characterized by periodic paralysis, cardiac arrhythmias, and dysmorphic features. We have mapped an Andersen's locus to chromosome 17q23 (maximum LOD = 3.23 at theta = 0) near the inward rectifying potassium channel gene KCNJ2. A missense mutation in KCNJ2 (encoding D71V) was identified in the linked family. Eight additional mutations were identified in unrelated patients. Expression of two of these mutations in Xenopus oocytes revealed loss of function and a dominant negative effect in Kir2.1 current as assayed by voltage-clamp. We conclude that mutations in Kir2.1 cause Andersen's syndrome. These findings suggest that Kir2.1 plays an important role in developmental signaling in addition to its previously recognized function in controlling cell excitability in skeletal muscle and heart.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Rochester, Sch Med, Rochester, NY 14642 USA; Hosp Gen Dr Manuel Gea Gonzalez, Dept Genet, Mexico City 14000, DF, Mexico; Texas Scottish Rite Hosp Children, Dept Neurol, Dallas, TX 75219 USA; Univ Groningen, Univ Med Ctr Groningen, Acad Ziekenhuis Groningen, Neurol Klin, NL-9700 RB Groningen, Netherlands; Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA; Childrens Hosp, Med Ctr, Akron, OH 44308 USA; Istanbul Univ, Tip Fak, Noroloji Anabilim, TR-34390 Istanbul, Turkey; Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; London Hlth Sci Ctr, Dept Clin & Neurol Sci, London, ON N6A 4GA, Canada; Indiana Univ, Med Ctr, Dept Neurol, Indianapolis, IN 46202 USA; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Rochester; Texas Scottish Rite Hospital for Children; University of Groningen; University of Kansas; University of Kansas Medical Center; Akron Children's Hospital; Istanbul University; Vanderbilt University; London Health Sciences Centre; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ptacek, LJ (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	ptacek@genetics.utah.edu	Wolfe, Gil/AAO-2786-2020	, Piraye/0000-0001-8202-5313	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038616] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NINDS NIH HHS [NS38616] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Canun S, 1999, AM J MED GENET, V85, P147, DOI 10.1002/(SICI)1096-8628(19990716)85:2<147::AID-AJMG9>3.0.CO;2-0; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Derst C, 1997, BIOCHEM BIOPH RES CO, V230, P641, DOI 10.1006/bbrc.1996.6024; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; Fouad G, 1997, NEUROMUSCULAR DISORD, V7, P33, DOI 10.1016/S0960-8966(96)00401-4; HOROWICZ P, 1994, MYOLOGY BASIC CLIN, P405; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; JEN J, 2001, METABOLIC MOL BASES, P5223; Jurkat-Rott K, 2000, P NATL ACAD SCI USA, V97, P9549, DOI 10.1073/pnas.97.17.9549; KANNEL WB, 1987, AM HEART J, V113, P799, DOI 10.1016/0002-8703(87)90722-8; Karschin C, 1997, MOL CELL NEUROSCI, V10, P131, DOI 10.1006/mcne.1997.0655; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MARTIN AB, 1995, AM J CARDIOL, V75, P950, DOI 10.1016/S0002-9149(99)80697-3; MCMANIS PG, 1986, MUSCLE NERVE, V9, P704, DOI 10.1002/mus.880090805; MORISHIGE KI, 1994, FEBS LETT, V346, P251, DOI 10.1016/0014-5793(94)00483-8; Nakamura TY, 1998, AM J PHYSIOL-HEART C, V274, pH892, DOI 10.1152/ajpheart.1998.274.3.H892; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1994, CELL, V77, P863; RAABGRAHAM KF, 1994, NEUROREPORT, V5, P2501, DOI 10.1097/00001756-199412000-00024; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; Ruff RL, 2000, P NATL ACAD SCI USA, V97, P9832, DOI 10.1073/pnas.170293197; Ruff RL, 1999, NEUROLOGY, V53, P1556, DOI 10.1212/WNL.53.7.1556; Ruff RL, 2000, NEUROLOGY, V54, P2191, DOI 10.1212/WNL.54.11.2191; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 2000, CARDIAC ELECTROPHYSI, P79; Sansone V, 1997, ANN NEUROL, V42, P305, DOI 10.1002/ana.410420306; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; TAWIL R, 1994, ANN NEUROL, V35, P326, DOI 10.1002/ana.410350313; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Topert C, 1998, J NEUROSCI, V18, P4096; Tricarico D, 1999, J CLIN INVEST, V103, P675, DOI 10.1172/JCI4552; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; Tucker SJ, 1999, J BIOL CHEM, V274, P33393, DOI 10.1074/jbc.274.47.33393; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WIBLE BA, 1995, CIRC RES, V76, P343, DOI 10.1161/01.RES.76.3.343; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7; Yang J, 1995, NEURON, V15, P1441, DOI 10.1016/0896-6273(95)90021-7; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160	48	687	724	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					511	519		10.1016/S0092-8674(01)00342-7	http://dx.doi.org/10.1016/S0092-8674(01)00342-7			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371347	Bronze			2022-12-28	WOS:000168840700010
J	Sinha, MK; Lachmann, HJ; Kuriakose, B; Abdulla, AK; Aggarwal, RK				Sinha, MK; Lachmann, HJ; Kuriakose, B; Abdulla, AK; Aggarwal, RK			An unusual cause of progressive heart failure	LANCET			English	Editorial Material							TRANSPLANTATION; AMYLOIDOSIS		Basildon Hosp, Dept Cardiol, Basildon SS16 5NL, Essex, England; Basildon Hosp, Dept Histopathol, Basildon SS16 5NL, Essex, England; Thurrock Hosp, Dept Histopathol, Basildon SS16 5NL, Essex, England; Thurrock Hosp, Dept Cardiol, Basildon SS16 5NL, Essex, England; UCL Royal Free & Univ Coll Sch Med, Natl Amyloidosis Ctr, London, England	University of London; University College London	Sinha, MK (corresponding author), Basildon Hosp, Dept Cardiol, Basildon SS16 5NL, Essex, England.	msinha@sghms.ac.uk		Lachmann, Helen/0000-0001-8378-2498				Dubrey SW, 2001, HEART, V85, P202, DOI 10.1136/heart.85.2.202; HALL R, 1994, BRIT MED J, V309, P1135, DOI 10.1136/bmj.309.6962.1135; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; McCarthy RE, 1998, CLIN CARDIOL, V21, P547; Saba N, 1999, BONE MARROW TRANSPL, V24, P853, DOI 10.1038/sj.bmt.1702005	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1498	1498		10.1016/S0140-6736(00)04648-1	http://dx.doi.org/10.1016/S0140-6736(00)04648-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377603				2022-12-28	WOS:000168614300015
J	Wang, HB; Huang, ZQ; Xia, L; Feng, Q; Erdjument-Bromage, H; Strahl, BD; Briggs, SD; Allis, CD; Wong, JM; Tempst, P; Zhang, Y				Wang, HB; Huang, ZQ; Xia, L; Feng, Q; Erdjument-Bromage, H; Strahl, BD; Briggs, SD; Allis, CD; Wong, JM; Tempst, P; Zhang, Y			Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor	SCIENCE			English	Article							METHYLTRANSFERASES; CELLS; YEAST; H3	Acetylation of core histone tails plays a fundamental role in transcription regulation. In addition to acetylation, other posttranslational modifications, such as phosphorylation and methylation, occur in core histone tails. Here, we report the purification, molecular identification, and functional characterization of a histone H4-specific methyltransferase PRMT1, a protein arginine methyltransferase. PRMT1 specifically methylates arginine 3 (Arg 3) of H4 in vitro and in vivo. Methylation of Arg 3 by PRMT1 facilitates subsequent acetylation of H4 tails by p300. However, acetylation of H4 inhibits its methylation by PRMT1. Most important, a mutation in the S-adenosyl-L-methionine-binding site of PRMT1 substantially crippled its nuclear receptor coactivator activity. Our finding reveals Arg 3 of H4 as a novel methylation site by PRMT1 and indicates that Arg 3 methylation plays an important role in transcriptional regulation.	Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; University of Virginia	Zhang, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.		Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259; Tempst, Paul/0000-0002-6680-3987; Zhang, Yi/0000-0002-2789-0811; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Briggs, Scott D/0000-0003-2852-3594; Wong, Jiemin/0000-0002-5311-842X	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NIGMS NIH HHS [GM63067-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063067] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANNUNZIATO AT, 1995, BIOCHEMISTRY-US, V34, P2916, DOI 10.1021/bi00009a023; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bao J, UNPUB; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luger K, 1999, METHOD ENZYMOL, V304, P3; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	19	547	576	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					853	857		10.1126/science.1060781	http://dx.doi.org/10.1126/science.1060781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11387442				2022-12-28	WOS:000170241000042
J	O'Shea, PG; Freund, HP				O'Shea, PG; Freund, HP			Laser technology - Free-electron lasers: Status and applications	SCIENCE			English	Review							AMPLIFIED SPONTANEOUS-EMISSION; HIGH-GAIN; HARMONIC-GENERATION; STIMULATED EMISSION; MAGNETIC-FIELD; 1ST OPERATION; RADIATION; WAVELENGTH; BEAM; FEL	A free-electron laser consists of an electron beam propagating through a periodic magnetic field. Today such Lasers are used for research in materials science, chemical : technology, biophysical science, medical applications, surface studies, and solid-state physics. Free-electron Lasers with higher average power and shorter wavelengths are under development. Future applications range from industrial processing of materials to light sources for soft and hard x-rays.	Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA; Univ Maryland, Inst Plasma Res, College Pk, MD 20742 USA; Sci Applicat Int Corp, Mclean, VA 22102 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Science Applications International Corporation (SAIC)	O'Shea, PG (corresponding author), Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA.		O'Shea, Patrick G/H-6195-2011	O'Shea, Patrick/0000-0002-9140-5673				ALLEN SJ, 1995, NUCL INSTRUM METH A, V358, P536, DOI 10.1016/0168-9002(94)01597-X; Andruszkow J, 2000, PHYS REV LETT, V85, P3825, DOI 10.1103/PhysRevLett.85.3825; BATCHELOR K, 1992, NUCL INSTRUM METH A, V318, P372, DOI 10.1016/0168-9002(92)91084-M; BIEDRON SG, IN PRESS NUCL INSTRU; BONIFACIO R, 1984, OPT COMMUN, V50, P359; BRAU CA, 1992, NUCL INSTRUM METH A, V318, P38, DOI 10.1016/0168-9002(92)91020-A; Budde M, 2000, PHYS REV LETT, V85, P1452, DOI 10.1103/PhysRevLett.85.1452; CHUI HC, 1995, APPL PHYS LETT, V66, P265, DOI 10.1063/1.113512; Couprie ME, 1996, NUCL INSTRUM METH A, V375, P639, DOI 10.1016/0168-9002(96)00058-7; DEACON DAG, 1977, PHYS REV LETT, V38, P892, DOI 10.1103/PhysRevLett.38.892; DOWELL DH, 1993, APPL PHYS LETT, V63, P2035, DOI 10.1063/1.110583; EDWARDS G, 1994, NATURE, V371, P416, DOI 10.1038/371416a0; ELIAS LR, 1976, PHYS REV LETT, V36, P717, DOI 10.1103/PhysRevLett.36.717; FELDMAN DW, 1989, NUCL INSTRUM METH A, V285, P11, DOI 10.1016/0168-9002(89)90418-X; Freund HP, 2000, IEEE J QUANTUM ELECT, V36, P275, DOI 10.1109/3.825873; Freund HP, 1999, P IEEE, V87, P782, DOI 10.1109/5.757255; FREUND HP, 1996, PRINCIPLES FREE ELEC; GRANATSTEIN VL, 1977, APPL PHYS LETT, V30, P384, DOI 10.1063/1.89413; Hogan M, 1998, PHYS REV LETT, V80, P289, DOI 10.1103/PhysRevLett.80.289; Huang ZR, 2000, PHYS REV E, V62, P7295, DOI 10.1103/PhysRevE.62.7295; Joos KM, 2000, LASER SURG MED, V27, P191, DOI 10.1002/1096-9101(2000)27:3<191::AID-LSM1>3.0.CO;2-D; Kelley MJ, 1997, P SOC PHOTO-OPT INS, V2988, P240, DOI 10.1117/12.274386; KIRKPATRICK DA, 1989, PHYS FLUIDS B-PLASMA, V1, P1511, DOI 10.1063/1.858927; Korobkin D, 1998, PHYS REV LETT, V81, P1607, DOI 10.1103/PhysRevLett.81.1607; *LCLS DES GROUP, 1998, DE98059292 NTIS LCLS; MADEY JMJ, 1971, J APPL PHYS, V42, P1906, DOI 10.1063/1.1660466; MILTON S, IN PRESS SCIENCE; Milton SV, 2000, PHYS REV LETT, V85, P988, DOI 10.1103/PhysRevLett.85.988; Minehara EJ, 2000, NUCL INSTRUM METH A, V445, P183, DOI 10.1016/S0168-9002(00)00061-9; MOTZ H, 1953, J APPL PHYS, V24, P826, DOI 10.1063/1.1721389; *NAT RES COUNC, 1994, REP COMM FREE EL LAS; Neil GR, 2000, PHYS REV LETT, V84, P662, DOI 10.1103/PhysRevLett.84.662; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Nguyen DC, 1998, PHYS REV LETT, V81, P810, DOI 10.1103/PhysRevLett.81.810; ORZECHOWSKI TJ, 1985, PHYS REV LETT, V54, P889, DOI 10.1103/PhysRevLett.54.889; OSHEA PG, 1993, PHYS REV LETT, V71, P3661, DOI 10.1103/PhysRevLett.71.3661; Parker R. K., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V791, P2, DOI 10.1117/12.940789; Peremans A, 1996, NUCL INSTRUM METH A, V375, P657, DOI 10.1016/0168-9002(95)01219-2; Petrov A.K., 1997, FEL ITS APPL ASIA, P245; PHILLIPS RM, 1988, NUCL INSTRUM METH A, V272, P1, DOI 10.1016/0168-9002(88)90185-4; POOLE M, 2000, SYNCHROTRON RAD NEWS, V13, P4; Prazeres R, 1997, PHYS REV LETT, V78, P2124, DOI 10.1103/PhysRevLett.78.2124; Rossbach J, 1996, NUCL INSTRUM METH A, V375, P269, DOI 10.1016/0168-9002(95)01332-6; ROSSBACH J, COMMUNICATION; SHEFFIELD RL, 1988, AIP C P, V184, P1500; Tomimasu T., 1997, FREE ELECT LASER ITS, P65; Tremaine A, 1998, PHYS REV LETT, V81, P5816, DOI 10.1103/PhysRevLett.81.5816; WU J, IN PRESS NUCL INSTRU; Yu LH, 2000, SCIENCE, V289, P932, DOI 10.1126/science.289.5481.932	49	207	215	8	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1853	1858		10.1126/science.1055718	http://dx.doi.org/10.1126/science.1055718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397938				2022-12-28	WOS:000169200700038
J	Nelson, KE; Sirisanthana, T				Nelson, KE; Sirisanthana, T			Disseminated Penicillium marneffei infection in a patient with AIDS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Johns Hopkins Univ, Baltimore, MD 21205 USA; Chiang Mai Univ, Chiang Mai 50200, Thailand	Johns Hopkins University; Chiang Mai University	Nelson, KE (corresponding author), Johns Hopkins Univ, Baltimore, MD 21205 USA.								0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2001	344	23					1763	1763		10.1056/NEJM200106073442305	http://dx.doi.org/10.1056/NEJM200106073442305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	439TL	11396443				2022-12-28	WOS:000169133600005
J	Prager, KM				Prager, KM			The list	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2692	2692		10.1001/jama.285.21.2692	http://dx.doi.org/10.1001/jama.285.21.2692			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386908				2022-12-28	WOS:000168985800001
J	Hatakka, K; Savilahti, E; Ponka, A; Meurman, JH; Poussa, T; Nase, L; Saxelin, M; Korpela, R				Hatakka, K; Savilahti, E; Ponka, A; Meurman, JH; Poussa, T; Nase, L; Saxelin, M; Korpela, R			Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; LACTOBACILLUS-GG; RESPIRATORY-INFECTIONS; ILLNESSES; HELSINKI; HEALTH; RISK	Objective To examine whether long term consumption of a probiotic milk could reduce gastrointestinal and respiratory infections in children in day care centres. Design Randomised, double blind, placebo controlled study over seven months. Setting 18 day care centres in Helsinki, Finland. Participants 571 healthy children aged 1-6 years: 282 (mean (SD) age 4.6 (1.5) years) in the intervention group and 289 (mean (SD) age 4.4 (1.5) years) in the control group. Intervention Milk with or without Lactobacillus GG. Average daily consumption of milk in both groups was 260 ml. Main outcome measures Number of days with respiratory and gastrointestinal symptoms, absences from day care because of illness, respiratory tract infections diagnosed by a doctor, and course of antibiotics. Results Children in the Lactobacillus group had fewer days of absence from day care because of illness (4.9 (95% confidence interval 4.4 to 5.5) v 5.8 (5.3 to 6.4) days, 16% difference, P = 0.03; age adjusted 5.1 (4.6 to 5.6) v 5.7 (5.2 to 6.3) days, 11% difference, P = 0.09). There was also a relative reduction of 17% in the number of children suffering from respiratory infections with complications and lower respiratory tract infections (unadjusted absolute % reduction - 8.6 (- 17.2 to - 0.1), P = 0.05; age adjusted odds ratio 0.75 (0.52 to 1.09), P = 0.13) and a 19% relative reduction in antibiotic treatments for respiratory infection (unadjusted absolute % reduction - 9.6 (- 18.2 to - 1.0), P = 0.03; adjusted odds ratio 0.72 (0.50 to 1.03), P = 0.08) in the Lactobacillus group. Conclusions Lactobacillus GG may reduce respiratory infections and their severity among children in day care. The effects of the probiotic Lactobacillus GG were modest but consistently in the same direction.	Fdn Nutr Res, FIN-00039 Helsinki, Finland; Valio Res & Dev, FIN-00039 Helsinki, Finland; Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, FIN-00029 Helsinki, Finland; Helsinki City, Ctr Environm, FIN-00530 Helsinki, Finland; STAT Consulting, FIN-33540 Tampere, Finland; Helsinki Univ Hosp, Dept Oral & Dent Dis, FIN-00029 Helsinki, Finland; Helsinki City Hlth Dept, FIN-00030 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Korpela, R (corresponding author), Fdn Nutr Res, POB 30, FIN-00039 Helsinki, Finland.	riitta.korpela@valio.fi		Meurman, Jukka/0000-0001-6702-6836				Arvola T, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.5.e64; BELL DM, 1989, AM J PUBLIC HEALTH, V79, P479, DOI 10.2105/AJPH.79.4.479; Carabin H, 1999, PEDIATRICS, V103, P556, DOI 10.1542/peds.103.3.556; Churchill RB, 1997, INFECT DIS CLIN N AM, V11, P347, DOI 10.1016/S0891-5520(05)70360-3; COLLET JP, 1994, RESPIRATION, V61, P16; COLLET JP, 1993, PEDIATR INFECT DIS J, V12, P648, DOI 10.1097/00006454-199308000-00005; COLLINS ME, 1994, GEODERMA, V61, P1, DOI 10.1016/0016-7061(94)90008-6; Erickson KL, 2000, J NUTR, V130, p403S, DOI 10.1093/jn/130.2.403S; KAILA M, 1992, PEDIATR RES, V32, P141, DOI 10.1203/00006450-199208000-00002; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Louhiala PJ, 1997, J PEDIATR-US, V131, P476, DOI 10.1016/S0022-3476(97)80083-2; MOTTONEN M, 1992, ACTA PAEDIATR, V81, P929, DOI 10.1111/j.1651-2227.1992.tb12138.x; Nafstad P, 1999, PEDIATRICS, V103, P753, DOI 10.1542/peds.103.4.753; NURMI T, 1991, INFECTION, V19, P331, DOI 10.1007/BF01645358; Pelto L, 1998, CLIN EXP ALLERGY, V28, P1474, DOI 10.1046/j.1365-2222.1998.00449.x; PONKA A, 1991, INFECTION, V19, P230, DOI 10.1007/BF01644951; PONKA A, 1994, SUOM LAAKARILEHTI, V49, P3579; Saxelin M, 1997, FOOD REV INT, V13, P293, DOI 10.1080/87559129709541107; SLITONEN S, 1990, ANN MED, V22, P57; Tynkkynen S, 1999, APPL ENVIRON MICROB, V65, P3908; Vanderhoof JA, 1999, J PEDIATR-US, V135, P564, DOI 10.1016/S0022-3476(99)70053-3; WALD ER, 1991, J PEDIATR-US, V118, P509, DOI 10.1016/S0022-3476(05)83370-0	22	399	429	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2001	322	7298					1327	1329		10.1136/bmj.322.7298.1327	http://dx.doi.org/10.1136/bmj.322.7298.1327			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387176	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000169167900015
J	Beguin, P; Nagashima, K; Gonoi, T; Shibasaki, T; Takahashi, K; Kashima, Y; Ozaki, N; Geering, T; Iwanaga, T; Seino, S				Beguin, P; Nagashima, K; Gonoi, T; Shibasaki, T; Takahashi, K; Kashima, Y; Ozaki, N; Geering, T; Iwanaga, T; Seino, S			Regulation of Ca2+ channel expression at the cell surface by the small G-protein kir/Gem	NATURE			English	Article							RAS-LIKE GTPASE; CALCIUM CHANNELS; BETA-SUBUNIT; FUNCTIONAL-CHARACTERIZATION; N-TYPE; FACILITATION; BINDING; ROLES; ACTIVATION; SIGNAL	Voltage-dependent calcium (Ca2+) channels are involved in many specialized cellular functions(1-3), and are controlled by intracellular signals such as heterotrimeric G-proteins(4), protein kinases(5,6) and calmodulin (CaM)(7,8). However, the direct role of small G-proteins in the regulation of Ca2+ channels is unclear. We report here that the GTP-bound form of kir/Gem, identified originally as a Ras-related small G-protein that binds CaM9-11, inhibits high-voltage-activated Ca2+ channel activities by interacting directly with the beta -subunit. The reduced channel activities are due to a decrease in alpha (1)-subunit expression at the plasma membrane. The binding of Ca2+/CaM to kir/Gem is required for this inhibitory effect by promoting the cytoplasmic localization of kir/Gem. Inhibition of L-type Ca2+ channels by kir/Gem prevents Ca2+ triggered exocytosis in hormone-secreting cells. We propose that the small G-protein kir/Gem, interacting with beta -subunits, regulates Ca2+ channel expression at the cell surface.	Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chuo Ku, Chiba 2608670, Japan; Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; Chiba Univ, Pathogen Fungi & Microbial Toxicoses Res Ctr, Chuo Ku, Chiba 2608673, Japan; Chiba Univ, Grad Sch Med, Dept Mol Immunol,CREST, Chuo Ku, Chiba 2608670, Japan; Hokkaido Univ, Grad Sch Vet Med, Lab Anat, Sapporo, Hokkaido 0600818, Japan	Chiba University; University of Lausanne; Chiba University; Chiba University; Japan Science & Technology Agency (JST); Hokkaido University	Seino, S (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.		, gonoi/GRS-0648-2022; gonoi, tohru/AAC-5181-2021	, gonoi/0000-0003-3655-7911; gonoi, tohru/0000-0003-3655-7911				ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; COHEN L, 1994, P NATL ACAD SCI USA, V91, P12448, DOI 10.1073/pnas.91.26.12448; Dolphin AC, 1996, TRENDS NEUROSCI, V19, P35, DOI 10.1016/0166-2236(96)81865-0; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; IHARA Y, 1995, MOL ENDOCRINOL, V9, P121, DOI 10.1210/me.9.1.121; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Kawaki J, 1999, DIABETES, V48, P2001, DOI 10.2337/diabetes.48.10.2001; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; NIIDOME T, 1994, BIOCHEM BIOPH RES CO, V203, P1821, DOI 10.1006/bbrc.1994.2399; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; Wakamori M, 1998, J NEUROPHYSIOL, V79, P622, DOI 10.1152/jn.1998.79.2.622; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	29	223	232	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					701	706		10.1038/35079621	http://dx.doi.org/10.1038/35079621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395774				2022-12-28	WOS:000169112500048
J	Ogura, Y; Bonen, DK; Inohara, N; Nicolae, DL; Chen, FF; Ramos, R; Britton, H; Moran, T; Karaliuskas, R; Duerr, RH; Achkar, JP; Brant, SR; Bayless, TM; Kirschner, BS; Hanauer, SB; Nunez, G; Cho, JH				Ogura, Y; Bonen, DK; Inohara, N; Nicolae, DL; Chen, FF; Ramos, R; Britton, H; Moran, T; Karaliuskas, R; Duerr, RH; Achkar, JP; Brant, SR; Bayless, TM; Kirschner, BS; Hanauer, SB; Nunez, G; Cho, JH			A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUPPORTS LINKAGE; GENETIC-ANALYSIS; CHROMOSOME-16; LOCUS; IDENTIFICATION; TOMATO; IBD1	Crohn's disease is a chronic inflammatory disorder of the gastrointestinal tract, which is thought to result from the effect of environmental factors in a genetically predisposed host. A gene location in the pericentromeric region of chromosome 16, IBD1, that contributes to susceptibility to Crohn's disease has been established through multiple linkage studies(1-6), but the specific gene(s) has not been identified. NOD2, a gene that encodes a protein with homology to plant disease resistance gene products is located in the peak region of linkage on chromosome 16 (ref. 7). Here we show, by using the transmission disequilibium test and case-control analysis, that a frameshift mutation caused by a cytosine insertion, 3020insC, which is expected to encode a truncated NOD2 protein, is associated with Crohn's disease. Wild-type NOD2 activates nuclear factor NF-kappaB, making it responsive to bacterial lipopolysaccharides; however, this induction was deficient in mutant NOD2. These results implicate NOD2 in susceptibility to Crohn's disease, and suggest a link between an innate immune response to bacterial components and development of disease.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Chicago Hosp, Dept Med, Gastroenterol Sect, Martin Boyer Labs, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Genom Sci, Pittsburgh, PA 15260 USA; Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA; Johns Hopkins Univ, Sch Med, Dept Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, Baltimore, MD 21205 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Chicago; University of Illinois System; University of Chicago; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; Johns Hopkins University	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Duerr, Richard H/B-4188-2009; Nuñez, Gabriel/A-7160-2014	Duerr, Richard H/0000-0001-6586-3905; Nicolae, Dan/0000-0002-0918-4630; Kirschner, Barbara/0000-0003-4640-2438				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Annese V, 1999, EUR J HUM GENET, V7, P567, DOI 10.1038/sj.ejhg.5200328; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Binder V, 1998, DIGEST DIS, V16, P351, DOI 10.1159/000016891; Cavanaugh JA, 1998, ANN HUM GENET, V62, P291, DOI 10.1046/j.1469-1809.1998.6240291.x; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Dixon MS, 2000, P NATL ACAD SCI USA, V97, P8807, DOI 10.1073/pnas.97.16.8807; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Han CS, 2000, GENOME RES, V10, P714, DOI 10.1101/gr.10.5.714; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; KYLE J, 1992, GASTROENTEROLOGY, V103, P392, DOI 10.1016/0016-5085(92)90826-K; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ohmen JD, 1996, HUM MOL GENET, V5, P1679, DOI 10.1093/hmg/5.10.1679; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Spielman RS, 1996, AM J HUM GENET, V59, P983	22	3764	3914	4	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					603	606		10.1038/35079114	http://dx.doi.org/10.1038/35079114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385577				2022-12-28	WOS:000168982500056
J	Thatcher, W				Thatcher, W			Geophysics - Silent slip on the Cascadia subduction interface	SCIENCE			English	Editorial Material							EARTHQUAKE; FAULT		US Geol Survey, Menlo Park, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Thatcher, W (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Park, CA 94025 USA.							ATWATER BF, 1996, EARTHQ SPECTRA, V11, P1; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Fluck P, 1997, J GEOPHYS RES-SOL EA, V102, P20539, DOI 10.1029/97JB01642; Heki K, 1997, NATURE, V386, P595, DOI 10.1038/386595a0; Linde AT, 1996, NATURE, V383, P65, DOI 10.1038/383065a0; Ozawa S, 2001, J GEOPHYS RES-SOL EA, V106, P787, DOI 10.1029/2000JB900317; Satake K, 1996, NATURE, V379, P246, DOI 10.1038/379246a0; Segall P, 1997, J GEOPHYS RES-SOL EA, V102, P22391, DOI 10.1029/97JB01795; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; THATCHER W, 1982, NATURE, V229, P12	10	11	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1495	1496		10.1126/science.1061770	http://dx.doi.org/10.1126/science.1061770			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11379629				2022-12-28	WOS:000168963800028
J	Goldstein, JL; Brown, MS				Goldstein, JL; Brown, MS			Molecular medicine - The cholesterol quartet	SCIENCE			English	Editorial Material							DENSITY-LIPOPROTEIN RECEPTOR; DIETARY-CHOLESTEROL; LXR-ALPHA; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; BETA; GENE; LDL; SITOSTEROLEMIA; XANTHOMATOSIS		Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA.							Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BHATTACHARYYA AK, 1974, J CLIN INVEST, V53, P1033, DOI 10.1172/JCI107640; BJORKHEM I, 2001, METABOLIC MOL BASES, pCH123; Blumenthal RS, 2000, AM HEART J, V139, P577, DOI 10.1016/S0002-8703(00)90033-4; Brown JM, 1999, CANC DRUG DISC DEV, V5, P1; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; GOLDSTEIN JL, 2001, METABOLIC MOL BASES, pCH120; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; KANE JP, 2001, METABOLIC MOL BASES, pCH115; KHACHADURIAN AK, 1973, NUTR METAB, V15, P132; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; MULLER C., 1938, ACTA MED SCAND SUPPL, V89, P75; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; SPADY DK, 1993, ANNU REV NUTR, V13, P355, DOI [10.1146/annurev.nutr.13.1.355, 10.1146/annurev.nu.13.070193.002035]; Steinberg D, 1997, CIRCULATION, V95, P1062; VEGA GL, 1986, J CLIN INVEST, V78, P1410, DOI 10.1172/JCI112729; Zuliani G, 1999, ARTERIOSCL THROM VAS, V19, P802, DOI 10.1161/01.ATV.19.3.802	24	165	207	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1310	1312		10.1126/science.1061815	http://dx.doi.org/10.1126/science.1061815			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360986				2022-12-28	WOS:000168862900027
J	Lower, SK; Hochella, MF; Beveridge, TJ				Lower, SK; Hochella, MF; Beveridge, TJ			Bacterial recognition of mineral surfaces: Nanoscale interactions between Shewanella and alpha-FeOOH	SCIENCE			English	Article							CRYSTALLINE IRON(III) OXIDES; ATOMIC-FORCE MICROSCOPY; PUTREFACIENS MR-1; OUTER-MEMBRANE; MICROBIAL REDUCTION; DISSIMILATORY REDUCTION; MN(IV) REDUCTION; CYTOCHROME-C; IRON; FE(III)	Force microscopy has been used to quantitatively measure the infinitesimal forces that characterize interactions between Shewanella oneidensis (a dissimilatory metal-reducing bacterium) and goethite (alpha -FeOOH), both commonly found in Earth near-surface environments. Force measurements with subnano-newton resolution were made in real time with living cells under aerobic and anaerobic solutions as a function of the distance, in nanometers, between a cell and the mineral surface. Energy values [in attojoules (10(-18) joules)] derived from these measurements show that the affinity between S. oneidensis and goethite rapidly increases by two to five times under anaerobic conditions in which electron transfer from bacterium to mineral is expected. Specific signatures in the force curves suggest that a 150-kilodalton putative iron reductase is mobilized within the outer membrane of S. oneidensis and specifically interacts with the goethite surface to facilitate the electron transfer process.	Virginia Polytech Inst & State Univ, Dept Geol Sci, Nanogeosci & Technol Lab, Blacksburg, VA 24061 USA; Univ Guelph, Coll Biol Sci, Dept Microbiol, Guelph, ON N1G 2W1, Canada	Virginia Polytechnic Institute & State University; University of Guelph	Lower, SK (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.		Lower, Steven/A-2440-2008	Lower, Steven/0000-0001-9796-0830				ARNOLD RG, 1990, APPL ENVIRON MICROB, V56, P2811, DOI 10.1128/AEM.56.9.2811-2817.1990; ARNOLD RG, 1988, BIOTECHNOL BIOENG, V32, P1081, DOI 10.1002/bit.260320902; Beliaev AS, 1998, J BACTERIOL, V180, P6292; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; BROWN S, 1992, P NATL ACAD SCI USA, V89, P8651, DOI 10.1073/pnas.89.18.8651; Caccavo F, 1997, APPL ENVIRON MICROB, V63, P3837, DOI 10.1128/AEM.63.10.3837-3843.1997; CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209; DCOSTA NP, 1995, REV SCI INSTRUM, V66, P5096, DOI 10.1063/1.1146135; DICHRISTINA TJ, 1994, J BACTERIOL, V176, P1468, DOI 10.1128/jb.176.5.1468-1474.1994; DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024; Flory P. J., 1989, STAT MECH CHAIN MOL, P401; Fredrickson JK, 1998, GEOCHIM COSMOCHIM AC, V62, P3239, DOI 10.1016/S0016-7037(98)00243-9; KARLSSON JJ, 1996, PROTEIN FOLDS DISTAN, P56; KORENEVSKY A, UNPUB; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; LOVLEY DR, 1986, APPL ENVIRON MICROB, V52, P751, DOI 10.1128/AEM.52.4.751-757.1986; Lower SK, 2000, GEOCHIM COSMOCHIM AC, V64, P3133, DOI 10.1016/S0016-7037(00)00430-0; Lower SK, 2001, GEOMICROBIOL J, V18, P63, DOI 10.1080/01490450151079798; Mueller H, 1999, BIOPHYS J, V76, P1072, DOI 10.1016/S0006-3495(99)77272-3; Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170; MYERS CR, 1992, J BACTERIOL, V174, P3429, DOI 10.1128/JB.174.11.3429-3438.1992; Myers CR, 1997, BBA-BIOMEMBRANES, V1326, P307, DOI 10.1016/S0005-2736(97)00034-5; MYERS CR, 1993, FEMS MICROBIOL LETT, V108, P15; Myers CR, 1997, J BACTERIOL, V179, P1143, DOI 10.1128/jb.179.4.1143-1152.1997; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; Myers JM, 1998, BBA-BIOMEMBRANES, V1373, P237, DOI 10.1016/S0005-2736(98)00111-4; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; OHMURA N, 1993, APPL ENVIRON MICROB, V59, P4044, DOI 10.1128/AEM.59.12.4044-4050.1993; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Roden EE, 1996, ENVIRON SCI TECHNOL, V30, P1618, DOI 10.1021/es9506216; Sokolov I, 2001, ENVIRON SCI TECHNOL, V35, P341, DOI 10.1021/es001258s; STUMM W, 1996, AQUAT CHEM, P534; Urrutia MM, 1999, ENVIRON SCI TECHNOL, V33, P4022, DOI 10.1021/es990447b; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Zachara JM, 1998, AM MINERAL, V83, P1426, DOI 10.2138/am-1998-11-1232	40	344	363	4	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1360	1363		10.1126/science.1059567	http://dx.doi.org/10.1126/science.1059567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359008				2022-12-28	WOS:000168862900041
J	Mumma, MJ; Dello Russo, N; DiSanti, MA; Magee-Sauer, K; Novak, RE; Brittain, S; Rettig, T; McLean, IS; Reuter, DC; Xu, LH				Mumma, MJ; Dello Russo, N; DiSanti, MA; Magee-Sauer, K; Novak, RE; Brittain, S; Rettig, T; McLean, IS; Reuter, DC; Xu, LH			Organic composition of C/1999 S4 (LINEAR): A comet formed near Jupiter?	SCIENCE			English	Article							O1 HALE-BOPP; B2 HYAKUTAKE; CARBON-MONOXIDE; WATER; EMISSION; PHOTODISSOCIATION; SPECTROSCOPY; CONSTRAINTS; ENRICHMENT; PHOTOMETRY	In the current paradigm, Oort cloud comets formed in the giant planets' region of the solar nebula, where temperatures and other conditions varied greatly. The measured compositions of four such comets (Halley, Hyakutake, Hale-Bopp, and Lee) are consistent with formation from interstellar ices in the cold nebular region beyond Uranus. The composition of comet C/1999 S4 (LINEAR) differs greatly, which suggests that its ices condensed from processed nebular gas, probably in the Jupiter-Saturn region. Its unusual organic composition may require reevaluation of the prebiotic organic material delivered to the young Earth by comets.	NASA, Goddard Space Flight Ctr, Extraterr Phys Lab, Greenbelt, MD 20771 USA; Catholic Univ Amer, Dept Phys, Washington, DC 20064 USA; RowanUniv, Dept Chem & Phys, Glassboro, NJ 08028 USA; Iona Coll, Dept Phys, New Rochelle, NY 10801 USA; Univ Notre Dame, Dept Phys & Astron, Notre Dame, IN 46556 USA; Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; Univ New Brunswick, Dept Phys Sci, St John, NB E2L 4L5, Canada	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Catholic University of America; Iona College; University of Notre Dame; University of California System; University of California Los Angeles; University of New Brunswick	Mumma, MJ (corresponding author), NASA, Goddard Space Flight Ctr, Extraterr Phys Lab, Code 690, Greenbelt, MD 20771 USA.	mmumma@kuiper.gsfc.nasa.gov	Xu, Li-Hong/J-5095-2015; Brittain, Sean D/K-9001-2012; mumma, michael j/I-2764-2013; Russo, Neil Dello/G-2727-2015; Magee-Sauer, Karen/K-6061-2015	Brittain, Sean D/0000-0001-5638-1330; mumma, michael j/0000-0003-4627-750X; Russo, Neil Dello/0000-0002-8379-7304; Magee-Sauer, Karen/0000-0002-4979-9875				AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; ANDRESEN P, 1984, J CHEM PHYS, V80, P2548, DOI 10.1063/1.447049; Biver N, 1999, ASTRON J, V118, P1850, DOI 10.1086/301033; Bockelee-Morvan D, 2001, SCIENCE, V292, P1339, DOI 10.1126/science.1058512; Bockelee-Morvan D., 2000, B AM ASTRON SOC, V32, P1081; BOCKELEEMORVAN D, 1995, ICARUS, V116, P18, DOI 10.1006/icar.1995.1111; BOCKELEEMORVAN D, 1994, PLANET SPACE SCI, V42, P655, DOI 10.1016/0032-0633(94)90043-4; Brooke TY, 1996, NATURE, V383, P606, DOI 10.1038/383606a0; BROOKE TY, 1991, ASTROPHYS J, V372, pL113, DOI 10.1086/186036; BUDZIEN SA, 1991, ICARUS, V90, P308, DOI 10.1016/0019-1035(91)90109-7; CARRINGTON T, 1964, J CHEM PHYS, V41, P2012, DOI 10.1063/1.1726197; CHARNLEY SB, 1992, APJ, V399, P71; CROVISIER J, 1989, ASTRON ASTROPHYS, V213, P459; Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904; Crovisier J, 1997, EARTH MOON PLANETS, V79, P125, DOI 10.1023/A:1006281115934; Dello Russo N, 1998, ICARUS, V135, P377, DOI 10.1006/icar.1998.5990; Dello Russo N, 2000, ICARUS, V143, P324, DOI 10.1006/icar.1999.6268; DELLORUSSO N, UNPUB; Delsemme AH, 2000, ICARUS, V146, P313, DOI 10.1006/icar.2000.6404; Delsemme AH, 1999, PLANET SPACE SCI, V47, P125, DOI 10.1016/S0032-0633(98)00093-2; Despois D, 1997, EARTH MOON PLANETS, V79, P103, DOI 10.1023/A:1006229131864; DiSanti MA, 1999, NATURE, V399, P662, DOI 10.1038/21378; DISANTI MA, 2000, B AM ASTRON SOC, V32, P1071; DONES L, 2000, B AM ASTRON SOC, V32, P1060; Drouart A, 1999, ICARUS, V140, P129, DOI 10.1006/icar.1999.6137; EBERHARDT P, 1994, ASTRON ASTROPHYS, V288, P315; Eberhardt P, 1999, SPACE SCI REV, V90, P45, DOI 10.1023/A:1005221309219; Farnham TL, 2001, SCIENCE, V292, P1348, DOI 10.1126/science.1058886; GREENE TP, 1993, P SOC PHOTO-OPT INS, V1946, P311; Hatchell J, 1998, ASTRON ASTROPHYS, V338, P713; HUNT RH, 1991, J MOL SPECTROSC, V149, P252, DOI 10.1016/0022-2852(91)90157-6; Irvine W. M., 2000, Protostars and planets 4, P1159; Krasnopolsky VA, 1997, SCIENCE, V277, P1488, DOI 10.1126/science.277.5331.1488; Krasnopolsky VA, 2001, ASTROPHYS J, V549, P629, DOI 10.1086/319064; LANG KR, 1980, ASTROPHYSICAL FORMUL, P162; LI H, 1997, J MOL SPECTROSC, V185, P158; Magee-Sauer K, 1999, ICARUS, V142, P498, DOI 10.1006/icar.1999.6215; MARSDEN B, COMMUNICATION; McLean IS, 1998, P SOC PHOTO-OPT INS, V3354, P566, DOI 10.1117/12.317283; Meier R, 1999, SPACE SCI REV, V90, P33, DOI 10.1023/A:1005269208310; Mousis O, 2000, ICARUS, V148, P513, DOI 10.1006/icar.2000.6499; Mumma M. J., 1997, Astronomical Society of the Pacific Conference Series, V122, P369; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; Mumma MJ, 2001, ASTROPHYS J, V546, P1183, DOI 10.1086/318314; Mumma MJ, 1996, NATURE, V383, P581, DOI 10.1038/383581a0; Mumma MJ, 2000, ASTROPHYS J, V531, pL155, DOI 10.1086/312530; Mumma MJ, 1996, SCIENCE, V272, P1310, DOI 10.1126/science.272.5266.1310; MUMMA MJ, 1989, INFRARED PHYS, V29, P167, DOI 10.1016/0020-0891(89)90043-2; MUMMA MJ, 1987, ASTRON ASTROPHYS, V187, P419; Notesco G, 1996, ICARUS, V122, P118, DOI 10.1006/icar.1996.0113; Notesco G, 1997, ICARUS, V125, P471, DOI 10.1006/icar.1996.5648; Nuth JA, 2000, NATURE, V406, P275, DOI 10.1038/35018516; REUTER DC, 1992, ASTROPHYS J, V386, P330, DOI 10.1086/171019; Stern SA, 2000, ASTROPHYS J, V544, pL169, DOI 10.1086/317312; Stokes GH, 2000, ICARUS, V148, P21, DOI 10.1006/icar.2000.6493; Teemu J, 2001, SCIENCE, V292, P1326, DOI 10.1126/science.1060858; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606; XIE XF, 1992, ASTROPHYS J, V386, P720, DOI 10.1086/171053; YAMASHITA I, 1975, J PHYS SOC JPN, V39, P205, DOI 10.1143/JPSJ.39.205	61	129	129	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1334	1339		10.1126/science.1058929	http://dx.doi.org/10.1126/science.1058929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359002				2022-12-28	WOS:000168862900035
J	Wang, YM; Zhang, WG; Jin, Y; Johansen, J; Johansen, KM				Wang, YM; Zhang, WG; Jin, Y; Johansen, J; Johansen, KM			The JIL-1 tandem kinase mediates histone H3 phosphorylation and is required for maintenance of chromatin structure in Drosophila	CELL			English	Article							MITOTIC CHROMOSOME CONDENSATION; DOSAGE COMPENSATION; X-CHROMOSOMES; GENE; ACETYLATION; MELANOGASTER; NUCLEOSOMES; ACTIVATION; SERINE-10; MITOSIS	To analyze the function of the chromosomal kinase JIL-1, we generated an allelic series of hypomorphic and null mutations. JIL-1 is an essential kinase for viability, and reduced levels of JIL-1 kinase activity lead to a global change in chromatin structure. in JIL-1 hypomorphs, euchromatic regions of polytene chromosomes are severely reduced and the chromosome arms condensed. This is correlated with decreased levels of histone H3 Ser10 phosphorylation. These levels can be restored by a JIL-1 transgene placing JIL-1 directly in the pathway mediating histone H3 phosphorylation. We propose a model where JIL-1 kinase activity is required for maintaining the structure of the more open chromatin regions that facilitate gene transcription.	Iowa State Univ, Dept Zool & Genet, Ames, IA 50011 USA	Iowa State University	Johansen, KM (corresponding author), Iowa State Univ, Dept Zool & Genet, 3154 Mol Biol Bldg, Ames, IA 50011 USA.			Zhang, Weiguo/0000-0002-3045-0569; Wang, Yanming/0000-0002-0710-043X	NIGMS NIH HHS [GM62916] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062916] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; BAKER BS, 1994, ANNU REV GENET, V28, P491, DOI 10.1146/annurev.ge.28.120194.002423; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; De Souza CPC, 2000, CELL, V102, P293, DOI 10.1016/S0092-8674(00)00035-0; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Johansen KM, 1996, J CELL BIOCHEM, V63, P268, DOI 10.1002/(SICI)1097-4644(19961201)63:3<268::AID-JCB2>3.3.CO;2-H; Kaszas E, 2000, J CELL SCI, V113, P3217; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KELLEY RL, 1995, SCIENCE, V270, P1607, DOI 10.1126/science.270.5242.1607; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; MITCHISON TJ, 1983, DEV BIOL, V99, P261, DOI 10.1016/0012-1606(83)90275-0; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Pimpinelli S., 2000, DROSOPHILA PROTOCOLS, P3; Preston CR, 1996, GENETICS, V144, P1611; Roberts D. B, 1986, DROSOPHILA PRACTICAL; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1998, DEVELOPMENT, V125, P1049; RYKOWSKI MC, 1988, CELL, V54, P461, DOI 10.1016/0092-8674(88)90067-0; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x; ZINK B, 1989, NATURE, V337, P468, DOI 10.1038/337468a0	39	166	173	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					433	443		10.1016/S0092-8674(01)00325-7	http://dx.doi.org/10.1016/S0092-8674(01)00325-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371341	Bronze			2022-12-28	WOS:000168840700004
J	Salama, P; Spiegel, P; Brennan, R				Salama, P; Spiegel, P; Brennan, R			No less vulnerable: the internally displaced in humanitarian emergencies	LANCET			English	Article							WAR; HEALTH; KOSOVO		Ctr Dis Control & Prevent, Epidem Intelligence Serv, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; Int Rescue Comm, Hlth Unit, New York, NY USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Salama, P (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Natl Ctr Environm Hlth, Mail Stop F48, Atlanta, GA 30341 USA.		Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; DENG F, 1999, GUIDING PRINCIPLES I, P1; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; TOOLE MJ, 1993, JAMA-J AM MED ASSOC, V270, P600, DOI 10.1001/jama.270.5.600	4	28	28	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1430	1431		10.1016/S0140-6736(00)04570-0	http://dx.doi.org/10.1016/S0140-6736(00)04570-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356464				2022-12-28	WOS:000168478200036
